Federal Register proposed rules — 1995-12-21

issue-1995-12-21Federal Register proposed rules — 1995-12-21Proposed Regulation

Published Federal Register documents, not public-inspection drafts. The GPO XML/text rendition is a research aid; the linked complete official PDF retains the printed layout and all graphics. Graphics are retained in that PDF and are not independently reproduced in this text rendition. Publication does not establish that every provision remains legally in force.

FR Doc. 95-81050 Oklahoma Abandoned Mine Land Reclamation Plan
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Pages 66244-66246]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-81050]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF THE INTERIOR

Office of Surface Mining Reclamation and Enforcement

30 CFR Part 936

[SPATS No. OK-015-FOR]

Oklahoma Abandoned Mine Land Reclamation Plan

agency: Office of Surface Mining Reclamation and Enforcement (OSM), 
Interior.

action: Proposed rule; public comment period and opportunity for public 
hearing.

-----------------------------------------------------------------------

summary: OSM is announcing receipt of a proposed amendment to the 
Oklahoma abandoned mine land reclamation plan (hereinafter referred to 
as the ``Oklahoma plan'') under the Surface Mining Control and 
Reclamation Act of 1977 (SMCRA). The proposed amendment pertains to 
abandoned mine land reclamation (AMLR) goals and objectives, project 
ranking and selection, coordination between reclamation agencies, 
reclamation on private land, eligible lands and waters, public 
participation, agency administrative and management structure, 
reclamation set-aside trust funds, contractor eligibility requirements, 
and acid mine drainage projects. The amendment is intended to bring the 
Oklahoma AMLR Program into compliance with Federal AMLR regulations. It 
will allow the Oklahoma Conservation Commission to participate in AMLR 
activities authorized by the Omnibus Budget Reconciliation Act of 1990 
and the Energy Policy Act of 1992.

dates: Written comments must be received by 4:00 p.m., c.s.t., January 
22, 1996. If requested, a public hearing on the proposed amendment will 
be held on January 16, 1996. Requests to speak at the hearing must be 
received by 4:00 p.m., c.s.t., on January 5, 1996.

addresses: Written comments and requests to speak at the hearing should 
be mailed or hand delivered to Jack R. Carson, Acting Director, Tulsa 
Field Office at the address listed below.
    Copies of the Oklahoma plan, the proposed amendment, a listing of 
any scheduled public hearings, and all written comments received in 
response to this document will be available for public review at the 
addresses listed below during normal business hours, Monday through 
Friday, excluding holidays. Each requester may receive one free copy of 
the proposed amendment by contacting OSM's Tulsa Field Office.

Jack R. Carson, Acting Director, Tulsa Field Office, Office of Surface 
Mining Reclamation and Enforcement, 5100 East Skelly Drive, Suite 470, 
Tulsa, Oklahoma 74135-6547, Telephone: (918) 581-6430.
Oklahoma Conservation Commission, 2800 N. Lincoln Blvd., Suite 160, 
Oklahoma City, Oklahoma 73105-4210, Telephone: (405) 521-2384.

for further information contact: Jack R. Carson, Acting Director, Tulsa 
Field Office, Telephone: (918) 581-6430.

SUPPLEMENTARY INFORMATION:

I. Background on the Oklahoma Plan

    On January 21, 1982, the Secretary of the Interior approved the 
Oklahoma plan. Background information on the Oklahoma plan, including 
the Secretary's findings, the disposition of comments, and the approval 
of the plan can be found in the January 21, 1982, Federal Register (47 
FR 2989).

II. Description of the Proposed Amendment

    By letter dated November 13, 1995 (Administrative Record No. OAML-
63), Oklahoma submitted a proposed amendment to its AMLR plan pursuant 
to SMCRA. Oklahoma submitted the proposed amendment in response to a 
September 26, 1994, letter from OSM (Administrative Record No. OAML-
65), in accordance with 30 CFR 884.15(d), concerning revisions to the 
AML regulations at 30 CFR Chapter VII, Subchapter R (59 FR 28136, May 
31, 1994).
    Oklahoma proposes to amend its administrative rules at OAC 155:15, 
Oklahoma Abandoned Mine Land Program. Oklahoma proposes to amend its 
Reclamation Plan at sections 884.13(c)1, Goals and Objectives; 
884.13(c)2, Project Ranking and Selection; 884.13(c)3, Interagency 
Coordination; 884.13(c)5, Eligible Lands and Waters; 884.13(c)7, Public 
Participation; and 884.13(d)1, Administrative and Management Structure.

(1) OAC 155:15, Oklahoma Abandoned Mine Land Reclamation Program Rules

    Subsection 1-2, is revised to clarify definitions used later in the 
rules. Subsection 1-3, subpart (4) is added to require that contracts 
for AML projects only be awarded to successful bidders who are 
determined eligible to receive funds by using OSM's Applicant Violator 
System. Subsection 1-3 is revised to ensure that certain coal mine 
sites damaged and abandoned after August 3, 1977, are eligible for 
reclamation funding if the mining (1) took place during the interim 
program or (2) ended on or before November 5, 1990, and the surety for 
the mining company became insolvent during that period. Changes to 
Subsection 1-6 revise the objectives of reclamation project funding and 
the priority of those objectives. Objectives (4), Research and 
Demonstration, and (7), Construction of Public Facilities, are 
eliminated. The priority of order of the other objectives remains 
unchanged. Subsection 1-14 is added to allow for the construction, 
repair or enhancement of facilities related to water supplies where 
such supplies have been adversely affected by coal mining practices. 
Subsection 1-15 adds requirements for the establishment of special 
trust accounts that will provide for coal reclamation after September 
30, 1995. Once established, Oklahoma may then set aside 10% of its 
annual grant funding 

[[Page 66245]]
for this use. Subsection 1-16 authorizes Oklahoma to receive and retain 
funds for Acid Mine Drainage Programs without regard to normal time 
limitations and establishes requirements for expenditure of granted 
funds.

(2) Section 884.13(c)1 Goals and Objectives

    This section is revised to eliminate goal 4 (Research and 
Demonstration) and goal 7 (Construction of Public Facilities). The 
remaining goals and their priorities are unchanged.

(3) Section 884.13(c)(2) Project Ranking and Selection

    A new sentence is added that (1) requires public notices to be 
published during the project selection process and (2) outlines 
requirements for public meetings and public comment during the 
selection process. The ``Project Selection Matrix'' is completely 
revised and Table 3 which outlines the project selection decision 
process is changed to place the general public into the project 
screening process.

(4) Section 884.13(c)(3) Coordination of Reclamation Work Between the 
State, the Soil Conservation Service and Other Reclamation Agencies

    This section revises the description of the State Reclamation 
Committee and its role in the reclamation program.

(5) Section 884.13(c)(5) Policies and Procedures for Reclamation on 
Private Land

    The subsection ``Eligible Lands and Water'' is revised to add 
eligibility for Interim Program and certain Insolvent Surety sites.

(6) Section 884.13(c)(7) Public Participation Policies

    The public participation policies are revised to increase public 
input into the beginning of the project selection process.

(7) Section 884.13(d)(1) Administrative and Management Structure

    Figure 7, which depicts the organizational structure of the 
Oklahoma Conservation Commission, is revised to reflect the current 
organization. The list of state agencies which may be involved in the 
reclamation program is changed to reflect current program operational 
practices. Figure 8, Oklahoma Executive Branch Organizational Chart, 
has been deleted.

III. Public Comment Procedures

    In accordance with the provisions of 30 CFR 884.15(a), OSM is 
seeking comments on whether the proposed amendment satisfies the 
applicable program approval criteria of 30 CFR 884.14. If the amendment 
is deemed adequate, it will become part of the Oklahoma plan.

Written Comments

    Written comments should be specific, pertain only to the issues 
proposed in this rulemaking, and include explanations in support of the 
commenter's recommendations. Comments received after the time indicated 
under DATES or at locations other than the Tulsa Field Office will not 
necessarily be considered in the final rulemaking or included in the 
Administrative Record.

Public Hearing

    Persons wishing to speak at the public hearing should contact the 
person listed under FOR FURTHER INFORMATION CONTACT by 4:00 p.m., 
c.s.t., on January 5, 1996. The location and time of the hearing will 
be arranged with those persons requesting the hearing. If no one 
requests an opportunity to speak at the public hearing, the hearing 
will not be held.
    Filing of a written statement at the time of the hearing is 
requested as it will greatly assist the transcriber. Submission of 
written statements in advance of the hearing will allow OSM officials 
to prepare adequate responses and appropriate questions.
    The public hearing will continue on the specified date until all 
persons scheduled to speak have been heard. Persons in the audience who 
have not been scheduled to speak, and who wish to do so, will be heard 
following those who have been scheduled. The hearing will end after all 
persons scheduled to speak and persons present in the audience who wish 
to speak have been heard.
    Any disabled individual who has need for a special accommodation to 
attend a public hearing should contact the individual listed under FOR 
FURTHER INFORMATION CONTACT.

Public Meeting

    If only one person requests an opportunity to speak at a hearing, a 
public meeting, rather than a public hearing, may be held. Persons 
wishing to meet with OSM representatives to discuss the proposed 
amendment may request a meeting by contacting the person listed under 
FOR FURTHER INFORMATION CONTACT. All such meetings will be open to the 
public and, if possible, notices of meetings will be posted at the 
locations listed under ADDRESSES. A written summary of each meeting 
will be made a part of the Administrative Record.

IV. Procedural Determinations

Executive Order 12866

    This proposed rule is exempted from review by the Office of 
Management and Budget (OMB) under Executive Order 12866 (Regulatory 
Planning and Review).

Executive Order 12778

    The Department of the Interior has conducted the reviews required 
by section 2 of Executive Order 12778 (Civil Justice Reform) and has 
determined that, to the extent allowed by law, this rule meets the 
applicable standards of subsections (a) and (b) of that section. 
However, these standards are not applicable to the actual language of 
State and Tribal abandoned mine land reclamation plans and revisions 
thereof since each such plan is drafted and promulgated by a specific 
State or Tribe, not by OSM. Decisions on proposed abandoned mine land 
reclamation plans and revisions thereof submitted by a State or Tribe 
are based on a determination of whether the submittal meets the 
requirements of Title IV of SMCRA (30 U.S.C. 1231-1243) AND 30 CFR 
Parts 884 and 888.

National Environmental Policy Act

    No environmental impact statement is required for this rule since 
agency decisions on proposed State or Tribal abandoned mine land 
reclamation plans and revisions thereof are categorically excluded from 
compliance with the National Environmental Policy Act (42 U.S.C. 4332) 
by the Manual of the Department of the Interior (516 DM 6, appendix 8, 
paragraph 8.4B(29)).

Paperwork Reduction Act

    This rule does not contain information collection requirements that 
require approval by OMB under the Paperwork Reduction Act (44 U.S.C. 
3507 et seq.).

Regulatory Flexibility Act

    The Department of the Interior has determined that this rule will 
not have a significant economic impact on a substantial number of small 
entities under the Regulatory Flexibility Act (5 U.S.C. 601 et seq.). 
The submittal which is the subject of this rule is based upon 
corresponding Federal regulations for which an economic analysis was 
prepared and certification made that such regulations would not have a 
significant economic effect upon a substantial number of small 
entities. Accordingly, this rule will ensure that existing requirements 
previously 

[[Page 66246]]
promulgated by OSM will be implemented. In making the determination as 
to whether this rule would have a significant economic impact, the 
Department relied upon the data and assumptions in the analyses for the 
corresponding Federal regulations.

List of Subjects in 30 CFR Part 936

    Abandoned mine land reclamation, Intergovernmental relations, 
Surface mining, Underground mining.

    Dated: December 14, 1995.
Russell Frum,
Acting Regional Director, Mid-Continent Regional Coordinating Center.
[FR Doc. 95-81050 Filed 12-20-95; 8:45 am]
BILLING CODE 4310-05-M

Complete official Federal Register PDF

FR Doc. 95-31119 Atlantic Mackerel, Squid, and Butterfish Fisheries; 1996 Specifications
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Pages 66249-66251]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-31119]

-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE
50 CFR Part 655

[Docket No. 951211295-5295-01; I.D. 111595C]

RIN 0648-XX37

Atlantic Mackerel, Squid, and Butterfish Fisheries; 1996 
Specifications

AGENCY: National Marine Fisheries Service (NMFS), National Oceanic and 
Atmospheric Administration (NOAA), Commerce.

ACTION: Proposed 1996 initial specifications; request for comments.

-----------------------------------------------------------------------

SUMMARY: NMFS proposes initial specifications for the 1996 fishing year 
for Atlantic mackerel, squid, and butterfish (SMB). Regulations 
governing these fisheries require NMFS to publish specifications for 
the upcoming fishing year and provide an opportunity for the public to 
comment. This action is intended to promote the development of the U.S. 
SMB fisheries.

DATES: Public comments must be received on or before January 17, 1996.

ADDRESSES: Copies of the Mid-Atlantic Fishery Management Council's 
quota paper and recommendations are available from David R. Keifer, 
Executive Director, Mid-Atlantic Fishery Management Council, Room 2115, 
Federal Building, 300 South New Street, Dover, DE 19901.
    Comments should be sent to Dr. Andrew A. Rosenberg, Director, 
Northeast Region, NMFS, 1 Blackburn Drive, Gloucester, MA 01930. Please 
mark the envelope ``Comments--1996 SMB specifications.''

FOR FURTHER INFORMATION CONTACT: Myles Raizin, 508-281-9104.

SUPPLEMENTARY INFORMATION: Regulations implementing the Fishery 
Management Plan for Atlantic Mackerel, Squid, and Butterfish Fisheries 
(FMP)

[[Page 66250]]

prepared by the Mid-Atlantic Fishery Management Council (Council) 
appear at 50 CFR part 655. These regulations stipulate that NMFS 
publish a document specifying the initial annual amounts of the optimum 
yield (IOY), allowable biological catch (ABC), domestic annual harvest 
(DAH), domestic annual processing (DAP), joint venture processing 
(JVP), and total allowable levels of foreign fishing (TALFF) for the 
species managed under the FMP. No reserves are permitted under the FMP 
for any of these species. Regulations implementing Amendment 4 to the 
FMP allow the Council to recommend specifications for these fisheries 
for up to 3 consecutive years. Procedures for determining the initial 
annual amounts are found in Sec. 655.22.
    The following table contains the proposed initial specifications 
for Atlantic mackerel, Loligo and Illex squids, and butterfish for 
1996. These specifications are based on the recommendations of the 
Council.

                     Preliminary Initial Annual Specifications for SMB for the Fishing Year                     
                                   [January 1 through December 31, 1996 (mt)]                                   
----------------------------------------------------------------------------------------------------------------
                                                                       Squids                                   
                       Specifications                        --------------------------   Atlantic    Butterfish
                                                                 Loligo       Illex       Mackerel              
----------------------------------------------------------------------------------------------------------------
Max OY \1\..................................................       44,000       30,000      \2\ N/A       16,000
ABC \3\.....................................................       30,000       30,000    1,175,500        7,200
IOY.........................................................       25,000       21,000  \4\ 105,500        5,900
DAH.........................................................       25,000       21,000      105,500        5,900
DAP.........................................................       25,000       21,000       50,000        5,900
JVP.........................................................            0            0       35,000            0
TALFF.......................................................            0            0            0           0 
----------------------------------------------------------------------------------------------------------------
\1\ Max optimum yield (OY) as stated in the FMP.                                                                
\2\ Not applicable, see the FMP.                                                                                
\3\ IOY can increase to this amount.                                                                            
\4\ Contains 20,500 mt projected recreational catch based on the formula contained in the regulations (50 CFR   
  part 655).                                                                                                    

Atlantic Mackerel

    The FMP provides that ABC in U.S. waters for the upcoming fishing 
year is that quantity of mackerel that could be caught in U.S. and 
Canadian waters minus the estimated catch in Canadian waters, while 
still maintaining a spawning stock biomass (SSB) in the year following 
the year for which catch estimates and quotas are being prepared, equal 
to or greater than 600,000 mt.
    The Council recommended an ABC of 125,500 mt, derived by 
subtracting the estimated Canadian catch of 24,500 mt from the long-
term potential yield of 150,000 mt, which was estimated at the 20th 
Northeast Regional Stock Assessment Workshop (20th SAW) concluded in 
August 1995. This recommendation for ABC was based on the provisions 
for deriving that value as contained in Amendment 5 to the FMP. 
However, NMFS has determined that ABC should be calculated in 
accordance with Sec. 655.21 (b)(2)(i), while still using the most 
recent stock assessment. It would be premature to use the provisions of 
Amendment 5 to determine ABC for 1996 since the amendment is still 
undergoing Secretarial review and has not been approved or implemented. 
The 20th SAW concluded that productivity appears to decline when SSB 
falls below 900,000 mt. Therefore, the ABC specification for Atlantic 
mackerel is proposed at 1,175,500 mt. This level of ABC would leave an 
SSB of 900,000 mt for the following year (1997) from a mean starting 
value of SSB of 2,100,000 mt while also taking into account a projected 
Canadian catch of 24,500 mt.
    The proposed IOY for the 1996 Atlantic mackerel fishery is set at 
105,500 mt, equal to the proposed DAH. The specification for DAH is 
computed by adding the estimated recreational catch, the proposed DAP, 
and the proposed JVP. The recreational component of DAH is estimated to 
be 20,500 mt, using a formula found at Sec. 655.21(b)(2)(ii). DAP and 
JVP components of DAH have historically been estimated using the 
Council's annual processor survey. However, for the years 1994 and 
1995, response was low and did not contain projections from the large, 
known processors. In addition, inquiries regarding the utilization of 
displaced Alaskan freezer trawlers and New England groundfish trawlers 
for possible entry into the Atlantic mackerel fishery have led the 
Council to recommend no change to the DAP and JVP for the 1996 fishery. 
It is generally agreed that joint ventures have had a positive impact 
on the development of the U.S. Atlantic mackerel fishery and should be 
encouraged.
    The Council has recommended and NMFS proposes a DAH of 105,500 mt, 
which includes the 20,500 mt recreational component. The Council also 
recommended and NMFS proposes a DAP of 50,000 mt. The difference 
between DAH (minus the recreational component) and DAP allows for a JVP 
of 35,000 mt.
    Zero TALFF is recommended for the 1996 Atlantic mackerel fishery by 
the Council and proposed by NMFS. In 1992, the Council used testimony 
from both the domestic fishing and processing industries and analysis 
of nine economic factors found at Sec. 655.21(b)(2)(ii) to determine 
that mackerel produced from directed foreign fishing would compete 
directly with U.S. processed products, thus limiting markets available 
to U.S. processors. The industry was nearly unanimous in its assessment 
that a specification of TALFF would impede the growth of the U.S. 
fishery. The Council sees no evidence that this evaluation has changed. 
Further, the Council believes that an expanding mackerel market and 
uncertainty regarding world supply, due to the economic and political 
restructuring in Eastern Europe, may substantially increase 
opportunities for U.S. producers to increase sales to new markets 
abroad. Although the U.S. industry has not been successful in capturing 
a substantial market share for mackerel in the Caribbean, North Africa, 
and Europe so far, several factors indicate that market expansion of 
Atlantic mackerel may occur soon. Atlantic mackerel stock abundance 
remains high. Also, the continued low abundance amounts of several 
important groundfish stocks in the Gulf of Maine, southern New England, 
and on Georges Bank are causing further restrictions in fishing effort 
for those species and the need for many 

[[Page 66251]]
fishermen to redirect their effort to underutilized species. Atlantic 
mackerel is now considered a prime candidate for innovation in 
harvesting, processing, and marketing.
    As a supplement to the quota paper for the 1993 and 1994 fisheries, 
benefit-cost and sensitivity analyses were prepared by the Council and 
NMFS. Results of the analyses indicated that in the long term a 
specification of zero TALFF will yield positive benefits to the fishery 
and to the Nation. In its 1996 quota paper, the Council provides an 
additional analysis of the costs and benefits of directed foreign 
fishing, which indicates that the conclusions reached in prior analyses 
of zero TALFF have not changed.
    The Council also recommended and NMFS proposes that four special 
conditions imposed in previous years continue to be imposed on the 1996 
Atlantic mackerel fishery as follows: (1) Joint ventures are allowed 
south of 37 deg.30' N. lat., but river herring bycatch may not exceed 
0.25 percent of the over-the-side transfers of Atlantic mackerel; (2) 
the Regional Director, Northeast region, NMFS, should ensure that 
adverse impacts on marine mammals are reduced in the prosecution of the 
Atlantic mackerel fishery; (3) the mackerel OY may be increased during 
the year as described under Sec. 655.21(b)(2)(iv) in consultation with 
the Council, but the total should not exceed 125,500 mt; and (4) 
applications from a particular nation for a joint venture for 1996 will 
not be approved until the Regional Director determines, based on an 
evaluation of performances, that the Nation's purchase obligations for 
previous years have been fulfilled.

Atlantic Squids

    The maximum OY (Max OY) for Loligo is 44,000 mt. The recommended 
ABC for the 1996 fishery is 30,000 mt, representing a decrease of 6,000 
mt from the 1995 ABC of 36,000 mt. This level of ABC is based on the 
most recent stock assessments and is determined to be at a level that 
will not harm the continued growth of the resource. The 17th SAW 
concluded that Loligo is an annual species and does not have a 3-year 
life span, as previously assumed. The 17th SAW recommended that a real-
time assessment/management system be used to ensure an adequate level 
of spawning stock. This will be addressed in Amendment 5 to the FMP, 
which has been submitted to the Secretary of Commerce for review. 
Amendment 5 will also address the need to lower the Max OY, which is 
defined in the regulations governing the fishery to be 44,000 mt. This 
specification can be changed only with a plan amendment. In the 
interim, the Council believes that it would be prudent to reduce the 
ABC for conservation purposes, as suggested by the 17th SAW. The 
Council recommended and NMFS proposes an IOY of 25,000 mt, which is 
5,000 mt less than ABC and equal to DAH and DAP. DAH and DAP have 
historically been estimated using the Council annual processor survey. 
However, for 1995, response was low and did not contain projections 
from the large, known processors. Furthermore, the Council believes 
that these stocks may be susceptible to recruitment overfishing due to 
the 1-year life span of the animals, and in the absence of real-time 
assessment/management, the Council has chosen a conservative strategy. 
The proposed IOY/DAH/DAP of 25,000 mt for the 1996 fishery represents a 
decrease of 11,000 mt from the final 1995 IOY/DAH/DAP of 36,000 mt.
    The expansion of the U.S. freezer trawler and refrigerated sea 
water fleets that participate in this fishery and substantially 
increased U.S. landings indicate that there is no longer a 
justification for foreign participation. Therefore, zero JVP and TALFF 
are specified for the 1996 Loligo fishery.
    The Max OY for Illex squid is 30,000 mt. The Council recommended 
and NMFS proposes an ABC of 30,000 mt, which is equal to the Max OY. 
However, the Council has recommended and the Regional Director proposes 
that the IOY for Illex be set at 21,000 mt, 9,000 mt below the ABC, due 
to the conclusion that Illex has a life span of only 1 year and is, 
therefore, susceptible to recruitment overfishing. Though the 17th SAW 
determined that Illex has a life span of 1 year, no recommendations to 
adjust Max OY ensued. The 17th SAW recommended that, since Illex is a 
transboundary stock between the United States and Canada, a joint 
assessment be conducted before a revised Max OY is recommended. 
However, the 17th SAW advised that the current MSY for Illex may be 
inappropriate and cautioned that, while the stock is under-exploited 
based on current MSY, the potential for recruitment overfishing may be 
substantial. No directed foreign fishery has been specified for Illex 
since 1986, which reflects the large increases in the capacity of the 
East Coast freezer trawler fleet and projected increases in the number 
of vessels using refrigerated seawater systems capable of landing high 
quality Illex. Because U.S. vessels have the capacity to harvest the 
IOY, no joint venture processing is proposed 1996 fishery.

Butterfish

    The FMP sets the Max OY for butterfish at 16,000 mt. Based on the 
most current stock assessments, the Council recommends and the Regional 
Director proposes an ABC of 7,200 mt for the 1996 fishery, representing 
a decrease of 8,800 mt from the 1995 final initial specification. 
Commercial landings of butterfish have been low at 4,000 mt, 2,285 mt, 
4,430 mt, and 3,537 mt for the 1991 through 1994 fisheries, 
respectively. Lack of market demand and the difficulty in locating 
schools of market size fish have caused severe reductions in the supply 
of butterfish. Discard data from the offshore fishery is lacking and 
high discard rates could be reducing potential yield.
    The Council recommended and NMFS proposes an IOY for butterfish of 
5,900 mt. The U.S. industry has the potential to fully utilize this 
IOY. Thus, there is no TALFF available. The Council recommends and the 
Regional Director proposes a DAH of 5,900 mt. There has been no 
interest expressed in joint ventures, thus, the IOY is proposed at a 
level that does not allow for a JVP. The Council recommended and NMFS 
proposes that both JVP and TALFF be specified at zero for the 1996 
fisheries. However, a 1,300 mt difference between ABC and IOY is 
available to accommodate an increase in IOY if economic conditions 
dictate.

Classification

    This action is authorized by 50 CFR part 655, and these proposed 
specifications are exempt from review under E.O. 12866.

    Authority: 16 U.S.C. 1801 et seq.

    Dated: December 15, 1995.
Gary Matlock,
Program Management Officer, National Marine Fisheries Service.
[FR Doc. 95-31119 Filed 12-18-95; 2:30 pm]
BILLING CODE 3510-22-P

Complete official Federal Register PDF

FR Doc. 95-31110 Defense Federal Acquisition Regulation Supplement; Small Disadvantaged Business Concerns
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Pages 66246-66247]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-31110]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

48 CFR Parts 219, 236, and 252

[DFARS Case 95-D039]

Defense Federal Acquisition Regulation Supplement; Small 
Disadvantaged Business Concerns

AGENCY: Department of Defense (DOD).

ACTION: Proposed rule with request for comment; correction.

-----------------------------------------------------------------------

SUMMARY: This document contains corrections to a proposed rule on Small 
Disadvantaged Business Concerns, which was published in the Federal 
Register on December 14, 1995 (60 FR 64135).

FOR FURTHER INFORMATION CONTACT:
Ms. Susan Schneider, (703) 602-0131.
Michele P. Peterson,
Executive Editor, Defense Acquisition Regulations Council.

    Accordingly, the Department of Defense is correcting 48 CFR Parts 
219, 236, and 252 as follows: 

[[Page 66247]]

PART 219--SMALL BUSINESS PROGRAMS

    1. On page 64137, middle column, section 219.7202, paragraph 
(c)(1), is corrected to read as follows:

219.7202  Applicability.

* * * * *
    (c) * * *
    (1) The contracting activity will meet its goal for SDB concerns, 
established pursuant to 10 U.S.C. 2323 and Departmental procedures, 
during the current fiscal year, without this preference;
* * * * *
    2. On page 64137, middle column, section 219.7203, paragraphs (b) 
and (d), are corrected to read as follows:

219.7302  Procedures.

* * * * *
    (b) Evaluate total offers. If the apparently successful offeror is 
an SDB concern, no preference-based evaluation is required under this 
subpart.
* * * * *
    (d) When using the procedures in 236.303-70, additive or deductive 
items, the evaluation preference in this subpart shall be applied.
    3. On page 64137, last column, section 219.7204, paragraph (2), is 
corrected to read as follows:

219.7204  Contract clause.

* * * * *
    (2) Where work is to be performed inside the U.S., its territories 
or possessions, Puerto Rico, the Trust Territory of the Pacific 
Islands, or the District of Columbia.

PART 236--CONSTRUCTION AND ARCHITECT-ENGINEER CONTRACTS

    4. On page 64137, last column, section 236.303-70, paragraph 
(c)(2), is corrected to read as follows:

236.303-70  Additive or deductive items.

* * * * *
    (c) * * *
    (2) Evaluate all bids, including those using the procedures in 
219.7203, on the basis of the same additive or deductive bid items.
* * * * *

PART 252--SOLICITATION PROVISIONS AND CONTRACT CLAUSES

    5. On page 64138, first column, section 252.219-7010, paragraphs 
(b)(2) and (b)(3)(i) are corrected to read as follows:

252.219-7010  Notice of evaluation preference for small disadvantaged 
business concerns--construction acquisitions--Test program.

* * * * *
    (b) * * *
    (2) Offers will be evaluated initially based on their total prices. 
If the apparently successful offeror is an SDB concern, no preference-
based evaluation will be conducted.
    (3) * * *
    (i) Offers from SDBs which have not waived the evaluation 
preference; and
* * * * *
[FR Doc. 95-31110 Filed 12-20-95; 8:45 am]
BILLING CODE 5000-04-M

Complete official Federal Register PDF

FR Doc. 95-31100 Proposed Alteration of V-99, V-451 and J-62
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Pages 66181-66182]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-31100]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION
14 CFR Part 71

[Airspace Docket No. 95-ANE-35]

Proposed Alteration of V-99, V-451 and J-62

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of proposed rulemaking.

-----------------------------------------------------------------------

SUMMARY: This proposed rule would alter Federal Airways V-99, V-451 and 
Jet Route J-62 in Massachusetts and Connecticut. Specific portions of 
each of the airways and jet route are no longer necessary for 
navigation and would be revoked. Removing the obsolete segments would 
eliminate clutter on the aeronautical charts.

DATES: Comments must be received on or before February 2, 1996.

ADDRESSES: Send comments on the proposal in triplicate to: Manager, Air 
Traffic Division, ANE-500, Docket No. 95-ANE-35, Federal Aviation 

[[Page 66182]]
Administration, 12 New England Executive Park, Burlington, MA 01803.
    The official docket may be examined in the Rules Docket, Office of 
the Chief Counsel, Room 916, 800 Independence Avenue, SW., Washington, 
DC, weekdays, except Federal holidays, between 8:30 a.m. and 5:00 p.m.
    An informal docket may also be examined during normal business 
hours at the office of the Regional Air Traffic Division.

FOR FURTHER INFORMATION CONTACT: Patricia P. Crawford, Airspace and 
Obstruction Evaluation Branch (ATP-240), Airspace-Rules and 
Aeronautical Information Division, Air Traffic Rules and Procedures 
Service, Federal Aviation Administration, 800 Independence Avenue, SW., 
Washington, DC 20591; telephone: (202) 267-9255.

SUPPLEMENTARY INFORMATION:

Comments Invited

    Interested parties are invited to participate in this proposed 
rulemaking by submitting such written data, views, or arguments as they 
may desire. Comments that provide the factual basis supporting the 
views and suggestions presented are particularly helpful in developing 
reasoned regulatory decisions on the proposal. Comments are 
specifically invited on the overall regulatory, aeronautical, economic, 
environmental, and energy-related aspects of the proposal. 
Communications should identify the airspace docket number and be 
submitted in triplicate to the address listed above. Commenters wishing 
the FAA to acknowledge receipt of their comments on this notice must 
submit with those comments a self-addressed, stamped postcard on which 
the following statement is made: ``Comments to Airspace Docket No. 95-
ANE-35.'' The postcard will be date/time stamped and returned to the 
commenter. All communications received on or before the specified 
closing date for comments will be considered before taking action on 
the proposed rule. The proposal contained in this notice may be changed 
in light of comments received. All comments submitted will be available 
for examination in the Rules Docket both before and after the closing 
date for comments. A report summarizing each substantive public contact 
with FAA personnel concerned with this rulemaking will be filed in the 
docket.

Availability of NPRM's

    Any person may obtain a copy of this Notice of Proposed Rulemaking 
(NPRM) by submitting a request to the Federal Aviation Administration, 
Office of Public Affairs, Attention: Public Inquiry Center, APA-220, 
800 Independence Avenue, SW., Washington, DC 20591, or by calling (202) 
267-3485. Communications must identify the notice number of this NPRM. 
Persons interested in being placed on a mailing list for future NPRM's 
should also request a copy of Advisory Circular No. 11-2A, which 
describes the application procedure.

The Proposal

    The FAA is considering an amendment to part 71 of the Federal 
Aviation Regulations (14 CFR part 71) to alter VOR Federal Airways V-
99, V-451 and Jet Route J-62. Specific portions of each of the airways 
and jet route are no longer necessary for navigation and would be 
revoked. The airspace designation for V-99 would be revoked between 
Hartford, CT, and the GRAYM intersection; V-451 would be revoked 
between Groton, CT, and the SEEDY intersection; and J-62 would be 
revoked east of the Nantucket, CT, Very High Frequency Omnidirectional 
Range (VOR). Removing the obsolete segments would eliminate clutter on 
the aeronautical charts. Jet Routes and Domestic VOR Federal airways 
are published in paragraphs 2004 and 6010(a), respectively, of FAA 
Order 7400.9C dated August 17, 1995, and effective September 16, 1995, 
which is incorporated by reference in 14 CFR 71.1. The jet route and 
airways listed in this document would be published subsequently in the 
Order.
    The FAA has determined that this proposed regulation only involves 
an established body of technical regulations for which frequent and 
routine amendments are necessary to keep them operationally current. 
It, therefore--(1) is not a ``significant regulatory action'' under 
Executive Order 12866; (2) is not a ``significant rule'' under DOT 
Regulatory Policies and Procedures (44 FR 11034; February 26, 1979); 
and (3) does not warrant preparation of a regulatory evaluation as the 
anticipated impact is so minimal. Since this is a routine matter that 
will only affect air traffic procedures and air navigation, it is 
certified that this rule, when promulgated, will not have a significant 
economic impact on a substantial number of small entities under the 
criteria of the Regulatory Flexibility Act.

List of Subjects in 14 CFR Part 71

    Airspace, Incorporation by reference, Navigation (air).

The Proposed Amendment

    In consideration of the foregoing, the Federal Aviation 
Administration proposes to amend 14 CFR part 71 as follows:

PART 71--[AMENDED]

    1. The authority citation for part 71 continues to read as follows:

    Authority: 49 U.S.C. 106(g), 40103, 40113, 40120; E.O. 10854, 24 
FR 9565, 3 CFR, 1959-1963 Comp., p. 389; 14 CFR 11.69.

Sec. 71.1  [Amended]

    2. The incorporation by reference in 14 CFR 71.1 of the Federal 
Aviation Administration Order 7400.9C, Airspace Designations and 
Reporting Points, dated August 17, 1995, and effective September 16, 
1995, is amended as follows:

Paragraph 2004-Jet Routes

* * * * *

J-62  [Revised]

    From Robbinsville, NJ; to Nantucket, MA.
* * * * *

Paragraph 6010(a)--Domestic VOR Federal Airways

* * * * *

V-99 [Revised]

    From LaGuardia, NY, via INT LaGuardia 043 deg. and Hartford, CT, 
245 deg. radials; Hartford.
* * * * *

V-451 [Revised]

    From LaGuardia, NY; INT LaGuardia 063 deg. and Hampton, NY, 
289 deg. radials; INT Hampton 289 deg. and Calverton, NY, 044 deg. 
radials; INT Calverton 044 deg. and Groton, CT, 243 deg. radials; 
Groton.
* * * * *
    Issued in Washington, DC, on December 12, 1995.
Harold W. Becker,
Manager, Airspace-Rules and Aeronautical Information Division.
[FR Doc. 95-31100 Filed 12-20-95; 8:45 am]
BILLING CODE 4910-13-P

Complete official Federal Register PDF

FR Doc. 95-31059 Finality of Decisions Regarding Railroad Retirement Annuities
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Pages 66203-66205]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-31059]

=======================================================================
-----------------------------------------------------------------------

RAILROAD RETIREMENT BOARD

20 CFR Part 261

RIN 3220-AB15

Finality of Decisions Regarding Railroad Retirement Annuities

AGENCY: Railroad Retirement Board.

ACTION: Proposed rule.

-----------------------------------------------------------------------

SUMMARY: The Railroad Retirement Board (Board) hereby proposes to adopt 
regulations pertaining to the finality of decisions under the Railroad 
Retirement Act of 1974 (Act).

DATES: Comments must be received on or before February 20, 1996.

ADDRESSES: Secretary to the Board, Railroad Retirement Board, 844 North 
Rush Street, Chicago, Illinois 60611.

FOR FURTHER INFORMATION CONTACT:
Michael C. Litt, General Attorney, Railroad Retirement Board, 844 North 
Rush Street, Chicago, Illinois 60611, telephone (312) 751-4929, TDD 
(312) 751-4701.

SUPPLEMENTARY INFORMATION: The Board's rules and procedures regarding 
the finality of decisions are presently contained in Board Orders, 
which are not readily available to the public. The Board Order 
regarding finality of decisions provides that finality of certain 
decisions is based on a number of factors; adjudication based on these 
factors is difficult to administer. Also the Board Order does not 
contain any time limits on reopening.
    The proposed regulation addresses the finality of benefit 
decisions. This proposed rule is similar to the regulation of the 
Social Security Administration (SSA) entitled ``Reopening and Revising 
Determinations and Decisions'' (20 CFR 404.987-404.996).
    Proposed Sec. 261.1 describes who may open a final decision issued 
by the agency. Proposed Sec. 261.2 describes when a final decision may 
be reopened. All final decisions, except decisions awarding separation 
allowance lump sum payments, may be reopened within 12 months of the 
date of notice of such decision; within 3 years of the date of notice 
if new and material evidence is furnished or if there was an 
adjudicative error not consistent with the evidence of record at the 
time of adjudication; or at any time under the conditions set forth in 
proposed Sec. 261.2(c).
    Proposed Sec. 261.3 provides that a change of legal interpretation 
or administrative ruling upon which a decision was based is not a basis 
for reopening.
    Proposed Sec. 261.4 provides that the annuity beginning date will 
not be changed if the annuitant was later found to be engaged in 
compensated service for an employer, as defined in part 202 of the 
Board's regulations, and the annuitant had no basis for knowing that he 
was engaged in such service. This section also provides that the award 
of an annuity would not be withdrawn if based upon incorrect records of 
service where the erroneously credited service months do not exceed 6 
months and the annuitant was not at fault in causing the error.
    Proposed Sec. 261.5 provides that a decision may be reopened after 
the 1 year and 3 year time limits set forth in Sec. 261.2 of this part 
if the Board had begun an investigation within those time limits. 
However, if the Board does not diligently pursue the investigation it 
will not reopen the decision if the decision was favorable to the 
annuitant.
    Proposed Secs. 261.6-261.8 are procedural and provide that if a 
decision is reopened, the annuitant will be given notice and will have 
a right to reconsideration and/or a hearing. Any hearing shall be 
conducted in accordance with part 260 of the Board's regulations (20 
CFR part 260).
    Proposed Sec. 261.9 provides that if a decision on a claim is 
reopened it may also cause a reopening of a decision on a previous 
claim based upon the same compensation record, even though the time 
limits for reopening a decision on the first claim have passed.
    Proposed Sec. 261.10 provides that where new evidence shows that 
the date of birth used in the initial decision was incorrect or where 
the record of compensation has been changed a decision may be revised 
even beyond the time limits of Sec. 261.2 of this part if such 
reopening is favorable to the annuitant, but any increase in benefits 
payable as the result of the reopening shall be paid prospectively 
only.
    Finally, proposed Sec. 261.11 provides that the three-member Board 
has the discretion to reopen or not to reopen any decision under these 
regulations.
    The Labor Member of the Board dissented from the action of the 
majority of the Board approving this proposed rule. The Labor Member's 
reasons for dissenting from this action are set out below.

[[Page 66204]]

Views of the Labor Member of the Board

    Proposed Sec. 261.2 would allow unlimited retroactivity for 
reopening where an overpayment resulted from the Board's failure to 
apply a proper reduction to the tier I component of an annuity. This 
same section would allow unlimited retroactivity in cases where an 
incorrect decision results in entitlement to an annuity where if the 
decision were correct there would be no entitlement.
    The Labor Member contends that failure to consider these cases 
final after a reasonable period of time clearly defeats the purpose of 
developing an administrative finality policy. He agrees that, where an 
individual through fraudulent or similar means causes an incorrect 
benefit to be paid, the Board should promptly take steps to correct the 
payment and collect the overpayment. However, in cases where an 
overpayment has been made due to an error on the part of the Board or 
the beneficiary and there was no intent at deception, he feels that a 
reasonable ``statute of limitations'' should be set. He feels a more 
reasonable approach would be to borrow a policy from the Social 
Security Administration and allow unlimited retroactivity for reopening 
decision that were unfavorable to a party, but only to correct clerical 
error or error that appears on the face of the evidence that was 
considered when the determination or decision was originally made. In 
most other cases, reopening should be limited.
    The Labor Member points out that in November 1985 the Board 
published a proposed rule in the Federal Register dealing with 
administrative finality (50 FR 48602, November 26, 1985). Several 
months later, the Office of Management and Budget submitted a letter to 
the then Chairman of the Board expressing dissatisfaction with the 
proposed rule comparing it unfavorably with SSA's.
    The Labor Member interprets this as a clear message that the Board 
should tailor its administrative finality policy to that of SSA's to 
the extent possible.
    The Labor Member wants our beneficiaries to have the security of 
knowing that benefits that they have come to rely on will not be 
suddenly taken away and argues that conforming our administrative 
finality regulations to those of SSA's where appropriate, lends itself 
to a true administrative finality, while still maintaining the 
integrity of the railroad retirement system. He thinks the proposed 
rule approved by the majority of the Board fails to do this, and for 
this reason he cannot endorse it.
    The Board, with the concurrence of the Office of Management and 
Budget, has determined that this is not a significant regulatory action 
under Executive Order 12866; therefore, no regulatory impact analysis 
is required. There are no information collections associated with this 
rule.

List of Subjects in 20 CFR Part 261

    Pensions, Railroad employees, Railroad retirement.

    For the reasons set out in the preamble, chapter II of title 20 of 
the Code of Federal Regulations is proposed to amended as follows:
    1. Part 261, Administrative Finality, is added to read as follows:

PART 261--ADMINISTRATIVE FINALITY

Sec.
261.1 Reopening and revising decisions.
261.2 Conditions for reopening.
261.3 Change of legal interpretation or administrative ruling.
261.4 Decisions which shall not be reopened.
261.5 Late completion of timely investigation.
261.6 Notice of revised decision.
261.7 Effect of revised decision.
261.8 Time and place to request review of a revised decision.
261.9 Finality of findings when later claim is filed on same 
earnings record.
261.10 Increase in future benefits where time period for reopening 
has expired.
261.11 Discretion of the three-member Board to reopen or not to 
reopen a final decision.

    Authority: 45 U.S.C. 231f.

Sec. 261.1  Reopening and revising decisions.

    (a) This part sets forth the Board's rules governing finality of 
decisions. After the expiration of the time limits for review as set 
forth in part 260 of this chapter, decisions of the agency may be 
reopened and revised under the conditions described in this part, by 
the bureau, office, or entity that made the earlier decision or by a 
bureau, office, or other entity at a higher level, which has the claim 
properly before it.
    (b) A final decision as that term is used in this part means any 
decision of the type listed in Sec. 260.1 of this chapter where the 
time limits for review as set forth in part 260 of this chapter or in 
the Railroad Retirement Act have expired.
    (c) Reopening a final decision under this part means a conscious 
determination on the part of the agency to reconsider an otherwise 
final decision for purposes of revising that decision.
    (d) New and material evidence as that phrase is used in this part 
means evidence that may reasonably be expected to affect a final 
decision, which was unavailable to the agency at the time the decision 
was made, and which the claimant could not reasonably have been 
expected to have submitted at that time.

Sec.  261.2  Conditions for reopening.

    A final decision may be reopened:
    (a) Within 12 months of the date or the notice of such decision, 
for any reason;
    (b) Within three years of the date of the notice of such decision, 
if there is new and material evidence or there was adjudicative error 
not consistent with the evidence of record at the time of adjudication; 
or
    (c) At any time if:
    (1) The decision was obtained by fraud or similar fault;
    (2) Another person files a claim on the same record of compensation 
and allowance of the claim adversely affects the first claim;
    (3) A person previously determined to be dead on whose earnings 
record a survivor annuity is based is found to be alive;
    (4) A claim was denied because of the absence of proof of death of 
the employee, and the death is later established:
    (i) By reason of an unexplained absence from his or her residence 
for a period of 7 years; or
    (ii) By location or identification of his or her body;
    (5) The Social Security Administration has awarded duplicate 
benefits on the same record of compensation;
    (6) The decision was that the claimant did not have an insured 
status, and compensation has been credited to the employee's record of 
compensation in accordance with part 211 of this chapter:
    (i) To enter items transferred by the Social Security 
Administration which were credited under the Social Security 
Administration which were credited under the Social Security Act when 
they should have been credited to the employee's railroad retirement 
compensation record; or
    (ii) To correct an error made in the allocation of earnings to an 
individual which, if properly allocated, would have given him or her an 
insured status at the time of the decision and the evidence of these 
earnings was in the possession of the Railroad Retirement Board or the 
Social Security Administration at the time of the decision;
    (7) The decision found the claimant entitled to an annuity or to a 
lump sum payment based on the earnings record of 

[[Page 66205]]
a deceased person, and it is later established that:
    (i) the claimant was convicted of a felony or an act in the nature 
of a felony for intentionally causing that person's death; or
    (ii) If the claimant was subject to the juvenile justice system, he 
or she was found by a court of competent jurisdiction to have 
intentionally caused that person's death by committing an act which, if 
committed by an adult, would have been considered a felony or an act in 
the nature of a felony;
    (8) The claimant shows that it is to his or her advantage to select 
a later annuity beginning date and refunds, by cash payment or setoff, 
past payments applying to the period prior to the later beginning date, 
subject, however, to the provisions of subpart D of part 217 and Sec.  
218.9 of this chapter;
    (9) The decision is incorrect because of a failure to apply a 
reduction, or the proper reduction, to the tier I component of an 
annuity;
    (10) Except as is provided in Sec.  261.4 of this part, the 
decision is incorrect for any reason and results in entitlement to an 
annuity in a case where if the decision were correct there would be no 
entitlement.
    (d) Revision of the amount or payment of a separation allowance 
lump sum amount pursuant to section 6(e) of the Railroad Retirement Act 
is limited to 60 days from the date of notification of the award of the 
separation allowance lump sum payment.

Sec.  261.3  Change of legal interpretation or administrative ruling.

    A change of legal interpretation or administrative ruling upon 
which a decision is based does not render a decision erroneous and does 
not provide a basis for reopening.

Sec.  261.4  Decisions which shall not be reopened.

    The following decisions shall not be reopened:
    (a) An award of an annuity beginning date to an applicant later 
found to have been in compensated service to an employer under part 202 
of this chapter on that annuity beginning date and who is found not to 
be at fault in causing the erroneous award; provided, however, that 
this exception shall not operate to permit payment of benefits for any 
month in which the claimant is found to be engaged in compensated 
service.
    (b) An award of an annuity based on a subsequently discovered 
erroneous crediting of months of service and compensation to a claimant 
where:
    (1) The loss of such months of service and compensation will cause 
the applicant to lose his or her eligibility for an annuity previously 
awarded;
    (2) The erroneously credited months of service do not exceed six 
months; and
    (3) The annuitant is found not to be at fault in causing the 
erroneous crediting.
    (c) An erroneous award of an annuity where the error is no greater 
than one dollar per month per annuity affected.
    (d) An erroneous award of a lump sum or accrued annuity payment 
where the error is no greater than $25.00.

Sec. 261.5  Late completion of timely investigation.

    (a) A decision may be revised after the applicable time period in 
Sec. 261.2(a) or Sec. 261.2(b) of this part expires if the Railroad 
Retirement Board begins an investigation into whether to revise the 
decision before the applicable time period expires and the agency 
diligently pursues the investigation to the conclusion. The 
investigation may be based on a request by a claimant or on action by 
the Railroad Retirement Board.
    (b) Diligently pursued for purposes of this section means that in 
view of the facts and circumstances of a particular case, the necessary 
action was undertaken and carried out as promptly as the circumstances 
permitted. Diligent pursuit will be presumed to have been met if the 
investigation is concluded and, if necessary, the decision is revised 
within 6 months from the date the investigation began.
    (c) If the investigation is not diligently pursued to its 
conclusion, the decision will be revised if a revision is applicable 
and if it is favorable to the claimant. It will not be revised if it 
would be unfavorable to the claimant.

Sec. 261.6  Notice of revised decision.

    (a) When a decision is revised, notice of the revision will be 
mailed to the parties to the decision at their last known address. The 
notice will state the basis for the revised decision and the effect of 
the revision. The notice will also inform the parties of the right to 
further review.
    (b) If a hearings officer or the three-member Board proposes to 
revise a decision, and the revision would be based only on evidence 
included in the record on which the prior decision was based, all 
parties will be notified in writing of the proposed action. If a 
revised decision is issued by a hearings officer, any party may request 
that it be reviewed by the three-member Board, or the three-member 
Board may review the decision on its own initiative.

Sec. 261.7  Effect of revised decision.

    A revised decision is binding unless:
    (a) The revised decision is reconsidered or appealed in accord with 
part 260 of this chapter;
    (b) The three-member Board reviews the revised decision; or
    (c) The revised decision is further revised consistent with this 
part.

Sec. 261.8  Time and place to request review of a revised decision.

    A party to a revised decision may request, as appropriate, further 
review of the decision in accordance with the rules set forth in part 
260 of this chapter.

Sec. 261.9  Finality of findings when later claim is filed on same 
earnings record.

    If two claims for benefits are filed on the same record of 
compensation, findings of fact made in a decision in the first claim 
may be revised in determining or deciding the second claim, even though 
the time limit for revising the findings made in the fist claim has 
passed. However, a finding in connection with a claim that a person was 
fully or currently insured at the time of filing an application, at the 
time of death, or any other pertinent time, may be revised only under 
the conditions stated in Sec. 261.2 of this part.

Sec. 261.10  Increase in future benefits where time period for 
reopening has expired.

    If, after the time period for reopening under Sec. 261.2(b) of this 
part has expired, new evidence is furnished showing a different date of 
birth or new evidence is furnished which would cause a correction in a 
record of compensation as provided for in part 211 of this chapter and, 
as a result of the new evidence, increased benefits would be payable, 
the Board will pay increased benefits, but only for the months 
following the month the new evidence is received.

Sec. 261.11  Discretion of the three-member Board to reopen or not to 
reopen a final decision.

    In any case in which the three-member Board may deem proper, the 
Board may direct that any decision, which is otherwise subject to 
reopening under this part, shall not be reopened or direct that any 
decision, which is otherwise not subject to reopening under this part, 
shall be reopened.

    Dated: December 14, 1995.

    By authority of the Board.

    For the Board
Beatrice Ezerski,
Secretary to the Board.
[FR Doc. 95-31059 Filed 12-20-95; 8:45 am]
BILLING CODE 7905-01-M

Complete official Federal Register PDF

FR Doc. 95-31051 Lamps, Reflective Devices and Associated Equipment; Advisory Committee Public Meetings
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Page 66247]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-31051]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

National Highway Traffic Safety Administration

49 CFR Part 571

[Docket No. 95-28; Notice 5]
RIN 2127-AF73

Lamps, Reflective Devices and Associated Equipment; Advisory 
Committee Public Meetings

AGENCY: National Highway Traffic Safety Administration (NHTSA); DOT.

ACTION: Notice; schedule of advisory committee meetings.

-----------------------------------------------------------------------

SUMMARY: This notice announces the final dates and locations of the 
three remaining series of meetings of NHTSA's Advisory Committee on 
Regulatory Negotiation (concerning the improvement of headlamp 
aimability performance and visual/optical headlamp aiming).

DATES: Tuesday-Thursday, January 16-18, 1996; Monday-Wednesday, March 
4-6, 1996; Tuesday-Thursday, April 23-25, 1996.

ADDRESSES: The January and March 1996 meetings of the Advisory 
Committee will be held at the Department of Transportation, Room 2230, 
Nassif Building, 400 Seventh Street SW., Washington, DC. The April 1996 
meeting will be held at the Federal Mediation and Conciliation Service, 
2100 K Street NW., Washington, DC. Meetings will begin at 9:00 a.m., 
except for the meeting of Tuesday, January 16, 1996, which will begin 
at 10:00 a.m.

FOR FURTHER INFORMATION CONTACT: Jere Medlin, Office of Vehicle Safety 
Standards, NHTSA (Phone: 202-366-5276; FAX: 202-366-4329). Mediator: 
Lynn Sylvester, Federal Mediation and Conciliation Service, (phone: 
202-606-9140; FAX: 202-606-3679).

SUPPLEMENTARY INFORMATION: On August 16, 1995, the National Highway 
Traffic Safety Administration (NHTSA) published a tentative schedule 
for its early 1996 meetings of the Advisory Committee on Regulatory 
Negotiation (concerning the improvement of headlamp aimability 
performance and visual/optical headlamp aiming) (60 FR 42496)). The 
notice announced that this schedule was subject to confirmation or 
modifications at the Committee's November 1995 meeting. It announced 
that if there were changes or additions to the schedule, NHTSA would 
publish a notice informing the public of the changes.
    At its meeting on November 30, 1995, in order to complete its tasks 
by the end of April 1996, the Committee decided to expand its three 
remaining series of meetings from a schedule of two days each to one of 
three days each, to be held on the days and in the locations shown 
above. The dates are approximately those announced in the August 
notice.

    The meetings are open to the public.

    Issued: December 15, 1996.
Barry Felrice,
Associate Administrator for Safety Performance Standards.
[FR Doc. 95-31051 Filed 12-20-95; 8:45 am]
BILLING CODE 4910-59-P

Complete official Federal Register PDF

FR Doc. 95-31047 Orthopedic Devices: Classification, Reclassification, and Codification of Pedicle Screw Spinal Systems; Correction
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Page 66227]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-31047]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

21 CFR Part 888

[Docket No. 95N-0176]

Orthopedic Devices: Classification, Reclassification, and 
Codification of Pedicle Screw Spinal Systems; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Proposed rule; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting certain 
statements in the preamble to a proposed rule that appeared in the 
Federal Register of October 4, 1995 (60 FR 51946). The document 
proposed to classify certain unclassified preamendments pedicle screw 
spinal systems into class II (special controls), and to reclassify 
certain postamendments pedicle screw spinal systems from class III 
(premarket approval) to class II. The document states further that FDA 
is issuing for public comment the recommendations of the Orthopedic and 
Rehabilitation Devices Panel (the Panel) concerning the classification/
reclassification of pedicle screw spinal systems, and the agency's 
tentative findings on the Panel's recommendations. The document is 
being corrected to reflect an accurate description of the formation, 
membership, and activities of the Spinal Implant Manufacturers Group 
(SIMG), and the Scientific Committee, two separate entities established 
by the spinal implant manufacturers and medical professional societies 
to collect and submit to FDA all available valid scientific data on the 
performance of pedicle screw spinal devices.

FOR FURTHER INFORMATION CONTACT: Mark N. Melkerson, Center for Devices 
and Radiological Health (HFZ-410), Food and Drug Administration, 9200 
Corporate Blvd., Rockville, MD 20850, 301-594-2036.

     In the FR Doc. 95-24686, appearing on page 51946 in the Federal 
Register of Wednesday, October 4, 1995, the following corrections are 
made:
    1.On page 51947, in the second column, in the fourth paragraph, 
beginning in line 7, the second, third, and fourth sentences are 
removed and the following text is added in their place to read as 
follows:
    In response, two groups were founded: The Spinal Implant 
Manufacturers Group (SIMG), and the Scientific Committee. SIMG, founded 
by 16 medical device manufacturers, agreed to provide the funding that 
would be required to conduct a nationwide study of pedicle screw 
devices. The Scientific Committee was formed by five professional 
medical societies, including the North American Spine Society, the 
American Academy of Orthopedic Surgeons, the Scoliosis Research 
Society, the Congress of Neurosurgeons, and the American Association of 
Neurological Surgeons. The Scientific Committee was formed to develop 
and implement a uniform research protocol to gather clinical experience 
from the use of the device. The Scientific Committee consisted of four 
surgeons and two nonvoting SIMG representatives, a biostatistician, and 
a clinical/regulatory affairs professional.
    2. On page 51947, in the third column, in the first paragraph, 
beginning in the fifteenth line, the fourth and fifth sentences are 
removed and the following text is added in their place to read as 
follows:
    At this meeting, the Scientific Committee presented clinical data 
from its nationwide ``Historical Cohort Study of Pedicle Screw Fixation 
in Thoracic, Lumbar, and Sacral Spinal Fusions'' (Cohort Study). FDA 
presented a comprehensive review of the medical literature, an analysis 
of the medical literature, an analysis of the Cohort study conducted by 
the Scientific Committee, and a summary of the clinical data that had 
been released by IDE sponsors.
    3. On page 51950, in the first column, in the fourth paragraph, in 
the first line, the abbreviation ``SIMG'' is corrected to read 
``Scientific Committee''.

    Dated: December 8, 1995.
D.B. Burlington,
Director, Center for Devices and Radiological Health.
[FR Doc. 95-31047 Filed 12-20-95; 8:45 am]
BILLING CODE 4160-01-F

Complete official Federal Register PDF

FR Doc. 95-31039 Approval and Promulgation of Implementation Plans and Designation of Areas for Air Quality Planning Purposes; State of Georgia
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Page 66246]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-31039]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 52

[GA27-1-7186b; FRL-5320-4]

Approval and Promulgation of Implementation Plans and Designation 
of Areas for Air Quality Planning Purposes; State of Georgia

AGENCY: Environmental Protection Agency (EPA).

ACTION: Proposed rule.

-----------------------------------------------------------------------

SUMMARY: The EPA proposes to approve the State Implementation Plan 
(SIP) revision submitted by the State of Georgia for the adoption of 
the Clean Fuel Fleet program. In the final rules section of this 
Federal Register, the EPA is approving the State's SIP revision as a 
direct final rule without prior proposal because the Agency views this 
as a noncontroversial revision amendment and anticipates no adverse 
comments. A detailed rationale for the approval is set forth in the 
direct final rule. If no adverse comments are received in response to 
that direct final rule, no further activity is contemplated in relation 
to this proposed rule. If EPA receives adverse comments, the direct 
final rule will be withdrawn and all public comments received will be 
addressed in a subsequent final rule based on this proposed rule. The 
EPA will not institute a second comment period on this document. Any 
parties interested in commenting on this document should do so at this 
time.

DATES: To be considered, comments must be received by January 22, 1996.

ADDRESSES: Written comments should be sent to Ben Franco, EPA Region 4, 
Air Programs Branch, 345 Courtland Street NE, Atlanta, Georgia, 30365. 
Copies of the State of Georgia submittal are available for public 
review during normal business hours at the addresses listed below.

Air and Radiation Docket and Information Center (Air Docket 6102), U.S. 
Environmental Protection Agency, 401 M Street, SW, Washington, DC 
20460.
Environmental Protection Agency, Region 4, Air Programs Branch, 345 
Courtland Street NE, Atlanta, Georgia 30365.
Georgia Department of Natural Resources, 4244 International Parkway, 
Suite 120, Atlanta, GA 30354.

FOR FURTHER INFORMATION CONTACT: Ben Franco of the EPA Region 4 Air 
Programs Branch at (404) 347-3555, ext. 4211, and at the above address.

SUPPLEMENTARY INFORMATION: For additional information see the direct 
final rule which is published in the rules section of this Federal 
Register.

    Dated: September 29, 1995.
Patrick M. Tobin,
Acting Regional Administrator.
[FR Doc. 95-31039 Filed 12-20-95; 8:45 am]
BILLING CODE 6560-50-P

Complete official Federal Register PDF

FR Doc. 95-31015 Petition for Rulemaking; Summary of Petitions Received; Dispositions of Petitions Issued
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Page 66181]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-31015]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Chapter I

[Summary Notice No. PR-95-4]

Petition for Rulemaking; Summary of Petitions Received; 
Dispositions of Petitions Issued

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of petitions for rulemaking received and of dispositions 
of prior petitions.

-----------------------------------------------------------------------

SUMMARY: Pursuant to FAA's rulemaking provisions governing the 
application, processing, and disposition of petitions for rulemaking 
(14 CFR part 11), this notice contains a summary of certain petitions 
requesting the initiation of rulemaking procedures for the amendment of 
specified provisions of the Federal Aviation Regulations and of denials 
or withdrawals of certain petitions previously received. The purpose of 
this notice is to improve the public's awareness of, and participation 
in, this aspect of FAA's regulatory activities. Neither publication of 
this notice nor the inclusion or omission of information in the summary 
is intended to affect the legal status of any petition or its final 
disposition.

DATES: Comments on petitions received must identify the petition docket 
number involved and must be received January 19, 1996.

ADDRESSES: Send comments on any petition in triplicate to: Federal 
Aviation Administration, Office of the Chief Counsel, Attn: Rules 
Docket No.________, 800 Independence Avenue, SW., Washington, D.C. 
20591.
    The petition, any comments received, and a copy of any final 
disposition are filed in the assigned regulatory docket and are 
available for examination in the Rules Docket (AGC-200), Room 915G, FAA 
headquarters Building (FOB 10A), 800 Independence Ave., SW., 
Washington, D.C. 20591; telephone (202) 267-3132. Comments may also be 
sent electronically to the following internet address: 
[email protected].

FOR FURTHER INFORMATION CONTACT: Mr. D. Michael Smith, Office of 
Rulemaking (ARM-1), Federal Aviation Administration, 800 Independence 
Avenue, SW, Washington, DC 20591; telephone (202) 267-7470.
    This notice is published pursuant to paragraphs (b) and (f) of 
Sec.  11.27 of part 11 of the Federal Aviation Regulations (14 CFR part 
11).
Donald P. Byrne,
Assistant Chief Counsel for Regulations.

Petitions for Rulemaking

    Docket No.: 28376.
    Petitioner: National Business Aircraft Association, Inc.
    Regulations Affected: 14 CFR 91.501.
    Description of Rulechange Sought: To add a new paragraph (e) to 
Sec.  91.501 defining the word ``company'' as it is used in Sec.  
91.501(b)(5) and (6) to include a governmental agency and governmental 
corporation, as well as defining the words ``parent'' and 
``subsidiary'' to include another governmental agency or governmental 
corporation within the same local, state, or federal jurisdiction. This 
amendment, if granted, would include government aircraft operations 
with corporate aircraft operations under part 91 and, therefore, allow 
government agencies to recover the costs of owning, operating, and 
maintaining their aircraft in certain circumstances.
    Petitioner's Reason for the Request: The petitioner feels that the 
current regulatory scheme discriminates against government owners and 
operators of civil aircraft without justification.

[FR Doc. 95-31015 Filed 12-20-95; 8:45 am]
BILLING CODE 4910-13-M

Complete official Federal Register PDF

FR Doc. 95-31008 Food Labeling: Nutrient Content Claims, General Principles; Health Claims, General Requirements and Other Specific Requirements for Individual Health Claims
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Pages 66205-66227]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-31008]

=======================================================================
-----------------------------------------------------------------------

[[Page 66206]]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 101

[Docket Nos. 94P-0390 and 95P-0241]

Food Labeling: Nutrient Content Claims, General Principles; 
Health Claims, General Requirements and Other Specific Requirements for 
Individual Health Claims

AGENCY: Food and Drug Administration, HHS.

ACTION: Proposed rule.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is proposing to amend 
its regulations on nutrient content claims and health claims to provide 
additional flexibility in the use of these claims on food products. 
These changes are intended to benefit public health by encouraging 
manufacturers to use health claims and nutrient content claims that 
will assist consumers in maintaining a healthy diet. The agency's 
current regulations were issued in January of 1993 to implement the 
Nutrition Labeling and Education Act of 1990. This document proposes 
refinements to those regulations to allow additional synonyms for 
nutrient content claims without specific preclearance by the agency, 
permit health claims on certain foods that do not currently qualify 
because they do not contain 10 percent of certain required nutrients, 
permit the use of shortened versions of authorized health claims under 
certain circumstances, eliminate some of the required elements for 
health claims, and provide additional guidance for petitioners seeking 
exemption from the disqualification of some foods from bearing a health 
claim because they contain high levels of certain nutrients. FDA is 
proposing these amendments in response to petitions submitted by the 
National Food Processors Association (NFPA) and the American Bakers 
Association (ABA).

DATES: Written comments by March 20, 1996. The agency is proposing that 
any final rules that may issue based upon this proposal become 
effective on the date of publication.

ADDRESSES: Written comments to the Dockets Management Branch (HFA-305), 
Food and Drug Administration, 12420 Parklawn Dr., rm. 1-23, Rockville, 
MD 20857, 301-443-1751.

FOR FURTHER INFORMATION CONTACT: F. Edward Scarbrough, Center for Food 
Safety and Applied Nutrition (HFS-2), Food and Drug Administration, 200 
C St. SW., Washington, DC 20204, 202-205-4561.

SUPPLEMENTARY INFORMATION:

I. Background

A. The Nutrition Labeling and Education Act of 1990

    On November 8, 1990, the President signed into law the Nutrition 
Labeling and Education Act of 1990 (the 1990 amendments) (Pub. L. 101-
535). This new law amended the Federal Food, Drug, and Cosmetic Act 
(the act) in a number of important ways. Among the more notable aspects 
of the 1990 amendments were that they confirmed FDA's authority to 
regulate nutrient content and health claims on food labels and in food 
labeling.
    Section 403(r)(1)(A) of the act (21 U.S.C. 343(r)(1)(A)), which was 
added by the 1990 amendments, provides that a product is misbranded if 
it bears a claim that characterizes the level of a nutrient of the type 
required to be included in nutrition labeling unless the claim uses 
terms that are defined and designated in regulations adopted by FDA and 
is made in accordance with all other regulatory requirements. 
Similarly, section 403(r)(1)(B) of the act provides that a product is 
misbranded if it bears a claim that characterizes the relationship of a 
nutrient to a disease or health-related condition unless the claim is 
made in accordance with the requirements of the act.
    The 1990 amendments instruct the Secretary of Health and Human 
Services (the Secretary) (and, by delegation, FDA) to issue regulations 
defining nutrient content claims that characterize levels of nutrients 
in food. The 1990 amendments also instruct the Secretary (and, by 
delegation, FDA) to issue regulations authorizing health claims only if 
he or she determines,

    ``based on the totality of publicly available scientific 
evidence (including evidence from well-designed studies conducted in 
a manner which is consistent with generally recognized scientific 
procedures and principles), that there is significant scientific 
agreement, among experts qualified by scientific training and 
experience to evaluate such claims, that the claim is supported by 
such evidence'' (section 403(r)(3)(B)(i) of the act).

    Section 403(r)(3)(B)(ii) and (r)(3)(B)(iii) of the act describe the 
information that must be included in any health claim authorized under 
the act. The act provides that the claim shall be an accurate 
representation of the significance of the substance in affecting the 
disease or health-related condition, and that it shall enable the 
public to comprehend the information and understand its significance in 
the context of the total daily diet. Section 403(r)(4)(A)(i) of the act 
also provides that any person may petition FDA to issue a regulation 
authorizing a nutrient content or health claim.
    In addition, the 1990 amendments directed FDA to consider 10 
disease-nutrient relationships as possible subjects for health claims.

B. FDA's Implementation of the 1990 Amendments

    In the Federal Register of January 6, 1993 (58 FR 2066-2941), FDA 
adopted final rules that implemented the 1990 amendments to the act. 
Among those final rules, Sec. 101.13 sets out general principles for 
nutrient content claims and provides for their use on food labels. 
Other regulations in subpart D of part 101 (21 CFR part 101) establish 
specific requirements for nutrient content claims. These regulations 
define specific terms such as ``free,'' ``low,'' ``good source,'' 
``high,'' ``reduced,'' ``less (or fewer),'' ``more,'' and ``light'' or 
``lite,'' and establish values for these terms for various nutrients. 
They also designate certain synonyms that can be used in place of these 
defined terms (58 FR 2302). In addition, Sec. 101.69 establishes 
procedures for petitioning the agency to authorize additional nutrient 
content claims and provide for additional synonyms which, if 
authorized, will be listed in the relevant regulations (Sec. 101.69) 
(e.g., ``extra'' as a synonym for ``more'').
    FDA also adopted final rules that implemented the health claims 
provisions of the act (58 FR 2478). Section 101.14 establishes general 
principles for health claims. This regulation prescribes the 
circumstances in which a substance is eligible to be the subject of a 
health claim (Sec. 101.14(b)), sets forth the standard in section 
403(r)(3)(B)(i) of the act as the standard that the agency will apply 
in deciding whether to authorize a claim about a substance-disease 
relationship (101.14(c)), sets forth general rules on how authorized 
claims are to be made in food labeling (Sec. 101.14(d)), and 
establishes limitations on the circumstances in which claims can be 
made (Sec. 101.14(e)). The agency also adopted Sec. 101.70, which 
established a process for petitioning the agency to authorize health 
claims about a substance-disease relationship (Sec. 101.70(a)) and sets 
out the types of information that any such petition must include 
(Sec. 101.70(f)).
    At the same time, the agency announced its decisions regarding 
health claims on the 10 disease-nutrient 

[[Page 66207]]
relationships specified in the 1990 amendments. Of the 10, FDA 
authorized health claims for calcium and osteoporosis (58 FR 2665); 
dietary lipids and cancer (58 FR 2787); sodium and hypertension (58 FR 
2820); dietary saturated fat and cholesterol and risk of coronary heart 
disease (58 FR 2739); fiber-containing grain products, fruits, and 
vegetables and cancer (58 FR 2537); fruits, vegetables, and grain 
products that contain fiber, particularly soluble fiber, and risk of 
coronary heart disease (58 FR 2552); and fruits and vegetables and 
cancer (58 FR 2622). The regulations on general requirements for health 
claims and on the claims specified above became effective May 8, 1993.
    In the Federal Register of January 6, 1993 (58 FR 2066), FDA also 
issued ``Food Labeling Regulations Implementing the Nutrition Labeling 
and Education Act of 1990; Opportunity for Comments,'' (the 
implementation final rule). The implementation final rule provided 30 
days for interested persons to comment on technical issues arising in 
any of the final rules implementing the 1990 amendments. In the Federal 
Register of August 18, 1993 (58 FR 44020 to 44096), FDA published 
technical amendments to the final rules in response to the comments it 
received.
    In the Federal Register of October 14, 1993 (58 FR 53254), FDA 
proposed to authorize the use of a health claim about the relationship 
between folate and the risk of neural tube defects on the labels or in 
labeling of foods in conventional food form and dietary supplements. 
This action was in response to provisions of the 1990 amendments and 
the Dietary Supplement Act of 1992 (Pub. L. 102-571). In the Federal 
Register of January 4, 1994 (59 FR 395), FDA announced that the 
proposed regulation to authorize use of the health claim about the 
association between folate and neural tube defects in food labeling was 
considered a final regulation for dietary supplements of vitamins, 
minerals, herbs, and other similar nutritional substances.

II. The Petition of the National Food Processors Association

    The National Food Processors Association (NFPA) submitted a citizen 
petition dated October 25, 1994, requesting initiation of rulemaking 
for the adoption of amendments to the regulations governing nutrient 
content and health claims. This petition was assigned FDA Docket No. 
94P-0390.
    For nutrient content claims, NFPA requested specific amendments to 
Secs. 101.13 and 101.65 allowing use of synonyms and implied nutrient 
content claims, without FDA preclearance, that are understood by 
consumers to have the same meaning as a defined term, where such claims 
are made in accordance with the requirements for the defined term, and 
the defined term also appears in the product's labeling.
    NFPA also requested several amendments to the health claim 
regulations. Among other changes, NFPA requested that FDA permit the 
use of an abbreviated or implied health claim with a referral statement 
directing consumers to the complete claim elsewhere in labeling. 
Currently, all required information must appear in one place without 
other intervening material.
    It also requested that health claims be permitted for foods with 
levels of nutrients that FDA had determined increase the risk of other 
diseases to the general population. Among the general requirements for 
health claims, FDA established in Sec. 101.14(a)(5) levels of total 
fat, saturated fat, cholesterol, and sodium in a food above which the 
food is disqualified from making a health claim. These are identified 
as ``disqualifying nutrient levels.'' In its petition, NFPA suggested 
that FDA amend the regulation so that a food with a nutrient at a 
disqualifying level would be prohibited from making a health claim only 
if the nutrient is directly and adversely associated with the disease 
to which the claim refers. Absent such an association, NFPA requested 
that the presence of a nutrient above a threshold level not disqualify 
a product from bearing a health claim but instead require disclosure of 
that fact in labeling.
    Finally, NFPA requested an amendment to Sec. 101.14(e)(6), which 
prohibits a food in conventional food form from bearing a health claim 
unless the food contains 10 percent or more of the Reference Daily 
Intake or Daily Reference Value for vitamin A, vitamin C, iron, 
calcium, protein, or fiber per reference amount customarily consumed 
before any nutrient addition (the ``10 percent nutrient contribution 
requirement''). NFPA requested that this prohibition be replaced by a 
requirement that any food bearing a health claim that refers to an 
added nutrient disclose the fact of that nutrient addition in labeling.
    FDA issued a letter on May 11, 1995, granting most of the requests 
to initiate rulemaking on the foregoing aspects of the petition 
(hereinafter referred to as the May 11, 1995, letter). However, the 
agency denied certain aspects of NFPA's petition, including NFPA's 
request that FDA change the levels in Sec. 101.14(a)(5) from 
disqualification levels to disclosure levels. Although the agency 
recognized that it has the authority under section 403(r)(3)(A)(ii) of 
the act to exempt any claim from the disqualifying nutrient levels if 
it finds that the claim would ``assist consumers in maintaining healthy 
dietary practices,'' the agency concluded that a generic change in its 
regulations would not be consistent with the underlying goals of the 
NLEA.
    FDA acknowledged, however, that disclosure rather than 
disqualification may be appropriate under certain circumstances. The 
agency said it will seek more limited criteria to define the conditions 
under which disclosure rather than disqualification could be permitted.

III. The Petition of the American Bakers Association

    A citizen petition, dated July 27, 1995, was submitted to FDA by 
the ABA (Docket No. 95P-0241/CP 1), requesting that FDA amend, among 
other things, the regulatory provision in Sec. 101.14(e)(6) to permit 
enriched cereal-grain products that conform to the standards of 
identity in part 136, 137, or 139 (21 CFR part 136, 137, or 139), and 
bread that conforms to the standard of identity for enriched bread in 
Sec. 136.115, except that it contains whole wheat or other grain 
products not permitted under that standard, to bear health claims. The 
petition specifically requested that FDA amend Sec. 101.14(e)(6) to 
read:

    Except for dietary supplements, enriched grain products that 
conform to a standard of identity in part 136, 137, or 139, and 
bread that conforms to the standard of identity for enriched bread 
in Sec. 136.115, except that it contains whole wheat or other grain 
products not permitted under that standard, or where provided for in 
other regulations in part 101, subpart E.

In the alternative, ABA suggested that the agency expand the list of 
qualifying nutrients to include complex carbohydrates, niacin, or 
thiamin or allow the 10 percent nutrient contribution requirement to 
apply to all foods for which the summation of the Daily Value of the 
applicable nutrients is 10 percent rather than requiring that the 10 
percent be based on a single serving.
    Because of the similarities in the NFPA and ABA petitions regarding 
the 10 percent nutrient contribution and health claims, FDA is 
responding to part of the ABA petition in this document, which 
implements FDA's May 11, 1995, letter response to the NFPA petition. 
Other issues raised in the ABA petition will be handled separately.

[[Page 66208]]

IV. The Proposals

    As the petitioners have requested, the agency is reconsidering its 
position on several of the issues raised in the NFPA and ABA petitions. 
The agency is well within its legal authority to reconsider the issues 
in the NFPA petition and propose changes to the current food labeling 
regulations. ``An agency may always change its mind and alter its 
policies.'' (See Conference of State Bank Examiners v. Office of Thrift 
Supervision, 792 F. Supp. 837, 845 (D.D.C. 1992)). While the burden is 
on the agency to justify the change from the status quo, that 
justification need not consist of an affirmative demonstration that the 
status quo is wrong. The agency need only supply ``a reasoned analysis 
for the change.'' (See Center for Auto Safety v. Peck, 751 F.2d 1336, 
1349 (D.C. Cir 1985) (citing Motor Vehicle Mfrs. Ass'n v. State Farm 
Mutual, 463 U.S. 29, 41, 103 S.Ct. 2856, 2865-2866 (1983))). The agency 
can justify its departure from past policy ``with reference to the 
objectives underlying statutory scheme it purports to construe.'' (See 
Simmons v. I.C.C., 829 F.2d 150, 156 (D.C. 1987)).
    One of the primary purposes of the 1990 amendments was to educate 
consumers about healthful dietary practices. The legislative history 
states, ``Health claims supported by significant scientific agreement 
can reinforce the Surgeon General's recommendations and help Americans 
to maintain a balanced and healthful diet'' (Ref. 1).
    If the current regulations hinder food companies who want to use 
one of the FDA-authorized claims, as NFPA has alleged, this public 
health objective will be frustrated. As the agency has stated, if valid 
health claims are not being used, ``there is a cost imposed on society 
in that some valuable information may not be conveyed to consumers'' 
(58 FR 2927 at 2940). Consumers cannot change their dietary practices 
if they do not have the necessary information.
    The agency is pleased that many food companies are using the health 
claims on the labels of their products. While the agency has not done 
an extensive survey, FDA notes that dozens of health claims have 
appeared on products such as cereal, cookies, frozen dessert bars, egg 
products, and frozen vegetables. Nonetheless, the agency is concerned 
that health claims are not being used as extensively as they could be, 
despite the fact that many foods qualify for such claims.
    FDA also notes that food companies are submitting petitions seeking 
approval of new claims. Since the final regulations have been 
published, the agency has received two such petitions, one regarding 
sugar alcohols and dental caries and one regarding oat products and 
coronary heart disease. A proposed regulation to authorize a health 
claim regarding sugar alcohols and dental caries was published in the 
Federal Register on July 20, 1995 (60 FR 37502) (hereinafter referred 
to as the sugar alcohols proposal). The agency expects to complete in 
the very near future its evaluation of the petition regarding oat 
products and coronary heart disease.
    Accordingly, the agency is proposing changes to the regulations 
regarding the use of synonyms for nutrient content claims, the 10 
percent nutrient contribution requirement for health claims, the use of 
abbreviated health claims, the specific requirements for individual 
health claims, and disqualifying levels for health claims to facilitate 
additional use of these claims.

A. Synonyms in Nutrient Content Claims

    Section 403(r)(1)(A) and (r)(2) of the act state that claims that 
either expressly or by implication characterize the level of a nutrient 
(nutrient content claims) may be made in the label or labeling of a 
food only if the characterization of the level made in the claim uses 
terms that are defined in regulations of the agency. Based on these 
provisions, the agency has defined expressed claims as any direct 
statement about the level (or range) of a nutrient in the food 
(Sec. 101.13(b)(1)). In addition, it has defined implied claims as 
nutrient content claims that describe the food or an ingredient therein 
in a manner that suggests that a nutrient is absent or present in a 
certain amount (e.g., ``high in oat bran'') (Sec. 101.13(b)(2)(i)) or 
that suggests that the food, because of its nutrient content, may be 
useful in maintaining healthy dietary practices and is made in 
association with an expressed claim or statement about a nutrient 
(e.g., ``healthy, contains 3 grams of fat'') (Sec. 101.13(b)(2)(ii)).
    The agency has specifically defined a number of expressed nutrient 
content claims (``free,'' ``low,'' ``reduced,'' ``light,'' ``good 
source,'' ``high,'' and ``more'') and provided for their synonyms, 
e.g., ``no,'' ``little,'' ``contains,'' and ``rich in.'' The agency 
also provided for certain implied nutrient content claims 
(Sec. 101.65(c) and (d)). Finally, the agency has defined the implied 
nutrient content claim ``healthy'' (Sec. 101.65(d)(2)).
    The agency considered the use of additional synonyms for the 
defined terms in the 1993 nutrient content claims final rule (58 FR 
2302 at 2320). At that time the agency provided for a limited number of 
specific synonyms and declined to provide for either long lists of 
synonyms or conditions for use of unevaluated terms. The agency 
concluded that permitting additional synonyms to be used in conjunction 
with either a defined claim or a disclosure statement explaining the 
synonym's intended meaning would not assist consumers in maintaining 
healthy dietary practices (58 FR 2302 at 2320). The agency stated that 
there is no provision in the act that allows for the use of undefined 
synonyms in the absence of action by the agency. Because of time 
constraints, in developing the final regulations FDA was unable to 
fully study the suggested schemes for use of terms without preclearance 
to determine whether a scheme could be devised that would constitute 
approval by the agency without preclearance of each term.
    The agency also considered but rejected (58 FR 2302 at 2373) the 
suggestion that implied claims that are defined on the label be 
permitted. The agency did provide for certain implied claims on 
products that meet the definition for certain expressed claims and gave 
specific examples of some of these claims in the preamble (58 FR 2302 
at 2374) and in the regulations (Sec. 101.65(c)(3)) (e.g., ``high in 
oat bran'' for foods that are a good source of fiber; ``no oil'' for 
fat free foods).
    In the October 25, 1994, petition, as stated above, NFPA requested 
that the agency reconsider allowing synonyms and implied nutrient 
content claims to be used without FDA preclearance under certain 
circumstances. NFPA maintained that FDA's strict interpretation and 
application of the 1990 amendments totally frustrated the achievement 
of the various statutory goals of improving consumer education about 
diet and health and thereby reducing the incidence of diet-related 
diseases.
    NFPA argued that, because the regulations sharply limit the 
terminology that can be used to make nutrient content claims for food 
products and require ``premarket clearance'' of terminology that FDA 
has not specifically authorized by regulation, the regulations ban a 
host of truthful and nonmisleading labeling statements. The petitioner 
requested that FDA propose amendments that would permit nonmisleading 
terms or statements that are reasonably understood by consumers to be 
synonyms of a term defined in subpart D of part 101 to be used in 
product labeling when the defined term also is used in the labeling. 
Requesting similar amendments for implied claims, NFPA 

[[Page 66209]]
stated that such amendments would ensure that claims characterizing the 
level of a nutrient in a food are truthful and nonmisleading but would 
give manufacturers greater freedom to construct such labeling messages 
creatively.
    In its May 11, 1995, response, FDA recognized that there may be 
some merit to the argument that more latitude in the use of truthful, 
nonmisleading nutrient content claims may assist consumers in 
maintaining healthy dietary practices because greater flexibility would 
provide the food industry with an increased incentive to develop more 
healthful products. Permitting synonyms for defined terms to be used on 
product labels without specific authorization for the particular 
synonyms has the potential to provide the industry with a greater 
variety of ways to convey nutrient information to the consumer because 
the nutrient content claims on the label would not be restricted to a 
finite list of terms that can only be expanded by filing an appropriate 
petition. This approach could facilitate the industry's efforts to 
arrive at terms that not only appropriately describe the nutrient level 
in a food but also effectively catch the attention of the consumer.
    In its May 11, 1995, letter, the agency noted that while a plethora 
of uncontrolled terms would confuse consumers by diminishing the 
usefulness of clearly defined and limited terms, NFPA's ``anchoring'' 
concept, if properly implemented, could offer the possibility of 
increasing the available terms without confusing consumers. The agency 
stated that it was granting NFPA's petition to initiate rulemaking on 
the use of additional synonyms anchored to specifically authorized 
terms.
    Consequently, the agency is proposing to add new paragraph (r) to 
Sec. 101.13, which provides that synonyms may be used in labeling in 
accordance with one of two provisions. First, proposed 
Sec. 101.13(r)(1) reflects the fact that a term may be used as a 
synonym when the agency has specifically listed it as a synonym for a 
defined term in one of the regulations listing authorized nutrient 
content claims in subpart D of part 101 (``listed synonym''). FDA 
included a number of synonyms in the regulation that it adopted as part 
of the 1993 nutrient content claims final rule. It has also adopted 
synonyms as a result of a petition filed in accordance with 
Sec. 101.69(n). Additional synonyms may be added to FDA's regulations 
following this procedure. Second, FDA is proposing in Sec. 101.13(r)(2) 
to authorize the use of synonyms that are not specifically listed by 
name in the regulations in subpart D of part 101, part 105, or part 107 
(21 CFR part 105 or part 107) (``unlisted synonyms'') but are used in 
labeling in accordance with the labeling requirements set out in this 
provision.
    Specifically, in Sec. 101.13(r)(2), the agency is proposing a 
number of requirements to ensure that the use of unlisted synonyms will 
not confuse or mislead consumers. In particular, FDA is proposing in 
Sec. 101.13(r)(2)(i) to require that an unlisted term be reasonably 
understood by consumers to be a synonym of a term defined in subpart D 
of part 101, part 105, or part 107. Such an understanding is necessary 
because the agency has, for example, defined the terms ``high'' and 
``good source'' to represent two different levels of a nutrient.
    Consumers can reasonably be expected to understand that ``without 
any [nutrient]'' is the same as ``free of [nutrient],'' and that ``not 
much'' of a nutrient is, in common usage, synonymous with ``low'' for 
that nutrient since ``not much'' implies that some but not a lot of the 
nutrient is present. Other ``synonyms'' however, may not be so clear. 
It is important, therefore, that the use of unlisted synonyms that FDA 
is proposing to authorize under Sec. 101.13(r)(2) be clear and 
unambiguous to consumers regarding the levels to which they apply. 
Without such clarity, consumers may be confused as to the nutrient 
content of the food bearing the claim. Thus, regardless of the 
prominent use of a listed term or other explanatory information 
discussed below, terms that are not clearly understood by consumers to 
be synonymous with specific listed terms may still be misleading and 
misbrand the food under both section 403(a) and section 403(r)(1)(A) of 
the act.
    Further, the agency is concerned that different manufacturers might 
use the same term but anchor it to different nutrient content claims. 
For example ``plenty of fiber'' might be anchored to ``good source'' on 
one product label and ``high'' on another. In this event, the agency 
reserves the right to call for petitions to define the term by 
regulation or to define the term on its own initiative.
    The agency agrees with NFPA that, in addition to considering the 
words of the individual claim, it is important to consider the meaning 
of the unlisted synonym in the context of the entire product label. It 
is possible, for instance, that other statements such as other nutrient 
content claims on the label or in labeling could establish a context in 
which the unlisted synonym would be misleading. Section 403(a) of the 
act states that a food is misbranded if it bears any labeling statement 
that is false or misleading in any particular. Therefore, proposed 
Sec. 101.13(r)(2)(i) requires that the unlisted synonym not be 
misleading in the context of the entire label.
    The agency seeks comments as to whether further requirements should 
be imposed to ensure that an unlisted term is truly synonymous with a 
listed term. For example, FDA seeks comments as to whether it should 
require companies to have data in their files demonstrating that 
consumers understand the unlisted term to be synonymous with the listed 
term in question as a condition for the use of the unlisted terms. In 
addition, the agency seeks comments on why, if it includes such a 
requirement, it should not also require that such data be available for 
review by regulatory officials.
    As stated above, for any term used as a synonym authorized under 
proposed Sec. 101.13(r)(2) not to be misleading, the defined term for 
which it purports to be a synonym would have to be clear to the 
consumer. Proposed Sec. 101.13(r)(2)(ii)(A) will require that the 
listed term appear prominently and conspicuously on the label.
    Proposed Sec. 101.13(r)(2)(ii)(A)(1) requires the listed term 
appear immediately adjacent to (with no intervening material) the most 
prominent (as defined in Sec. 101.13(j)(2)(iii)) use of the unlisted 
synonym. The agency tentatively concludes that having a listed term 
immediately adjacent to the most prominent use of each such unlisted 
synonym will help to ensure that consumers understand the claim that is 
being made and thus to ascertain the level of the nutrient that the 
food purports to contain.
    The agency tentatively concludes that it is not sufficient for the 
listed term to appear anywhere on the label, as suggested in the NFPA 
petition. Such a scheme would not guarantee that the unlisted synonym 
is read in conjunction with a listed term and would hinder the consumer 
from ascertaining the level of the nutrient that the food purports to 
have. For example, with such a provision, the unlisted synonym 
authorized under Sec. 101.13(r)(2) could be very large and prominent, 
and the listed term could be a part of the fine print (i.e., in small 
print that is in sentence or paragraph form elsewhere on the label). 
Although such defining information may be read by consumers at some 
point, it would be unlikely to be fully read and comprehended at the 
same 

[[Page 66210]]
time as the unlisted term and thus would not make clear to the consumer 
that the two statements are synonymous.
    The agency's proposal is consistent with section 403(f) of the act 
which deems a food to be misbranded if any word, statement, or other 
information required by the act to appear on the label or labeling is 
not prominently placed with such conspicuousness (as compared with 
other words, statements, designs, or devices, in the labeling) and in 
such terms as to render it likely to be read and understood by the 
ordinary individual under customary conditions of purchase and use. 
Section 403(f) of the act necessitates placement of the listed term on 
the label so that it is likely to be read and understood, and thereby 
to eliminate any ambiguity as to the meaning of the unlisted synonym. 
Allowing the listed term to be anywhere on the label that the 
manufacturer chooses would not ensure that this requirement is met.
    There are a number of precedents for requiring clarifying 
information in labeling to be adjacent to the text that it clarifies. 
For example, Sec. 101.3(e) requires that the word ``imitation'' precede 
the name of the food imitated; the term ``artificial'' is required by 
Sec. 101.22(i)(1)(i), (i)(1)(ii), and (i)(3) to be adjacent to the name 
of the flavor; and Sec. 102.5(b)(2) (21 CFR 102.5(b)(2)) requires that 
if the percentage of a characterizing ingredient is required to be 
included in the common or usual name of the food, it must be adjacent 
to the name of the food. Further, several aspects of the nutrient 
content claims regulations require that clarifying statements such as 
the referral statement, ``See [side] panel for nutrition information'' 
(Sec. 101.13(g)); the disclosure statement, ``See [side] panel for 
information about [sodium] and other nutrients'' (Sec. 101.13(h)); the 
percentage reduction and identity of the reference food for a relative 
claim (Sec. 101.14(j)(2)(ii)); and other clarifying information about 
the food in relation to the claim, e.g., Sec. 101.13(i)(2) and (p)(2), 
be immediately adjacent to the claim to which the statement pertains.
    As with accompanying information for relative claims (i.e., percent 
reduction in the nutrient and identity of the reference food 
(Sec. 101.13(j)(2)(i) through (j)(2)(iii)), the agency considers the 
presence of a listed term to be necessary to ensure that the claim is 
understood by, and is not misleading to, consumers. However, as with 
accompanying information, it recognizes that to require that this 
information be included each time an unlisted synonym is used may 
overburden the label. Consequently, as with relative claims, the agency 
is proposing to require only that the defined term or listed synonym be 
placed immediately adjacent to the most prominent declaration of each 
unlisted synonym. Because of the similar purposes of the two 
requirements, the agency believes that the provisions in 
Sec. 101.1(j)(2)(iii) for determining the order of prominence of 
relative claims are also appropriate for determining the order of 
prominence of presentations of an unlisted synonym. The order of 
prominence for relative claims is: (1) A claim on the principal display 
panel adjacent to the statement of identity, (2) a claim elsewhere on 
the principal display panel, (3) a claim on the information panel, or 
(4) a claim elsewhere on the label or labeling.
    The agency is proposing in Sec. 101.13(r)(2)(ii)(A)(2) that the 
listed term be at least half as prominent as the unlisted synonym. If 
it adopts these changes, FDA will evaluate prominence using type size, 
style, and color. In the past, FDA has required certain clarifying 
information to be in type at least half the size of that of the 
statement it is clarifying. For example, when the term ``light'' is 
used to describe a physical or organoleptic property of a food (e.g., 
``light in color''), the clarifying information ``in color'' is 
required to be at least half the type size as the word ``light'' 
(Sec. 101.56(e)(2)). Similarly, when the term ``light'' is used on a 
meal type product to describe a nutrient reduction, a clarifying 
statement as to whether the food is ``low in calories'' or ``low in 
fat'' is required and must be at least half the size of the term 
``light'' (Sec. 101.56(d)(1)(ii)). Further, Sec. 102.5 requires that 
the percentage declaration of a characterizing ingredient or component 
be no less than half the height of the largest type appearing in the 
common or usual name when it has a material bearing on the nature of 
the product. Further, this information must appear in bold-faced type. 
As a final example, Sec. 101.13(f) requires that any nutrient content 
claim not be more than two times larger than, and not unduly prominent 
in type style compared to, the statement of identity. All of these 
provisions are examples of requirements where clarifying information 
must be at least half as large or prominent as the statement that it is 
clarifying.
    FDA is proposing section 101.13(r)(2)(ii)(A)(1) and 
(r)(2)(ii)(A)(2) to ensure that the combination of unlisted and listed 
terms that appear on a food label are understood by consumers to be 
making a single claim. This understanding is crucial because the act 
requires that a nutrient content claim be made ``only if the 
characterization of the level made in the claim uses terms which are 
defined in regulations * * *.'' (Section 403(r)(2)(A)(i) of the act 
(emphasis added).) In its petition, NFPA argues that there is nothing 
in the act that defines a claim to mean individual label statements--as 
opposed to the overall message conveyed by labeling for a product. The 
petition stated that, in NFPA's view, a ``claim'' is properly viewed 
under the statute as referring to the message about the level of a 
particular nutrient in the food conveyed in the context of the entire 
product labeling. NFPA maintained that, while the labeling should 
include terms defined by FDA, other synonyms or implied statements 
concerning the nutrient should be viewed as components of the single 
labeling claim. FDA tentatively concludes that the use of unlisted 
synonyms in the manner proposed will ensure that consumers understand 
them to be part of a single nutrient content claim that uses terms 
defined by regulation. As stated in its May 11, 1995, letter to NFPA, 
however, the agency cannot finalize this rule unless it receives 
evidence demonstrating that consumers understand the terms used in this 
way.
    FDA also recognizes that there may be some labels on which the 
listed term is significantly more prominent than an unlisted synonym. 
This would be the case, for example, if the listed term was made in a 
``burst'' or in the statement of identity and the unlisted synonym was 
used in a paragraph in smaller sized type. Such usage might occur if a 
manufacturer wanted to use a variety of ways to express the level of a 
nutrient in a discussion about the food. The agency tentatively finds 
that, in this case, the level of the nutrient described by the listed 
term would be clearly understood, and additional clarification next to 
the smaller print on the same label would not be necessary. Therefore, 
FDA is proposing in Sec. 101.13(r)(2)(ii)(B) that if the listed term is 
more than twice as prominent on a label as the listed synonym, such 
that the claimed nutrient level is clearly understood, e.g., a bold 
faced listed term versus an unlisted synonym used only in a paragraph 
in smaller sized type, the listed need not be placed adjacent to the 
unlisted synonym. The agency requests comment on whether this approach 
is consistent with a nonmisleading label.
    The agency is also providing in proposed Sec. 101.13(r)(2)(iv) that 
a listed term may not be used with an unlisted synonym to form a new 
term, e.g., extra low, extra high, especially good source, or great 
source. In its review of food 

[[Page 66211]]
labels before the passage of the 1990 amendments, the Institute of 
Medicine (IOM) stated that consumers were confused by the plethora of 
terms on food labels and recommended that definitions of nutrient 
levels for label claims be severely restricted (Ref. 2). The IOM 
recommended that four levels be defined for explicit claims: Low, very 
low, high and very high or their equivalents. The agency has 
essentially done just that in defining, ``low,'' ``free,'' ``good 
source'' and ``high.'' With the use of unlisted synonyms, the agency is 
concerned that there may be instances when the use of unapproved 
modifiers for these terms (e.g., ``extra low,'' ``extra high,'' 
``especially good source,'' ``great source'') would confuse consumers 
by unjustifiably suggesting that there is a distinction between the 
listed term with and without the modifier. To avoid this confusion, the 
agency tentatively concludes that it is necessary to prohibit the use 
of claims that consist of a term that modifies an existing listed term.
    In the course of developing the definitions and other requirements 
for the use of nutrient content claims, the agency made a diligent 
effort to determine the various meanings and requirements of the 
nutrient content claims it defined. In some cases the agency determined 
that, in order for the label not to be misleading, it was necessary for 
certain additional information to be conveyed to consumers along with 
the claim. This information included referral or disclosure statements 
(required by the statute), additional label statements such as 
accompanying information for foods bearing relative claims 
(Sec. 101.13(j)(2)), and other statements such as ``not a sodium free 
food'' on a food bearing an ``unsalted'' claim that was not ``sodium 
free'' (Sec. 101.61(c)(2)(iii)). Just as this information is necessary 
for a listed term not to be misleading and for a label bearing such a 
claim to provide full and relevant information to the consumer, the 
agency tentatively concludes that such additional information is 
equally important and necessary when unlisted synonyms are used. 
Consequently, the agency is proposing in Sec. 101.13(r)(2)(iii) to 
require that unlisted synonyms be used in conformance with all of the 
requirements for the use of the listed terms.
    The petitioners also requested that the agency permit the use of 
unlisted synonyms with implied claims such as terms, statements, or 
symbols. As with unlisted synonyms, FDA tentatively finds that this 
concept may have some merit. However, the agency points out that 
implied claims that are consistent with a listed term may currently be 
used on a label. Therefore, the agency is not proposing further 
provisions for the use of implied nutrient content claims.

B. Section 101.14(e)(6): The 10 Percent Nutrient Contribution 
Requirement

    In the Federal Register of January 6, 1993, FDA published a final 
rule entitled ``Food Labeling: General Requirements for Health Claims 
for Food'' (58 FR 2478) (hereinafter referred to as the 1993 health 
claims final rule). Among other things, this rule requires that, to be 
eligible to bear a health claim, a food other than a dietary supplement 
contain 10 percent or more of the Daily Value (DV) for vitamin A, 
vitamin C, iron, calcium, protein, or fiber, before any nutrient 
addition (Sec. 101.14(e)(6)). As explained in that document, FDA 
concluded that such a requirement was necessary to assure that the 
value of health claims would not be trivialized or compromised by their 
use on foods of little or no nutritional value. Furthermore, such a 
requirement responded to Congress's intent that health claim provisions 
consider the role of the nutrients in food in a way that will enhance 
the chances of consumers constructing total daily diets that meet 
dietary guidelines. Thus, foods bearing health claims should be 
consistent with current dietary guidelines. Furthermore, the agency 
concluded that fortification of foods of little or no nutritional value 
for the sole purpose of qualifying that food for a health claim is 
misleading, especially if foods such as confections, soda, and sweet 
desserts are fortified to qualify for a health claim, because such 
foods have been cited in dietary guidance as those that should be used 
sparingly.
    In the Federal Register of August 18, 1993 (58 FR 44036), FDA 
published technical amendments to the health claim regulations in 
response to comments that the agency received on the implementation 
final rule (hereinafter referred to as the 1993 health claims technical 
amendment). One of the comments stated that if a health claim petition 
were submitted for the claim ``useful only in not promoting tooth 
decay,'' virtually none of the sugar-free products on the market would 
be eligible to bear the claim because of the 10 percent nutrient 
contribution requirement.
    In the 1993 health claims technical amendments, FDA acknowledged 
that certain food products of limited nutritional value that have been 
specially formulated relative to a specific disease condition, such as 
dental caries, may be determined to be appropriate foods to bear a 
health claim. The agency commented that its intention was to deal with 
such situations within the regulations authorizing specific health 
claims. Therefore, FDA amended Sec. 101.14(e)(6) to state that:

    Except for dietary supplements not in conventional food form or 
where provided for in other regulations in part 101, subpart E, the 
food contains 10 percent or more of the Reference Daily Intake or 
Daily Reference Value for vitamin A, vitamin C, iron, calcium, 
protein, or fiber per reference amount customarily consumed prior to 
any nutrient addition.

The terminology ``not in conventional food form'' was subsequently 
deleted in the final rules pertaining to health claims for dietary 
supplements published in the Federal Register on January 4, 1994 (59 FR 
395).
    The sugar alcohols proposal proposes such an exemption from the 10 
percent nutrient contribution requirement.
    Following publication of the health claims final rule, two trade 
associations--NFPA and the ABA--submitted petitions to FDA requesting 
that the agency revise the general requirements for health claims and 
reconsider its decision regarding the 10 percent nutrient contribution 
requirement. The NFPA petition argued that the 10 percent nutrient 
contribution requirement precludes truthful, nonmisleading health 
claims because it sets an arbitrary nutritional contribution a food 
must make to the diet to qualify for any claim. Consequently, NFPA 
argued, the 10 percent nutrient contribution requirement prohibits some 
common fruits, vegetables, and other wholesome and nutritious foods 
from making health claims. While NFPA agreed that a food bearing a 
health claim should contain levels of the nutrient consistent with the 
health claim, it contended that the lack of significant levels of other 
nutrients should not prevent a food from bearing a health claim. NFPA 
argued that if other nutrient levels are deemed to be material with 
respect to consumers' understanding of a health claim, then such levels 
should be disclosed in the Nutrition Facts panel.
    Furthermore, NFPA contended that the 1993 health claims final rule 
precludes truthful, nonmisleading claims because it prohibits a food 
from satisfying the 10 percent nutrient contribution requirement 
through fortification. NFPA stressed that even though fortification of 
a food to support a health claim is material information that should be 
disclosed in labeling, added and indigenous nutrients are equally 
nutritious, and, therefore, 

[[Page 66212]]
prohibiting fortified foods from bearing a health claim is not 
justified.
    NFPA requested that FDA amend Sec. 101.14(e) by revoking the 
requirement that foods bearing a health claim contain 10 percent of the 
DV of vitamin A, vitamin C, calcium, protein, iron, or fiber before any 
nutrient addition, so that fruits, vegetables, and other nutritious 
foods could bear health claims.
    The ABA petition did not request that the agency revoke the 10 
percent nutrient contribution requirement. Rather, it requested that 
FDA modify the 10 percent nutrient contribution requirement to permit 
health claims on certain enriched grain products. ABA contended that 
while some enriched breads might meet the 10 percent nutrient 
contribution requirement for fiber, most enriched grain products cannot 
meet the 10 percent nutrient contribution requirement for any of the 
six listed nutrients because they are precluded by the standards of 
identity from containing 10 percent of the six listed nutrients. ABA 
also stated that the standards of identity require specific nutrient 
addition at levels that were established by FDA as optimal for reducing 
the risk of certain diet-related diseases. These foods, in fact, have 
been used for many years to improve the nutrition of U.S. consumers and 
to reduce the risk of diet-related diseases. Therefore, ABA contended 
that these foods are precisely the kinds of foods that should be 
permitted to bear health claims.
    ABA argued that the 10 percent nutrient contribution requirement 
was obviously not intended to apply to foods that conform to the 
standards of identity for enriched grain products because it precludes 
virtually all enriched grain products from bearing health claims. It 
contended that this exclusion is inconsistent with the basis of the 
health claims because these foods are not only beneficial in reducing 
the risk of diet-related diseases but, more importantly, are also 
recommended in current dietary guidelines as foods whose consumption 
should be increased to maintain a balanced and healthful diet. The 
petition noted that the Food Guide Pyramid recommends that 6 to 11 
servings of grain products be consumed per day. ABA contended that this 
recommendation demonstrates the importance of including these foods in 
the diet. ABA argued that the 10 percent nutrient contribution 
requirement has had the unintended effect of precluding foods that FDA 
concluded could appropriately bear a health claim from bearing the 
claim. Thus, ABA requested that the agency amend Sec. 101.14(e) to 
exempt from the 10 percent nutrient contribution requirement enriched 
grain products that conform to a standard of identity in part 136, 137, 
or 139, and bread that conforms to the standard of identity for 
enriched bread in Sec. 136.115, except that it contains whole wheat or 
other grain products not permitted under that standard.
    In the alternative, ABA suggested that the agency expand the list 
of nutrients that must be present at 10 percent to include complex 
carbohydrates, niacin, or thiamin. Such action, the petition explained, 
would permit enriched grain products to bear health claims because 
these products are a significant source of such nutrients.
    As a second alternative, ABA suggested that FDA amend the 10 
percent nutrient contribution requirement to allow it to apply to a 
daily consumption of grain products rather than to the nutrient profile 
of a specific food.
    FDA has fully evaluated and considered the arguments raised in both 
petitions. FDA recognizes that the 10 percent nutrient contribution 
requirement may have had the unintended effect of prohibiting health 
claims on certain foods that could be beneficial for consumers and help 
them to maintain a balanced and healthful diet. The agency is 
concerned, however, that eliminating the 10 percent nutrient 
contribution requirement will permit misleading health claims on foods 
with little or no nutritional value such as candies and soft drinks or 
will encourage overfortification of the food supply (e.g., vitamin or 
mineral addition to soft drinks). The appearance of health claims on 
such foods would be inconsistent with Congress's intent when it enacted 
the health claims provisions. As discussed in the 1993 health claims 
final rule, Congress enacted the health claims provisions of the 1990 
amendments to not only protect consumers from health claims that are 
not scientifically valid but also to help consumers maintain healthy 
dietary practices by providing information that would be useful in 
constructing total daily diets that meet current dietary guidelines. 
Thus, an important part of the significance and benefit of health 
claims is that they appear on foods that are compatible with current 
dietary recommendations. (See H. Rept. 101-538, 101st Cong., 2d sess. 
pp. 9-10 (1990).)
    During the development of the health claims final rule, FDA 
considered other alternatives that would ensure that health claims are 
not trivialized or rendered meaningless by appearing on foods of little 
or no nutritional value. For example, the agency considered prohibiting 
health claims on specific foods, such as confections, soda, and snack 
foods, based on the foods' categorization or characteristic use. 
However, as fully discussed in the 1993 health claims final rule (58 FR 
2478 at 2521), the agency was not persuaded that such action was in 
keeping with the intent of the statute. The agency concluded that 
Congress did not intend that specific foods that could be in general 
use be prohibited from bearing a health claim. Thus, the agency 
concluded that a prohibition on health claims for specific categories 
of foods was not a viable option.
    However, given the requirement in section 403(r)(3)(B)(iii) of the 
act that a claim should enable the public to comprehend the information 
in a claim and understand the relative significance of that information 
in the context of a total daily diet, FDA concluded (as discussed in 
the 1993 health claims final rule (58 FR 2478 at 2521-2522)) that it is 
appropriate to provide a basis for health claims that takes into 
account the nutritional contribution of the food beyond its role as a 
source of calories. The agency noted that ``Congress intended that FDA 
establish provisions of health claims regulations by considering the 
role of the nutrients in food in a way that will enhance the chances of 
consumers constructing total daily diets that meet dietary guidelines'' 
(Id. at 2521). Without such provisions, foods that are not compatible 
with dietary guidelines could bear health claims. In addition to being 
inconsistent with Congress's intent when it established the health 
claim provisions, and section 403(r) of the act, claims intended to 
promote the consumption of a food that is incompatible with dietary 
guidelines would be misleading to consumers and, therefore, would be in 
violation of section 403(a) (id.). Such claims would be misleading 
because consumers would be purchasing the food, in part, to achieve a 
more healthful diet, when, in fact, such foods are inconsistent with 
dietary guidelines. Further, such claims could be damaging if consumers 
are encouraged to replace wholesome and nutritious foods that are 
recommended in dietary guidelines with these foods.
    Thus, the agency concluded then, and reiterates now, that the 10 
percent nutrient contribution requirement is a necessary component of 
the health claims provisions to ensure that such claims appear on foods 
that make a nutritional contribution to the diet and are consistent 
with dietary guidelines. If the agency were to revoke this requirement, 
it would have to establish 

[[Page 66213]]
an alternative mechanism to ensure that health claims are not made on 
inappropriate foods. The NFPA petition did not suggest any alternatives 
to the 10 percent nutrient contribution requirement to preclude 
misleading health claims on inappropriate foods.
    The agency also tentatively concludes that the alternatives 
suggested in the ABA petition would not ensure that health claims were 
made only on foods that are consistent with dietary guidelines. Relying 
on either of the two alternatives suggested in the ABA petition would 
not adequately assist consumers in placing foods that bear health 
claims in their proper dietary context.
    The ABA's suggestion that the nutrients required to be present at 
10 percent be expanded to include thiamin, niacin, or carbohydrates 
would not encourage consumers to increase their intake of vitamins and 
minerals that have been identified as those of continuing public health 
significance. Public health concerns for deficient intakes of thiamin, 
niacin, or carbohydrates have lessened considerably in the last 20 
years, whereas the inadequate intakes of vitamin A, vitamin C, calcium, 
and iron remain a public health concern especially because of the 
possible association between several of these nutrients and the risk of 
chronic disease. Furthermore, expanding the list of nutrients required 
to be at 10 percent to include thiamin, niacin, or carbohydrates would 
permit only certain foods to bear health claims, such as enriched 
cereal grain products. Certain fruit and vegetable products that are 
promoted in dietary guidelines but that are currently prohibited from 
bearing health claims would still not be able to bear a health claim. 
Consequently, the agency tentatively concludes that expanding the list 
of nutrients would not sufficiently address the concern that the 
current regulation precludes certain foods that contribute to a 
healthful diet, and whose consumption is encouraged by the dietary 
guidelines, from bearing health claims.
    Likewise, permitting the 10 percent nutrient contribution 
requirement to be based on the daily consumption of a food group would 
not enhance the likelihood of consumers achieving dietary goals. In 
fact, such a requirement would be contrary to dietary goals because it 
would reduce the likelihood that a consumer would reach 100 percent of 
the DV if daily consumption of an entire food group only supplies 10 
percent of one of the listed nutrients. One reason for requiring that a 
serving of the food provide 10 percent of one or more of the listed 
nutrients is to assist the consumer in achieving daily intakes 
recommended in current dietary guidelines. Permitting a food that does 
not meet the 10 percent nutrient requirement to bear a claim on the 
basis that the total daily consumption of foods from that category 
would provide 10 percent of the nutrient would be inconsistent with one 
of the basic principles of the requirement. Accordingly, the agency has 
not been persuaded by the arguments raised in the petitions to propose 
to eliminate the 10 percent nutrient contribution requirement, to 
expand the list of nutrients that will qualify a food to bear a health 
claim, or to allow the 10 percent nutrient requirement to apply to a 
daily consumption of grain products rather than to the nutrient profile 
of a specific food.
    Regarding the request that FDA permit fortification to meet the 10 
percent nutrient contribution requirement, the agency is concerned that 
fortification of foods solely to bear a health claim could result in 
deceptive or misleading labeling and, thereby, be in violation of 
section 403(a) of the act. As fully addressed in the 1993 health claims 
final rule (58 FR 2478 at 2522), fortification of a food of little or 
no nutritional value for the purpose of bearing a health claim has the 
great potential of misleading and confusing consumers if foods like 
confections, soda, and sweet desserts are fortified to qualify for a 
health claim when, at the same time, dietary guidance as contained in 
the Food Guide Pyramid, for example, states that ``[T]hese foods 
provide calories and little else nutritionally. Most people should use 
them sparingly'' (Ref. 3). Indiscriminate fortification of such foods 
with one nutrient would not make such foods consistent with dietary 
guidelines. Consequently, FDA has not been persuaded that foods should 
be permitted to be fortified to qualify to bear a health claim. 
Accordingly, FDA is denying NFPA's request to permit fortification to 
specifically qualify a food to bear a health claim.
    The agency notes, as discussed in the 1993 health claims technical 
amendments (58 FR 44036 at 44037), that some foods either have been 
traditionally formulated in accordance with the fortification policy or 
to meet standards of identity that include fortification and, in that 
form, contain 10 percent or more of one of the six nutrients listed. In 
such cases, the agency notes that the food would not be precluded by 
Sec. 101.14(e)(6) from being fortified to qualify for a health claim.
    Although the agency has not been persuaded that elimination of the 
10 percent nutrient contribution requirement is in order, or that it 
should permit fortification so that a food could qualify to bear a 
health claim, the agency has been persuaded by the arguments raised in 
the petitions that it should act to modify the 10 percent nutrient 
contribution requirement. As stated above, the agency acknowledges that 
the 10 percent nutrient contribution requirement has had the unintended 
effect of precluding some foods that contribute to a healthful diet, 
and whose consumption is encouraged by the dietary guidelines, from 
bearing health claims. As discussed above, the agency's primary goals 
in establishing the 10 percent nutrient contribution requirement were 
to preclude foods of little or no nutritional value from bearing health 
claims and, at the same time, to enhance the likelihood of consumers 
constructing overall daily diets that conform to current dietary 
guidelines.
    FDA recognizes that precluding certain fruits, vegetables, and 
grain products from bearing health claims because of the 10 percent 
nutrient contribution requirement is contrary to that goal. The agency 
agrees with the arguments raised in the petitions that certain fruits, 
vegetables, and grain products that otherwise meet the requirements of 
the specific health claim should be able to bear the claim even though 
they do not contain 10 percent of one of the six listed nutrients 
because these foods comprise a major part of a balanced and healthful 
diet, and because current dietary guidance promotes consumption of 
these foods. Moreover, diets high in fruits, vegetables, and grain 
products have been associated with various specific health benefits, 
including lower occurrence of coronary heart disease and of some 
cancers (Refs. 4 and 5) and therefore, are exactly the types of foods 
that should be included in the diet to reduce the risk of specific 
diet-related diseases. Precluding such foods from bearing health claims 
could confuse consumers and undermine the utility of health claims.
    Furthermore, the foods described in the petitions are not the types 
of foods FDA intended to preclude from bearing health claims when it 
established the 10 percent nutrient contribution requirement. In fact, 
these foods can contribute significantly to a balanced and healthful 
diet and to achieving compliance with dietary guidelines even though 
they do not meet the 10 percent nutrient contribution requirement. 
Consequently, the agency 

[[Page 66214]]
tentatively concludes that fruit and vegetable products comprised 
solely of fruits and vegetables, enriched grain products that conform 
to a standard of identity, and bread that conforms to the standard of 
identity for enriched bread except that it contains whole wheat or 
other grain products not permitted under that standard, that do not 
meet the 10 percent nutrient contribution requirement but that meet all 
other aspects of the health claim should be permitted to bear a health 
claim. Accordingly, the agency is proposing to amend Sec. 101.14(e)(6) 
to exempt these products from the 10 percent nutrient contribution 
requirement.
    The agency is proposing to limit the exemption for fruit and 
vegetable products to those products comprised solely of fruits and 
vegetables because it is concerned that permitting health claims on 
fruit and vegetable products that do not contain 10 percent of one of 
the six listed nutrients, but that contain ingredients that may raise 
the level of certain other nutrients, such as fat, cholesterol, and 
sodium, would be inconsistent with the purpose of the health claim and 
incompatible with current dietary guidelines. While the agency 
recognizes that fruit and vegetable products with added syrups, sauces, 
and other ingredients that have increased levels of fat, cholesterol, 
or sodium have an appropriate place in the diet, the agency tentatively 
concludes that to exempt these products from the 10 percent nutrient 
contribution requirement would be to promote the consumption of foods 
that do not fall within the recommendations in dietary guidelines. 
Accordingly, the agency is not prepared to extend the exemption to 
these products. However, FDA requests comment on whether the exemption 
proposed in this document should be extended to include fruit and 
vegetable products with added oils, sodium, sauces, syrups, or other 
ingredients.
    The agency also requests comment on whether other foods, for 
example, other types of grain products such as breakfast cereals, 
should be exempt from the 10 percent nutrient contribution requirement. 
The agency advises that comments submitted in support of extending this 
exemption to other foods should provide valid data and sound 
justification for exempting such foods from the 10 percent nutrient 
contribution requirement. If the comments persuade the agency that such 
foods are being unfairly precluded from bearing health claims, and that 
the foods are consistent with the intent of the health claims, the 
agency will consider including such foods in the exemption provided in 
any final regulation based on this proposal.

C. Abbreviated Health Claims

    Current Sec. 101.14(d)(2)(iv) mandates that all information 
required to be included in the claim appear in one place without other 
intervening material. The current rule, however, does permit a 
reference statement ``See-------- for information about the 
relationship between-------- and--------,'' with the blanks filled in 
with the location of the labeling containing the health claim, the name 
of the substance, and the disease or health-related condition (e.g., 
``See attached pamphlet for information about calcium and 
osteoporosis'') with the complete health claim appearing elsewhere on 
the other labeling. The current rule also permits the use of graphic 
material, such as a symbol that constitutes an expressed or implied 
health claim, to be used on the label or labeling of the product 
provided that it is accompanied by the complete claim, an abbreviated 
claim, or a referral statement (Sec. 101.14(d)(2)(iv)).
    In the preamble to its 1993 health claims final rule, the agency 
stated that it did not believe that it is appropriate to use 
abbreviated health claims as referral statements (58 FR 2478 at 2512). 
The agency was concerned that an abbreviated claim did not include 
facts that are material in light of the representation that is made and 
that are necessary to understand the claim in the context of the daily 
diet. The agency was concerned that such confusion is possible 
``whenever the full health claim information appears in a location 
different from that of the reference statement and is especially likely 
to occur when a multiplicity of labeling is associated with a product'' 
(Id.). The agency then described the situation where the grocer 
displays an abbreviated claim on a display (labeling) near the product 
but only puts the full claim on a billboard in a far corner of the 
store (labeling) (id.).
    In its petition, NFPA requested that the agency reconsider this 
position and permit greater latitude in constructing and presenting 
health claims. More specifically, the petition requested that FDA 
permit abbreviated health claims that are accompanied by a referral 
statement directing the consumer to the label panel where the complete 
health claim appears.
    The agency has no desire for its regulations to unnecessarily stand 
in the way of the use of health claims and the presentation of the 
important information contained therein. While health claims are 
currently being used on the label and in labeling, the agency would 
like to see them used more extensively. Consequently, the agency agreed 
to initiate rulemaking in this area. The agency stated, however, that 
it must have assurance that the claims will be presented in a 
scientifically valid, truthful, and nonmisleading manner.
    FDA notes that in this document the agency is proposing to provide 
the basis for shorter health claims by making optional some of the 
elements that it has required to be included in claims. If those 
changes are finalized, many of the complete claims will be brief enough 
to permit their use on the principal display panel. For example, a 
claim for sodium and hypertension could be made in 12 words: ``Diets 
low in sodium may reduce the risk of high blood pressure.'' Most other 
claims would be of a similar length. The agency believes that these 
shortened claims will, for the most part make this issue moot. 
Nevertheless, the agency recognized that some claims may still remain 
somewhat complex.
    In those cases where the complete health claim remains long and 
somewhat complex, the agency recognizes that there may be a need to 
permit a shortened version of the claim on the principal display panel. 
Although the entire health claim contains important information 
necessary for consumers to fully understand the subject substance-
disease relationship, the agency recognizes that a short message that 
captures the consumer's attention will facilitate use of the claim. As 
a result, the communication of formation will assist consumers in 
achieving healthful dietary practices.
    The agency tentatively concludes that the use of an abbreviated 
health claim on the principal display panel is consistent with the act. 
The full health claim includes information required under section 
403(a) and 403(r)(3)(B)(iii) of the act. Section 403(r)(3)(B)(iii) 
requires that the complete health claim ``enable[] the public to 
comprehend the information provided in the claim and to understand the 
relative significance of such information in the context of a total 
daily diet.'' Section 403(a) of the act requires only that a claim not 
be false and misleading. FDA has long required that all information 
that is necessary to make the claim truthful and not misleading appear 
in one place, without any intervening material. (See, e.g., United 
States v. An Article of Food * * * ``Manischewitz * * * Diet Thins'', 
377 F. Supp. 746 (E.D. New York 1974)). However, there is nothing in 
the act that would require that information required under section 
403(r)(3)(B)(iii) appear as 

[[Page 66215]]
part of the claim each time it is presented on the label.
    Thus, an abbreviated health claim that is a scientifically valid 
representation of the relationship between a substance and a diet-
related disease may be permissible under section 403(a) of the act if 
it is truthful and not misleading. If such an abbreviated claim 
includes a prominent and immediately adjacent reference to the full 
claim elsewhere on the label, the requirements of section 403(a) and 
(r)(3)(B)(iii) of the act would be fulfilled. Consequently, the agency 
is proposing to amend Sec. 101.14(d)(2)(iv). In addition to permitting 
the current reference statement to the full claim 
(Sec. 101.14(d)(2)(iv)(A)), the agency is proposing to permit an 
abbreviated health claim to be used on the principal display panel of 
the label provided that it is accompanied by a reference statement to 
the complete health claim on the same label or in the same labeling 
(proposed Sec. 101.14(d)(2)(iv)(B)).
    It is vital to compliance with the act that the complete claim 
appear elsewhere on the same label or in the same labeling as the 
abbreviated claim. For example, as discussed below for the calcium and 
osteoporosis health claim, the agency is concerned that consumers might 
be less likely to read the full health claim if an abbreviated claim 
appears on the principal display panel of a label, and the full health 
claim appears in a separate brochure that accompanies the product.
    The agency is also proposing to require that the reference 
statement be prominent and in immediate proximity to the abbreviated 
claim. The agency notes, of course, that if the proposed provision is 
adopted, an abbreviated claim could not be used unless the food meets 
the criteria necessary to make the complete health claim.
    As stated above, in the section D.IV. of this document, the agency 
is proposing to amend the regulations in subpart E of part 101, where 
appropriate, to set forth the elements that are required to ensure that 
an abbreviated health claim complies with section 403(a) of the act. As 
stated above, provision for an abbreviated claim will not be needed for 
most of the nutrient-disease relationships about which FDA has 
authorized claims if the revisions proposed in this document are 
adopted. Consumers may benefit, however, from abbreviated claims for a 
few of the longer, more complicated claims, such as those for calcium/
osteoporosis and folic acid/neural tube defects.
    The agency strongly emphasizes that the diet-disease relationship 
may not be overstated. Even with a prominent referral to the full 
claim, the abbreviated claim must not overemphasize the importance of 
the substance in the diet-disease relationship or in the total daily 
diet. The concept of risk reduction must be accurately conveyed.
    The agency notes that some of the diet-disease relationships may 
already be well-known by consumers. Therefore, nutrient content claims 
such as ``low sodium'' and ``reduced cholesterol'' on the principal 
display panel and elsewhere on the label may serve as a reminder of the 
diet-disease relationship and provide a way to market a product for its 
contribution to a healthy diet.
    FDA encourages the use of all authorized claims by the food 
industry in order to educate consumers about the importance of a 
healthy diet. The agency believes that the proposed changes to 
Sec. 101.14(d)(2)(iv) will result in increased use of the authorized 
health claims and, consequently, will fulfill the legislative intent to 
educate the public about diet-disease relationships.

D. Specific Requirements for Health Claims

    To date, FDA has authorized eight health claims that are codified 
in the Code of Federal Regulations, Title 21, subpart E of part 101 
(Secs. 101.72 to 101.79). Among the actions requested by NFPA in its 
petition is one to ``* * * modify the regulations in subpart E of part 
101 prescribing the content of authorized health claims so that they 
constitute `safe harbors' rather than requirements for claims; * * *.'' 
To accomplish this request, NFPA requested that the health claims 
regulations be modified to permit simplified, nondeceptive claims that 
are likely to be more easily understood. NFPA contended that the 
specific health claims regulations contained in subpart E of part 101 
include several provisions that prescribe the content and form of 
health claims to an extent that far exceeds that necessary to ensure 
that claims are truthful and not misleading. Mentioned as an example 
was that some regulations require claims to include references to 
specific nondietary factors even though, in NFPA's view, this 
information is unnecessary to ensure a claim is stated in a truthful, 
nonmisleading manner. Cited as illustrative of the nature of the 
problem was the model claim from the calcium/osteoporosis regulation 
(Sec. 101.72(e)) containing all required elements:

    Regular exercise and a healthy diet with enough calcium helps 
teen and young adult white and Asian women maintain good bone health 
and may reduce their high risk of osteoporosis later in life.

Each of the other regulations authorizing claims in subpart E of part 
101 was identified as requiring similar information.
    NFPA requested that the regulations in subpart E of part 101 
governing the specific information that
FR Doc. 95-31008 Food Labeling: Nutrient Content Claims, General Principles; Health Claims, General Requirements and Other Specific Requirements for Individual Health Claims
 must appear in a health claim, 
and the circumstances in which a claim could be used, be amended. 
Where, for example, Sec. 101.14(d)(2)(i) requires that labeling 
statements about a health claim be based on, and consistent with, the 
conclusions set forth in the regulations in subpart E of part 101, NFPA 
recommended amending Sec. 101.14(d)(2)(i), along with Sec. 101.14(d)(1) 
and the rest of (d)(2), so that such statements are objective and 
either consistent with applicable guidelines set forth in subpart E of 
part 101, or a reasonable basis for the claim is otherwise 
substantiated. The petitioner contended that such changes would operate 
to allow truthful, nonmisleading health claims that either omit 
information currently required under the regulations (e.g., nondietary 
information) or that include other useful information not expressly 
authorized by the regulations.
    Responding to NFPA in the May 11, 1995, letter, FDA acknowledged 
that, although use of health claims in food labeling has increased over 
the period of time that they have been in effect, the number of 
products bearing such claims is not as great as the agency had 
anticipated. Because of the importance of the information conveyed to 
consumers by health claims, the agency stated that it would review the 
authorizing regulations to determine whether they contain any 
unnecessary barriers to the use of the claims and, if so, take steps to 
remove those barriers. FDA stated that, as part of this assessment, it 
would conduct a review of what are referred to as ``required elements'' 
in each of the eight authorized health claims to determine whether any 
of them are unnecessary or can be made optional and initiate rulemaking 
to propose any changes identified in its internal review.
    The eight authorized health claims in subpart E of part 101 are 
codified following the same format. Thus the ``required elements'' for 
each claim are contained in paragraph (c) of the respective regulation 
under the heading ``Requirements.'' For example, specific requirements 
that apply to the calcium/osteoporosis health claim are contained in 
Sec. 101.72(c)(2)(i)(A) through (c)(2)(i)(E).

[[Page 66216]]

    The agency has reviewed all of the required elements in the eight 
authorized claims codified in subpart E of part 101. This document 
presents the results of this review for the following seven claims: 
Sec. 101.72 on calcium and osteoporosis; Sec. 101.73 on dietary lipids 
and cancer; Sec. 101.74 on sodium and hypertension; Sec. 101.75 on 
dietary saturated fat and cholesterol and risk of coronary heart 
disease; Sec. 101.76 on fiber-containing grain products, fruits, and 
vegetables and cancer; Sec. 101.77 on fruits, vegetables, and grain 
products that contain fiber, particularly soluble fiber, and risk of 
coronary heart disease; and Sec. 101.78 on fruits and vegetables and 
cancer. The health claim on folate and neural tube defects 
(Sec. 101.79) will be dealt with separately but in a manner consistent 
with the review of the other health claims.
    Since the final rules on the seven claims addressed in this 
document were published on January 6, 1993 (58 FR 2537 to 2849), new 
data have become available allowing FDA to reconsider the need for some 
information that, at the time the specific health claim regulations 
were issued, was considered necessary to preclude a claim from being 
misleading. Most notable among these data are two documents, one a 
National Institutes of Health (NIH) consensus statement on optimal 
calcium intake (hereinafter referred to as the 1994 consensus 
statement) and the other an FDA report on consumer understanding of 
health claims (hereinafter referred to as the 1995 consumer report) 
(Refs. 6 and 7, respectively).
1. The Calcium/Osteoporosis Health Claim
    The 1994 consensus statement is the result of the Consensus 
Development Conference on Optimal Calcium Intake convened by NIH on 
June 6 through 8, 1994, which brought together experts in public 
education and different biomedical sciences dealing with osteoporosis 
and bone and dental health. Directly relevant to the calcium/
osteoporosis health claim, this conference addressed questions and 
provided recommendations on optimal calcium intake for various 
population segments, on important cofactors for achieving optimal 
intake, on the risks associated with increased intake, on the best ways 
to attain optimal intake, and on the public health strategies that are 
available or are needed to implement optimal calcium intake 
recommendations.
    The 1995 consumer report is part of FDA's ongoing review of its 
regulations governing health claims. The report evaluated consumer 
understanding of four health claims (dietary lipids and cancer, fruits 
and vegetables and cancer, calcium and osteoporosis, and folate and 
neural tube defects) and consumer reaction to possible variations on 
the messages. The report describes the content, the manner of 
presentation, and the results of a consumer survey of knowledge about 
the four health claims mentioned above among consumer groups at 
eastern, central, and western locations in the United States.
    For the calcium/osteoporosis health claim, the first required 
element is contained in Sec. 101.72(c)(2)(i)(A) and provides that:

    The claim makes clear that adequate calcium intake throughout 
life is not the only recognized risk factor in this multifactorial 
bone disease by listing specific factors, including sex, race, and 
age that place persons at risk of developing osteoporosis and 
stating that an adequate level of exercise and a healthful diet are 
also needed.

The effect of presenting the information required by this element is to 
convey the message that, for any individual, several factors define the 
disease risk.
    The focus of the 1994 consensus statement is, as stated in its 
title, optimal calcium intake for promotion of public health. The first 
of several significant conclusions in the report is that a large 
percentage of Americans fail to meet currently recommended guidelines 
for optimal calcium intake. Because of the need to correct this public 
health shortfall and to improve bone health in the United States, 
thereby reducing the risk of osteoporosis, FDA tentatively concludes 
that a singular focus on achieving and maintaining adequate calcium 
intake as a required element in the calcium/osteoporosis health claim 
is important.
    Accordingly, FDA is proposing to simplify Sec. 101.72(c)(2)(i)(A) 
by limiting the requirement to a balanced statement that reflects the 
importance of the essential nutrient calcium over a lifetime in a 
healthful diet to reduce osteoporosis risk, but that does not imply 
that calcium is the only risk factor for the development of 
osteoporosis. To this end, proposed Sec. 101.72(c)(2)(i)(A) states that 
the claim must make clear that adequate calcium intake as part of a 
healthful diet throughout life is essential to reduce the risk of 
osteoporosis.
    FDA has included the reference to a ``healthful diet'' in proposed 
Sec. 101.72(c)(2)(i)(A) for consistency with the general requirement in 
Sec. 101.14(d)(2)(v) that ``the claim enable[ ] the public * * * to 
understand the relative significance of such information [in this case, 
the relationship between calcium and osteoporosis] in the context of a 
total daily diet.'' The effect of adequate calcium intake can only be 
realized if the calcium is a part of a healthy diet that provides all 
essential and other nutrients to optimize nutritional health status.
    The proposed revision of Sec. 101.72(c)(2)(i)(A) emphasizes the 
most important risk factor in the development of osteoporosis on the 
label of a food product, i.e., adequacy of dietary calcium intake. 
Nevertheless, the agency is concerned that such a claim could lead 
consumers to believe that adequacy of dietary calcium intake is the 
only risk factor for the disease. In the proposal to authorize the 
calcium/osteoporosis health claim, the following was stated:

    Calcium intake is not the only recognized risk factor in the 
development of osteoporosis. Other factors include a person's sex, 
race, hormonal status, family history, body stature, level of 
exercise, general diet, and specific life style choices, such as 
smoking and excess alcohol consumption.

(56 FR 60689 at 60698, November 27, 1991). Based on that information in 
part, Sec. 101.72(c)(2)(i)(A) requires a listing of several specific 
risk factors, in addition to dietary calcium intake, in the calcium/
osteoporosis health claim.
    As stated above, however, FDA acknowledges that the number of food 
products bearing health claims is not as great as the agency had 
anticipated. FDA is concerned that manufacturers have been disinclined 
to use lengthy health claims on food labels, and that too many words 
will detract from the central consumer message of the claim. As a 
result, FDA is concerned that health claims like the calcium/
osteoporosis claim will continue to be infrequently used, and that the 
benefits of communicating information on diet-disease relationships 
through such claims will not be realized.
    Because of these concerns, the agency has reevaluated the 
requirement in Sec. 101.72(c)(2)(i)(A) that a calcium/osteoporosis 
health claim ``* * * list[ ] specific factors, including sex, race, and 
age that place persons at risk of developing osteoporosis and stat[e] 
that an adequate level of exercise * * * [is] also needed.'' Given the 
consensus statement's central focus on optimal calcium intake and the 
agency's desire to make health claims as useful and useable as 
possible, FDA is proposing to replace the requirement in 
Sec. 101.72(c)(2)(i)(A) that specific risk factors and the need for an 
adequate level of exercise be stated in any claim with the more simple 
requirement that the claim not imply that adequate dietary calcium 
intake is the only recognized risk factor for a reduced risk 

[[Page 66217]]
of osteoporosis. This revision will ensure that the scientific validity 
of claims about osteoporosis is preserved by recognizing the 
multifactorial nature of this disease without adding words to the 
claim.
    In concert with the proposed change in Sec. 101.72(c)(2), the 
agency is proposing to redesignate Sec. 101.72(d)(2) as paragraph 
(d)(5) and to add a new paragraph (d)(2) that provides for the 
provision of the following information from current 
Sec. 101.72(c)(2)(i)(A) as optional information:

    The claim may list specific risk factors for osteoporosis, 
identifying them among the multifactorial risks for the disease. 
Such factors include a person's sex, age, and race. The claim may 
state that an adequate amount of exercise is also needed to reduce 
risk for the disease.

    The 1995 consumer report identified the calcium/osteoporosis model 
health claim as the one most actively disliked (Ref. 7). This dislike 
most likely arises primarily from a misunderstanding one of the 
concepts required in Sec. 101.72(c)(2)(i)(B), specific identification 
of the populations at particular risk for the disease. The current 
regulation states:

    The claim does not state or imply that the risk of osteoporosis 
is equally applicable to the general United States population. The 
claim shall identify the populations at particular risk for the 
development of osteoporosis. These populations include white (or the 
term ``Caucasian'') women and Asian women in their bone forming 
years (approximately 11 to 35 years of age or the phrase ``during 
teen or early adult years'' may be used). The claim may also 
identify menopausal (or the term ``middle-aged'') women, persons 
with a family history of the disease, and elderly (or ``older'') men 
and women as being at risk.

    The 1995 consumer report states that minority women were unanimous 
in objecting to the inference that black American women do not need 
calcium. Accordingly, minority participants questioned the accuracy of 
the information. All of the survey participants recognized that calcium 
is essential for everyone. Although there was some recognition based on 
prior knowledge that younger women need to be concerned about 
osteoporosis, no participant thought the model claim communicated that 
concept very well. For these and other reasons, older women tended to 
dismiss the model claim as incorrect.
    The agency did not intend that the calcium/osteoporosis health 
claim imply that calcium is not needed by any individual or specific 
population. Given that calcium is essential for every person, the 
agency attempted to craft requirements for presenting this disease 
claim in a truthful, nonmisleading, and scientifically valid manner. In 
reviewing the scientific data supporting the claim, including the 
incidence of low-trauma bone fracture in the elderly, FDA stated in the 
preambles to the calcium/osteoporosis proposed and final rules (56 FR 
60689 and 58 FR 2665, respectively) that those individuals in the 
general population at greatest risk of developing osteoporosis, and for 
whom the health claim would have greatest benefit, include Caucasian 
and possibly Asian women and adolescent girls and young adult women 
between 11 and 35 years of age. For this and other reasons, a 
requirement for identifying these high risk groups was included in 
Sec. 101.72(c)(2)(i)(B). In identifying those at highest risk, there 
was no intent by the agency to imply that other consumers are risk 
free.
    The 1994 consensus statement is silent in ascribing relative risk 
for osteoporosis on the basis of race or ethnicity of population 
groups. For adolescents and young adults of both sexes, 11 through 24 
years of age, the optimal calcium requirement is given as a range of 
1,200 to 1,500 milligrams (mg) of calcium daily. The report says the 
following about a subset of this population, 12 to 19 year old females:

    Importantly, population surveys of girls and young women 12-19 
years of age show their average calcium intake to be less than 900 
mg/day, which is well below the calcium intake threshold. The 
consequences of low calcium intake during this crucial period of 
rapid skeletal accrual raise concerns that achievement of optimal 
peak adult peak bone mass may be seriously compromised. Special 
education and public measures aimed at improving dietary calcium 
intake in this age group are essential.

(Ref. 6.)
    FDA tentatively concludes that greater use in food labeling of the 
calcium/osteoporosis health claim, articulated in a manner that will be 
accepted and followed by consumers, can help support significant 
strides in improving calcium intake in all segments of the U.S. 
population. Accordingly, the agency is proposing to revise 
Sec. 101.72(c)(2)(i)(B) in several ways.
    First, it is proposing to revise Sec. 101.72(c)(2)(i)(B) by 
removing the requirement to identify by race those populations at 
particular risk for the development of osteoporosis. In neither the 
statement cited above nor elsewhere in the 1994 consensus statement is 
any racial or ethnic segment among girls and young women 12 to 19 years 
of age identified as being more at risk for the consequences of a less 
than optimal calcium intake. The 1994 NIH consensus statement found 
that the recommendation for optimal nutrient requirements for any 
particular age/sex population segment to forestall the impact of a 
degenerative disease applies to all members of that segment, although 
not necessarily to the same degree for everyone. Thus, the agency is 
proposing not to require mention of race or ethnicity as a required 
element but to permit such information as an option since it is useful 
and important to those to whom it applies.
    Nevertheless, retention of teen and young adult women, irrespective 
of race or ethnicity, as the focus of the claim is important because, 
as stated succinctly in the 1994 consensus statement:

    Two important factors that influence the occurrence of 
osteoporosis are optimal bone mass attained in the first two or 
three decades of life and the rate at which bone is lost in later 
years.

    Failure to attain optimal bone mass during the bone-forming years 
of adolescence and early adulthood is a loss that cannot be recovered 
during middle age or later in life (Ref. 6). Once peak adult bone mass 
is reached at about age 25, bone turnover is stable in men and women 
such that bone formation and bone resorption (breakdown) are balanced. 
In women, resorption rates increase, and bone mass declines, beginning 
with the fall in estrogen production that is associated with the onset 
of menopause. Unlike hormone replacement therapy, supplemental calcium 
during this initial phase will not slow the decline in bone mass 
attributable to estrogen deficiency. The effects of calcium in reducing 
the rate of bone loss can be shown more clearly in postmenopausal women 
after the period when the effects of estrogen deficiency are no longer 
dominant (i.e., about 10 years after menopause).
    Osteoporosis affects more than 25 million people in the United 
States and is the major underlying cause of bone fractures in 
postmenopausal women and the elderly (Ref. 6). Given this tremendous 
cost to public health, it is essential that the health claim on calcium 
and osteoporosis inform consumers, particularly those at great risk for 
the disease, of the importance of adequate calcium intake throughout 
life for attaining peak adult bone mass and for reducing the rate of 
bone resorption or loss, two processes that occur at different periods 
over a lifetime.
    Thus, FDA is proposing to retain the requirement in 
Sec. 101.72(c)(2)(i)(B) that the claim not suggest that the risk of 
osteoporosis applies equally to the general U.S. population. However, 
it is proposing to remove the required 

[[Page 66218]]
reference to any racial or ethnic group in identifying the at-risk 
population. The agency is proposing to identify this population in the 
following way:

    * * * The claim shall identify the population at particular risk 
for the development of osteoporosis as women in their bone forming 
years from approximately 11 to 35 years of age. An optional 
statement that further characterizes this and other populations at 
risk for developing osteoporosis may be made in accordance with 
paragraph (d)(3) of this section.

    FDA is proposing to permit identification of Caucasian women and 
Asian women as among those at particular risk for the disease as 
optional information, along with other information from 
Sec. 101.72(c)(2)(i)(B), in new Sec. 101.72(d)(3). While the 1995 
consumer report (Ref. 7) found evidence that some consumers could be 
misled by references in the calcium/osteoporosis health claim to 
Caucasian and Asian women, FDA tentatively concludes that, if properly 
qualified, this information could be helpful in informing such women 
who may be unaware of their risk of developing this disease. By 
providing for this information as an optional element in 
Sec. 101.72(d), the agency is attempting to encourage manufacturers to 
use this information in formats where the message can be phrased in 
enough detail to clarify its meaning. For example, ``while all women 
may be at risk of osteoporosis, Caucasian and Asian women are 
particularly at risk,'' may be understood and not rejected by 
consumers. While this statement provides more detail than seems to be 
necessary in the basic health claim, this information could be useful 
in a longer discussion of calcium and osteoporosis, for example in a 
paragraph format on a large label or in a pamphlet. The agency requests 
comment, and is particularly interested in data, on whether its 
tentative view that consumer understanding would be helped is correct.
    Section 101.72(c)(2)(i)(C) established a requirement for 
identifying the mechanism whereby adequate dietary calcium over a 
lifetime should reduce the risk of osteoporosis:

    The claim states that adequate calcium intake throughout life is 
linked to reduced risk of osteoporosis through the mechanism of 
optimizing peak bone mass during adolescence and early adulthood. 
The phrase ``build and maintain good bone health'' may be used to 
convey the concept of optimizing peak bone mass. When reference is 
made to persons with a family history of the disease, menopausal 
women, and elderly men and women, the claim may also state that 
adequate calcium intake is linked to reduced risk of osteoporosis 
through the mechanism of slowing the rate of bone loss.

    The agency concluded in developing this requirement that it is 
important for consumers to have a basic understanding of the biological 
and physiological mechanisms by which adequate dietary intake of 
calcium achieves a reduced risk of osteoporosis. However, information 
developed since the regulation was published indicates that a health 
claim may not be the best way to provide this information. The 1995 
consumer survey (Ref. 7) found that, because participants had learned 
elsewhere that calcium intake is related to general bone health, they 
thought the food label was not the right means for conveying this 
information. In addition, this awareness by consumers that calcium's 
ability to ``build and maintain good bone health'' is the mechanism 
whereby risk of osteoporosis is reduced, raises a question as to 
whether there is a need to state that fact in a health claim. In the 
interest of streamlining the claim, therefore, FDA is proposing to make 
the statement of the mechanism by which calcium intake affects the risk 
of osteoporosis optional information. The agency is proposing to move 
Sec. 101.72(c)(2)(i)(C) to Sec. 101.72(d)(4), changing only the word 
``shall'' to ``may''.
    Section 101.72(c)(2)(i)(D) requires that:

    The claim does not attribute any degree of reduction in risk of 
osteoporosis to maintaining an adequate calcium intake throughout 
life;

This paragraph is consistent with requirements in regulations for all 
other authorized claims that no attribution to degree of risk reduction 
for the respective disease or health-related condition be made in 
reference to the nutrient or substance that is the subject of the claim 
(see, for example: Secs. 101.73(c)(2)(i)(E), 101.74(c)(2)(i)(D), 
101.75(c)(2)(i)(D), 101.76(c)(2)(i)(E), 101.77(c)(2)(i)(G), 
101.78(c)(2)(i)(E), and 101.79(c)(2)(i)(F).
    Unlike these other regulations, Sec. 101.72 does not contain an 
express requirement that the claim state that adequate calcium intake 
throughout life ``may'' or ``might'' reduce the risk of osteoporosis 
(see, for example, paragraphs (c)(2)(i)(A) in Secs. 101.73 through 
101.79). However, it is clear that FDA also intended that this 
requirement apply to the calcium/osteoporosis health claim. This 
intention may be inferred from the two model health claims that use the 
term ``may'' in relating calcium intake with a reduction in risk of 
osteoporosis. Accordingly, the agency is proposing to revise 
Sec. 101.72(c)(2)(i)(D) and redesignate it as Sec. 101.72(c)(2)(i)(C) 
to read as follows:

    The claim does not attribute any degree to which maintaining 
adequate calcium intake throughout life may reduce the risk of 
osteoporosis;

This proposed revision retains the prohibition against attributing the 
degree to which adequate calcium intake is associated with a reduced 
risk for osteoporosis while introducing the concept that, because of 
the multifactorial nature of the disease, maintenance of an adequate 
calcium intake throughout life may reduce risk of developing the 
disease.
    Section 101.72(c)(2)(i)(E) contains the conditional requirement 
that a calcium/osteoporosis health claim include a statement that 
reflects the limit on the benefit derived from dietary calcium intake 
as follows:

    The claim states that a total dietary intake greater than 200 
percent of the recommended daily intake (2,000 milligrams (mg) of 
calcium) has no further known benefit to bone health. This 
requirement does not apply to foods that contain less than 40 
percent of the recommended daily intake of 1,000 mg of calcium per 
day or 400 mg of calcium per reference amount customarily consumed 
as defined in Sec. 101.12(b) or per total daily recommended 
supplement intake.

    Most conventional foods and many calcium-fortified foods do not 
exceed the threshold of 40 percent of the DV for calcium for adults and 
children 4 or more years of age and, therefore, do not trigger the 
required use of the statement in Sec. 101.72(c)(2)(i)(E). Dietary 
supplements containing calcium, particularly single nutrient 
supplements containing 500 or 600 mg of calcium per tablet, exceed the 
threshold and are therefore required to bear the statement as part of a 
health claim. The Dietary Supplement Health and Education Act of 1994 
(the DSHEA) (Pub. L. 103-417) was enacted on October 25, 1994, and 
amends the act (Ref. 8). Among the findings of Congress for this new 
law regarding the benefits of dietary supplements to health promotion 
and disease prevention is one that identifies a link between ingestion 
of certain nutrients or dietary supplements and reduced risk for 
several chronic diseases including osteoporosis. Another finding states 
that the Federal Government should not take any actions to impose 
unreasonable regulatory barriers limiting or slowing the flow of safe 
products and accurate information to consumers.
    Among the issues addressed in the 1994 consensus statement is the 
question of the ways by which optimal calcium intake may be attained. 
The 

[[Page 66219]]
document draws the following conclusion:

    The preferred source of calcium is through calcium-rich foods 
such as dairy products. Calcium-fortified foods and calcium 
supplements are other means by which optimal calcium intake can be 
reached in those who cannot meet this need by ingesting conventional 
foods.

    The agency has taken into consideration the expressed intent of the 
DSHEA and this finding from the 1994 consensus statement and 
tentatively concludes that revision of Sec. 101.72(c)(2)(i)(E) is in 
order. The agency is proposing to raise the threshold for the required 
statement from 400 to 1,500 mg of calcium, along with other changes.
    With regard to adverse effects and the risks associated with 
increased levels of calcium intake, the 1994 consensus statement states 
the following:

    Even at intake levels of less than 4 g/day, certain otherwise 
healthy persons may be more susceptible to developing hypercalcemia 
or hypercalciuria. Likewise, subjects with mild or subclinical 
illnesses marked by dysregulation of 1,25-dihydroxyvitamin D 
synthesis (e.g., primary hyperparathyroidism, sarcoidosis) may be at 
increased risk from higher calcium intakes. Nevertheless, in 
intervention studies (albeit of relatively short duration--less than 
4 years), no adverse effects of moderate supplementation up to 1500 
mg/day have been reported.

(Ref. 6.)
    The same document concludes that daily calcium intake, up to a 
total of 2,000 mg, appears to be safe in most individuals (Ref. 6). For 
major segments of the U.S. population the 1994 consensus statement 
identifies an optimal calcium requirement of either 1,500 mg or a range 
of 1,200 to 1,500 mg of calcium per day. These population groups 
include adolescents and young adults 11 to 24 years of age, pregnant 
and lactating women, women over 50 (postmenopausal) who are not on 
estrogens, and men over 65 years of age (Ref. 6). Therefore, the agency 
tentatively finds that a level of 1,500 mg of calcium as the proposed 
threshold for the statement in Sec. 101.72(c)(2)(i)(E) is not only 
consistent with current recommendations for dietary calcium intake but 
is also well within a range that is not known to cause adverse effects.
    The agency is consequently proposing to require that the statement 
of limited benefit appear only on foods that provide more than 1,500 mg 
of calcium per day. FDA has expressed this proposed threshold level as 
a percentage of the Daily Values (DV's) for adults and children 4 or 
more years of age and for pregnant or lactating women. The agency notes 
that the calcium DV's for adults and children 4 or more years of age 
and for pregnant or lactating women have not changed and are 1,000 and 
1,300 mg, respectively. (See Sec. 101.9(c)(8)(iv) and 58 FR 2206 at 
2213.) The agency intends to redesignate this requirement as 
Sec. 101.72(c)(2)(i)(D).
    A common form of a calcium dietary supplement in the marketplace is 
as a tablet containing either 500 or 600 mg of calcium as the sole 
nutrient with directions for use in labeling that recommend an intake 
of one or two tablets per day. A health claim in the labeling of such a 
product would not require the additional statement in proposed 
Sec. 101.72(c)(2)(i)(D). FDA tentatively concludes that this proposed 
change is consistent with the recommendation from the 1994 consensus 
statement on dietary sources for this nutrient.
    For consistency with the proposed revisions in Sec. 101.72(c) and 
(d), FDA has revised the model health claims in proposed 
Sec. 101.72(e). FDA has used the phrase ``Especially for teen and young 
adult women'' in example 1, which sets out how a claim that conforms 
with Sec. 101.72(c) might look to reflect the effects on the risk of 
developing osteoporosis that may be realized by this population segment 
without implying that adequate calcium intake is without benefit for 
others.
    The agency solicits comment on the proposed revisions to the 
calcium/osteoporosis health claim and is particularly interested in 
data on consumer understanding of this claim, and how such 
understanding can be improved.
2. Other Health Claims
    A common requirement in the authorized claims for dietary fat and 
cancer (Sec. 101.73); sodium and hypertension (Sec. 101.74); dietary 
saturated fat and cholesterol and risk of coronary heart disease 
(Sec. 101.75); fiber-containing grain products, fruits, and vegetables 
and cancer (Sec. 101.76); fruits, vegetables, and grain products that 
contain fiber, particularly soluble fiber, and risk of coronary heart 
disease (Sec. 101.77); and fruits and vegetables and cancer 
(Sec. 101.78) is a statement that development of the particular disease 
depends on many factors.
    It is well documented over the past 10 years that consumers are 
generally aware that development of major chronic diseases, such as 
cancer and coronary heart disease, is dependent on a number of 
different factors such as smoking, excess body weight, family history 
of the disease, exposure to environmental chemicals, and dietary and 
other factors (Refs. 9 and 10). Additionally, the requirement that 
authorized claims use the term ``may'' or ``might'' to relate the 
ability of the substance that is the subject of the claim to reduce the 
risk of the corresponding disease or health-related condition is an 
indication to consumers of the multifactorial nature of the disease or 
health-related condition. In responding to comments on the scientific 
standard for health claims as to whether or not a claim based on 
preliminary scientific data would be consistent with that standard, the 
agency said:

    * * * Further, absolute claims about diseases affected by diet 
are generally not possible because such diseases are almost always 
multifactorial. Diet is only one factor that influences whether a 
person will get such a disease. For example, in the case of calcium 
and osteoporosis, genetic predisposition (e.g., where there is a 
family history of fragile bones with aging) can play a major role in 
whether an individual will develop the disease. Because of factors 
other than diet, some individuals may develop the disease regardless 
of how they change their dietary patterns to avoid the disease. For 
those individuals, a claim that changes in dietary patterns will 
reduce the risk of disease would be false. Thus, health claims must 
be free to use the term ``may'' with respect to the potential to 
reduce the risk of disease. However, use of this term would not be 
appropriate for health claims on food labeling where significant 
scientific agreement does not exist that there is a high probability 
that a reduction in disease risk will occur.

(58 FR 2478 at 2505.)
    Given these facts, as part of its review of required elements for 
all health claims the agency has reconsidered the need to remind 
consumers of the multifactorial nature of hypertension, heart disease, 
and cancer. Based on its review, FDA tentatively concludes that the 
statement of that fact in each claim can be made optional. In place of 
the requirement for stating the multifactorial nature of the disease, 
the agency proposes to substitute a requirement that the claim not 
imply that the substance that is the subject of the health claim is the 
only recognized risk factor for the corresponding disease or health-
related condition. Thus, the agency tentatively concludes that the 
concept of the multifactorial nature of the disease or health-related 
condition for each health claim will be preserved without adding 
additional words to the claim. The agency requests comment on whether 
consumers will be misled to believe reduction of risk will be achieved 
if the multifactorial nature of 

[[Page 66220]]
the disease or health-related condition is not stated in the claim.
    Accordingly, the agency is proposing to revise 
Secs. 101.73(c)(2)(i)(F), 101.74(c)(2)(i)(E), 101.75(c)(2)(i)(E), 
101.76(c)(2)(i)(D), 101.77(c)(2)(i)(F), and 101.78(c)(2)(i)(I) in 
similar fashion to ensure that the health claim not imply that there is 
only one recognized risk factor for the development of the 
corresponding disease or health-related condition. The agency is also 
proposing to revise Secs. 101.73(d)(1), 101.74(d)(1), 101.75(d)(1), 
101.76(d)(2), 101.77(d)(1), and 101.78(d)(2) to state that development 
of the disease in question depends on many factors and to list the 
relevant factors for each disease. For consistency, the agency is also 
proposing to revise the model claims to reflect the proposed revisions 
to Secs. 101.73, 101.74, 101.75, 101.76, 101.77, and 101.78.
    In addition, the agency is proposing to correct Sec. 101.77(e) by 
adding the phrase ``and the risk of coronary heart disease'' which was 
inadvertently omitted in the final rule.
    The health claim for fruits and vegetables and cancer (Sec. 101.78) 
contains one additional element that FDA tentatively concludes could be 
optional instead of a mandatory part of the claim. In 
Sec. 101.78(c)(2)(i)(D) the regulation states:

    The claim characterizes the food bearing the claim as containing 
one or more of the following, for which the food is a good source 
under Sec. 101.54: dietary fiber, vitamin A, or vitamin C.

This required statement is very similar to the one required by 
Sec. 101.78(c)(2)(i)(C):

    The claim characterizes fruits and vegetables as foods that are 
low in fat and may contain vitamin A, vitamin C, and dietary fiber.

    The agency believes that the statement required by 
Sec. 101.78(c)(2)(i)(C) is necessary to describe the relationship 
between the food and the disease. In the 1993 health claims final rule, 
FDA stated that by requiring that all characterizing nutrients be 
identified as characteristic of dietary patterns rich in fruits and 
vegetables without specifically attributing reduced cancer risk to a 
single nutrient, the claim is consistent with current scientific 
knowledge. However, the requirement in Sec. 101.78(c)(2)(i)(D) 
identifies for the consumer which of the characterizing nutrients is 
contributed by the labeled food. FDA tentatively concludes that this 
information need not be a required element of the claim because it is 
available as part of the nutrition label.
    Therefore, the agency has tentatively concluded that the 
information in Sec. 101.78(c)(2)(i)(D) can be made optional. 
Accordingly, the agency is proposing to remove Sec. 101.78(c)(2)(i)(D); 
redesignate Sec. 101.78(d)(3) through (d)(5) as Sec. 101.78(d)(4) 
through (d)(6), and add new Sec. 101.78(d)(3) which reads:

    The claim may characterize fruits and vegetables that meet the 
requirements described in paragraph (c)(2)(ii) of this section as 
foods that are low in fat and that contain (or are a good source of) 
one or more of vitamin A, vitamin C, or dietary fiber.

    FDA is also proposing to revise the model health claims in 
Sec. 101.78(e) to reflect these changes.
3. Abbreviated Health Claims
    In addition to eliminating some of the requirements for a full 
health claim, as stated above, NFPA requested that FDA permit the use 
of abbreviated health claims in labeling, such as on the principal 
display panel. FDA has reviewed the health claims as it is proposing to 
revise them to determine whether the required elements can be 
reorganized in accordance with proposed Sec. 101.14(d)(2)(iv) to 
facilitate their use on the food label.
    With the revisions to Secs. 101.73, 101.74, 101.75, 101.76, 101.77, 
and 101.78 proposed in this document, the agency tentatively finds that 
all of the required elements for each of the claims are required under 
section 403(a) of the act to ensure that the claims are truthful and 
not misleading as well as under section 403(r) to ensure that they are 
scientifically valid. Accordingly, the agency tentatively concludes 
that there is no basis upon which it can propose to permit the 
splitting of these required elements between the principal display 
panel and another part of the food label.
    Using the health claim for dietary fat and cancer as an example, 
the agency is proposing to remove the requirement that the claim state 
that cancer is a multifactorial disease. The remaining specific 
requirements in Sec. 101.73(c)(2)(i)(A) through (c)(2)(i)(E) are 
necessary so that claims on the relationship between dietary fat and 
cancer are truthful, not misleading, and scientifically valid. A claim 
consistent with these requirements can be expressed in 11 or fewer 
words (e.g., ``A low fat diet may reduce the risk of some cancers''). 
These requirements also ensure that consumers will be able to 
understand the relative significance of the information presented in 
the claim in the context of a total daily diet. Accordingly, the agency 
tentatively finds that there is no need to divide the required elements 
of Sec. 101.73 into those that must be included whenever the claim is 
presented and those that need only be included as part of the full 
claim. Based on the same reasoning, FDA has reached the same judgment 
about the elements of the claims authorized by Secs. 101.74 through 
101.78.
    The agency tentatively concludes, however, that such a split is 
appropriate among the required elements of health claims on calcium and 
osteoporosis (Sec. 101.72). The various proposed revisions for the 
specific requirements in Sec. 101.72(c)(2)(i) would produce a claim 
that is shorter than is provided for in the current regulation. 
Nonetheless, even with the proposed revisions, the length of the claim 
that would be required under Sec. 101.72 is such that, to facilitate 
use of the claim, FDA is proposing to distinguish between those 
elements necessary to ensure that the claim is truthful and not 
misleading, and those elements that are necessary to understand the 
significance of the claim in the context of the total daily diet.
    Section 101.72(c)(2)(i)(A), which the agency is proposing to 
revise, sets forth the most important requirement. It establishes the 
essence of the calcium/osteoporosis claim in that it requires clarity 
in a statement that associates adequacy of dietary calcium intake over 
a lifetime with a reduced risk of osteoporosis, a degenerative disease 
that affects more than 25 million Americans, particularly 
postmenopausal women and the elderly, and that is manifested by an 
incidence of 1.5 million bone fractures annually (Ref. 6). This 
provision sets out information that is fundamental if a claim 
associating calcium and osteoporosis is to be truthful and not 
misleading.
    Section 101.72(c)(2)(i)(C), which requires that the claim not 
attribute any particular degree of risk reduction to adequate calcium 
intake is also necessary to ensure that claims are truthful, not 
misleading, and scientifically valid. Compliance with this requirement, 
however, does not add any words to the claim.
    For the remaining requirements, Sec. 101.72(c)(2)(i)(B) prohibits 
the implication that risk for the disease applies equally across the 
U.S. population. Instead, it requires identification of that segment of 
the population that is most at risk for developing the disease later in 
life, women in their bone forming years. The agency requires this 
information in response to section 403(r)(3)(b)(iii) of the act, which 
as stated above, requires that the claim accurately represent the 
relationship between calcium and osteoporosis in a manner that is 
comprehensible to the public. It is also under section 
403(r)(3)(b)(iii) of the act 

[[Page 66221]]
that FDA is requiring in Sec. 101.72(c)(2)(i)(D) that the claim 
disclose that further benefit does not derive from a daily dietary 
intake of calcium that exceeds 2,000 mg.
    Given these bases for the calcium/osteoporosis claim, an 
abbreviated claim consistent with the principles proposed earlier in 
this document may be developed that sets out the information required 
under Sec. 101.72(c)(2)(i)(A) and (c)(2)(i)(C). To reflect this fact, 
the agency is proposing to renumber current Sec. 101.72(c)(2)(ii), 
which deals with the nature of a food bearing a calcium/osteoporosis 
health claim, as Sec. 101.72(c)(2)(iii), and it is proposing a new 
Sec. 101.72(c)(2)(ii) that describes how the health claim is to be 
presented on the label or in labeling. This proposed new paragraph 
states that all of the elements listed in Sec. 101.72(c)(2)(i) must be 
included in one presentation of the claim on the label or labeling. 
However, it also provides that a short, simple statement of the claim 
that includes the elements in Sec. 101.72(c)(2)(i)(A) and (c)(2)(i)(C), 
and thus that is truthful, not misleading, and scientifically valid, 
may be used on the principal display panel as long as the full claim 
appears on the label or in the labeling, and, there is a referral 
statement to the full claim in immediate proximity to the abbreviated 
statement.
    The referral statement that FDA is proposing accompany the 
abbreviated claim is consistent with that provided for in the general 
requirements for nutrient content claims (Sec. 101.13) and health 
claims (Sec. 101.14(d)(2)(iv)). Because this referral statement is 
short, it is also consistent with the use of an abbreviated claim.
    In the 1993 health claims final rule, the agency stated that it did 
not believe that it is appropriate to use abbreviated health claims as 
referral statements (58 FR 2478 at 2512). The agency was concerned that 
an abbreviated claim did not include facts that are material in light 
of the representation that is made and that are necessary to understand 
the claim in the context of the daily diet. The agency was concerned 
that such confusion is possible whenever the full health claim 
information is in a location different from that of the reference 
statement, and that such confusion is especially likely to occur when a 
multiplicity of labeling is associated with a product. If these 
concerns can be addressed, however, the use of an abbreviated claim on 
the principal display panel would facilitate use of the claim and, as a 
result, the communication of information that will assist consumers in 
achieving healthful dietary practices.
    The agency has tentatively concluded that this proposed rule 
addresses these concerns. It is providing for an abbreviated statement 
that reflects the facts that are material under section 201(n) of the 
act (21 U.S.C. 321(n)) and that are necessary to ensure that the claim 
is scientifically valid. It is also providing for an accompanying 
referral statement to additional information that is necessary for a 
full understanding of the claim. The agency is concerned, however, 
about the possibility that consumers may not read the complete claim, 
and thus that they will not have all the facts necessary to fully 
understand the significance of the claim being made and to comprehend 
the claim in the context of the daily diet. For this reason, the agency 
is asking for data to demonstrate that permitting an abbreviated claim 
in the manner that FDA has proposed will not significantly decrease the 
likelihood that consumers will read the full claim.
    In Sec. 101.72(c)(2)(ii)(A) and (c)(2)(ii)(B), the agency is 
proposing requirements for the type size and location of the referral 
statement that are consistent with those for nutrient content claims in 
Sec. 101.13(g)(1) and (g)(2).
    FDA has long held that accompanying information should be in a size 
reasonably related to that of the information that it modifies. Section 
403(f) of the act requires that information required under the act be 
placed on the label with such conspicuousness as to render it likely to 
be read. Section 403(r)(2)(B) of the act requires that a referral 
statement for nutrient content claims appear prominently, although it 
does not specify requirements such as to type size or style.
    For nutrient content claims, FDA established type size requirements 
for referral and disclosure statements that are related to the area of 
the surface bearing the principal display panel rather than to the type 
size used for the nutrient content claim. The proportionality between 
size of the referral statement and the size of the label panel ensures 
that the referral statement is presented with appropriate prominence. 
However, when the claim is less than twice what the minimum size of the 
referral statement would be, given the size of the label and 
Sec. 101.105(i), the type size of the referral statement may be less 
than that required under Sec. 101.105 for net quantity of contents. In 
such circumstances, the referral statement is of appropriate prominence 
if it is at least one-half the size of the claim and not less than one-
sixteenth of an inch. This approach to the type size requirement for 
the referral statement provides additional flexibility to firms in 
utilizing label space but still ensures adequate prominence for this 
statement.
    Because, under this proposal, health claim referral statements are 
to be used in a manner that is similar to how nutrient content claim 
referral statements are used, and because they are likely to appear on 
the principal display panel, the agency tentatively concludes that a 
health claim referral statement should be subject to the same type size 
requirements as those for nutrient content claims. Therefore, the 
agency tentatively concludes that the requirements for the referral 
statement set forth in Sec. 101.72(c)(2)(ii)(A) and (c)(2)(ii)(B) are 
appropriate when an abbreviated health claim is used, and it is 
including them in this proposed rule.
    In concert with the proposed requirements for an abbreviated health 
claim, the agency is including an abbreviated health claim among the 
examples of other model claims in proposed Sec. 101.72(e).

E. Disclosure Versus Disqualifying Nutrient Levels for Health Claims

    Section 403(r)(3)(A)(ii) of the act provides that a health claim 
may only be made for a food that ``does not contain, as determined * * 
* by regulation, any nutrient in an amount which increases to persons 
in the general population the risk of a disease or health-related 
condition which is diet related, taking into account the significance 
of the food in the total daily diet.'' This section helps to ensure 
that consumers who rely on health claims will be consuming foods that 
will assist them in structuring a healthful diet that meets dietary 
guidelines.
    As discussed more fully in the preamble to the 1993 health claims 
final rule, the agency implemented this provision by considering a 
food's role in the total daily diet and calculating levels of total 
fat, saturated fat, cholesterol, and sodium that would increase the 
risk of disease or health-related conditions in the general population. 
FDA calculated these levels by considering the number of foods consumed 
each day, as well as the number of foods that are likely to contain 
significant levels of these nutrients.
    The agency has established different disqualifying levels for 
different types of foods, depending on the role that they play in the 
daily diet. Section 101.14(a)(5) defines the disqualifying level for 
individual foods as 20 percent of the DV's for total fat, saturated 
fat, cholesterol, and sodium. These levels 

[[Page 66222]]
translate to 13.0 grams (g) of total fat, 4.0 g of saturated fat, 60 mg 
of cholesterol, and 480 mg of sodium per reference amount customarily 
consumed, per label serving size, and for foods with reference amounts 
customarily consumed of 30 g or less or 2 tablespoons or less, per 50 
g. The regulations make additional allowances for main dish products 
and meal-type products. The disqualifying levels for main dish and meal 
products are 30 percent and 40 percent of the DV, respectively. These 
different levels are consistent with the legislative history, which 
states, ``a particular level of fat in a frozen dinner might not 
trigger the provision, whereas the same amount of fat in a snack food 
might trigger it.''
    A food that exceeds the disqualifying level for any of the four 
disqualifying nutrients may not bear a health claim unless the agency 
has granted an exemption ``based on a finding that such a claim would 
assist consumers in maintaining healthy dietary practices.'' (Section 
403(r)(3)(A)(ii) of the act.) To date, the agency has received no 
petitions for an exemption from this provision.
    The NFPA petition requested that the defined disqualification 
levels be converted to disclosure levels under certain circumstances. 
More specifically, the petition suggested that ``the presence of one of 
these nutrients at the prescribed level would require disqualification 
only if the nutrient was found in another health claim regulation to be 
directly and adversely related to the disease mentioned in the claim.'' 
The petition went on to state that ``[i]f the nutrient is not so 
directly related to the disease to which the claim refers, the 
regulations would require only disclosure by an appropriate referral 
statement in conjunction with the health claim on the label, as the 
regulations now require for nutrient content claims.''
    As stated in the May 11, 1995, letter to NFPA, FDA concludes that a 
generic change in its regulations would not be consistent with the 
underlying goals of the NLEA. The current disqualifying levels assist 
consumers in constructing total daily diets that meet dietary 
guidelines. The agency considered the role a food plays in the daily 
diet when it calculated the disqualifying levels. Health claims on 
foods with levels of fat, saturated fat, cholesterol, or sodium that 
exceed the disqualifying levels would encourage increased intake of 
these foods and would make it difficult for consumers to follow the 
Surgeon General's recommendations and to construct a healthful diet. 
Even with the current disqualification levels, consumers could reach 
the DV's for total fat, saturated fat, cholesterol, or sodium by eating 
as few as five foods that bear health claims.
    The agency considers the current disqualification rules to be 
consistent with congressional intent. Congress contemplated that health 
claims would be reserved for those foods that can contribute to a 
healthful diet. As the House Report states, ``Health claims supported 
by a significant scientific agreement can reinforce the Surgeon 
General's recommendations and help Americans to maintain a balanced and 
healthful diet.'' (See H. Rept. 101-538, 101st Cong., 2d sess. pp. 9-10 
(1990).)
    Nevertheless, the agency tentatively finds that there may be some 
instances where disclosure rather than disqualification is appropriate. 
While FDA continues to believe that exceptions should be granted on a 
case-by-case basis, using a petition process, the agency recognizes 
that further guidance on the criteria that it will use to evaluate 
petitions for exceptions would be useful. FDA is, therefore, proposing 
to amend its regulations to give such guidance.
    Proposed Sec. 101.70(f) provides guidance for petitioners 
requesting an exception to the prohibition in Sec. 101.14(e)(3) against 
health claims for foods exceeding the disqualifying levels identified 
in Sec. 101.14(a)(5). This proposed amendment to the petition 
procedures sets out some of the factors that the agency will consider 
when evaluating a petition.
    The first factor that FDA is proposing to list is whether the risk 
of the disease or health-related condition is of such public health 
significance, and the role of the diet so critical, that 
disqualification is not appropriate (proposed Sec. 101.70(f)(1)). The 
agency recognizes that there may be instances where extraordinary 
efforts are needed to address a particular public health problem. In 
such cases, the agency would consider providing for disclosure rather 
than disqualification levels.
    The second factor is whether the availability of foods that qualify 
for a health claim is adequate to address the public health concern 
that is the subject of the health claim (proposed Sec. 101.70(f)(2)). 
The agency intends to consider whether the application of the claim is 
so limited because of the disqualification levels that it will not be 
possible to meet the public health goal of the health claim. If only a 
limited number of food products qualify to bear the claim because of 
the disqualifying levels, the agency would consider providing for 
disclosure rather than disqualification levels.
    The third factor that FDA intends to consider is whether there is 
some evidence that the population to which the health claim is targeted 
is not at risk for the disease or health-related condition associated 
with the disqualifying nutrient (proposed Sec. 101.70(f)(3)). Although 
the current disqualifying nutrients are associated with diseases or 
health-related conditions that pose risks to the general population, 
there may be some categories of foods that are targeted to specific 
subpopulations that are not at particular risk for the disease or 
health-related condition associated with the disqualifying nutrient 
(toddlers, for example). The agency would be willing to look at data 
and to consider whether an exception to the disqualifying levels should 
be made for foods intended for such subgroups.
    Related to this criterion, is the question of whether there is 
evidence that consumers can identify themselves as being at risk for a 
particular disease or health-related condition associated with the 
disqualifying levels. For instance, some individuals can already 
identify themselves as being sensitive to sodium and, therefore, would 
recognize the risk of a high sodium food if it were disclosed. If the 
ability to self-identify for these risks becomes widespread, disclosure 
might be sufficient to reduce the risk from the disqualifying nutrient. 
FDA would expect to receive data that demonstrate that this ability 
exists, however, before it would be willing to grant an exemption on 
this basis.
    Finally, the agency intends to consider whether there are any other 
public health reasons for providing for disclosure rather than 
disqualification (proposed Sec. 101.70(f)(4)). The agency does not 
consider the above list of criteria exhaustive. There may be other 
criteria that would be useful in determining whether the agency should 
provide for disclosure rather that disqualification levels for health 
claims, and the agency is open to considering such factors.
    The agency requests comments on the appropriateness of these 
criteria.
    The agency notes that there are ways to convey important health 
information other than through health claims. A food may still be able 
to bear a nutrient content claim or a structure/function claim in order 
to highlight a particular attribute even if it exceeds the 
disqualification level for a health claim. For example, while whole 
milk may not be able to bear a calcium and osteoporosis health claim, 
it can still bear a ``high calcium'' nutrient content claim, so long as 
the levels of fat and saturated fat are disclosed. Similarly, 

[[Page 66223]]
cooking oils that are lower in saturated fat may not be able to bear a 
``healthy heart'' claim but can still bear a ``low'' or ``less'' 
saturated fat nutrient content claim.
    In addition, some products can make other truthful and not 
misleading claims. For example, the label of whole milk can state 
``Calcium builds strong bones.'' While such a claim is not considered a 
health claim under the 1990 amendments, it still conveys important 
dietary advice useful to consumers in constructing a healthful diet.

V. Environmental Impact

    The agency has determined under 21 CFR 25.24(a)(11) that this 
action is of a type that does not individually or cumulatively have a 
significant effect on the human environment. Therefore, neither an 
environmental assessment nor an environmental impact statement is 
required.

VI. Analysis of Impacts

    FDA has examined the impacts of the proposed rule under Executive 
Order 12866 and the Regulatory Flexibility Act (Pub. L. 96-354). 
Executive Order 12866 directs agencies to assess all costs and benefits 
of available regulatory alternatives and, when regulation is necessary, 
to select regulatory approaches that maximize net benefits (including 
potential economic, environmental, public health and safety, and other 
advantages; distributive impacts; and equity). The agency believes that 
this proposed rule is consistent with the regulatory philosophy and 
principles identified in the Executive Order. In addition, the proposed 
rule is not a significant regulatory action as defined by the Executive 
Order and so is not subject to review under the Executive Order.
    FDA is proposing to: (1) Specify circumstances under which synonyms 
may be used, authorizing the use of unlisted synonyms provided that 
they are properly anchored to a listed term; (2) exempt certain types 
of products from the 10 percent nutrient contribution requirement; (3) 
provide the basis for shorter health claims by eliminating some of the 
required elements; and (4) permit an abbreviated health claim to be 
used on the principal display panel. FDA is also providing guidance for 
petitioners requesting an exception to the prohibition against health 
claims for foods exceeding FDA's defined disqualifying levels. The 
agency anticipates that the costs of this proposed rule will be 
minimal. If this rule is finalized as proposed, it will not require any 
manufacturers currently making claims to change their labels or 
labeling. Also, this rule may reduce the costs of making future claims 
by reducing the uncertainty and relaxing the requirements of the 
petition process for claims.
    Although many health claims have appeared on a variety of products, 
the agency is concerned that health claims are not being used as 
extensively as they could be. To the extent that valid claims are not 
being used, a cost is imposed on society in that some valuable 
information may not be conveyed to consumers. This proposed rule will 
reduce the cost of lost beneficial information by making it easier for 
firms to make nutrient content and health claims. The agency is aware 
that the food label or labeling is a major means of providing 
information on foods at the point-of-purchase. By adopting a less 
restrictive approach to claims, the agency is providing industry with a 
method by which the label can be used to inform consumers of the health 
benefits of foods in such a way that will catch the attention of 
consumers. As long as the claims are truthful, not misleading, and 
scientifically valid, the additional information will benefit consumers 
by reinforcing the Surgeon General's recommendations and helping 
consumers maintain healthful dietary practices. In addition, the 
greater flexibility provided to industry will increase the incentive to 
develop more healthful products.
    The Regulatory Flexibility Act requires analyzing options for 
regulatory relief for small businesses. The current claims regulations 
may have discouraged small businesses from making valid nutrient 
content claims and health claims. To the extent that this rule relaxes 
the restrictions on the ability of firms to use claims on the labels or 
in the labeling of their products, this rule will benefit small firms. 
In accordance with the Regulatory Flexibility Act, the agency certifies 
that the proposed rule will not have a significant economic impact on a 
substantial number of small businesses.

VII. Paperwork Reduction Act

    FDA tentatively concludes that this proposed rule contains no 
reporting, recordkeeping, labeling, or other third party disclosure 
requirements; thus there is not ``information collection'' 
necessitating clearance by the Office of Management and Budget. 
However, to ensure the accuracy of this tentative conclusion, FDA is 
seeking comment on whether this proposed rule to permit additional 
flexibility in the use of health claims and synonyms for nutrient 
content claims on food labels imposes any paperwork burden.

VIII. Comments

    Interested persons may, on or before March 20, 1996, submit to the 
Dockets Management Branch (address above) written comments regarding 
this proposal. Two copies of any comments are to be submitted, except 
that individuals may submit one copy. Comments are to be identified 
with the docket number found in brackets in the heading of this 
document. Received comments may be seen in the office above between 9 
a.m. and 4 p.m., Monday through Friday.

IX. References

    The following references have been placed on display in the Dockets 
Management Branch (address above) and may be seen by interested persons 
between 9 a.m. and 4 p.m., Monday through Friday.

    1. House Committee on Energy and Commerce, ``Nutrition Labeling 
and Education Act of 1990,'' 101st Congress, 2d sess., Report 101-
538, pp. 9-10, June 13, 1990.
    2. Committee on the Nutrition Components of Food Labeling, Food 
and Nutrition Board, IOM, National Academy of Science, ``Nutrition 
Labeling, Issues and Directions for the 1990's,'' Washington, DC, 
National Academy Press, 1990.
    3. United States Department of Agriculture, Human Nutrition 
Information Services, ``USDA's Food Guide Pyramid,'' Home and Garden 
Bulletin No. 249, April, 1992.
    4. ``The Surgeon General's Report on Nutrition and Health,'' 
DHHS, Public Health Service Publication No. 88-50210 (Government 
Printing Office Stock No. 017-001-00465-1), U.S. Government Printing 
Office, Washington, DC, 1988.
    5. Committee on Diet and Health, Food and Nutrition Board, 
Commission on Life Sciences, National Research Council, National 
Academy of Science, ``Diet and Health: Implications for Reducing 
Chronic Disease Risk,'' National Academy Press, Washington, DC, 
1989.
    6. National Institutes of Health, Office of the Director, ``NIH 
Consensus Statement, Optimal Calcium Intake,'' vol. 12, No. 4, June 
6-8, 1994. Available from: NIH Consensus Program Information 
Service, P.O. Box 2577, Kensington, MD 20891, 1-800-644-6627.
    7. Levy, A., Food and Drug Administration, Center for Food 
Safety and Applied Nutrition, Division of Market Studies, ``Summary 
Report on Health Claims Focus Groups,'' June 15, 1995.
    8. Dietary Supplement Health and Education Act of 1994 (Pub. L. 
103-417), October 25, 1994.
    9. Technical Report--Cancer Prevention Awareness Survey--Wave 
II, Office of Cancer Communications, National Cancer Institute, 
National Institutes of Health, Bethesda, MD, November 1986.
    10. Brenda Derby, Memorandum to Victor Frattali, ``Consumer 
Understanding of 

[[Page 66224]]
Multifactoriality of Disease,'' October 25, 1995.-

List of Subjects in 21 CFR Part 101

    Food labeling, Nutrition, Reporting and recordkeeping requirements.
    Therefore, under the Federal Food, Drug, and Cosmetic Act, and 
under authority delegated to the Commissioner of Food and Drugs, it is 
proposed that 21 CFR part 101 be amended as follows:

PART 101--FOOD LABELING

    1. The authority citation for 21 CFR part 101 continues to read as 
follows:

    Authority: Secs. 4, 5, 6 of the Fair Packaging and Labeling Act 
(15 U.S.C. 1453, 1454, 1455); secs. 201, 301, 402, 403, 409, 701 of 
the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 331, 342, 
343, 348, 371).

    2. Section 101.13 is amended by revising the introductory text of 
paragraph (b) and adding new paragraph (r) to read as follows:

Sec. 101.13  Nutrient content claims--general principles.

* * * * *
    (b) A claim that expressly or implicitly characterizes the level of 
a nutrient (nutrient content claim) of the type required in nutrition 
labeling under Sec. 101.9 with the exception of such claims on 
restaurant menus and except as noted in paragraph (r) of this section 
for unlisted synonyms, may not be made on the label or in labeling of 
foods unless the claim is made in accordance with this regulation and 
with the applicable regulations in subpart D of this part or in part 
105 or part 107 of this chapter.
* * * * *
    (r) Expressed synonyms for nutrient content claims may be used, 
provided:
    (1) The term is listed as a synonym of a defined term in the 
regulations in subpart D of this part or in part 105 or part 107 of 
this chapter; or
    (2) The term is used in a manner that complies with the following 
requirements:
    (i) Such term is not misleading and, in the context of the entire 
label, is reasonably understood by consumers to be a synonym of a term 
listed in subpart D of this part or in part 105 or part 107 of this 
chapter;
    (ii)(A) The term that is listed in subpart D of this part or in 
part 105 or part 107 of this chapter, and for which the unlisted term 
is being used as a synonym, appears prominently and conspicuously on 
the label, such that it is:
    (1) Immediately adjacent (with no intervening material) to the most 
prominent use of the unlisted synonym (as determined in accordance with 
Sec. 101.13(j)(2)(iii)); and
    (2) At least half as prominent (including type size, style, and 
color) as the unlisted synonym authorized under this paragraph.
    (B) If the term listed in subpart D of this part or in part 105 or 
part 107 of this chapter is more than twice as prominent on a label as 
the synonym authorized under this paragraph such that the claimed 
nutrient level is clearly understood (e.g., a claim in the statement of 
identity versus an unlisted synonym used only in a paragraph in small 
sized type), the term listed in subpart D of this part or in part 105 
or part 107 of this chapter need not be placed adjacent to the unlisted 
synonym authorized under this paragraph.
    (iii) The unlisted synonym is used in conformance with all the 
requirements for the use of the defined term, i.e., the referral 
statement required in Sec. 101.13(g) and any other required label 
statements appear in the prescribed manner; and
    (iv) This paragraph does not authorize a term listed in subpart D 
of this part or in part 105 or part 107 of this chapter to be used in 
conjunction with an unlisted qualifying term (e.g., ``extra low,'' 
``extra high,'' ``especially good source,'' or ``great source'').
    3. Section 101.14 is amended by revising paragraphs (d)(2)(iv) and 
(e)(6) to read as follows:

Sec. 101.14  Health claims: general requirements.

* * * * *
    (d) * * *
    (2) * * *
    (iv) All information required to be included in the claim appears 
in one place without other intervening material, except that the 
principal display panel of the label or labeling may bear:
    (A) The reference statement, ``See---------- for information about 
the relationship between-------- and ---------- ,'' with the blanks 
filled in with the location of the labeling containing the health 
claim, the name of the substance, and the name of the disease or 
health-related condition (e.g., ``See attached pamphlet for information 
about calcium and osteoporosis''), with the entire claim appearing 
elsewhere on the other labeling, Provided that, where any graphic 
material (e.g., a heart symbol) constituting an explicit or implied 
health claim appears on the label or labeling, the reference statement 
or the complete claim shall appear in immediate proximity to such 
graphic material; or
    (B) As authorized under subpart E of this part, an abbreviated 
claim consisting only of a truthful, nonmisleading, and scientifically 
valid description of the relationship between the substance and the 
disease or health-related condition, Provided that:
    (1) Such an abbreviated claim is accompanied by a reference 
statement to the complete health claim;
    (2) The reference statement is prominent and in immediate proximity 
to the abbreviated claim; and
    (3) The complete health claim appears on the same label, or in the 
same labeling, in which the abbreviated claim appears.
* * * * *
    (e) * * *
    (6) Except for dietary supplements, fruit or vegetable products 
composed solely of fruits and vegetables, enriched grain products that 
conform to a standard of identity in part 136, 137, or 139 of this 
chapter, and bread which conforms to the standard of identity for 
enriched bread in Sec. 136.115 of this chapter except that it contains 
whole wheat or other grain products not permitted under that standard, 
or where provided for in other regulations in part 101, subpart E, the 
food contains 10 percent or more of the Reference Daily Intake or Daily 
Reference Value for vitamin A, vitamin C, iron, calcium, protein, or 
fiber per reference amount customarily consumed prior to any nutrient 
addition.
* * * * *
    4. Section 101.70 is amended in paragraph (f) by adding in the 
model petition new text immediately preceding the last undesignated 
paragraph of section B to read as follows:

Sec. 101.70  Petitions for health claims.

* * * * *
    (f) * * *
    B. * * *
    In deciding the merits of a petition filed for an exception to the 
prohibition in Sec. 101.14(e)(3) against health claims for foods 
exceeding the disqualifying levels identified in Sec. 101.14(a)(5), the 
agency will consider the following factors:
    1. The public health significance of the risk of the disease or 
health-related condition that is the subject of the claim and the role 
that the diet plays in decreasing that risk;
    2. The availability of foods that qualify for a claim to address 
the underlying public health concerns;
    3. Evidence demonstrating the population to which the health claim 
is targeted is not at risk for the disease or health-related condition 
associated with the disqualifying nutrient, including, 

[[Page 66225]]
but not limited to, the ability of individuals to identify themselves 
as being at risk for the disease or health-related condition associated 
with the disqualifying nutrient; and
    4. All other evidence demonstrating the public health need for 
waiving the disqualification requirements.
* * * * *
    5. Section 101.72 is amended by revising paragraph (c)(2)(i); by 
redesignating paragraphs (c)(2)(ii) and (d)(2) as (c)(2)(iii) and 
(d)(5), respectively; by adding new paragraphs (c)(2)(ii), (d)(2), 
(d)(3), and (d)(4); and by revising paragraph (e) to read as follows:

Sec. 101.72  Health claims: calcium and osteoporosis.

* * * * *
    (c)(2) Specific requirements. (i) Nature of the claim. A health 
claim associating calcium with a reduced risk of osteoporosis may be 
made on the label or labeling of a food described in paragraph 
(c)(2)(iii) of this section, provided that:
    (A) The claim makes clear that adequate calcium intake as part of a 
healthful diet throughout life is essential to reduce the risk of 
osteoporosis. The claim does not imply that adequate dietary calcium 
intake is the only recognized risk factor for the development of 
osteoporosis;
    (B) The claim does not state or imply that the risk of osteoporosis 
is equally applicable to the general United States population. The 
claim shall identify the population at particular risk for the 
development of osteoporosis as women in their bone forming years from 
approximately 11 to 35 years of age. An optional statement that further 
characterizes this and other populations at risk for developing 
osteoporosis may be made in accordance with paragraph (d)(3) of this 
section;
    (C) The claim does not attribute any degree to which maintaining 
adequate calcium intake throughout life may reduce the risk of 
osteoporosis; and
    (D) The claim states that total dietary intake of calcium greater 
than 2,000 milligrams (mg) per day (200 percent of the DV for calcium 
for adults and children 4 or more years of age or 154 percent of the 
daily value (DV) for pregnant or lactating women) provides no further 
benefit to bone health in reducing the risk of osteoporosis. This 
requirement does not apply to a food that provides 1,500 mg or less of 
calcium per day (150 percent or less of the DV for calcium for adults 
and children 4 or more years of age or 115 percent or less of the DV 
for pregnant or lactating women) when used as directed in labeling.
    (ii) Presentation of the claim. All of the elements listed in 
paragraph (c)(2)(i) of this section must be included in one 
presentation of the claim displayed prominently on the label or 
labeling on which the claim appears. Other presentations of the claim 
on that label or labeling, including on the principal display panel, 
need not include the information in paragraphs (c)(2)(i)(B) and 
(c)(2)(i)(D) of this section provided that, displayed prominently and 
in immediate proximity to such claim, the following referral statement 
is used: ``See -------- for more information'' with the blank filled in 
with the identity of the panel on which is presented the statement of 
the claim that includes all of the elements in paragraph (c)(2)(i) of 
this section.
    (A)-The referral statement ``See [appropriate panel] for more 
information'' shall be in easily legible boldface print or type, in 
distinct contrast to other printed or graphic matter, that is no less 
than that required by Sec. 101.105(i) for net quantity of contents, 
except where the size of the claim is less than two times the required 
size of the net quantity of contents statement, in which case the 
referral statement shall be no less than one-half the size of the claim 
but no smaller than one-sixteenth of an inch.
    (B) The referral statement shall be immediately adjacent to any 
presentation of the health claim that does not include all of the 
elements of paragraph (c)(2)(i) of this section, and there may be no 
intervening material between the claim and the referral statement. If 
the abbreviated health claim appears on more than one panel of the 
label, the referral statement shall be adjacent to the claim on each 
panel except for the panel that bears the full health claim where it 
may be omitted.
-* * * * *
    (d) * * *
    (2) The claim may list specific risk factors for osteoporosis, 
identifying them among the multifactorial risks for the disease. Such 
factors include a person's sex, age, and race. The claim may state that 
an adequate amount of exercise is also needed to reduce risk for the 
disease.
    (3) The claim may further identify the population at particular 
risk for the development of osteoporosis as including white (or 
``Caucasian'') women and Asian women in their bone forming years 
(approximately 11 to 35 years of age). The claim may also identify 
menopausal (or the term ``middle-aged'') women, persons with a family 
history of the disease, and elderly (or ``older'') men and women as 
being at risk.
    (4) The claim may state that adequate calcium intake throughout 
life is linked to reduced risk of osteoporosis through the mechanism of 
optimizing peak bone mass during adolescence and early adulthood. The 
phrase ``build and maintain good bone health'' may be used to convey 
the concept of optimizing peak bone mass. When reference is made to 
persons with a family history of the disease, menopausal women, and 
elderly men and women, the claim may also state that adequate calcium 
intake is linked to reduced risk of osteoporosis through the mechanism 
of slowing the rate of bone loss.
-* * * * *
    (e) Model health claims. The following are examples of model health 
claims that may be used in food labeling to describe the relationship 
between calcium and osteoporosis:
    (1) Examples 1 and 2. Model health claims for a food that does not 
require the statement specified in paragraph (c)(2)(i)(D) of this 
section:

    Especially for teen and young adult women, adequate calcium in a 
healthful diet may reduce the risk of osteoporosis later in life.
    A healthful diet with adequate calcium and regular exercise help 
teen and young adult white and Asian women maintain good bone health 
and may reduce their high risk of osteoporosis later in life.

    (2) Example 3. Model health claims for a food labeled for use by 
adults and children 4 or more years of age that requires the statement 
specified in paragraph (c)(2)(i)(D) of this section:

    Exercise and a healthful diet with enough calcium may help teen 
and young adult women reduce their high risk of osteoporosis later 
in life. Adequate calcium is important for everyone (women and men 
at all ages) but daily intakes above 2,000 mg (200 percent of the 
DV) may not provide added benefit.

    (3) Example 4. Abbreviated model health claim for use with a full 
health claim and that conforms with the requirements of paragraph 
(c)(2)(ii) of this section:

    Adequate calcium in a healthful diet may reduce the risk of 
osteoporosis. See [appropriate panel] for more information.

    6. Section 101.73 is amended by revising paragraphs (c)(2)(i)(F), 
(d)(1), and (e)(1) to read as follows:

Sec. 101.73  Health claims: dietary lipids and cancer.

* * * * *
    (c) * * *
    (2) * * *
    (i) * * *
    (F) The claim does not imply that dietary fat consumption is the 
only 

[[Page 66226]]
recognized risk factor for the development of cancer.
* * * * *
    (d) Optional information. (1) The claim may indicate that 
development of cancer depends on many factors and identify one or more 
of the following as risk factors for the disease: Family history of a 
specific type of cancer, cigarette smoking, alcohol consumption, 
overweight and obesity, ultraviolet or ionizing radiation, exposure to 
cancer-causing chemicals, and dietary factors.
* * * * *
    (e) * * *
    (1) A low fat diet may reduce the risk of some cancers.
-* * * * *
    7. Section 101.74 is amended by revising paragraphs (c)(2)(i)(E), 
(d)(1), (e)(1), and (e)(2) to read as follows:

Sec. 101.74  Health claims: sodium and hypertension.

-* * * * *
    (c) * * *
    (2) * * *
    (i) * * *
    (E) The claim does not imply that dietary sodium consumption is the 
only recognized risk factor for the development of high blood pressure.
-* * * * *
    (d) Optional information. (1) The claim may indicate that 
development of high blood pressure depends on many factors and identify 
one or more of the following as risk factors for the disease in 
addition to dietary sodium consumption: Family history of high blood 
pressure, growing older, alcohol consumption, and excess weight.
-* * * * *
    (e) * * *
    (1) A low sodium diet may reduce the risk of high blood pressure.
    (2) [This product] can be part of a low sodium, low salt diet that 
might reduce the risk of hypertension or high blood pressure.
    8. Section 101.75 is amended by revising paragraphs (c)(2)(i)(E), 
(d)(1), (e)(1), and (e)(2) to read as follows:

Sec. 101.75  Health claims: dietary saturated fat and cholesterol and 
risk of coronary heart disease.

-* * * * *
    (c) * * *
    (2) * * *
    (i) * * *
    (E) The claim does not imply that consumption of dietary saturated 
fat and cholesterol is the only recognized risk factor for the 
development of coronary heart disease.
-* * * * *
    (d) Optional information. (1) The claim may indicate that coronary 
heart disease risk depends on many factors and identify one or more of 
the following in addition to saturated fat and cholesterol about which 
there is general scientific agreement that they are major risk factors 
for this disease: A family history of coronary heart disease, elevated 
blood total and LDL-cholesterol, excess body weight, high blood 
pressure, cigarette smoking, diabetes, and physical inactivity.
-* * * * *
    (e) * * *
    (1) Diets low in saturated fat and cholesterol may reduce the risk 
of heart disease;
    (2) Your risk of heart disease might be reduced by a diet low in 
saturated fat and cholesterol and a healthy lifestyle;
-* * * * *
    9. Section 101.76 is amended by revising paragraphs (c)(2)(i)(D), 
(d)(2), (e)(1), and (e)(2) to read as follows:

Sec. 101.76  Health claims: fiber-containing grain products, fruits, 
and vegetables and cancer.

-* * * * *
    (c) * * *
    (2) * * *
    (i) * * *
    (D) The claim does not imply that consumption of diets low in fat 
and high in fiber-containing grain products, fruits, and vegetables is 
the only recognized risk factor for a reduced risk of developing 
cancer.
-* * * * *
    (d) * * *
    (2) The claim may indicate that development of cancer depends on 
many factors and identify one or more of the following as risk factors 
for the disease: Family history of a specific type of cancer, cigarette 
smoking, alcohol consumption, overweight and obesity, ultraviolet or 
ionizing radiation, exposure to cancer-causing chemicals, and dietary 
factors.
-* * * * *
    (e) * * *
    (1) Low fat diets rich in fiber-containing grain products, fruits, 
and vegetables may reduce the risk of some types of cancer.
    (2) A diet low in fat and high in grain products, fruits, and 
vegetables that contain fiber may reduce your risk of some cancers.
-* * * * *
    10. Section 101.77 is amended by revising paragraphs (c)(2)(i)(F), 
(d)(1), and (e) to read as follows:

Sec. 101.77  Health claims: fruits, vegetables, and grain products -
that contain fiber, particularly soluble fiber, and risk of -coronary 
heart disease.

    (c) * * *
    (2) * * *
    (i) * * *
    (F) The claim does not imply that consumption of diets low in 
saturated fat and cholesterol and high in fruits, vegetables, and grain 
products that contain fiber, particularly soluble fiber, is the only 
recognized risk factor for a reduced risk of developing coronary heart 
disease.
-* * * * *
    (d) Optional information. (1) The claim may indicate that 
development of coronary heart disease depends on many factors and 
identify one or more of the following as risk factors for the disease: 
A family history of coronary heart disease, elevated blood-, total- and 
LDL-cholesterol, excess body weight, high blood pressure, cigarette 
smoking, diabetes, and physical inactivity.
-* * * * *
    (e) Model health claims. The following model health claims may be 
used in food labeling to characterize the relationship between diets 
low in saturated fat and cholesterol and high in fruits, vegetables, 
and grain products that contain soluble fiber and the risk of coronary 
heart disease:
    (1) Diets low in saturated fat and cholesterol and rich in fiber-
containing fruits, vegetables, and grain products may reduce the risk 
of heart disease.
    (2) A diet low in saturated fat and cholesterol and high in fruits, 
vegetables, and grain products that contain fiber may lower blood 
cholesterol levels and reduce your risk of heart disease.
    11. Section 101.78 is amended by removing paragraph (c)(2)(i)(D); 
by redesignating paragraphs (c)(2)(i)(E) through (c)(2)(i)(J) and 
(d)(3) through (d)(5) as (c)(2)(i)(D) through (c)(2)(i)(I) and (d)(4) 
through (d)(6), respectively; by revising newly redesignated paragraph 
(c)(2)(i)(I), paragraphs (d)(2), (e)(1), and (e)(2); and by adding new 
paragraph (d)(3) to read as follows:

Sec. 101.78  Health claims: fruits and vegetables and cancer.

 -* * * * *
    (c) * * *
    (2) * * *
    (i) * * *
    (I) The claim does not imply that consumption of diets low in fat 
and high in fruits and vegetables is the only recognized risk factor 
for a reduced risk of developing cancer.
-* * * * * 

[[Page 66227]]

    (d) * * *
    (2) The claim may indicate that development of cancer depends on 
many factors and identify one or more of the following as risk factors 
for the disease: Family history of a specific type of cancer, cigarette 
smoking, alcohol consumption, overweight and obesity, ultraviolet or 
ionizing radiation, exposure to cancer-causing chemicals, and dietary 
factors.
    (3) The claim may characterize fruits and vegetables that meet the 
requirements described in paragraph (c)(2)(ii) of this section as foods 
that are low in fat and that contain (or are a good source of) one or 
more of vitamin A, vitamin C, or dietary fiber.
-* * * * *
    (e) * * *
    (1) Low fat diets rich in fruits and vegetables (foods that are low 
in fat and may contain dietary fiber, vitamin A and vitamin C), may 
reduce the risk of some types of cancer.
    (2) A diet low in fat and high in certain fruits and vegetables, 
foods that are low in fat and that may contain vitamin A and vitamin C, 
may reduce your risk of some cancer.

    Dated: December 13, 1995.
William B. Schultz,
Deputy Commissioner for Policy.
[FR Doc. 95-31008 Filed 12-20-95; 8:45 am]
BILLING CODE 4160-01-F

Complete official Federal Register PDF

FR Doc. 95-30996 Federal Acquisition Regulation; Allowable Cost and Payment Clause
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Page 66472]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-30996]

[[Page 66471]]

_______________________________________________________________________

Part III

Department of Defense

General Services Administration

National Aeronautics and Space Administration
_______________________________________________________________________

48 CFR Parts 52 and 44

Allowable Cost and Payment Clause and Contractors' Purchasing Systems 
Reviews; Proposed Rule

Federal Register  / Vol. 60, No. 245 / Thursday, December 21, 1995 / 
Proposed Rules

[[Page 66472]]

DEPARTMENT OF DEFENSE

GENERAL SERVICES ADMINISTRATION

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

48 CFR Part 52

[FAR Case 93-024]
RIN 9000-AG74

Federal Acquisition Regulation; Allowable Cost and Payment Clause

AGENCIES Department of Defense (DOD), General Services Administration 
(GSA), and National Aeronautics and Space Administration (NASA).

ACTION: Proposed rule.

-----------------------------------------------------------------------

SUMMARY: The Civilian Agency Acquisition Council and the Defense 
Acquisition Regulations Council are proposing changes to the Federal 
Acquisition Regulation (FAR) to clarify payment provisions for large 
business prime contractors which are awarded cost-type contracts. This 
regulatory action was not subject to Office of Management and Budget 
review under Executive Order 12866, dated September 30, 1993.

DATES: Comments should be submitted on or before February 20, 1996 to 
be considered in the formulation of a final rule.

ADDRESSES: Interested parties should submit written comments on: 
General Services Administration, FAR Secretariat (VRS), 18th and F 
Streets, NW, Room 4037, Washington, DC 20405.
    Please cite FAR case 93-024 in all correspondence related to this 
case.

FOR FURTHER INFORMATION CONTACT:
Jeremy F. Olson at (202) 501-3221 in reference to this FAR case. For 
general information, contact the FAR Secretariat, Room 4037, GS 
Building, Washington, DC 20405 (202) 501-4755. Please cite FAR case 93-
024.

SUPPLEMENTARY INFORMATION: 

A. Background

    The Office of Federal Procurement Policy SWAT Team on Civilian 
Agency Contracting in its report of December 1992, entitled ``Improving 
Contracting Practices and Management Controls on Cost-Type Federal 
Contracts'', recommended several FAR revisions which were viewed to 
have Government-wide benefit.
    One area identified for clarification included the payment 
provisions in FAR clauses 52.216-7, Allowable Cost and payment, and 
52.232-7, Payment Under Time-and-Materials and Labor-Hour Contracts. 
The SWAT Team concluded that these clauses did not clearly convey the 
Government's intent that payments to subcontractors by large business 
prime contractors were not billable to the Government until the 
contractor had actually paid the subcontractors. The proposed rule 
amends these payment clauses to clarify that, on cost-type 
contracts,payments to subcontractors are not billable by large business 
prime contractors until the subcontractors have been paid by the prime 
contractor.

B. Regulatory Flexibility Act

    This proposed rule is not expected to have a significant economic 
impact on a substantial number of small entities within the meaning of 
the Regulatory Flexibility Act, 5 U.S.C. 601, et seq., because the rule 
only applies to large business entities who wish to be reimbursed under 
cost-type contracts. An Initial Regulatory Flexibility Analysis has, 
therefore, not been performed. Comments from small entities concerning 
the affected FAR subpart will be considered in accordance with 5 U.S.C. 
610 of the Act. Such comments must be submitted separately and cite 
(FAR case 93-024), in correspondence.

C. Paperwork Reduction Act

    The Paperwork Reduction Act does not apply because the proposed 
changes to the FAR do not impose recordkeeping or information 
collection requirements, or collections of information from offerors, 
contractors, or members of the public which require the approval of the 
Office of Management and Budget under 44 U.S.C. 3501, et seq.

List of Subjects in 48 CFR Part 52

    Government procurement.

    Dated: December 15, 1995.
Edward C. Loeb,
Acting Director, Office of Federal Acquisition Policy.

    Therefore, it is proposed that 48 CFR Part 52 be amended as set 
forth below:

PART 52--SOLICITATION PROVISIONS AND CONTRACT CLAUSES

    1. The authority citation for 48 CFR Part 52 continues to read as 
follows:

    Authority: 40 U.S.C. 486(c); 10 U.S.C. chapter 137; and 42 
U.S.C. 2473(c).

    2. Section 52.216-7 is amended by revising the clause date and 
paragraph (b)(i)(iii) to read as follows:

52.216-7  Allowable cost and payment.

* * * * *

Allowable Cost and Payment (Date)

* * * * *
    (b) * * *
    (1) * * *
    (iii) The amount of progress and other payments that have been 
paid by cash, check or other form of payment to the Contractor's 
subcontractors under similar cost standards.
* * * * *
    3. Section 52.232-7 is amended by revising the clause date and the 
second sentence of paragraph (b)(2) to read as follows:

52.232-7  Payments under time-and-materials and labor-hour contracts.

* * * * *

Payments Under Time-and-Materials and Labor-Hour Contracts (Date)

* * * * *
    (b) * * *
    (2) * * * Reimbursable costs in connection with subcontracts 
shall be limited to the amounts paid to the subcontractor for items 
and services purchased directly for the contract only when cash, 
checks, or other form of payment has been made for such purchased 
items or services; however, this requirement shall not apply to a 
Contractor that is a small business concern. * * *
* * * * *
[FR Doc. 95-30996 Filed 12-20-95; 8:45 am]
BILLING CODE 6820-EP-M

Complete official Federal Register PDF

FR Doc. 95-30995 Federal Acquisition Regulation; Contractors' Purchasing Systems Reviews
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Pages 66472-66473]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-30995]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE
GENERAL SERVICES ADMINISTRATION
NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
48 CFR Part 44

[FAR Case 94-605]
[RIN 9000-AG75]

Federal Acquisition Regulation; Contractors' Purchasing Systems 
Reviews

AGENCY: Department of Defense (DOD), General Services Administration 
(GSA),and National Aeronautics and Space Administration (NASA).

ACTION: Proposed rule.

-----------------------------------------------------------------------

SUMMARY: The Civilian Agency Acquisition Council and the Defense 
Acquisition Regulations Council (Councils) are proposing a revision to 
the Federal Acquisition Regulation (FAR) concerning requirements under 
Contractors' Purchasing Systems Reviews (CPSR's). This regulatory 
action was not subject to Office of Management and Budget review under 

[[Page 66473]]
Executive Order 12866, dated September 30, 1993.

DATES: Comments should be submitted on or before February 20, 1996 to 
be considered in the formulation of a final rule.

ADDRESSES: Interested parties should submit written comments to: 
General Services Administration, FAR Secretariat (VRS), 18th & F 
Streets, NW., Room 4037, Washington, DC 20405.
    Please cite FAR case 94-605 in all correspondence related to this 
case.

FOR FURTHER INFORMATION CONTACT:
Ms. Linda Klein at (202) 501-3775 in reference to this FAR case. For 
general information, contact the FAR Secretariat, Room 4037, GS 
Building, Washington, DC 20405 (202) 501-4755. Please cite FAR case 94-
605.

SUPPLEMENTARY INFORMATION:

A. Background

    Concern has been expressed that FAR 44.302(a) includes contractors 
in the CPSR process that will be severely inconvenienced by the review, 
and allows for the review of systems even when there is no benefit to 
the Government. Under the current FAR 44.302, a CPSR is to be conducted 
for each contractor whose sales to the Government are expected to 
exceed $10 million during the next 12 months. However, the Councils 
have agreed to raise the $10 million threshold to $25 million and have 
determined that contractors meeting the $25 million threshold should be 
reviewed before conducting a CPSR, to decide if a CPSR is necessary. 
The increased thresholds ($10 million to $25 million) that are 
reflected in this proposed rule have previously been approved under FAR 
case 94-40, Contractors' Purchasing Systems Reviews and Subcontractor 
Consent, and is awaiting publication as a final rule. The need for a 
CPSR will be determined based on volume, complexity, and dollar value 
of subcontracting activity. The proposed revision is intended to 
prevent unwarranted CPSR's from being conducted.

B. Regulatory Flexibility Act

    This proposed rule is not expected to have a significant economic 
impact on a substantial number of small entities within the meaning of 
the Regulatory Flexibility Act, 5 U.S.C. 601, et seq., because the rule 
will reduce the number of CPSR's being conducted by requiring a review 
to determine if a CPSR is needed. An Initial Regulatory Flexibility 
Analysis has, therefore, not been performed. Comments from small 
entities concerning the affected FAR subpart will be considered in 
accordance with 5 U.S.C. 610 of the Act. Such comments must be 
submitted separately and should cite 5 U.S.C. 601, et seq. (FAR case 
94-605), in correspondence.

C. Paperwork Reduction Act

    The information collection requirements for CPSR's have been 
previously approved under Office of Management and Budget Number 9000-
0132. This proposed rule does not contain any increased information 
collection requirements.

List of Subjects in 48 CFR Part 44

    Government procurement.

    Dated: December 15, 1995.
Edward C. Loeb,
Acting Director, Office of Federal Acquisition Policy.

    Therefore, it is proposed that 48 CFR Part 44 be amended as set 
forth below:

PART 44--SUBCONTRACTING POLICIES AND PROCEDURES

    1. The authority citation for 48 CFR Part 44 continues to read as 
follows:

    Authority: 40 U.S.C. 486(c); 10 U.S.C. chapter 137; and 42 
U.S.C. 2473(c).

    2. Section 44.302 is revised to read as follows:

Sec. 44.302  Requirements.

    (a) Each contractor whose sales to the Government, using other than 
sealed bid procedures, are expected to exceed $25 million during the 
next 12 months, shall be reviewed to determine if Contractors' 
Purchasing Systems Review (CPSR) is needed. Such sales include those 
represented by prime contracts, subcontracts under Government prime 
contracts, and modifications. The need for a CPSR will be determined 
based on volume, complexity, and dollar value of subcontracting 
activity. Generally, a CPSR is not performed for a specific contract. 
The head of the agency responsible for contract administration may 
raise or lower the $25 million review level if such action is 
considered to be in the Government's best interest.
    (b) Once an initial determination has been made under paragraph (a) 
of this section, at least every 3 years the cognizant contract 
administration activity will either: conduct a follow-up purchasing 
review; or determine that a purchasing system review is not required 
based on volume, complexity, and dollar value of subcontracting 
activity.

[FR Doc. 95-30995 Filed 12-20-95; 8:45 am]
BILLING CODE 6820-EP-M

Complete official Federal Register PDF

FR Doc. 95-30994 Truth in Lending
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Pages 66179-66181]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-30994]

=======================================================================
-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM

12 CFR Part 226

[Reg. Z; Docket No. R-0908]

Truth in Lending

AGENCY: Board of Governors of the Federal Reserve System.

ACTION: Request for comments.

-----------------------------------------------------------------------

SUMMARY: The Board is soliciting comment on how the finance charge 
could more accurately reflect the cost of consumer credit. In 
particular, the Board is asking for the public's views on the 
feasibility of treating as finance charges all costs imposed by the 
creditor or payable by the consumer as an incident to the extension of 
credit. The Truth in Lending Act Amendments of 1995 direct the Board to 
submit a report to the Congress regarding these issues. Under present 
law, costs such as interest are part of the finance charge; other 
costs, including many associated with real estate-secured lending, are 
excluded from the finance charge. The Board is also required to address 
in its report abusive refinancing practices engaged in by creditors for 
the purpose of avoiding a consumer's rescission rights.

DATES: Comments must be received on or before February 9, 1996.

ADDRESSES: Comments should refer to Docket No. R-0908, and may be 
mailed to William W. Wiles, Secretary of the Board of Governors of the 
Federal Reserve System, 20th Street and Constitution Avenue, NW., 
Washington, DC 20551. Comments also may be delivered to Room B-2222 of 
the Eccles Building between 8:45 a.m. and 5:15 p.m. weekdays, or to the 
guard station in the Eccles Building courtyard on 20th Street, NW., 
(between Constitution Avenue and C Street) at any time. Comments may be 
inspected in Room MP-500 of the Martin Building between 9 a.m. and 5 
p.m. weekdays, except as provided in 12 CFR 261.8 of the Board's rules 
regarding the availability of information.

FOR FURTHER INFORMATION CONTACT: Jane E. Ahrens, Senior Attorney, or 
Sheilah Goodman, or Kurt Schumacher, Staff Attorneys, Division of 
Consumer and Community Affairs, Board of Governors of the Federal 
Reserve System, at (202) 452-3667 or 452-2412. For users of 
Telecommunications Devices for the Deaf, contact Dorothea Thompson, at 
(202) 452-3544.

SUPPLEMENTARY INFORMATION:

I. Background

    The Truth in Lending Act Amendments of 1995 (1995 Amendments Act), 
Pub. L. 104-29, 109 Stat. 271, enacted into law on September 30, 1995, 
direct the Board to submit a report to the Congress concerning the use 
of finance charges to accurately reflect the cost of consumer credit. 
The Board must consider the feasibility of including in the finance 
charge all charges payable directly or indirectly by the consumer and 
imposed directly or indirectly by the creditor as an incident to the 
credit transaction--especially costs associated with real estate- or 
home-secured lending that are currently excluded from the finance 
charge under section 106 of the Truth in Lending Act. As contemplated 
by the Congress, perhaps only charges payable in a comparable cash 
transaction would continue to be excluded from the finance charge. The 
report must also address abusive refinancing practices engaged in by a 
creditor for the purpose of avoiding a consumer's rescission rights. 
The Board will submit its report to the Congress in early spring 1996, 
based on the comments of interested parties and on its own analysis.

[[Page 66180]]

II. Finance Charges

Definition

    The Truth in Lending Act (15 U.S.C. 1601 et seq.) contains rules 
governing the disclosure of finance charges (Section 106). The act is 
implemented by the Board's Regulation Z (12 CFR part 226). Rules on 
finance charges are contained in Regulation Z Sec. 226.4 and 
accompanying official staff interpretations. The finance charge is 
defined as the cost of consumer credit expressed as a dollar amount. It 
includes any charge payable directly or indirectly by the consumer and 
imposed directly or indirectly by the creditor as an incident to or a 
condition of the extension of credit. The term ``imposed'' is 
interpreted broadly, to include any cost charged by the creditor 
(unless otherwise excluded), including charges for optional services 
paid by the consumer. Examples of a finance charge include interest, 
points, and service or transaction fees.
    The act excludes certain costs from the finance charge, such as 
charges payable in a comparable cash transaction and fees paid to 
third-party closing agents (unless the creditor requires the services 
provided or retains the fee). Many costs associated with loans secured 
by real estate or a principal dwelling are specifically excluded; 
examples are fees for appraisals, document preparation, title 
insurance, and pest inspections prior to loan closing. The regulation 
also excludes charges such as application fees (charged to all 
applicants), late payment fees, and most taxes.
    Still other costs that are generally included in the finance charge 
may nevertheless be excluded. For example, the act provides that credit 
report fees are finance charges, but provides an exception for credit 
report fees associated with real estate- or home-secured loans. The act 
also excludes optional credit life insurance premiums and fees to 
record a security interest if the cost is disclosed to the consumer and 
meets other conditions.

Annual percentage rate

    In addition to requiring disclosure of finance charges as a dollar 
amount, the act and regulation require creditors to disclose the cost 
of consumer credit as an annual percentage rate (APR). Creditors must 
disclose an APR for all types of consumer credit--installment loans 
(closed-end credit) and credit card accounts or home equity lines of 
credit (open-end plans). The APR for closed-end credit and open-end 
plans reflect finance charges, but the distinct nature of these 
products calls for differences in how the APR is calculated.
    The APR for closed-end credit is based on the amounts borrowed by 
the consumer in relation to the amount and timing of payments to the 
creditor. It factors in interest and all other finance charges. Costs 
such as recording fees or title insurance fees may be disclosed, but 
are not a part of the finance charge and thus, are excluded from the 
APR calculation.
    Under open-end plans such as a home equity line of credit, the 
creditor typically sets the maximum amount that can be borrowed at any 
time. The amount that will actually be borrowed by the consumer, 
however, is typically unknown when the credit plan is established. The 
APR stated in advertisements and account-opening disclosures reflects 
only the rate of interest that will be applied to any outstanding 
balance the consumer may have in the future. Additional costs--whether 
finance or other charges--are separately identified.
    Consumers with outstanding balances receive an APR on periodic 
statements. That APR is based on the outstanding balance and certain 
finance charges imposed during the cycle. Some finance charges, such as 
points charged in connection with establishing a home equity plan or 
other fees to open or renew plans, would skew the APR for the billing 
cycle in which they are imposed. These types of finance charges are 
disclosed on periodic statements but are not figured in the APR.

Request for Comment

    The Board requests comments on how the definition of the finance 
charge could be modified, if at all, to reflect the cost of consumer 
credit more accurately. The Congress directs the Board to make 
recommendations on any necessary statutory and regulatory changes. 
(1995 Amendments, Section 2(f).) The Board believes the scope of the 
study is limited to possible modifications to the definition of the 
finance charge.
    The 1995 Amendments contain, for the most part, provisions 
affecting closed-end credit that is real estate- or home-secured. The 
Board believes that the scope of the report is intended to cover the 
treatment of costs as finance charges for all types of consumer credit, 
although a focus of the study will be on those fees associated with 
real estate lending that are currently excluded from the finance 
charge. For example, many costs associated with entering into home-
secured loans are the same whether the credit is an installment loan or 
a line of credit. Similarly, certain application fees are excluded from 
the finance charge for all types of credit transactions, not just those 
affecting installment loans.
    Comment is requested on the feasibility of including in the finance 
charge all charges payable directly or indirectly by the consumer and 
imposed directly or indirectly by the creditor as an incident to the 
credit transaction (other than costs imposed in comparable cash 
transactions), particularly costs associated with real estate- or home-
secured credit that are currently excluded from the finance charge. For 
example, mortgage brokers fees are sometimes, but not always, a finance 
charge under present law: A new statutory provision categorizes all 
brokers fees paid by the consumer to the broker (or to the creditor for 
delivery to the broker) as finance charges, and will go into effect 
when the Board issues a final rule in 1996.
    In assessing the feasibility of this approach, the Board must 
consider the implications of including charges imposed by third 
parties--settlement agents and others--that may not be within the 
creditor's knowledge or control. Comment is requested on compliance 
issues that would arise if the definition of the finance charge were 
expanded to include charges by third parties.
    Treating all costs as a finance charge would, of course, simplify 
creditor compliance with the TILA and Regulation Z; it would reduce the 
potential for disclosure errors. The Board believes the study is, in 
part, a reaction to the spate of class action lawsuits that followed 
the court decision of Rodash v. AIB Mortgage Company. (16 F.3d 1142 
(11th Cir. 1994)). In Rodash, the court found, among other TILA 
violations, that the creditor improperly excluded several fees from the 
finance charge calculation--totalling about $225. The court awarded 
civil money damages and allowed the consumer to rescind a $100,000 
loan.
    Including all costs in the finance charge, however, would also 
increase the APR disclosed for closed-end credit transactions--
dramatically, in some cases. For example, the APR for home-secured 
loans would reflect closing costs such as appraisal fees, title 
insurance and the like. Including premiums for optional credit life 
insurance or for property insurance in the finance charge could also 
have a significant impact on the APR. The resulting APR for installment 
loans may seem distorted, particularly in relation to the APR disclosed 
for a comparable open-end product. For example, disclosures for a home-
secured open-

[[Page 66181]]
end plan would include closing costs and insurance premiums as finance 
charges, but those fees would not be included in the APR stated in 
advertisements or account-opening disclosures, unless the current rules 
on calculating the APR are changed.

III. Abusive Refinancing Practices

    The act and regulation allow consumers to cancel (or rescind) 
certain credit transactions secured by the consumer's principal 
dwelling. For example, the right of rescission applies if a consumer's 
principal dwelling is used to secure a loan financing home improvements 
or a child's education. Other loans secured by a consumer's principal 
dwelling are not rescindable, such as a loan for a business purpose.
    A consumer's right to rescind a refinanced loan depends on both the 
creditor and amount of money involved. If the creditor refinancing the 
loan is the same creditor that initially extended the credit, consumers 
may rescind the refinancing only to the extent new monies are advanced. 
For example, if a consumer's principal dwelling secures a loan with a 
creditor and the consumer seeks to refinance an outstanding balance of 
$100,000 with the same creditor, the transaction is not rescindable. If 
the consumer obtains $25,000 in an additional advance, the refinancing 
could be rescinded up to the new advance of $25,000. If the consumer 
refinances the loan with a new creditor instead, the entire transaction 
is rescindable, whether or not new monies are advanced.
    The Board's report must include recommendations, if any, for 
statutory or regulatory changes necessary to address abusive 
refinancing practices engaged in by a creditor for the purpose of 
avoiding a consumer's rescission rights. Comment is requested on the 
issue.

IV. Form of Comment Letters

    Comment letters should refer to Docket No. R-0908, and, when 
possible, should use a standard courier typeface with a type size of 10 
or 12 characters per inch. This will enable the Board to convert the 
text to machine-readable form through electronic scanning, and will 
facilitate automated retrieval of comments for review. Also, if 
accompanied by an original document in paper form, comments may be 
submitted on 3\1/2\ inch or 5\1/4\ inch computer diskettes in any IBM-
compatible DOS-based format.

    By order of the Board of Governors of the Federal Reserve 
System, December 15, 1995.
William W. Wiles,
Secretary of the Board.
[FR Doc. 95-30994 Filed 12-20-95; 8:45 am]
BILLING CODE 6210-01-P

Complete official Federal Register PDF

FR Doc. 95-30988 South Atlantic Fishery Management Council; Public Hearings
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Pages 66247-66249]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-30988]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

National Oceanic and Atmospheric Administration

50 CFR Parts 642 and 659

[I.D. 120695B]

South Atlantic Fishery Management Council; Public Hearings

AGENCY: National Marine Fisheries Service (NMFS), National Oceanic and 
Atmospheric Administration (NOAA), Commerce.

ACTION: Public hearings.

-----------------------------------------------------------------------

SUMMARY: The South Atlantic Fishery Management Council (Council) will 
hold 13 public hearings on Draft Amendment 8 to the Fishery Management 
Plan for Coastal Migratory Pelagic Resources of the Gulf of Mexico and 
South Atlantic (FMP). In conjunction with these hearings, the Council 
will also hold seven public hearings to solicit comments on management 
measures for Draft Amendment 2 to the Fishery Management Plan for the 
Shrimp Fishery of the South Atlantic Region (FMP). Both Draft Amendment 
8 and 

[[Page 66248]]
Draft Amendment 2 include Supplemental Environmental Impact Statements 
(SEISs).

DATES: Written comments will be accepted until 5 p.m., January 19, 
1996. The hearings will be held from January 1 to January 5, 1996, and 
from January 8 to January 12, 1996. See SUPPLEMENTARY INFORMATION for 
specific dates and times.

ADDRESSES: Copies of the draft amendments are available from Susan 
Buchanan, Public Information Officer, at (803) 571-4366. Written 
comments may be faxed or sent to Bob Mahood, Executive Director, South 
Atlantic Fishery Management Council, One Southpark Circle, Suite 306, 
Charleston, SC 29407. Fax: 813-225-7015. The draft amendments will be 
available to the public at the hearings.
    The hearings for draft Amendment 8 (Coastal Pelagics) will be held 
in Florida, Georgia, South Carolina, North Carolina, Virginia, 
Maryland, New Jersey, and New York. The hearings for draft Amendment 2 
(Shrimp) will be held in South Carolina, Florida, Georgia, and North 
Carolina. See SUPPLEMENTARY INFORMATION for locations of the hearings 
and special accommodations.

FOR FURTHER INFORMATION CONTACT: Susan Buchanan, 803-571-4366.

SUPPLEMENTARY INFORMATION: The hearings are scheduled to begin at 7 
p.m. and will end when all business is completed. The dates and 
locations are scheduled as follows:
    1. Tuesday, January 2, 1996, (Coastal Pelagics) Ft. Pierce--Holiday 
Inn, 7151 Okeechobbe Road, Ft. Pierce, FL; telephone: (407) 464-5000;
    2. Tuesday, January 2, 1996, (Coastal Pelagics & Shrimp) Murrell's 
Inlet--Murrell's Inlet Community Center, 4450 Murrell's Inlet Road, 
Murrell's Inlet, SC; telephone: (803) 651-7373;
    3. Wednesday, January 3, 1996, (Coastal Pelagics & Shrimp) 
Jacksonville--Sea Turtle Days Inn, 10 Ocean Blvd., Atlantic Beach, FL; 
telephone: (904) 249-7402;
    4. Wednesday, January 3, 1996, (Coastal Pelagics & Shrimp) 
Wilmington--Holiday Inn, 1706 N. Lumina Avenue, Wrightsville Beach, NC; 
telephone: (910) 256-2231;
    5. Thursday, January 4, 1996, (Coastal Pelagics & Shrimp) 
Brunswick--Comfort Inn--I95, 5308 New Jesup Highway,
    Brunswick, GA; telephone: (912) 264-6540;
    6. Thursday, January 4, 1996, (Coastal Pelagics & Shrimp) Morehead 
City--Carteret Community College, 3505 Arendell Street, Morehead City, 
NC; telephone: (919) 247-3094;
    7. Friday, January 5, 1996, (Coastal Pelagics & Shrimp) Savannah--
Holiday Inn-Mid-Town, 7100 Abercorn Street,
    Savannah, GA; telephone: (912) 352-7100;
    8. Monday, January 8, 1996, (Coastal Pelagics & Shrimp) 
Charleston--Town & Country Inn, 2008 Savannah Highway, Charleston, SC; 
telephone: (803) 571-1000;
    9. Monday, January 8, 1996, (Coastal Pelagics) Ronkonkoma--Holiday 
Inn, 3845 Veterans Memorial Highway, Ronkonkoma, NY; telephone: (516) 
585-9500;
    10. Tuesday, January 9, 1996, (Coastal Pelagics) Tom's River--
Holiday Inn, 290 Route 37 East, Tom's River, NJ; telephone: (908) 244-
4000;
    11. Wednesday, January 10, 1996, (Coastal Pelagics) Salisbury--
Holiday Inn, 2625 N. Salisbury Blvd., Salisbury, MD; telephone: (410) 
742-7194;
    12. Thursday, January 11, 1996, (Coastal Pelagics) Norfolk--Quality 
Inn Lake Wright, 6280 Northampton Blvd, Norfolk, VA; telephone: (804) 
461-6251;
    13. Friday, January 12, 1996, (Coastal Pelagics) Manteo--North 
Carolina Aquarium, Airport Road, Manteo, NC; telephone: (919) 473-3494;

Draft Amendment 8 to the Coastal Migratory Pelagic FMP

    The South Atlantic, Gulf of Mexico and Mid-Atlantic Fishery 
Management Councils will hold public hearings on draft Amendment 8 to 
the FMP and the draft SEIS. Amendment 8 proposes management measures 
for the fisheries for king and Spanish mackerel, cobia, and dolphin 
(fish). Amendment 8 proposes measures that (1) apply only to the South 
Atlantic and Mid-Atlantic Council's jurisdiction, (2) apply only to the 
Gulf Council's jurisdiction, or (3) apply to the three Councils' 
jurisdictions.
    Proposed actions that would affect only the stocks and area under 
the jurisdiction of the South Atlantic and Mid-Atlantic Council are as 
follows: Harvest Spanish mackerel only with hook and line, run-around 
nets and stab nets (nets shall not exceed 600 yd (549 m) in length), 
and along Florida's east coast nets are limited to 1 hour soak time; 
harvest king mackerel with hook and line only; allow the harvest of 
other directed coastal pelagics with surface longline, hook and line 
including manual, electric, or hydraulic rod and reels, and bandit gear 
only; allow the use of cast nets and other nets with mesh sizes no 
larger than 2 1/2-inch (6.35 cm) stretch mesh and no longer than 50 yd 
(46 m) for the purpose of catching bait; allow the introduction of 
experimental gear; provide that non-conforming gear be limited to the 
bag limit for species with a bag limit; allow the transfer at sea of 
Spanish mackerel between permitted vessels; establish a 5-year 
moratorium beginning on October 16, 1995 on the issuance of commercial 
vessel permits with a king mackerel endorsement; provide for the 
transfer of vessel permits to other vessels; require that anyone 
applying for a commercial vessel permit demonstrate that 25 percent of 
annual income or $5,000 is from commercial fishing; require that as a 
condition for a Federal commercial or charter vessel permit, the 
applicant comply with the more restrictive of state or Federal rules 
when fishing in state waters; extend the range of cobia management 
through New York; establish the following commercial trip limits for 
Atlantic king mackerel of 3,500 lb (1.6 mt) for Volusia/Flagler County, 
FL to the New York/Connecticut border from April 1 - March 31, a 3,500 
lb (1.6 mt) limit for Volusia/Flagler to Brevard/Volusia, FL from April 
1 to October 31, and a 50-fish limit for Brevard/Volusia to Dade/
Monroe, FL from April 1 to October 31.
    Amendment 8 also includes the following measures that apply to the 
three Councils' jurisdictions: Require commercial dealer permits to buy 
and sell coastal pelagic fish managed under the FMP and require that 
dealers keep and make available records of purchase by vessel; 
recreational bag and commercial trip limit alternatives for cobia and 
dolphin (fish); retention of king mackerel damaged by barracuda bites 
by vessels under commercial trip limits; an alternative trip limit for 
Atlantic group king mackerel for Monroe County, FL of 125 fish from 
April 1 to October 31; changes to procedures used to set total 
allowable catch; and changes to definitions of overfishing and optimum 
yield.
    Proposed measures in Amendment 8 applying only to the area and 
stocks under the jurisdiction of the Gulf of Mexico Council were 
published in the Federal Register on December 5, 1995.

Draft Amendment 2 to the Shrimp FMP

    At its meeting of August 21-25, 1995, the Council approved draft 
Amendment 2 to the Shrimp FMP for public hearing. At its October 23-27 
meeting, at the request of the Director, Southeast Region, NMFS 
(Regional Director), the Council approved additional options concerning 
a bycatch reduction device (BRD) certification protocol for inclusion 
in Amendment 2.
    The Council is holding public hearings to solicit views on certain 
management measures in the draft amendment that are intended to reduce 

[[Page 66249]]
bycatch in South Atlantic penaeid shrimp fisheries included in the 
amendment.
    Draft Amendment 2 would also modify the management unit to include 
the populations of brown and pink shrimp occurring along the U.S. 
Atlantic coast from the east coast of Florida, including the Atlantic 
side of the Florida Keys, to the North Carolina/Virginia border. This 
amendment includes measures to reduce bycatch only in the penaeid 
shrimp fishery.
    Shrimp trawls have a significant bycatch of non-target finfish and 
invertebrates, most of which are discarded dead. This may reduce 
ecosystem diversity, adversely impact other fauna, and significantly 
reduce yield in other fisheries directed at these discarded species. 
The Council is proposing regulations to address a mandate established 
by the Atlantic States Marine Fishery Commission to minimize the impact 
of bycatch on Spanish mackerel and weakfish resources.
    Also, the South Atlantic states, North Carolina, South Carolina, 
Georgia, and Florida are directed under the interjurisdictional 
weakfish management plan to implement management measures that will 
reduce bycatch of weakfish in shrimp trawls by 50 percent for the 1996 
shrimp season. The Council, in order to create compatible regulations 
with the South Atlantic states, is addressing bycatch in Federal waters 
to ensure effective reduction of weakfish bycatch throughout the range 
of the species.

Management Measures under Consideration

    The following management measures are under consideration by the 
Council for inclusion in Amendment 2 to the Shrimp FMP:
    1. Add brown and pink shrimp to the management unit,
    2. Define overfishing for brown and pink shrimp,
    3. Define optimum yield for the pink and brown shrimp fisheries,
    4. Require the use of certified BRDs in all penaeid shrimp trawls 
in the South Atlantic Exclusive Economic Zone (EEZ). All shrimp nets 
(any net with mesh less than 2 1/2 inches (6.35 cm) stretch mesh) and 
all nets greater than 15 ft (4.6 m) in footrope length (or compatible 
with Turtle Excluder Device requirements for try nets) that are used as 
try (test) nets would be required to use a certified BRD.
    A. Upon implementation of Amendment 2, BRDs that have passed the 
operational testing phase of the NMFS cooperative bycatch research 
program (fish eyes, extended funnels and large mesh) are de facto 
certified for use in the EEZ.
    B. Other BRDs will subsequently be certified according to 
procedures and criteria specified in item 5.
    5. Establish a BRD certification process and specify certification 
criteria for new or modified BRDs. The Council is specifically 
requesting input from industry members concerning protocol options for 
future BRD certification of new or modified BRDs:
    A. The following are options for BRD certification protocol being 
considered by the Council:
    Option 1: The Council makes final recommendations for certification 
to the NMFS Regional Director;
    Option 2: The Regional Director makes the decision based on direct 
application to NMFS; and
    Option 3: BRDs developed, tested and approved by state agencies, 
meeting the criteria specified in the amendment, may be used in the EEZ 
in lieu of BRDs certified by NMFS.
    Three geographical sub-options are identified for Option 3 to 
specify where state-approved BRDs would be allowed for use in the EEZ:
    i: Adjacent to the state in which the BRD was approved,
    ii: Throughout the EEZ in the South Atlantic region, or
    iii: In the EEZ by vessels registered in the state where BRDs have 
been approved.
    B. The Amendment will also establish certification criteria for new 
or modified BRDs. New or modified BRDs must be certified or approved by 
NMFS for use in the South Atlantic penaeid shrimp fishery based on the 
following criteria:
    i. The BRD must reduce the bycatch component of fishing mortality 
for Spanish mackerel and weakfish by 50 percent, and
    ii. The shrimp loss rate (by weight) must be acceptable to 
fishermen.
    The Council intends to finalize both Amendments at its meeting in 
St. Augustine, FL, from February 12-16, 1996. The public will have an 
opportunity to comment at the full Council session before the Council 
takes final action to adopt the amendment's management measures. Once 
finalized, the amendment will be submitted to NMFS for review, approval 
and implementation. NMFS will provide a 60-day public comment period on 
the amendment and a 45-day public comment period on the proposed 
implementing rule during its 110-day review period.

Special Accommodations

    These hearings are physically accessible to people with 
disabilities. Requests for sign language interpretation or other 
auxiliary aids should be directed to the Council office (see ADDRESSES) 
by December 27, 1995.

    Authority: 16 U.S.C. 1801 et seq.

    Dated: December 15, 1995.
Richard W. Surdi,
Acting Director, Office of Fisheries Conservation and Management, 
National Marine Fisheries Service.
[FR Doc. 95-30988 Filed 12-20-95; 8:45 am]
BILLING CODE 3510-22-F

Complete official Federal Register PDF

FR Doc. 95-30971 Fiduciary Activities of National Banks; Rules of Practice and Procedure
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Pages 66163-66179]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-30971]

-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY
12 CFR Parts 9 and 19

[Docket No. 95-32]
RIN 1557-AB12

Fiduciary Activities of National Banks; Rules of Practice and 
Procedure

AGENCY: Office of the Comptroller of the Currency, Treasury.

ACTION: Notice of proposed rulemaking.

-----------------------------------------------------------------------

SUMMARY: The Office of the Comptroller of the Currency (OCC) proposes 
to revise its rules that govern the fiduciary activities of national 
banks. The OCC also proposes to relocate provisions concerning 
disciplinary sanctions imposed by clearing agencies to its rules of 
practice and procedure. This proposal is another component of the OCC's 
Regulation Review Program, which is intended to update and streamline 
OCC regulations and to reduce unnecessary regulatory costs and other 
burdens.

DATES: Comments must be received by February 20, 1996.

ADDRESSES: Comments should be directed to: Communications Division, 
Office of the Comptroller of the Currency, 250 E Street, SW, 
Washington, DC 20219, Attention: Docket No. 95-32. Comments will be 
available for public inspection and photocopying at the same location. 
In addition, comments may be sent by facsimile transmission to FAX 
number (202) 874-5274 or by electronic mail to 
[email protected]

FOR FURTHER INFORMATION CONTACT: Andrew T. Gutierrez, Attorney, 
Legislative and Regulatory Activities Division, (202) 874-5090; Donald 
N. Lamson, Assistant Director, Securities and Corporate Practices 
Division, (202) 874-5210; Lisa Lintecum, Director, Fiduciary 
Activities, (202) 874-5419; Dean Miller, Special Advisor, Fiduciary 
Activities, (202) 874-4852; Aida M. Plaza, Director for Compliance, 
Multinational Banking, (202) 874-4610.

SUPPLEMENTARY INFORMATION:

Background

    The OCC proposes to revise 12 CFR part 9, which governs the 
fiduciary activities of national banks, as a component of its 
Regulation Review Program. One goal of the Regulation Review Program is 
to review all of the OCC's rules with a view toward eliminating 
provisions that do not contribute significantly to maintaining the 
safety and soundness of national banks or to accomplishing the OCC's 
other statutory responsibilities, including the oversight of national 
banks' fiduciary activities. Another goal of the Program is to improve 
clarity of the OCC's regulations.
    This rulemaking is the OCC's first comprehensive revision of the 
rule since 1963.\1\ Much about national banks' fiduciary business has 
changed since that time, including the nature and scope of the 
fiduciary services that banks offer and the structures and operational 
methods that banks use to deliver those services. The OCC's particular 
goal in revising part 9 is to accommodate those changes by lifting 
unnecessary regulatory burden and facilitating the continued 
development of national banks' fiduciary business consistent with safe 
and sound banking practices and national banks' fiduciary obligations. 
Three principal themes have emerged from the OCC's review of part 9.

    \1\ National banks have been authorized to exercise fiduciary 
powers since 1913. In 1962, the responsibility for the oversight of 
their fiduciary activities was transferred from the Board of 
Governors of the Federal Reserve System to the OCC. See 12 U.S.C. 
92a. Following the transfer of oversight responsibilities, the OCC 
promulgated 12 CFR part 9 in 1962 (27 FR 9764), and revised it soon 
thereafter in 1963 (28 FR 3309).
---------------------------------------------------------------------------

    First, bank organizational structures, particularly with respect to 
the geographic structure of banking organizations, have changed 
significantly since Congress created the basic framework for national 
banks' fiduciary operations. These changes strongly suggest that part 9 
should be adjusted so that its requirements are more workable for both 
large, multistate fiduciary banking organizations and small banks that 
conduct fiduciary activities primarily on a local basis.
    Second, national banks' fiduciary activities, in many respects, are 
subject to state law. In some cases, however, the OCC has the 
flexibility either to prescribe a uniform Federal standard or to direct 
national banks to follow state law.
    Third, over the years, part 9 has been applied to a wide variety of 
investment advisory activities and related services, not all of which 
involve the bank's exercise of investment discretion. In some cases, 
banks engaged in these activities are subject to different standards 
than other types of entities that conduct the same type of business, 
raising the question of whether the OCC should narrow the range of 
investment advisory activities to which part 9 applies.
    These three themes form the basis for requests for comment on 
specific provisions and issues described in detail in the remainder of 
this preamble discussion.
    More generally, the proposal revises part 9 in its entirety. The 
proposal updates, clarifies, and streamlines part 9, incorporates 
significant interpretive positions, and eliminates unnecessary 
regulatory burden wherever possible to promote more efficient operation 
and supervision of national banks' fiduciary activities. The proposal 
adds headings for ease of reference, but, for the most part, retains 
the numbering system used in the current regulation. Commenters are 
invited to address all aspects of the proposal, including recommending 
further improvements to its organization, structure, and content.

Section-by-Section Description of the Proposal

Authority, Purpose, and Scope (Proposed Sec. 9.1)

     The proposal adds a new provision that explicitly sets forth the 
statutory authority for, and the purpose and scope of, part 9. In 
addition to standards found in part 9, the OCC provides guidance 
(including policies, procedures, precedents, circulars, and bulletins) 
regarding the fiduciary activities of national banks in the 
``Comptroller's Handbook for Fiduciary Activities.'' The OCC currently 
is revising the guidance contained in the ``Comptroller's Handbook for 
Fiduciary Activities.'' The OCC anticipates that the revised fiduciary 
guidance will consist of a 

[[Page 66164]]
series of booklets in a comprehensive ``Comptroller's Handbook,'' which 
will replace the ``Comptroller's Handbook for Fiduciary Activities'' 
and other OCC guidance currently found in separate publications.

Definitions (Proposed Sec. 9.2)

    The proposal moves the definitions currently found at Sec. 9.1 to 
proposed Sec. 9.2. Some definitions are removed, and others are added. 
Significant changes are noted below.

Affiliate (Proposed Sec. 9.2(a))

    The proposal adds a definition of ``affiliate'' to part 9. This 
definition cross-references the definition in the Federal Reserve Act 
at 12 U.S.C. 221a(b), which is consistent with the way the OCC defines 
the term ``affiliate'' in a number of its other regulations.

Applicable Law (Proposed Sec. 9.2(b))

    The current regulation uses the term ``local law,'' as defined at 
Sec. 9.1(g), to refer to the laws of the state or other jurisdiction 
governing a fiduciary relationship. The proposal replaces ``local law'' 
with ``applicable law'' in order to streamline some of the operative 
provisions of part 9 and to make clear that the bodies of authority 
that govern a national bank's fiduciary relationships include Federal 
law (including regulations), state law governing a national bank's 
fiduciary relationships (that is, fiduciary duties and 
responsibilities) the terms of the instrument governing a fiduciary 
relationship, and any court order pertaining to the relationship. The 
Federal law relevant to a national bank's fiduciary activities 
includes, for example, provisions of the Federal banking laws (12 
U.S.C. 1 et seq.), the Employee Retirement Income Security Act of 1974 
(29 U.S.C. 1001 et seq.), the Securities Act of 1933 (15 U.S.C. 77a et 
seq.), the Securities Exchange Act of 1934 (15 U.S.C. 78a et seq.), the 
Investment Company Act of 1940 (15 U.S.C. 80a-1 et seq.), the 
Investment Advisers Act of 1940 (15 U.S.C. 80b-1 et seq.), the Trust 
Indenture Act of 1939 (15 U.S.C. 77aaa et seq.), the Internal Revenue 
Code of 1986 (26 U.S.C. 1 et seq.), and the rules issued pursuant to 
those acts. The OCC does not intend the term ``applicable law'' to 
incorporate any state law or other body of authority that would not 
otherwise apply to a national bank's fiduciary relationships. The OCC 
invites comment on the adequacy of this definition.

Fiduciary Capacity (Proposed Sec. 9.2(e))

    Under the current regulation, the term ``fiduciary,'' defined at 
Sec. 9.1(b), includes ``a bank undertaking to act alone or jointly with 
others primarily for the benefit of another in all matters connected 
with its undertaking'' and goes on to list the ``traditional'' 
fiduciary capacities enumerated by 12 U.S.C. 92a: Trustee, executor, 
administrator, registrar of stocks and bonds, guardian of estates, 
assignee, receiver, and committee of estates of lunatics. The proposed 
definition of ``fiduciary capacity'' retains the current regulation's 
list of traditional fiduciary capacities with minor modification. For 
example, the phrase ``committee of estates of lunatics'' is removed 
because it is outdated and because the definition of the term 
``guardian'' is broad enough to encompass that capacity. The proposed 
definition also clarifies that acting as registrar of stocks and bonds 
includes acting as transfer agent.
    The current regulation's definition of ``fiduciary'' also includes 
fiduciary capacities that are not listed in the fiduciary powers 
statute. These capacities include ``managing agent'' and, as a catch-
all category, ``any other similar capacity.''
    The proposal attempts to establish a clearer and more objective 
boundary for the coverage of part 9 while retaining the traditional 
concept that acting on another's behalf is at the heart of serving in a 
fiduciary capacity. Under the proposal, the term ``fiduciary capacity'' 
includes, in addition to the statutory fiduciary capacities, ``any 
capacity involving investment discretion on behalf of another'' and 
``any other similar capacity that the OCC authorizes pursuant to 12 
U.S.C. 92a.'' 2 The proposal uses investment discretion as the 
factor that distinguishes fiduciary from non-fiduciary investment 
advisory activities. Thus, under the proposal, part 9 applies to (and, 
accordingly, requires a national bank to obtain fiduciary powers for) 
any investment advisory activity in which the bank manages the assets 
of another. Conversely, a national bank is not subject to part 9 with 
respect to an activity in which the bank does not have investment 
discretion, unless, of course, the bank acts in one of the 
``traditional'' fiduciary capacities. For example, part 9 does not 
govern a directed custodian account (absent a ``traditional'' fiduciary 
capacity) because the customer, and not the bank, has investment 
discretion, although the bank may provide advice about investments 
appropriate to the customer's objectives. The proposed investment 
discretion test affects only those activities in which the bank does 
not act in one of the enumerated ``traditional'' fiduciary capacities. 
Part 9 continues to apply to activities in which the bank acts in a 
``traditional'' fiduciary capacity regardless of whether the bank has 
investment discretion, e.g., self-directed IRA accounts for which the 
bank is a named trustee.

    \2\ The term ``fiduciary capacity'' under the proposal also 
includes acting as a custodian under a uniform gifts to minors act, 
because a custodian under a uniform gifts to minors act is a 
fiduciary under current part 9.
---------------------------------------------------------------------------

    As an alternative to using investment discretion as the dividing 
line between fiduciary and non-fiduciary investment advisory 
activities, the OCC could adopt an approach that relies on state law. 
Under a state law approach, for example, part 9 would apply to a 
national bank's investment advisory activity if that activity, when 
engaged in by competing state fiduciaries, requires state authorization 
and is regulated as a fiduciary activity under state law. Thus, the 
applicability of part 9 to a national bank's investment advisory 
activities could differ among states. The OCC invites comment on this 
and other alternative approaches to defining which investment advisory 
activities to regulate under part 9.
    Adopting an approach that excludes some types of investment 
advisory activities from part 9's coverage raises the question of how 
to oversee these ``non-fiduciary'' investment advisory activities. Some 
of these activities already are subject to the Interagency Statement on 
Retail Sales of Nondeposit Investment Products (February 14, 
1994),3 the anti-fraud provisions of the Securities Exchange Act 
of 1934, and the recordkeeping and confirmation requirements for 
brokerage customers under the OCC's rules at 12 CFR part 12. In 
addition, a national bank must conduct its investment advisory 
activities (as with all its activities) in a manner consistent with 
safe and sound banking practices. Furthermore, the national bank must 
adhere to any conditions imposed by the OCC in writing in connection 
with approval of an application or request. The OCC invites comment on 
whether these existing regulatory safeguards are adequate to regulate 
non-fiduciary investment advisory activities. If the existing 
safeguards are not adequate, the OCC invites comment on what additional 
safeguards are appropriate.

    \3\ The four Federal banking agencies have recently issued a 
clarification of the Interagency Statement. See ``Joint 
Interpretation of the Interagency Statement on Retail Sales of 
Nondeposit Investment Products (September 12, 1995).
---------------------------------------------------------------------------

    For example, even if the OCC adopts the investment discretion 
approach, the OCC could continue to subject non-discretionary 
investment advice to pertinent provisions of part 9 (e.g., those 

[[Page 66165]]
governing self-dealing and conflicts of interest). Alternatively, the 
OCC could use provisions of the Investment Advisers Act of 1940 
(Advisers Act) 4 as a point of reference. Under the Advisers Act, 
as implemented by the Securities and Exchange Commission (SEC),5 
an investment adviser must, among other things: (1) Provide clients and 
prospective clients with a written disclosure statement about the 
adviser's business practices and educational and business background; 
(2) comply with specific contractual requirements in their dealings 
with clients, including a prohibition against assigning an advisory 
contract without client consent and restrictions on performance fee 
arrangements; (3) comply with prohibitions against misstatements or 
misleading omissions of material facts and fraudulent acts or 
practices; and (4) comply with anti-fraud provisions dealing with 
advertising, solicitations, and custody or possession of client funds. 
In addition, the Supreme Court has held that a registered investment 
adviser owes its clients an affirmative duty of good faith and full and 
fair disclosure of all material facts, especially where the adviser's 
interests may conflict with those of its clients.6

    \4\ 15 U.S.C. 80b-1-80b-21. Under the Advisers Act, investment 
advisers generally must register with the Securities and Exchange 
Commission if, for compensation, they engage in the business of 
advising others, either directly or through certain types of 
publications or writings, as to the value of securities or the 
advisability of investing in, purchasing, or selling securities. 
Banks and bank holding companies are, for the most part, exempt from 
the requirements of the Advisers Act.
    \5\ The SEC's rules governing investment advisers are found at 
17 CFR part 275.
    \6\ See SEC v. Capital Gains Research Bureau, 375 U.S. 180 
(1963); Transamerica Mortgage Advisors, Inc., v. Lewis, 444 U.S. 11, 
17 (1979).
---------------------------------------------------------------------------

Fiduciary Officers and Employees (Proposed Sec. 9.2(f))

    The proposal replaces the term ``trust department,'' defined at 
Sec. 9.1(j), with the term ``fiduciary officers and employees,'' to 
reflect the increasing diffusion of fiduciary functions throughout a 
national bank.

Investment Discretion (Proposed Sec. 9.2(j))

    As mentioned earlier, the proposal defines the term ``fiduciary 
capacity'' to include any capacity involving investment discretion on 
behalf of another. The new term ``investment discretion,'' in turn, 
includes any account for which a national bank has the authority to 
determine what securities or other assets to purchase or sell on behalf 
of the account. The OCC considers this term to apply whether or not the 
bank itself in fact exercises that discretion or delegates that 
function to another.

Approval Requirements (Proposed Sec. 9.3)

    Consistent with Sec. 9.2 of the current regulation, the proposal 
directs a national bank seeking approval to exercise fiduciary powers 
and a person seeking approval to organize a special-purpose national 
bank limited to fiduciary powers, to appropriate provisions in 12 CFR 
part 5 (rules, policies, and procedures for corporate activities).

Administration of Fiduciary Powers (Proposed Sec. 9.4)

    The proposal relocates most of the substance of current Sec. 9.7 to 
proposed Sec. 9.4, but relocates provisions in current Sec. 9.7 
relating to policies and procedures, review of assets, and 
recordkeeping, to other sections specifically addressing those topics 
(proposed Secs. 9.5, 9.6, and 9.8, respectively). The proposal also 
relocates a provision in current Sec. 9.7 relating to the need for 
fiduciary counsel to proposed Sec. 9.5 (policies and procedures).
    The proposal continues to place the primary responsibility for a 
national bank's fiduciary activities on its directors. Under the 
proposal, as under the current rule, the board may assign functions 
related to the exercise of fiduciary powers to bank directors, 
officers, employees, and committees thereof. The proposal allows a 
national bank to use personnel and facilities of the bank to perform 
services related to the exercise of its fiduciary powers, and to allow 
any department of the bank to use fiduciary officers and employees and 
facilities to perform services unrelated to the exercise of fiduciary 
powers, to the extent not prohibited by applicable law. The proposal 
retains the requirement that all fiduciary officers and employees must 
be adequately bonded.
    The proposal adds a new provision, at proposed Sec. 9.4(c), to 
clarify that a national bank may enter into an agency agreement with 
another entity to purchase or sell services related to the exercise of 
fiduciary powers. This provision reflects the OCC position contained in 
Fiduciary Precedent 9.1300 (found in the ``Comptroller's Handbook for 
Fiduciary Activities'').7

     7  See also 12 U.S.C. 1867 (regulation and examination of bank 
service corporations); Fiduciary Precedent 9.1390 (fiduciary support 
services rendered by agent); and Trust Interpretive Letter #168 
(August 3, 1988) (use of an affiliate to perform trust 
administrative and investment services).
---------------------------------------------------------------------------

Policies and Procedures (Proposed Sec. 9.5)

    Current Sec. 9.5 requires a national bank to adopt policies and 
procedures with respect to brokerage placement practices but not with 
respect to other areas of fiduciary practice. The proposal, on the 
other hand, requires that a national bank have written policies and 
procedures to ensure that its fiduciary practices comply with 
applicable law. The proposal lists particular areas that a bank's 
policies and procedures should address.
    Several of the items on this list of required policies and 
procedures stem from provisions located in other sections of the 
current regulation, including methods for ensuring that fiduciary 
officers and employees do not use material inside information in 
connection with any decision or recommendation to purchase or sell any 
security (current Sec. 9.7(d)); selection and retention of legal 
counsel readily available to advise the bank and its fiduciary officers 
and employees on fiduciary matters (current Sec. 9.7(c)); and 
investment of funds held as fiduciary, including short-term investments 
and the treatment of fiduciary funds awaiting investment or 
distribution (current Sec. 9.10(a)).
    Other items on the list are not based on requirements in the 
current regulation, including methods for preventing self-dealing and 
conflicts of interest, allocation to fiduciary accounts of any 
financial incentives the bank may receive for investing fiduciary funds 
in a particular investment,8 and disclosure to beneficiaries and 
other interested parties of fees and expenses charged to fiduciary 
accounts. The OCC believes that these new items are important to the 
proper exercise of national bank fiduciary powers, and should be 
addressed in a bank's policies and procedures.

     8 See Fiduciary Precedent 9.3115 (acceptance of financial 
benefits by bank fiduciaries).
---------------------------------------------------------------------------

    The OCC invites comment on whether to add any items to, or delete 
any items from, the proposed list.

Review of Assets of Fiduciary Accounts (Proposed Sec. 9.6)

    The proposal clarifies current Sec. 9.7(a)(2) by explicitly 
requiring national banks to perform two distinct types of written asset 
reviews with respect to fiduciary accounts: individual account reviews 
and reviews of assets by issuer.9 Before accepting a fiduciary 
account, a national bank must review the account to determine whether 
it can administer the account properly. After accepting a fiduciary 
account for which 

[[Page 66166]]
a national bank has investment discretion, and each year thereafter, 
the bank promptly must conduct an individual account review of the 
account's assets to evaluate whether they are appropriate, individually 
and collectively, for the account. In addition to the individual 
account review, a bank must conduct an annual review of assets by 
issuer to determine the investment merit of the assets (or potential 
assets) in fiduciary accounts for which the bank has investment 
discretion, to the extent appropriate for that asset. The OCC 
anticipates that the scope of a bank's assets review will vary, 
depending on the nature of the particular asset.

     9 See Fiduciary Precedent 9.4102.
---------------------------------------------------------------------------

    To contrast the two types of review, a review of assets by issuer 
determines what investments, by issuer, (e.g., common stock of 
Corporation X) are potentially appropriate investments for the bank's 
fiduciary accounts. In some banks, for example, the review of assets by 
issuer results in a list of permissible fiduciary investments for the 
bank's fiduciary accounts. The person or committee in charge of 
investing for a particular fiduciary account chooses investments from 
this list. An individual account review, on the other hand, determines 
whether the investments chosen for that particular account are 
appropriate, individually and collectively, given the objectives of the 
account.
    The OCC invites comment on whether these specific standards are 
necessary or appropriate and, if not, what alternative approaches are 
preferable. For example, commenters may wish to discuss approaches that 
distinguish between large and small accounts or between large and small 
institutions.

Recordkeeping (Proposed Sec. 9.8)

    The proposal clarifies the recordkeeping requirements currently 
found at Secs. 9.7(a)(2) and 9.8. In particular, a national bank must 
document the establishment and termination of fiduciary accounts, must 
maintain adequate records for fiduciary accounts, must retain records 
for a specified period of time, and must make sure its fiduciary 
records are distinguishable from other bank records.

Audit of Fiduciary Activities (Proposed Sec. 9.9)

    The proposal retains the current Sec. 9.9 requirement that a 
national bank perform suitable audits of its fiduciary activities 
annually (specifically, at least once during each calendar year and not 
later than 15 months after the last audit), and that the bank report 
the results of the audit (including all actions taken as a result of 
the audit) in the minutes of the board. The proposal removes as 
redundant the requirement that the national bank ascertain compliance 
with ``law, this part, and sound fiduciary principles.''
    The proposal clarifies that if a bank adopts a continuous audit 
system in lieu of performing annual audits, the bank may perform 
discrete audits of each fiduciary activity, on an activity-by-activity 
basis, at intervals appropriate for that activity. For example, a bank 
may determine that it is appropriate to audit certain low-risk 
fiduciary activities every 18 months. A bank that adopts a continuous 
audit system must report the results of any discrete audits performed 
since the last audit report (including all actions taken as a result of 
the audits) in the minutes of the board of directors at least once 
during each calendar year and not later than 15 months after the last 
audit report.
    The proposal also clarifies that a national bank's audit committee 
may not include directors who are members of a fiduciary committee of 
the bank.10 The proposal also modifies the current regulation's 
position that active officers of the bank may not serve on the audit 
committee. Under the proposal, only officers who participate 
significantly in the administration of the bank's fiduciary activities 
are barred from serving on the audit committee. This proposed position 
provides some degree of flexibility to smaller banks, which may have a 
limited number of outside directors.

     10  See Fiduciary Precedent 9.2505 (a member of a 
fiduciary committee may not serve on the trust audit committee).
---------------------------------------------------------------------------

    Finally, the proposal permits an audit committee of an affiliate of 
the bank to conduct the required audit. This change allows a bank 
holding company to audit the fiduciary activities of its subsidiary 
national banks through a central audit committee. This approach 
facilitates consolidation of functions, and the accompanying 
efficiencies, within a bank holding company structure.
    The OCC invites comment on these proposed changes and, in addition, 
on the relationship between the audit requirement and the OCC's 
fiduciary examination process (in particular, the extent to which OCC 
examiners should rely on a bank's internal or external fiduciary 
audits).

Fiduciary Funds Awaiting Investment or Distribution (Proposed 
Sec. 9.10)

    As mentioned earlier, the proposal relocates to proposed Sec. 9.5 
the current regulation's requirement that a national bank adopt 
policies and procedures regarding short-term investments. The proposal 
retains the current regulation's general prohibition against allowing 
fiduciary funds to remain uninvested and undistributed any longer than 
reasonable for proper account management. The OCC invites comment on 
whether reasonableness is a sufficiently clear standard and, if not, on 
what standard is appropriate.
    The proposal continues to allow a national bank to deposit idle 
fiduciary funds (i.e., fiduciary funds awaiting investment or 
distribution) in its commercial, savings, or another department, 
provided that the bank secures the deposit with appropriate collateral. 
Additionally, the proposal explicitly allows a national bank to use, as 
collateral for self- deposits of idle fiduciary funds, assets 
(including surety bonds) that qualify under state law as appropriate 
security for deposits of fiduciary funds. The proposal also permits a 
national bank to deposit idle fiduciary funds with affiliates.
    Surety bonds as collateral. Under 12 U.S.C. 92a(d), a national bank 
may deposit idle fiduciary funds with itself (e.g., in its commercial 
or savings department) only if it pledges United States bonds or 
``other securities'' approved by the OCC. Current Sec. 9.10(b)(3) 
allows a bank to meet this requirement by pledging qualifying assets of 
the bank to secure a deposit in compliance with local law.
    Under the OCC's interpretation of Sec. 9.10(b)(3), a national bank 
may pledge, as a qualifying asset, a surety bond as collateral for a 
deposit of idle fiduciary funds if a surety bond is permissible 
collateral under state law, unless the instrument governing the 
fiduciary relationship prohibits the use of a surety bond. This 
interpretation recognizes that a surety bond provides protection that 
is functionally at least equivalent to the protection provided by other 
types of assets that the OCC has approved under section 92a(d). 
Moreover, this interpretation promotes Congress' policy objective of 
protecting the interests of beneficiaries and ensures that national 
banks are not disadvantaged in a state that permits its institutions to 
use surety bonds to secure deposits of idle fiduciary funds.
    The proposal explicitly incorporates this interpretation into part 
9 by allowing a national bank to secure deposits of idle fiduciary 
funds with assets, including surety bonds, that qualify under state law 
as appropriate security for deposits of fiduciary funds. The theory 
that a surety bond is comparable to other forms of security permitted 
by the OCC could have a broader application, however. In particular, 
the OCC invites comment on 

[[Page 66167]]
whether to adopt a uniform standard allowing national banks in all 
states to use surety bonds as collateral for these deposits.
    Deposits with affiliates. Section 92a(d) authorizes a national bank 
to pledge assets to secure self-deposits of idle fiduciary funds. Thus, 
section 92a(d) accommodates a bank with a trust department and a 
commercial or savings department, the bank organizational structure 
prevalent when Congress enacted the statutory language in 1918. 
However, the statutory language does not address other organizational 
structures that have evolved since 1918. For example, some banks today 
are special-purpose trust companies. These entities do not have 
commercial or savings departments in which to deposit idle fiduciary 
funds, but many are affiliated with banks that do. Other banks operate 
as part of a large system of affiliated banks and wish, for reasons of 
efficiency, to consolidate their fiduciary payment and disbursement 
functions in a single bank. In these situations, a bank may want to 
deposit idle fiduciary funds with an affiliated bank. However, the OCC 
has previously applied 12 CFR 9.12(c) to restrict a national bank from 
depositing idle fiduciary funds with an affiliated bank unless 
authorized by the instrument governing the account, court order, or 
state law.
    Some states explicitly authorize their banks to deposit idle 
fiduciary funds with affiliated banks, however. Thus, a national bank 
in any of these states may deposit idle fiduciary funds in an 
affiliated bank in accordance with current 12 CFR 9.12(c) (because the 
deposit is authorized by state law). Additionally, however, many of 
these states require that these deposits be secured with a pledge of 
assets. The OCC previously took the position that neither a national 
bank making a deposit of idle fiduciary funds with an affiliate, nor a 
national bank accepting the deposit, can pledge assets to secure the 
deposit, regardless of whether state banks can pledge in that 
situation. Consequently, a national bank could not legitimately comply 
with a state's pledging requirement and, thus, could not avail itself 
of the state's authorization to deposit idle fiduciary funds with an 
affiliate bank. The OCC believes that a prohibition on pledging assets 
to secure idle fiduciary funds deposited by or with affiliates is not 
legally required and may prevent a national bank from achieving 
efficiencies in its fiduciary operations.
    Consequently, the OCC proposes to allow a national bank to secure a 
deposit of idle fiduciary funds by or with an affiliate if consistent 
with applicable law. This change is consistent with a recent OCC 
interpretative letter,11 and should facilitate more efficient 
fiduciary operations in multi-bank holding companies.

     11  Letter from Julie L. Williams, Chief Counsel (November 
6, 1995).
---------------------------------------------------------------------------

Investment of Fiduciary Funds (proposed Sec. 9.11)

    The proposal condenses current Sec. 9.11 without changing its 
substance. The proposal simply directs a national bank to invest 
fiduciary funds in a manner consistent with applicable law. Applicable 
law, as described earlier, includes Federal law, state law governing a 
national bank's fiduciary relationships, the terms of the instrument 
governing the relationships, and any court order pertaining to the 
relationships.

Self-dealing and Conflicts of Interest (Proposed Sec. 9.12)

    The proposal retains the substance of current Sec. 9.12, which 
addresses fiduciary conflicts of interest. However, the proposal 
clarifies a point concerning the general rule, found at current 
Sec. 9.12(b), that a national bank may not lend, sell, or otherwise 
transfer assets held in a fiduciary capacity to the bank or any of its 
directors, officers, or employees, or to affiliates of the bank or any 
of their directors, officers, or employees, or to individuals or 
organizations with whom there exists an interest that might affect the 
exercise of the best judgment of the bank. Current Sec. 9.12(b) 
provides certain exceptions to this general rule, such as where local 
law authorizes those loans. However, under 12 U.S.C. 92a(h), it is 
unlawful for a national bank to lend to its directors, officers, or 
employees any funds it holds in trust. A national bank cannot invoke 
the exceptions in current Sec. 9.12(b) in contravention of section 
92a(h). Thus, the proposal clarifies that despite the exceptions to the 
general rule, a bank may not lend to any of its directors, officers, or 
employees any funds it holds in trust, except with respect to bank's 
own employee benefit plans in accordance with section 408(b)(1) of the 
Employee Retirement Income Security Act of 1974 (29 U.S.C. 1108(b)(1)), 
which specifically authorizes loans to participants and beneficiaries 
of such plans under certain circumstances.

Custody of Fiduciary Assets (Proposed Sec. 9.13)

    The proposal retains the substance of current Sec. 9.13, which 
addresses custody of fiduciary assets. The proposal continues to 
require joint custody or control of fiduciary assets, separation of 
fiduciary assets from the assets of the bank, and separation or 
identification of the assets of each fiduciary account from all other 
accounts (except when assets are invested in collective investment 
funds). The proposal also continues to allow a national bank to 
maintain fiduciary assets off-premises.

Deposit of Securities With State Authorities (Proposed Sec. 9.14)

    Under current Sec. 9.14, whenever state law requires institutions 
acting as fiduciaries to deposit securities with state authorities for 
the protection of trust accounts, a national bank in that state must 
make a similar deposit before it can act in a fiduciary capacity.\12\ 
The proposal retains this general requirement.

    \12\ This provision stems from the fiduciary powers statute. See 
12 U.S.C. 92a(f).
---------------------------------------------------------------------------

    However, current Sec. 9.14 does not address how a bank should 
calculate the amount of its required deposit when the bank administers 
trust assets from offices located in more than one state--i.e., whether 
the bank must compute the amount of deposit required by a particular 
state on the basis of all of the bank's trust assets nationwide, or on 
the basis of the bank's trust assets in that state. This issue will 
become increasingly significant as interstate branching becomes more 
common. Many states have laws requiring a state fiduciary to deposit an 
amount of securities based on its total trust assets. These laws 
apparently did not contemplate that state fiduciaries would expand 
geographically and administer significant amounts of trust assets from 
other states.
    It is unnecessary to require a bank with multistate trust 
operations to deposit in each state in which it administers trust 
assets an amount based on its total trust assets nationwide. To do so 
goes far beyond the deposit requirement's purpose of protecting trust 
assets relating to a particular state, and unnecessarily burdens a bank 
that conducts fiduciary operations in multiple states. Consequently, 
the proposal allows a national bank to meet its deposit requirement in 
each state based on the 

[[Page 66168]]
amount of trust assets administered from offices located in that 
state.\13\

    \13\ See also Op. Chief Counsel, Office of Thrift Supervision 
(December 24, 1992) (interpreting 12 U.S.C. 1464(n)(5) (the Federal 
savings association equivalent of 12 U.S.C. 92a(f) with virtually 
identical language) and concluding that a Federal savings 
association should compute the amount of a required state deposit 
based on the amount of trust assets administered from offices 
located in that particular state, rather than on the basis of the 
bank's total trust assets nationwide).
---------------------------------------------------------------------------

Fiduciary Compensation (Proposed Sec. 9.15)

    The proposal retains the substance of current Sec. 9.15, which 
addresses fiduciary compensation. Under the proposal, a national bank 
may charge a reasonable fee for its fiduciary services if the amount is 
not set or governed by applicable law. Moreover, the proposal prohibits 
an officer or an employee of a national bank from retaining any 
compensation for acting as a co-fiduciary with the bank in the 
administration of a fiduciary account, except with the specific 
approval of its board of directors.

Receivership or Voluntary Liquidation of Bank (Proposed Sec. 9.16)

    The proposal retains the substance of current Sec. 9.16, which 
addresses receivership and voluntary liquidation. The proposal directs 
a receiver or liquidating agent to close promptly all fiduciary 
accounts to the extent practicable (in accordance with OCC instructions 
and the orders of the court having jurisdiction) and to transfer all 
remaining fiduciary accounts to substitute fiduciaries.

Surrender or Revocation of Fiduciary Powers (Proposed Sec. 9.17)

    The proposal retains the substance of current Sec. 9.17, which 
addresses surrender and revocation of fiduciary powers. The proposal 
sets forth the standards and procedures that apply when a national bank 
seeks to surrender its fiduciary powers. The proposal also describes 
the standards that apply when the OCC seeks to revoke a bank's 
fiduciary powers.

Collective Investment Funds (Proposed Sec. 9.18)

    The proposal revises current Sec. 9.18, which governs the 
establishment and operation of common trust funds and other collective 
investment funds by national banks.\14\ The central purpose of this 
proposed revision is to lift certain unnecessary regulatory burdens 
currently imposed on institutions that administer collective investment 
funds, while preserving appropriate protections to beneficiaries (and 
other interested parties) of fiduciary accounts participating in those 
funds.

    \14\ Because the regulations of the Office of Thrift Supervision 
incorporate Sec. 9.18, this revision also affects collective 
investment funds administered by Federally-chartered savings and 
loan associations. 12 CFR 550.13(b). Moreover, because common trust 
funds must comply with Sec. 9.18 in order to qualify for tax-exempt 
status under section 584 of the Internal Revenue Code of 1986, as 
amended (26 U.S.C. 584), this revision affects state-chartered 
banks, trust companies, and other financial institution fiduciaries 
that administer collective investment funds.
---------------------------------------------------------------------------

    The OCC has not rewritten Sec. 9.18 since 1972. In 1982, the OCC 
published an advance notice of proposed rulemaking requesting public 
comment on Sec. 9.18 (47 FR 27833, June 25, 1982). The OCC specifically 
solicited comments on several issues.\15\ Moreover, the OCC indicated 
its intention to undertake a comprehensive review of its collective 
investment fund regulation.

    \15\ These issues included: (1) operations of guaranteed 
insurance contract funds; (2) establishment of commingled agency 
accounts; (3) commingling of Keogh trusts with corporate employee 
benefit funds; (4) establishment of common trust funds for 
individual retirement accounts; (5) advertising of common trust 
funds; and (6) commingling of charitable trusts with employee 
benefit trusts.
---------------------------------------------------------------------------

    The OCC received over 70 comments, most of which indicated that 
technological advances and new customer needs rendered portions of 
Sec. 9.18 obsolete or even counter-productive. In November 1984, 
however, the OCC suspended its consideration of amendments to 
Sec. 9.18, due to pending litigation stemming from the OCC's approval 
of collective investment funds consisting of Individual Retirement 
Accounts, Keogh Accounts, or other employee benefit accounts that are 
exempt from taxation (collective IRA funds).\16\ The OCC determined 
that it would be premature to pursue significant changes to Sec. 9.18 
under the circumstances.

    \16\ See, e.g., ``Decision of the Comptroller of the Currency on 
the Application by Citibank, N.A., pursuant to 12 CFR 9.18(c)(5) to 
Establish Common Trust Funds for the Collective Investment of 
Individual Retirement Account Trusts Exempt from Taxation under 
Section 408 of the Internal Revenue Code of 1954'' (Oct 31, 1982), 
reprinted in 1 Comptroller of the Currency Q.J. No. 4 (1982), at 45; 
and ``Decision of the Office of the Comptroller of the Currency on 
the Application by Wells Fargo Bank, N.A. to Establish a Common 
Trust Fund for the Collective Investment of Individual Retirement 
Account Trust Assets Exempt From Taxation Under section 408(a) of 
the Internal Revenue Code of 1954, as amended'' (Jan. 28, 1984) 
(Wells Fargo Decision).
---------------------------------------------------------------------------

    In view of the disposition of the collective IRA fund 
litigation,\17\ the OCC decided in 1990 to resume the rulemaking 
process by publishing a proposal to amend Sec. 9.18 (55 FR 4184, 
February 7, 1990) (1990 Proposal) based largely on the public comments 
received in 1982.\18\ The OCC received 150 comment letters on the 1990 
Proposal. In 1994, the OCC decided to revise Sec. 9.18 as part of the 
comprehensive review of part 9 under its Regulation Review Program, 
rather than proceed with Sec. 9.18 alone. This proposal incorporates 
many of the elements of the 1990 Proposal. Readers seeking additional 
background on these elements may refer to the 1990 Proposal.

    \17\ See Investment Company Institute v. Clarke, 789 F.2d 175 
(2d Cir. 1986), cert. denied, 479 U.S. 940 (1986); Investment 
Company Institute v. Conover, 790 F.2d 925 (D.C. Cir. 1986), cert. 
denied, 479 U.S. 939 (1986), Investment Company Institute v. Clarke, 
No. 86-3725 (W.D.N.C. August 25, 1986, appeal withdrawn by 
stipulation, Jan. 6, 1987).
    \18\ The 1990 proposal included revisions that would: (1) 
Eliminate the requirement for specific approval by an institution's 
board of directors prior to establishing a collective investment 
fund, and eliminate the requirement for national banks to file fund 
plans of operation with the OCC; (2) clarify the participation in 
collective investment funds by certain tax-exempt employee benefit 
funds; (3) broaden the authority to establish ``closed-end'' 
collective investment funds, the assets of which are illiquid; (4) 
eliminate the specific regulatory prohibition in Sec. 9.18(b)(5)(v) 
on advertising the availability and performance of common trust 
funds; (5) eliminate the fixed percentage limitation in 
Secs. 9.18(b)(9)(i) and 9.18(c)(3) on the interest a single 
participating account may have in a particular common trust fund; 
(6) eliminate the fixed percentage limitation in Sec. 9.18(b)(9)(ii) 
on the concentration of investment by a common trust fund in the 
obligations of any one entity; (7) eliminate the liquidity 
requirement in Sec. 9.18(b)(9)(iii) applicable to the assets of 
common trust funds; (8) eliminate the limitations in 
Sec. 9.18(b)(12) on fees and expenses incurred by an institution in 
the administration of a collective investment fund, but require 
appropriate disclosure; (9) eliminate the requirement in 
Sec. 9.18(c)(2)(ii) that investments in variable-amount notes be 
made on a short-term basis; (10) provide an expeditious procedure 
for the review of new types of funds; and (11) codify the authority 
to establish registered collective investment funds whose assets 
consist solely of Individual Retirement Accounts, Keogh Accounts, or 
other eligible employee benefit accounts.
---------------------------------------------------------------------------

    This current proposal retains the general structure of Sec. 9.18. 
Paragraph (a) authorizes national banks to invest fiduciary assets in 
two types of collective investment funds. Paragraph (b) sets forth the 
requirements applicable to funds authorized under paragraph (a). 
Paragraph (c) describes other types of collective investments available 
to national bank fiduciaries. Significant changes to current Sec. 9.18 
are noted below.

(a)(1) and (a)(2) Funds (Proposed Sec. 9.18(a)).

    The proposal retains the substance of current Sec. 9.18(a), which 
authorizes national banks to invest fiduciary assets in common trust 
funds ((a)(1) funds) and funds consisting of employee benefit and other 
tax-exempt trusts ((a)(2) funds). The proposal, however, relocates to 
Sec. 9.18(a) the substance of current Sec. 9.18(b)(2), which provides 

[[Page 66169]]
guidance on the circumstances under which a bank may place employee 
benefit and other tax-exempt trust assets in either an (a)(1) or an 
(a)(2) fund, and on the circumstances under which a bank may place 
trusts for which the bank is not the trustee in an (a)(2) fund.\19\

    \19\ Like the 1990 Proposal, this proposal eliminates from 
current Sec. 9.18(b)(2) references to specific sections of the 
Internal Revenue Code and to specific Internal Revenue Service 
rulings to make clear that the OCC promulgates this regulation 
solely on the authority of Federal banking law and not under 
authority of the Internal Revenue Code.
---------------------------------------------------------------------------

    The proposal makes significant changes to current Sec. 9.18(b), 
which sets forth the requirements for (a)(1) and (a)(2) funds. On 
balance, these changes, described below, will reduce the Federal 
regulatory burdens imposed on collective investment funds and enable 
banks to operate collective investment funds more efficiently. The term 
``collective investment fund,'' as used in Sec. 9.18, encompasses both 
(a)(1) funds and (a)(2) funds.

Written Plan (Proposed Sec. 9.18(b)(1)).

     Like the 1990 Proposal, this proposal eliminates as unnecessary 
two requirements from current Sec. 9.18(b)(1). First, instead of 
requiring the full board of directors to approve new collective 
investment fund plans, the proposal allows a committee of the board to 
perform this function. Second, the proposal removes the requirement 
that the bank file (a)(1) and (a)(2) fund plans with the OCC.\20\ 
Additionally, the proposal relocates a provision on fund valuation from 
current Sec. 9.18(b)(1) to proposed Sec. 9.18(b)(4), described below.

    \20\ However, national banks must file written plans with the 
OCC in order to establish special exemption funds (i.e., funds that 
deviate from the requirements of Sec. 9.18(a) and (b)), in 
accordance with proposed Sec. 9.18(c)(5).
---------------------------------------------------------------------------

Fund Management (Proposed Sec. 9.18(b)(2))

    The proposal provides an exception to the ``exclusive management'' 
requirement, found in current Sec. 9.18(b)(12), to allow prudent 
delegation of responsibilities to others.\21\ This exception is 
consistent with the modern prudent investor rule as set forth in the 
American Law Institute's Restatement (Third) of Trusts (1992).\22\

    \21\ In the past, the OCC recognized only limited exceptions to 
the exclusive management requirement. See, e.g., Fiduciary Precedent 
9.5320 (an affiliate may manage a bank's collective investment 
fund).
    \22\ See Rest. 3rd, Trusts (Prudent Investor Rule), section 171 
(Duty with Respect to Delegation): ``A trustee has a duty personally 
to perform the responsibilities of the trusteeship except as a 
prudent person might delegate those responsibilities to others. In 
deciding whether, to whom and in what manner to delegate fiduciary 
authority in the administration of a trust, and thereafter in 
supervising agents, the trustee is under a duty to the beneficiaries 
to exercise fiduciary discretion and to act as a prudent person 
would act in similar circumstances.''
---------------------------------------------------------------------------

    The proposal also provides an exception to the exclusive management 
requirement for collective IRA funds registered under the Investment 
Company Act of 1940. A bank with a collective IRA fund generally 
registers that fund as an investment company under the Investment 
Company Act because the SEC takes the position that IRA, Keogh, and 
certain other similar trusts may not qualify for exemption from 
registration. However, the exclusive management requirement of current 
Sec. 9.18(b)(12) arguably conflicts with the Investment Company 
Act.\23\ Currently, the OCC grants waivers of the exclusive management 
requirement for collective IRA funds that register as investment 
companies. The proposal obviates the need for these routine waivers.

    \23\ See, e.g., Wells Fargo Decision, supra note 16, at 10.
---------------------------------------------------------------------------

Proportionate Interests (Proposed Sec. 9.18(b)(3))

    The proposal retains the requirement in current Sec. 9.18(b)(3) 
that all participating accounts in a collective investment fund must 
have a proportionate interest in all of the fund's assets. However, the 
proposal eliminates the language concerning the propriety of investing 
fiduciary assets in a collective investment fund. The permissibility of 
investing the assets of a fiduciary account in a particular collective 
investment fund is governed by proposed Sec. 9.11, which allows 
investments consistent with applicable law.

Valuation (Proposed Sec. 9.18(b)(4))

    The proposal consolidates existing provisions relating to valuation 
of collective investment funds, including current Sec. 9.18(b)(1) 
(method of valuation), current Sec. 9.18(b)(4) (frequency and date of 
valuation), and current Sec. 9.18(b)(15) (valuation of short-term 
investment funds). The OCC invites comment on the need to clarify 
valuation issues in the regulatory text or an interpretive ruling 
accompanying part 9.
    The OCC also invites comment on the proposed exception to the 
quarterly valuation requirement for collective investment funds that 
are invested primarily in real estate or other assets that are not 
readily marketable. Allowing banks to value these illiquid collective 
investment funds annually rather than quarterly appears consistent with 
the one-year prior notice allowance for withdrawals from these funds, 
found at Sec. 9.18(b)(4).

Admission and Withdrawal of Accounts (Proposed Sec. 9.18(b)(5))

    The proposal consolidates existing provisions relating to 
admissions and withdrawals of accounts, including current 
Sec. 9.18(b)(4) (prior request or notice), current Sec. 9.18(b)(6) 
(method of distribution), and current Sec. 9.18(b)(7) (segregation of 
investments).
    The proposal also substantially revises the current regulation's 
standard for distributions to an account withdrawing from a collective 
investment fund. Current Sec. 9.18(b)(6) sets a Federal standard 
requiring the bank to make distributions in cash, ratably in kind 
(i.e., a proportional share in each of the assets held by the 
collective investment fund), or a combination of the two. The OCC 
believes that this Federal standard may not be sufficiently flexible to 
address distribution problems that arise, particularly with respect to 
collective investment funds that invest primarily in assets that are 
not readily marketable (illiquid assets). Even with respect to these 
collective investment funds that invest primarily in illiquid assets, 
banks generally make distributions in cash only, either from the fund's 
cash reserves or after selling some of the fund's assets within the 
one-year prior notice period. However, if withdrawal requests exceed 
the fund's cash reserves, and if the bank believes the market for the 
fund's assets is depressed, a bank under the constraint of the one-year 
time limit may have to resort to ratable in-kind distributions rather 
than (1) sell fund assets at depressed prices, or (2) liquidate the 
fund. With ratable in-kind distributions of certain assets, such as 
readily marketable securities, a withdrawing participant may easily 
convert the distribution into cash. However, that may not be the case 
for ratable in-kind distributions of illiquid assets, where valuation 
may be complicated and a recipient may have no practical avenue to 
liquidate its proportionate share of an asset.
    In response to these concerns, the proposal allows any 
distributions consistent with applicable law. The OCC believes that 
this approach will provide banks with sufficient flexibility to address 
complex distribution problems that may arise (particularly with respect 
to collective investment funds that invest primarily in illiquid 
assets), while maintaining the basic 

[[Page 66170]]
protections of state fiduciary law.\24\ The OCC invites comment on 
whether to adopt this proposed state law-based approach instead of 
retaining a Federal standard. In the event that the OCC does not adopt 
the state law-based approach, the OCC also invites comment on what 
Federal standard is appropriate.

    \24\ Thus, for example, a bank with a collective investment fund 
facing distribution problems, or beneficiaries (or interested 
parties) of fiduciary accounts participating in that fund, could 
seek from a court of competent jurisdiction an order authorizing an 
equitable solution. Allowing a bank to make distributions in 
accordance with a court order allows the bank to seek a solution 
more flexible than what current OCC regulations prescribe. A court-
ordered solution also provides all interested parties with the 
opportunity to present their concerns in a judicial forum, ensuring 
that the distribution reflects a consideration of all relevant 
interests.
---------------------------------------------------------------------------

    Moreover, the OCC invites comment on whether, if the OCC adopts a 
state law-based standard, there is a need to retain the provision that 
allows a prior notice period of up to one year for withdrawals from 
funds with assets not readily marketable (proposed 
Sec. 9.18(b)(5)(iii)).

Audits and Financial Reports (Proposed Sec. 9.18(b)(6))

    The proposal retains the requirements in current 
Sec. 9.18(b)(5)(i)-(iv) regarding collective investment fund annual 
audits and financial reports. The proposal also adds a requirement that 
a national bank disclose in the annual financial report fees and 
expenses charged to the fund, consistent with OCC precedent.\25\

    \25\ See, e.g., Fiduciary Precedent 9.5330 (requiring disclosure 
of management fees).
---------------------------------------------------------------------------

    The proposal, however, provides an exception to this requirement 
for collective IRA funds registered under the Investment Company Act. 
As mentioned earlier, a bank generally registers a collective IRA fund 
as an investment company under the Investment Company Act. The 
requirement that the auditors are responsible only to the bank's board 
of directors arguably conflicts with the Investment Company Act.\26\ 
Currently, the OCC grants waivers of this requirement for collective 
IRA funds registered as investment companies. The proposal obviates the 
need for these routine waivers.

    \26\ See, e.g., Wells Fargo Decision, supra note 16, at 11-12.
---------------------------------------------------------------------------

Advertising Prohibition for Common Trust Funds (Proposed 
Sec. 9.18(b)(7))

    The proposal retains and clarifies the current regulation's 
prohibition on advertising (a)(1) funds. Current Sec. 9.18(b)(5)(v) 
prohibits a national bank from advertising or publicizing (a)(1) funds 
except as provided in the regulation. Current Sec. 9.18(b)(5)(iv) 
allows a national bank to publicize the availability of financial 
reports for (a)(1) funds in connection with the promotion of the 
general fiduciary services of the bank. The OCC interprets these 
provisions to allow a bank to advertise (a)(1) funds only in connection 
with the advertisement of the general fiduciary services of the 
bank.\27\

    \27\ See, e.g., Fiduciary Precedent 9.5113.
---------------------------------------------------------------------------

Self-dealing and Conflicts of Interest (Proposed Sec. 9.18(b)(8))

    The proposal retains the substance of current Sec. 9.18(b)(8), 
which addresses self-dealing and conflicts of interest specific to 
collective investment funds. A national bank administering a collective 
investment fund must comply with these provisions in addition to the 
self-dealing and conflicts of interest provisions found in Sec. 9.12, 
which apply to all fiduciary activities of national banks.

Mortgage Reserve Account (Proposed Sec. 9.18(b)(9))

    The proposal retains the substance of current Sec. 9.18(b)(11), 
which allows a bank administering a collective investment fund to 
establish a mortgage reserve account for overdue interest payments on 
mortgages in the fund. The OCC invites comment on the extent to which 
banks use mortgage reserve accounts, and whether their experience 
suggests the need for any modifications to this provision.

Fees and Expenses (Proposed Sec. 9.18(b)(10))

    The proposal retains the quantitative management fee limitation, 
found in current Sec. 9.18(b)(12). Under this limitation, a bank 
administering a collective investment fund may charge a fund management 
fee only if the total fees charged to a participating account 
(including the fund management fee) does not exceed the total fees that 
the bank would have charged if it had not invested assets of the 
account in the fund. Moreover, the proposal retains the requirement 
that the bank absorb fund establishment and reorganization expenses, 
also found in current Sec. 9.18(b)(12).
    The proposal, however, eliminates other provisions in Sec. 9.18(b) 
that specifically permit or prohibit certain expenses, including 
current Sec. 9.18(b)(5)(i) (expenses for audits performed by 
independent public accountants), current Sec. 9.18(b)(5)(iv) (expenses 
for printing and distributing financial reports), and current 
Sec. 9.18(b)(10) (expenses incurred in servicing mortgages). Rather 
than mandating the treatment of specific expenses (other than 
establishment and reorganization expenses), the proposal defers to 
state law, in effect, by allowing a bank to charge any reasonable 
expenses incurred in operating the collective investment fund to the 
extent not prohibited by applicable law. When expenses of a fund are 
reasonable and permissible under state law, and are fully disclosed in 
appropriate documentation,\28\ the OCC believes that it is not 
necessary to micromanage the precise types of expenses charged directly 
to collective investment funds.

    \28\ See proposed Sec. 9.18(b)(1)(iii) (disclosure of 
anticipated fees and expenses in the written plan) and proposed 
Sec. 9.18(b)(6)(ii) (disclosure of fees and expenses in the annual 
financial report).
---------------------------------------------------------------------------

    Additionally, the OCC invites comment on whether to defer to 
applicable law instead of retaining the quantitative management fee 
limitation.

Prohibition Against Certificates (Proposed Sec. 9.18(b)(11))

    The proposal retains the substance of current Sec. 9.18(b)(13), 
which prohibits a national bank administering a collective investment 
fund from issuing certificates evidencing an interest in the fund.

Good Faith Mistakes (Proposed Sec. 9.18(b)(12))

    The proposal retains the substance of current Sec. 9.18(b)(14), 
which provides that if a bank, in good faith and in the exercise of due 
care, makes a mistake in administering a collective investment fund, 
the bank will not be in violation of this part if it takes prompt 
action to remedy the mistake.

Elimination of Participation, Investment, and Liquidity Requirements

    The proposal eliminates the 10 percent participation limitation, 
the 10 percent investment limitation, and the liquidity requirement 
applicable to common trust funds under current Sec. 9.18(b)(9), in 
accordance with the 1990 Proposal. These Federal restrictions have at 
times interfered with optimal management of common trust funds, and the 
protections found in state fiduciary law adequately address the 
concerns underlying these restrictions.

Other Collective Investments (Proposed Sec. 9.18(c))

    In addition to (a)(1) and (a)(2) funds, current Sec. 9.18 
authorizes other means by which a national bank may invest fiduciary 
assets collectively. These other collective investments, described in 

[[Page 66171]]
proposed Sec. 9.18(c), are not subject to the requirements of 
Sec. 9.18(b).
    The proposal eliminates the requirement in current 
Sec. 9.18(c)(2)(ii) that investments in variable-amount notes be made 
on a short-term basis, in accordance with the 1990 Proposal. The 
proposal also eliminates the requirement applicable to mini-funds 
(i.e., funds established for the collective investment of cash 
balances) that no participating account's interest in the fund exceed 
$10,000, again in accordance with the 1990 Proposal.\29\ Moreover, the 
proposal expands the total amount of assets permitted in a mini-fund to 
$1,000,000.

    \29\ Under current Sec. 9.18(c)(3), a mini-fund may not exceed 
$100,000. Limiting participation in this fund to $10,000 is 
equivalent to limiting participation to 10 percent. Thus, 
eliminating the $10,000 limitation is consistent with eliminating 
the 10 percent participation limitation found in current 
Sec. 9.18(b)(9).
---------------------------------------------------------------------------

    Finally, the proposal provides an expeditious procedure for the 
review of new types of funds, in accordance with the 1990 Proposal. The 
purpose of this new procedure is to encourage innovation by improving 
the approval procedures for banks that wish to establish new types of 
funds.

Transfer Agents (Proposed Sec. 9.20)

    The proposal incorporates by means of cross-reference the SEC's 
rules prescribing procedures for registration of transfer agents for 
which the SEC is the appropriate regulatory agency (17 CFR 240.17Ac2-
1). Although section 17A(d)(1) of the Securities Exchange Act of 1934 
(15 U.S.C. 78q-1(d)(1)) generally subjects all transfer agents to SEC 
rules, section 17A(c) (15 U.S.C. 78q-1(c)) provides that transfer 
agents shall register with their appropriate regulatory agencies. 
Current 12 CFR 9.20 sets forth procedural requirements for national 
banks that register as transfer agents that are virtually identical to 
the SEC's registration rules. Thus, the OCC does not need to maintain 
separate procedures, and the proposal simply incorporates the SEC's 
rule instead.
    The proposal also clarifies that a national bank transfer agent 
must comply with rules adopted by the SEC pursuant to section 17A of 
the Securities Exchange Act (15 U.S.C. 78q-1) prescribing operational 
and reporting requirements that apply to all transfer agents (17 CFR 
240.17Ac2-2, and 240.17Ad-1 through 240.17Ad-16).
    The OCC's ``National Bank Transfer Agents' Guide'' provides 
additional guidance regarding the transfer agent activities of national 
banks, including the forms that national banks must file. The OCC sends 
the Guide to all national bank transfer agents, and to any person who 
requests it from the Communications Division, Office of the Comptroller 
of the Currency, 250 E Street, SW, Washington, DC 20219.

Disciplinary Sanctions Imposed by Clearing Agencies (Proposed 
Sec. 19.135)

    The proposal relocates provisions concerning applications by 
national banks for stay or review of disciplinary sanctions imposed by 
registered clearing agencies from current Secs. 9.21 and 9.22 to 12 CFR 
part 19, the OCC's rules of practice and procedure. Proposed 
Sec. 19.135 incorporates by cross-reference the SEC's rules on this 
subject, which are virtually identical to current Secs. 9.21 and 9.22.

Other Issues for Comment

    The OCC has identified several other issues that relate to national 
banks' fiduciary activities. The OCC is not proposing specific 
regulatory text on these issues at this time, but invites comment on 
whether and how to address these issues in part 9.

Multistate Fiduciary Operations

    As noted at the outset of this preamble discussion, bank 
organizational structures have changed significantly since 1913, when 
Congress first enacted the national bank fiduciary powers statute. Many 
bank holding companies currently conduct multistate fiduciary 
operations through separate bank or trust company subsidiaries 
chartered in different states. The Riegle-Neal Interstate Banking and 
Branching Efficiency Act of 1994 (Interstate Act) facilitates the 
consolidation of multistate fiduciary operations by permitting 
interstate bank mergers. Moreover, the ability to branch interstate may 
encourage some banks to expand the multistate fiduciary business they 
already have, and others to enter the fiduciary business on a 
multistate basis for the first time. However, the Interstate Act does 
not define the scope of a national bank's multistate fiduciary 
authority. For example, it does not address activities conducted at 
places other than interstate branches.
    In a recent letter, the OCC analyzed the authority of a national 
bank to exercise fiduciary powers on an interstate basis under 12 
U.S.C. 92a. See Letter from Julie L. Williams, Chief Counsel (December 
8, 1995). The letter dealt with a proposal for a national bank to 
establish non-branch trust offices in many states and to conduct 
fiduciary business in each state. But the interstate considerations 
discussed below also apply to fiduciary activities conducted at 
interstate branches.
    In brief, section 92a authorizes a national bank to conduct 
fiduciary activities but imposes no limitations on the places where, or 
the customers for whom, the bank may conduct those activities.30 
Since an office that conducts only fiduciary activities and does not 
engage in any of the so-called ``core banking functions'' in 12 U.S.C. 
36(j) is not a branch for purposes of the McFadden Act (12 U.S.C. 
36(c)), a bank may establish non-branch trust offices at any location, 
without regard to branching limitations. Thus, a national bank may 
conduct fiduciary activities at non-branch trust offices in states 
other than the state in which it has its main office. A national bank 
may also offer fiduciary services at its interstate branches.

    \30\ The basic authority for national banks to exercise 
fiduciary powers is found in 12 U.S.C. 92(a) and (b):
    (a) Authority of the Comptroller of the Currency
      The Comptroller of the Currency shall be authorized and 
empowered to grant by special permit to national banks applying 
therefor, when not in contravention of State or local law, the right 
to act as trustee, executor, administrator, registrar of stocks and 
bonds, guardian of estates, assignee, receiver, committee of estates 
of lunatics, or in any other fiduciary capacity in which State 
banks, trust companies, or other corporations which come into 
competition with national banks are permitted to act under the laws 
of the State in which the national bank is located.
    (b) Grant and exercise of powers deemed not in contravention of 
State or local law
      Whenever the laws of such State authorize or permit the 
exercise of any or all of the foregoing powers by State banks, trust 
companies, or other corporations which compete with national banks, 
the granting to and the exercise of such powers by national banks 
shall not be deemed to be in contravention of State or local law 
within the meaning of this section.
---------------------------------------------------------------------------

    The OCC believes that the effect of section 92a is that in any 
specific state, the extent of fiduciary powers is the same for out-of-
state national banks as for in-state national banks and depends upon 
what the state permits for its own state institutions. A state may 
limit national banks from exercising any or all fiduciary powers in 
that state, but only if it also bars its own institutions from 
exercising the same powers. Therefore, a national bank with its main 
office in one state may exercise fiduciary powers in that state and 
other states, depending upon--with respect to each state--the powers 
each state allows its own institutions to exercise. In essence, with 
respect to national bank fiduciary powers in a given state, the OCC 
believes that section 92a applies the same standards to all national 
banks, regardless of where a national bank has its main office. Whether 
state administrative requirements connected 

[[Page 66172]]
with fiduciary activities apply to national banks (other than the 
requirements specifically made applicable by sections 92a(f), (g), and 
(h)), is determined by principles of federal preemption and must be 
considered on a case-by-case basis.31

    \31\ Some earlier OCC letters suggesting that all aspects of 
state law governing fiduciary institutions apply to national banks 
have generally dealt with substantive fiduciary law and have not 
fully distinguished between state substantive fiduciary duties and 
standards and state administrative requirements. See, e.g., OCC 
Letter No. 525 (August 8, 1990), reprinted in Fed. Banking L. Rep. 
(CCH) para. 83,236.
---------------------------------------------------------------------------

    The OCC invites comment on the legal framework under section 92a 
for interstate fiduciary powers of national banks as discussed above 
and in the Letter (December 8, 1995). The OCC also invites comment on 
whether to add any new provisions to part 9, or modify any existing 
provisions (in addition to the modification of Sec. 9.14(b)), to 
address other issues presented by fiduciary activities conducted on an 
interstate basis.

Investment Adviser to an Investment Company

    When a bank or its operating subsidiary acts as an investment 
adviser to an investment company (such as a mutual fund), that activity 
raises conflicts of interest and other concerns that part 9 was not 
designed to address. The OCC currently addresses these concerns by 
imposing certain conditions on a case-by-case basis in connection with 
operating subsidiary filings involving mutual fund advisory 
activities.32 The OCC has generally imposed the following 
conditions when a national bank's operating subsidiary acts as 
investment adviser to an investment company:

    \32\ See, e.g., Interpretive Letter No. 647 (April 15, 1994), 
reprinted in, [1994 Transfer Binder] Fed. Banking L. Rep. (CCH) 
para. 83,558 (Letter approving notification by First Union National 
Bank of North Carolina to establish three wholly-owned operating 
subsidiaries to acquire the partnership interests of Lieber and 
Company and the assets and liabilities of Evergreen Management 
Corporation); Interpretive Letter No. 648 (May 4, 1994), reprinted 
in, [1994 Transfer Binder] Fed. Banking L. Rep. (CCH) para. 83,557 
(Letter approving notification by Mellon Bank, N.A. and Mellon Bank 
(DE), N.A. to establish certain operating subsidiaries to acquire 
most of the assets, operations, and activities of The Dreyfus 
Corporation).
---------------------------------------------------------------------------

    (1) The investment company is treated as an affiliate of the bank 
and its operating subsidiary for purposes of Sections 23A and 23B of 
the Federal Reserve Act (12 U.S.C. 371c and 371c-1) and thus is subject 
to the restrictions on transactions between affiliates;
    (2) The bank's aggregate direct and indirect investments in and 
advances to the subsidiary may not exceed an amount equal to the bank's 
legal lending limit under 12 CFR part 32;
    (3) Neither the bank nor the subsidiary may purchase shares of the 
investment company for its own account; and
    (4) The bank and the subsidiary are subject to the Interagency 
Statement on Retail Sales of Nondeposit Investment Products (February 
15, 1994).
    The OCC invites comment on whether these conditions are appropriate 
in all situations where a national bank or its operating subsidiary 
acts as investment adviser to an investment company, and, if so, 
whether to include them in part 9.

Indenture Trustee Conflicts of Interest

    A national bank that serves as an indenture trustee to an issue of 
debt
FR Doc. 95-30971 Fiduciary Activities of National Banks; Rules of Practice and Procedure
 securities and also provides additional banking services to, or 
has additional relationships with, the securities issue or issuer, is 
subject to potential conflicts of interest. An indenture trustee to a 
debt securities issuance represents the security holders as their 
fiduciary, seeking interest and principal payments from the securities 
issuer on their behalf. If a bank provides a letter of credit to an 
issuer while acting as the indenture trustee for the issuer's 
securities, and the issuer fails to make a scheduled payment to the 
security holders, the bank, as indenture trustee, must declare the 
issuer in default and seek payment from itself as issuer of the letter 
of credit. In this situation, the bank's role as trustee may conflict 
with its own interest as issuer of the letter of credit. Upon default, 
when the bank extends credit to the defaulted securities issuance, the 
bank, as creditor, becomes a competing creditor with itself as trustee 
for the security holders.
    Before 1990, the Trust Indenture Act of 1939 contained conflict of 
interest prohibitions that disqualified banks from serving as indenture 
trustees to certain debt securities issuances if they provided credit 
to the securities issuer. Given the provisions of the statute, the OCC 
did not need to address conflicts of interest that a national bank 
might face with respect to securities covered by the Trust Indenture 
Act.
    Some securities issuances, however, are exempt from the Trust 
Indenture Act. Exempt securities include those exempt from registration 
under the Securities Exchange Act of 1934, such as municipal industrial 
revenue bond issuances. With respect to exempt securities issuances, 
the OCC recommended, consistent with the pre-1990 policies articulated 
in the Trust Indenture Act, that a national bank avoid acting both as 
indenture trustee and as issuer of a letter of credit.33

    \33\ See Interpretive Letter No. 293 (May 11, 1984), reprinted 
in Fed. Banking L. Rep. (CCH) para. 85,463.
---------------------------------------------------------------------------

    In 1990, Congress amended the Trust Indenture Act to permit a bank 
to serve as both creditor and indenture trustee.34 The Trust 
Indenture Act now requires that, upon default of the issuance, the 
indenture trustee must eliminate the conflict within 90 days or 
disqualify itself from further service as indenture trustee. As a 
result of the 1990 amendments, OCC precedent treats exempt securities 
more stringently than the Trust Indenture Act treats covered 
securities. These developments raise the issue of whether and how to 
address conflicts that may arise when a national bank serves as 
indenture trustee.

    \34\ See Securities Act Amendments of 1990, Pub. L. 101-550.
---------------------------------------------------------------------------

    The OCC is inclined to allow a national bank to act as creditor and 
indenture trustee until 90 days after default, consistent with the 
Trust Indenture Act, with the added condition that the banks maintain 
adequate controls to manage the potential conflicts of interest. 
Additionally, the OCC is inclined to apply this policy consistently to 
all debt securities issuances, including debt securities issuances 
exempt from the Trust Indenture Act.
    Because many national banks already have adopted policies and 
procedures to manage these potential conflicts of interest,35 the 
OCC may not need to address this issue by regulation. It may be 
sufficient for the OCC to develop guidance on what controls banks 
should maintain in order to manage potential conflicts.

    \35\ Among these policies and procedures are: (1) Favoring debt 
issuers that have a low risk rating to minimize the possibility of 
default; (2) ensuring that the credit is fully collateralized by 
cash or cash equivalents to give the bank a lower credit and asset 
quality risk and superior credit rights (compared to bondholders); 
(3) participating out most of the credit to reduce the bank's total 
credit risk; and (4) employing an independent, third party to become 
trustee upon default.
---------------------------------------------------------------------------

    The OCC invites comment on how banks are managing these conflicts, 
and on the need to address this issue in part 9.

Waiver of Regulatory Requirements

    The OCC also is considering whether to establish standards and 
procedures for obtaining waivers of any of the requirements in part 9. 
The OCC notes that a banking circular, BC-205 (dated July 26, 1985), 
already provides general guidance to national banks, bank counsel, and 
interested members of the public on requests for staff no-objection 
positions. The banking circular 

[[Page 66173]]
establishes procedures for obtaining the informal views of the OCC 
legal staff regarding the applicability of national banking law 
requirements to contemplated transactions or activities, including 
fiduciary activities. The OCC invites comment on whether these 
procedures are sufficient to accommodate meet banks that seek 
clarification of, or relief from, requirements in part 9, or whether 
the OCC should add a waiver provision specific to part 9.
    This table directs readers to the provisions of the current 12 CFR 
part 9, if any, on which the revised 12 CFR part 9 and the amended 12 
CFR part 19 are based

                   DERIVATION TABLE FOR 12 CFR PART 9                   
------------------------------------------------------------------------
    Revised  Provision        Current Provision           Comments      
------------------------------------------------------------------------
Sec.  9.1.................  .....................  Added.               
Sec.  9.2(a)..............  .....................  Added.               
    (b)...................  Sec.  9.1(g).........  Significantly        
                                                    modified.           
    (c)...................  Sec.  9.1(l).........  Modified.            
    (d)...................  Sec.  9.1(a).........  Modified.            
    (e)...................  Sec.  9.1(b) and (h).  Significantly        
                                                    modified.           
    (f)...................  Sec.  9.1(j).........  Modified.            
    (g)...................  Sec.  9.1(d).........  Modified.            
    (h)...................  Sec.  9.1(c).........  Modified.            
    (i)...................  Sec.  9.1(e).........  Modified.            
    (j)...................  .....................  Added.               
Sec.  9.3.................  Sec.  9.2............  Modified.            
Sec.  9.4.................  Sec.  9.7(a)(1), (b),  Significantly        
                             and (d).               modified.           
Sec.  9.5.................  Secs.  9.5, 9.7(c),    Significantly        
                             9.7(d), and 9.10(a).   modified.           
Sec.  9.6.................  Sec.  9.7(a)(2)......  Significantly        
                                                    modified.           
Sec.  9.8.................  Secs.  9.7(a)(2) and   Modified.            
                             9.8.                                       
Sec.  9.9.................  Sec.  9.9............  Significantly        
                                                    modified.           
Sec.  9.10................  Sec.  9.10...........  Significantly        
                                                    modified.           
Sec.  9.11................  Sec.  9.11...........  Modified.            
Sec.  9.12................  Sec.  9.12...........  Modified.            
Sec.  9.13................  Sec.  9.13...........  Modified.            
Sec.  9.14................  Sec.  9.14...........  Significantly        
                                                    modified.           
Sec.  9.15................  Sec.  9.15...........  Modified.            
Sec.  9.16................  Sec.  9.16...........  Modified.            
Sec.  9.17................  Sec.  9.17...........  Modified.            
Sec.  9.18(a).............  Sec.  9.18 (a) and     Modified.            
                             (b)(2).                                    
    (b)(1)................      (b)(1)...........  Significantly        
                                                    modified.           
    (b)(2)................      (b)(12)..........  Significantly        
                                                    modified.           
    (b)(3)................      (b)(3)...........  Modified.            
    (b)(4)................      (b) (1), (4), and  Significantly        
                             (15).                  modified.           
    (b)(5)................      (b) (4), (6), and  Significantly        
                             (7).                   modified.           
    (b)(6)................      (b) (5)(i)-(iv)..  Significantly        
                                                    modified.           
    (b)(7)................      (b) (5)(iv) and    Significantly        
                             (v).                   modified.           
    (b)(8)................      (b)(8)...........  Modified.            
    (b)(9)................      (b)(11)..........  Modified.            
    (b)(10)...............      (b)(12)..........  Significantly        
                                                    modified.           
    (b)(11)...............      (b)(13)..........  Modified.            
    (b)(12)...............      (b)(14)..........  Modified.            
    (c)(1)................      (c)(1)...........  Modified.            
    (c)(2)................      (c)(2)...........  Modified.            
    (c)(3)................      (c)(3)...........  Significantly        
                                                    modified.           
    (c)(4)................      (c)(4)...........  Modified.            
    (c)(5)................      (c)(5)...........  Significantly        
                                                    modified.           
    Sec.  9.20............  Sec.  9.20...........  Modified.            
    Sec.  19.135..........  Secs.  9.21 and 9.22.  Modified.            
------------------------------------------------------------------------

Regulatory Flexibility Act

    It is hereby certified that this proposal will not have a 
significant economic impact on a substantial number of small entities. 
Accordingly, a regulatory flexibility analysis is not required. The 
proposal's requirements, for the most part, are not new to the 
regulation. The proposal liberalizes requirements and reduces burden 
for all national banks that exercise fiduciary powers, regardless of 
size.

Executive Order 12866

    The OCC has determined that this proposal is not a significant 
regulatory action under Executive Order 12866.

Paperwork Reduction Act of 1995

    The OCC invites comment on:
    (1) Whether the proposed information collection contained in this 
proposal is necessary for the proper performance of the OCC's 
functions, including whether the information has practical utility;
    (2) The accuracy of the OCC's estimate of the burden of the 
proposed information collection;
    (3) Ways to enhance the quality, utility, and clarity of the 
information to be collected; and
    (4) Ways to minimize the burden of the information collection on 
respondents, including through the use of automated collection 
techniques or other forms of information technology.
    Respondents/recordkeepers are not required to respond to this 
collection of 

[[Page 66174]]
information unless it displays a currently valid OMB control number.
    The collection of information requirements contained in this 
proposal have been submitted to the Office of Management and Budget for 
review in accordance with the Paperwork Reduction Act of 1995 (44 
U.S.C. 3507(d)). Comments on the collections of information should be 
sent to the Office of Management and Budget, Paperwork Reduction 
Project (1557-AB12), Washington, DC 20503, with copies to the 
Legislative and Regulatory Activities Division (1557-AB12), Office of 
the Comptroller of the Currency, 250 E Street, SW, Washington, DC 
20219.
    The collection of information requirements in this proposed rule 
are found in 12 CFR 9.8, 9.9, 9.17, and 9.18. The OCC requires this 
information for the proper supervision of national banks' fiduciary 
activities. The likely respondents/recordkeepers are national banks.
    Estimated average annual burden hours per respondent/recordkeeper: 
15.01 hours.
    Estimated number of respondents and/or recordkeepers: 1,000.
    Estimated total annual reporting and recordkeeping burden: 15,010 
hours.
    Start-up costs to respondents: None.

Unfunded Mandates Act of 1995

    The OCC has determined that this proposal will not result in 
expenditures by state, local, and tribal governments, or by the private 
sector, of more than $100 million in any one year. Accordingly, a 
budgetary impact statement is not required under section 202 of the 
Unfunded Mandates Act of 1995.

List of Subjects

12 CFR Part 9

    Estates, Investments, National banks, Reporting and recordkeeping 
requirements, Trusts and trustees.

12 CFR Part 19

    Administrative practice and procedure, Crime, Investigations, 
National banks, Penalties, Securities.

Authority and Issuance

    For the reasons set out in the preamble, chapter I of title 12 of 
the Code of Federal Regulations is proposed to be amended as follows:
    1. Part 9 is revised to read as follows:

PART 9--FIDUCIARY ACTIVITIES OF NATIONAL BANKS

Sec.
9.1  Authority, purpose, and scope.
9.2  Definitions.
9.3  Approval requirements.
9.4  Administration of fiduciary powers.
9.5  Policies and procedures.
9.6  Review of assets of fiduciary accounts.
9.8  Recordkeeping.
9.9  Audit of fiduciary activities.
9.10  Fiduciary funds awaiting investment or distribution.
9.11  Investment of fiduciary funds.
9.12  Self-dealing and conflicts of interest.
9.13  Custody of fiduciary assets.
9.14  Deposit of securities with state authorities.
9.15  Fiduciary compensation.
9.16  Receivership or voluntary liquidation of bank.
9.17  Surrender or revocation of fiduciary powers.
9.18  Collective investment funds.
9.20  Transfer agents.
    Authority: 12 U.S.C. 24(Seventh), 92a, and 93a; 15 U.S.C. 78q, 
78q-1, and 78w.

Sec. 9.1  Authority, purpose, and scope.

    (a) Authority. The OCC issues this part pursuant to its authority 
under 12 U.S.C. 24 (Seventh), 92a, and 93a, and 15 U.S.C. 78q, 78q-1, 
and 78w.
    (b) Purpose. The purpose of this part is to set forth the standards 
that apply to the fiduciary activities of national banks.
    (c) Scope. This part applies to all national banks that act in a 
fiduciary capacity, as defined in Sec. 9.2(e).

Sec. 9.2  Definitions.

    For the purposes of this part, the following definitions apply:
    (a) Affiliate has the same meaning as in 12 U.S.C. 221a(b).
    (b) Applicable law means Federal law, state law governing a 
national bank's fiduciary relationships, the terms of the instrument 
governing a fiduciary relationship, or any court order pertaining to 
the relationship.
    (c) Custodian under a uniform gifts to minors act means a fiduciary 
relationship established pursuant to a state law substantially similar 
to the Uniform Gifts to Minors Act as published by the American Law 
Institute.
    (d) Fiduciary account means an account administered by a national 
bank acting in a fiduciary capacity.
    (e) Fiduciary capacity means: acting as trustee, executor, 
administrator, registrar of stocks and bonds (including transfer 
agent), guardian, assignee, receiver, or custodian under a uniform 
gifts to minors act; any capacity involving investment discretion on 
behalf of another; or any other similar capacity that the OCC 
authorizes pursuant to 12 U.S.C. 92a.
    (f) Fiduciary officers and employees means all officers and 
employees of a national bank to whom the board of directors or its 
designees has assigned functions involving the exercise of the bank's 
fiduciary powers.
    (g) Fiduciary records means all written or otherwise recorded 
information that a national bank creates or receives relating to a 
fiduciary account or the fiduciary activities of the bank.
    (h) Fiduciary powers means the authority the OCC grants to a 
national bank to act in a fiduciary capacity pursuant to 12 U.S.C. 92a.
    (i) Guardian means the guardian or committee, by whatever name 
employed by state law, of the estate of an infant, an incompetent 
person, an absent person, or a person over whose estate a court has 
taken jurisdiction, other than under bankruptcy or insolvency laws.
    (j) Investment discretion means, with respect to an account, the 
authority to determine what securities or other assets to purchase or 
sell on behalf of the account.

Sec. 9.3  Approval requirements.

    (a) A national bank may not exercise fiduciary powers unless it 
obtains prior approval from the OCC to the extent required under 12 CFR 
5.26.
    (b) A person seeking approval to organize a special-purpose 
national bank limited to fiduciary powers shall file an application 
with the OCC pursuant to 12 CFR 5.20.

Sec. 9.4  Administration of fiduciary powers.

    (a) Responsibilities of the board of directors. A national bank's 
fiduciary activities shall be managed by or under the direction of its 
board of directors. In discharging its responsibilities, the board may 
assign any function related to the exercise of fiduciary powers to any 
director, officer, employee, or committee thereof.
    (b) Use of other personnel. The national bank may use any qualified 
personnel and facilities of the bank to perform services related to the 
exercise of its fiduciary powers, and any department of the bank may 
use fiduciary officers and employees and facilities to perform services 
unrelated to the exercise of fiduciary powers, to the extent not 
prohibited by applicable law.
    (c) Agency agreements. A national bank exercising fiduciary powers 
may perform services related to the exercise of fiduciary powers for 
another bank or other entity, and may purchase services related to the 
exercise of fiduciary powers from another bank or other entity, 
pursuant to a written agreement.
    (d) Bond requirement. A national bank shall ensure that all 
fiduciary officers and employees are adequately bonded. 

[[Page 66175]]

Sec. 9.5  Policies and procedures.

    A national bank exercising fiduciary powers shall adopt and follow 
written policies and procedures adequate to ensure that its fiduciary 
practices comply with applicable law. Among other relevant matters, the 
policies and procedures should address, where appropriate, the bank's:
    (a) Brokerage placement practices, including:
    (1) Selection of persons to effect securities transactions and the 
evaluation of the reasonableness of any brokerage commissions paid to 
those persons;
    (2) Acquisition of services or products, including research 
services, in return for brokerage commissions;
    (3) Allocation of research or other services among accounts, 
including those that did not generate commissions to pay for that 
research or other services; and
    (4) Disclosure of information concerning these brokerage placement 
policies and procedures to prospective and existing customers;
    (b) Methods for ensuring that fiduciary officers and employees do 
not use material inside information in connection with any decision or 
recommendation to purchase or sell any security;
    (c) Methods for preventing self-dealing and conflicts of interest;
    (d) Selection and retention of legal counsel who is readily 
available to advise the bank and its fiduciary officers and employees 
on fiduciary matters;
    (e) Investment of funds held as fiduciary, including short-term 
investments and the treatment of fiduciary funds awaiting investment or 
distribution;
    (f) Allocation to fiduciary accounts of any financial incentives 
the bank may receive for investing fiduciary funds in a particular 
investment; and
    (g) Disclosure to beneficiaries and other interested parties of 
fees and expenses charged to fiduciary accounts.

Sec. 9.6  Review of assets of fiduciary accounts.

    (a) Individual account review--(1) Pre-acceptance review. Before 
accepting a fiduciary account, a national bank shall review the 
prospective account to determine whether it can properly administer the 
account.
    (2) Initial post-acceptance review. Upon the acceptance of a 
fiduciary account for which a national bank has investment discretion, 
the bank shall conduct a prompt, written review of all assets of the 
account to evaluate whether they are appropriate, individually and 
collectively, for the account.
    (3) Annual review. At least once during every calendar year, and 
not later than 15 months after the last review, a bank shall conduct a 
written review of all assets of each account for which the bank has 
investment discretion to evaluate whether they are appropriate, 
individually and collectively, for the account.
    (b) Annual review of assets by issuer. At least once during every 
calendar year, and not later than 15 months after the last review, a 
bank shall conduct a written review of the investment merit of each 
asset in fiduciary accounts for which the bank has investment 
discretion, to the extent appropriate for that asset.

Sec. 9.8  Recordkeeping.

    (a) Documentation of accounts. A national bank shall adequately 
document the establishment and termination of each fiduciary account 
and shall maintain adequate records for all fiduciary accounts, 
including any records required under 12 CFR part 12.
    (b) Retention of records. A national bank shall retain all 
fiduciary records relating to an account for a period of three years 
from the later of the termination of the account or the termination of 
any litigation relating to the account.
    (c) Separation of records. The bank shall ensure that its fiduciary 
records are separate and distinct from other records of the bank.

Sec. 9.9  Audit of fiduciary activities.

    (a) Annual audit. At least once during each calendar year and not 
later than 15 months after the last audit, a national bank shall 
perform, through its audit committee, a suitable audit of all of its 
fiduciary activities, unless the bank adopts a continuous audit system 
in accordance with paragraph (b) of this section. The bank shall note 
the results of the audit (including all actions taken as a result of 
the audit) in the minutes of the board of directors.
    (b) Continuous audit. In lieu of performing annual audits under 
paragraph (a) of this section, a national bank may adopt a continuous 
audit system under which the bank performs, through its audit 
committee, a discrete audit of each fiduciary activity (i.e., on an 
activity-by-activity basis) at intervals appropriate for that activity. 
Thus, a bank may audit certain fiduciary activities at intervals 
greater or less than one year, as appropriate. A bank that adopts a 
continuous audit system shall note the results of all discrete audits 
performed since the last audit report (including all actions taken as a 
result of the audits) in the minutes of the board of directors at least 
once during each calendar year and not later than 15 months after the 
last audit report.
    (c) Audit committee. A national bank's audit committee may consist 
of a committee of the bank's directors or an audit committee of an 
affiliate of the bank. However, the national bank's audit committee 
must not include:
    (i) Any officers of the bank who participate significantly in the 
administration of the bank's fiduciary activities or;
    (ii) Any members of a fiduciary committee of the bank.

Sec. 9.10  Fiduciary funds awaiting investment or distribution.

    (a) In general. A national bank shall not allow funds of a 
fiduciary account that are awaiting investment or distribution to 
remain uninvested and undistributed any longer than is reasonable for 
the proper management of the account and consistent with applicable 
law.
    (b) Self-deposits--(1) In general. Unless prohibited by applicable 
law, a national bank may deposit funds of a fiduciary account that are 
awaiting investment or distribution in the commercial, savings, or 
another department of the bank. To the extent that the funds are not 
insured by the Federal Deposit Insurance Corporation, the bank shall 
secure them by setting aside collateral, under the control of 
appropriate fiduciary officers and employees, in accordance with 
paragraph (b)(2) of this section. The market value of the collateral 
set aside must at all times equal or exceed the amount of the uninsured 
fiduciary funds.
    (2) Acceptable collateral. A national bank may satisfy the 
collateral requirement of paragraph (b)(1) of this section with any of 
the following:
    (i) Direct obligations of the United States, or other obligations 
fully guaranteed by the United States as to principal and interest;
    (ii) Readily marketable securities that qualify as investment 
securities pursuant to 12 CFR part 1;
    (iii) Readily marketable securities of the classes in which state 
banks, trust companies, or other corporations exercising fiduciary 
powers are permitted to invest fiduciary funds under state law; and
    (iv) Assets, including surety bonds, that qualify under applicable 
state law as appropriate security for deposits of fiduciary funds.
    (c) Affiliate deposits. If consistent with applicable law, a 
national bank may deposit funds of a fiduciary account that are 
awaiting investment or 

[[Page 66176]]
distribution with an affiliate insured depository institution. If 
consistent with applicable law, a national bank may secure a deposit by 
or with an affiliate of fiduciary funds awaiting investment or 
distribution.

Sec. 9.11  Investment of fiduciary funds.

    A national bank shall invest funds that it holds as fiduciary in a 
manner consistent with applicable law.

Sec. 9.12  Self-dealing and conflicts of interest.

    (a) Investments for fiduciary accounts--(1) In general. Unless 
consistent with applicable law, a national bank shall not invest 
fiduciary funds in the stock or obligations of, or in assets acquired 
from: the bank or any of its directors, officers, or employees; 
affiliates of the bank or any of their directors, officers, or 
employees; or individuals or organizations with whom there exists an 
interest that might affect the exercise of the best judgment of the 
bank.
    (2) Additional securities investments. If retention of stock or 
obligations of the bank or its affiliates is consistent with applicable 
law, the bank may:
    (i) Exercise rights to purchase additional stock (or securities 
convertible into additional stock) when offered pro rata to 
stockholders; and
    (ii) Purchase fractional shares to complement fractional shares 
acquired through the exercise of rights or the receipt of a stock 
dividend resulting in fractional share holdings.
    (b) Loans, sales, or other transfers from fiduciary accounts--(1) 
In general. A national bank shall not lend, sell, or otherwise transfer 
assets held in a fiduciary capacity to the bank or any of its 
directors, officers, or employees, or to affiliates of the bank or any 
of their directors, officers, or employees, or to individuals or 
organizations with whom there exists an interest that might affect the 
exercise of the best judgment of the bank, unless:
    (i) The transaction is consistent with applicable law;
    (ii) Legal counsel advises the bank in writing that the bank has 
incurred, in its fiduciary capacity, a contingent or potential 
liability, in which case the bank, upon the sale or transfer of assets, 
shall reimburse the fiduciary account in cash at the greater of book or 
market value of the assets;
    (iii) As provided in Sec. 9.18(b)(8)(iii) for defaulted fixed-
income investments; or
    (iv) Required in writing by the OCC.
    (2) Loans of funds held in trust. Notwithstanding paragraph (b)(1) 
of this section, a national bank shall not lend to any of its 
directors, officers, or employees any funds held in trust, except with 
respect to the bank's own employee benefit plans in accordance with 
section 408(b)(1) of the Employee Retirement Income Security Act of 
1974 (29 U.S.C. 1108(b)(1)).
    (c) Loans to fiduciary accounts. A national bank may make a loan to 
a fiduciary account and may hold a security interest in assets of the 
account if the transaction is fair to the account and is not prohibited 
by applicable law.
    (d) Sales between fiduciary accounts. A national bank may sell 
assets between any of its fiduciary accounts if the transaction is fair 
to both accounts and is not prohibited by applicable law.
    (e) Loans between fiduciary accounts. A national bank may make a 
loan between any of its fiduciary accounts if the transaction is 
authorized by the instrument creating the account from which the loan 
is made and is not prohibited by applicable law.

Sec. 9.13  Custody of fiduciary assets.

    (a) Control of fiduciary assets. A national bank shall place assets 
of fiduciary accounts in the joint custody or control of not fewer than 
two of the fiduciary officers or employees designated for that purpose 
by the board of directors. A national bank may maintain the investments 
of a fiduciary account off-premises, if the bank maintains adequate 
safeguards and controls.
    (b) Separation of fiduciary assets. A national bank shall keep the 
assets of fiduciary accounts separate from the assets of the bank. A 
national bank shall keep the assets of each fiduciary account separate 
from all other accounts or shall identify the investments as the 
property of a particular account, except as provided in Sec. 9.18.

Sec. 9.14  Deposit of securities with state authorities.

    (a) In general. If state law requires corporations acting in a 
fiduciary capacity to deposit securities with state authorities for the 
protection of private or court trusts, then before a national bank acts 
as a private or court-appointed trustee in that state, it shall make a 
similar deposit with state authorities. If the state authorities refuse 
to accept the deposit, the bank shall deposit the securities with the 
Federal Reserve Bank of the district in which the national bank is 
located, to be held for the protection of private or court trusts to 
the same extent as if the securities had been deposited with state 
authorities.
    (b) Assets held in more than one state. If a national bank 
administers trust assets in more than one state, the bank may compute 
the amount of deposit required for each state on the basis of trust 
assets that the bank administers from offices located in that state.

Sec. 9.15  Fiduciary compensation.

    (a) Compensation of bank. If the amount of a national bank's 
compensation for acting in a fiduciary capacity is not set or governed 
by applicable law, the bank may charge a reasonable fee for its 
services.
    (b) Compensation of co-fiduciary officers and employees. A national 
bank shall not permit any officer or employee to retain any 
compensation for acting as a co-fiduciary with the bank in the 
administration of a fiduciary account, except with the specific 
approval of the bank's board of directors.

Sec. 9.16  Receivership or voluntary liquidation of bank.

    If the OCC appoints a receiver for a national bank, or if a 
national bank places itself in voluntary liquidation, the receiver or 
liquidating agent shall promptly close all fiduciary accounts to the 
extent practicable, in accordance with OCC instructions and the orders 
of the court having jurisdiction. The receiver or liquidating agent 
shall transfer all remaining fiduciary accounts to substitute 
fiduciaries.

Sec. 9.17  Surrender or revocation of fiduciary powers.

    (a) Surrender. In accordance with 12 U.S.C. 92a(j), a national bank 
seeking to surrender its fiduciary powers shall file with the OCC a 
certified copy of the resolution of its board of directors evidencing 
that intent. If satisfied that the bank has been discharged from all 
fiduciary duties, the OCC will provide written notice that the bank is 
no longer authorized to exercise fiduciary powers.
    (b) Revocation. If the OCC determines that a national bank has 
unlawfully or unsoundly exercised, or has failed for a period of five 
consecutive years to exercise, its fiduciary powers, the Comptroller 
may, in accordance with the provisions of 12 U.S.C. 92a(k), revoke the 
bank's fiduciary powers.

Sec. 9.18  Collective investment funds.

    (a) In general. Where consistent with applicable law, a national 
bank may invest assets that it holds as fiduciary in the following 
collective investment funds:
    (1) A fund maintained by the bank, or by one or more affiliate 
banks,1 

[[Page 66177]]
exclusively for the collective investment and reinvestment of money 
contributed to the fund by the bank, or by one or more affiliate banks, 
in its capacity as trustee, executor, administrator, guardian, or 
custodian under a uniform gifts to minors act.

     1  A fund established pursuant to Sec. 9.18(a)(1) that 
includes moneys contributed by entities that are affiliates under 12 
U.S.C. 221a(b), but are not members of the same affiliated group, as 
defined at 26 U.S.C. 1504, may fail to qualify for tax-exempt status 
under the Internal Revenue Code. See 26 U.S.C. 584.
---------------------------------------------------------------------------

    (2) A fund consisting solely of assets of retirement, pension, 
profit sharing, stock bonus or other trusts that are exempt from 
Federal income taxation under the Internal Revenue Code.
    (i) A national bank may invest assets of retirement, pension, 
profit sharing, stock bonus or other trusts exempt from Federal income 
taxation and that the bank holds in its capacity as trustee in a 
collective investment fund established under paragraph (a)(1) or (a)(2) 
of this section.
    (ii) A national bank may invest assets of retirement, pension, 
profit sharing, stock bonus or other employee benefit trusts exempt 
from Federal income taxation and that the bank holds in any capacity 
(including agent), in a collective investment fund established under 
paragraph (a)(2) of this section if the fund itself qualifies for 
exemption from Federal income taxation.
    (b) Requirements. A national bank administering a collective 
investments fund authorized under paragraph (a) of this section shall 
comply with the following requirements:
    (1) Written plan. The bank shall establish and maintain each 
collective investment fund in accordance with a written plan approved 
by a resolution of the bank's board of directors or by a committee 
thereof (Plan). The bank shall make a copy of the Plan available for 
public inspection at its main office during all banking hours, and 
shall provide a copy of the Plan to any person who requests it. The 
Plan must contain appropriate provisions, not inconsistent with this 
part, regarding the manner in which the bank will operate the fund, 
including provisions relating to:
    (i) Investment powers and policies with respect to the fund;
    (ii) Allocation of income, profits, and losses;
    (iii) Fees and expenses that will be charged to the fund and to 
participating accounts;
    (iv) Terms and conditions governing the admission and withdrawal of 
participating accounts;
    (v) Audits of participating accounts;
    (vi) Basis and method of valuing assets in the fund;
    (vii) Expected frequency for income distribution to participating 
accounts;
    (viii) Minimum frequency for valuation of fund assets;
    (ix) Period following each valuation date during which the 
valuation must be made;
    (x) Bases upon which the bank may terminate the fund; and
    (xi) Any other matters necessary to define clearly the rights of 
participating accounts.
    (2) Fund management. A bank administering a collective investment 
fund shall have exclusive management thereof, except as a prudent 
person might delegate responsibilities to others.2

     2 If a fund, the assets of which consist solely of Individual 
Retirement Accounts, Keogh Accounts, or other employee benefit 
accounts that are exempt from taxation, is registered under the 
Investment Company Act of 1940 (15 U.S.C. 80a-1 et seq.), the fund 
will not be deemed in violation of paragraph (b)(2) of this section 
as a result of its compliance with section 10(c) of the Investment 
Company Act of 1940 (15 U.S.C. 80a-10(c)).
---------------------------------------------------------------------------

    (3) Proportionate interests. Each participating account in a 
collective investment fund must have a proportionate interest in all 
the fund's assets.
    (4) Valuation--(i) Frequency of valuation. A bank administering a 
collective investment fund shall determine the value of the fund's 
assets at least once every three months. However, in the case of a fund 
that is invested primarily in real estate or other assets that are not 
readily marketable, the bank shall determine the value of the fund's 
assets at least once each year.
    (ii) Method of valuation--(A) In general. Except as provided in 
paragraph (b)(4)(ii)(B) of this section, a bank shall value each fund 
asset at market value as of the date set for valuation, unless the bank 
cannot readily ascertain market value, in which case the bank shall use 
a fair value determined in good faith.
    (B) Short-term investment funds. A bank may value a fund's assets 
on a cost, rather than market value, basis for purposes of admissions 
and withdrawals, if the Plan requires the bank to:
    (1) Invest at least 80 percent of the fund's assets in bonds, 
notes, or other evidences of indebtedness that are payable on demand 
(including variable amount notes), or that have a maturity date not 
exceeding 91 days from the date of purchase;
    (2) Accrue on a straight-line basis the difference between the cost 
and anticipated principal receipt on maturity;
    (3) Hold the fund's assets until maturity under usual 
circumstances; and
    (4) Ensure that, after effecting admissions and withdrawals, at 
least 20 percent of the value of the remaining fund assets are cash, 
demand obligations, or assets that will mature on the fund's next 
business day.
    (5) Admission and withdrawal of accounts--(i) In general. A bank 
administering a collective investment fund shall admit an account to or 
withdraw an account from the fund only on the basis of the valuation 
described in paragraph (b)(4) of this section.
    (ii) Prior request or notice. A bank administering a collective 
investment fund may admit an account to or withdraw an account from a 
collective investment fund only if the bank has approved a request for 
or notice of intention of taking that action on or before the valuation 
date on which the admission or withdrawal is based. No requests or 
notices may be canceled or countermanded after the valuation date.
    (iii) Prior notice period for withdrawals from funds with assets 
not readily marketable. A bank administering a collective investment 
fund described in paragraph (a)(2) of this section that is invested 
primarily in real estate or other assets that are not readily 
marketable, may require a prior notice period, not to exceed one year, 
for withdrawals.
    (iv) Method of distributions. A bank administering a collective 
investment fund shall make distributions to accounts withdrawing from 
the fund in a manner consistent with applicable law.
    (v) Segregation of investments. If an investment is withdrawn in 
kind from a collective investment fund for the benefit of all 
participants in the fund at the time of the withdrawal but the 
investment is not distributed ratably in kind, the bank shall segregate 
and administer it for the benefit ratably of all participants in the 
collective investment fund at the time of withdrawal.
    (6) Audits and financial reports--(i) Annual audit. At least once 
during each 12-month period, a bank administering a collective 
investment fund shall arrange for an audit of the collective investment 
fund by auditors responsible only to the board of directors of the 
bank.3

     3 If a fund, the assets of which consist solely of Individual 
Retirement Accounts, Keogh Accounts, or other employee benefit 
accounts that are exempt from taxation, is registered under the 
Investment Company Act of 1940 (15 U.S.C. 80a-1 et seq.), the fund 
will not be deemed in violation of paragraph (b)(6)(i) of this 
section as a result of its compliance with section 10(c) of the 
Investment Company Act of 1940 (15 U.S.C. 80a-10(c)), if the bank 
has access to the audit reports of the fund.
---------------------------------------------------------------------------

    (ii) Financial report. At least once during each 12-month period, a 
bank administering a collective investment fund shall prepare a 
financial report of 

[[Page 66178]]
the fund based on the audit required by paragraph (b)(6)(i) of this 
section. The report must disclose fees and expenses charged to the 
fund. This report must contain a list of investments in the fund 
showing the cost and current market value of each investment, and a 
statement covering the period after the previous report showing the 
following (organized by type of investment):
    (A) Summaries of all purchases (with costs);
    (B) Summaries of all sales (with profit or loss and any other 
investment changes);
    (C) Income and disbursements; and
    (D) An appropriate notation as to any investments in default.
    (iii) Limitation on representations. A bank may include in the 
financial report a description of the fund's value on previous dates, 
as well as its income and disbursements during previous accounting 
periods. A bank shall not publish in the financial report any 
predictions or representations as to future results. In addition, with 
respect to funds described in paragraph (a)(1) of this section, a bank 
shall not publish the performance of funds other than those 
administered by the bank or its affiliates.
    (iv) Availability of the report. A bank administering a collective 
investment fund shall provide a copy of the financial report, or shall 
provide notice that a copy of the report is available upon request 
without charge, to each person who ordinarily would receive a regular 
periodic accounting with respect to each participating account. The 
bank may provide a copy of the financial report to prospective 
customers. In addition, the bank shall provide a copy of the report 
upon request to any person for a reasonable charge.
    (7) Advertising prohibition for common trust funds. A bank shall 
not advertise or publicize any fund authorized under paragraph (a)(1) 
of this section, except in connection with the advertisement of the 
general fiduciary services of the bank.
    (8) Self-dealing and conflicts of interest--(i) Bank interests. A 
bank administering a collective investment fund shall not have an 
interest in that fund other than in its fiduciary capacity. Except for 
temporary net cash overdrafts or as otherwise specifically provided in 
this paragraph, the bank shall not lend to, sell assets to, or purchase 
assets from a fund. The bank shall not invest fund assets in stock or 
obligations, including time or savings deposits, of the bank or any of 
its affiliates, except for funds awaiting investment or distribution. 
If, because of a creditor relationship or otherwise, the bank acquires 
an interest in a participating account, the participating account must 
be withdrawn on the next withdrawal date. However, a bank may invest 
assets that it holds as fiduciary for its own employees in a collective 
investment fund.
    (ii) Loans to participating accounts. A bank administering a 
collective investment fund shall not make any loan on the security of a 
participant's interest in the fund. An unsecured advance to a fiduciary 
account participating in the fund until the time of the next valuation 
date does not constitute the acquisition of an interest in a 
participating account by the bank.
    (iii) Purchase of defaulted fixed-income investments. A bank 
administering a collective investment fund may purchase for its own 
account any defaulted fixed-income investment held by the fund if, in 
the judgment of the bank, the cost of segregation of the investment is 
greater than the difference between its market value and its principal 
amount plus interest and penalty charges due. If the bank elects to 
purchase a defaulted fixed-income investment, it shall do so at the 
greater of market value or the sum of cost, accrued unpaid interest, 
and penalty charges.
    (9) Mortgage reserve account--(i) In general. A bank administering 
a collective investment fund may transfer to a reserve account up to 5 
percent of the net income derived by the fund from mortgages held by 
the fund during any regular accounting period. The amount held in the 
reserve account must not exceed 1 percent of the outstanding principal 
amount of all mortgages held in the fund. The bank shall deduct the 
amount of the reserve account from the fund's assets in determining the 
fair market value of the fund for the purposes of admissions and 
withdrawals.
    (ii) Charges against reserve account. At the end of each accounting 
period, the bank shall charge all interest payments that are due but 
unpaid with respect to mortgages in the fund against the reserve 
account to the extent available, and shall credit the payments to 
income distributed to participating accounts. In the event of 
subsequent recovery of the payments by the fund, the bank shall credit 
the reserve account with the amounts recovered.
    (10) Fees and expenses--(i) Fund management fees. A bank 
administering a collective investment fund may charge a fund management 
fee if the total fees charged to a participating account (including the 
fund management fee) does not exceed the total fees that the bank would 
have charged had it not invested assets of the account in the fund.
    (ii) Reasonable expenses. A bank administering a collective 
investment fund may charge reasonable expenses incurred in operating 
the collective investment fund, to the extent not prohibited by 
applicable law. However, a bank shall absorb the expenses of 
establishing or reorganizing a collective investment fund.
    (11) Prohibition against certificates. A bank administering a 
collective investment fund shall not issue any certificate or other 
document evidencing a direct or indirect interest in the fund.
    (12) Good faith mistakes. No mistake made in good faith and in the 
exercise of due care in connection with the administration of a 
collective investment fund will be deemed to be a violation of this 
part if, promptly after the discovery of the mistake, the bank takes 
whatever action is practicable under the circumstances to remedy the 
mistake.
    (c) Other collective investments. In addition to the collective 
investment funds authorized under paragraph (a) of this section, a 
national bank may invest assets that it holds as fiduciary, to the 
extent not prohibited by applicable law, as follows:
    (1) Bank fiduciary funds. In shares of a mutual trust investment 
company, organized and operated pursuant to a statute that specifically 
authorizes the organization of those companies exclusively for the 
investment of funds held by corporate fiduciaries.
    (2) Single loans or obligations. In the following loans or 
obligations, if the bank's only interest in the loans or obligations is 
its capacity as fiduciary:
    (i) A single real estate loan, a direct obligation of the United 
States, or an obligation fully guaranteed by the United States, or a 
single fixed amount security, obligation, or other property, either 
real, personal, or mixed, of a single issuer; or
    (ii) A variable amount note of a borrower of prime credit, if the 
bank uses the note solely for investment of funds held in its fiduciary 
accounts.
    (3) Mini-funds. In a fund maintained by the bank for the collective 
investment of cash balances received or held by a bank in its capacity 
as trustee, executor, administrator, or guardian, or custodian under a 
uniform gifts to minors act, that the bank considers to be too small to 
be invested separately to advantage. The total assets in the fund must 
not exceed $1,000,000, and the number of participating accounts must 
not exceed 100.
    (4) Trust funds of corporations and closely-related settlors. In 
any 

[[Page 66179]]
investment specifically authorized by the instrument creating the 
fiduciary account or a court order, in the case of trusts created by a 
corporation, including its affiliates and subsidiaries, or by several 
individual settlors who are closely related.
    (5) Special exemption funds. In any other manner described by the 
bank in a written plan approved by the OCC. The written plan is deemed 
approved by the OCC 30 days after it receives the plan, unless the OCC 
notifies the bank that the OCC has disapproved the plan or is extending 
review beyond the 30-day period because the proposal raises issues that 
require additional information or additional time for analysis. The 
written plan must set forth:
    (i) The reason that the proposed fund requires a special exemption;
    (ii) The provisions of the proposed fund that are inconsistent with 
paragraphs (a) and (b) of this section;
    (iii) The provisions of paragraph (b) of this section for which the 
bank seeks an exemption; and
    (iv) The manner in which the proposed fund addresses the rights and 
interests of participating accounts.

Sec. 9.20  Transfer agents.

    (a) The rules adopted by the Securities and Exchange Commission 
(SEC) pursuant section 17A of the Securities Exchange Act of 1934 (15 
U.S.C. 78q-1) prescribing procedures for registration of transfer 
agents for which the SEC is the appropriate regulatory agency (17 CFR 
240.17Ac2-1) apply to national bank transfer agents. References to the 
``Commission'' are deemed to refer to the ``OCC.''
    (b) The rules adopted by the SEC pursuant section 17A of the 
Securities Exchange Act of 1934 prescribing operational and reporting 
requirements for transfer agents (17 CFR 240.17Ac2-2, and 240.17Ad-1 
through 240.17Ad-16) apply to national bank transfer agents.

PART 19--RULES OF PRACTICE AND PROCEDURE

    2. The authority citation for part 19 is revised to read as 
follows:

    Authority: 5 U.S.C. 504, 554-557; 12 U.S.C. 93(b), 164, 505, 
1817, 1818, 1820, 1831o, 1972, 3102, 3108(a), and 3909; 15 U.S.C. 
78(h), 78(i), 78o-4(c), 78o-5, 78q-1, 78s, 78u, 78u-2, 78u-3, and 
78w; and 31 U.S.C. 330.

    3. A new Sec. 19.135 is added to subpart E to read as follows:

Sec. 19.135  Applications for stay or review of disciplinary actions 
imposed by registered clearing agencies.

    (a) Stays. The rules adopted by the Securities and Exchange 
Commission (SEC) pursuant to section 19 of the Securities Exchange Act 
of 1934 (15 U.S.C. 78s) regarding applications by persons for whom the 
SEC is the appropriate regulatory agency for stays of disciplinary 
sanctions or summary suspensions imposed by registered clearing 
agencies (17 CFR 240.19d-2) apply to applications by national banks. 
References to the ``Commission'' are deemed to refer to the ``OCC.''
    (b) Reviews. The regulations adopted by the SEC pursuant to section 
19 of the Securities Exchange Act of 1934 (15 U.S.C. 78s) regarding 
applications by persons for whom the SEC is the appropriate regulatory 
agency for reviews of final disciplinary sanctions, denials of 
participation, or prohibitions or limitations of access to services 
imposed by registered clearing agencies (17 CFR 240.19d-3(a)-(f)) apply 
to applications by national banks. References to the ``Commission'' are 
deemed to refer to the ``OCC.''

    Dated: December 11, 1995.
Eugene A. Ludwig,
Comptroller of the Currency.
[FR Doc. 95-30971 Filed 12-20-95; 8:45 am]
BILLING CODE 4810-33-P

Complete official Federal Register PDF

FR Doc. 95-30969 Investment Securities
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Pages 66152-66163]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-30969]

      
========================================================================
Proposed Rules
                                                Federal Register
________________________________________________________________________

This section of the FEDERAL REGISTER contains notices to the public of 
the proposed issuance of rules and regulations. The purpose of these 
notices is to give interested persons an opportunity to participate in 
the rule making prior to the adoption of the final rules.

========================================================================

Federal Register / Vol. 60, No. 245 / Thursday, December 21, 1995 / 
Proposed Rules

[[Page 66152]]

DEPARTMENT OF THE TREASURY

Office of the Comptroller of the Currency

12 CFR Parts 1 and 7

[Docket No. 95-34]
RIN 1557-AB37

Investment Securities

AGENCY: Office of the Comptroller of the Currency, Treasury.

ACTION: Notice of proposed rulemaking.

-----------------------------------------------------------------------

SUMMARY: The Office of the Comptroller of the Currency (OCC) is 
proposing to clarify and update its rules that prescribe the standards 
under which national banks may purchase, sell, deal in, and underwrite 
securities. This proposal is part of the OCC's Regulation Review 
Program, a project designed to review comprehensively, modernize and 
simplify OCC regulations and reduce unnecessary regulatory burdens. The 
proposed revisions reorganize the regulation by placing related 
subjects together, clarify areas where the rules are unclear and 
confusing, and update various provisions to address market developments 
and to incorporate significant OCC interpretations, judicial decisions 
and statutory amendments.

DATES: Comments must be received by February 20, 1996.

ADDRESSES: Comments should be directed to: Communications Division, 250 
E Street, SW., Washington, DC 20219, Attention: Docket No. 95-34. 
Comments will be available for public inspection and photocopying at 
the same location. In addition, comments may be sent by facsimile 
transmission to FAX number 202/874-5274 or by electronic mail to 
[email protected]

FOR FURTHER INFORMATION CONTACT: Kay Bondehagen, Special Assistant to 
the Deputy Chief Counsel (202) 874-5200; Stuart Feldstein, Senior 
Attorney, Legislative and Regulatory Activities Division (202) 874-
5090; Lee Walzer, Senior Attorney, Securities and Corporate Practices 
Division, (202) 874-5210; Lisa Lintecum, Director, Fiduciary 
Activities, (202) 874-5419.

SUPPLEMENTARY INFORMATION:

Background

OCC Regulation Review Program

    The OCC is proposing to revise 12 CFR part 1 pursuant to its 
Regulation Review Program. Pursuant to this Program, the OCC is 
reviewing all its rules. Rules that are not necessary to protect 
against unacceptable risks, that do not support equitable access to 
banking services for all consumers or that are not needed to accomplish 
other statutory responsibilities of the OCC will be revised or 
eliminated.
    Where risks are meaningful and regulation is appropriate, rules 
will be examined to determine if they achieve their purpose at the 
least possible cost. The OCC also recognizes that one source of 
regulatory cost is the failure of regulations to provide clear guidance 
because they are difficult to follow and understand. Therefore, an 
important component of the Regulation Review Program is to revise 
regulations, where appropriate, to improve clarity and better 
communicate the standards that the rules are intended to convey.

Investment Securities Limitations

    Most of the limitations on the ability of national banks to 
purchase, sell, deal in, and underwrite securities trace to the Banking 
Act of 1933, Section 16, Public Law 73-66, 48 Stat. 184 (codified as 
amended at 12 U.S.C. 24 (Seventh) (1933)). More recently, the Secondary 
Mortgage Market Enhancement Act of 1984 (SMMEA) 1 and the Riegle 
Community Development and Regulatory Improvement Act of 1994 (RCDRI 
Act) 2 removed quantitative limits on national banks' purchases of 
certain types of mortgage- and small business-related securities, 
subject to any regulations prescribed by the OCC.

    \1\ Sec. 105(c), Pub. L. 98-440, Title I, 98 Stat. 1691 
(codified as amended at 12 U.S.C. 24 (Seventh) (1984)).
    \2\ Pub. L. 103-325, 108 Stat. 2160 (1994).
---------------------------------------------------------------------------

    Although the OCC has revised part 1 a number of times since the 
early 1960s, the current version still contains many provisions dating 
from 1963. See 28 FR 9916 (1963). The OCC revised part 1 in 1971, 
adding the distinctions among ``Type I security,'' ``Type II security'' 
and ``Type III security.'' See 36 FR 6737 (1971). Guidelines were added 
to the part in 1982. See 47 FR 5701 (1982). The OCC revised part 1 
again in 1989 principally to reflect amendments to 12 U.S.C. 24 
(Seventh) by adding obligations of the African Development Bank and 
Inter-American Investment Corporation to the description of Type II 
securities. See 54 FR 1333 (1989). To reduce regulatory burden, the OCC 
also amended part 1 in 1993 to eliminate a requirement that a national 
bank maintain certain information for a specified period of time to 
demonstrate prudence in making determinations and carrying out 
securities transactions. See 58 FR 27443 (1993). The OCC tended to 
graft these changes onto the previous regulatory framework, resulting 
in a sometimes confusing combination of definitions and restrictions.
    The OCC did not amend part 1 to reflect the statutory change 
resulting from the enactment of SMMEA in 1984. Nor have changes been 
made to the rule to reflect significant judicial decisions and 
interpretations of the OCC.

Proposal

    This proposal modernizes the rules in part 1 and furthers the goals 
of the OCC's Regulation Review Program. In order to make part 1 more 
accessible and comprehensive, the proposal restructures many sections 
of the rule. The proposal also updates the rule to incorporate 
statutory changes to 12 U.S.C. 24 (Seventh), judicial decisions and 
long-standing OCC interpretations. The following discussion identifies 
and explains the significant proposed changes. The OCC requests 
comments on all aspects of this proposal, and, in addition, requests 
specific comments on certain changes that are highlighted. The OCC also 
welcomes any additional comments relevant to this proposal. A table 
summarizing the areas where changes are proposed is set forth at the 
end of this preamble.

Authority, purpose, and scope (section 1.1)

    The proposal consolidates the current ``Scope and application'' 
section (Sec. 1.2) with the ``Authority'' section (Sec. 1.1). The 
sections are substantially condensed to eliminate redundant and 
unnecessary language.
    The limitations set forth in part 1 apply to national banks, 
Federal branches of foreign banks, District of 

[[Page 66153]]
Columbia banks and state banks that are members of the Federal Reserve 
System.3 This section further clarifies that foreign branches of 
national banks may be authorized to conduct additional international 
activities pursuant to 12 CFR part 211.

    \3\ State banks that are members of the Federal Reserve System 
are subject to the same limitations and conditions with respect to 
the purchasing, selling, underwriting and holding of investment 
securities and stock applicable to national banks under 12 U.S.C. 24 
(Seventh). 12 U.S.C. 335.
---------------------------------------------------------------------------

Definitions (section 1.2)

    The proposal substantially revises the definitions section to add 
several definitions, updates others, and brings the definitions that 
currently appear in various places in the regulation into a single 
section. The following definitions have been added: ``investment 
company,'' ``Type IV security,'' and ``Type V security.'' The 
definitions of Type I, II, and III securities also have been 
substantially revised so that these types of securities are defined by 
their characteristics, not by the statutory limitations on the extent 
to which national banks may deal in, underwrite, purchase, or sell 
them. No substantive change in the authority of a national bank results 
from these revisions. In addition, as indicated with various individual 
definitions below, many definitions are revised to clarify their 
meaning and to incorporate the results of statutory changes, judicial 
decisions, and established OCC interpretations. Of particular note are 
the following proposed revisions:

Capital and surplus (section 1.2(a))

    The proposal defines ``capital and surplus'' as Tier 1 and Tier 2 
capital includable in risk-based capital under the Minimum Capital 
Ratios in 12 CFR part 3, plus the balance of a bank's allowance for 
loan and lease losses that is not included in Tier 2 capital. This is 
the same standard used in the OCC's recent revisions to its lending 
limit regulation. See 60 FR 8526 (February 15, 1995). As stated in the 
Preamble to the new lending limit rule, 60 FR 8528, the OCC's reasons 
for revising the definition of ``capital and surplus'' are to reduce 
the different definitions of capital currently used for various 
regulatory purposes and to use a well-recognized standard that banks 
are already required to calculate.

Investment grade (section 1.2(d))

    ``Investment grade'' means that a security is rated in one of the 
top four rating categories by each nationally recognized statistical 
rating organization that has rated the security. For example, if two 
nationally recognized statistical rating organizations rate the 
security in one of their top four categories, the security would 
qualify as ``investment grade'' even if other nationally recognized 
statistical rating organizations had not rated the security. However, 
if one of the two organizations rating the security did not rate the 
security in one of the top four categories, the security would not 
qualify as ``investment grade.'' Thus, when a security is given 
different ratings by different nationally recognized rating 
organizations, the lowest rating governs for purposes of this 
definition.

Investment security (section 1.2(e))

    To be an ``investment security'' under the proposed definition, a 
security must be an investment grade marketable debt obligation or, if 
the security is not rated, it must be the credit equivalent of an 
investment grade marketable debt obligation. These standards reflect 
current OCC guidance and practice.
    The OCC requests comments on whether the regulation should describe 
more specifically the characteristics of securities that are the 
``credit equivalent of investment grade'' securities, and, if so, what 
description would be appropriate.
    Commenters also are requested to address whether other securities 
with characteristics functionally equivalent to a debt obligation might 
be classified as an ``investment security.''

Marketable (section 1.2(f))

    This proposed definition attempts to rely on more objective 
standards than the current definition of ``marketable.'' Currently, a 
marketable security is defined in Sec. 1.5(a) as one that ``may be sold 
with reasonable promptness at a price which corresponds reasonably to 
its fair value.'' The proposed definition places more emphasis on 
indicators of a ready market for a security rather than a prediction of 
whether the security can be sold quickly at a particular price. As 
proposed, marketable securities include: (1) Securities registered 
under the Securities Act of 1933 (the Securities Act), 15 U.S.C. 77a et 
seq.; (2) certain government securities and municipal revenue bonds not 
required to be registered under the Securities Act; and (3) investment 
grade securities sold pursuant to SEC Rule 144A, 17 CFR 230.144A.
    SEC Rule 144A provides a ``safe harbor'' exemption from the 
registration requirements of the Securities Act for resales of 
privately offered or ``restricted'' securities to qualified 
institutional buyers. The rationale for treating securities that 
qualify under SEC Rule 144A as readily marketable is that they may be 
sold without the need to prepare and receive SEC clearance of a 
registration statement used in connection with the sale. There may be a 
situation, however, based upon the particular security, when the 
security is not necessarily immediately sellable.
    The OCC requests comments regarding whether this definition of 
``marketable'' is sufficiently inclusive, particularly regarding other 
exemptions under the Securities Act, such as the statutory nonpublic 
offering exemption, that enable a seller to sell a security promptly at 
market or fair value, and whether the definition is appropriately 
inclusive of foreign sovereign debt.
    The OCC also welcomes comments regarding alternative definitions of 
``marketable'' that would address the OCC's concerns about liquidity. 
Commenters may suggest adopting a more general standard, or retaining 
the current standard whereby a security sold with reasonable promptness 
for a price that reasonably corresponds to its fair value is 
marketable. Commenters are asked to address how the OCC might 
objectively measure such a standard.

Type I security (section 1.2(h))

    As in the current rule, the proposal defines a ``Type I'' security 
to mean specified government securities. The proposal also incorporates 
into the definition the key elements of the interpretation now found in 
Sec. 1.110 regarding securities backed by the full faith and credit of 
the U.S. Government. The proposed definition is consistent with 12 
U.S.C. 24 (Seventh), which does not require that government securities 
be ``marketable'' or otherwise qualify as ``investment securities.''

Type II security (section 1.2(i))

    The proposal redefines a ``Type II'' security to mean an investment 
security that is issued by certain state, international or multilateral 
organizations, or that is otherwise listed or described in the statute. 
The definition differs from the current rule, which describes a Type II 
security both by the investment limits that apply to it, and by 
examples of qualifying types of issuers. The proposed definition also 
includes the statutory requirement that this type of security must 
qualify as an ``investment security,'' in addition to being issued by a 
qualifying type of issuer.

Type III security (section 1.2(j))

    Part 1 currently defines a ``Type III'' security to mean a security 
that ``a bank may purchase and sell for its own 

[[Page 66154]]
account, subject to a 10 percent limitation, but may neither deal in 
nor underwrite.'' Sec. 1.3(e). Instead of defining a Type III security 
in this manner, the proposal redefines a Type III security as an 
investment security that does not qualify as a Type I, II, IV, or V 
security. Examples of Type III securities include corporate bonds and 
municipal revenue bonds.
    Commenters are asked to address whether other examples of Type III 
securities also should be specifically referenced in the regulation. In 
particular, commenters are asked to address whether foreign securities 
that are currently eligible for investment by foreign branches of U.S. 
banks should be included as Type III securities.

Type IV security (section 1.2(k))

    The substance of a ``Type IV'' security was established, although 
not named ``Type IV,'' by amendments made to 12 U.S.C. 24 (Seventh) in 
1984 by SMMEA and in 1994 by the RCDRI Act. The proposed definition 
tracks the statutory changes. SMMEA amended 12 U.S.C. 24 (Seventh) to 
permit national banks to purchase without limitation certain 
residential and commercial mortgage-related securities offered and sold 
pursuant to section 4(5) of the Securities Act, 15 U.S.C. 77d(5), or 
residential mortgage-related securities as defined in section 3(a)(41) 
of the Securities Exchange Act of 1934 (the Exchange Act), 15 U.S.C. 
78c(a)(41). As previously noted, part 1 was never amended to 
incorporate this 1984 statutory revision. The RCDRI Act defined a new 
type of small business-related security in section 3(a)(53)(A) of the 
Exchange Act, 15 U.S.C. 78c(a)(53)(A), and added a class of commercial 
mortgage-related securities to section 3(a)(41) of the Exchange Act, 15 
U.S.C. 78c(a)(41).
    The amendments to 12 U.S.C. 24 (Seventh) made by the RCDRI Act 
removed limitations on purchases by national banks of certain small 
business-related and commercial mortgage-related securities. The 
amendments provide the OCC authority to prescribe regulations to ensure 
that acquisitions of such securities are conducted in a manner 
consistent with safe and sound banking practices. The OCC has concerns 
that undue concentration of risk could arise if a bank invested in a 
security backed by a small number of loans or where one or a small 
number of loans represented a large percentage of the assets in the 
pool. This type of concentration of risk is more likely to arise with 
respect to commercial mortgage- and small business-related securities 
than with respect to residential mortgage-related securities. For this 
reason, the proposal requires a Type IV security that is small 
business- or commercial mortgage-related be fully secured by interests 
in a pool of homogeneous loans of numerous obligors. The definitions of 
a Type IV small business-related security and a commercial mortgage-
related security also require that the aggregate amount of collateral 
from loans of any one obligor not exceed 5 percent of the total amount 
of collateral for the security when the security is issued, in order to 
assure diversification.
    In some instances, such as the prepayment of underlying loans, an 
issuer or trustee may have the legal right to substitute collateral. If 
the issuer or trustee has the legal right to substitute collateral, the 
diversification requirement applies whenever the issuer or trustee 
substitutes collateral throughout the term of an issue, rather than 
merely at issuance.
    Where the issuer or trustee does not have the legal right to 
substitute collateral or elects not to exercise the right, the 
diversification requirement applies only at issuance. If the 
diversification requirement applied throughout the term of an issue 
without ongoing substitution of collateral, prepayment of loans in the 
pool would reduce the number of loans that serve as collateral for the 
security and, at some point, the aggregate amount of collateral from 
loans of one obligor could exceed the proposed 5 percent limit and 
result in a violation of the regulation. Such a result would have the 
unintended consequence of deterring potential issuers from securitizing 
existing collateral.
    The OCC requests comments on whether the term ``homogeneous loans'' 
should be specifically defined. The OCC also welcomes comments on 
whether the proposed requirement for certain Type IV and all Type V 
securities, that the aggregate amount of collateral from loans of any 
one obligor may not exceed 5 percent of the total amount of collateral 
for that security, or some other standard, would be appropriate to 
assure adequate diversification of the collateral.

Type V security (Section 1.2(l))

    The proposal adds a definition of ``Type V security'' in order to 
address separately investment grade securities that represent interests 
in assets a national bank may invest in directly. The definition 
reflects the OCC's long-standing interpretations that in addition to 
the investments specifically described in 12 U.S.C. 24 (Seventh), 
national banks may hold securitized forms of assets in which they may 
invest directly.4 In order to assure the high quality of this type 
of asset-backed security, however, the definition requires that Type V 
securities be rated investment grade. The practical effect of the 
definition is that Type V securities are recognized as high quality 
indirect interests in assets in which a national bank could invest 
directly.

    \4\ Interpretive Letter No. 362 (May 22, 1986), reprinted in 
[1985-1987 Transfer Binder] Fed. Banking L. Rep. (CCH) para. 85,532 
(bonds collateralized by mortgages); Interpretive Letter No. 388 
(June 16, 1987), reprinted in [1988-1989 Transfer Binder] Fed. 
Banking L. Rep. (CCH) para. 85,612 (mortgage-backed pass-through 
certificates); Interpretive Letter No. 416 (February 16, 1988), 
reprinted in [1988-1989 Transfer Binder] Fed. Banking L. Rep. (CCH) 
para. 85,640 (securitized automobile loans); Investment Securities 
Letter No. 29 (August 3, 1988), reprinted in [1988-1989 Transfer 
Binder] Fed. Banking L. Rep. (CCH) para. 85,899 (investment limits 
for asset-backed securities consisting of GMAC receivables); 
Interpretive Letter No. 514 (May 5, 1990), reprinted in [1990-1991 
Transfer Binder] Fed. Banking L. Rep. (CCH) para. 83,218 
(securitized mortgages); Interpretive Letter No. 540 (December 12, 
1990), reprinted in [1990-1991 Transfer Binder] Fed. Banking L. Rep. 
(CCH) para. 83,252 (securitized credit card receivables); Security 
Pacific v. Clarke, 885 F.2d 1034 (2d Cir. 1989), cert. denied, 493 
U.S. 1070 (1990) (national bank authority to securitize assets).
---------------------------------------------------------------------------

    A Type V security also must be fully secured by interests in a pool 
of homogeneous loans to numerous obligors. The definition requires a 
pool of loans homogeneous as to type of loan, term of loan, or other 
distinguishing characteristics, in order to facilitate performance 
projections based on the common features of loans in the pool. As an 
added safeguard to assure diversification of the collateral supporting 
the security, the definition requires that the aggregate amount of 
collateral from loans of any one obligor not exceed 5 percent of the 
total amount of collateral for the security. Like the similar 
requirement for Type IV securities, this diversification requirement 
applies throughout the term of the issue only if the issuer exercises a 
legal right to substitute collateral.
    Commenters are invited to address whether these standards, which 
also apply to certain Type IV securities, are appropriate.

Limitations on dealing in, underwriting, and purchasing and selling 
securities (Section 1.3)

    The proposal consolidates into one section the provisions regarding 
limitations on dealing in, underwriting, purchasing, and selling 
different types of securities. Proposed Sec. 1.3 incorporates portions 
of current Secs. 1.4, ``Type I securities; standards for authorized 
transactions;'' 1.5(b), ``Judgment based predominantly upon 

[[Page 66155]]
reliable estimates;'' 1.6, ``Type II securities; authority to deal in 
and underwrite;'' and 1.7, ``Types II and III securities; limitations 
on holdings.'' Current Sec. 1.7(c), ``Limitations prescribed in 
eligibility rulings,'' has been removed as unnecessary. Current 
references to ``prudent banking judgment'' have been changed to ``safe 
and sound banking practices.'' The latter change is consistent with the 
OCC's implementation of this requirement and is not intended to change 
the applicable standard. Most of the limitations on Type I, II, III, 
and IV securities reflected in this section are derived from 12 U.S.C. 
24 (Seventh).
    In the proposal, the limitations with respect to Types II, III, and 
V securities are expressed in terms of ``the aggregate par value of the 
obligations of any one obligor,'' which is essentially the current 
approach. The OCC requests comments on whether this is an appropriate 
measure and, if not, whether alternative measures would be preferable.

Type II and III securities; other investment securities limitations 
(Section 1.3(d))

    As in current Sec. 1.7, the proposal provides that a national bank 
may not hold Type II and III securities of any one obligor that have a 
combined aggregate par value exceeding 10 percent of the bank's capital 
and surplus. However, aggregation is not required with respect to 
industrial development bonds. Instead, the 10 percent limitation 
applies separately to each security issue of a single obligor when the 
proceeds of that issuance are to be used to acquire and lease real 
estate and related facilities to economically and legally separate 
industrial tenants, and the issuance is payable solely from and secured 
by a first lien on the revenues to be derived from rentals paid by the 
lessee under net noncancellable leases. This provision incorporates the 
substance of the interpretation that currently appears at 12 CFR 
7.7570. The OCC proposes to remove Sec. 7.7570 in conjunction with this 
change.

Type IV securities (Section 1.3.(e))

    The new section describing eligible Type IV securities confirms the 
authority granted to national banks by SMMEA and the RCDRI Act to 
purchase and sell certain mortgage- and small business-related 
securities. The section also reflects OCC interpretations concerning 
the authority of a national bank to deal in obligations that are fully 
secured by Type I securities, in which national banks may deal.5 
These interpretations reflect the OCC's consistent approach of looking 
to the substance of an instrument, and not just its form, to determine 
the activities a bank may conduct in connection with the instrument. In 
the case of Type IV securities that are fully secured by Type I 
securities, the ultimate source of repayment is Type I securities. The 
proposal does not limit the categories of Type IV securities in which 
banks may deal, provided that the securities are collateralized by Type 
I securities. Thus, a bank's authority to deal in the securities under 
this part would be determined with reference to the standards that 
apply to Type I securities. (The ability of a bank to securitize and 
sell its loans, including loans that qualify as collateral for Type IV 
securities, is addressed in Sec. 1.3(g).)

    \5\ See Interpretive Letter No. 514 (May 5, 1990), reprinted in 
[1990-1991 Transfer Binder] Fed. Banking L. Rep. (CCH) para. 83,218; 
Interpretive Letter No. 362 (May 22, 1986), reprinted in [1985-1987 
Transfer Binder] Fed. Banking L. Rep. (CCH) para. 85,532.
---------------------------------------------------------------------------

Type V securities (Section 1.3(f))

    The proposal establishes a quantitative concentration limitation of 
15 percent of a bank's capital and surplus for purchases and sales of 
Type V securities of any one obligor (or certain related obligors), 
rather than the 10 percent limit that the OCC currently applies to 
asset-backed securities that qualify as Type III securities. The OCC 
believes this approach is appropriate because: (1) The 15 percent 
standard is the same level used for the basic lending limit threshold; 
(2) the qualitative standards for a Type V security have been 
tightened, so that Type V securities are a high quality type of asset-
backed security; and (3) under certain circumstances set forth in 
Sec. 1.4(c), holdings of Type V securities of different issuers will be 
aggregated for purposes of calculating compliance with the 15 percent 
limitation. Therefore, the OCC believes an investment limitation of 15 
percent of a bank's capital and surplus should not present undue 
investment or concentration risk.
    The OCC solicits comments on whether a higher investment 
limitation, such as 25 percent of a bank's capital and surplus, would 
be sufficient to prevent excessive concentration.

Asset securitization (Section 1.3(g))

    This new section reflects the OCC's established position that 
national banks may securitize and sell their loan assets. The ability 
of banks to sell conventional bank assets through the issuance and sale 
of certificates evidencing interests in pools of the assets provides 
flexibility that can enhance banks' safety and soundness.6 Asset 
securitization provides an important source of liquidity by allowing 
banks to convert relatively illiquid assets into instruments with 
maturities and other features that investors are readily willing to 
purchase. Another important benefit is the increased credit available, 
due to the fact that a bank may make more loans with a given level of 
capital (when the assets are removed from the bank's balance sheet) and 
may diversify its lending into new markets without incurring undue 
risk. Also, a bank is less dependent on deposits to fund its loans, 
improving bank profitability, with positive implications for reducing 
bank failure rates and minimizing draws on the deposit insurance funds. 
The treatment described in the proposal reflects the OCC's long-
standing treatment of national banks' asset sales activities as 
affirmed by case law.7

     6  See, e.g., Remarks by Alan Greenspan, Chairman, Board of 
Governors of the Federal Reserve System before the American Bankers 
Association (October 8, 1994). See also Statement by Donald G. 
Coonley, Chief National Bank Examiner, OCC, Asset Securitization and 
Secondary Markets: Hearings Before the Subcomm. on Policy, Research, 
and Insurance of the Comm. on Banking, Finance and Urban Affairs, 
102d Cong., 1st Sess. 2-4 (1991), reprinted in OCC Quarterly Journal 
(December 1991); and Joint Statement by Richard Spillenkothen, 
Director, Division of Banking Supervision and Regulation, Board of 
Governors of the Federal Reserve System, and Donald H. Wilson, 
Financial Markets Officer, Federal Reserve Bank of Chicago, 
Secondary Market for Commercial Real Estate Loans: Hearings Before 
the Subcomm. on Policy, Research, and Insurance of the Comm. on 
Banking, Finance and Urban Affairs, 102d Cong., 2d Sess. 16-19 
(1992), reprinted in 78 Fed. Res. Bull. 492 (1992).
     7  See, e.g., Interpretive Letter No. 585 (June 8, 1992), 
reprinted in [1992-1993 Transfer Binder] Fed. Banking L. Rep. (CCH) 
para. 83,406 (securitized motor vehicle retail installment sales 
contracts purchased from automobile dealers); Interpretive Letter 
No. 540 (December 12, 1990), reprinted in [1990-1991 Transfer 
Binder] Fed. Banking L. Rep. (CCH) para. 83,252 (securitized credit 
card receivables originated by bank or purchased from others); 
Interpretive Letter No. 514 (May 5, 1990), reprinted in [1990-1991 
Transfer Binder] Fed. Banking L. Rep. (CCH) para. 83,218 
(securitized mortgages); Interpretive Letter No. 416 (February 16, 
1988), reprinted in [1988-1989 Transfer Binder] Fed. Banking L. Rep. 
(CCH) para. 85,640 (securitized automobile loans); Interpretive 
Letter No. 388 (June 16, 1987), reprinted in [1988-1989 Transfer 
Binder] Fed. Banking L. Rep. (CCH) para. 85,612 (sale of mortgage-
backed pass-through certificates); No Objection Letter No. 87-9 
(December 16, 1987), reprinted in [1988-1989 Transfer Binder] Fed. 
Banking L. Rep. (CCH) para. 84,038(securitization of commercial 
loans originated by the bank); Interpretive Letter No. 362 (May 22, 
1986), reprinted in [1985-1987 Transfer Binder] Fed. Banking L. Rep. 
(CCH) para. 85,532 (sales of bonds collateralized by mortgages). 
Regarding sales of participations in pools of loans, see Letter from 
Billy C. Wood, Deputy Comptroller, Multinational Banking (May 29, 
1981), reprinted in [1981-82 Transfer Binder] Fed. Banking L. Rep. 
(CCH) para. 85,275; Letter from Paul M. Homan, Senior Deputy 
Comptroller for Bank Supervision (February 1, 1980), reprinted in 
[1981-82 Transfer Binder] Fed. Banking L. Rep. (CCH) para. 85,213; 
Letter from John M. Miller, Deputy Chief Counsel (July 31, 1979), 
reprinted in [1978-79 Transfer Binder] Fed. Banking L. Rep. (CCH) 
para. 85,182; Letter from Paul M. Homan, Senior Deputy Comptroller 
for Bank Supervision (April 20, 1979), reprinted in [1978-79 
Transfer Binder] Fed. Banking L. Rep. (CCH) para. 85,167; Letter 
from H. Joe Selby, Deputy Comptroller for Operations (October 17, 
1978), reprinted in [1978-79 Transfer Binder] Fed. Banking L. Rep. 
(CCH) para. 85,144; Letter from John G. Heimann, Comptroller of the 
Currency (May 18, 1978), reprinted in [1978-79 Transfer Binder] Fed. 
Banking L. Rep. (CCH) para. 85,116; Letter from Charles B. Hall, 
Deputy Comptroller for Banking Operations (February 14, 1978), 
reprinted in [1978-79 Transfer Binder] Fed. Banking L. Rep. (CCH) 
para. 85,100; Letter from Robert Bloom, Acting Comptroller of the 
Currency (March 30, 1977), reprinted in [1973-78 Transfer Binder] 
Fed. Banking L. Rep. (CCH) para. 97,093. Regarding national bank 
authority to securitize assets, see Security Pacific v. Clarke, 885 
F.2d 1034 (2d Cir. 1989), cert. denied, 493 U.S. 1070 (1990). 

[[Page 66156]]

---------------------------------------------------------------------------

Investment company shares (Section 1.3(h))

    The proposal permits a national bank to purchase and sell for its 
own account shares of a registered investment company, subject to two 
requirements: First, the investment company's portfolio must be 
comprised entirely of assets in which the bank could invest directly. 
Second, the amount of the bank's investment in shares of any one 
investment company is subject to the most stringent investment 
limitations applicable to the underlying securities and loans that 
comprise that investment company's portfolio. This provision 
incorporates OCC interpretations concerning the authority of a national 
bank to hold instruments representing indirect interests in assets that 
the bank could invest in directly. See Banking Circular 220 (November 
21, 1986); An Examiner's Guide to Investment Products and Practices at 
23 (December 1992).8

     8  The Federal Reserve Board has adopted a similar 
interpretation relating to state member banks' investments in mutual 
funds that invest only in eligible securities. See 12 CFR 208.124.
---------------------------------------------------------------------------

    The OCC seeks comments on whether the definition of ``investment 
company'' should be revised to include limited partnerships with 
fewer than 100 investors, i.e., a partnership that would not qualify 
as an investment company within the meaning of section 3(c)(1) of 
the Investment Company Act of 1940, 15 U.S.C. 80a-3(c)(1), provided 
that the partnerships' portfolios consist solely of Type I 
securities that the bank may purchase and sell for its own account.

Securities held based on estimates of obligor's performance (Section 
1.3(i))

    Notwithstanding the general definition of an investment security 
(Sec. 1.2(e)), the proposal retains the flexibility contained in the 
current rule, for a bank to treat certain debt securities as investment 
securities when the bank concludes, on the basis of estimates that the 
bank reasonably believes are reliable, that the obligor will be able to 
meet its obligations under that security. The bank may not hold 
securities classified as investment securities solely in reliance on 
projections of an obligor's future performance that in the aggregate 
exceed 5 percent of the bank's capital and surplus. The bank must also 
believe that the security may be sold with reasonable promptness at a 
price which corresponds reasonably to its fair value. This approach is 
modeled upon the OCC's current rule, which allows banks an additional 
degree of flexibility to determine the quality of debt obligations, for 
a limited portion of the bank's investment portfolio. The OCC notes 
that securities representing interests in loans made for community 
development purposes are one type of security that could, depending 
upon their characteristics, be eligible for investment by national 
banks under this standard.
    The OCC requests comments as to whether it should provide further 
clarification of the standards applicable to securities held based on 
estimates of obligor's performance and, if so, in what respects 
clarification is needed.

Calculation of limits (Section1.4)

    Proposed Sec. 1.4 is new. Paragraphs (a) and (b), relating to the 
calculation date and authority to require more frequent calculations, 
are modeled on provisions contained in the OCC's new lending limit 
regulation. As explained in connection with the lending limit rule, the 
provision reduces regulatory burden by allowing banks to rely on 
information they already collect for their Call Reports to calculate 
compliance with their lending limits. The same reasoning applies to 
calculating limits of banks' securities holdings, and the proposal 
achieves a consistent approach in those two areas.

Calculation of Type III and Type V securities holdings (Section 1.4(c))

    This proposed paragraph is a new approach to investment securities 
limitations designed to address situations where a bank's investments 
in securities of different issuers present similar sources of risk, 
and, therefore, warrant aggregation. In calculating the amount of its 
investment in Type III or Type V securities, the proposal requires a 
bank to combine obligations of issuers that are related directly or 
indirectly through common control and securities that are credit-
enhanced by the same entity. These aggregation rules, which result in a 
bank being treated as if it has a greater investment in the securities 
of one obligor than would otherwise be the case, apply separately to 
Type III and Type V securities held by a bank. Current OCC policies 
already apply comparable standards for aggregation of Type III 
securities. As applied to Type V securities, the aggregation rules 
provide important safeguards in connection with the 15 percent limit 
provided for investments in Type V securities. Thus, banks are given 
more investment flexibility with Type V securities, but the increased 
investment authority is subject to explicit safeguards to address risk 
concentrations.
    Comment is invited regarding other bases upon which a bank should 
combine its holdings when calculating its investment in Type III or 
Type V securities of any one obligor. Specifically, the OCC seeks 
comments as to whether a bank should combine obligations that are 
predominately collateralized by loans made by the same originator or by 
originators that are related directly or indirectly through common 
control. In addition, commenters are asked to address whether and under 
what circumstances an issuer or affiliate of the issuer would provide a 
guarantee or other form of credit enhancement for Type V securities 
that could be a source of credit exposure of the investing bank to the 
issuer or its affiliate. Comment is also invited on whether the 15 
percent investment limitation or a lower limitation is appropriate 
under these circumstances.
    The OCC is not at this time proposing to apply an aggregate limit 
to a bank's combined holdings of Type III and Type V securities, but 
requests commenters to address whether some form of an aggregate 
limitation should apply to a bank's exposure to a single obligor, 
regardless of the type of the obligation. For example, under the 
proposal, a bank could invest in Type V securities of any one obligor 
in an amount not exceeding 15 percent of the bank's capital and 
surplus, and Type III securities of the same obligor in an amount not 
exceeding 10 percent of the bank's capital and surplus. In addition, 
under the lending limit rules, the bank could also make loans to the 
same obligor in an amount up to 15 percent--or 25 percent depending 
upon the collateral--of the bank's capital and surplus. Of course, the 
OCC retains the ability to take action in connection with 
concentrations inconsistent with safe and sound banking practices. 

[[Page 66157]]

Calculation of investment company holdings (section 1.4(d))

    In calculating the amount of its investment in investment company 
shares under this proposal, a bank must use reasonable efforts to 
calculate and combine its pro rata share of a particular security in 
the portfolios of each investment company with the bank's direct 
holdings of securities of that issuer.

Safe and sound banking practices; credit information required (Section 
1.5)

    The requirement of ``prudent banking judgment'' in current Sec. 1.8 
is moved to Sec. 1.5 and changed to require banks to adhere to ``safe 
and sound banking practices,'' in addition to any specific requirements 
of part 1. The OCC will continue its supervision of national bank 
investment securities activities, including those activities covered by 
the changes to part 1, to ensure that these investments are effected in 
a safe and sound manner. In recognition of the different types of risks 
that may affect the quality of a security, the proposal reflects the 
OCC position that safe and sound banking practices entail appropriate 
consideration of the market, interest rate, liquidity, legal, and 
operations and systems risks, as well as credit risk, posed by certain 
types of securities investments.9 These standards are made clearly 
applicable to all types of permissible securities activities and 
holdings described in Sec. 1.3. This change also makes the language of 
part 1 consistent with the authority of a federal banking agency to 
institute a cease-and-desist proceeding against an insured depository 
institution that has engaged or is about to engage in an ``unsafe and 
unsound practice.'' 12 U.S.C. 1818(b). The ``unsafe and unsound 
practice'' standard is well recognized by the courts. See, e.g., 
Northwest National Bank, Fayetteville, Arkansas v. U.S. Department of 
the Treasury, Office of the Comptroller of the Currency, 917 F.2d 1111 
(8th Cir. 1990); Gulf Federal Savings and Loan v. Federal Home Loan 
Bank Board, 651 F.2d 259 (5th Cir.. 1981), cert. denied, 458 U.S. 1121 
(1982); Groos National Bank v. Comptroller of the Currency, 573 F.2d 
889 (5th Cir. 1978). The proposed section also gives banks additional 
flexibility in maintenance of records for examination purposes.

     9  See OCC Banking Circular 277, reprinted in 5 Fed. 
Banking L. Rep. (CCH) para. 58,717 (October 27, 1993).
---------------------------------------------------------------------------

Convertible securities (section 1.6)

    Proposed Sec. 1.6 revises current Sec. 1.9 to clarify the 
restrictions on investment in certain convertible securities and how 
banks must account for securities that are convertible into stock or 
have stock purchase warrants attached.

Securities held in satisfaction of debts previously contracted; holding 
period; disposal; accounting treatment; non-speculative purpose 
(section 1.7)

    Proposed Sec. 1.7 contains new information in paragraphs (b) 
``holding period,'' (c) ``accounting treatment,'' and (d) ``non-
speculative purpose,'' which embody standards consistent with OCC's 
Other Real Estate Owned regulation, see 58 FR 46529 (September 2, 
1993), and the OCC's related interpretation, see Interpretive Letter 
No. 604 (October 8, 1992). A national bank holding securities in 
satisfaction of debts previously contracted may do so for a period of 
five years from the date that ownership of the securities was 
originally transferred to the bank, plus an additional five years, if 
permitted by the OCC.

Nonconforming investments (section 1.8)

    This new section clarifies that a bank does not violate an 
applicable investment limitation when an investment in securities that 
was legal when made becomes nonconforming as a result of any of certain 
enumerated events, provided the bank exercises reasonable efforts to 
bring the investment into conformity with applicable limitations. The 
events included in the regulation are: A decline in the bank's capital; 
a merger of obligors, issuers, or credit-enhancers; issuers becoming 
related directly or indirectly related through common control; 
deterioration in the quality of a security so that the security is no 
longer an investment security; the substitution of collateral by an 
issuer or trustee that causes a Type IV or Type V security no longer to 
conform to the diversification requirements of Secs. 1.2(k)(1) and (2) 
and 1.2(l); a change in the investment securities limitations rules; or 
other events identified by the OCC. This approach to nonconforming 
holdings is based upon the approach contained in the OCC's new lending 
limit regulation.
    Commenters are specifically asked to address whether: (1) The 
phrase ``reasonable efforts'' needs additional clarification, and if 
so, how it might be defined or should be documented for the purposes of 
this section; (2) the OCC should require a bank to make ``reasonable 
efforts'' to bring into conformity an investment where the quality of a 
security deteriorates so that the security is no longer an investment 
security; and (3) any other events should be added to the list of 
circumstances that may cause an investment in securities to become 
nonconforming.

Amortization of premiums (current section 1.10)

    Current Sec. 1.10 is removed. The OCC believes the section is no 
longer necessary because generally accepted accounting principles 
(GAAP) appropriately govern the treatment of premiums. GAAP requires 
that a bank defer recognition of a premium paid for an investment 
security and amortize the premium over the period to maturity of the 
security. In contrast, current Sec. 1.10 permits a bank to charge off 
the entire premium at the time of purchase or to amortize the premium 
in any manner the bank considers appropriate as long as the premium is 
extinguished entirely at or before the maturity of the security.

Interpretations

Indirect general obligations (section 1.100)

    Proposed Sec. 1.100 is derived from current Sec. 1.120, but 
clarifies and shortens the text. Current paragraphs (f) ``Tax 
anticipation notes,'' and (g) ``Bond anticipation notes'' of Sec. 1.120 
are removed as unnecessary.

Eligibility of securities for purchase, dealing in, and underwriting by 
national banks; general guidelines (current section 1.100)

    The proposal removes current Sec. 1.100, which contains 
introductory and explanatory comments that the OCC believes are 
unnecessary in light of other proposed changes to part 1.

Taxing powers of a State or a political subdivision (section 1.110)

    Section 1.110 is a shortened version of current Sec. 1.130, with 
portions removed that are no longer necessary. New text is added to 
provide standards for determining when obligations that are expressly 
or implicitly dependent upon voter or legislative authorization of 
appropriations are considered supported by the full faith and credit of 
a State or political subdivision.

Prerefunded or escrowed bonds and obligations secured by Type I 
securities (section 1.120)

    Proposed Sec. 1.120 is derived from current Sec. 1.120(e).

Type II securities; guidelines for obligations issued for university 
and housing purposes (section 1.130)

    Proposed Sec. 1.130 is a streamlined version of current Sec. 1.140, 
and also clarifies the types of issuers whose 

[[Page 66158]]
obligations qualify as Type II securities. Current Sec. 1.140(c)(1) and 
portions of (c)(2) have been removed. See Proposed Sec. 1.130(c).
    The OCC welcomes comments on any aspect of the proposed regulation, 
particularly, those issues specifically noted in this preamble.

                            Derivation Table                            
  [Only Substantive Modifications, Additions and Changes are Indicated] 
------------------------------------------------------------------------
     Revised provision        Original provision          Comments      
------------------------------------------------------------------------
Sec.  1.1.................  Secs.  1.1, 1.2......  Modified.            
Sec.  1.2(a)..............    ...................  Added.               
Sec.  1.2(b)..............  Sec.  1.3(g).........  Modified.            
Sec.  1.2(c)..............    ...................  Added.               
Sec.  1.2(d)..............    ...................  Added.               
Sec.  1.2(e)..............  Sec.  1.3(b).........  Modified.            
Sec.  1.2(f)..............  Sec.  1.5(a).........  Significant change.  
Sec.  1.2(g)..............  Sec.  1.3(f).........                       
Sec.  1.2(h)..............  Secs.  1.3(c), 1.110.  Modified.            
Sec.  1.2(i)..............  1.3(d)...............  Modified.            
Sec.  1.2(j)..............  Sec.  1.3(e).........  Modified.            
Sec.  1.2(k)..............    ...................  Added.               
Sec.  1.2(l)..............    ...................  Added.               
                            Sec.  1.3(a).........  Removed.             
Sec.  1.3(a)..............  Sec.  1.4............  Modified.            
Sec.  1.3(b)..............  Secs.  1.3(d), 1.6,    Modified.            
                             1.7(a).                                    
Sec.  1.3(c)..............  Secs.  1.3(e), 1.7(a)  Modified.            
Sec.  1.3(d)..............  Sec.  1.7(a), 12 CFR   Modified.            
                             7.7570.                                    
Sec.  1.3(e)..............    ...................  Added.               
Sec.  1.3(f)..............    ...................  Added.               
Sec.  1.3(g)..............    ...................  Added.               
Sec.  1.3(h)..............    ...................  Added.               
Sec.  1.3(i)..............  Secs.  1.5(b), 1.7(b)  Modified.            
Sec.  1.4.................    ...................  Added.               
Sec.  1.5.................  Sec.  1.8............  Significant change.  
Sec.  1.6.................  Sec.  1.9............  Modified.            
Sec.  1.7(a)..............  Sec.  1.11...........                       
Sec.  1.7(b)..............    ...................  Added.               
                            Sec.  1.7(c).........  Removed.             
                            Sec.  1.7(d).........  Added.               
Sec.  1.7(c)..............    ...................  Added.               
Sec.  1.8.................    ...................  Added.               
                            Sec.  1.10...........  Removed.             
                            Sec.  1.100..........  Removed.             
Sec.  1.100(a)............  Sec.  1.120..........                       
Sec.  1.100(b)(1).........  Sec.  1.120(a).......                       
Sec.  1.100(b)(2).........  Sec.  1.120(b).......                       
Sec.  1.100(b)(3).........  Sec.  1.120(c).......                       
Sec.  1.100(b)(4).........  Sec.  1.120(d).......                       
Sec.  1.110...............  Sec.  1.130..........  Modified.            
                            Sec.  1.120(f).......  Removed.             
                            Sec.  1.120(g).......  Removed.             
Sec.  1.120...............  Sec.  1.120(e).......                       
Sec.  1.130(a)............  Sec.  1.140(a).......  Modified.            
Sec.  1.130(b)............  Sec.  1.140(b).......                       
Sec.  1.130(c)............  Sec.  1.140(c).......  Modified.            
------------------------------------------------------------------------

Regulatory Flexibility Act

    It is hereby certified that this regulation will not have a 
significant economic impact on a substantial number of small entities. 
Accordingly, a regulatory flexibility analysis is not required. This 
regulation will reduce the regulatory burden on national banks, 
regardless of size, by simplifying and clarifying existing regulatory 
requirements.

Paperwork Reduction Act of 1995

    The OCC invites comment on:
    (1) Whether the proposed collection of information contained in 
this notice of proposed rulemaking is necessary for the proper 
performance of OCC functions, including whether the information has 
practical utility;
    (2) The accuracy of the estimate of the burden of the proposed 
information collection;
    (3) Ways to enhance the quality, utility, and clarity of the 
information to be collected; and
    (4) Ways to minimize the burden of the information collection on 
respondents, including through the use of automated collection 
techniques or other forms of information technology.
    Respondents/recordkeepers are not required to respond to this 
collection of information unless it displays a currently valid OMB 
control number.
    The collection of information requirements contained in this notice 
of proposed rulemaking have been submitted to the Office of Management 
and Budget for review in accordance with the Paperwork Reduction Act of 
1995 (44 U.S.C. 3507(d)). Comments on 

[[Page 66159]]
the collections of information should be sent to the Office of 
Management and Budget, Paperwork Reduction Project (1557), Washington, 
DC 20503, with copies to the Legislative and Regulatory Activities 
Division (1557), Office of the Comptroller of the Currency, 250 E 
Street, SW., Washington, DC 20219.
    The collection of information requirements in this proposed rule 
are found in 12 CFR 1.6 and 1.7. This information is required to 
evidence compliance with statutory limitations on the quantity and type 
of investments by national banks. The likely respondents/recordkeepers 
are national banks.
    Estimated average annual burden hours per respondent/recordkeeper: 
2 hours.
    Estimated number of respondents and/or recordkeepers: 3,000.
    Estimated total annual reporting and recordkeeping burden: 6,000 
hours.
    Start-up costs to respondents: None.
    Records are to be maintained for life of the investment.

Executive Order 12866

    The OCC has determined that this proposal is not a significant 
regulatory action.

Unfunded Mandates Act of 1995

    Section 202 of the Unfunded Mandates Reform Act of 1995 (Unfunded 
Mandates Act) (signed into law on March 22, 1995) requires that an 
agency prepare a budgetary impact statement before promulgating a rule 
that includes a Federal mandate that may result in the expenditure by 
State, local, and tribal governments, in the aggregate, or by the 
private sector, of $100 million or more in any one year. If a budgetary 
impact statement is required, Section 205 of the Unfunded Mandates Act 
also requires an agency to identify and consider a reasonable number of 
regulatory alternatives before promulgating a rule. Because the OCC has 
determined that the proposed rule will not result in expenditures by 
State, local, and tribal governments or by the private sector of $100 
million or more in any one year, the OCC has not prepared a budgetary 
impact statement or specifically addressed the regulatory alternatives 
considered. Nevertheless, as discussed in the preamble, the rule has 
the effect of reducing burden and increasing the discretion of national 
banks regarding their sound investment activities.

List of Subjects

12 CFR Part 1

    Banks, banking, National banks, Reporting and recordkeeping 
requirements, Securities.

12 CFR Part 7

    Credit, Insurance, Investments, National banks, Reporting and 
recordkeeping requirements, Securities, Surety bonds.

Authority and Issuance

    For the reasons set out in the preamble, chapter I of title 12 of 
the Code of Federal Regulations is proposed to be amended as set forth 
below:
    1. Part 1 is revised to read as follows:

PART 1--INVESTMENT SECURITIES REGULATION

Sec.
1.1  Authority, purpose, and scope.
1.2  Definitions.
1.3  Limitations on dealing in, underwriting, and purchase and sale 
of securities.
1.4  Calculation of limits.
1.5  Safe and sound banking practices; credit information required.
1.6  Convertible securities.
1.7  Securities held in satisfaction of debts previously contracted; 
holding period; disposal; accounting treatment; non-speculative 
purpose.
1.8  Nonconforming investments.

Interpretations

1.100  Indirect general obligations.
1.110  Taxing powers of a State or political subdivision.
1.120  Prerefunded or escrowed bonds and obligations secured by Type 
I securities.
1.130  Type II securities; guidelines for obligations issued for 
university and housing purposes.

    Authority: 12 U.S.C. 1 et seq., 24 (Seventh), and 93a.

Sec. 1.1  Authority, purpose, and scope.

    (a) Authority. This part is issued pursuant to 12 U.S.C. 1 et seq., 
12 U.S.C. 24 (Seventh), and 12 U.S.C. 93a.
    (b) Purpose. This part prescribes standards under which national 
banks may purchase, sell, deal in, underwrite, and hold securities, 
consistent with the authority contained in 12 U.S.C. 24 (Seventh) and 
safe and sound banking practices.
    (c) Scope. The standards set forth in this part apply to national 
banks, District of Columbia banks, and federal branches of foreign 
banks. Further, pursuant to 12 U.S.C. 335, State banks that are members 
of the Federal Reserve System are subject to the same limitations and 
conditions that apply to national banks in connection with purchasing, 
selling, dealing in, and underwriting securities and stock. In addition 
to activities authorized under this part, foreign branches of national 
banks also may be authorized to conduct international activities 
pursuant to part 211 of this title.

Sec. 1.2  Definitions.

    (a) Capital and surplus means:
    (1) A bank's Tier 1 and Tier 2 capital included in the bank's risk-
based capital under the OCC's Minimum Capital Ratios in Appendix A to 
part 3 of this chapter based upon the bank's Consolidated Report of 
Condition and Income filed under 12 U.S.C. 1817(a)(3); plus
    (2) The balance of a bank's allowance for loan and lease losses not 
included in the bank's Tier 2 capital, for purposes of the calculation 
of risk-based capital under 12 CFR part 3, based upon the bank's 
Consolidated Report of Condition and Income filed under 12 U.S.C. 
1817(a)(3).
    (b) General obligation of a State or political subdivision means:
    (1) An obligation supported by the full faith and credit of an 
obligor possessing general powers of taxation, including property 
taxation; or
    (2) An obligation payable from a special fund or by an obligor not 
possessing general powers of taxation, when an obligor possessing 
general powers of taxation, including property taxation, has 
unconditionally promised to make payments into the fund or otherwise 
provide funds to cover all required payments on the obligation.
    (c) Investment company means an investment company, including a 
mutual fund, registered under section 8 of the Investment Company Act 
of 1940, 15 U.S.C. 80a-8.
    (d) Investment grade means a security rated investment grade (in 
one of the top four rating categories) by each nationally recognized 
statistical rating organization that has rated the security.
    (e) Investment security means a marketable debt obligation that is 
not predominantly speculative in nature. A security is not 
predominantly speculative in nature if it is rated investment grade. 
When a security is not rated, the security must be the credit 
equivalent of securities rated investment grade.
    (f) Marketable means that the security is:
    (1) Registered under the Securities Act of 1933, 15 U.S.C. 77a et 
seq.;
    (2) Exempt from registration under the Securities Act of 1933, 15 
U.S.C. 77c, and authorized under 12 U.S.C. 24 (Seventh) as eligible for 
investment without limitation by a national bank, such as a security 
issued or guaranteed by: 

[[Page 66160]]

    (i) The United States or a territory thereof;
    (ii) The District of Columbia;
    (iii) A State of the United States;
    (iv) A political subdivision of a State or territory;
    (v) A public instrumentality of one or more States or territories; 
or
    (vi) A person controlled or supervised by and acting as an 
instrumentality of the Government of the United States pursuant to 
authority granted by the Congress of the United States;
    (3) A municipal revenue bond exempt from registration under the 
Securities Act of 1933, 15 U.S.C. 77c(a)(2); or
    (4) Offered and sold pursuant to Securities and Exchange Commission 
Rule 144A, 17 CFR 230.144A, and rated investment grade.
    (g) Political subdivision means a county, city, town, or other 
municipal corporation, a public authority, and generally any publicly-
owned entity that is an instrumentality of a State or of a municipal 
corporation.
    (h) Type I security means:
    (1) Obligations of the United States;
    (2) Obligations issued, insured, or guaranteed by a department or 
an agency of the United States Government, if the obligation, insurance 
or guarantee commits the full faith and credit of the United States for 
the repayment of the obligation;
    (3) Obligations issued by a department or agency of the United 
States, or an agency or political subdivision of a State of the United 
States, that represent an interest in a loan or a pool of loans made to 
third parties, if the full faith and credit of the United States has 
been validly pledged for the full and timely payment of interest on, 
and principal of, the loans in the event of non-payment by the third 
party obligor(s);
    (4) General obligations of a State of the United States or any 
political subdivision;
    (5) Obligations authorized under 12 U.S.C. 24 (Seventh) as 
permissible for a national bank to deal in, underwrite, purchase, and 
sell for the bank's own account; and
    (6) Other securities the OCC deems eligible as Type I securities in 
accordance with 12 U.S.C. 24 (Seventh).
    (i) Type II security means an investment security that represents:
    (1) Obligations issued by a State, or a political subdivision or 
agency of a State, for housing, university, or dormitory purposes;
    (2) Obligations of international and multilateral development banks 
and organizations listed in 12 U.S.C. 24 (Seventh);
    (3) Other obligations listed in 12 U.S.C. 24 (Seventh) as 
permissible for a bank to deal in, underwrite, purchase, and sell for 
the bank's own account, subject to a limitation of 10 percent of the 
bank's capital and surplus; and
    (4) Other securities the OCC deems eligible as Type II securities 
in accordance with 12 U.S.C. 24 (Seventh).
    (j) Type III security means an investment security that does not 
qualify as a Type I, II, IV, or V security, such as corporate bonds and 
municipal revenue bonds.
    (k) Type IV security means:
    (1) A small business-related security as defined in section 
3(a)(53)(A) of the Securities Exchange Act of 1934, 15 U.S.C. 
78c(a)(53)(A), that is fully secured by interests in a pool of 
homogeneous loans to numerous obligors. The aggregate amount of 
collateral from loans of any one obligor may not exceed 5 percent of 
the total amount of collateral for the security;
    (2) A commercial mortgage-related security that is offered or sold 
pursuant to section 4(5) of the Securities Act of 1933, 15 U.S.C. 
77d(5), or a commercial mortgage-related security as defined in section 
3(a)(41) of the Securities Exchange Act of 1934, 15 U.S.C. 78c(a)(41), 
that represents ownership of a promissory note or certificate of 
interest or participation that is directly secured by a first lien on 
one or more parcels of real estate upon which one or more commercial 
structures are located and that is fully secured by interests in a pool 
of homogeneous loans to numerous obligors. The aggregate amount of 
collateral from loans of any one obligor may not exceed 5 percent of 
the total amount of collateral for the security.
    (3) A residential mortgage-related security that is offered and 
sold pursuant to section 4(5) of the Securities Act of 1933, 15 U.S.C. 
77d(5), or a residential mortgage-related security as defined in 
section 3(a)(41) of the Securities Exchange Act of 1934, 15 U.S.C. 
78c(a)(41)), and that does not otherwise qualify as a Type I security.
    (l) Type V security means a security that:
    (1) Is rated investment grade;
    (2) Is not a Type IV security; and
    (3) Is fully secured by interests in a pool of homogeneous loans 
(that a national bank could invest in directly) to numerous obligors. 
The aggregate amount of collateral from loans of any one obligor may 
not exceed 5 percent of the total amount of collateral for the 
security.

Sec. 1.3  Limitations on dealing in, underwriting, and purchase and 
sale of securities.

    (a) Type I securities. A national bank may deal in, underwrite, 
purchase, and sell Type I securities for its own account. The amount of 
Type I securities that the bank may deal in, underwrite, purchase, and 
sell is not limited to a specified percentage of the bank's capital and 
surplus.
    (b) Type II securities. A national bank may deal in, underwrite, 
purchase, and sell Type II securities for its own account, provided the 
aggregate par value of the obligations of any one obligor held by the 
bank does not exceed 10 percent of the bank's capital and surplus. This 
limitation applies to obligations that the bank is legally committed to 
purchase and sell in addition to existing holdings.
    (c) Type III securities. A national bank may purchase and sell Type 
III securities for its own account, provided the aggregate par value of 
the obligations of any one obligor held by the bank does not exceed 10 
percent of the bank's capital and surplus. This limitation applies to 
obligations that the bank is legally committed to purchase and sell in 
addition to existing holdings.
    (d) Type II and III securities; other investment securities 
limitations. A national bank may not hold Type II and III securities of 
any one obligor with an aggregate par value exceeding 10 percent of the 
bank's capital and surplus. However, if the proceeds of each issue are 
to be used to acquire and lease real estate and related facilities to 
economically and legally separate industrial tenants, and if each issue 
is payable solely from and secured by a first lien on the revenues to 
be derived from rentals paid by the lessee under net noncancellable 
leases, the bank may apply the 10 percent investment limitation 
separately to each security issue of a single issuer of such 
securities.
    (e) Type IV securities. A national bank may purchase and sell Type 
IV securities for its own account. The amount of the Type IV securities 
that a bank may purchase and sell is not limited to a specified 
percentage of the bank's capital and surplus. A national bank also may 
deal in Type IV securities that are fully secured by Type I securities.
    (f) Type V securities. A national bank may purchase and sell Type V 
securities for its own account provided the aggregate par value of the 
obligations of any one obligor does not exceed 15 percent of the bank's 
capital and surplus. This limitation includes obligations the bank is 
legally committed to purchase and sell in addition to existing 
holdings.
    (g) Asset securitization. A national bank may securitize and sell 
its loan assets as a part of its banking business. 

[[Page 66161]]
The amount of securitized loans that a bank may sell is not limited to 
a specified percentage of the bank's capital and surplus.
    (h) Investment company shares. A national bank may purchase and 
sell for its own account investment company shares, provided that the 
portfolio of the investment company consists wholly of securities and 
loans that the national bank may purchase and sell for its own account 
under this part, subject to the most stringent investment and/or 
lending limitation that would apply to the underlying securities or 
loans that comprise such company's portfolio.
    (i) Securities held based on estimates of obligor's performance. 
(1) Notwithstanding Sec. 1.2(e) of this part, a national bank may treat 
a debt security as an investment security for purposes of this part if 
the bank concludes, on the basis of estimates that the bank reasonably 
believes are reliable, that the obligor will be able to satisfy its 
obligations under that security, and the bank believes that the 
security may be sold with reasonable promptness at a price which 
corresponds reasonably to its fair value.
    (2) The aggregate value of securities treated as investment 
securities under paragraph (i)(1) of this section may not exceed 5 
percent of the bank's capital and surplus.

Sec. 1.4  Calculation of limits.

    (a) Calculation date. For purposes of determining compliance with 
12 U.S.C. 24 (Seventh) and this part, a bank's limitations shall be 
determined as of the most recent of the following dates:
    (1) The date on which the bank's Consolidated Report of Condition 
and Income is properly signed and submitted;
    (2) The date on which the bank's Consolidated Report of Condition 
and Income is required to be submitted; or
    (3) When there is a change in the bank's capital category for 
purposes of 12 U.S.C. 1831o and 12 CFR 6.3.
    (b) Authority of OCC to require more frequent calculations. If the 
OCC determines for safety and soundness reasons that a bank should 
calculate its investment limits more frequently than required by 
paragraph (a) of this section, the OCC may provide written notice to 
the bank directing the bank to calculate its investment limitations at 
a more frequent interval. The bank shall thereafter calculate its 
investment limits at that interval until further notice.
    (c) Calculation of Type III and Type V securities holdings. In 
calculating the amount of its investment in Type III or Type V 
securities of any one obligor, a bank shall combine:
    (1) Obligations of issuers that are related directly or indirectly 
through common control; and
    (2) Securities that are credit-enhanced by the same entity.
    (d) Calculation of investment company holdings. In calculating the 
amount of its investment in investment company shares under this part, 
a bank shall use reasonable efforts to calculate and combine its pro 
rata share of a particular security in the portfolios of each 
investment company with the bank's direct holdings of securities of 
that issuer.

Sec. 1.5  Safe and sound banking practices; credit information 
required.

    (a) A national bank shall adhere to safe and sound banking 
practices and the specific requirements of this part in conducting the 
activities described in Sec. 1.3. This includes appropriate 
consideration of the market, interest rate, credit, liquidity, legal, 
and operations and systems risks presented by a proposed activity. The 
bank's particular activities must be appropriate for that bank.
    (b) In conducting these activities, the bank shall determine that 
there is adequate evidence that an obligor possesses resources 
sufficient to provide for all required payments on its obligations, or, 
in the case of securities deemed to be investment securities on the 
basis of reliable estimates of an obligor's performance, that the bank 
reasonably believes that the obligor will be able to satisfy the 
obligation.
    (c) Each bank shall maintain records available for examination 
purposes adequate to demonstrate that it meets the requirements of this 
section. The bank may store the information in any manner that can be 
readily retrieved and reproduced in a readable form.

Sec. 1.6  Convertible securities.

    (a) When a national bank purchases an investment security 
convertible into stock, or with a stock purchase warrant attached, the 
bank shall write down the carrying value of the security to an amount 
that represents the value of the security considered independently of 
the conversion feature or attached stock purchase warrant.
    (b) A national bank may not purchase securities convertible into 
stock at the option of the issuer.

Sec. 1.7  Securities held in satisfaction of debts previously 
contracted; holding period; disposal; accounting treatment; non-
speculative purpose.

    (a) Securities held in satisfaction of debts previously contracted. 
The restrictions and limitations of this part, other than those set 
forth in paragraphs (b),(c), and (d) of this section, do not apply to 
securities acquired:
    (1) Through foreclosure on collateral;
    (2) In good faith by way of compromise of a doubtful claim; or
    (3) To avoid loss in connection with a debt previously contracted.
    (b) Holding period. A national bank holding securities pursuant to 
paragraph (a) of this section may do so for a period not to exceed five 
years from the date that ownership of the securities was originally 
transferred to the bank. The OCC may extend the holding period for up 
to an additional five years.
    (c) Accounting treatment. A bank shall mark-to-market securities 
held pursuant to paragraph (a) of this section.
    (d) Non-speculative purpose. A bank may not hold securities 
pursuant to paragraph (a) of this section for speculative purposes.

Sec. 1.8  Nonconforming investments.

    (a) An investment in securities, which conforms to this part when 
made, will not be deemed a violation, but will be treated as 
nonconforming if the investment no longer conforms to this part 
because;
    (1) The bank's capital declines;
    (2) Issuers, obligors, or credit-enhancers merge;
    (3) Issuers become related directly or indirectly through common 
control;
    (4) The investment securities rules change;
    (5) The security no longer qualifies as an investment security;
    (6) The substitution of collateral by an issuer or trustee causes a 
Type IV or Type V security no longer to conform to the diversification 
requirements of Secs. 1.2(k)(1) and (2) and 1.2(l)(3); or
    (7) Other events identified by the OCC occur;
    (b) A bank shall exercise reasonable efforts to bring an investment 
that is nonconforming as a result of events described in paragraph (a) 
of this section into conformity with this part unless to do so would be 
inconsistent with safe and sound banking practices.

Interpretations

Sec. 1.100  Indirect general obligations.

    (a) Obligation issued by an obligor not possessing general powers 
of taxation. Pursuant to Sec. 1.2(c) of this part, an obligation issued 
by an obligor not possessing general powers of taxation qualifies as a 
general obligation of a State or political subdivision for the purposes 
of 12 U.S.C. 24 (Seventh), if a party possessing general powers of 
taxation unconditionally promises to make sufficient funds available 
for all required payments in connection with the obligation. 

[[Page 66162]]

    (b) Indirect commitment of full faith and credit. The indirect 
commitment of the full faith and credit of a State or political 
subdivision (that possesses general powers of taxation) in support of 
an obligation may be demonstrated by any of the following methods, 
alone or in combination, when the State or political subdivision 
pledges its full faith and credit in support of the obligation.
    (1) Lease/rental agreement. The lease agreement must be valid and 
binding on the State or the political subdivision, and the State or 
political subdivision must unconditionally promise to pay rentals that, 
together with any other available funds, are sufficient for the timely 
payment of interest on, and principal of, the obligation. These lease/
rental agreements may, for instance, provide support for obligations 
financing the acquisition or operation of public projects in the areas 
of education, medical care, transportation, recreation, public 
buildings, and facilities.
    (2) Service/purchase agreement. The agreement must be valid and 
binding on the State or the political subdivision, and the State or 
political subdivision must unconditionally promise in the agreement to 
make payments for services or resources provided through or by the 
issuer of the obligation. These payments, together with any other 
available funds, must be sufficient for the timely payment of interest 
on, and principal of, the obligation. An agreement to purchase 
municipal sewer, water, waste disposal, or electric services may, for 
instance, provide support for obligations financing the construction or 
acquisition of facilities supplying those services.
    (3) Refillable debt service reserve fund. The reserve fund must at 
least equal the amount necessary to meet the annual payment of interest 
on, and principal of, the obligation as required by the applicable law. 
The maintenance of a refillable reserve fund may be provided, for 
instance, by statutory direction for an appropriation, or by statutory 
automatic apportionment and payment from the State funds of amounts 
necessary to restore the fund to the required level.
    (4) Other grants or support. A statutory provision or agreement 
must unconditionally commit the State or the political subdivision to 
provide funds which, together with other available funds, are 
sufficient for the timely payment of interest on, and principal of, the 
obligation. Those funds may, for instance, be supplied in the form of 
annual grants or may be advanced whenever the other available revenues 
are not sufficient for the payment of principal and interest.

Sec. 1.110  Taxing powers of a State or political subdivision.

    (a) An obligation is considered supported by the full faith and 
credit of a State or political subdivision possessing general powers of 
taxation when the promise or other commitment of the State or the 
political subdivision will produce funds, which (together with any 
other funds available for the purpose) will be sufficient to provide 
for all required payments on the obligation. In order to evaluate 
whether a commitment of a State or political subdivision is likely to 
generate sufficient funds, a bank shall consider the impact of any 
possible limitations regarding the State's or political subdivision's 
taxing powers, as well as the availability of funds in view of the 
projected revenues and expenditures. Quantitative restrictions on the 
general powers of taxation of the State or political subdivision do not 
necessarily mean that an obligation is not supported by the full faith 
and credit of the State or political subdivision. In such case, the 
bank shall determine the eligibility of obligations by reviewing, on a 
case-by-case basis, whether tax revenues available under the limited 
taxing powers are sufficient for the full and timely payment of 
interest on, and principal of, the obligation. The bank shall use 
current and reasonable financial projections in calculating the 
availability of the revenues. An obligation expressly or implicitly 
dependent upon voter or legislative authorization of appropriations may 
be considered supported by the full faith and credit of a State or 
political subdivision if the bank determines, on the basis of past 
actions by the voters or legislative body in similar situations 
involving similar types of projects, that it is reasonably probable 
that the obligor will obtain all necessary appropriations.
    (b) An obligation supported exclusively by excise taxes or license 
fees is not a general obligation for the purposes of 12 U.S.C. 24 
(Seventh). Nevertheless, an obligation that is primarily payable from a 
fund consisting of excise taxes or other pledged revenues qualifies as 
a ``general obligation,'' if, in the event of a deficiency of those 
revenues, the obligation is also supported by the general revenues of a 
State or a political subdivision possessing general powers of taxation.

Sec. 1.120  Prerefunded or escrowed bonds and obligations secured by 
Type I securities.

    (a) An obligation qualifies as a Type I security if it is secured 
by an escrow fund consisting of obligations of the United States or 
general obligations of a State or a political subdivision, and the 
escrowed obligations produce interest earnings sufficient for the full 
and timely payment of interest on, and principal of, the obligation.
    (b) If the interest earnings from the escrowed Type I securities 
alone are not sufficient to guarantee the full repayment of an 
obligation, a promise of a State or a political subdivision possessing 
general powers of taxation to maintain a reserve fund for the timely 
payment of interest on, and principal of, the obligation may further 
support a guarantee of the full repayment of an obligation.
    (c) An obligation issued to refund an indirect general obligation 
may be supported in a number of ways that, in combination, are 
sufficient at all times to support the obligation with the full faith 
and credit of the United States or a State or a political subdivision 
possessing general powers of taxation. During the period following its 
issuance, the proceeds of the refunding obligation may be invested in 
U.S. obligations or municipal general obligations that will produce 
sufficient interest income for payment of principal and interest. Upon 
the retirement of the outstanding indirect general obligation bonds, 
the same indirect commitment, such as a lease agreement or a reserve 
fund, that supported the prior issue, may support the refunding 
obligation.

Sec. 1.130  Type II securities; guidelines for obligations issued for 
university and housing purposes.

    (a) Investment quality. An obligation issued for housing, 
university, or dormitory purposes is a Type II security only if it:
    (1) Qualifies as an investment security, as defined in Sec. 1.2(e); 
and
    (2) Is issued for the appropriate purpose and by a qualifying 
issuer.
    (b) Obligation issued for university purposes. (1) An obligation 
issued by a State or political subdivision or agency of a State or 
political subdivision for the purpose of financing the construction or 
improvement of facilities at or used by a university or a degree-
granting college- level institution, or financing loans for studies at 
such institutions, qualifies as a Type II security. Facilities financed 
in this manner may include student buildings, classrooms, university 
utility buildings, cafeterias, stadiums, and university parking lots. 

[[Page 66163]]

    (2) An obligation that finances the construction or improvement of 
facilities used by a hospital may be eligible as a Type II security, if 
the hospital is a department or a division of a university, or 
otherwise provides a nexus with university purposes, such as an 
affiliation agreement between the university and the hospital, faculty 
positions of the hospital staff, and training of medical students, 
interns, residents, and nurses (e.g., a ``teaching hospital'').
    (c) Obligation issued for housing purposes. An obligation issued 
for housing purposes may qualify as a Type II security if the security 
otherwise meets the criteria for a Type II security.

PART 7--INTERPRETIVE RULINGS

    3. The authority citation for part 7 continues to read as follows:

    Authority: 12 U.S.C. 1 et seq., 93a.

Sec. 7.7570  [Removed]

    4. Section 7.7570 is removed.

    Dated: December 14, 1995.
Eugene A. Ludwig,
Comptroller of the Currency.
[FR Doc. 95-30969 Filed 12-20-95; 8:45 am]
BILLING CODE 4810-33-P

Complete official Federal Register PDF

FR Doc. 95-30884 Real-Time Information Networks and Standards of Conduct; Notice of Proposed Rulemaking
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Pages 66182-66203]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-30884]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Rregulatory Commission

18 CFR Part 37

[Docket No. RM95-9-000]

Real-Time Information Networks and Standards of Conduct; Notice 
of Proposed Rulemaking

December 13, 1995
AGENCY: Federal Energy Regulatory Commission.

ACTION: Notice of Proposed Rulemaking.

-----------------------------------------------------------------------

[[Page 66183]]

SUMMARY: The Federal Energy Regulatory Commission proposes to amend its 
regulations to add Part 37 containing rules establishing and governing 
real-time information networks (RINs) and prescribing standards of 
conduct. Under this proposal, each public utility (or its agent) that 
owns and/or controls facilities used for the transmission of electric 
energy in interstate commerce would be required to create and/or 
participate in a RIN that would provide wholesale transmission 
customers and potential wholesale transmission customers with 
electronically provided information on available wholesale transmission 
capacity, prices, and other information that will enable them to obtain 
open access non-discriminatory transmission service.

DATES: Written comments (an original and 14 paper copies and one copy 
on a computer diskette) must be received by the Commission by February 
5, 1996.

ADDRESSES: Office of the Secretary, Federal Energy Regulatory 
Commission, 888 First Street, NE., Washington, DC 20426.

FOR FURTHER INFORMATION CONTACT:

Marvin Rosenberg (Technical Information), Office of Economic Policy, 
Federal Energy Regulatory Commission, 888 First Street, NE., 
Washington, DC 20426 (202) 208-1283
William C. Booth (Technical Information), Office of Electric Power 
Regulation, Federal Energy Regulatory Commission, 888 First Street, NE. 
, Washington, DC 20426 (202) 208-0849
Gary D. Cohen (Legal Information), Office of the General Counsel, 
Federal Energy Regulatory Commission, 888 First Street, NE. , 
Washington, DC 20426 (202) 208-0321

SUPPLEMENTARY INFORMATION: In addition to publishing the full text of 
this document in the Federal Register, the Commission also provides all 
interested persons an opportunity to inspect or copy the contents of 
this document during normal business hours in the Public Reference Room 
at 888 First Street, NE., Washington, DC 20426.
    The Commission Issuance Posting System (CIPS), an electronic 
bulletin board service, provides access to the texts of formal 
documents issued by the Commission. CIPS is available at no charge to 
the user and may be accessed using a personal computer with a modem by 
dialing 202-208-1397 if dialing locally or 1-800-856-3920 if dialing 
long distance. To access CIPS, set your communications software to 
19200, 14400, 12000, 9600, 7200, 4800, 2400, or 1200 bps, full duplex, 
no parity, 8 data bits and 1 stop bit. The full text of this order will 
be available on CIPS indefinitely in ASCII and Wordperfect 5.1 format. 
The complete text on diskette in WordPerfect format may also be 
purchased from the Commission's copy contractor, La Dorn Systems 
Corporation, also located in the Public Reference Room at 888 First 
Street, NE., Washington, DC 20426.
    Real-time Information Networks and Standards of Conduct, Docket 
No. RM95-9-000, Notice of Proposed Rulemaking Table of Contents.
I. Introduction
II. Public Reporting Burden
III. Discussion
    A. Background
    B. Overview
    C. What Types of Information Need to Be Posted on a RIN
    1. Summary of the ``What'' Working Group Report
    a. Introduction
    b. Scope and Definitions
    c. Posting Transaction Information
    2. Discussion
    a. RIN Objectives
    b. ATC for Network Integration Service
    c. ATC Calculation Methodology
    d. Provisions for Unscheduled Flows
    e. Paths for which ATC is not Posted
    f. Differences in ATCs
    g. Format for Transmission Tariffs
    h. Posting Requirements for Recallability and Curtailability
    i. Communicating Curtailments and Denials of Requests for 
Service
    j. Posting Information about Ancillary Services
    k. Must Transmission Customers Resell Unused Capability?
    l. Posting Information about Resales
    m. Mechanism for Discounting Transmission Service Rates
    n. Discussion of Generation Information Related to Redispatch/
Opportunity Costs
    o. Discussion of Providing Additional Information Beyond ATC
    p. Requested Start and End Times/Dates
    q. Transaction Anonymity
    r. Auditing Transmission Service Information
    D. Technical Issues Concerning the Development and 
Implementation of RINS
    1. Summary of the ``How'' Working Group Report
    a. Phase I Recommendations
    b. Phase II Requirements
    2. Discussion
    a. Phasing
    b. Standards Issues
    i. Phase I Data Definitions for HTML Pages and File Transfers
    ii. Internet Browsers
    iii. Bandwidth of Node Connections to the Internet
    iv. Common Codes
    v. Data Compression Standards
    vi. Templates for Upload and Download Header Information
    c. Costs
    d. Access to RIN Information by the Public
    e. The Number of RIN Nodes
    f. Connections to Third Party Networks
    g. Unresolved Issues
    i. Price Discrimination Issues
    ii. Transmission Services Information Timing Requirements
    iii.The Posting of Capacity Available for Resale
    E. Standards of Conduct
    F. Applicability
    1. Non-Public Utility Transmission Providers
    2. Public Utilities having no Transmission Facilities with 
Commercial Value
IV. Regulatory Flexibility Act
V. Environmental Statement
VI. Information Collection Statement
VII. Public Comment Procedure
Regulatory Text
Attachment 1

I. Introduction

    The Federal Energy Regulatory Commission (Commission) proposes to 
amend 18 CFR to add Part 37 containing rules establishing and governing 
real-time information networks (RINs) and standards of conduct. We are 
issuing this notice of proposed rulemaking in conjunction with our 
previously proposed Open Access rule.1

    \1\ See Promoting Wholesale Competition Through Open Access Non-
Discriminatory Transmission Services by Public Utilities and 
Recovery of Stranded Costs by Public Utilities and Transmitting 
Utilities, Notice and Supplemental Notice of Proposed Rulemaking, 60 
FR 17662 (April 7, 1995), IV FERC Stats. & Regs. para. 32,514 (March 
29, 1995) (hereinafter Open Access NOPR).
---------------------------------------------------------------------------

    Under the proposed Open Access rule, public utilities that own and/
or control facilities used for the transmission of electric energy in 
interstate commerce would be required to provide open access, non-
discriminatory wholesale transmission services. To ensure non-
discriminatory service, the proposed Open Access rule requires the 
functional unbundling of wholesale services. A public utility's uses of 
its own transmission system for the purpose of engaging in wholesale 
sales and purchases of electric energy must be separated from other 
activities and transmission services (including ancillary services) 
must be taken under filed transmission tariffs of general 
applicability.
    To ensure this separation of service, the public utility must 
provide customers with timely access to transmission-related 
information. As we stated in the Open Access NOPR, ``functional 
unbundling means that the public utility, in order to provide non-
discriminatory open access to transmission and ancillary services 
information, must rely upon the same electronic network that its 
transmission customers rely upon to obtain transmission information 
about its 

[[Page 66184]]
system when buying or selling power.'' 2 The rule we propose today 
is designed to begin the process of achieving this objective.

    \2\ Open Access NOPR at pp. 95-96.
---------------------------------------------------------------------------

    Under the proposed rule, each public utility as defined in section 
201(e) of the Federal Power Act, 16 U.S.C. 824(e) (1994), (or its 
agent) that owns and/or controls facilities used for the transmission 
of electric energy in interstate commerce would be required to develop 
and/or participate in a RIN. The proposed regulations, relying heavily 
on work already done by representatives of all segments of the electric 
power industry, describe what information must be provided on the RIN 
and how RINs are to be implemented and used.
    The Commission also proposes a code of conduct that would apply to 
all public utility transmission providers. This code of conduct would 
require, among other matters, a separation of the utilities' 
transmission system operations and wholesale marketing functions, and 
would define permissible and impermissible contacts between employees 
that conduct wholesale generation marketing functions and employees 
that handle transmission system operations and reliability in the 
system control center or at other facilities or locations.
    Within 60 days of publication of a final rule in the Federal 
Register, public utilities would be required to file with the 
Commission procedures that would enable customers and the Commission to 
determine that public utilities are in compliance with the RINs and 
code of conduct requirements.

II. Public Reporting Burden

    The proposed rule would require transmission providers to establish 
and/or participate in a RIN, which would provide wholesale transmission 
users and potential wholesale transmission users with information by 
electronic means about transmission capacity and prices.
    The following collection of information contained in this Notice of 
Proposed Rulemaking has been submitted to the Office of Management and 
Budget for review under section 3507(d) of the Paperwork Reduction Act 
of 1995, 44 U.S.C. 3507(d). For copies of the OMB submission, contact 
Michael Miller at 202-208-1415. Comments are solicited on the 
Commission's need for this information, whether the information will 
have practical utility, the accuracy of the provided burden estimates, 
ways to enhance the quality, utility, and clarity of the information to 
be collected, and any suggested methods for minimizing respondents' 
burden, including the use of automated information techniques. Persons 
wishing to comment on the collections of information should direct 
their comments to the Desk Officer FERC, Office of Management and 
Budget, Room 3019NEOB, Washington, D.C. 20503, phone 202-395-3087, 
facsimile: 202-395-7285 or via the Internet at [email protected]. 
Comments must be filed with the Office of Management and Budget within 
60 days of publication of this document in the Federal Register. 3 
A copy of any comments filed with the Office of Management and Budget 
also should be sent to the following address at the Commission: Federal 
Energy Regulatory Commission, Information Services Division, Room 41-
l7, Washington, DC 20426. For further information, contact Michael 
Miller, 202-208-1415.

    \3\ Although the full text of this document and Attachment 1 
will be published in the Federal Register, the three appendices 
attached to this document (Appendix ``A''--the report of the 
``what'' working group, Appendix ``B''--the report of the ``how'' 
working group, and Appendix ``C''--templates for upload and download 
of files and HTML displays) will not. The complete NOPR, including 
these appendices, is available for inspection and copying in the 
Commission's Public Reference Room and is accessible through the 
Commission Issuance Posting System (CIPS), an electronic bulletin 
board service providing access to Commission documents.

                                             Estimated Annual Burden                                            
----------------------------------------------------------------------------------------------------------------
                                                                                                         Total  
                         Data Collection                              No. of       No. of   Hours per    annual 
                                                                    Respondents  Responses   Response    hours  
----------------------------------------------------------------------------------------------------------------
Reporting........................................................            84          1       8352    701,568
Recordkeeping....................................................            84          1       1670    140,280
Total Annual Hours for Collection (Reporting + Recordkeeping, (if                                               
 appropriate))=841,848...........................................                                               
----------------------------------------------------------------------------------------------------------------

    Data collection costs: The Commission seeks comments on the costs 
to comply with these requirements. It has projected the average 
annualized cost per respondent to be the following:

Annualized Capital/Startup Costs.............................   $190,000
Annualized Costs (Operations & Maintenance)..................   $620,000
  Total Annualized Costs.....................................   $810,000
                                                                        

Internal Review

    The Commission has reviewed the proposed collection of information 
and has determined that the collection of information is necessary and 
conforms to the Commission's plan, as described in this notice of 
proposed rulemaking, for the collection, efficient management, and use 
of the required information. The Commission has assured itself, by 
means of its internal review, that there is specific, objective support 
for the information burden estimate set forth above.4

    \4\ See 44 U.S.C. 3506 (c).
---------------------------------------------------------------------------

III. Discussion

A. Background

    On March 29, 1995, the Commission issued the Open Access NOPR 
(referenced above). In the Open Access NOPR, the Commission proposed 
rules that would require public utilities that own and/or control 
facilities used for the transmission of electric energy in interstate 
commerce to provide wholesale customers with transmission services 
comparable to those that they provide to themselves. The goal of the 
Open Access NOPR is to eliminate unduly discriminatory practices in the 
provision of wholesale transmission services in interstate commerce, 
and to facilitate the development of a competitive bulk power market.
    The Open Access NOPR includes minimum terms and conditions that a 
public utility would have to include in its wholesale transmission 
tariffs, the types of transmission and related ancillary services it 
must offer to its customers, and a requirement that each public utility 
purchase wholesale transmission services for its new wholesale sales 
and purchases under the same transmission tariffs applicable to its 
wholesale customers. The Open Access NOPR also proposes that public 
utilities be allowed to recover certain 

[[Page 66185]]
legitimate and verifiable stranded costs associated with certain 
requirements contracts entered into prior to July 11, 1994.
    We do not believe that open access non-discriminatory transmission 
services can be completely realized until we remove real-world 
obstacles that prevent transmission customers from competing 
effectively with the Transmission Provider. One of these obstacles is 
unequal access to transmission information. In the Commission's view, 
transmission customers must have simultaneous access to the same 
information available to the Transmission Provider if truly non-
discriminatory transmission services are to be a reality.
    For this reason, when we issued the Open Access NOPR we also issued 
a notice of technical conference and request for comments (RIN Notice) 
that initiated this proceeding.5 In the RIN Notice, the Commission 
announced that we were considering establishing RIN rules to effectuate 
the non-discrimination goals of the Open Access NOPR, and that we 
expected to require a RIN or other options to ensure that potential and 
actual transmission service customers will receive access to 
information.6

    \5\ Real-Time Information Networks, 60 FR 17726 (April 7, 1995), 
IV FERC Stats. & Regs. para. 35,028 (March 29, 1995).
    \6\ In the RIN Notice, we chose the term ``Real-Time Information 
Network'' to describe the electronic information system envisioned 
by that notice. We chose that term because we wanted to distinguish 
the RIN from the electronic bulletin board (EBB) rules developed for 
the natural gas industry and because we wanted to emphasize that 
information would not be distributed to different users at different 
times. However, we did not mean to suggest that transmission 
providers would be precluded from taking adequate time to evaluate 
requests for service before responding to them. Perhaps a more 
precise term would have been a same-time information network.
    In the two working group reports (discussed below) we are urged 
to change the name ``RIN'' to ``electronic information network'', by 
the ``what'' working group, and to ``transmission services 
information network'', by the ``how'' working group. Either of these 
designations would be equally acceptable. In the meantime, however, 
we are retaining the title ``RIN'' to make clear that this NOPR is 
proposing rules consistent with the ideas expressed in the RIN 
Notice.
---------------------------------------------------------------------------

    The Commission also announced its goal to establish uniform 
requirements for a RIN or other communications device at the same time 
that it adopts a rule requiring open access non-discriminatory 
transmission services. To accomplish this objective, the Commission 
invited interested persons to file comments and to participate in a 
technical conference, where they could make presentations on their 
positions. As a starting point, the Commission attached to the RIN 
Notice a Commission Staff paper identifying various RIN-related issues, 
and directed commenters to respond to the specific issues identified in 
the Staff paper and to provide their general comments on the RIN 
concept. The RIN Notice stated that the Commission expected to hold 
informal conferences, enlisting working groups to discuss any remaining 
issues, and that input from the technical conference and informal 
conferences would be the basis for subsequent procedures. The RIN 
Notice set a timetable to be followed, so that RIN requirements could 
be in place no later than the effective date of a final rule on open 
access.

    Question 1. We seek comment on whether to continue to call the 
information network a ``RIN'' and, if not, what name should be used 
in its place.

    In response to the RIN Notice, Kansas City Power & Light Company 
and Continental Power Exchange, Inc. sponsored a forum on EBBs held on 
March 31, 1995 in Kansas City. That forum was attended by more than 50 
representatives of the 17 entities with open access filings (at that 
time) at the Commission, along with state regulators from Kansas and 
Missouri, and the Edison Electric Institute (EEI). A follow-up workshop 
on EBBs and RINs, sponsored by EEI, was held in Kansas City on April 
19, 1995, and was attended by more than 150 people from all segments of 
the electric industry.
    The North American Electric Reliability Council (NERC) and its nine 
regional councils offered to act as sponsor and neutral facilitator for 
the electric industry regarding electronic information systems to:

     Determine the information requirements of transmission 
users;
     Develop industry wide standards for reporting and using 
this information;
     Ensure that any information systems developed can build 
upon and be compatible with existing information systems in the 
industry; and
     Meet the Commission's goal of ensuring that potential 
purchasers of transmission services would receive access to 
information to enable them to obtain open access transmission 
service on a non-discriminatory basis.

    The EEI workshop participants accepted NERC's offer to facilitate 
industry discussions on RINs. They also decided that, rather than 
awaiting Commission-drafted standards, they would try to develop an 
industry wide consensus, for submittal to the Commission, that would 
ensure fair and equal participation by both transmission customers and 
transmission providers and that would define the necessary information 
requirements and standards for a RIN.
    Accordingly, on May 3-4, 1995, NERC called together a sub-group of 
workshop participants, representing all categories of transmission 
users and providers, to draft a model or ``straw man'' document that 
would outline a preliminary list of minimum information requirements 
for transmission users (i.e., what information should be included on a 
RIN) and to reach agreement on what would constitute a fair and 
inclusive process for reaching consensus among transmission user groups 
on information requirements for a RIN. The resulting consensus document 
(Strawman 1) set the agenda for subsequent discussions at five regional 
workshops, held across the country, with participation by over 500 
individuals from all segments of the electric power industry. The 
strawman group issued a revised document (Strawman 2), on June 2, 1995, 
based on those discussions. Strawman 2 was distributed to the 
participants in the regional workshops and to Commission Staff and 
served as the discussion point for a NERC-sponsored workshop held in 
Washington, DC on June 26-28, 1995. Although participants at this 
workshop were not able to reach consensus on numerous issues, they were 
able to identify the important unresolved issues and where efforts 
would need to be made to reach consensus.
    Other groups also got involved early on with RIN-related issues. 
For example, the Western Group 7 began working in February 1995 
(prior to issuance of the RIN Notice) on standards for the electronic 
information systems needed for implementation of comparable 
transmission service. WRTA members were joined in their discussions by 
members of the Southwest Regional Transmission Association (SWRTA), and 
the Northwest Regional Transmission Association (NWRTA). Together, 
WRTA, SWRTA, and NWRTA held a series of informal workshops to discuss 
tariff issues. Representatives of the Western Group also attended the 
April 19, 1995 meeting sponsored by EEI on national RIN standards and 
participated in the NERC process.

    \7\ This group is composed of 17 major transmitting utilities, 3 
non-utility suppliers, 10 transmission dependent utilities (or 
groups of utilities), and two state commissions, all located in the 
western United States and western Canada (the geographic area 
covered by the interconnected systems of the Western Systems 
Coordinating Council).
---------------------------------------------------------------------------

    In all, 108 sets of comments were submitted to the Commission in 
response to the RIN Notice. Although the comments were nearly uniformly 
favorable to the RIN concept, the 

[[Page 66186]]
comments exposed many disagreements about what information should be 
contained on a RIN, what kind of a RIN system or systems should be 
required, what transactions should be covered, how terms should be 
defined, etc. However, most commenters understood that access to 
transmission information--by all parties at the same time--is essential 
to ensuring non-discriminatory open access transmission services.
    The comments led to a technical conference on RINs (Technical 
Conference) held in Washington, DC on July 27 and 28, 1995. Panels at 
the Technical Conference discussed the status of industry efforts to 
date, industry standards for information systems, what information is 
needed on a RIN, how a RIN should be structured, what issues need to be 
resolved, and what steps should be taken next. In addition, 
demonstrations were presented on different transmission information 
systems and energy trading systems.
    The participants in the July 27, 1995 conference agreed that the 
NERC-sponsored process, seeking to reach consensus and make 
recommendations to the Commission on what information should be 
included on a RIN, should continue, with NERC acting as a facilitator 
to promote participants reaching consensus and to prepare a ``what'' 
report to the Commission describing areas of consensus and non-
consensus. The participants also agreed that another industry-sponsored 
working group should be created, with the Electric Power Research 
Institute (EPRI) acting as a facilitator to promote consensus on 
``how'' to implement a system that would accomplish these objectives, 
and to prepare a ``how'' report to the Commission.
    The NERC and EPRI representatives pledged to conduct an open 
process that would keep all interested persons informed of developments 
by the working groups and that would provide input from interested 
persons to working group members. Interested persons also were invited 
to attend open workshops sponsored by both working groups.
    The ``what'' industry working group consisted of 26 members 
providing balanced representation from all segments of the electric 
power industry and included liaisons from the Commission, the ``how'' 
working group, NARUC, and Canadian utilities. Major industry trade 
groups sent observers. On October 9, 1995, the ``what'' working group 
made a draft report available for public review. On October 16, 1995, 
it submitted a final report to the Commission.
    Following the Technical Conference, the ``how'' working group used 
a similar open and representative process that included participation 
by all industry and customer segments. On October 16, 1995, the ``how'' 
working group submitted to the Commission its report on how a RIN 
should be implemented.
    The two working group reports address both the issues on which the 
participants were able to reach consensus and the issues on which no 
consensus was reached. Additionally, nine sets of comments were filed 
by working group participants who wished to provide a fuller 
explanation of their views on particular issues. We will address the 
issues raised by the working group reports below.

B. Overview

    In what follows we discuss first, in section C below, what types of 
information must be posted on the RIN. The Commission proposes to adopt 
most of the technical parameters agreed to by the ``what'' working 
group. Our final rule would include general regulations governing who 
must develop and maintain RINs and what information must be posted on 
the RIN. Next, in section D below, we discuss the technical issues 
surrounding the implementation and use of RINs. We propose to set out 
the details of these requirements in a publication that would be 
entitled Standardized Data Sets and Communication Protocols and that 
would be issued as part of our final RIN rule. We propose to implement 
the RINS in two phases, with the first phase (Phase I) being completed 
when the Open Access rule goes into effect. In the discussion below, we 
address the specific, and at times very technical, issues considered 
respectively by the ``what'' and ``how'' working groups.
    In section E below, we consider proposed standards of conduct 
governing the separation of transmission and generation functions. 
These standards are, we believe, a necessary adjunct to the RINs to 
ensure non-discriminatory access. The proposed standards are drawn from 
those that have been developed in our regulation of the natural gas 
industry. Last, in section F, we discuss issues of applicability for 
the proposed RINS and standards of conduct.
    In setting out proposed requirements for implementing RINs, our 
primary objective is to establish regulations that ensure the 
accessibility of all information necessary to the full and fair 
implementation of the requirements of the Open Access NOPR. The 
problem, of course, is that we do not now know the specifics of the 
final Open Access rule. Yet, the information that will be required to 
be posted depends upon what is required or permitted under the final 
Open Access rule. For example, what must be posted on the RIN regarding 
the resale of transmission depends upon whether, in the final Open 
Access Rule, resales are permitted and, if so, under what conditions. 
Similarly, what information must be posted regarding transmission 
pricing discounting will depend upon whether, in the final Open Access 
Rule, discounting is permitted and, if so, under what conditions. These 
are just two examples, and are not inclusive, of RINs information that 
may change depending on what is in the final open access rule.
    The final RIN rule will be designed to accommodate whatever final 
open access rules the Commission adopts and whatever industry 
structures evolve to meet those rules. In the interim, the RIN proposal 
follows the Proposed Open Access Rule. For example, it assumes that 
resales will be permitted 8 Similarly, the proposed RIN standards 
are designed to accommodate the so called ``contract path'' approach 
presently used in today's electricity markets. However, the Commission 
is open to other approaches that may develop in the future under an 
Open Access regime. Consequently, commenters should consider how the 
proposed RINS and standards of conduct regulations can be designed to 
meet these needs.

    \8\ In designing proposed RINs regulations dealing with what may 
be required in the Final Open Access rule, our assumptions should in 
no way be taken as prejudging the various issues involved in the 
Open Access rulemaking.
---------------------------------------------------------------------------

    Question 2. What issues associated with RIN standards would have 
to be addressed if in an open access transmission environment the 
electric power industry moves to regional pricing, flow-based 
pricing, or other pricing models that depart from the ``contract 
path'' approach presently used for pricing electric transmission 
service? How in structuring RIN standards can the Commission provide 
for this contingency?

C. What Types of Information Need To Be Posted on a RIN

1. Summary of the ``What'' Working Group Report
    The ``what'' working group report (What Report), represents a broad 
consensus of all segments of the electric utility industry. It 
summarizes the functional requirements for Real-Time Information 
Networks to facilitate open access to the transmission system. 

[[Page 66187]]

a. Introduction
    The What Report starts with a number of general assumptions and 
definitions. They include phasing of RIN implementation (Phases I and 
II), functional separation, accessibility to the RIN and definitions 
for ``transmission provider'', ``transmission customer'', and 
``transmission provider's tariff.'' The What Report for the most part 
only addresses recommended Phase I requirements.
    The What Report states that the RIN will include viewing tools 
enabling equivalent, basic access to the data base for all RIN users. 
However, many users will desire to customize their access to the data 
base and have the information presented in a variety of ways tailored 
to their individual needs. The RIN itself will not seek to satisfy this 
need. Instead, private software developers will be permitted and 
encouraged to develop and market customized viewing tools for the RIN.
    The What Report lists five objectives of the RIN which are 
discussed in section C.2.(a) below. It recommends that, at least 
initially, the RIN be used as a transmission service reservation 
system, and not as a transmission scheduling system. Scheduling 
involves actually implementing a service on control area computers. 
Thus, the RIN is separate from system operations, and system 
reliability is handled separately. The decision to include transmission 
service scheduling on the RIN is left to later development.
    Finally, the report discusses the requirement that information 
posted on the RIN will be date and time stamped and automatically 
stored in downloadable log files so that audits can be performed as 
required.
b. Scope and Definitions
    The second section of the report deals with scope and definitions. 
The What Report makes a distinction between ``near-term'' and ``far-
term'' transmission service requests. ``Near-term'' requests can be 
responded to quickly without additional work. ``Far-term'' requests 
require off-line studies to determine if the request for service can be 
accommodated.
    The What Report also states that it does not seem possible to post 
availability for Network Integration Service Transmission on the RIN. 
Therefore, only the available transmission capability (ATC) for point-
to-point transmission service would be posted on the RIN.
    The What Report discusses the concept of ATC and gives some 
consideration to calculating it. Although the What Report recognizes 
that a consistent methodology is needed, no such methodology is 
proposed in the report.
    The What Report discusses the concept of ``transmission paths'' for 
which ATC is to be reported and provides some guidelines for 
calculating ATC. It appears from the discussion in the What Report that 
ATC calculations over transmission paths would reflect the impacts of 
parallel flows. Although a contract path can be the basis for a 
commercial transmission transaction, such a transaction will use a 
combination of one or more transmission paths. A transmission path may 
be a single path or sequence of contiguous paths that form a continuous 
electrical connection. In alternating current systems, electricity will 
not flow solely on the contract path, but will flow on the entire 
transmission system of the interconnection in accordance with the laws 
of physics. Transmission Providers are urged to develop regionally 
accepted methods of attributing all contributions of loading to each 
transmission path including the effects of the real flow contribution 
of all transactions.
    A major concern for the ``what'' working group (What Group) is over 
potential differences between the ATC posted on the RIN and the 
capability actually available when requested. The What Report points 
out that ATC calculations are only engineering estimates. There is no 
guarantee that they are correct. It states that ``[t]he amount of ATC 
posted shall be that amount that the Responsible Party expects, in good 
faith, to be available on a specific interface or Path in a specific 
direction, based on engineering analysis and other information that is 
available to the Responsible Party at the time of the posting.'' 9 
Also, conditions may change between the time the ATC is calculated and 
when service is requested.

    \9\ What Report at 8.
---------------------------------------------------------------------------

    Under the What Group's proposal, the posting of ATC is not to be 
required until a business need arises for a transmission path. ``A 
`business need' is signified by a request from a Transmission Customer 
concerning information or a reservation on a Path which has the 
potential to be constrained.'' 10 The What Report proposes two new 
attributes for transmission service to replace the terms ``firm'' and 
``non-firm'' that are believed to be causing confusion as to the basic 
nature of transmission services. The new attributes are recallability 
and curtailability. All transmission service is curtailable. 
Curtailment is made only in cases ``where system reliability is 
threatened and/or emergency conditions exist.'' 11 Recallability 
is ``the right of a Transmission Provider to interrupt all or part of a 
transmission service for any reason that is not unduly discriminatory * 
* * .'' 12 The What Report states that recallability distinguishes 
between firm and non-firm service. According to the What Report, firm 
service is not recallable.

    \10\ What Report at 10.
    \11\ What Report at 15.
    \12\ What Report at 14.
---------------------------------------------------------------------------

    The What Report defines a standard set of attributes for describing 
transmission products on the RIN.
    The scope and definitions section concludes with discussions of 
several areas of non-consensus. The What Group could not agree on the 
following: whether and how to post information about ancillary services 
on the RIN; whether transmission customers not using transmission 
capability that they reserve must make it available to others; whether 
to post all discounts or only those provided to affiliates; and whether 
generator cost and status information to verify redispatch/opportunity 
cost charges must be available on the RIN.
c. Posting Transaction Information
    The Posting Transaction Information section discusses four major 
types of information that are to be posted on the RIN:
    1. Available Transmission Capability Information;
    2. Transmission Providers' Product Offerings and Prices;
    3. Specific Transmission Service Requests; and
    4. Informal Transmission Communications.
    The What Report itemizes the information that should be posted in 
each of these areas. A table identifies who is responsible for posting 
what on the RIN. The What Group was unable to reach consensus on 
whether to require the posting of additional information beyond ATC. 
Some believe that additional information is needed as a safeguard 
against anti-competitive behavior and provides valuable information 
about transmission constraints. This information includes the run 
status of generators that have a significant impact on ATC, information 
about constrained transmission lines, and the identity and status of 
facilities causing curtailments. Others believe that this additional 
information is unnecessary and burdensome. This 

[[Page 66188]]
information also is believed to be commercially sensitive.
    A second area of non-consensus was whether individual transmission 
requests and responses should be made known only to the Transmission 
Customer making the request, the Transmission Provider to whom the 
request was made and, to the extent necessary, the affected control 
area operators and/or security centers or to all users of the RIN on a 
same-time basis. Some argue that this information is commercially 
sensitive and should be limited just to the parties in a transaction. 
Others believe that full disclosure is important to safeguard against 
potential anti-competitive behavior. A compromise was proposed, but not 
agreed to, to delay release of this information for a certain time.
2. Discussion
    The What Group assumed the task of developing recommended 
requirements for the information to be posted on a RIN that would meet 
the industry's need for customer access to information about wholesale 
transmission services. In the text that follows, we will discuss these 
recommendations and will identify those recommendations that at this 
stage we reject (as previously noted, further background is provided by 
the complete What Report, attached to this NOPR as Appendix ``A''). We 
also will discuss certain issues not addressed by the What Group.
a. RIN Objectives
    The Commission proposes to modify slightly the five objectives 
listed in the What Report. The changes are intended to expand and 
better define the objectives. The revised objectives are:

    1. Allow Transmission Customers to make requests for 
transmission services offered by Transmission Providers and the 
secondary market;
    2. Allow Transmission Customers to view and download in standard 
formats, using standard protocols, necessary information regarding 
the transmission system to enable prudent business decision making;
    3. Provide a mechanism for posting, viewing, uploading and 
downloading of information between customers and providers regarding 
available products and desired services;
    4. Enable all Transmission Customers to clearly identify the 
extent to which their transmission service requests and/or schedules 
were denied or curtailed and how their treatment compares to that of 
their competitors; and
    5. Allow Transmission Customers to access in electronic format 
information supporting ATC calculations and historical transmission 
service requests and schedules for various audit purposes.

    The What Report states that ``[i]n instances where requests are 
denied or transactions are curtailed, the RIN should provide a 
mechanism for Transmission Providers to communicate to Transmission 
Customers (1) the reason those transactions could not be accommodated 
and (2) the options, if any, for adjusting operation of the system to 
increase transfer capability in order to accommodate those 
transactions.'' 13 The Commission wishes to clarify that since 
scheduling and the curtailment of schedules will not be done through 
the RIN initially, this curtailment information would be for 
information purposes only.

    \13\ What Report at 6.
---------------------------------------------------------------------------

b. ATC for Network Integration Service
    The What Report states that it is not possible to post the 
availability of Network Integration Service Transmission on a RIN. The 
Commission recognizes that before-the-fact measurement of the 
availability of network transmission service is difficult. Nonetheless, 
the Commission believes that it is important to give potential network 
customers an easy-to-understand indicator of service availability 
(e.g., in MWs), in addition to power flow data and other studies used 
by utilities to support the calculation of ATC.

    Question 3. The Commission requests comments on how best to post 
the availability of network transmission service on the RIN. Should 
Transmission Providers be required to post conservative estimates as 
a preliminary matter that could be improved with additional study? 
Is there an alternative service concept that is more suitable to 
measurement than the current version of network service?

    As discussed in section C.2.(o) below, information supporting 
``point-to-point'' service ATC calculations is required to be available 
for download. This information should help potential network customers 
assess the availability of network service capability.
c. ATC Calculation Methodology
    The What Group notes that the proposed Open Access rule requires 
that the utility ``describe the method used to estimate ATC in 
sufficient detail to allow others to do the same analysis.'' 14 
However, the proposed Open Access rule does not propose a methodology 
for calculating ATC. The What Report contains some useful guidelines 
for calculating ATC/Total Transmission Capability (TTC), but does not 
present specific methodologies.

    \14\ What Report at 121.
---------------------------------------------------------------------------

    In calculating ATC, public utilities will need to reserve enough 
capacity to ensure the reliable operation of the transmission system. 
Thus, the Transmission Provider (or its designated agent) will need to 
calculate the additional transfer capability that is available without 
violating reliability limits. Because of uncertainties in system 
conditions and utilities' reliance on interconnections to provide 
generation reserves during emergencies, the Transmission Provider must 
calculate an appropriate transmission margin. Transmission margin 
calculations should be based on the published standards, criteria and 
guides, and operating experience of the individual Transmission 
Provider (as filed with FERC as part of FERC Form 715 and as filed in 
transmission tariffs). These calculations must be consistent with 
industry standards, and these standards must be available for review on 
the RIN.
    The Commission expects that an ATC/TTC calculation methodology can 
be developed on a consistent, industry-wide basis and encourages 
efforts to do so. We understand that some of the details may need to 
differ to reflect regional or utility- specific situations. 
Transmission Providers are expected to use prudent utility practice to 
determine ATC. The Commission understands that utilities have 
historically responded to requests for transmission service using 
prudent utility practice to determine if sufficient capacity is 
available to accommodate the request. These practices vary by region 
and even by utility. Determination of ATC has been made with computer 
software with a level of complexity that varies from one Transmission 
Provider to another or with simple formulas or graphical tools 
(nomograms) created with a mixture of engineering analysis and 
engineering judgment. The Commission requires the use of the best tools 
for determining ATC available to the Transmission Provider at the time. 
Our requirement to provide data and methods on the RIN is to be 
understood in this context; it may require, for example, posting of the 
nomograms, the data applied to them, a description of the procedure for 
applying the data to the nomogram, and an explanation of how the 
nomogram is derived.
    However, the Transmission Provider must strictly adhere to the 
limits imposed by the resulting ATC determination in its own use of 
transmission. It must also provide adequate data for the Commission and 
other industry participants to monitor 

[[Page 66189]]
any potential violations of the ATC limit by the Transmission Provider. 
Further, if the Transmission Provider revises its ATC calculation for 
any time period, the new availability of transmission capacity must be 
posted on the RIN in a manner that allows all transmission customers an 
equal opportunity to apply for its use.
    The Commission urges Transmission Providers to improve and 
coordinate methods of estimating ATC. This will improve the efficiency 
of capacity utilization by all parties, including the Transmission 
Provider itself, while maintaining system reliability. We expect that 
such improved methods and prudent utility practice in the future will 
require cooperative regional calculation of ATC by all Transmission 
Providers in a region. We believe that all Transmission Providers 
should take the same approach to calculating ATC/TTC and use the same 
basic methodology.

    Question 4. The Commission requests comment on how to develop a 
consistent, industry-wide method of calculating ATC/TTC.
d. Provisions for Unscheduled Flows
    The What Report states that ``[a]ppropriate provision must be made 
to properly account for ``unscheduled flow'' through each Path 
resulting from each known transaction.'' 15 This should not be 
interpreted as making the requirements in this proposed rulemaking 
depend on resolution of this issue.

    \15\ What Report at 8.
---------------------------------------------------------------------------

e. Paths for Which ATC Is Not Posted
    The What Report states that ATC should be posted for paths as 
business needs arise. Some Paths are minor ties between utilities or 
control areas for which transfer capability calculations have not yet 
been performed and on which no constraint is anticipated because of the 
lack of commercial activity. A ``business need'' is defined, in part, 
by a transmission customer requesting information about a path.
    The business need limitation is intended to limit the number of 
paths for which ATC must be posted. However, it is not clear that it 
does. For example, the Open Access rulemaking proposes that 
Transmission Providers must take wholesale transmission service under 
their own tariff. This makes them transmission customers. Any wholesale 
trade they do over these minor ties would appear to trigger the 
``business need'' requirement for ATC posting.
    Another approach to limiting the burden of ATC calculations is to 
allow Transmission Providers to adjust the amount of effort put into 
calculating ATC and the frequency of recalculating ATC based on the 
level of commercial interest in a path and how constrained the path is 
over time. For paths that are never constrained because of the lack of 
commercial activity, a rough estimate of capability could be posted and 
could be updated rarely. For constrained paths, a much more accurate 
calculation of capability is needed and it should be updated 
frequently.

    Question 5. The Commission requests comments on ways to minimize 
the burden of ATC calculations, while ensuring that wholesale 
transmission customers have the information they need.
f. Differences in ATCs
    Because parties on either side of an interface each may use 
different engineering assumptions, they may calculate different ATC 
values. The What Report says that the lower ATC must be used. The 
Commission expects that differences in ATCs will be small and will 
narrow over time as Transmission Providers work to develop consistent 
methods of calculating ATC.
g. Format for Transmission Tariffs
    The Commission agrees with the recommendation of the What Group 
that providers must provide downloadable files of their complete 
tariffs on the RIN. However, the What Report says that the format of 
these files should be one generally accepted by all utilities in the 
region. The issue of the format for the transmission tariffs will be 
addressed in the Open Access rule. This format would also be the format 
for tariffs available on the RIN.

    Question 6. The Commission requests comment on a standard format 
for electronic submission of transmission tariffs to the Commission.
h. Posting Requirements for Recallability and Curtailability
    The What Report states that ``[o]ther elements of Recallable 
service which will be posted on an EIN include: permissible reasons for 
recall, recall procedures, reinstatement provisions and placement in 
the request queue as applicable.'' 16 Because the permissible 
reasons for recall, recall procedures, and reinstatement provisions are 
defined in the tariff and the tariff is available for download on the 
RIN, they do not need to be posted separately.

    \16\ What Report at 14.
---------------------------------------------------------------------------

    Similarly, the report says ``curtailment information which will be 
posted on the RIN as part of the product definition includes: 
permissible reasons for curtailment, notice required, curtailment 
procedures, and curtailment priority relative to other classes and 
other customers in the same class if necessary due to FERC curtailment 
queuing policy.'' 17 The Commission proposes that if the 
permissible reasons for curtailment, notice required, curtailment 
procedures, and curtailment priority are defined in the tariff and the 
tariff is available for download on the RIN, they do not need to be 
posted separately.

    \17\ What Report at 15.
---------------------------------------------------------------------------

i. Communicating Curtailments and Denials of Requests for Service

    The Commission proposes that when requests for service are denied, 
or when transactions are curtailed, Transmission Providers must 
communicate to transmission customers, through a mechanism that they 
must install into the RIN: (1) The reason(s) that the transaction(s) 
could not be accommodated; and (2) the available options, if any, for 
adjusting the operation of the Transmission Provider's system to 
increase transfer capability in order to accommodate the 
transaction(s).

    Question 7. The Commission requests comments on what information 
about curtailments and denials of requests for service should be 
communicated on a RIN.
    Question 8. What specifications would be needed for information 
about curtailments and denials of requests for service to be posted 
in HTML displays and what specifications and formats would be needed 
to standardize downloadable files? 18

    \18\ HTLM stands for Hyper Text Markup Language.
---------------------------------------------------------------------------

j. Posting Information About Ancillary Services
    The What Group was unable to define requirements for the posting of 
information about ancillary services. Ancillary services are those 
services necessary to support the transmission of electric power from 
seller to purchaser at wholesale given the obligations of control areas 
and transmitting utilities within those control areas to maintain 
reliable operations of the interconnected transmission system. Basic 
wholesale transmission service without ancillary services may be of 
little or no value to prospective customers. A variety of ancillary 
services is needed in conjunction with providing basic wholesale 
transmission service to a customer. The following six ancillary 
services are identified in the Open Access NOPR: 19

    \19\ 60 FR at 17683-85.
---------------------------------------------------------------------------

    1. Loss Compensation Service;
    2. Load Following Service;
    3. System Protection Service; 
    
[[Page 66190]]

    4. Energy Imbalance Service;
    5. Reactive Power/Voltage Control Service; and
    6. Scheduling and Dispatching Service.
    The Commission proposes that the Transmission Provider post offers 
for ancillary services on the RIN. Other entities offering the same 
ancillary services shall have a comparable right to post offers on the 
RIN.

    Question 9. The Commission requests comment on where on the RIN 
offers by other entities to provide ancillary service should be 
placed. The What Report states that these offers should be posted in 
the ``Informal Transmission Communications'' section of the RIN. 
Would this place third-party providers at a disadvantage relative to 
the Transmission Provider?

    The Commission proposes that entities that post offers to provide 
ancillary services on the RIN should pay the costs associated with 
posting this information.

    Question 10. The Commission requests comments on how to 
determine the costs associated with posting ancillary services on 
the RIN.

    Question 11. With regard to information about offers to provide 
ancillary services provided by an entity other than the Transmission 
Provider, what specifications would be needed for this information 
to be posted in HTML displays and what specifications and formats 
would be needed to standardize downloadable files?

    The following information about ancillary services is important to 
wholesale transmission users and should be posted on the RIN:

     Ancillary services that are available from the 
Transmission Provider;
     Ancillary services that may be provided by the 
transmission customer or third parties;
     Price of each ancillary service;
     Which ancillary services, if any, are bundled with 
transmission service;
     Paths that the ancillary services information pertains 
to;
     Deviation band, if any;
     Whether the rates for any specific ancillary service 
would change if taken in combination with any other ancillary 
service, such as operating reserve and load following;
     Whether any technical limitations exist on who could 
provide specific ancillary services;
     Whether the rights of ancillary services are 
reassignable; and
     Identity of third party if ancillary services are being 
procured from a third party.

    Question 12. The Commission requests comment on whether there is 
any additional information needed about ancillary services that is 
not included in the list. Is any information on the list not needed?

    Although the ancillary service information on the RIN should be the 
most current information available to the Transmission Provider, the 
information on ancillary services will not change as frequently as the 
information on the capability availability. However, there is 
definitely a need to update ancillary services information on RIN on an 
ongoing basis.

    Question 13. The Commission requests comment on how often 
ancillary services information should be updated.

    Ancillary services information should be posted for each 
transmission path of the Transmission Provider for which ATC is posted. 
If there are exceptions to the general applicability of the ancillary 
services posting requirements because of technical limitations on a 
specific interface, it should be so stated.
k. Must Transmission Customers Resell Unused Capability?
    The What Report raised the question of whether Transmission 
Customers should be required to make available to other wholesale 
customers unused transmission capability to which they have rights. 
This issue is not a RINs issue and will be addressed in the Open Access 
rule.
l. Posting Information About Resales
    Although the What Report states that a Transmission Customer should 
be able to post its transmission capability rights for resale, it does 
not say where resale offers are to be posted on the RIN. This issue is 
addressed in section D.2(g)iv below.
m. Mechanism for Discounting Transmission Service Rates
    The What Report raises a question about whether all transmission 
rate discounts should be posted on the RIN on the basis that a 
competitive market can be achieved only through non-discriminatory 
discounting. An alternative posed in the What Report is to post only 
discounts that a Transmission Provider provides to itself or its 
affiliates. This is to police self-dealing and affiliate favoritism 
which are not an issue in other transactions. It is important to 
distinguish between an offer of a discount and a discount already 
given. The Commission is proposing, in the proposed standards of 
conduct, to require a Transmission Provider that offers any discount to 
itself or to its merchant function or an affiliate to offer, at the 
same time, on the RIN, comparable discounts for similar service to all 
Transmission Customers. As to discounts that the Transmission Provider 
has agreed to give to any Transmission Customer (affiliated or 
unaffiliated), the Commission is proposing that these discounts must be 
posted on the RIN within 24 hours after the agreement is entered into 
(measured from when ATC is adjusted in response to the agreement), and 
that they remain posted for 30 days.

    Question 14. The Commission seeks comment on whether all 
transmission discounts should be posted on the RIN, or only those 
provided to the Transmission Provider or its affiliates. If 
discounts are to be posted, when should this be done? Also, 
commenters should address whether requiring the Transmission 
Provider to offer ``comparable discounts for similar service to all 
transmission customers'' is necessary and/or sufficient to prevent 
unduly discriminatory pricing practices.

    The Commission proposes that the information about discounts to 
affiliates should be posted on the RIN using HTML displays and as files 
that are available for download.

    Question 15. Regarding information on affiliate discounts, what 
specifications are needed for the information to be posted in HTML 
displays and what specifications and formats are needed for the 
downloadable files?
n. Discussion of Generation Information Related To Redispatch/
Opportunity Costs
    Opportunity or redispatch costs are meant to compensate a party 
that gives up its right to wholesale transmission service so that 
another party can take service. The opportunity/redispatch costs 
associated with increasing the ATC of a constrained Transmission Path 
will depend upon the time, duration and nature of the requested 
transmission use because of the dynamics of system loads, economic 
dispatch, outages, loop flow, the types of generation resources 
involved, the availability and cost of energy storage, and other 
operating conditions expected during the time of use. The What Report 
raises the issue of whether the ability of the Transmission Provider to 
impose these costs on the Transmission Customer requires the posting of 
generator run status and cost information on the RIN.
    Transmission Providers may charge only for legitimate and 
verifiable opportunity/redispatch costs. Information needed to verify 
these costs is required to be provided to the Transmission Customer 
charged on request. This information is not required to be posted on 
the RIN.
o. Discussion of Providing Additional Information Beyond ATC
    The proposed rules on Open Access state that ``[t]he utility must 
make all data used in calculating the ATC 

[[Page 66191]]
publicly available.'' 20 This information must be available for 
download on the RIN.

    \20\ What Report at 121.
---------------------------------------------------------------------------

    Question 16. The Commission requests comments on how the data 
used in calculating ATC should be formatted. Should it be in free 
form text, predefined tables, or comma delimited ASCII files? If in 
free form text, should it be in plain ASCII text or in a word 
processor format, such as WordPerfect or Word?

    Question 17. The Commission requests comments on what is the 
appropriate time delay for making supporting information on ATC 
available. Should the Commission require specific formats for ATC 
supporting data? If so, what should the formats be?

Near-Term Transmission Information

    The What Report provides arguments for and against providing 
additional information beyond ATC on the RIN. Those entities who are 
against providing additional information argue that this information is 
of little practical use, sufficiently voluminous to substantially 
reduce performance of the RIN, and burdensome to provide. They further 
argue that some of this information is competitive data. Those entities 
who are in favor of providing additional information beyond ATC on the 
RIN argue that the additional information will increase the confidence 
of transmission customers in the validity of the posted ATC and that 
this information will help the transmission customers anticipate with 
greater certainty whether to attempt to request and schedule resources 
that may be subject to curtailment due to projected loading trends on 
certain system components.
    The Commission believes that the issue of customer confidence can 
be addressed through audits of posted ATC values or by raising the 
issue at regional forums or filing a complaint with the Commission. 
However, the Commission also believes that transmission customers 
should have as much pertinent information available as will enable them 
to make informed decisions about the relative quality of wholesale 
transmission services they intend to request and purchase.
    The Commission therefore proposes to require that Transmission 
Providers post information about those system elements that have a 
direct and significant impact on ATC. Such elements could include 
generators, transmission lines, phase shifters, series and shunt 
capacitors, static VAR compensators, special protection systems or 
remedial action schemes, etc. In addition, the Commission proposes to 
require the posting of actual path loadings in addition to the path 
schedules.

    Question 18. To keep the amount of information on the RIN 
manageable, the Commission requests comment on whether it is 
sufficient to provide information only about planned outages and 
return dates (for both planned and forced outages) for those system 
elements deemed to have a direct and significant impact on ATC and 
whether posting this information on the RIN would cause any 
confidentiality concerns.
    Question 19. Since many system elements can impact the ATC of a 
path, how should ``significant and direct impact'' be defined? Is it 
acceptable to limit the additional information to those system 
elements for which nomograms, derating tables, and operating guides 
have been developed?
    Question 20. Are there any difficulties, technical or otherwise, 
associated with posting actual path flows on the RIN?

    The ATC of some transmission paths is a function of run status and/
or megawatt output of certain generators. For example, the Southern 
California Import Transmission Nomogram is affected by the run status 
of units in the Palo Verde Generation Complex. When one or more of the 
Palo Verde units are not on line, the nomogram is reduced by several 
hundred megawatts.21

    \21\ A nomogram defines the interactive relationship of the 
transfer capability of a transmission path to other system 
conditions, especially power flows on one or more other transmission 
paths.
---------------------------------------------------------------------------

    Question 21. In cases where ATC of a path is a function of run 
status of one or more generators, is it sufficient to post the 
expected amount and date of changes to ATC on the RIN, corresponding 
to the planned outage or return dates of generators?
    Question 22. If operating guides, nomograms, operating studies, 
and similar information are to be made available on the RIN for 
download, would it be logical to expect that transmission customers 
will be able to deduce the run status of those generators which 
significantly and directly impact ATC by observing the changes to 
ATC?

Far-Term Transmission Information

    The What Report proposes that for ``far-term'' transmission service 
(over one year), firm service (non-recallable) ATC should be posted 
``seasonal[ly], by year, for years 1-10 (as available).'' 22 The 
caveat ``as available'' suggests that the What Group does not want 
utilities to have to perform additional transmission studies to 
calculate ``far-term'' ATCs beyond those done for normal planning and 
special requests.

    \22\ What Report at 24.
---------------------------------------------------------------------------

    The Commission agrees with this. However, we find the ``as 
available'' requirement vague. It appears to leave the posting of this 
information to the discretion of the Transmission Provider. For 
clarity, the Commission proposes to require that any planning or 
specifically requested studies of the transmission network performed by 
the Transmission Provider be provided on the RIN on a same-time basis. 
This would include only those parts of customer-specific 
interconnection studies that relate to network impacts.

    Question 23. The Commission requests comments on how 
transmission studies should be formatted for download from the RIN. 
Should they be in free form ASCII text, or in a word processor 
format, such as WordPerfect or Word?
p. Requested Start and End Times/Dates
    In the section in the What Report on ``Information Provided by 
Transmission Customer in Requesting Service'', under ``duration'' the 
report states that ``[t]his must correspond to full clock hour 
periods.'' 23 The Commission proposes to enhance flexibility by 
requiring instead that the duration must be a specific time as stated 
in the Transmission Provider's tariff.

    \23\ What Report at 26.
---------------------------------------------------------------------------

q. Transaction Anonymity
    The What Report raises a question about whether individual 
transmission requests and responses should be made known only to the 
Transmission Customer making the request, the Transmission Provider to 
whom the request is made and, to the extent necessary, the affected 
control area operators and/or security centers, or to all users of the 
RIN on a same-time basis. The Commission proposes to restrict 
information about the request and response process, while it is 
ongoing, to those parties directly involved.
    We believe that this procedure will be adequate because we are 
proposing standards of conduct that would require Transmission 
Providers to separate the functions of their marketing employees and 
their system operations employees and that would restrict access by 
wholesale marketing employees to information available on the RIN. 
Information about a completed request and response process should be 
recorded in the audit file.
r. Auditing Transmission Service Information
    The Commission proposes that RIN audit log files \24\ must be 
downloadable from the RIN in a standard format and must be retained on 
a rolling basis for three years from entry on the RIN.

    \24\ See What Report at 31.
---------------------------------------------------------------------------

    The Commission notes that transmission transaction prices are to be 

[[Page 66192]]
included in the information in the audit file proposed in the What 
Report.\25\ We do not consider price information concerning cost-based 
transmission services to be commercially sensitive. With respect to 
information concerning negotiations on transmission requests, we 
propose that such information not be posted unless an agreement to 
provide the transmission is reached.\26\ This information is to be 
available only in the audit file. In addition, if an agreement is 
reached, we propose that the identity of parties to transmission 
transactions be masked until a standard release period elapses. This 
release period should be a standard period after which it is commonly 
recognized that most information is no longer commercially sensitive. 
The Commission proposes that a reasonable standard release period is 30 
days after the date when the Transmission Provider's ATC was adjusted 
in response to the transaction; after that date all transaction data 
---------------------------------------------------------------------------
will be made available.

    \25\ See What Report at 31-32.
    \26\ An exception would be where the Transmission Provider 
offers discounts to its merchant function or an affiliate. As noted 
elsewhere, such information would need to be posted regardless of 
whether an agreement to provide transmission was reached.
---------------------------------------------------------------------------

    Question 24. The Commission requests comment on what information 
should be considered commercially sensitive, the 30-day release 
period proposal, and on how and when commercially sensitive 
information should be released to concerned parties before the 
standard release period. Should affiliated transactions be treated 
differently?

D. Technical Issues Concerning the Development and Implementation of 
RINS

1. Summary of the ``How'' Working Group Report
    After a review of the process used by the ``how'' working group 
(How Group) in formulating its views, and after consideration of the 
Group's efforts to invite input from a broad spectrum of industry 
segments, the Commission is satisfied that the How Group conducted its 
process in an inclusive and open manner. The How Group report (How 
Report) represents a broad agreement among all segments of the electric 
power industry. It presents the agreed minimum requirements for 
computer systems and associated communications facilities needed by 
public utilities to provide comparable access to transmission and 
ancillary services information by all wholesale transmission users.\27\

    \27\ The version of this report attached to this proposal 
intentionally omits Appendix C (Workshop Participants), Appendix D 
(Survey Questionnaire and Results), and Appendix F (Correspondence 
with ``What'' Working Group). The How Report, in its entirety, is 
posted on CIPS.
---------------------------------------------------------------------------

    The How Group proposes a two-phase approach. It believes that the 
Phase I implementation provides the information needed for the 
Commission's open access program and works well enough to communicate 
this information to customers. Under the How Group proposal, RINs would 
become fully functional in Phase II. The How Report recommends that 
Phase II requirements be implemented 24 months after the effective date 
of the final rule establishing Phase I RIN requirements.
a. Phase I Recommendations
    The How Group proposes that the required transmission service 
information be posted on RINs operated by the transmission-owning 
public utility, jointly with other utilities, or by a third party.\28\ 
Each RIN implementation, whether on behalf of a single entity or a 
group of utilities, is referred to as a Node. A RIN operated jointly by 
several utilities would be considered one Node. RIN Nodes must be 
accessible through the Internet. By connecting each Node through the 
Internet, transmission service information from each utility becomes 
part of a network. With a single Internet connection, customers would 
be able to access information from any utility and would even be able 
to display information from several Nodes at the same time.\29\

    \28\ How Report at Sec. 2.4.1 (a).
    \29\ How Report at Sec. 2.4.1 (f).
---------------------------------------------------------------------------

    Nodes must support the use of Internet tools. These inexpensive, 
widely available, and well-tested tools will permit customers to access 
RIN information easily and to download \30\ it to available desk-top 
database programs, spreadsheets, and other applications.\31\ Customers 
would also be able to upload \32\ information to RIN Nodes. The 
specific tools for doing so are described in Appendix B.

    \30\ Download refers to the transfer of a file from a RIN Node 
to the user's computer system.
    \31\ How Report at Sec. 2.4.1 (c).
    \32\ This is accomplished by transferring a file from the user's 
computer system to a RIN Node.
---------------------------------------------------------------------------

    RIN users would access Nodes using World Wide Web (WWW) 
browsers.\33\ Each Node would display information using the HTML 
protocol required by World Wide Web browsers. Screen displays would 
consist of a series of pages that may be viewed by customers without 
requiring them to download the pages.\34\ Under the standards that will 
accompany issuance of a final rule on RINs, the information on each 
page, but not the actual displays, must be standardized. Information 
would also be required to be made available for downloading, in a 
standardized ASCII \35\ format, using the Internet's File Transfer 
Protocol (FTP).

    \33\ The World Wide Web is a system of computer resources that 
are accessed through the Internet.
    A 
FR Doc. 95-30884 Real-Time Information Networks and Standards of Conduct; Notice of Proposed Rulemaking
Browser is a computer program for retrieving and reading 
hypermedia documents from the WWW. A hypermedia document can 
contain, text, graphics, video, sound or data. These documents are 
often linked to other documents.
    \34\ How Report at Sec. 3.2.3
    \35\ ASCII refers to the American Standard Code for Information 
Interchange, a code for character representation.
---------------------------------------------------------------------------

    In Phase I, customers would be able to use the RIN to purchase 
transmission from public utilities. They would be able to request 
capacity either by completing a standardized form contained in an on-
line HTML page or by uploading a filled-out form using FTP.\36\ 
Customers who want to resell transmission capacity would upload (post) 
the relevant information to the same RIN Node used by the primary 
provider from whom they purchased the ATC.\37\ Customers would also be 
able to upload Want Ads containing such information as requests to 
purchase transmission capacity.\38\

    \36\ How Report at Sec. 3.2.6.
    \37\ How Report at Sec. 3.2.4
    \38\ How Report at Sec. 3.2.3 (e).
---------------------------------------------------------------------------

    In Phase I, transmission-owning public utilities may, but would not 
be required to, provide private connections at the request of a 
customer. These connections could include leased-lines or connections 
to a private network. These connections would have to use the same 
Internet tools as are required for the Internet connection.\39\ 
Customers would pay for the cost of the connections. If a connection is 
made for one customer, the same type of private connection must be made 
available to all customers in a comparable manner. In Phase II, 
utilities would be required to provide these connections.

    \39\ How Report at Sec. 2.4.1 (g).
---------------------------------------------------------------------------

    The How Report proposes that utilities may provide value-added 
services for a fee on a fair and non-discriminatory basis. Such 
services would include notifying customers of changes in available 
capacity, beyond simply posting a notice of the change.\40\

    \40\ How Report at Secs. 3.1.2 (c) and 3.2.2.
---------------------------------------------------------------------------

    The How Group developed a model of the information requirements 
that the What Group identified as needed for comparable access. For 
Phase I, the model specifies the information that must be available at 
each RIN Node, how the information may be requested and the layout of 
the information received by customers. Customers would be limited to 
obtaining 

[[Page 66193]]
information from HTML text displays and selecting from menus of 
downloadable files. Customers would receive the information either as 
HTML pages or as ASCII files in a predetermined form and layout.
    The information model for Phase II, while not fully specified, 
would provide customers with much more flexibility in requesting and 
receiving information. Customers would be able to make complex queries 
of a data base and specify the order in which the information will be 
received.
    For security purposes, and as an aid in auditing performance and 
transactions, customers would be required to register with the 
transmission-owning utility or its agent before they are permitted 
access to the utility's transmission service information on the 
RIN.\41\

    \41\ How Report at Sec. 3.2.1.
---------------------------------------------------------------------------

    The How Report provides a number of performance standards and a 
limited set of security precautions. Performance requirements include 
sizing RIN Nodes to handle the loading of registered subscribers, 
responding to subscriber requests, backing up the system, and other 
areas that are necessary for the system to function as desired. 
Security precautions include firewalls \42\ between computer systems 
and the Internet, the use of passwords, the use of data encryption for 
uploads of sensitive or confidential information, and the use of ASCII 
text for uploads of other information.

    \42\ A firewall increases security by blocking access to certain 
services on a private network from the Internet.
---------------------------------------------------------------------------

b. Phase II Requirements
    The specifications for Phase II are less detailed than those for 
Phase I, but the How Group anticipates that Phase II RINs would be an 
upgrade of Phase I and would not make Phase I investments obsolete. 
Phase I is envisioned as a prototype for Phase II. Once Phase I becomes 
operational, the full information and functional requirements needed to 
support open access transmission service will become clearer. The How 
Report recommends the formation of a RIN Management Organization to 
develop Phase II standards for submission to the Commission. The How 
Group proposes that Phase II be implemented two years after issuance of 
the final rule on Phase I RIN requirements.
    The How Group foresees the need for several key additional 
requirements in Phase II.\43\ In Phase II, they foresee that RIN Nodes 
must provide connections to private networks if requested by a 
customer, for a negotiated cost-based fee, whereas in Phase I public 
utilities would not be required to make these connections. In Phase II, 
RIN Nodes would have to offer the capability of informing customers 
immediately when information of interest to them is changed by the 
provider. RIN Nodes would be required to support search and select 
tools to access information in RIN Node data bases, and to meet a more 
complete set of performance requirements.

    \43\ How Report at Sec. 2.4.2.
---------------------------------------------------------------------------

    In Phase II, the information model would change, although the 
information in the data base would be the same. Customers would be able 
to receive information by querying a data base. The information would 
no longer be received in a predetermined fixed layout. Customers would 
be able to specify the exact information they want to receive and the 
layout they want to receive it in. For example, customers would be able 
to request available capacity by quantity of capacity, point of 
delivery, date of availability, and have it sorted by the name of the 
transmission-owning public utility. The customer also would be able to 
define the order in which the information is received in the file.
2. Discussion
    The How Group assumed the task of specifying, in a very short 
period of time, a RIN that would meet the Commission's requirement for 
customer access to information about transmission services. It 
developed a proposed solution that places the RIN of each transmission-
owning public utility on a network that can be accessed by all 
customers, using inexpensive tools with a single connection, with what 
the group believes to be a reasonable cost to both utilities and 
customers, sufficient security, and sufficient response time. The 
proposal to use the Internet to tie RIN Nodes together appears to be an 
inexpensive way for customers to access transmission services 
information and for transmission-owning public utilities to provide it 
to them.
    The Commission proposes to adopt the proposals contained in the How 
Report, with the exceptions discussed below.\44\ Except where noted, 
the issues discussed are Phase I issues.

    \44\ The Report refers to Buy/Sell transactions. As used in the 
Report, the term refers to a request to purchase transmission 
capacity and the response to the request. The reader of the How 
Report should substitute Purchase request/Response for buy/sell 
whenever it is encountered.
---------------------------------------------------------------------------

a. Phasing
    Because of the complexity of building RINs, and the need to begin 
the Commission's transmission open access program promptly, the 
Commission agrees with the How Report that a phased approach to 
implementation is warranted. The Commission proposes to require Phase I 
implementation as of the effective date of a final rule on non-
discriminatory open access transmission and stranded costs.
    At How Group meetings, many transmission-owning public utilities 
expressed the view that implementing Phase I within 90 days of the date 
of a final RIN Rule may not allow sufficient time to design, build, and 
test RINs. The How Report notes that a large risk exists that many RINs 
will not be fully functioning at that time. These transmission-owning 
public utilities request that the Commission permit a six-month 
implementation period.

    Question 25. The Commission requests comments on how long the 
implementation schedule should be for Phase I.

    Phase I would provide a good first step toward ensuring that 
sufficient information is available to utility customers to achieve the 
Commission's goal of comparable access to transmission information. It 
would not, however, provide all of the performance requirements or 
information needed for a long-term open access RIN.
    Phase II would provide for more expanded services. The How Report 
addresses Phase II issues, but does not fully specify them. It proposes 
that Phase II be implemented within two years of a final rule on RINs. 
The Commission believes that the need for the additional functions and 
performance requirements proposed for Phase II requires expeditious 
implementation. Accordingly, the Commission requests that the industry 
continue the process of developing standards, and provide a consensus 
report to the Commission on Phase II recommendations by no later than 
January 1, 1997. We anticipate that this report would be the basis of 
supplemental RIN proceedings to implement Phase II RIN requirements.
b. Standards Issues
    Based on our experience with implementing standards for natural gas 
pipeline electronic bulletin boards,45 a 

[[Page 66194]]
major concern of the Commission is that the proposed standards be 
sufficiently unambiguous to provide consistent implementation of the 
standards on every RIN Node. Customers and other users of RINs should 
be able to use the same software to access all RIN Nodes and should be 
able to expect that procedures and data definitions will be the same on 
all Nodes. The Commission must ensure that every RIN Node would be 
presenting information that would be clearly understood.

    \45\ See Order No. 563, Standards for Electronic Bulletin Boards 
Required Under Part 284 of the Commission's Regulations, Final Rule, 
III FERC Stats. & Regs. para. 30,988 (1993); Order 563-A, Order on 
Reh'g, III FERC Stats. & Regs. para. 30,994 (1994); Order 563-B, 
Order Denying Reh'g, 68 FERC para. 61,002 (1994); Order 563-C, Order 
Accepting Modifications, 68 FERC para. 61,362 (1994); Order 563-D, 
Order Accepting Modifications, 69 FERC para. 61,418 (1994); Order 
563-E, Order Granting Clarification, 70 FERC para. 61,188 (1995).
---------------------------------------------------------------------------

i. Phase I Data Definitions for HTML Pages and File Transfers
    The information model, data dictionary and various templates 
appearing in the How Report specify the name, definition and format of 
the data items to be communicated on the RIN. They are intended to be 
the basis for the standards specifying file uploads and downloads and 
HTML displays. Because of the importance of these standards to the 
usability and uniformity of RINs, the Commission must ensure that 
downloadable and uploadable files will have the same unambiguous 
structure, field formats, units and definitions, etc., no matter which 
RIN Node they come from or go to. The Commission is similarly concerned 
that all WWW page displays, while not necessarily having the same 
appearance, contain the same information and use the same definitions, 
etc.

    Question 26. Does the How Report define HTML displays and 
downloadable files with sufficient clarity to permit public 
utilities to implement Phase I such that the downloaded files and 
HTML displays received by customers from each RIN have the same 
definitions, etc.? If not, what clarifications are needed? 
Similarly, are uploaded files sufficiently defined in the How 
Report?

    With these goals in mind, the Commission has compiled a series of 
templates (tables) that show in one place the specifications that 
appear in various sections of the How Report. The templates contained 
in Appendix ``C,'' are intended to help produce a consistent 
implementation of RIN requirements and highlight problems that could 
hinder consistent implementation of RIN standards.
    In Appendix ``C'', the Commission proposes to make changes to 
certain definitions, data formats, and specifications appearing in the 
How Report.
    Question 27. The Commission invites comment on the issues 
discussed in Appendix ``C''.

    The Commission proposes to add a price field to the templates that 
would specify available capacity and those templates associated with 
the purchase of capacity. The price field would allow primary providers 
to offer capacity to buyers at a discount. The price field in the 
available capacity templates would contain the initially offered price, 
whether this is the tariff price or a discount. Adding the price field 
to the templates for the purchase of capacity would allow buyers to 
offer a price for capacity below the posted price. Further discounts 
from any posted offered price could be negotiated. The price field in 
the purchase of capacity templates would permit customers to offer a 
price different than the offering price.
ii. Internet Browsers
    There are a large number of Internet browsers available 
commercially and in the public domain. The How Report proposes that 
browsers support ``at least'' HTML version 3 and ``optionally'' support 
Secure Sockets Layer. The HTML standards used by browsers change from 
time to time, and, in addition, various browsers can support different 
extensions to the standards. The Commission does not want to stifle 
innovation, but at the same time it does not want chaos on the RIN. The 
Commission does not want customers to be forced to use different 
browsers for different RIN Nodes. The Commission wants to ensure that a 
customer will be able to choose a browser and use it to access all RIN 
Nodes.

    Question 28. The Commission requests comments on how to ensure 
that a customer will be able to choose a browser and use it to 
access all RIN Nodes.
iii. Bandwidth of Node Connections to the Internet
    The How Report proposes a formula to calculate the minimum 
bandwidth connection between a RIN Node and the Internet using the 
criteria of customers receiving data at the rate of 8,000 bits per 
second.46 This speed may be adequate for customers reading HTML 
pages, which are about 8,000 bits in size, but it might be too slow for 
customers downloading many 100,000 byte files.47 Eight thousand 
bits per second is much slower than the 28,800 bit per second telephone 
connections many private individuals use to connect to the Internet. 
Electric utilities will likely have even faster direct connections to 
the Internet. The Commission is concerned that the basis for the 
calculation in the Report will lead to connections that are too slow 
and proposes to use 28,800 bits per second instead of 8,000 bits per 
second in the bandwidth formula.

    \46\ How Report at Sec. 3.4.3.
    \47\ A bit is the smallest unit of computer data and can have a 
value of zero or one. A byte is eight bits and is often used to 
represent a character of text.
---------------------------------------------------------------------------

    Question 29. The Commission requests comments on the use of 
28,800 bits per second in the calculation of the minimum bandwidth 
connection between a RIN Node and the Internet in the formula 
appearing in the How Report.
iv. Common Codes
    The How Report does not address a standardized method of uniquely 
identifying transmission-owning public utilities and customers, nor 
does it address a standardized method of identifying facilities.
(1) Company Codes
    The Commission's experience with implementing standards for file 
transfers and electronic bulletin boards in the natural gas industry 
shows that the use of a common system of identifying companies enhances 
the efficiency of data transfers. The Commission is satisfied with the 
results of using DUNS numbers 48 as the standard to uniquely 
identify pipelines and shippers in the natural gas transactions.49 
The Commission proposes to require the use of DUNS numbers to identify 
transmission-owning utilities and customers on RIN Nodes.

    \48\ DUNS numbers refer to the Data Universal Numbering System, 
maintained by Dun and Bradstreet.
    \49\ See Standardized Data Sets and Communication Protocols for 
Electronic Bulletin Boards in Docket No. RM93-4, Order 563(a), supra 
n.45, Reg. Preambles at 31,034.
---------------------------------------------------------------------------

    Question 30. The Commission requests comments on the use of DUNs 
numbers to identify RIN participants.
(2) Common Location Codes
    The Commission's experience in the natural gas industry also 
demonstrates that a common method of uniquely identifying location 
points will be needed to facilitate movement of power across the grid. 
The natural gas industry uses a sophisticated system of ``smart'' codes 
(PI-GRID Codes), developed by the Petroleum Information Corporation. 
This coding system uses ``smart'' codes, which identify each 
transaction point by such items as state, county, latitude, longitude 
and type of facility.50 Thus, the code will tell RIN users where a 
posted receipt, delivery point or path is 

[[Page 66195]]
located, the function it performs, and whether there are multiple 
facilities at that location. The Commission proposes to use a smart 
code system to identify location, including paths, on the electric 
transmission grid.

    \50\ See Order 563(c), supra n.45, 68 FERC at 62,462-65.
---------------------------------------------------------------------------

    Question 31. The Commission requests comments on how to develop 
common location codes for the electric power industry.
v. Data Compression Standards
    The How Report recommends that RINs support data compression of 
downloadable and uploaded files, using standard, commonly available 
compression applications.51 The Commission believes that data 
compression will speed up the transmission of files. However, it 
believes communication of the RIN information would be enhanced if 
every RIN Node used the same compression techniques.

    \51\ How Report at Sec. 3.3.8 (c).
---------------------------------------------------------------------------

    Question 32. The Commission requests comments on what data 
compression technique or techniques should be made standard for all 
RIN Nodes.
vi. Templates for Upload and Download Header Information
    The How Report does not completely specify how to use the upload 
and download header templates in Phase I.52 The templates require 
a series of header fields specifying such information as: (1) who is 
sending the data; (2) the kind of data, such as Provider Hourly 
Capacity Available for Purchase; (3) the column headings of the data; 
and (4) the number of rows of data. This header information is followed 
by rows of actual data. The discussion of the template does not specify 
delimiters between rows of data. The result would be that an entire 
file of Provider Hourly Capacity Available for Purchase downloaded from 
a RIN Node would be received as one long record. However, customers 
downloading data into personal computer spreadsheets may have trouble 
using the information since spreadsheets cannot handle very long 
records. To remedy the problem the Commission proposes to require, at 
least for Phase I, the sending RIN Node to separate each row of data 
with carriage return and line feed characters. Similarly, customers 
uploading data to a RIN node would separate each row of data with 
carriage return and line feed characters.

    \52\ How Report at Sec. 3.3.8.
---------------------------------------------------------------------------

    Question 33. The Commission requests comments on whether the 
upload and download templates are sufficiently specified to be 
functional and whether they are sufficiently specified to permit all 
RIN Nodes to implement them in the same way.
c. Costs
    Transmission-owning public utilities will be entitled to recover 
reasonable expenses associated with developing and running RINs. The 
costs of developing and operating the system will generally be fixed 
and not attributable to individual users. The Commission, therefore, 
proposes to roll these costs into wholesale transmission rates. The 
Commission also proposes to permit costs that can be identified as 
dependent on usage to be charged as usage fees to individual customers.

    Question 34. The Commission requests comments on whether it 
should allow the recovery of reasonable expenses associated with 
developing and running RINs by rolling these costs into wholesale 
transmission rates. How should fees associated with RIN usage be 
calculated and recovered?
d. Access to RIN Information by the Public
    The Commission believes that the registration procedures described 
in the How Report are useful security tools.53 The Commission also 
believes that the Commission, state regulators, and the public should 
have access to transmission services information consistent with the 
need to maintain the security of the system.54 The Commission, 
therefore, proposes that once Commission Staff and members of the 
general public have complied with the requisite registration 
procedures, they be granted ``read only'' access to RINs.

    \53\ How Report at Secs. 3.2.1 (b)-(f).
    \54\ cf. 16 U.S.C. 824l.
---------------------------------------------------------------------------

e. The Number of RIN Nodes
    The How Report does not put a limit on the number of RIN Nodes, but 
raises the issue of how many RIN Nodes there should be.55 Public 
utilities would be permitted to combine the function of their RINs into 
a single Node. Consequently, there could be as many Nodes as there are 
transmission-owning public utilities or only a very small number of 
Nodes. The How Group sees merit in a small number of Nodes and goes on 
to suggest a small number of Nodes be actively encouraged in order to 
minimize the networking management requirements for the RIN and to help 
ensure seamlessness of access. On the other hand, it recognizes that 
the advantages of a small number of separate Nodes must be weighed 
against the complexity and size that each Node would have to be to 
handle the correspondingly large number of transmission-owning 
utilities.

    \55\ How Report at Sec. 3.1.2 (f).
---------------------------------------------------------------------------

    Question 35. The Commission requests comments on whether it 
should encourage a small number of RIN Nodes.
f. Connections to Third Party Networks
    The How Group proposes, in Phase I, to permit transmission owning 
utilities to provide connections to private networks, if requested to 
do so. In Phase II, the How Group proposes that public utilities be 
required to provide these connections. It proposes that customers be 
required to pay the cost of the connections and the connections would 
be required to use the same Internet tools as are required for the 
Internet connections.
    The Commission believes that private networks and third party 
services can provide valuable contributions to the successful operation 
of RINs. The Commission, therefore, proposes to require utilities to 
provide private connections in Phase I. As proposed by the How Group, 
the cost of the connections would be paid for by the customers making 
the requests and the networks would be required to use Internet tools.

    Question 36. The Commission requests comments on whether 
transmission owning utilities should be required, in Phase I, to 
provide connections to private networks.
g. Unresolved Issues
    The How Group was unable to resolve a number of issues. Many of 
them concern issues covered by the What Group and are discussed 
elsewhere.56 The Commission requests comments on the following 
unresolved issues.

    \56\ Supra at 40-60.
---------------------------------------------------------------------------

i. Price Discrimination Issues
    The How Report would permit public utilities to offer value-added 
RIN services above the basic level of service. The Commission proposes 
to allow these services. However, such services would remain cost based 
until the Commission is satisfied that market-based (value added) rates 
should be allowed for such services. Requests for market-based rates 
for such services will be addressed, initially, on a case-by-case 
basis.
    Some customers are concerned that price could be used to 
discriminate between customers if public utilities are permitted to 
charge for different optional services, such as higher speed 
connections, value-added services, and automatic notification of 
changed data. If public utilities charge relatively high prices for 
these additional services, then some customers may not be able to 
afford them. These customers fear, for example, that they could be 
effectively 

[[Page 66196]]
locked out of the transmission market if they could rarely get timely 
access to the queue for purchasing transmission access.
    These customers felt that the Commission should monitor and 
possibly regulate the prices charged for the services to ensure that 
they were non-discriminatory.
ii. Transmission Services Information Timing Requirements
    The How Group proposes several timing requirements for posting 
transmission service information and suggests that the requirements be 
reviewed for reasonableness, possibly during Phase I. The Commission 
believes that some timing requirements should be operative during Phase 
I.

    Question 37. The Commission requests comments on whether the 
following How Group Proposals are adequate:
    (1) Transmission Service Information Availability: The most 
recent Provider transmission service information, including updates 
reflecting power system changes, shall be available to all Customers 
within 5 minutes of its scheduled posting time at least 98 percent 
of the time. The remaining 2 percent of the time the transmission 
service information shall be available within 10 minutes of its 
scheduled posting time;
    (2) Notification of Posted or Changed Transmission Service 
Information: Notification of transmission service information posted 
or changed by a Provider shall be made available within 60 seconds 
to all subscribed Customers who are currently connected; and
    (3) Acknowledgment by the Transmission Service Information 
Provider: Acknowledgment by the transmission service information 
provider of the receipt of Customer purchase request/response 
requests shall occur within 1 minute for Phase I. The actual 
negotiations and agreements on purchase request/response requests do 
not have time constraints. For Phase II, acknowledgment shall occur 
within 30 seconds.
iii. The Posting of Capacity Available for Resale
    The How Report also raises issues concerning posting of capacity to 
be resold.57 The report requires the reseller to post the relevant 
information on the Node of the facility owner.58

    \57\ How Report at Sec. 6.6.
    \58\ How Report at Sec. 3.2.4.
---------------------------------------------------------------------------

    The Commission is concerned that unless primary capacity and 
secondary capacity appear in the same location on the Node and require 
the same forms to be filled out and the same procedures followed, the 
capacity for sale by the facility owner will be easier to find and 
purchase, thereby giving the facility owner a competitive advantage. 
Therefore, the Commission proposes that secondary capacity be posted on 
the same page, using the same tables as similar capacity being sold by 
the facility owner.

    Question 38. The Commission requests comments on how to redesign 
the download templates in Appendix C so that primary and secondary 
capacity can be offered through downloadable files that have the 
same format. The Commission also requests comments on how primary 
and secondary capacity can be displayed in the same tables on a RIN 
Node.
    Question 39. What is the best way to handle the purchase request 
and response process when primary and secondary capacity appear in 
the same RIN displays and files?

    The Commission proposes that resellers pay the costs associated 
with posting this information on the RIN.

    Question 40. The Commission requests comments on how to 
determine the costs associated with posting resales on the RIN?

E. Standards of Conduct

    The What Group and the How Group both focused on the specific 
issues that the participants at the Technical Conference agreed that 
they should address. Nevertheless, other important RINS-related issues 
must also be decided. One such issue is whether the Commission needs to 
promulgate generic standards of conduct for jurisdictional utilities in 
the electric industry akin to the ones that we promulgated for the 
natural gas industry,59 or whether this issue should be decided on 
a case-by case basis. For the reasons explained below, we propose to 
address this issue on a generic basis by issuing Standards of Conduct 
patterned on those we promulgated for the natural gas industry.

    \59\ See 18 CFR Part 161. See also the primary Commission orders 
addressing natural gas pipeline marketing affiliate regulation, and 
the other cases cited therein: Order No. 497, 53 FR 22,139 (June 14, 
1988), III FERC Stats. & Regs. para. 30,820 (1988); Order No. 497-A, 
order on rehearing, 54 FR 52,781 (December 22, 1989), III FERC 
Stats. & Regs. para. 30,868 (1989); Order Nos. 566, 59 FR 32,885 
(June 27, 1994), III FERC Stats. & Regs. para. 30,997 (1994); Order 
No. 566-A, order on rehearing, 59 FR 52,896 (October 20, 1994), 69 
FERC para. 61,044 (1994); Order No. 566-B, order on rehearing, 59 FR 
65,707 (December 21, 1994), 69 FERC para. 61,334 (1994); appeal 
docketed, Conoco, Inc. v. FERC, D.C. Cir. No. 94-1745 (December 13, 
1994).
---------------------------------------------------------------------------

    As we stated in the RIN Notice,

    Any requirement we establish must have safeguards to ensure that 
public utilities owning and/or controlling transmission facilities 
use the same procedures and meet the same substantive requirements 
when they arrange transmission to support their wholesale sales and 
purchases as are required for third parties. Further, we expect that 
each public utility (or a control area operator acting as its agent) 
that provides transmission service must, at a minimum, give its 
customers electronic access in real time to information on 
transmission capacity availability, ancillary services, scheduling 
of power transfers, economic dispatch, current operating and 
economic conditions, system reliability, and responses to system 
conditions * * *
    This means that public utilities or their agents must give 
competitors and other users of the transmission system access to the 
same information available to the public utility personnel who trade 
(sell or purchase) power in the wholesale market, and at the same 
time. Moreover, this information cannot be declared privileged (and 
kept from competitors) if it is available to the company's own 
employees who trade wholesale power. Thus, if a utility wishes to 
keep this information confidential, it must assign control over this 
information to employees whose duties do not involve trading in 
wholesale power, and it must implement procedures to ensure that the 
traders do not get access to the information unless and until that 
information becomes public. The Commission invites parties to 
comment on the best way to implement these requirements * * *

    In response to this discussion and the accompanying request for 
comments, the comments (in preparation for the technical conference) 
debated how the control room could be functionally unbundled. 
Currently, marketing and transmission functions are performed in the 
same control room and sometimes these functions are performed by the 
same people. However, same-time access to transmission information 
means that, somehow, these functions must be separated. A related 
matter that we are concerned about is the potential for informal 
communication among colleagues if utility traders have preferred access 
to limited access control rooms and buildings.
    In discussing this issue, the commenters asked--how much separation 
is enough? They wondered whether the Commission would set requirements 
for separating marketing and transmission functions and, if so, what 
those requirements would be. Commenters came down on both sides of this 
issue. The East Texas Cooperatives and the Ohio PUC believe that 
separation is essential. American Electric Power points out that 
requiring the transmitting utility's marketing personnel to use only 
that transmission information posted on a RIN would be a powerful 
incentive for utilities to provide adequate disclosure on the RINs (or 
else the marketing employees couldn't properly do their jobs). El Paso 
Electric and Houston L&P are concerned about the reliability 
consequences of separating control room functions. NYSEG and Sierra 
Pacific do not believe 

[[Page 66197]]
that separating control room functions is needed.
    Additionally, this issue was renewed by the power marketers, in the 
discussion of non-consensus issues in the What Report and in separate 
comments, where they argued that a lack of organizational separation 
and the absence of formal standards of conduct similar to those the 
Commission imposed on natural gas pipelines undermines their confidence 
in functional unbundling and the RIN. In the absence of such standards, 
the marketers request that voluminous supplemental information about 
transactions be posted on the RINs.
    To help ensure non-discriminatory access to information, the 
Commission believes it is appropriate to impose standards of conduct 
for Transmission Providers. Therefore, we are proposing standards that 
would require Transmission Providers to separate their wholesale 
merchant functions (i.e., purchases or sales for resale of electric 
energy in interstate commerce) from their wholesale transmission system 
operations and reliability functions, and that would further require 
employees performing merchant functions to obtain access to information 
on wholesale transmission services through the RIN, on the same basis 
available to all other RIN users.
    In deciding this issue, we have been influenced by the differing 
views expressed by interested persons as to what conduct should be 
deemed proper or improper, our experience in the gas industry, and the 
generic nature of these issues. We have concluded that the industry 
needs explicit guidelines on separating transmission and power trading 
functions. In formulating proposed standards of conduct, our goal is to 
prevent employees of the Transmission Provider that perform merchant 
functions from having preferential access to any relevant information 
about the Transmission Provider's wholesale transmission availability 
and costs. In other words, those employees should not have access to 
any relevant information that is not also available to all wholesale 
transmission customers and potential wholesale transmission customers, 
regardless of whether this information is obtained through access to 
the control center, access to other locations or files, or through 
informal communications.

    Question 41. Are the standards of conduct proposed herein 
sufficient? Should they be modified in any way?

    Question 42. In particular, if the Commission in its final rule 
requires functional unbundling of all transmission from generation, 
how would these standards of conduct need to be modified? Would any 
other organizational changes need to be made? Would any 
modifications be needed with regard to ancillary services?

    We note that, although formal rules prescribing standards of 
conduct were deemed necessary in the natural gas industry, the 
potential for improper communications between transmission and trading 
personnel is even more of a concern for electric utilities than for gas 
pipelines. Absent divestiture, transmission and power trading jobs will 
be performed by individuals working for the same company (or corporate 
group). These tasks have traditionally been done in the same control 
room and, in some cases, are now being performed by the same person.
    We believe that explicit guidance would be helpful to all 
concerned. Transmission Providers will have a better idea of what 
conduct is permissible and what is impermissible. Customer complaints 
on preferential access should be minimized. Enforcement efforts by the 
Commission will be easier when specific guidelines are available. 
Additionally, to the extent this standard of conduct allays concerns 
about improper conduct, it could reduce what information needs to be 
posted on the RIN.
    In the event that Transmission Providers are concerned that this 
proposal somehow will impede system reliability, we invite them to 
articulate their concerns in their comments by addressing the question 
below.

    Question 43. Would the Commission's proposed separation of 
functions jeopardize system reliability? If so, what other mechanism 
would provide wholesale transmission customers and potential 
customers with assurance that they would be obtaining access to the 
same information, at the same time, as that used by transmission 
providers in making their own wholesale transmission purchasing 
decisions?

F. Applicability

1. Non-Public Utility Transmission Providers
    As with the requirements in the Open Access NOPR, the RINs 
requirement applies only to public utilities. Issues relating to 
potential gaps in the provision of comparable open access to wholesale 
transmission services or access to transmission information due to the 
fact that the requirements do not apply to non-public utilities will be 
addressed in the Open Access rulemaking proceeding. Although the RINs 
requirements would not apply to non-public utilities, the Commission 
expects non-public utilities to provide comparable access to wholesale 
transmission information under the reciprocity provision in the Open 
Access rule pro forma tariffs.
    In this regard, we also note our general authority under section 
311 of the Federal Power Act, 16 USC Sec. 825j (1994), to secure 
information (and conduct appropriate investigations) concerning, among 
other things, the transmission of electric energy throughout the United 
States, regardless of whether such transmission is otherwise subject to 
our jurisdiction.

    Question 45. The Commission requests comments on whether and to 
what extent the Commission should exercise this statutory authority 
to extend the RINs requirements to non-public utilities that own 
and/or control facilities used for the transmission of electric 
energy in interstate commerce.

    Question 46. Should reciprocity require that a non-public 
utility (such as a co-op or publicly-owned utility) have a RIN?
2. Public Utilities Having No Transmission Facilities With Commercial 
Value
    Some public utilities claim that none of their transmission 
facilities that could be used to provide wholesale service has 
commercial value that would justify the burden and expense of 
developing and maintaining a RIN. Although the Commission would still 
require same-time access to wholesale transmission and ancillary 
service information, simpler means of satisfying this requirement may 
be considered for utilities with wholesale transmission of little 
commercial value.

    Question 47. In light of the proposal in the How Report to use a 
low cost Internet-based approach, the Commission requests specific 
comments on circumstances in which the RINs requirements are 
believed to be an unnecessary burden. Are there less burdensome ways 
to meet the same-time access requirement in circumstances where the 
utility's wholesale transmission facilities have little commercial 
value? What criteria should the Commission use in determining 
whether and when to relax the RINs requirements?

IV. Regulatory Flexibility Act

    The Regulatory Flexibility Act (RFA),60 requires the 
Commission to describe the impact a proposed rule would have on small 
entities or to certify that the rule will not have a significant 
economic impact on a substantial number of small entities. The entities 
that would have to comply with the proposed rule are public utilities 
and transmitting utilities that do not fall within RFA's definition of 

[[Page 66198]]
small entities.61 Therefore, under section 605(b) of RFA, the 
Commission hereby certifies that this proposed rule will not, if 
promulgated, have a significant economic impact on small entities 
within the meaning of RFA. Accordingly, no regulatory flexibility 
analysis is required pursuant to section 603 of RFA.

    \60\ 5 U.S.C. 601-612.
    \61\ See 5 U.S.C. 601(3) and 601(6) and 15 U.S.C. 632(a).
---------------------------------------------------------------------------

V. Environmental Statement

    Commission regulations require that an environmental assessment or 
an environmental impact statement be prepared for a Commission action 
that may have a significant effect on the human environment.62 
Although this regulation does not directly affect any physical 
transmission facilities, but merely proposes the electronic posting by 
computers of certain information about transmission availability and 
prices, it nevertheless is being covered by the environmental impact 
statement being prepared in the Open Access NOPR proceeding in Docket 
Nos. RM95-8-000 and RM94-7-001. Thus, no separate environmental 
assessment or environmental impact statement is being prepared for this 
proposed rule.

    \62\ Regulations Implementing National Environmental Policy Act, 
Order No. 486, 52 FR 47897 (Dec. 17, 1987); 1986-90 Regs. Preambles 
FERC Stats. & Regs. para. 30,783 (Dec. 10, 1987) (codified at 18 CFR 
Part 380).
---------------------------------------------------------------------------

VI. Information Collection Statement

    There are approximately 328 public utilities, including marketers 
and wholesale generation entities. The Commission estimates that 
approximately 166 of these utilities own and/or control facilities used 
for the transmission of electric energy in interstate commerce and thus 
are subject to this proposal. However, since the operation of a RIN 
will be closely associated with control areas, we assume that RINs will 
be developed at the control area level and not by each public utility 
that owns and/or controls interstate transmission facilities. We 
estimate, therefore, that 84 respondents will be required to collect 
information. We believe that this estimate is conservative because some 
regions are likely to develop a region-wide RIN that will cover more 
than one control area.

Information Collection Statement

    Title: FERC-717, Real-Time Information Network Standards.
    Action: Proposed Collection.
    OMB Control No: None.
    Respondents: Business or other for profit, including small 
business.
    Frequency of Responses: On Occasion.
    Necessity of the information: The Notice of Proposed rulemaking 
solicits public comments to respond to the uniform requirements for a 
Real-time information network (RIN) established by the Commission to 
ensure simultaneous access to information on transmission service. The 
proposed requirements were developed after technical conferences with 
industry to ensure that safeguards are installed to provide procedures 
and substantive requirements for all parties seeking transmission 
service. These requirements would support arrangements made for 
wholesale sales and purchases for third parties. Public utilities and/
or their agents would give competitors and other users of the 
transmission system access to same information available to the public 
utility personnel who initiate the acquisition or disposition of power 
in the wholesale market and at the same time. The Commission would use 
the information to monitor the networks to ensure that potential 
purchasers of transmission services obtain the services on a non-
discriminatory basis.
    The Office of Management and Budget's (OMB) regulations,63 
require OMB to approve certain information collection requirements 
imposed by agency rule. The information collection requirements in the 
proposed rule will be reported directly to transmission users and will 
be subject to subsequent audit by the Commission. The distribution of 
these data will help the Commission carry out its responsibilities 
under Part II of the FPA.

    \63\ 5 CFR 1320.11.
---------------------------------------------------------------------------

    The Commission is submitting notification of this proposed rule to 
OMB. Interested persons may obtain information on the reporting 
requirements by contacting the Federal Energy Regulatory Commission, 
888 First Street, NE., Washington, DC 20426 [Attention Michael Miller, 
Information Services Division, (202) 208-1415], and to the Office of 
Management and Budget [Attention: Desk Officer for the Federal Energy 
Regulatory Commission (202) 395-3087].

VII. Public Comment Procedure

    This NOPR gives notice of our intention to add Part 37 to the 
Commission's Regulations. As described in the discussion above, under 
this proposal each Transmission Provider would be required to create 
and participate in a RIN, to ensure that potential purchasers of 
transmission services have access to information to enable them to 
obtain open access transmission services on a non-discriminatory basis 
from the Transmission Provider. Additionally, the proposal would 
require public utilities to comply with standards of conduct designed 
to prevent discriminatory practices and affiliate abuse.
    Prior to taking final action on this proposed rulemaking, we are 
inviting comments from interested persons on 47 specific questions 
enumerated in the body of this order (and compiled in Attachment 
``1''), on the proposed templates in Appendix ``C'' and, more 
generally, on whether the Commission should proceed to promulgate this 
proposal as a final rule. Additionally, the Commission invites comments 
on any suggested changes or modifications to the proposal that would, 
in the view of the commenter, improve the proposal, and if so, why. 
Moreover, the Commission is not intending to allow the filing of reply 
comments in this proceeding and, therefore, we also invite parties to 
discuss why policy options advocated by other parties (as described in 
the comments in preparation for the Technical Conference, the working 
group reports, and in comments in response to the working group 
reports), should not be adopted by the Commission.
    The Commission invites interested persons to submit written 
comments or other information concerning this proposed rulemaking and 
the issues identified above. All comments in response to this notice 
should be submitted to the Office of Secretary, Federal Energy 
Regulatory Commission, 888 First Street, NE., Washington, DC 20426, and 
should refer to Docket No. RM95-9-000. An original and fourteen (14) 
copies of such comments should be filed with the Commission on or 
before [insert date 45 days from the date of publication in the Federal 
Register]. Additionally, a copy of the comments also should be 
submitted to the Commission on computer diskette in Wordperfect 5.1 or 
ASCII format.
    All written submissions to this NOPR will be placed in the public 
file and will be available for public inspection in the Commission's 
Public Reference Room, 888 First Street, NE., Washington, DC 20426, 
during regular business hours.

List of Subjects in 18 CFR Part 37

    Real-Time Information Networks.

    By direction of the Commission.
Lois D. Cashell,
Secretary.
    In consideration of the foregoing, the Commission proposes to amend 
Title 

[[Page 66199]]
18, Code of Federal Regulations, to add a new Part 37, as set forth 
below.

PART 37--REAL-TIME INFORMATION NETWORKS AND STANDARDS OF CONDUCT 
FOR PUBLIC UTILITIES

Sec.
37.1  Applicability.
37.2  Purpose.
37.3  Definitions.
37.4  Standardization of data sets and communication protocols.
37.5  Obligations of transmission providers.
37.6  Standards of conduct.
37.7  RIN uses.
37.8  Information requirements for transmission service.
37.9  Information to be posted on a RIN.
37.10  Posting and updating information on a RIN.
37.11  Posting of discounts.
37.12  Procedure for transmission providers to respond to customer 
requests for transmission service.
37.13  Communicating denials of requests for service and 
curtailments.
37.14  Auditing transmission service information.
37.15  Implementation schedule for rin requirements; phases.

    Authority: 16 U.S.C. 791-825r, 2601-2645; 31 U.S.C. 9701; 42 
U.S.C. 7101-7352.

Sec. 37.1  Applicability.

    This part applies to any public utility that owns and/or controls 
facilities used for the transmission of electric energy in interstate 
commerce.

Sec. 37.2  Purpose.

    The purpose of this part is to ensure that potential customers of 
transmission service receive access to information that will enable 
them to obtain open access transmission service on a non-discriminatory 
basis from public utilities that own and/or control facilities used for 
the transmission of wholesale electric energy in interstate commerce. 
These rules require public utilities (or their agents) to create and 
operate a real-time information network (RIN) that gives competitors 
and other users of the transmission system access to the same 
information available to the public utility personnel who trade (sell 
or purchase) power in the wholesale market, and at the same time, so 
that potential customers may obtain open access transmission service 
that is comparable to that provided by transmission owning public 
utilities to themselves.

Sec. 37.3  Definitions.

    (a) Transmission Provider means any public utility that owns and/or 
controls facilities used for the transmission of electric energy in 
interstate commerce.
    (b) Transmission Customer means any eligible customer (or its 
designated agent) that executes a service agreement and/or receives 
transmission service.
    (c) Responsible Party means the Transmission Provider or a third 
party to whom the Transmission Provider has delegated the 
responsibility of meeting the requirements of this Part.
    (d) Resellers means Transmission Customers who offer to sell 
transmission capability they have purchased to other Transmission 
Customers.
    (e) Wholesale Merchant Function means the sale for resale or 
purchase of electric energy in interstate commerce.
    (f) Affiliate means:
    (1) for any non-exempt wholesale generator public utility, another 
person which controls, is controlled by, or is under common control 
with such person;
    (2) for any public utility that is an exempt wholesale generator, 
as defined in section 2(a)(11) of the Public Utility Holding Company 
Act of 1935, as amended.

Sec. 37.4  Standardization of data sets and communication protocols.

    (a) A public utility subject to this Part must provide access on a 
RIN to standardized information relevant to the availability of 
transmission capability, prices, and other information (as described 
elsewhere in this Part) pertaining to its transmission system; it must 
also provide the ability to display, download and upload the 
standardized information in compliance with standardized procedures and 
protocols.
    (b) The standardized information, procedures and protocols are 
found in ``Standardized Data Sets and Communication Protocols,'' which 
can be obtained from the Office of Public Information, Federal Energy 
Regulatory Commission, 888 North Capitol Street NE, Washington, DC 
20426.

Sec. 37.5  Obligations of Transmission Providers.

    Each Transmission Provider is required to provide for the operation 
of a RIN, either individually or jointly with other Transmission 
Providers, in accordance with the requirements of this Part.

Sec. 37.6  Standards of conduct.

    A public utility subject to this Part must conduct its business to 
conform with the following standards:
    (a) The employees of the public utility that are engaged in 
wholesale merchant functions (i.e., wholesale purchases and sales for 
resale of electric energy in interstate commerce) are prohibited from 
also conducting transmission system operations and/or reliability 
functions. The employees of the public utility that are engaged in 
merchant functions also are prohibited from having preferential access 
to the system control center and other facilities of the public utility 
that differs from the access available to other wholesale transmission 
customers or potential wholesale transmission customers. To the maximum 
extent practicable, the employees of the public utility engaged in 
transmission system operations must function independently of the 
employees engaged in wholesale merchant functions and of the employees 
of any affiliate of the public utility. Employees are not precluded 
from transferring between departments as long as they do not conduct 
both transmission system operations functions and wholesale merchant 
functions or functions on behalf of any affiliate, and as long as these 
standards of conduct are observed. Notices of any employee transfers to 
or from transmission system operations must be posted on the RIN.
    (b) When buying or selling power, employees of the public utility 
that are engaged in wholesale merchant functions and employees of any 
affiliate of the public utility must rely upon the same information 
relied upon by the public utility's wholesale transmission customers 
(i.e., the information posted on the RIN), and must not have 
preferential access to any information about the public utility's 
transmission system that is not available to all users of the RIN.
    (c) Employees of the public utility that are engaged in wholesale 
merchant functions and employees of any affiliate of the public utility 
are prohibited from obtaining information about the public utility's 
transmission system (including information about available transmission 
capability, price, curtailments, ancillary services, etc.) through 
communications conducted off the RIN or through access to information 
not posted on the RIN.
    (d) Employees of the public utility that are engaged in 
transmission system operations or reliability functions may not 
disclose to employees engaged in the wholesale merchant function or to 
employees of any affiliate of the public utility any information 
concerning the public utility's transmission system (including 
information received from non-affiliates or information about available 
transmission capability, price, curtailments, ancillary services, etc.) 
through communications conducted off the RIN or through access to 
information not posted on the RIN.
    (e) If a public utility employee that is engaged in transmission 
system 

[[Page 66200]]
operations or reliability functions provides information not contained 
on the RIN to an employee of the public utility that is engaged in the 
merchant function or to an employee of an affiliate of the public 
utility, the public utility must immediately post such information on 
the RIN.
    (f)(1) The employees of the public utility that are engaged in 
transmission system operations must apply all tariff provisions 
relating to the sale or purchase of wholesale transmission service in a 
fair and impartial manner that treats all customers (including the 
public utility's employees conducting wholesale merchant functions and 
employees of any affiliate) alike, if these provisions involve 
discretion.
    (2) The public utility must keep a log, available for after-the-
fact Commission audit, detailing the circumstances and manner in which 
it exercised its discretion under any terms of the tariff.
    (g) The employees of the public utility that are engaged in 
transmission system operations must strictly enforce all tariff 
provisions relating to the sale or purchase of wholesale transmission 
service, if these provisions do not provide for the use of discretion.
    (h) The public utility may not, through its tariffs or otherwise, 
give preference to wholesale purchases or sales made for itself or any 
affiliate over the interests of any other wholesale customer in matters 
relating to the sale or purchase of transmission service (including 
issues of price, curtailments, scheduling, priority, etc.).
    (i) If the public utility offers discounts to purchases made for 
itself or for any affiliate, then it must, at the same time, offer on 
the RIN comparable discounts for similar service to all transmission 
customers.
    (j) A public utility must maintain its books of account and records 
separately from those of its affiliates.
    (k) Within 60 days of publication of the final rule in the Federal 
Register, the public utility must file with the Commission procedures 
that will enable customers and the Commission to determine that the 
public utility is in compliance with the requirements in this section.

Sec. 37.7  RIN uses.

    The information posted on the RIN must allow transmission customers 
to:
    (a) make requests for transmission services offered by Transmission 
Providers and the secondary market;
    (b) view and download in standard formats, using standard 
protocols, necessary information regarding the transmission system to 
enable prudent business decision making;
    (c) post, view, upload and download information regarding available 
products and desired services;
    (d) clearly identify the degree to which their transmission service 
requests and/or schedules were denied or curtailed relative to those of 
their competitors; and
    (e) obtain access in electronic format information to support 
available transmission capability calculations and historical 
transmission service requests and schedules for various audit purposes.

Sec. 37.8  Information requirements for transmission service.

    (a) The RIN must support the posting of available transmission 
capability and the processing of requests electronically.
    (b) The RIN must provide a mechanism to enable Transmission 
Providers and Customers to promptly communicate requests and responses 
to buy and sell available transmission capability offered under the 
Transmission Providers' tariffs.
    (c) For requests for transmission service to begin more than one 
year from the date of the request, transmission studies need not be 
performed to calculate ATCs, see Sec. 37.9(a)(1), until a request for 
service is made. However, any planning or specifically requested 
studies of the transmission network performed by the Transmission 
Provider are to be available for download on the RIN. (This applies 
only to those parts of customer-specific interconnection studies that 
relate to network impacts).

Sec. 37.9  Information to be posted on a RIN.

    (a) Five major types of information must be posted on the RIN: (1) 
Available Transfer Capability (ATC) and Total Transfer Capability 
(TTC);
    (2) Transmission Providers' and Resellers' Transmission Service 
Product Offerings and Prices;
    (3) Transmission Providers' and Third Parties' Ancillary Service 
Product Offerings and Prices;
    (4) Specific Transmission Service Requests/Responses; and
    (5) Informal Transmission Communications.
    (b) Information on ATC and TTC shall be posted on the RIN in 
accordance with the following: (1) The Transmission Provider must 
inform all participants simultaneously in the wholesale market of the 
transfer capability that is expected to be available on transmission 
paths of the Transmission Provider's system and each paths' total 
transfer capability. The Transmission Provider may delegate this 
responsibility to a suitable third party who maintains that 
Transmission Providers' RIN, such as an Independent System Operator, a 
Regional Transmission Group, or a Regional Reliability Council.
    (2) The ATC/TTC shall be calculated by the Responsible Party (the 
Transmission Provider or its designated agent) according to 
consistently applied industry practices, standards and criteria, or 
criteria referenced in the Transmission Provider's transmission tariff.
    (3) The amount of ATC posted shall be that amount that the 
Responsible Party expects, in good faith, to be available on a specific 
interface or Path in a specific direction, based on engineering 
analysis and other information that is available to the Responsible 
Party at the time of the posting. ATCs and TTCs as required in the 
Posting Schedule must be posted in megawatts.
    (4) Curtailment provisions associated with ATC must be incorporated 
in the posting and must be made available to all Transmission 
Customers.
    (5) Transmission tariffs provide an application procedure for 
Transmission Customers to request transmission service. At the time of 
the application, and in accordance with the provisions of those 
tariffs, the Transmission Provider (or its designated agent) must 
inform the requester if the Transmission Provider can honor the 
request. If not, the Transmission Provider must provide an explanation 
of additional information that is needed to evaluate the request, or 
identify prior pending requests that prevent acceptance of the full 
request, regardless of the posted ATC/TTC values.
    (6) The public utility must make all data used to calculate ATC/TTC 
publicly available. This information must be available for download on 
the RIN. The Transmission Provider must identify in its information 
supporting its ATC calculations the limiting element and the cause of 
the limit (e.g., thermal, voltage, stability). Whatever method is used 
to determine capability must be applied consistently.
    (c) Information on Transmission Providers' and Resellers' 
Transmission Service Product Offerings and Prices must be posted on the 
RIN in accordance with the following: (1) Transmission Providers and 
Resellers must post the prices, terms and conditions associated with 
the transmission products that they offer to Transmission Customers. 
Transmission Providers must also provide a downloadable file of their 
complete tariff in the format required in the Open Access rule.

[[Page 66201]]

    (2) Customers who desire to resell capability must post the 
relevant information to the same RIN node used by the primary provider 
from whom the customer purchased the transmission capability.
    (3) If the Transmission Customer resells its rights, in whole or in 
part, it must promptly notify the Transmission Provider, or the 
Transmission Provider's agent, of the new owner of the rights, any 
subdivision of these rights that may have occurred, and any changes in 
the terms and conditions of these rights, subject to the terms and 
conditions of the tariff.
    (d) Information on Transmission Providers' and Third Parties' 
Ancillary Service Product Offerings and Prices must be posted on the 
RIN in accordance with the following: (1) To the extent that the final 
Open Access rule requires that a Transmission Provider offer ancillary 
services, the Transmission Provider will post such offers on the RIN.
    (2) Other entities offering the same ancillary services shall have 
a comparable right to post offers on the RIN.
    (e) All requests for transmission service must be made on the RIN. 
Requests for transmission service and the responses to such requests 
must be consistent with the Transmission Provider's tariff, the Federal 
Power Act, and FERC regulations.
    (f) RINs must permit the posting of informal communications related 
to transmission services. Postings made in this section carry no 
obligation to respond on the part of any market participant. These 
communications include ``want ads'' and ``other communications'' 
(including using the RIN as a conference space or to provide messaging 
services between RIN users).

Sec. 37.10  Posting and Updating Information on the RIN.

    (a) Information about ATC/TTC posted on the RIN must be updated 
when transactions are scheduled or end or as other system conditions 
change that significantly affect TTC/ATC.
    (b) Information must be posted in accordance with the following 
procedures:
    (1) All information will be date/time stamped;
    (2) Firm (Non-Recallable) ATC/TTC must be posted:
    (i) 24 hours per day for the next seven days, updating the next six 
days and adding day seven at a reasonable pre-specified time daily;
    (ii) On-peak and off-peak each day, for days 8-30, updating the 
next 29 days and adding day 30 at a reasonable pre-specified time 
daily;
    (iii) By month, both on and off peak, for next 12 months updating 
the next 11 months and adding month 12 on the 15th of each month;
    (iv) Seasonal, by year, for years 1-10 (when planning and specially 
requested transmission planning studies have been done).
    (3) Non-Firm (Recallable) ATC/TTC must be posted:
    (i) 24 hours per day for the next seven days, updating the next six 
days and adding day seven at a reasonable pre-specified time daily;
    (ii) On-peak and off-peak each day, for days 8-30, updating the 
next 29 days and adding day 30 at a reasonable pre-specified time 
daily;
    (iii) Longer term by request.
    (4) Daily updates must be posted at the same universal time for 
each RIN.

Sec. 37.11  Posting of discounts.

    A public utility, within 24 hours of agreeing to a discount (as 
measured from when ATC must be adjusted in response to the 
transaction), must post on the RIN and make available for download, 
information describing the transaction (including price, quantity, and 
any other relevant terms and conditions) and shall keep such 
information posted on the RIN for at least 30 days. Thereafter, records 
of the transaction must be retained and kept available for after-the-
fact Commission audit as part of the audit log required in section 
37.14(e).

Sec. 37.12  Procedure for transmission providers to respond to customer 
requests for transmission service.

    The following steps must be followed in processing a transmission 
service request, with the time for each step specified in the service 
tariff:
    (a) Requester: Submits request, including all information, as 
required by the tariff.
    (b) Provider: Places request in queue and posts applicable 
information to the RIN. Posts request status and provides time/date 
stamps throughout the process.
    (c) Provider: Approves or denies request and provides reason, if 
denied. Posts result to the RIN. Tenders service offer.
    (d) Requester: Accepts service or withdraws request.
    (e) Provider: If service accepted by Customer, adjusts ATC on the 
RIN.
    (f) Requester: Holds for scheduling, arranges scheduling, or 
arranges for resale.

Sec. 37.13  Communicating denials of requests for service and 
curtailments.

    When requests for service are denied or transactions are curtailed, 
the RIN must provide a mechanism for Transmission Providers to 
communicate to transmission customers:
    (a) the reason those transactions could not be accommodated; and
    (b) the options, if any, for adjusting operation of the system to 
increase transfer capability in order to accommodate those 
transactions.

Sec. 37.14  Auditing Transmission Service Information.

    (a) All RIN database transactions must be automatically copied, 
recorded in a log file, and date/time stamped. If there is a question 
concerning a transmission transaction, the log file may be downloaded 
to identify the sequence of events concerning the transaction.
    (b) Information on scheduling transmission service must be recorded 
in a log file by the entity scheduling the transmission service and 
must be available for download on the RIN by interested parties.
    (c) Transmission Service Schedules must be posted to the RIN within 
one week of the start of the transmission service schedule agreed upon 
by the parties, unless otherwise reasonably requested by a party with a 
legitimate concern.
    (d) With the exception of discounted prices to its merchant 
functions or to its affiliates, information about negotiations for 
transmission do not have to be posted on the RIN unless an agreement 
for transmission is reached. If an agreement is reached, the identity 
of the parties, to a transmission transaction may be masked for 30 days 
from the date when the transaction was agreed upon by the parties.
    (e) Audit logs must be available for download on RINs for 90 days 
and retained and available upon request for three years from the date 
when they are first posted on a RIN.

Sec. 37.15  Implementation schedule for RIN requirements; phases.

    The RIN(s) established under this part may be constructed in 
phases, with the initial phase consisting of core requirements and 
later phases increasing the number of functions, efficiency, and/or 
effectiveness of the RIN. The first phase requirements must be 
implemented as of the effective date of the Open Access rule.

    Note: The following attachment will not appear in the Code of 
Federal Regulations.

Attachment 1--(Questions for Comment)

    Question 1. We seek comment on whether to continue to call the 
information network 

[[Page 66202]]
a ``RIN'' and, if not, what name should be used in its place.
    Question 2. What issues associated with RIN standards would have 
to be addressed if in an open access transmission environment the 
electric power industry transitions to regional pricing, flow-based 
pricing, or other pricing models that depart from the ``contract 
path'' approach presently used for pricing electric transmission 
service? How in structuring RIN standards can the Commission provide 
for this contingency?
    Question 3. The Commission requests comments on how best to post 
the availability of network transmission service on the RIN. Should 
Transmission Providers be required to post conservative estimates as 
a preliminary matter that could be improved with additional study? 
Is there an alternative service concept that is more suitable to 
measurement than the current version of network service?
    Question 4. The Commission requests comment on how to develop a 
consistent, industry-wide method of calculating ATC/TTC.
    Question 5. The Commission requests comments on ways to minimize 
the burden of ATC calculations, while ensuring that wholesale 
transmission customers have the information they need.
    Question 6. The Commission requests comment on a standard format 
for electronic submission of transmission tariffs to the Commission.
    Question 7. The Commission requests comments on what information 
about curtailments and denials of requests for service should be 
communicated on a RIN.
    Question 8. What specifications would be needed for information 
about curtailments and denials of requests for service to be posted 
in HTML displays and what specifications and formats would be needed 
to standardize downloadable files?
    Question 9. The Commission requests comment on where on the RIN 
offers by other entities to provide ancillary service should be 
placed. The What Report states that these offers should be posted in 
the ``Informal Transmission Communications'' section of the RIN. 
Would this place third party providers at a disadvantage relative to 
the Transmission Provider?
    Question 10. The Commission requests comments on how to 
determine the costs associated with posting ancillary services on 
the RIN.
    Question 11. With regard to information about offers to provide 
ancillary services provided by an entity other than the Transmission 
Provider, what specifications would be needed for this information 
to be posted in HTML displays and what specifications and formats 
would be needed to standardize downloadable files?
    Question 12. The Commission requests comment on whether there is 
any additional information needed about ancillary services that is 
not included in the list. Is any information on the list not needed?
    Question 13. The Commission requests comment on how often 
ancillary services information should be updated.
    Question 14. The Commission seeks comment on whether all 
transmission discounts should be posted on the RIN, or only those 
provided to the Transmission Provider or its affiliates. Also, if 
discounts are to be posted, when should this be done?
    Question 15. Regarding information on affiliate discounts, what 
specifications are needed for the information to be posted in HTML 
displays and what specifications and formats are needed for the 
downloadable files?
    Question 16. The Commission requests comments on how the data 
used in calculating ATC should be formatted. Should it be in free 
form text, predefined tables, or comma delimited ASCII files? If in 
free form text, should it be in plain ASCII text or in a word 
processor format, such as WordPerfect or Word?
    Question 17. The Commission requests comments on what is the 
appropriate time delay for making supporting information on ATC 
available. Should the Commission require specific formats for ATC 
supporting data? If so, what should the formats be?
    Question 18. To keep the amount of information on the RIN 
manageable, the Commission requests comment on whether it is 
sufficient to provide information only about planned outages and 
return dates (for both planned and forced outages) for those system 
elements deemed to have a direct and significant impact on ATC and 
whether posting this information on the RIN would cause any 
confidentiality concerns.
    Question 19. Since many system elements can impact the ATC of a 
path, how should ``significant and direct impact'' be defined? Is it 
acceptable to limit the additional information to those system 
elements for which nomograms, derating tables, and operating guides 
have been developed?
    Question 20. Are there any difficulties, technical or otherwise, 
associated with posting actual path flows on the RIN?
    Question 21. In cases where ATC of a path is a function of run 
status of one or more generators, is it sufficient to post the 
expected amount and date of changes to ATC on the RIN, corresponding 
to the planned outage or return dates of generators.
    Question 22. If operating guides, nomograms, operating studies, 
and similar information are to be made available on the RIN for 
download, would it be logical to expect that transmission customers 
will be able to deduce the run status of those generators which 
significantly and directly impact ATC by observing the changes to 
ATC?
    Question 23. The Commission requests comments on how 
transmission studies should be formatted for download from the RIN. 
Should they be in free form ASCII text, or in a word processor 
format, such as WordPerfect or Word?
    Question 24. The Commission requests comment on what information 
should be considered commercially sensitive, the 30-day release 
period proposal, and on how and when commercially sensitive 
information should be released to concerned parties before the 
standard release period? Should affiliated transactions be treated 
differently?
    Question 25. The Commission requests comments on how long the 
implementation schedule should be for Phase I.
    Question 26. Does the How Report define HTML displays and 
downloadable files with sufficient clarity to permit public 
utilities to implement Phase I such that the downloaded files and 
HTML displays received by customers from each RIN have the same 
definitions, etc.? If not, what clarifications are needed? 
Similarly, are uploaded files sufficiently defined in the How 
Report?
    Question 27. The Commission invites comment generally, on the 
issues discussed in Appendix ``C''.
    Question 28. The Commission requests comments on how to ensure 
that a customer will be able to choose a browser and use it to 
access all RIN Nodes.
    Question 29. The Commission requests comments on the use of 
28,800 bits per second in the calculation of the minimum bandwidth 
connection between a RIN Node and the Internet in the formula 
appearing in the How Report.
    Question 30. The Commission requests comments on the use of DUNs 
numbers to identify RIN participants.
    Question 31. The Commission requests comments on how to develop 
common location codes for the electric power industry.
    Question 32. The Commission requests comments on what data 
compression technique or techniques should be made standard for all 
RIN Nodes.
    Question 33. The Commission requests comments on whether the 
upload and download templates are sufficiently specified to be 
functional and whether they are sufficiently specified to permit all 
RIN Nodes to implement them in the same way.
    Question 34. The Commission requests comments on whether it 
should allow the recovery of reasonable expenses associated with 
developing and running RINs by rolling these costs into wholesale 
transmission rates. How should fees associated with RIN usage be 
calculated and recovered?
    Question 35. The Commission requests comments on whether it 
should encourage a small number of RIN Nodes.
    Question 36. The Commission requests comments on whether 
transmission owning utilities should be required, in Phase I, to 
provide connections to private networks.
    Question 37. The Commission requests comments on whether the 
following How Group Proposals are adequate:
    (1) Transmission Service Information Availability: The most 
recent Provider transmission service information, including updates 
reflecting power system changes, shall be available to all Customers 
within 5 minutes of its scheduled posting time at least 98 percent 
of the time. The remaining 2 percent of the time the transmission 
service information shall be available within 10 minutes of its 
scheduled posting time;
    (2) Notification of Posted or Changed Transmission Service 
Information: Notification of transmission service information posted 
or changed by a Provider shall be made available within 60 seconds 
to all subscribed Customers who are currently connected; and
    (3) Acknowledgment by the Transmission Service Information 
Provider: Acknowledgment by the transmission service 

[[Page 66203]]
information provider of the receipt of Customer purchase request/
response requests shall occur within 1 minute for Phase I. The 
actual negotiations and agreements on purchase request/response 
requests do not have time constraints. For Phase II, acknowledgment 
shall occur within 30 seconds.
    Question 38. The Commission requests comments on how to redesign 
the download templates in Appeat primary and secondary capacity can 
be offered through downloadable files that have the same format. The 
Commission also requests comments on how primary and secondary 
capacity can be displayed in the same tables on a RIN Node.
    Question 39. What is the best way to handle the purchase request 
and response process when primary and secondary capacity appear in 
the same RIN displays and files?
    Question 40. The Commission requests comments on how to 
determine the costs associated with posting resales on the RIN?
    Question 41. Are the standards of conduct proposed herein 
sufficient? Should they be modified in any way?
    Question 42. In particular, if the Commission in its final rule 
requires functional unbundling of all transmission from generation, 
how would these standards of conduct need to be modified? Would any 
other organizational changes need to be made? Would any 
modifications be needed with regard to ancillary services?
    Question 43. Would the Commission's proposed separation of 
functions jeopardize system reliability? If so, what other mechanism 
would provide wholesale transmission customers and potential 
customers with assurance that they would be obtaining access to the 
same information, at the same time, as that used by Transmission 
Providers in making their own wholesale transmission purchasing 
decisions?
    Question 44. Regarding information on affiliate discounts, what 
specifications are needed for the information to be posted in HTML 
displays and what specifications and formats are needed for the 
downloadable files?
    Question 45. The Commission requests comments on whether and to 
what extent the Commission should exercise this statutory authority 
to extend the RINs requirements to non-public utilities' that own 
and/or control facilities used for the transmission of electric 
energy in interstate commerce.
    Question 46. Should reciprocity require that a non-public 
utility (such as a co-op or publicly owned utility) have a RIN?
    Question 47. In light of the proposal in the How Report to use a 
low cost Internet-based approach, the Commission requests specific 
comments on circumstances in which the RINs requirements are 
believed to be an unnecessary burden. Are there less burdensome ways 
to meet the same-time access requirement in circumstances where the 
utility's wholesale transmission facilities have little commercial 
value? What criteria should the Commission use in determining 
whether and when to relax the RINs requirements?

[FR Doc. 95-30884 Filed 12-20-95; 8:45 am]
BILLING CODE 6717-01-P

Complete official Federal Register PDF

FR Doc. 95-30874 Loans to plan participants
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Pages 66233-66237]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-30874]

-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY
26 CFR Part 1

[EE-106-82]
RIN 1545-AE45

Loans to plan participants

AGENCY: Internal Revenue Service (IRS), Treasury.

ACTION: Notice of proposed rulemaking.

-----------------------------------------------------------------------

SUMMARY: This document contains proposed Income Tax Regulations under 
section 72(p) of the Internal Revenue Code relating to loans made from 
a qualified employer plan to plan participants or beneficiaries. 
Section 72(p) was added by section 236 of the Tax Equity and Fiscal 
Responsibility Act of 1982, and amended by the Technical Corrections 
Act of 1982, the Deficit Reduction Act of 1984, the Tax Reform Act of 
1986 and the Technical and Miscellaneous Revenue Act of 1988. These 
regulations provide guidance to the public with respect to this 
provision, and affect any plan participant or beneficiary who receives 
a loan from a qualified employer plan.

DATES: Written comments and requests for a public hearing must be 
received by March 20, 1996.

ADDRESSES: Send submissions to: CC:DOM:CORP:R (EE-106-82), Attention: 
Plan Loans Guidance, room 5228, Internal Revenue Service, POB 7604, Ben 
Franklin Station, Washington, DC 20044. In the alternative, submissions 
may be hand delivered between the hours of 8 a.m. and 5 p.m. to: 
CC:DOM:CORP:R (EE-106-82), Courier's Desk, Internal Revenue Service, 
1111 Constitution Avenue, NW, Washington, DC.

FOR FURTHER INFORMATION CONTACT: Vernon S. Carter, of the Office of the 
Associate Chief Counsel (Employee Benefits and Exempt Organizations), 
IRS, at (202) 622-6070 (not a toll free number).

SUPPLEMENTARY INFORMATION:

Background

    This document contains proposed amendments to the Income Tax 
Regulations (26 CFR Part 1) under section 72 of the Internal Revenue 
Code of 1986 (Code). These amendments are proposed to conform the 
regulations to section 236 of the Tax Equity and Fiscal Responsibility 
Act of 1982 (TEFRA), which added section 72(p) to the Code, and to the 
amendments to section 72(p) made by the Technical Corrections Act of 
1982, the Deficit Reduction Act of 1984, the Tax Reform Act of 1986 and 
the Technical and Miscellaneous Revenue Act of 1988.

Explanation of Provisions

    Section 72(p) of the Code generally provides that an amount 
received as a loan from a qualified employer plan by a participant or 
beneficiary is treated as received as a distribution from the plan for 
purposes of section 72 (a deemed distribution), except to the extent 
certain conditions are satisfied. For purposes of section 72, a 
qualified employer plan includes a plan that qualifies under section 
401 (relating to qualified trusts), 403(a) (relating to qualified 
annuities) or 403(b) (relating to tax sheltered annuities), as well as 
a plan (whether or not qualified) maintained by the United States, a 
State or a political subdivision thereof, or an agency or 
instrumentality thereof. A qualified employer plan also includes a plan 
which was (or was determined to be) a qualified plan or a government 
plan. A loan from a contract purchased under a qualified employer plan 
is also treated as a loan from the plan. Section 72(p) also provides 
that an assignment or pledge of (or an agreement to assign or pledge) 
any portion of a participant's or beneficiary's interest in a qualified 
employer plan is to be treated as a loan from the plan.
    Under section 72(p), a loan from a qualified employer plan to a 
participant or beneficiary is not treated as a distribution from the 
plan if the loan satisfies certain requirements relating to the terms 
of the loan and the repayment schedule, and to the extent the loan 
satisfies certain limitations on the amount loaned. The proposed 
regulations require that the loan be evidenced by an enforceable 
agreement, set forth in writing or in another form that is approved by 
the Commissioner of Internal Revenue, that includes terms that satisfy 
the statutory requirements. Thus, the agreement must specify the amount 
of the loan, the term of the loan, and the repayment schedule. The 
agreement may be set forth in more than one document.
    If a loan fails to satisfy the repayment requirements or the 
enforceable agreement requirement, the proposed regulations provide for 
the balance then due under the loan to be treated as a distribution 
from the plan. This may occur at the time the loan is made or at a 
later date if the loan is not repaid in accordance with the repayment 
schedule. If the loan satisfies the repayment requirements and the 
enforceable agreement requirement, but at the time the loan is made the 
amount of the loan exceeds the statutory limitation on the amount that 
is permitted to be loaned, the proposed regulations provide that only 
the excess amount is a deemed distribution.
    One of the repayment requirements is that the loan be repaid within 
five years, unless the loan is used to acquire a dwelling unit which 
within a reasonable time is used as the principal residence of the 
participant. The proposed regulations provide that a principal 
residence has the same meaning as under section 1034 (relating to the 
taxation of a sale of a residence) and that tracing rules established 
under section 163(h)(3)(B) (relating to interest deductions for 
indebtedness incurred with respect to the acquisition of a principal 
residence) will be used to determine whether the section 
72(p)(2)(B)(ii) exception to the five-year repayment requirement 
applies. (Notice 88-74 (1988-2 C.B. 385), sets forth certain standards 
applicable under section 163(h)(3).)
    The Tax Reform Act of 1986 amended section 72(p) to require that, 
in order for a loan to not be treated as a distribution, the loan must 
be repaid in substantially level installments (not less frequently than 
quarterly) over the term of the loan. Section 72(p) authorizes 
regulations to allow exceptions from this requirement. Pursuant to this 
authorization, the proposed regulations permit loan repayments to be 
suspended during a leave of absence of up to one year, if the 
participant's pay from the employer is insufficient to service the 
debt, but only if the loan is repaid by the latest date permitted under 
section 72(p)(2)(B).
    If the repayment terms of a loan are not satisfied after the loan 
has been made due to a failure to make a scheduled loan repayment, the 
proposed regulations provide for the balance then due under the loan to 
be deemed to be distributed. The proposed regulations permit a grace 
period, to the extent the grace period does not extend beyond the end 
of the calendar quarter next following the calendar quarter in which 
the repayment was scheduled to be made.
    If a loan is treated as a distribution under section 72(p), the 
proposed regulations state that the amount so distributed is to be 
treated as a taxable distribution, subject to the normal rules of 
section 72 if the participant's interest in the plan includes after-tax 
contributions (or other tax basis). A deemed distribution would also be 
a distribution for purposes of the 10 

[[Page 66234]]
percent tax in section 72(t) and the excise tax on excess distributions 
under section 4980A. However, a deemed distribution under section 72(p) 
is not treated as an actual distribution for purposes of the 
qualification requirements of section 401, the rollover and income 
averaging provisions of section 402 and the distribution restrictions 
of section 403(b).
    By contrast, if a participant's accrued benefit is reduced (offset) 
in order to repay a loan, an actual distribution occurs for purposes of 
the provisions in sections 401, 402 and 403(b) referred to above. Thus, 
for example, a plan is prohibited from enforcing its security interest 
in a participant's account balance attributable to amounts contributed 
pursuant to an election under section 401(k) until a date on which 
distribution is permitted under section 401(k).
    The proposed regulations do not address all issues arising under 
section 72(p). Comments are requested on whether further guidance 
should be provided on issues that are not addressed and how the issues 
should be resolved, including the effect of a deemed distribution on 
the tax treatment of subsequent distributions from the plan and the 
application of the $50,000 limitation and the five year repayment 
requirement to a refinancing and to multiple loan arrangements.
    Taxpayers may rely on these proposed regulations for guidance 
pending the issuance of final regulations. If, and to the extent, 
future guidance is more restrictive than the guidance in these proposed 
regulations, the future guidance will be applied without retroactive 
effect.

Special Analysis

    It has been determined that this notice of proposed rulemaking is 
not a significant regulatory action as defined in EO 12866. Therefore, 
a regulatory assessment is not required. It also has been determined 
that section 553(b) of the Administrative Procedure Act (5 U.S.C. 
chapter 5) and the Regulatory Flexibility Act (5 U.S.C. chapter 6) do 
not apply to these regulations, and, therefore, a Regulatory 
Flexibility Analysis is not required. Pursuant to section 7805(f), this 
notice of proposed rulemaking will be submitted to the Chief Counsel 
for Advocacy of the Small Business Administration for comment on its 
impact on small business.

Comments and Request for Public Hearing

    Before these proposed regulations are adopted as final regulations, 
consideration will be given to any written comments (a signed original 
and eight (8) copies) that are submitted timely to the following 
address: CC:DOM:CORP:R (EE-106-82), Attention: Plan Loans Guidance, 
room 5228, Internal Revenue Service, POB 7604, Ben Franklin Station, 
Washington, DC 20044. All comments will be available for public 
inspection and copying. A public hearing may be scheduled if requested 
in writing by any person that timely submits written comments. If a 
public hearing is scheduled, notice of the date, time, and place for 
the hearing will be published in the Federal Register.

Drafting Information

    The principal author of these proposed regulations is Vernon S. 
Carter, Office of the Associate Chief Counsel (Employee Benefits and 
Exempt Organizations). However, other personnel from the IRS and 
Treasury Department participated in their development.

List of Subjects in 26 CFR Part 1

    Income taxes, Reporting and recordkeeping requirements.

Proposed Amendments to the Regulations

    Accordingly, 26 CFR part 1 is proposed to be amended as follows:

PART 1--INCOME TAXES

    Paragraph 1. The authority citation for part 1 continues to read, 
in part, as follows:

    Authority: 26 U.S.C. 7805. * * *

    Par. 2. Section 1.72-17A is amended as follows:
    1. Paragraphs (d)(1), (d)(2) and (d)(3) are redesignated as 
paragraphs (d)(2), (d)(3) and (d)(4), respectively.
    2. New paragraph (d)(1) is added to read as follows:

Sec. 1.72-17A  Special rules applicable to employee annuities and 
distributions under deferred compensation plans to self-employed 
individuals and owner-employees.

* * * * *
    (d) * * * (1) The references in this paragraph (d) to section 
72(m)(4) are to that section as in effect on August 13, 1982. Section 
236(b)(1) of the Tax Equity and Fiscal Responsibility Act of 1982 
repealed section 72(m)(4), generally effective for assignments, pledges 
and loans made after August 13, 1982, and added section 72(p). See 
section 72(p) and Sec. 1.72(p)-1 for rules governing the income tax 
treatment of certain assignments, pledges and loans from qualified 
employer plans made after August 13, 1982.
* * * * *
    Par. 3. Section 1.72(p)-1 is added to read as follows:

Sec. 1.72(p)-1  Loans treated as distributions.

    The questions and answers in this section provide guidance under 
section 72(p) pertaining to loans from qualified employer plans 
(including government plans and tax-sheltered annuities and employer 
plans that were formerly qualified). The examples included in the 
questions and answers in this section are based on the assumption that 
a bona fide loan is made to a participant from a qualified defined 
contribution plan pursuant to an enforceable agreement (in accordance 
with Q&A-3(b) of this section), with adequate security and with an 
interest rate and repayment terms that are commercially reasonable. 
(The particular interest rate used for illustration in this section is 
8.75 percent compounded annually.) In addition, unless the contrary is 
specified, it is assumed in the examples that the amount of the loan 
does not exceed 50 percent of the participant's nonforfeitable account 
balance, the participant has no other outstanding loan (and had no 
prior loan) from the plan or any other plan maintained by the 
participant's employer or any other person required to be aggregated 
with the employer under section 414(b), (c) or (m), and the loan is not 
excluded from section 72(p) as a loan made in the ordinary course of an 
investment program as described in Q&A-18 of this section. No inference 
should be drawn from these regulations or the examples therein that a 
loan would not result in a prohibited transaction under section 4975 or 
would be consistent with the fiduciary standards of Title I of the 
Employee Retirement Income Security Act of 1974, as amended. See, for 
example, 29 CFR Sec. 2550.408b-1 (interpreting the statutory prohibited 
transaction exemption for loans to participants and beneficiaries).

Questions and Answers

    Q-1: In general, what does section 72(p) provide with respect to 
loans from a qualified employer plan?
    A-1: (a) Loans. Under section 72(p), an amount received by a 
participant or beneficiary as a loan from a qualified employer plan is 
treated as having been received as a distribution from the plan (a 
deemed distribution), unless the loan satisfies the requirements of 
Q&A-3 of this section. For purposes of section 72(p), a loan made from 
a contract that has been purchased under a qualified employer plan 
(including a contract that 

[[Page 66235]]
has been distributed to the participant or beneficiary) shall be 
considered a loan made under a qualified employer plan.
    (b) Pledges and assignments. Under section 72(p), if a participant 
or beneficiary assigns or pledges (or agrees to assign or pledge) any 
portion of his or her interest in a qualified employer plan as security 
for a loan, the portion of the individual's interest assigned or 
pledged (or subject to an agreement to assign or pledge) is treated as 
a loan from the plan to the individual, with the result that such 
portion is subject to the deemed distribution rule described in 
paragraph (a) of this Q&A-1. For purposes of section 72(p), any 
assignment or pledge of (or agreement to assign or to pledge) by a 
participant or beneficiary of any portion of his or her interest in a 
contract that has been purchased under a qualified employer plan 
(including a contract that has been distributed) shall be considered an 
assignment or pledge of (or agreement to assign or pledge) an interest 
in a qualified employer plan. However, if all or a portion of a 
participant's or beneficiary's interest in a qualified employer plan is 
pledged or assigned as security for a loan from the plan to the 
participant or the beneficiary, only the amount of the loan received by 
the participant or the beneficiary, not the amount pledged or assigned, 
is treated as a loan.
    Q-2: What is a qualified employer plan for purposes of section 
72(p)?
    A-2: For purposes of section 72(p), a qualified employer plan 
means--
    (a) A plan described in section 401(a) which includes a trust 
exempt from tax under section 501(a);
    (b) An annuity plan described in section 403(a);
    (c) A plan under which amounts are contributed by an individual's 
employer for an annuity contract described in section 403(b);
    (d) Any plan, whether or not qualified, established and maintained 
for its employees by the United States, by a State or political 
subdivision thereof, or by an agency or instrumentality of the United 
States, a State or a political subdivision of a State; or
    (e) Any plan which was (or was determined to be) described in 
paragraph (a), (b), (c), or (d) of this Q&A-2.
    Q-3: What requirements must be satisfied in order for a loan to a 
participant or beneficiary from a qualified employer plan not to be a 
deemed distribution?
    A-3: (a) In general. A loan to a participant or beneficiary from a 
qualified employer plan will not be a deemed distribution to the 
participant or beneficiary if the loan satisfies the repayment term 
requirement of section 72(p)(2)(B), the level amortization requirement 
of section 72(p)(2)(C), and the enforceable agreement requirement of 
paragraph (b) of this Q&A-3, but only to the extent the loan satisfies 
the amount limitations of section 72(p)(2)(A).
    (b) Enforceable agreement requirement. A loan does not satisfy the 
requirements of this paragraph unless the loan is evidenced by a 
legally enforceable agreement (which may include more than one 
document) set forth in writing or in such other form as may be approved 
by the Commissioner, and the terms of the agreement demonstrate 
compliance with the requirements of section 72(p)(2) and this section. 
Thus, the agreement must specify the amount of the loan, the term of 
the loan, and the repayment schedule.
    Q-4: If a loan from a qualified employer plan to a participant or 
beneficiary fails to satisfy the requirements of Q&A-3 of this section, 
when does a deemed distribution occur?
    A-4: (a) Deemed distribution. For purposes of section 72, a deemed 
distribution occurs at the first time that the requirements of Q&A-3 of 
this section are not satisfied, in form or in operation, with respect 
to that amount. This may occur at the time the loan is made or at a 
later date. If the terms of the loan do not require repayments that 
satisfy the repayment term requirement of section 72(p)(2)(B) or the 
level amortization requirement of section 72(p)(2)(C), or the loan is 
not evidenced by an enforceable agreement satisfying the requirements 
of Q&A-3(b) of this section, the entire amount of the loan is a deemed 
distribution under section 72(p) at the time the loan is made. If the 
loan satisfies the requirements of Q&A-3 of this section except that 
the amount loaned exceeds the limitations of 72(p)(2)(A), the amount of 
the loan in excess of the applicable limitation is a deemed 
distribution under section 72(p) at the time the loan is made. If the 
loan initially satisfies the requirements of section 72(p)(2)(A), (B) 
and (C) and the enforceable agreement requirement of Q&A-3(b) of this 
section, but payments are not made in accordance with the terms 
applicable to the loan, a deemed distribution occurs as a result of the 
failure to make such payments. See Q&A-10 of this section regarding 
when such a deemed distribution occurs and the amount thereof and Q&A-
11 of this section regarding the tax treatment of a deemed 
distribution.
    (b) Examples. The following examples illustrate the rules in 
paragraph (a) of this Q&A-4 and are based upon the assumptions 
described in ASSUMPTIONS FOR EXAMPLES:

    Example 1. (a) A participant has a nonforfeitable account balance 
of $200,000 and receives $70,000 as a loan repayable in level quarterly 
installments over five years.
    (b) Under section 72(p), the participant has a deemed distribution 
of $20,000 (the excess of $70,000 over $50,000) at the time of the 
loan, because the loan exceeds the $50,000 limit in section 
72(p)(2)(A)(i). The remaining $50,000 is not a deemed distribution.
    Example 2. (a) A participant with a nonforfeitable account balance 
of $30,000 borrows $20,000 as a loan repayable in level monthly 
installments over five years.
    (b) Because the amount of the loan is $5,000 more than 50% of the 
participant's nonforfeitable account balance, the participant has a 
deemed distribution of $5,000 at the time of the loan. The remaining 
$15,000 is not a deemed distribution. (Note also that, if the loan is 
secured solely by the participant's account balance, the loan may be a 
prohibited transaction under section 4975 because the loan may not 
satisfy 29 CFR Sec. 2550.408b-1(f)(2)).
    Example 3. (a) The nonforfeitable account balance of a participant 
is $100,000 and a $50,000 loan is made to the participant repayable in 
level quarterly installments over seven years. The loan is not eligible 
for the section 72(p)(2)(B)(ii) exception for loans used to acquire 
certain dwelling units.
    (b) Because the repayment period exceeds the maximum five-year 
period in section 72(p)(2)(B)(i), the participant has a deemed 
distribution of $50,000 at the time the loan is made.
    Example 4. (a) On August 1, 1998, a participant has a 
nonforfeitable account balance of $45,000 and borrows $20,000 from a 
plan to be repaid over five years in level monthly installments due at 
the end of each month. After making monthly payments through July 1999, 
the participant fails to make any of the payments due thereafter.
    (b) As a result of the failure to satisfy the requirement that the 
loan be repaid in level monthly installments, the participant has a 
deemed distribution. See Q&A-10(c) Example of this section regarding 
when such a deemed distribution occurs and the amount thereof.

    Q-5: What is a principal residence for purposes of the exception in 
section 72(p)(2)(B)(ii) from the requirement that a loan be repaid in 
five years? 

[[Page 66236]]

    A-5: Section 72(p)(2)(B)(ii) provides that the requirement in 
section 72(p)(2)(B)(i) that a plan loan be repaid within five years 
does not apply to a loan used to acquire a dwelling unit which will 
within a reasonable time be used as the principal residence of the 
participant (a principal residence plan loan). For this purpose, a 
principal residence has the same meaning as a principal residence under 
section 1034.
    Q-6: In order to satisfy the requirements for a principal residence 
plan loan, is a loan required to be secured by the dwelling unit that 
will within a reasonable time be used as the principal residence of the 
participant?
    A-6: A loan is not required to be secured by the dwelling unit that 
will within a reasonable time be used as the participant's principal 
residence in order to satisfy the requirements for a principal 
residence plan loan.
    Q-7: What tracing rules apply in determining whether a loan 
qualifies as a principal residence plan loan?
    A-7: The tracing rules established under section 163(h)(3)(B) apply 
in determining whether a loan is treated as for the acquisition of a 
principal residence in order to qualify as a principal residence plan 
loan.
    Q-8: Can a refinancing qualify as a principal residence plan loan?
    A-8: (a) Refinancings. In general, no. However, a loan from a 
qualified employer plan used to repay a loan from a third party will 
qualify as a principal residence plan loan if the plan loan qualifies 
as a principal residence plan loan without regard to the loan from the 
third party.
    (b) Example. The following example illustrates the rules in 
paragraph (a) of this Q&A-8 and is based upon the assumptions described 
in ASSUMPTIONS FOR EXAMPLES:

    Example. (a) On July 1, 1999, a participant requests a $50,000 plan 
loan to be repaid in level monthly installments over 15 years. On 
August 1, 1999, the participant acquires a principal residence and pays 
a portion of the purchase price with a $50,000 bank loan. On September 
1, 1999, the plan loans $50,000 to the participant, which the 
participant uses to pay the bank loan.
    (b) Because the plan loan satisfies the requirements to qualify as 
a principal residence plan loan (taking into account the tracing rules 
of section 163(h)(3)(B)), such plan loan qualifies for the exception in 
section 72(p)(2)(B)(ii).

    Q-9: Does the level amortization requirement of section 72(p)(2)(C) 
apply when a participant is on a leave of absence without pay?
    A-9: (a) Leave of absence. The level amortization requirement of 
section 72(p)(2)(C) does not apply for a period, not longer than one 
year, that a participant is on a leave of absence, either without pay 
from the employer or at a rate of pay (after income and employment tax 
withholding) that is less than the amount of the installment payments 
required under the terms of the loan. However, the loan must be repaid 
by the latest date permitted under section 72(p)(2)(B) and the 
installments due after the leave ends (or, if earlier, after the first 
year of the leave) must not be less than those required under the terms 
of the original loan.
    (b) Example. The following example illustrates the rules of 
paragraph (a) of this Q&A-9 and is based upon the assumptions described 
in ASSUMPTIONS FOR EXAMPLES:
    Example. (a) On July 1, 1997, a participant with a nonforfeitable 
account balance of $80,000, borrows $40,000 to be repaid in level 
monthly installments of $825 each over five years. The loan is not a 
principal residence plan loan. The participant makes nine monthly 
payments and commences an unpaid leave of absence that lasts for 12 
months. Thereafter, the participant resumes active employment and 
resumes making repayments on the loan until the loan is repaid. The 
amount of each monthly installment is increased to $1,130 in order to 
repay the loan by June 30, 2002.
    (b) Because the loan satisfies the requirements of section 
72(p)(2), the participant does not have a deemed distribution. 
Alternatively, section 72(p)(2) would be satisfied if the participant 
continued the monthly installments of $825 after resuming active 
employment and on June 30, 2002 repaid the full balance remaining due.
    Q-10: If a participant fails to make the installment payments 
required under the terms of a loan that satisfied the requirements of 
Q&A-3 of this section when made, when does a deemed distribution occur 
and what is the amount of the deemed distribution?
    A-10: (a) Timing of deemed distribution. Failure to make any 
installment payment when due in accordance with the terms of the loan 
violates section 72(p)(2)(C) and, accordingly, results in a deemed 
distribution at the time of such failure. However, the plan 
administrator may allow a grace period, and section 72(p)(2)(C) will 
not be considered to have been violated until the last day of the grace 
period. Any such grace period shall be given effect for purposes of 
section 72(p)(2)(C) only to the extent it does not continue beyond the 
last day of the calendar quarter following the calendar quarter in 
which the required installment payment was due.
    (b) Amount of deemed distribution. If a loan satisfies Q&A-3 of 
this section when made, but there is a failure to pay the installment 
payments required under the terms of the loan (taking into account any 
grace period allowed under the preceding paragraph (a) of this Q&A-10), 
then the amount of the deemed distribution equals the entire 
outstanding balance of the loan at the time of such failure.
    (c) Example. The following example illustrates the rules in Q&A-
10(a) and (b) of this section and is based upon the assumptions 
described in ASSUMPTIONS FOR EXAMPLES:
    Example. (1) On August 1, 1998, a participant has a nonforfeitable 
account balance of $45,000 and borrows $20,000 from a plan to be repaid 
over five years in level monthly installments due at the end of each 
month. After making all monthly payments due through July 31, 1999, the 
participant fails to make the payment due on August 31, 1999 or any 
other monthly payments due thereafter. The plan administrator allows a 
three-month grace period.
    (2) As a result of the failure to satisfy the requirement that the 
loan be repaid in level installments pursuant to section 72(p)(2)(C), 
the participant has a deemed distribution on November 30, 1999, which 
is the last day of the three-month grace period for the August 31, 1999 
installment. The amount of the deemed distribution is $17,157, which is 
the outstanding balance on the loan at November 30, 1999. 
Alternatively, if the plan administrator had allowed a grace period 
through the end of the next calendar quarter, there would be a deemed 
distribution on December 31, 1999 equal to $17,282, which is the 
outstanding balance of the loan at December 31, 1999.
    Q-11: Do sections 72 and 4980A apply to a deemed distribution as if 
it were an actual distribution?
    A-11: (a) Tax Basis. If the employee's account includes after-tax 
contributions or other investment in the contract under section 72(e), 
section 72 applies to a deemed distribution as if it were an actual 
distribution, with the result that all or a portion of the deemed 
distribution may not be taxable.
    (b) Sections 72(t) and (m). Section 72(t) (which imposes a 10 
percent tax on certain early distributions) and section 72(m)(5) (which 
imposes a separate 10 percent tax on certain amounts received by a 5-
percent owner) apply to a deemed distribution under section 72(p) 

[[Page 66237]]
in the same manner as if the deemed distribution were an actual 
distribution.
    (c) Section 4980A. For purposes of section 4980A, a deemed 
distribution under section 72(p) is taken into account in determining 
an individual's excess distributions, as provided in Sec. 54.4981A-1T, 
Q&A a-8.
    Q-12: Is a deemed distribution under section 72(p) treated as an 
actual distribution for purposes of the qualification requirements of 
section 401, the distribution provisions of section 402, or the 
distribution restrictions of section 401(k)(2)(B) or 403(b)(11)?
    A-12: No. Thus, for example, if a participant in a money purchase 
plan who is an active employee has a deemed distribution under section 
72(p), the plan will not be considered to have made an in-service 
distribution to the participant in violation of the qualification 
requirements applicable to money purchase plans. Similarly, the deemed 
distribution is not eligible to be rolled over to an eligible 
retirement plan and the participant is not eligible to elect income 
averaging with respect to the deemed distribution. See also 
Secs. 1.402(c)-2, Q&A-4(d) and Sec. 1.401(k)-1(d)(6)(ii).
    Q-13: How does a reduction (offset) of an account balance in order 
to repay a plan loan differ from a deemed distribution?
    A-13: (a) Difference between deemed distribution and plan loan 
offset amount. (1) Loans to a participant from a qualified employer 
plan can give rise to two types of taxable distributions--
    (i) A deemed distribution pursuant to section 72(p); and
    (ii) A distribution of an offset amount.
    (2) As described in Q&A-4 of this section, a deemed distribution 
occurs when the requirements of Q&A-3 of this section are not 
satisfied, either when the loan is made or at a later time. A deemed 
distribution is treated as a distribution to the participant or 
beneficiary only for certain tax purposes and is not a distribution of 
the accrued benefit. A distribution of a plan loan offset amount (as 
defined in Sec. 1.402(c)-2, Q&A-9(b)) occurs when, under the terms 
governing a plan loan, the accrued benefit of the participant or 
beneficiary is reduced (offset) in order to repay the loan (including 
the enforcement of the plan's security interest in the accrued 
benefit). A distribution of a plan loan offset amount could occur in a 
variety of circumstances, such as where the terms governing the plan 
loan require that, in the event of the participant's request for a 
distribution, a loan be repaid immediately or treated as in default.
    (b) Plan loan offset. In the event of a plan loan offset, the 
amount of the account balance that is offset against the loan is an 
actual distribution for purposes of the Internal Revenue Code, not a 
deemed distribution under section 72(p). Accordingly, a plan may be 
prohibited from making such an offset under the provisions of section 
401(a), 401(k)(2)(B) or 403(b)(11) prohibiting or limiting 
distributions to an active employee. See Sec. 1.402(c)-2, Q&A-9(c) 
Example 6.
    Q-14: How is the amount includible in income as a result of a 
deemed distribution under section 72(p) required to be reported?
    A-14: The amount includible in income as a result of a deemed 
distribution under section 72(p) is required to be reported on Form 
1099-R (or any other form prescribed by the Commissioner).
    Q-15: What withholding rules apply to plan loans?
    A-15: To the extent that a loan, when made, is a deemed 
distribution or an account balance is reduced (offset) to repay a loan, 
the amount includible in income is subject to withholding. If a deemed 
distribution of a loan or a loan repayment by benefit offset results in 
income at a date after the date the loan is made, withholding is 
required only if a transfer of cash or property (excluding employer 
securities) is made to the participant or beneficiary from the plan at 
the same time. See Secs. 35.3405-1(f)(4) and 31.3405(c)-1, Q&A-9 and 
Q&A-11 of this chapter for further guidance on withholding rules.
    Q-16: If a loan fails to satisfy the requirements of Q&A-3 of this 
section and is a prohibited transaction under section 4975, is the 
deemed distribution of the loan under section 72(p) a correction of the 
prohibited transaction?
    A-16: A deemed distribution is not a correction of a prohibited 
transaction under section 4975. See Secs. 141.4975-13 and 53.4941(e)-
1(c)(1) of this chapter for guidance concerning correction of a 
prohibited transaction.
    Q-17: What are the income tax consequences if an amount is 
transferred from a qualified employer plan to a participant or 
beneficiary as a loan, but there is an express or tacit understanding 
that the loan will not be repaid?
    A-17: If there is an express or tacit understanding that the loan 
will not be repaid, or, for any reason, the transaction does not create 
a debtor-creditor relationship, then the amount transferred is treated 
as an actual distribution from the plan for purposes of the Internal 
Revenue Code, and is not treated as a loan or as a deemed distribution 
under section 72(p).
    Q-18: If a qualified employer plan maintains a program to invest in 
residential mortgages, are loans made pursuant to the investment 
program subject to section 72(p)?
    A-18: Residential mortgage loans made by a plan in the ordinary 
course of an investment program are not subject to section 72(p) if the 
property acquired with the loans is the primary security for such loans 
and the amount loaned does not exceed the fair market value of the 
property. An investment program exists only if the plan has 
established, in advance of a specific investment under the program, 
that a certain percentage or amount of plan assets will be invested in 
residential mortgages available to persons purchasing the property who 
satisfy commercially customary financial criteria. Loans will not be 
considered as made under an investment program if the loans are only 
made available to, or any loan is earmarked for, any person or persons 
who are participants or beneficiaries in the plan, or if such loans 
mature upon a participant's termination from employment. In addition, 
no loan that benefits an officer, director, or owner of the employer 
maintaining the plan, or his or her beneficiaries, will be treated as 
made under an investment program. No inference should be drawn that a 
transaction under such an investment program is not a prohibited 
transaction under section 503 or 4975 or is not a violation of the 
applicable fiduciary standards for an employee benefit plan, so that 
such a loan could be a prohibited transaction if it does not satisfy 
the requirements of 29 CFR 2550.408b-1.
    Q-19: When is the effective date of these regulations?
    A-19: This section applies to assignments, pledges, and loans made 
on or after the date that is three months after the date of publication 
of the final regulations in the Federal Register.
Margaret Milner Richardson,
Commissioner of Internal Revenue.
[FR Doc. 95-30874 Filed 12-20-95; 8:45 am]
BILLING CODE 4830-01-U

Complete official Federal Register PDF

FR Doc. 95-30832 Treatment of Gain From the Disposition of Interest in Certain Natural Resource Recapture Property by S Corporations and Their Shareholders
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Pages 66237-66243]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-30832]

-----------------------------------------------------------------------

[[Page 66238]]

DEPARTMENT OF THE TREASURY
26 CFR Part 1

[PS-7-89]
RIN 1545-AM98

Treatment of Gain From the Disposition of Interest in Certain 
Natural Resource Recapture Property by S Corporations and Their 
Shareholders

AGENCY: Internal Revenue Service (IRS), Treasury.

ACTION: Notice of proposed rulemaking.

-----------------------------------------------------------------------

SUMMARY: This document contains proposed regulations under section 1254 
of the Internal Revenue Code relating to the tax treatment by S 
corporations and their shareholders of gain from the disposition by an 
S corporation (and a former S corporation) of certain natural resource 
recapture property (section 1254 property after enactment of the Tax 
Reform Act of 1986 and oil, gas, or geothermal property before 
enactment of the Tax Reform Act of 1986), and also rules relating to 
the disposition of stock in an S corporation that holds certain natural 
resource recapture property. Changes to the applicable tax law were 
made by the Tax Reform Act of 1986, and the Subchapter S Revision Act 
of 1982. The regulations provide the public with guidance in complying 
with the changed tax laws.

DATES: Written comments and requests for a public hearing must be 
received by February 20, 1996.

ADDRESSES: Send comments and requests for a public hearing to: 
CC:DOM:CORP:R (PS-7-89), room 5228, Internal Revenue Service, P.O. Box 
7604, Ben Franklin Station, Washington, DC 20044. In the alternative, 
submissions may be hand-delivered to CC:DOM:CORP:R (PS-7-89), Room 
5228, Internal Revenue Service Building, 1111 Constitution Avenue, NW., 
Washington, DC 20224.

FOR FURTHER INFORMATION CONTACT: James A. Quinn, 202-622-3060 (not a 
toll-free number).

SUPPLEMENTARY INFORMATION:

Paperwork Reduction Act

    The collection of information contained in this notice of proposed 
rulemaking has been submitted to the Office of Management and Budget 
(OMB) for review in accordance with the Paperwork Reduction Act of 1995 
(44 U.S.C. 3507).
    Comments on the collection of information should be sent to the 
Office of Management and Budget, Attn: Desk Officer for the Department 
of the Treasury, Office of Information and Regulatory Affairs, 
Washington, DC 20503, with copies to the Internal Revenue Service, 
Attn: IRS Reports Clearance Officer PC:FP, Washington, DC 20224. 
Comments on the collection of information should be received by January 
22, 1996.
    An agency may not conduct or sponsor, and a person is not required 
to respond to, a collection of information unless the collection of 
information displays a valid control number.
    The collection of information is contained in Sec. 1.1254-4(c) of 
the proposed regulations. This information is required by the Internal 
Revenue Service to verify that taxpayers have reported the appropriate 
amount of gain as ordinary income under section 1254 when a shareholder 
sells stock in an S corporation that holds natural resource recapture 
property. The likely respondents are individuals and businesses and 
other for-profit institutions.
    Books or records relating to a collection of information must be 
retained as long as their contents may become material in the 
administration of any internal revenue law. Generally, tax returns and 
tax return information are confidential, as required by 26 U.S.C. 6103.
    Estimated total annual reporting burden: 1,000 hours. The estimated 
annual burden per respondent varies from .5 hours to 1.5 hours, 
depending on individual circumstances, with an estimated average of 1 
hour.
    Estimated number of respondents: 1,000.
    Estimated annual frequency of responses: On occasion.

Background

    On June 11, 1980, proposed amendments to the Income Tax 
Regulations, 26 CFR part 1, under sections 170, 301, 312, 341, 453, 
751, 1254, and 1502 of the Internal Revenue Code of 1954 (Code) were 
published in the Federal Register (45 FR 39512). These amendments were 
proposed to conform the regulations to section 205(a), (b), (c)(1) and 
(2) of the Tax Reform Act of 1976, Public Law 94-455, 90 Stat. 1533, 
and section 402(c) of the Energy Tax Act of 1978, Public Law 95-618, 92 
Stat. 3202, and to make certain other technical amendments to the 
regulations to conform them to section 1(c) of the Act of September 12, 
1966, Public Law 89-570, 80 Stat. 762, section 211(b)(6) of the Tax 
Reform Act of 1969, Public Law 91-172, 83 Stat. 570, and sections 
1042(c)(2), 1101(d)(2), 1901(a)(93), and 2110(a) of the Tax Reform Act 
of 1976, 90 Stat. 1637, 1658, 1780, 1905. Section 1.1254-3 of the 
proposed regulations provided rules relating to the sale or exchange of 
stock in an electing small business corporation (hereinafter referred 
to as an S corporation). Because of the substantial changes in the tax 
treatment of S corporations since the proposed regulations were issued, 
the proposed regulations contained in Sec. 1.1254-3 needed to be 
completely revised.
    This document revises and reproposes Sec. 1.1254-3 of the above- 
referenced notice of proposed rulemaking as amendments to the Income 
Tax Regulations, 26 CFR part 1, under section 1254 of the Code, 
relating to S corporations (redesignated as Sec. 1.1254-4). These 
amendments are proposed to conform the regulations to section 5(a)(37) 
of the Subchapter S Revision Act of 1982, Public Law 97-354, 96 Stat. 
1669, and sections 411 and 413 of the Tax Reform Act of 1986, Public 
Law 99-514, 100 Stat. 2225, 2227. The amendments are to be issued under 
the authority contained in sections 1254(b) and 7805 of the Code.

Explanation of Provisions

    These proposed regulations contain rules for applying the 
provisions of section 1254 to the disposition of natural resource 
recapture property by an S corporation (and a former S corporation) and 
the disposition of S corporation stock.
    The proposed regulations provide that the recognition of ordinary 
income under section 1254 upon the disposition of natural resource 
recapture property by an S corporation is generally computed at the 
shareholder level. Determining the amount of ordinary income to be 
recognized under section 1254 at the shareholder level is appropriate 
because the determination of section 1254 costs can be affected by 
shareholder elections and characteristics. See, for example, sections 
59(e) and 1363(c)(2)(A). Similarly, in the case of oil and gas 
properties, gain on the disposition of the property and depletion with 
respect to the property are computed at the shareholder level. See 
section 613A(c)(11).
    The proposed regulations also contain rules relating to the 
recognition of ordinary income under section 1254 upon a sale or 
exchange of S corporation stock. Under section 1254(b)(2), rules 
similar to the rules of section 751 are to be applied to that portion 
of the excess of the amount realized over the adjusted basis of the 
stock that is attributable to section 1254 costs. Pursuant to section 
1254(b)(2), the proposed regulations provide that, as a general rule, a 

[[Page 66239]]
shareholder must treat any gain recognized on a sale or exchange of S 
corporation stock as ordinary income to the extent of the shareholder's 
section 1254 costs with respect to the shares sold or exchanged.
    The proposed regulations provide two exceptions to the general rule 
for determining the amount treated as ordinary income under section 
1254 upon a sale or exchange of stock. The first exception is that the 
general rule does not apply to the extent that the shareholder 
establishes that the gain is not attributable to the section 1254 
costs. The portion of the gain recognized that is not attributable to 
section 1254 costs is that portion of the gain recognized that exceeds 
the amount of ordinary income that the shareholder would have 
recognized under section 1254 (with respect to the shares sold or 
exchanged) if, immediately prior to the sale or exchange of the stock, 
the corporation had sold at fair market value all of the corporation's 
property the disposition of which would result in the recognition by 
the shareholder of ordinary income under section 1254. To establish 
that a portion of the gain recognized is not attributable to a 
shareholder's section 1254 costs, the shareholder must attach to the 
shareholder's tax return a statement detailing the shareholder's share 
of the fair market value and basis, and the shareholder's section 1254 
costs, for each of the S corporation's natural resource recapture 
properties held immediately before the sale or exchange of stock.
    The second exception to the general rule for sales or exchanges of 
stock is that, in the case of a contribution of property to the S 
corporation prior to a stock sale or exchange pursuant to a plan a 
principal purpose of which is to avoid the recognition of ordinary 
income under section 1254, the selling or exchanging shareholder must 
recognize as ordinary income under section 1254 the amount of ordinary 
income the shareholder would have recognized under section 1254 (with 
respect to the shares sold or exchanged) had the S corporation sold all 
of its natural resource recapture property the disposition of which 
would result in ordinary income under section 1254. Section 1.1254-
4(c)(3) Example 3 of the proposed regulations illustrates this 
exception. The proposed regulations also provide rules for determining 
an S corporation shareholder's section 1254 costs. Generally, an S 
corporation shareholder's section 1254 costs with respect to any 
natural resource recapture property held by the corporation include all 
of the shareholder's section 1254 costs with respect to the property 
while in the hands of the S corporation. In the case of a person 
(acquiring shareholder) who acquires stock from another shareholder, 
the proposed regulations provide that the acquiring shareholder's 
section 1254 costs are zero if the acquiring shareholder's basis for 
the stock transferred is determined by reference to its cost (within 
the meaning of section 1012) or by reference to the fair market value 
of the stock on the date of the decedent's death or on the applicable 
date provided in section 2032 (relating to alternate valuation date). 
However, an acquiring shareholder's section 1254 costs include any 
section 1254 costs paid or incurred before the decedent's death, to the 
extent that the basis of the stock is reduced under section 1014(b)(9) 
(relating to adjustments to basis if the property is acquired from a 
decedent prior to death). For stock that is acquired in a transfer that 
is a gift, in a transfer that is part sale or exchange and part gift, 
or a transfer described in section 1041, the acquiring shareholder 
generally acquires the section 1254 costs of the transferor but reduces 
the section 1254 costs by the amount of any gain treated as ordinary 
income under section 1254 by the transferor on the transfer.
    The proposed regulations provide rules for applying section 1254 to 
the shareholders of an S corporation that incurred section 1254 costs 
while it was a C corporation (former C corporation). In the case of a C 
corporation that holds natural resource recapture property and that 
elects to be an S corporation, each shareholder's section 1254 costs as 
of the beginning of the corporation's first taxable year as an S 
corporation include a pro rata share of the section 1254 costs of the 
corporation as of the close of the last taxable year that the 
corporation was a C corporation.
    The proposed regulations also provide rules for applying section 
1254 to a corporation that holds natural resource recapture property 
after the termination of its S corporation election (former S 
corporation). In the case of an S corporation that becomes a C 
corporation, the C corporation's section 1254 costs with respect to any 
natural resource recapture property held by the corporation as of the 
beginning of the corporation's first taxable year as a C corporation 
include the sum of its shareholders' section 1254 costs with respect to 
the property as of the close of the last taxable year for which the 
corporation was an S corporation. In the case of an S termination year 
as defined in section 1362(e)(4), the shareholders' section 1254 costs 
are determined as of the close of the S short year as defined in 
section 1362(e)(1)(A).
    Because certain transactions will change the allocation to the 
shareholders of gain or amount realized from the natural resource 
recapture property if the S corporation disposes of it subsequent to 
these transactions, the proposed regulations require that section 1254 
costs be reallocated to reflect the effects of these transactions. 
Transactions requiring reallocation of the section 1254 costs are 
transactions involving the issuance of stock by an S corporation in a 
reorganization or otherwise, and transfers of natural resource 
recapture property to the S corporation in exchange for stock of the S 
corporation (for example, in a section 351 transaction or in a 
reorganization).
    The rules for former S corporations and the rules for allocating 
section 1254 costs upon certain transfers require the S corporation to 
determine the aggregate of its shareholders' section 1254 costs. The 
proposed regulations provide rules for the S corporation to apply in 
determining a shareholder's section 1254 costs with respect to natural 
resource recapture property held by the S corporation. In general, the 
S corporation may determine a shareholder's section 1254 costs by using 
written data provided by the shareholder or by applying certain 
assumptions.
    These regulations are proposed to apply to dispositions of natural 
resource recapture property by an S corporation (and a former S 
corporation) and dispositions of S corporation stock occurring after 
publication of these regulations as final regulations in the Federal 
Register.

Comments and Requests for a Public Hearing

    Before the adoption of these proposed regulations, consideration 
will be given to any written comments that are timely submitted 
(preferably an original and eight copies) to the IRS. All comments will 
be available for public inspection and copying. A public hearing will 
be held upon written request to the Internal Revenue Service by any 
person who also submits written comments. If a public hearing is held, 
notice of the time and place will be published in the Federal Register.

Special Analyses

    It has been determined that this proposed regulation is not a 
significant regulatory action as defined in Executive Order 12866. 
Therefore, a regulatory assessment is not required. It also has been 
determined that section 

[[Page 66240]]
553(b) of the Administrative Procedure Act (5 U.S.C. chapter 5) and the 
Regulatory Flexibility Act (5 U.S.C. chapter 6) do not apply to these 
regulations, and, therefore, a Regulatory Flexibility Analysis is not 
required. Pursuant to section 7805(f) of the Internal Revenue Code, 
this notice of proposed rulemaking will be submitted to the Chief 
Counsel for Advocacy of the Small Business Administration for comment 
on its impact on small business.

Drafting Information

    The principal author of these regulations is James A. Quinn of the 
Office of Assistant Chief Counsel (Passthroughs and Special 
Industries), IRS. However, other personnel from the IRS and Treasury 
Department participated in their development.

List of Subjects in 26 CFR Part 1

    Income taxes, Reporting and recordkeeping requirements.

Proposed Amendments to the Regulations

    Accordingly, 26 CFR part 1 is proposed to be amended as follows:

PART 1--INCOME TAXES

    Paragraph 1. The authority citation for part 1 continues to read in 
part as follows:

    Authority: 26 U.S.C. 7805. * * *
    Section 1.1254-4 also issued under 26 U.S.C. 1254(b). * * *

    Par. 2. Section 1.1254-0 is amended by revising the entry for 
Sec. 1.1254-4 to read as follows:

Sec. 1.1254-0  Table of contents for section 1254 recapture rules.

* * * * *

Sec. 1.1254-4  Special rules for S corporations and their shareholders.

    (a) In general.
    (b) Determination of gain treated as ordinary income under section 
1254 upon a disposition of natural resource recapture property by an S 
corporation.
    (1) General rule.
    (2) Examples.
    (c) Character of gain recognized by a shareholder upon a sale or 
exchange of S corporation stock.
    (1) General rule.
    (2) Exceptions.
    (3) Examples.
    (d) Section 1254 costs of a shareholder.
    (e) Section 1254 costs of an acquiring shareholder after certain 
acquisitions.
    (1) Basis determined under section 1012.
    (2) Basis determined by reason of the application of section 
1014(a).
    (3) Basis determined by reason of the application of section 
1014(b)(9).
    (4) Gifts and section 1041 transfers.
    (f) Special rules for former S corporations and former C 
corporations.
    (1) Section 1254 costs of an S corporation that was formerly a C 
corporation.
    (2) Examples.
    (3) Section 1254 costs of a C corporation that was formerly an S 
corporation.
    (g) Determination of a shareholder's section 1254 costs upon 
certain stock transactions.
    (1) Issuance of stock.
    (2) Natural resource recapture property acquired in exchange for 
stock.
    (3) Treatment of nonvested stock.
    (4) Exception.
    (5) Aggregate of S corporation shareholders' section 1254 costs 
with respect to natural resource recapture property held by the S 
corporation
    (6) Examples.
    (h) Effective date.
* * * * *
    Par. 3. Section 1.1254-4 is amended by adding text to read as 
follows:

 Sec. 1.1254-4  Special rules for S corporations and their 
shareholders.

    (a) In general. This section provides rules for applying the 
provisions of section 1254 to S corporations and their shareholders 
upon the disposition by an S corporation (or a former S corporation) of 
natural resource recapture property and upon the disposition by a 
shareholder of stock of an S corporation that holds natural resource 
recapture property.
    (b) Determination of gain treated as ordinary income under section 
1254 upon a disposition of natural resource recapture property by an S 
corporation--(1) General rule. Upon a disposition of natural resource 
recapture property by an S corporation, the amount of gain treated as 
ordinary income under section 1254 is determined at the shareholder 
level. Each shareholder must recognize as ordinary income under section 
1254 the lesser of--
    (i) The shareholder's section 1254 costs with respect to the 
property disposed of; or
    (ii) The shareholder's share of the amount, if any, by which the 
amount realized on the sale, exchange, or involuntary conversion, or 
the fair market value of the property upon any other disposition 
(including a distribution), exceeds the adjusted basis of the property.
    (2) Examples. The following examples illustrate the provisions of 
paragraph (b)(1) of this section:

    Example 1. Disposition of natural resource recapture property 
other than oil and gas property. A and B are equal shareholders in 
X, an S corporation. On January 1, 1995, X acquires for $90,000 an 
undeveloped mineral property, its sole property. During 1995, X 
expends and deducts $100,000 in developing the property. On January 
15, 1996, X sells the property for $250,000 when X's basis in the 
property is $90,000. Thus, X recognizes gain of $160,000 on the 
sale. A and B's share of the $160,000 gain recognized is $80,000 
each. Each shareholder has $50,000 of section 1254 costs with 
respect to the property. Under these circumstances, A and B each are 
required to recognize $50,000 of the $80,000 of gain on the sale of 
the property as ordinary income under section 1254.
    Example 2. Disposition of oil and gas property the adjusted 
basis of which is allocated to the shareholders under section 
613A(c)(11). C and D are equal shareholders in Y, an S corporation. 
On January 1, 1995, Y acquires for $150,000 an undeveloped oil and 
gas property, its sole property. During 1995, Y expends in 
developing the property $40,000 in intangible drilling costs which 
it elects to expense under section 263(c). On January 15, 1996, Y 
sells the property for $200,000. C and D's share of the $200,000 
amount realized on the sale is $100,000 each. C and D each have a 
basis of $75,000 in the property and $20,000 of section 1254 costs 
with respect to the property. Under these circumstances, C and D 
each are required to recognize $20,000 of the $25,000 gain on the 
sale of the property as ordinary income under section 1254.

    (c) Character of gain recognized by a shareholder upon a sale or 
exchange of S corporation stock--(1) General rule. Except as provided 
in paragraph (c)(2) of this section, if an S corporation shareholder 
recognizes gain upon a sale or exchange of stock in the S corporation 
(determined without regard to section 1254), the gain is treated as 
ordinary income under section 1254 to the extent of the shareholder's 
section 1254 costs (with respect to the shares sold or exchanged).
    (2) Exceptions--(i) Gain not attributable to section 1254 costs--
(A) General rule. Paragraph (c)(1) of this section does not apply to 
any portion of the gain recognized on the sale or exchange of the stock 
that the taxpayer establishes is not attributable to section 1254 
costs. The portion of the gain recognized that is not attributable to 
section 1254 costs is that portion of the gain recognized that exceeds 
the amount of ordinary income that the shareholder would have 
recognized under section 1254 (with respect to the shares sold or 
exchanged) if, immediately prior to the sale or exchange of the stock, 
the corporation had sold at fair market value all of the corporation's 
property the disposition of which would result in the recognition by 
the shareholder of ordinary income under section 1254. 

[[Page 66241]]

    (B) Substantiation. To establish that a portion of the gain 
recognized is not attributable to a shareholder's section 1254 costs so 
as to qualify for the exception contained in paragraph (c)(2)(i)(A) of 
this section, the shareholder must attach to the shareholder's tax 
return a statement detailing the shareholder's share of the fair market 
value and basis, and the shareholder's section 1254 costs, for each of 
the S corporation's natural resource recapture properties held 
immediately before the sale or exchange of stock.
    (ii) Transactions entered into as part of a plan to avoid 
recognition of ordinary income under section 1254. In the case of a 
contribution of property prior to a sale or exchange of stock pursuant 
to a plan a principal purpose of which is to avoid recognition of 
ordinary income under section 1254, paragraph (c)(1) of this section 
does not apply. Instead, the amount recognized as ordinary income under 
section 1254 is the amount of ordinary income the selling or exchanging 
shareholder would have recognized under section 1254 (with respect to 
the shares sold or exchanged) had the S corporation sold its natural 
resource recapture property the disposition of which would have 
resulted in the recognition of ordinary income under section 1254. The 
amount recognized as ordinary income under the preceding sentence 
reduces the amount realized on the sale or exchange of the stock. This 
reduced amount realized is used in determining any gain or loss on the 
sale or exchange.
    (3) Examples. The following examples illustrate the provisions of 
this paragraph (c):

    Example 1. Application of general rule upon a sale of S 
corporation stock. C and D are equal shareholders in Y, an S 
corporation. As of January 1, 1995, Y holds two mining properties: 
Blackacre, with an adjusted basis of $5,000 and a fair market value 
of $35,000, and Whiteacre, with an adjusted basis of $20,000 and a 
fair market value of $15,000. Y also holds securities with a basis 
of $5,000 and a fair market value of $10,000. On January 1, 1995, D 
sells 50 percent of D's Y stock to E for $15,000. As of the date of 
the sale, D's adjusted basis in the Y stock sold is $7,500, and D 
has $18,000 of section 1254 costs with respect to Blackacre and 
$12,000 of section 1254 costs with respect to Whiteacre. Under this 
paragraph (c), the gain recognized by D upon the sale of Y stock is 
treated as ordinary income to the extent of D's section 1254 costs 
with respect to the stock sold, unless D establishes that a portion 
of such excess is not attributable to D's section 1254 costs. 
However, because D would recognize $7,500 in ordinary income under 
section 1254 with respect to the stock sold if Y sold Blackacre (the 
only asset the disposition of which would result in ordinary income 
to D under section 1254), the $7,500 of gain recognized by D upon 
the sale of D's Y stock is attributable to D's section 1254 costs. 
Therefore, upon the sale of stock to E, D recognizes $7,500 of 
ordinary income under this paragraph (c).
    Example 2. Sale of S corporation stock where gain is not 
entirely attributable to section 1254 costs. Assume the same facts 
as in Example 1, except that Blackacre has a fair market value of 
$25,000, and the securities have a fair market value of $20,000. 
Immediately prior to the sale of stock to E, if Y had sold Blackacre 
(its only asset the disposition of which would result in the 
recognition of ordinary income to D under section 1254), D would 
recognize $5,000 in ordinary income with respect to the stock sold 
under section 1254. D attaches a statement to D's tax return for 
1995 detailing D's share of the fair market values and bases, and 
D's section 1254 costs with respect to Blackacre and Whiteacre. 
Therefore, upon the sale of stock to E, of the $7,500 gain 
recognized by D, $5,000 is ordinary income under this paragraph (c).
    Example 3. Contribution of property prior to sale of S 
corporation stock as part of a plan to avoid recognition of ordinary 
income under section 1254. H owns all of the stock of Z, an S 
corporation. As of January 1, 1995, H has $3,000 of section 1254 
costs with respect to property P, which is natural resource 
recapture property and Z's only asset. Property P has an adjusted 
basis of $5,000 and a fair market value of $8,000. H has a basis of 
$5,000 in Z stock, which has a fair market value of $8,000. On 
January 1, 1995, H contributes securities to Z which have a basis of 
$7,000 and a fair market value of $4,000. On April 15, 1995, H sells 
all of the Z stock to J for $12,000. On that date, H's adjusted 
basis in the Z stock is also $12,000. Based on all the facts and 
circumstances, the sale of stock is part of a plan (along with the 
contribution by H of the securities to Z) that has a principal 
purpose to avoid recognition of ordinary income under section 1254. 
Consequently, under paragraph (c)(2)(ii) of this section, H must 
recognize $3,000 as ordinary income under section 1254, the amount 
of ordinary income that H would recognize as ordinary income under 
section 1254 if property P were sold at fair market value. In 
addition, H reduces the amount realized on the sale of the stock 
($12,000) by $3,000. As a result, H also recognizes a $3,000 capital 
loss on the sale of the stock ($9,000 amount realized less $12,000 
adjusted basis).

    (d) Section 1254 costs of a shareholder. An S corporation 
shareholder's section 1254 costs with respect to any natural resource 
recapture property held by the corporation include all of the 
shareholder's section 1254 costs with respect to the property in the 
hands of the S corporation. See Sec. 1.1254-1(b)(1) for the definition 
of section 1254 costs.
    (e) Section 1254 costs of an acquiring shareholder after certain 
acquisitions--(1) Basis determined under section 1012. If stock in an S 
corporation that holds natural resource recapture property is acquired 
and the acquiring shareholder's basis for the stock is determined 
solely by reference to its cost (within the meaning of section 1012), 
the amount of section 1254 costs with respect to the property held by 
the corporation in the acquiring shareholder's hands is zero on the 
acquisition date.
    (2) Basis determined by reason of the application of section 
1014(a). If stock in an S corporation that holds natural resource 
recapture property is acquired from a decedent and the acquiring 
shareholder's basis is determined, by reason of the application of 
section 1014(a), solely by reference to the fair market value of the 
stock on the date of the decedent's death or on the applicable date 
provided in section 2032 (relating to alternate valuation date), the 
amount of section 1254 costs with respect to the property held by the 
corporation in the acquiring shareholder's hands is zero on the 
acquisition date.
    (3) Basis determined by reason of the application of section 
1014(b)(9). If stock in an S corporation that holds natural resource 
recapture property is acquired before the death of the decedent, the 
amount of section 1254 costs with respect to the property held by the 
corporation in the acquiring shareholder's hands includes the amount, 
if any, of the section 1254 costs deducted by the acquiring shareholder 
before the decedent's death, to the extent that the basis of the stock 
(determined under section 1014(a)) is required to be reduced under 
section 1014(b)(9) (relating to adjustments to basis when the property 
is acquired before the death of the decedent).
    (4) Gifts and section 1041 transfers. If stock is acquired in a 
transfer that is a gift, in a transfer that is a part sale or exchange 
and part gift, or in a transfer that is described in section 1041(a), 
the amount of section 1254 costs with respect to the property held by 
the corporation in the acquiring shareholder's hands immediately after 
the transfer is an amount equal to--
    (i) The amount of section 1254 costs with respect to the property 
held by the corporation in the hands of the transferor immediately 
before the transfer; minus
    (ii) The amount of any gain recognized as ordinary income under 
section 1254 by the transferor upon the transfer.
    (f) Special rules for former S corporations and former C 
corporations--(1) Section 1254 costs of an S corporation that was 
formerly a C corporation. In the case of a C 

[[Page 66242]]
corporation that holds natural resource recapture property and that 
elects to be an S corporation, each shareholder's section 1254 costs as 
of the beginning of the corporation's first taxable year as an S 
corporation include a pro rata share of the section 1254 costs of the 
corporation as of the close of the last taxable year that the 
corporation was a C corporation.
    (2) Examples. The following examples illustrate the application of 
the provisions of paragraph (f)(1) of this section:

    Example 1. Sale of natural resource recapture property held by 
an S corporation that was formerly a C corporation--(i) Y is a C 
corporation that elects to be an S corporation effective January 1, 
1996. On that date, Y owns Oil Well, which is natural resource 
recapture property and a capital asset. Y has section 1254 costs of 
$20,000 as of the close of the last taxable year that it was a C 
corporation. On January 1, 1996, Oil Well has a value of $200,000 
and a basis of $100,000. Thus, under section 1374, Y's net 
unrealized built-in gain is $100,000. Also on that date, Y's basis 
in Oil Well is allocated to A, Y's sole shareholder, under section 
613A(c)(11) and the section 1254 costs are allocated to A under 
Sec. 1.1254-4(f)(1). In addition, A has a basis in A's Y stock of 
$100,000.
    (ii) On November 1, 1996, Y sells Oil Well for $250,000. During 
1996, Y has taxable income greater than $100,000, and no other 
transactions or items treated as recognized built-in gain or loss. 
Under section 1374, Y has net recognized built-in gain of $100,000. 
Assuming a tax rate of 35 percent on capital gain, Y has a tax of 
$35,000 under section 1374. The tax of $35,000 is treated as a 
capital loss under section 1366(f)(2). A has a realized gain on the 
sale of $150,000 ($250,000 minus $100,000) of which $20,000 is 
recognized as ordinary income under section 1254, and $130,000 is 
recognized as capital gain. Consequently, A recognizes ordinary 
income of $20,000 and net capital gain of $95,000 ($130,000 minus 
$35,000) on the sale.
    Example 2. Sale of stock followed by sale of natural resource 
recapture property held by an S corporation that was formerly a C 
corporation--(i) Assume the same facts as in Example 1(i). On 
November 1, 1996, A sells all of A's Y stock to P for $250,000. A 
has a realized gain on the sale of $150,000 ($250,000 minus 
$100,000) of which $20,000 is recognized as ordinary income under 
section 1254, and $130,000 is recognized as capital gain.
    (ii) On November 2, 1996, Y sells Oil Well for $250,000. During 
1996, Y has taxable income greater than $100,000, and no other 
transactions or items treated as recognized built-in gain or loss. 
Under section 1374, Y has net recognized built-in gain of $100,000. 
Assuming a tax rate of 35 percent on capital gain, Y has a tax of 
$35,000 under section 1374. The tax of $35,000 is treated as a 
capital loss under section 1366(f)(2). P has a realized gain on the 
sale of $150,000 ($250,000 minus $100,000), which is recognized as 
capital gain. Consequently, P recognizes net capital gain of 
$115,000 ($150,000 minus $35,000) on the sale.

    (3) Section 1254 costs of a C corporation that was formerly an S 
corporation. In the case of an S corporation that becomes a C 
corporation, the C corporation's section 1254 costs with respect to any 
natural resource recapture property held by the corporation as of the 
beginning of the corporation's first taxable year as a C corporation 
include the sum of its shareholders' section 1254 costs with respect to 
the property as of the close of the last taxable year that the 
corporation was an S corporation. In the case of an S termination year 
as defined in section 1362(e)(4), the shareholders' section 1254 costs 
are determined as of the close of the S short year as defined in 
section 1362(e)(1)(A). See paragraph (g)(5) of this section for rules 
on determining the aggregate amount of the shareholders' section 1254 
costs.
    (g) Determination of a shareholder's section 1254 costs upon 
certain stock transactions--(1) Issuance of stock. Upon an issuance of 
stock (whether such stock is newly-issued or had been held as treasury 
stock) by an S corporation in a reorganization or otherwise--
    (i) Each recipient of shares must be allocated a pro rata share 
(determined solely with respect to the shares issued in the 
transaction) of the aggregate of the S corporation shareholders' 
section 1254 costs with respect to natural resource recapture property 
held by the S corporation immediately before the issuance (as 
determined pursuant to paragraph (g)(5) of this section); and
    (ii) Each pre-existing shareholder must reduce his or her section 
1254 costs with respect to natural resource recapture property held by 
the S corporation immediately before the issuance by an amount equal to 
the pre-existing shareholder's section 1254 costs immediately before 
the issuance multiplied by the percentage of stock of the corporation 
issued in the transaction.
    (2) Natural resource recapture property acquired in exchange for 
stock. If natural resource recapture property is transferred to an S 
corporation in exchange for stock of the S corporation (for example, in 
a section 351 transaction, or in a reorganization described in section 
368), the S corporation must allocate to its shareholders a pro rata 
share of the S corporation's section 1254 costs with respect to the 
property immediately after the transaction (as determined under 
Sec. 1.1254-3(b)(1)).
    (3) Treatment of nonvested stock. Stock issued in connection with 
the performance of services that is substantially nonvested (within the 
meaning of Sec. 1.83-3(b)) is treated as issued for purposes of this 
section at the first time it is treated as outstanding stock of the S 
corporation for purposes of section 1361.
    (4) Exception. Paragraph (g)(1) of this section does not apply to 
stock issued in exchange for stock of the same S corporation (as for 
example, in a recapitalization described in section 368(a)(1)(E)).
    (5) Aggregate of S corporation shareholders' section 1254 costs 
with respect to natural resource recapture property held by the S 
corporation--(i) In general. The aggregate of S corporation 
shareholders' section 1254 costs is equal to the sum of each 
shareholder's section 1254 costs. The S corporation must determine each 
shareholder's section 1254 costs under either paragraph (g)(5)(i)(A) 
(written data) or paragraph (g)(5)(i)(B) (assumptions) of this section. 
The S corporation may determine the section 1254 costs of some 
shareholders under paragraph (g)(5)(i)(A) of this section and of others 
under paragraph (g)(5)(i)(B) of this section.
    (A) Written data. An S corporation may determine a shareholder's 
section 1254 costs by using written data provided by a shareholder 
showing the shareholder's section 1254 costs with respect to natural 
resource recapture property held by the S corporation unless the S 
corporation knows or has reason to know that the written data is 
inaccurate. If an S corporation does not receive written data upon 
which it may rely, the S corporation must use the assumptions provided 
in paragraph (g)(5)(i)(B) of this section in determining a 
shareholder's section 1254 costs.
    (B) Assumptions. An S corporation that does not use written data 
pursuant to paragraph (g)(5)(i)(A) of this section to determine a 
shareholder's section 1254 costs must use the following assumptions to 
determine the shareholder's section 1254 costs.
    (1) The shareholder deducted his or her share of the amount of 
deductions under sections 263(c), 616, and 617 in the first year in 
which the shareholder could claim a deduction for such amounts, unless 
in the case of expenditures under sections 263(c) or 616 the S 
corporation elected to capitalize such amounts;
    (2) The shareholder was not subject to the following limitations 
with respect to the shareholder's depletion allowance under section 
611, except to the extent a limitation applied at the corporate 

[[Page 66243]]
level: the taxable income limitation of section 613(a); the depletable 
quantity limitations of section 613A(c); or the limitations of sections 
613A(d)(2), (3), and (4) (exclusion of retailers and refiners).
    (6) Examples. The following examples illustrate the provisions of 
this paragraph (g):

    Example 1. Transfer of natural resource recapture property to an 
S corporation in a section 351 transaction. As of January 1, 1996, A 
owns all the stock (20 shares) in X, an S corporation. X holds 
property that is not natural resource recapture property that has a 
fair market value of $2,000 and an adjusted basis of $2,000. On 
January 1, 1996, B transfers natural resource recapture property, 
Property P, to X in exchange for 80 shares of X stock in a 
transaction that qualifies under section 351. Property P has a fair 
market value of $8,000 and an adjusted basis of $5,000. Pursuant to 
section 351, B does not recognize gain on the transaction. 
Immediately prior to the transaction, B's section 1254 costs with 
respect to Property P equaled $6,000. Under Sec. 1.1254-2(c)(1), B 
does not recognize any gain under section 1254 on the section 351 
transaction and, under Sec. 1.1254-3(b)(1), X's section 1254 costs 
with respect to Property P immediately after the contribution equal 
$6,000. Under paragraph (g)(2) of this section, each shareholder is 
allocated a pro rata share of X's section 1254 costs. The pro rata 
share of X's section 1254 costs that is allocated to A equals $1,200 
(20 percent interest in X multiplied by X's $6,000 of section 1254 
costs). The pro rata share of X's section 1254 costs that is 
allocated to B equals $4,800 (80 percent interest in X multiplied by 
X's $6,000 of section 1254 costs).
    Example 2. Contribution of money in exchange for stock of an S 
corporation holding natural resource recapture property. As of 
January 1, 1996, A and B each own 50 percent of the stock (50 shares 
each) in X, an S corporation. X holds natural resource recapture 
property, Property P, which has a fair market value of $20,000 and 
an adjusted basis of $14,000. A's and B's section 1254 costs with 
respect to Property P are $4,000 and $1,500, respectively. On 
January 1, 1996, C contributes $20,000 to X in exchange for 100 
shares of X's stock. Under paragraph (g)(1)(i) of this section, X 
must allocate to C a pro rata share of its shareholders' section 
1254 costs. Using the assumptions set forth in paragraph 
(g)(5)(i)(B) of this section, X determines that A's section 1254 
costs with respect to natural resource recapture property held by X 
equal $4,500. Using written data provided by B, X determines that 
B's section 1254 costs with respect to Property P equal $1,500. 
Thus, the aggregate of X's shareholders' section 1254 costs equals 
$6,000. C's pro rata share of the $6,000 of section 1254 costs 
equals $3,000 (C's 50 percent interest in X multiplied by $6,000). 
Under paragraph (g)(1)(ii) of this section, A's section 1254 costs 
are reduced by $2,000 (A's actual section 1254 costs ($4,000) 
multiplied by 50 percent). B's section 1254 costs are reduced by 
$750 (B's actual section 1254 costs ($1,500) multiplied by 50 
percent).
    Example 3. Merger involving an S corporation that holds natural 
resource recapture property. X, an S corporation with one 
shareholder, A, holds as its sole asset natural resource recapture 
property that has a fair market value of $120,000 and an adjusted 
basis of $40,000. A has section 1254 costs with respect to the 
property of $60,000. For valid business reasons, X merges into Y, an 
S corporation with one shareholder, B, in a reorganization described 
in section 368(a)(1)(A). Y holds property that is not natural 
resource recapture property that has a fair market value of $120,000 
and basis of $120,000. Under paragraph (c) of this section, A does 
not recognize ordinary income under section 1254 upon the exchange 
of stock in the merger because A did not otherwise recognize gain on 
the merger. Under paragraph (g)(2) of this section, Y must allocate 
to A and B a pro rata share of its $60,000 of section 1254 costs. 
Thus, A and B are each allocated $30,000 of section 1254 costs (50 
percent interest in X, each, multiplied by $60,000).

    (h) Effective date. This section applies to dispositions of natural 
resource recapture property by an S corporation (and a former S 
corporation) and dispositions of S corporation stock occurring after 
publication of these regulations as final regulations in the Federal 
Register.
Margaret Milner Richardson,
Commissioner of Internal Revenue.
[FR Doc. 95-30832 Filed 12-20-95; 8:45 am]
BILLING CODE 4830-01-U

Complete official Federal Register PDF

FR Doc. 95-30830 Requirements for Tax Exempt Section 501(c)(5) Organizations
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Pages 66228-66229]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-30830]

-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY
26 CFR Part 1

[EE-53-95]
RIN 1545-AT95

Requirements for Tax Exempt Section 501(c)(5) Organizations

AGENCY: Internal Revenue Service (IRS), Treasury.

ACTION: Notice of Proposed Rulemaking.

-----------------------------------------------------------------------

SUMMARY: This document contains proposed regulations clarifying certain 
requirements of section 501(c)(5). The requirements are being clarified 
to provide needed guidance to organizations as to the requirements an 
organization must meet in order to be exempt from tax as an 
organization described in section 501(c)(5).

DATES: Written comments and requests for a public hearing must be 
received by March 20, 1996.

ADDRESSES: Send submissions to: CC:DOM:CORP:T:R (EE-53-95), room 5228, 
Internal Revenue Service, POB 7604, Ben Franklin Station, Washington, 
DC 20044. In the alternative, submissions may be hand delivered between 
the hours of 8 a.m. and 5 p.m. to: CC:DOM:CORP:T:R (EE-53-95), 
Courier's Desk, Internal Revenue Service, 1111 Constitution Avenue NW., 
Washington, DC.

FOR FURTHER INFORMATION CONTACT: Robin Ehrenberg, (202) 622-6080 (not a 
toll-free number).

SUPPLEMENTARY INFORMATION:

Background

    This notice of proposed rulemaking clarifies the scope of the 
exemption provided in section 501(c)(5) of the Internal Revenue Code 
for labor, agricultural and horticultural organizations.
    An income tax exemption for labor organizations was first provided 
in the Corporation Excise Tax Act of 1909, Public Law No. 61-5, 36 
Stat. 11, 112-118, and has been in effect continuously since that time. 
A labor organization is an entity that is organized ``to protect and 
promote the interests of labor.'' Portland Cooperative Labor Temple 
Association v. Commissioner, 39 B.T.A. 450 (1939), acq., 1939-1 C.B. 
28. The principal purpose of the organization must be to better the 
working conditions of people engaged in a common pursuit. See, Treas. 
Reg. Sec. 1.501(c)(5)-1. Organizations meeting this requirement have 
traditionally engaged in collective action directed toward the workers' 
common objective of improving working conditions. They include labor 
unions that negotiate with employers on behalf of workers for improved 
wages, fringe benefits, hours and similar working conditions, and 
certain union-controlled organizations, like strike funds, that provide 
benefits to workers that enhance the union's ability to bargain 
effectively. See Rev. Rul. 67-7 (1967-1 C.B. 137). They do not include 
strike funds that provide income to union members but are not 
controlled by unions. See Rev. Rul. 76-420 (1976-2 C.B. 153). Such an 
organization will not pay the strike benefits ``with the objective of 
bettering conditions of employment, but by reason of its contractual 
agreements with the workers.''
    Labor organizations may also meet the requirements of section 
501(c)(5) by providing benefits that directly improve working 
conditions or compensate for unpredictable hazards that interrupt work. 
Examples of such benefits include operating a dispatch hall to match 
union members with work assignments and providing industry stewards who 
represent employees with grievances against management. See Rev. Rul. 
75-473 (1975-2 C.B. 213); Rev. Rul. 77-5 (1977-1 C.B. 148). On the 
other hand, managing saving and investment plans for workers, including 
retirement plans, does not bear directly on working conditions. See 
Rev. Rul. 77-46 (1977-1 C.B. 147). Accordingly, section 501(c)(5) has 
not been applied to organizations that manage retirement savings plans 
as their principal activity.
    Nevertheless, in Morganbesser v. United States, 984 F.2d 560 (2d 
Cir. 1993), the court held that a trust managing a pension benefit plan 
pursuant to a collective bargaining agreement qualified as a labor 
organization described in section 501(c)(5). The IRS and the Treasury 
Department believe that this decision is contrary to existing law, and 
the IRS is issuing an action on decision reflecting its view that the 
Morganbesser court erred in its holding. These proposed regulations are 
a clarification of the existing legal standard.

    Like labor organizations, agricultural and horticultural 
organizations must also better the conditions of those engaged in a 
common pursuit in order to be described in section 501(c)(5). See 
Sec. 1.501(c)(5)-1. There is no authority indicating that the law is to 
be interpreted differently for agricultural and horticultural 
organizations than for labor organizations. Accordingly, the proposed 
regulations clarify the law as it applies to all section 501(c)(5) 
organizations.

    Certain organizations have taken the position in refund actions 
that they are labor organizations described in section 501(c)(5) even 
though their principal activity was to manage retirement savings plans 
for workers. In addition, some such foreign organizations have claimed 
exemption from withholding on dividend, interest and similar income 
that they have earned. The IRS will continue to oppose these claims for 
refund and exemption from withholding.

    A health plan is not a retirement savings plan. Thus, the IRS will 
continue to follow Rev. Rul. 62-17 (1962-1 C.B. 87) (regarding a labor 
organization providing health benefits) even in circumstances where a 
majority of the organization's members are retired. Furthermore, the 
IRS will continue to recognize that negotiating the terms of a 
retirement plan and other postretirement benefits and designating one 
or more representatives to the board of a multiemployer pension trust 
are proper activities for a labor organization. The proposed 
regulations are not intended to apply to or affect 

[[Page 66229]]
any other provision of federal law, including provisions of the 
Employee Retirement Income Security Act of 1974 (ERISA) administered by 
the Secretary of Labor.

Explanation of Provisions

    The proposed regulations add a new paragraph to Sec. 1.501(c)(5)-1 
providing that an organization is not an organization within the 
meaning of section 501(c)(5) if the organization's principal activity 
is to manage savings or investment plans or programs, including 
retirement savings plans.

Proposed Effective Date

    These regulations are proposed to be effective December 21, 1995.

Special Analyses

    It has been determined that this notice of proposed rulemaking is 
not a significant regulatory action as defined in EO 12866. Therefore, 
a regulatory assessment is not required. It also has been determined 
that section 553(b) of the Administrative Procedure Act (5 U.S.C. 
chapter 5) and the Regulatory Flexibility Act (5 U.S.C. chapter 6) do 
not apply to these regulations, and, therefore, a Regulatory 
Flexibility Analysis is not required. Pursuant to section 7805(f) of 
the Internal Revenue Code, this notice of proposed rulemaking will be 
submitted to the Chief Counsel for Advocacy of the Small Business 
Administration for comment on its impact on small business.

Comments and Public Hearing

    Before these proposed regulations are adopted as final regulations, 
consideration will be given to any written comments (a signed original 
and eight (8) copies) that are submitted timely to the IRS. All 
comments will be available for public inspection and copying. A public 
hearing may be scheduled if requested in writing by a person that 
timely submits written comments. If a public hearing is scheduled, 
notice of the date, time, and place for the hearing will be published 
in the Federal Register.

Drafting Information

    The principal author of these regulations is Robin Ehrenberg, 
Office of Associate Chief Counsel (Employee Benefits and Exempt 
Organizations). However, other personnel from the IRS and Treasury 
Department participated in their development.

List of Subjects in 26 CFR Part 1

    Income taxes, Reporting and recordkeeping requirements.

Proposed Amendments to the Regulations

    Accordingly, 26 CFR part 1 is proposed to be amended as follows:

PART 1--INCOME TAXES

    Paragraph 1. The authority citation for part 1 continues to read in 
part as follows:

    Authority: 26 U.S.C. 7805 * * *

    Par. 2. Section 1.501(c)(5)-1 is amended by:
    1. Redesignating paragraph (b) as paragraph (c).
    2. Adding a new paragraph (b) to read as follows:

Sec. 1.501(c)(5)-1  Labor, agricultural, and horticultural 
organizations.

* * * * *
    (b)(1) An organization is not an organization described in section 
501(c)(5) if the principal activity of the organization is to receive, 
hold, invest, disburse, or otherwise manage funds associated with 
savings or investment plans or programs, including pension or other 
retirement savings plans or programs.

    (2) Example. Trust A is organized in accordance with a 
collective bargaining agreement between a labor union and multiple 
employers. Representatives of both the employers and the union serve 
as trustees. Trust A receives funds from the employers who are 
subject to the agreement, invests the funds and uses the funds and 
accumulated earnings to pay pension benefits to union members as 
specified in the agreement. It also provides information to union 
members about their retirement benefits and assists them with 
administrative tasks associated with the benefits. Most of Trust A's 
activities are devoted to these functions. From time to time, Trust 
A also participates in the renegotiation of the collective 
bargaining agreement. Because Trust A's principal activity is to 
manage funds associated with a pension plan, it is not an 
organization described in section 501(c)(5).
* * * * *
Margaret Milner Richardson,
Commissioner of Internal Revenue.
[FR Doc. 95-30830 Filed 12-20-95; 8:45 am]
BILLING CODE 4830-01-U

Complete official Federal Register PDF

FR Doc. 95-30741 Tramroads and Logging RoadsSubpart 2812Over O. and C. and Coos Bay Revested Lands
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Page 66246]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-30741]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF THE INTERIOR

Bureau of Land Management

43 CFR Part 2810

[WO-420-6310-00]

Tramroads and Logging Roads--Subpart 2812--Over O. and C. and 
Coos Bay Revested Lands

AGENCY: Bureau of Land Management, Interior.

ACTION: Notice of extension of comment period.

-----------------------------------------------------------------------

SUMMARY: On November 16, 1995, the Bureau of Land Management (BLM) 
published an advance notice of proposed rulemaking in the Federal 
Register (60 FR 57561). The notice announced BLM's plans to revise 
regulations governing logging roads over revested Oregon and California 
Railroad grant lands and reconveyed Coos Bay Wagon Road grant lands 
(collectively known as the O&C lands). The changes will bring the 
existing cost-sharing road program under the regulatory framework of 
Section 502 of the Federal Land Policy and Management Act of 1976 
(FLPMA) and incorporate environmental protection and other requirements 
for rights-of-way over public lands found in Title V of FLPMA. The 
notice allowed 30 days for public comment. In response to a request 
from a representative of interested parties, the comment period is 
being extended until January 15, 1996.

DATES: Comments on this advance notice of proposed rulemaking must be 
received by January 15, 1996. Comments postmarked after this date may 
not be considered in the preparation of the proposed rule.

ADDRESSES: Comments may be mailed to: Regulatory Management Team (420), 
Bureau of Land Management, 1849 C Street NW., Room 401LS, Washington, 
DC 20240.
    Comments may be sent via Internet to: WO[email protected]. Please 
include ``ATTN: O&C'' and your name and return address in your Internet 
message.
    Comments may be hand-delivered to the Bureau of Land Management 
Administrative Record, Room 401, 1620 L Street, NW., Washington, DC.
    Comments will be available for public review at the L Street 
address during regular business hours (7:45 a.m. to 4:15 p.m.), Monday 
through Friday.

FOR FURTHER INFORMATION CONTACT: John Styduhar, Oregon State Office, 
Bureau of Land Management, (503) 952-6454.

    Dated: December 13, 1995.
Patrick W. Boyd,
Regulatory Management Team.
[FR Doc. 95-30741 Filed 12-20-95; 8:45 am]
BILLING CODE 4310-84-M

Complete official Federal Register PDF

FR Doc. 95-30735 Statements to Recipients of Dividends and Patronage Dividends
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Pages 66227-66228]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-30735]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY

Internal Revenue Service

26 CFR Part 1

[INTL-52-86]
RIN 1545-AL99

Statements to Recipients of Dividends and Patronage Dividends

AGENCY: Internal Revenue Service (IRS), Treasury.

ACTION: Partial withdrawal of a notice of proposed rulemaking.

-----------------------------------------------------------------------

SUMMARY: This document withdraws a portion of the notice of proposed 
rulemaking under sections 6042 and 6044 of the Internal Revenue Code 
that was published in the Federal Register on February 29, 1988, as 
proposed to be amended on September 27, 1990. The proposed regulations 
prescribed rules for official statements to recipients of dividends and 
patronage dividends paid after December 31, 1983.

DATES: This withdrawal is effective on December 21, 1995.

FOR FURTHER INFORMATION CONTACT: Renay France, (202)622-4910 (not a 
toll-free number).

SUPPLEMENTARY INFORMATION:

Background

    On February 29, 1988, the IRS issued proposed regulations on backup 
withholding (INTL-52-86, 53 FR 5991). The proposed regulations related, 
in part, to official statements to recipients of dividends and 
patronage dividends under sections 6042 and 6044, respectively 
(proposed Secs. 1.6042-5 and 1.6044-6). On September 27, 1990, the IRS 
issued additional proposed regulations on backup withholding (IA-224-
82, 55 FR 39427). Those proposed

[[Page 66228]]

regulations contained amendments to the regulations previously proposed 
under sections 6042 and 6044.
    In the Rules and Regulations section of this issue of the Federal 
Register, the IRS is issuing final regulations relating to backup 
withholding that were proposed in INTL-52-86 and IA- 224-82. Those 
final regulations do not include proposed Secs. 1.6042-5 and 1.6044-6. 
Further, when the IRS issues additional final regulations that were 
proposed under INTL-52-86, those additional final regulations will not 
include proposed Secs. 1.6042- 5 and 1.6044-6. Accordingly, this 
document withdraws those proposed regulations sections. See 
Secs. 1.6042-4 and 1.6044-5 of the final regulations for substantive 
rules proposed under the withdrawn sections.

List of Subjects 26 CFR Part 1

    Income taxes, Reporting and recordkeeping requirements.

Withdrawal of Portion of Notice of Proposed Rulemaking

    Accordingly, under the authority of 26 U.S.C. 7805, proposed 
Secs. 1.6042-5 and 1.6044-6 that were published in the Federal Register 
on February 29, 1988 (53 FR 5991) and amended in the Federal Register 
on September 27, 1990 (55 FR 39427) are withdrawn.

Margaret Milner Richardson,
Commissioner of Internal Revenue
[FR Doc. 95-30735 Filed 12-20-95; 8:45 am]
BILLING CODE 4830-01-U

Complete official Federal Register PDF

FR Doc. 95-30734 Effective Date of Temporary Backup Withholding Regulations
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Pages 66243-66244]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-30734]

-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY
26 CFR Part 31

[IA-33-95]
RIN 1545-AT77

Effective Date of Temporary Backup Withholding Regulations

AGENCY: Internal Revenue Service (IRS), Treasury.

ACTION: Notice of proposed rulemaking by cross-reference to temporary 
regulations.

-----------------------------------------------------------------------

SUMMARY: In the Rules and Regulations section of this issue of the 
Federal Register, the IRS is issuing temporary regulations relating to 
the effective date of the Temporary Employment Tax Regulations under 
the Interest and Dividend Tax Compliance Act of 1983, relating to 
backup withholding, statement mailing requirements, and due diligence. 
The text of those temporary regulations also serves as the text of 
these proposed regulations.

DATES: Written comments and requests for a public hearing must be 
received by March 20, 1996.

ADDRESSES: Send submissions to: CC:DOM:CORP:R (IA-33-95), room 5228, 
Internal Revenue Service, POB 7604, Ben Franklin Station, Washington, 
DC 20044. In the alternative, submissions may be hand delivered between 
the hours of 8 a.m. and 5 p.m. to: CC:DOM:CORP:R (IA-33-95), Courier's 
Desk, Internal Revenue Service, 1111 Constitution Avenue, NW, 
Washington, DC.

FOR FURTHER INFORMATION CONTACT: Concerning the regulations, Renay 
France, (202) 622-4910; concerning submissions, Michael Slaughter, 
(202) 622-7190 (not toll-free numbers).

SUPPLEMENTARY INFORMATION:

Background

    Temporary regulations in the Rules and Regulations section of this 
issue of the Federal Register amend the Temporary Employment Tax 
Regulations under the Interest and Dividend Tax Compliance Act of 1983 
(26 CFR part 35a). The temporary regulations contain rules relating to 
the effective date of Secs. 35a.9999-1, 35a.9999-2, 35a.9999-3, 
35a.9999-3A, 35a.9999-4T, and 35a.9999-5.
    The text of those temporary regulations also serves as the text of 
these proposed regulations. The preamble to the temporary regulations 
explains the temporary regulations.

Special Analyses

    It has been determined that this notice of proposed rulemaking is 
not a significant regulatory action as defined in EO 12866. Therefore, 
a regulatory assessment is not required. It has also been determined 
that section 553(b) of the Administrative Procedure Act (5 U.S.C. 
chapter 5) and the Regulatory Flexibility Act (5 U.S.C. chapter 6) do 
not apply to these regulations, and therefore, a Regulatory Flexibility 
Analysis is not required. Pursuant to section 7805(f) of the Internal 
Revenue Code, this notice of proposed rulemaking will be submitted to 
the Chief Counsel for Advocacy of the Small Business Administration for 
comment on its impact on small business.

Comments and Requests for a Public Hearing

    Before these proposed regulations are adopted as final regulations, 
consideration will be given to any written comments (a signed original 
and eight (8) copies) that are submitted timely to the IRS. All 
comments will be available for public inspection and copying. A public 
hearing may be scheduled if requested in writing by any person that 
timely submits written comments. If a public hearing is scheduled, 
notice of the date, time, and 

[[Page 66244]]
place for the hearing will be published in the Federal Register.

Drafting Information

    The principal author of the regulations is Renay France, Office of 
Assistant Chief Counsel (Income Tax and Accounting), IRS. However, 
other personnel from IRS and Treasury Department participated in their 
development.

List of Subjects in 26 CFR Part 31

    Employment taxes, Income taxes, Penalties, Pensions, Railroad 
retirement, Reporting and recordkeeping requirements, Social security, 
Unemployment compensation.

Proposed Amendments to the Regulations

    Accordingly, 26 CFR part 31 is proposed to be amended as follows:

PART 31--EMPLOYMENT TAXES AND COLLECTION OF INCOME TAX AT SOURCE

    Paragraph 1. The authority citation for part 31 continues to read 
in part as follows:

    Authority: 26 U.S.C. 7805 * * *

    Par. 2. Section 31.9999-0 is added to read as follows:

Sec. 31.9999-0  Effective date.

    [The text of this proposed section is the same as the text of 
Sec. 35a.9999-0T published elsewhere is this issue of the Federal 
Register].
Margaret Milner Richardson,
Commissioner of Internal Revenue.
[FR Doc. 95-30734 Filed 12-20-95; 8:45 am]
BILLING CODE 4830-01-U

Complete official Federal Register PDF

FR Doc. 95-30681 Effect of the Family and Medical Leave Act on the Operation of Cafeteria Plans
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Pages 66229-66233]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-30681]

-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY
26 CFR Part 1

[EE-20-95]
RIN 1545-AT47

Effect of the Family and Medical Leave Act on the Operation of 
Cafeteria Plans

AGENCY: Internal Revenue Service (IRS), Treasury.

ACTION: Notice of proposed rulemaking.

-----------------------------------------------------------------------

SUMMARY: This document contains proposed regulations relating to 
cafeteria plans that reflect changes made by the Family and Medical 
Leave Act of 1993. The proposed regulations provide the public with 
guidance needed to comply with the Act and affect employees who 
participate in cafeteria plans.

DATES: Written comments and requests for a public hearing must be 
received by March 20, 1996.

ADDRESSES: Send submissions to: CC:DOM:CORP:R (EE-20-95), room 5228, 
Internal Revenue Service, POB 7604, Ben Franklin Station, Washington, 
DC 20044. In the alternative, submissions may be hand delivered between 
the hours of 8 a.m. and 5 p.m. to: CC:DOM:CORP:R (EE-20-95), Courier's 
Desk, Internal Revenue Service, 1111 Constitution Avenue NW., 
Washington, DC.

FOR FURTHER INFORMATION CONTACT: Concerning the regulations, Catherine 
Fuller, (202) 622-6080; concerning submissions and the hearing, Mike 
Slaughter, (202) 622-8452 (not toll-free numbers).

SUPPLEMENTARY INFORMATION:

Background

    This document contains proposed additions to the Income Tax 
Regulations (26 CFR Part 1) under section 125 of the Internal Revenue 
Code of 1986 (Code). These additions are proposed to conform the 
regulations to the Family and Medical Leave Act of 1993 (FMLA), Public 
Law 103-3. FMLA imposes certain requirements on employers regarding 
coverage, including family coverage, under group health plans for 
employees taking FMLA leave, and regarding the restoration of benefits 
to employees who return from FMLA leave. This notice of proposed 
rulemaking addresses a number of the principle questions that have been 
raised about how these FMLA requirements affect the operation of 
cafeteria plans (including flexible spending arrangements) maintained 
under section 125 of the Code. The rules in this notice of proposed 
rulemaking supplement the proposed Income Tax Regulations under section 
125 of the Code. Except as otherwise provided in this notice of 
proposed rulemaking, all of the existing rules governing cafeteria 
plans, including the nondiscrimination rules, continue to apply.
    The requirements pertaining to FMLA leave, including the employer's 
obligation to maintain coverage under a group health plan during FMLA 
leave and to restore benefits upon return from FMLA leave, are 
established by FMLA, 

[[Page 66230]]
not the Code. The U.S. Department of Labor, in 29 CFR part 825, has 
published rules interpreting the requirements of FMLA, and the 
Department of Labor has jurisdiction relating to those rights or 
obligations. This notice of proposed rulemaking does not interpret 
FMLA; it provides guidance on the cafeteria plan rules that apply to an 
employee in circumstances to which FMLA and the Labor Regulations 
thereunder also apply. The Department of Labor has advised the 
Department of the Treasury, including the Internal Revenue Service 
(IRS), that the provisions of this notice of proposed rulemaking do not 
conflict with, and are not inconsistent with, the provisions of FMLA or 
the Labor Regulations thereunder.

Special Analyses

    It has been determined that this notice of proposed rulemaking is 
not a significant regulatory action as defined in EO 12866. Therefore, 
a regulatory assessment is not required. It also has been determined 
that section 553(b) of the Administrative Procedure Act (5 U.S.C. 
chapter 5) and the Regulatory Flexibility Act (5 U.S.C. chapter 6) do 
not apply to these regulations, and, therefore, a Regulatory 
Flexibility Analysis is not required. Pursuant to section 7805(f) of 
the Code, this notice of proposed rulemaking will be submitted to the 
Chief Counsel for Advocacy of the Small Business Administration for 
comment on its impact on small business.

Comments and Requests for a Public Hearing

    Before these proposed regulations are adopted as final regulations, 
consideration will be given to any written comments (a signed original 
and eight (8) copies) that are submitted timely to the IRS. All 
comments will be available for public inspection and copying. A public 
hearing may be scheduled if requested in writing by a person that 
timely submits written comments. If a public hearing is scheduled, 
notice of the date, time, and place for the hearing will be published 
in the Federal Register.

Drafting Information

    The principal author of these regulations is Catherine Fuller, 
Office of Associate Chief Counsel (Employee Benefits and Exempt 
Organizations). However, other personnel from the IRS and Department of 
the Treasury participated in their development.

List of Subjects in 26 CFR Part 1

    Income taxes, Reporting and recordkeeping requirements.

Proposed Amendments to the Regulations

    Accordingly, 26 CFR part 1 is proposed to be amended as follows:

PART 1--INCOME TAXES

    Paragraph 1. The authority for part 1 continues to read in part as 
follows:

    Authority: 26 U.S.C. 7805 * * *

    Par.Section 1.125-3 is added to read as follows:

Sec. 1.125-3  Effect of the Family and Medical Leave Act (FMLA) on the 
operation of cafeteria plans.

    Q-1: May an employee taking FMLA leave revoke an existing election 
of group health plan coverage under a cafeteria plan?
    A-1: Yes. An employee taking FMLA leave may revoke an existing 
election of group health plan coverage (including a health flexible 
spending arrangement (FSA)) under a cafeteria plan for the remaining 
portion of the coverage period. See 29 CFR 825.209(e). FMLA also 
requires that an employee be permitted to choose to be reinstated in 
the group health plan coverage (including a health FSA) provided under 
a cafeteria plan upon returning from FMLA leave if the employee's group 
health plan coverage terminated while on FMLA leave (either by 
revocation or nonpayment of premiums). Such an employee is entitled, 
under FMLA, to be reinstated on the same terms as prior to taking FMLA 
leave (including family or dependent coverage). See 29 CFR 825.209(e) 
and 825.215(d). However, the employee has no greater right to benefits 
for the remainder of the plan year than an employee who has been 
continuously working during the plan year. In addition to the rights 
granted under FMLA, such an employee has the right to revoke or change 
elections (e.g., because of changes in family status or significant 
cost or coverage changes imposed by a third-party provider) under the 
same terms and conditions as are available to employees participating 
in the cafeteria plan who are not on FMLA leave.
    Q-2: Who is responsible for making premium payments under a 
cafeteria plan when an employee on FMLA leave continues group health 
plan coverage?
    A-2: An employee is entitled to continue group health plan coverage 
(including a health FSA) during FMLA leave whether or not provided 
under a health FSA or other component of a cafeteria plan. See 29 CFR 
825.209(b). An employee making premium payments under a cafeteria plan 
who chooses to continue group health plan coverage (including a health 
FSA) while on FMLA leave is responsible for the share of group health 
premiums that the employee was paying while working, such as amounts 
paid pursuant to a salary reduction agreement. The employer must 
continue to contribute the share of the cost of the employee's coverage 
that the employer was paying before the employee commenced FMLA leave. 
See 29 CFR 825.100(b) and 825.210(a).
    Q-3: What payment options are required or permitted to be offered 
under a cafeteria plan to an employee who continues group health plan 
coverage (including a health FSA) while on unpaid FMLA leave, and what 
is the tax treatment of these payments?
    A-3: (a) In general A cafeteria plan may, on a nondiscriminatory 
basis, offer one or more of the following payment options (subject to 
the limitations described in paragraph (b) of this Q&A-3) to an 
employee who continues group health plan coverage (including a health 
FSA) while on unpaid FMLA leave. These options are referred to in this 
section as pre-pay, pay-as-you-go and catch-up.
    (1) Pre-pay. (i) Under the pre-pay option, a cafeteria plan may 
permit an employee to pay, prior to commencement of the FMLA leave 
period, the amounts due for the FMLA leave period. However, the Labor 
Regulations under FMLA provide that under no circumstances may the 
employer mandate that an employee pre-pay the amounts due for the leave 
period. See 29 CFR 825.210(c)(3) and (4).
    (ii) Contributions under the pre-pay option may be made on a pre-
tax salary reduction basis from any taxable compensation (including the 
cashing out of unused sick days or vacation days). These contributions 
will not be included in the employee's gross income, provided that all 
cafeteria plan requirements are satisfied. For example, see Q&A-5 of 
this section regarding restrictions on pre-tax salary reduction 
contributions when an employee's FMLA leave spans two cafeteria plan 
years.
    (iii) Contributions under the pre-pay option may also be made on an 
after-tax basis. See Prop. Treas. Reg. Sec. 1.125-1, Q&A-5.\1\

    \1\ Published as a proposed rule at 49 FR 19321 (May 7, 1984).
    
[[Page 66231]]

---------------------------------------------------------------------------

    (2) Pay-as-you-go. (i) Under the pay-as-you-go option, employees 
may pay their share of the premium payments on the same schedule as 
payments would be made if the employee were not on leave or under any 
other payment schedule permitted by the Labor Regulations at 29 CFR 
825.210(c) (i.e., on the same schedule as payments are made under the 
Consolidated Omnibus Reconciliation Act of 1985, Public Law 99-272; 
under the employer's existing rules for payment by employees on leave 
without pay; or under any other system voluntarily agreed to between 
the employer and the employee that is not inconsistent with this 
section or with 29 CFR 825.210(c)).
    (ii) Contributions under the pay-as-you-go option are generally 
made by the employee on an after-tax basis. However, contributions may 
be made on a pre-tax basis to the extent that the contributions are 
made from taxable compensation (e.g., cashing out unused sick or 
vacation days) that is due the employee during the leave period, and 
provided that all cafeteria plan requirements are satisfied.
    (iii) An employer is not required to continue the health coverage 
of an employee who fails to make required premium payments while on 
FMLA leave. See 29 CFR 825.212. However, if the employer chooses to 
continue the health coverage of an employee who fails to make required 
premium payments while on FMLA leave, the employer is entitled to 
recoup those payments as set forth in paragraph (a)(3)(i) of this Q&A-
3. See also Q&A-6 of this section regarding coverage under a health FSA 
when an employee fails to make the required premium payments while on 
FMLA leave.
    (3) Catch-up. (i) An employer that continues providing group health 
coverage to an employee who does not pay premiums on FMLA leave is, to 
the extent provided under the Labor Regulations, permitted to utilize 
the catch-up option to recoup the employee's share of premium payments. 
See, e.g., 29 CFR 825.212(b).
    (ii) Where an employee is electing to use the catch-up option, the 
employer and the employee must agree in advance of the coverage period 
that: the employee elects to continue health coverage while on unpaid 
FMLA leave; the employer will assume responsibility for advancing 
payment of the premiums on the employee's behalf during the FMLA leave; 
and these advance amounts must be paid by the employee when the 
employee returns from FMLA leave.
    (iii) Contributions under the catch-up option may be made on a pre-
tax salary reduction basis when the employee returns from FMLA leave 
from any available taxable compensation (including the cashing out of 
unused sick days and vacation days). These contributions will not be 
included in the employee's gross income, provided that all cafeteria 
plan requirements are satisfied.
    (iv) Contributions under the catch-up option may also be made on an 
after-tax basis. See Prop. Treas. Reg. Sec. 1.125-1, Q&A-5.\2\

    \2\ Published as a proposed rule at 49 FR 19321 (May 7, 1984).
---------------------------------------------------------------------------

    (b) Exceptions. Cafeteria plans may offer (pursuant to 29 CFR 
825.210(c)) one or more of the payment options described in paragraph 
(a) of this Q&A-3, with the following exceptions:
    (1) The pre-pay option cannot be the sole option offered to 
employees on FMLA leave. However, the cafeteria plan may include pre-
payment as an option for employees on FMLA leave, even if such option 
is not offered to employees on non-FMLA leave- without-pay.
    (2) The catch-up option can be the sole option offered to employees 
on FMLA leave if and only if the catch-up option is the sole option 
offered to employees on non-FMLA leave-without-pay.
    (3) A cafeteria plan cannot offer employees on FMLA leave a choice 
of either the pre-pay option or the catch-up option without also 
offering the pay-as-you-go option, if the pay-as-you- go option is 
offered to employees on non-FMLA leave-without-pay.
    (c) Voluntary waiver of employee payments. In addition to the 
foregoing payment options, an employer may voluntarily waive, on a 
nondiscriminatory basis, the requirement that employees who elect to 
continue health coverage while on FMLA leave pay the amounts the 
employees would otherwise be required to pay for the leave period.
    Q-4: Do the special FMLA requirements concerning an employee who 
continues group health plan coverage under a cafeteria plan apply if 
the employee is on paid FMLA leave?
    A-4: No. The Labor Regulations provide that, if an employee's FMLA 
leave is substituted paid leave as described at 29 CFR 825.207 and the 
employee continues group health plan coverage while on FMLA leave, the 
employee's share of the premiums must be paid by the method normally 
used during any paid leave (i.e., salary reduction). See 29 CFR 
825.210(b).
    Q-5: What restrictions apply to contributions when an employee's 
FMLA leave spans two cafeteria plan years?
    A-5: (a) Contributions to a cafeteria plan during FMLA leave will 
not be included in an employee's gross income, provided that the plan 
complies with all cafeteria plan requirements. Among other 
requirements, a plan may not operate in a manner that enables employees 
on FMLA leave to defer compensation from one cafeteria plan year to a 
subsequent cafeteria plan year. See Prop. Treas. Reg. Sec. 1.125-2, 
Q&A-5.\3\

    \3\ Published as a proposed rule at 54 FR 9460 (March 7, 1989).
---------------------------------------------------------------------------

    (b) The following example illustrates this Q&A-5:

    Example. Employee A elects health coverage under a calendar year 
cafeteria plan maintained by Employer X. A's premium for health 
coverage is $100 per month throughout the 12-month period of 
coverage. A takes FMLA leave for 12 weeks beginning on October 31 
after making 10 months worth of premiums totalling $1000 (10 months 
x  $100 = $1000). A maintains health coverage while on FMLA leave. A 
utilizes the pre-pay option by cashing-out A's unused sick days in 
order to make the required premium payments due while A is on FMLA 
leave. Because A cannot defer compensation from one plan year to a 
subsequent plan year, A may pre-pay the premiums due in November and 
December (i.e., $100 per month) on a pre-tax basis, but A cannot 
pre-pay the premium payment due in January on a pre-tax basis. If A 
participates in the cafeteria plan in the subsequent plan year, A 
must use another option (e.g., pay-as-you-go or catch-up) to make 
the premium payment due in January.

    Q-6: Are there special rules concerning employees taking FMLA leave 
who participate in health FSAs offered under a cafeteria plan?
    A-6: (a) In general. (1) A health plan that is a flexible spending 
arrangement (FSA) offered under a cafeteria plan must conform to the 
generally applicable rules in this section concerning employees who 
take FMLA leave. Thus, FMLA requires that an employee taking FMLA leave 
be permitted to--
    (i) Continue coverage under a health FSA while on FMLA leave; or
    (ii) Revoke an existing health FSA election under the cafeteria 
plan for the remainder of the coverage period. See 29 CFR 825.209(e).
    (2) FMLA also requires the plan to permit the employee to be 
reinstated in the health FSA upon return from FMLA leave on the same 
terms as prior to taking FMLA leave. See 29 CFR 825.215(d) and 
paragraph (b)(2) of this Q&A-6. However, reinstatement is at the 
employee's election and under no circumstances may an employer require 

[[Page 66232]]
an employee whose coverage has terminated while on FMLA leave to 
reinstate coverage under a health FSA upon return from FMLA leave. See 
29 CFR 825.214(a).
    (b) Uniform Coverage Rule (1) Q&A-7(b)(2) of Sec. 1.125-2\4\ (the 
uniform coverage rule) applies during the FMLA leave period as long as 
the employee continues health coverage. Therefore, regardless of the 
payment option selected under Q&A-3 of this section, for so long as the 
employee continues coverage (or for so long as the employer continues 
the coverage of an employee who fails to make the required 
contributions as described in Q&A-3(a)(2)(iii) of this section), the 
full amount of the elected coverage, less any prior reimbursements, 
must be available to the employee at all times, including the FMLA 
leave period.

    \4\ Published as a proposed rule at 54 FR 9460 (March 7, 1989).
---------------------------------------------------------------------------

    (2)(i) If an employee's coverage under the health FSA terminates 
while the employee is on FMLA leave, the employee is not entitled to 
receive reimbursements for claims incurred during the period when the 
coverage is terminated. If that employee subsequently elects to be 
reinstated in the health FSA upon return from FMLA leave for the 
remainder of the plan year, the employee may not retroactively elect 
health FSA coverage for claims incurred during the period when the 
coverage was terminated. Further, the employee is not entitled to 
greater FSA benefits relative to premiums paid than an employee who has 
been continuously working during the plan year. See 29 CFR 825.216. 
Therefore, if an employee elects to be reinstated in a health FSA upon 
return from FMLA leave, the employee's coverage for the remainder of 
the plan year is equal to the employee's election for the 12-month 
period of coverage (or such shorter period as provided under 
Sec. 1.125-2 \5\), prorated for the period during the FMLA leave for 
which no premiums were paid, and reduced by prior reimbursements.

    \5\ Published as a proposed rule at 54 FR 9460 (March 7, 1989).
---------------------------------------------------------------------------

    (ii) An employee on FMLA leave has the right to revoke or change 
elections (e.g., because of changes in family status) under the same 
terms and conditions that apply to employees participating in the 
cafeteria plan who are not on FMLA leave. Thus, notwithstanding the 
rules described in paragraph (b)(2)(i) of this Q&A-6, an employee who 
returns from FMLA leave may make a new health FSA election for the 
remainder of the plan year if return from leave without pay constitutes 
a change of family status under the employer's cafeteria plan.
    (3) The following examples illustrate the rules in this Q&A-6:

    Example 1: (a) Employee A elects $1200 worth of coverage under a 
calendar year health FSA provided under a cafeteria plan, with an 
annual premium of $1200. A is permitted to pay the $1200 through 
pre-tax salary reduction amounts of $100 per month throughout the 
12-month period of coverage. A incurs no medical expenses prior to 
April 1. On April 1, A takes FMLA leave after making three months 
worth of contributions totalling $300 (3 months  x  $100 = $300). 
The plan does not permit a revocation of election on account of a 
change in family status. However, pursuant to A's rights under FMLA, 
A elects to terminate coverage upon going on FMLA leave. 
Consequently, A makes no premium payments for the months of April, 
May, and June, and A is not entitled to submit claims or receive 
reimbursements for expenses incurred during this period. A returns 
from FMLA leave and elects to be reinstated in the health FSA on 
July 1.
    (b) Under FMLA, A has no greater right to benefits upon 
reinstatement than if A had been continuously working during the 
plan year. Therefore, A is reinstated to A's annual election (i.e., 
$1200) prorated for the period during the FMLA leave for which no 
premiums were paid (i.e., reduced for 3 months or \1/4\ of the plan 
year) less prior reimbursements (i.e., $0). Consequently, A's 
coverage for the remainder of the plan year equals $900. A must also 
begin making premium payments of $100 per month for the remainder of 
the plan year.
    Example 2: Assume the same facts as Example 1 except that A 
incurs medical expenses totaling $200 in February and obtains 
reimbursement of these expenses. The results are the same as in 
Example 1, except that A's coverage for the remainder of the plan 
year equals $700.
    Example 3: Assume the same facts as Example 1 except that prior 
to taking FMLA leave, A elects to continue health FSA coverage 
during the FMLA leave. The plan permits A (and A elects) to use the 
catch-up payment option described in Q&A-3 of this section, and as 
further permitted under the plan, A chooses to repay the $300 in 
missed payments on a ratable basis over the remaining six-month 
period of coverage (i.e., $50 per month). Thus, A's monthly premium 
payments for the remainder of the plan year will be $150 ($100 + 
$50).

    Q-7: Are employees entitled to non-health benefits while taking 
FMLA leave?
    A-7: FMLA does not require an employer to maintain an employee's 
non-health benefits (e.g., life insurance) during FMLA leave. An 
employee's entitlement to benefits other than group health benefits 
under a cafeteria plan during a period of FMLA leave is to be 
determined by the employer's established policy for providing such 
benefits when the employee is on non-FMLA leave (paid or unpaid). See 
29 CFR 825.209(h). Therefore, an employee who takes FMLA leave is 
entitled to revoke an election of non-health benefits under a cafeteria 
plan to the same extent employees taking non-FMLA leave are permitted 
to revoke elections of non-health benefits under a cafeteria plan. For 
example, election changes are permitted due to changes of family status 
or upon enrollment for a new plan year. See Sec. 1.125-2, Q&A-6(c) \6\ 
and Sec. 1.125-1, Q&A-8.\7\ However, the FMLA regulations provide that, 
in certain cases, an employer may continue an employee's non-health 
benefits under the employer's cafeteria plan while the employee is on 
FMLA leave to ensure that the employer can meet its responsibility to 
provide equivalent benefits to the employee upon return from unpaid 
FMLA. If the employer continues an employee's non-health benefits 
during FMLA leave, the employer is entitled to recoup the costs 
incurred for paying the employee's share of the premiums during the 
FMLA leave period. See 29 CFR 825.213(b). In addition, a cafeteria plan 
must, as required by FMLA, permit an employee whose coverage terminated 
while on FMLA leave (either by revocation or nonpayment of premiums) to 
be reinstated in the cafeteria plan on return from FMLA leave. See 29 
CFR 825.214(a) and 825.215(d).

    \6\ Published as a proposed rule at 54 FR 9460 (March 7, 1989).
    \7\ Published as a proposed rule at 49 FR 19321 (May 7, 1984).
---------------------------------------------------------------------------

    Q-8: How may taxpayers rely on these proposed regulations?
    A-8: (a) The guidance provided by the questions and answers in this 
section may be relied upon to comply with provisions of section 125 and 
will be applied by the Internal Revenue Service in resolving issues 
arising under cafeteria plans and related Internal Revenue Code 
sections. If final regulations are more restrictive than the guidance 
in this section, the regulations will not be applied retroactively. No 
inference, however, should be drawn regarding issues not expressly 
raised that may be suggested by a particular question or answer or by 
the inclusion or exclusion of certain questions.
    (b) The Department of Labor has advised the Department of the 
Treasury, including the Internal Revenue Service, that the provisions 
of this section are not inconsistent with the provisions of 

[[Page 66233]]
FMLA and the Labor Regulations thereunder.
Margaret Milner Richardson,
Commissioner of Internal Revenue.
[FR Doc. 95-30681 Filed 12-20-95; 8:45 am]
BILLING CODE 4830-01-U

Complete official Federal Register PDF

FR Doc. 95-29458 Hazardous Waste Management System: Identification and Listing of Hazardous Waste: Hazardous Waste Identification Rule (HWIR)
[Federal Register Volume 60, Number 245 (Thursday, December 21, 1995)]
[Proposed Rules]
[Pages 66344-66469]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-29458]

[[Page 66343]]

_______________________________________________________________________

Part II

Environmental Protection Agency

_______________________________________________________________________

40 CFR Parts 260, 261, 266, and 268

_______________________________________________________________________

Hazardous Waste: Identification and Listing; Proposed Rule

Federal Register / Vol. 60, No. 245 / Thursday, December 21, 1995 / 
Proposed Rules 

[[Page 66344]]

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Parts 260, 261, 266, and 268

[FRL-5337-9]
RIN 2050-AE07

Hazardous Waste Management System: Identification and Listing of 
Hazardous Waste: Hazardous Waste Identification Rule (HWIR)

AGENCY: Environmental Protection Agency.

ACTION: Proposed rule, tentative response to Chemical Manufacturers 
Association petition and the Hazardous Waste Identification Dialogue 
Committee recommendations, and request for comments.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) today is proposing 
to amend its regulations under the Resource Conservation and Recovery 
Act (RCRA) by establishing constituent-specific exit levels for low-
risk solid wastes that are designated as hazardous because they are 
listed, or have been mixed with, derived from, or contain listed 
hazardous wastes. Under this proposal, generators of listed hazardous 
wastes that meet the self-implementing exit levels would no longer be 
subject to the hazardous waste management system under Subtitle C of 
RCRA as listed hazardous wastes. Today's Notice, commonly referred to 
as the Hazardous Waste Identification Rule (HWIR), establishes a risk-
based ``floor'' to hazardous waste listings that will encourage 
pollution prevention, waste minimization, and the development of 
innovative waste treatment technologies.
    Many of the exit levels are established using an innovative risk 
assessment which evaluates potential exposure pathways, both direct and 
indirect, from a variety of sources, such as waste piles and surface 
impoundments. This assessment focuses on both human and environmental 
receptors and is presented for comment in today's Notice. The remaining 
exit levels are based on an alternative risk analysis.
    The Agency is also proposing to modify some of the land disposal 
restriction (LDR) numerical treatment standards listed in subpart D of 
40 CFR part 268. This notice proposes to cap technology-based treatment 
standards with the risk-based exit levels which minimize threats to 
human health and the environment. This notice also takes comment on 
several general approaches and one specific approach for conditional 
exemptions from subtitle C management. Today's notice also contains the 
Agency's tentative response to a petition for rulemaking submitted by 
the Chemical Manufacturers Association and the Agency's tentative 
response to the recommendations made by the Dialogue Committee on 
Hazardous Waste Identification. This committee was formally chartered 
in July 1993 in accordance with the Federal Advisory Committee Act 
(FACA).

DATES: EPA will accept public comments on this proposed rule until 
February 20, 1996. Comments postmarked after this date may not be 
considered. However, the Agency recognizes that, because of the 
complexity of this proposed rulemaking, some commenters may want to 
request additional time for comment submittal. In anticipation of these 
requests, EPA will be communicating with the litigants and the court 
regarding the implications on our rulemaking schedule of a possible 
extension of the comment period for this proposal. If the comment 
period is extended, the Agency will provide notice of such in the 
Federal Register.
    Any person may request a public hearing on this amendment by filing 
a request with Mr. David Bussard, whose address appears below, by 
January 5, 1996.

ADDRESSES: The public must send an original, two copies, and whenever 
possible, a 3.5 inch computer disk containing the comments in a common 
word processing format such as WordPerfect version 5.1 1. to: EPA 
RCRA Docket (5305W), 401 M Street, SW., Washington, DC 20460.

    \1\ This will greatly facilitate EPA's preparation of the 
comment responses and will significantly reduce the cost associated 
with responding to the comments.
---------------------------------------------------------------------------

    Place ``Docket number F-95-WHWP-FFFFF'' on your comments. The RCRA 
docket is located at: EPA's Crystal Gateway Office, 1235 Jefferson 
Davis Highway, Arlington, Virginia, and is open from 9 a.m. to 4 p.m., 
Monday through Friday, excluding Federal holidays. The public must make 
an appointment to review docket materials by calling (703) 603-9230. 
The public may copy material from any regulatory docket at a cost of 
$0.15 per page. Copies of the background documents, Integrated Risk 
Information System (IRIS) chemical files, and other references (which 
are not readily available) are available for viewing and copying only 
in the RCRA docket.
    Requests for a public hearing should be addressed to Mr. David 
Bussard, Director, Characterization and Assessment Division, Office of 
Solid Waste (OS-330), U.S. Environmental Protection Agency, 401 M 
Street, SW., Washington, DC 20460.

FOR FURTHER INFORMATION CONTACT: The RCRA/Superfund Hotline at (800) 
424-9346 or at (703) 412-9810. For technical information contact Mr. 
William A. Collins, Jr., Mr. Greg Helms, or Ms. Pamela McMains, Office 
of Solid Waste (5304), U.S. Environmental Protection Agency, 401 M 
Street, S.W., Washington, DC 20460, (202) 260-4770.

Preamble Outline

I. Authority
II. Background
    A. Overview of Hazardous Waste Identification Program
    B. The Mixture and Derived-From Rules and the Contained-In 
Policy
    C. Overview of Expected Impacts of the Exit Rule
III. Scope of Revisions to the Mixture and Derived-From Rules
    A. Rationale for Retention of the Mixture and Derived-From Rules
    B. Revision to Derived-from Rule for Wastes Listed Because They 
Exhibit the Characteristics of Ignitability, Corrosivity, or 
Reactivity
IV. Development of Exit Levels and Minimize Threat Levels
    A. Need for an Exit
    B. Overview of the Exit
    C. Selection of Constituents of Concern
    1. Development of the Master List
    2. Development of the Exit Constituent List
    3. Constituents of Ecological Concern
    D. Risk-Based Information
    1. Human Health Benchmarks
    a. Non-carcinogens
    b. Carcinogens
    c. Consideration of MCLs
    2. Ecological Benchmarks
    3. Sources of Data
    a. Human
    b. Ecological
    E. Risk Assessment
    1. The Risk Analysis
    a. Introduction
    b. How the Analysis was Structured
    c. How Uncertainty is Addressed
    d. Linkage of the Risk Analysis to the Groundwater Fate and 
Transport
    e. Risk Targets Used
    2. Detailed Overview of the Non-Groundwater Risk Analysis
    a. Waste Management Units
    1. Use of Subtitle D Survey
    2. Fate and Transport
    3. Ash Monofill
    i. Particle Size Distribution for Air Dispersion Modeling
    ii. Monofill Characterization
    iii. Vehicle Traffic
    iv. Emission Equations for Ash Blown from Trucks and Spreading 
and Compacting
    4. Land Application Unit
    i. Particle Size Distribution for Air Dispersion Modeling
    ii. Area of Land Application Unit Relative to Agricultural Field
    iii. Application Rate
    iv. Waste Characteristics 
    
[[Page 66345]]

    v. Depth of Contamination
    vi. Partitioning
    5. Waste Pile
    i. Waste Pile Height
    ii. Particle Size Distribution for Air Dispersion Modeling
    iii. Waste Characteristics
    iv. Vehicle Traffic
    v. Emission Equation for Ash Blown from Trucks
    6. Surface Impoundments
    i. Two-Phase Sludge Formation Model
    ii. Dilution of Waste During a Spill
    7. Tank
    i. Unit Characterization
    ii. Volatilization
    8. Combustors
    b. Fate and Transport
    1. Pathways
    2. Equations
    3. Specific Issues on Pathways and Equations
    i. Chemical Transformation
    ii. Biodegradation
    iii. Meteorological Data
    iv. Soil Data
    v. Soil Pathways
    vi. Surface Water Pathways
    vii. Food-Chain Pathways
    c. Receptors
    1. Human Receptors
    2. Ecological Receptors
    3. Groundwater Fate and Transport Modeling
    a. Fate and Transport Processes
    1. Effects of groundwater mounding
    2. Transformation products
    3. Fate and transport of metals
    b. Enhanced solution algorithms
    1. Linkage between unsaturated zone and saturated zone modules
    2. Numerical transport solution
    3. Solution for metals transport
    4. Elimination of biases in determination of receptor well 
concentrations
    c. Revision of Monte Carlo methodology for nationwide 
assessments
    1. Data sources
    2. Finite-source methodology
    3. Site-based regional analysis
    d. Implementation of EPACMTP
    e. Waste management scenarios
    1. Landfills
    2. Surface impoundments
    3. Waste piles
    4. Land application units
    f. Determination of regulatory limits
    g. Chemical specific fate and transport processes
    1. Organic constituents
    2. Metals
    4. Other Risk Assessment Issues
    a. Difference between groundwater and nongroundwater pathways
    1. Infiltration
    2. Density of waste applied to land application unit
    3. Unsaturated zone characteristics
    4. Hydrolysis rates
    b. Other groundwater pathway analysis issues
    1. Use of 1000 years versus 10,000 years exposure time horizon
    2. Implementation of parameter bounds in Monte Carlo procedure
    3. Hydraulic conductivity of surface impoundment bottom layer
    4. Waste pile infiltration rates
    5. Land application unit infiltration rates
    6. Aggregate effects of alternative groundwater modeling 
procedures
    F. Additional Eco-Receptor Consideration
    G. Background Concentrations in Soils and other Issues Relating 
to Results
    H. Constituents with Extrapolated Risk-based Levels
    I. Analytical Considerations
    1. Development of Exemption Quantitation Criteria (EQC)
    2. EQCs and LDR Requirements as Exemption Criteria
    a. EQCs as exit levels
    b. LDR Requirements in combination with EQC Exit Levels
    3. Exemption for Constituents Without EQCs
V. Presentation of Exit Levels
    A. Constituents with Modeled or Extrapolated Risk-based Exit 
Levels
    B. Constituents with Quantitation-based Exit Levels
    C. How to Read the Exit Level Tables
VI. Minimize Threat Levels
    A. Background
    1. Summary of the Hazardous and Solid Waste Amendments of 1984
    2. EPA's Interpretation of Standard for Treatment Requirements
    B. Risk Assessment and Minimize Threat Levels
    1. Rationale
    2. Public Policy Considerations
    C. Minimize threat levels
    1. List of Constituents and Minimize Threat Concentrations
    2. Constituents for which Exit Levels are not Minimize Threat 
Levels
    D. Meeting LDR requirements
    1. Wastes Below Exit Levels as Generated
    2. Wastes Above Exit Levels as Generated
VII. Dilution
VIII. Implementation of Exit
    A. Implementation Requirements
    1. Testing Requirements
    a. Data Evaluation
    i. Compliance with the Exit Levels
    ii. Wastewater and Nonwastewater Categories
    iii. Totals and TCLP Analyses
    iv. Oily Wastes
    b. Initial Test
    2. Notification Requirements
    B. Implementation Conditions
    1. Records Maintained on Site
    2. Testing Conditions
    3. Testing Frequency and Process Change
    C. Public Participation
IX. Request for Comment on Options for Conditional Exemptions
    A. Legal Basis for Conditional Exemptions
    B. Improvements in Management of Non-Hazardous Waste and in Risk 
Assessment Methodology
    C. Overview of Options for Conditional Exemptions
    1. National Approach
    a. Eliminate Disposal in Land Application Units
    b. Unit-Specific Exit Levels for Each Disposal
    c. Consideration of Additional Management Unit Design or 
Management Practices
    2. State Program Approach
    3. Establish Exit Levels that Consider Regional or Site-Specific 
Factors that might Affect Constituent Fate and Transport
    4. Relief from Land Disposal Restrictions
    D. Land Disposal Restrictions for Contingent Management Options
    E. Contingent Management of Mixed Waste
X. Implementation of Conditional Exemption Option 1
    A. Introduction and Overview
    B. When Contingent Management Exemptions Become Effective
    1. Placement of the waste in a qualifying unit
    2. Point of generation
    C. Requirements for Obtaining an Exemption
    1. Sampling and Testing Requirements for Contingent Management 
Exemptions
    2. Requirements for Public Participation in contingent 
Management Exemptions
    3. Notification Requirements for Contingent Management
    D. Implementation Conditions
    1. Tracking conditions
    2. Qualifying Unit
    3. Claimant's Duty to Ensure Compliance with all Conditions
    E. Retesting and Recordkeeping Conditions for Contingent 
Management Exemptions
    F. Compliance Monitoring and Enforcement for Contingent 
Management Exemptions
    1. Compliance Monitoring
    2. Enforcement
    G. Exports of Wastes Eligible for Contingent Management 
Exemptions
     H. Land Disposal Restrictions
XI. Relationship to Other RCRA Regulatory Programs
    A. Hazardous Waste Determination
    B. Characteristic Hazardous Waste
    C. Toxicity Characteristic Level for Lead
    D. Hazardous Waste Listings
    E. Delisting
    F. Requirements for Treatment, Storage, and Disposal Facilities 
and Interim Status Facilities
    G. Closure
    H. HWIR-Media Rule/Subtitle C Corrective Action
    I. Land Disposal Restriction Program
    J. RCRA Air Emission Standards
    K. Hazardous Debris
    L. Hazardous Wastes Used in a Manner Constituting Disposal
XII. CERCLA Impact
XIII. State Authority
    A. Applicability of Rules in Authorized States
    B. Effect of State Authorizations
    C. Streamlining Issues
XIV. Regulatory Requirements
XV. References
Appendix A: Background Tables for Risk Analysis Receptors and 
Pathways
Appendix B: Table Comparing Groundwater Modeling Effects of 1000 vs. 
10,000 years
Appendix C: Tables Comparing the Modeled or Extrapolated Risk Levels 
vs. the EQCs for Each Constituent
Appendix D: Tables Comparing the Exit Levels and the UTS Levels
Regulatory Language

[[Page 66346]]

I. Authority

    These regulations are proposed under the authority of sections 
2002(a), 3001, 3002, 3004 and 3006 of the Solid Waste Disposal Act of 
1970, as amended by the Resource Conservation and Recovery Act of 1976 
(RCRA), as amended by the Hazardous and Solid Waste Amendments of 1984 
(HSWA), 42 U.S.C. 6912(a), 6921, 6922, 6924 and 6926.

II. Background

A. Overview of the Hazardous Waste Identification Program

    Section 1004(5) of the Resource Conservation and Recovery Act 
(RCRA) as amended by the Hazardous and Solid Waste Amendments (HSWA) of 
1984, defines ``hazardous waste'' as ``a solid waste, or combination of 
solid waste, which because of its quantity, concentration, or physical, 
chemical, or infectious characteristics may (A) cause, or significantly 
contribute to an increase in the mortality or an increase in serious 
irreversible, or incapacitating reversible, illness; or (B) pose a 
substantial present or potential hazard to human health or the 
environment when improperly treated, stored, transported, or disposed 
of, or otherwise managed.''
    Section 3001 of RCRA requires EPA to identify those wastes that 
should be classified as ``hazardous.'' The Agency's hazardous waste 
identification rules designate wastes as hazardous in one of two ways. 
First, the Agency has established four hazardous waste characteristics 
which identify properties or attributes of wastes which would pose a 
potential hazard if the waste is improperly managed. See 40 CFR 261.21-
261.24. Any generator of a solid waste is responsible for determining 
whether a solid waste exhibits any of these characteristics. See 40 CFR 
262.11. Any solid waste that exhibits any of the characteristics 
remains hazardous until it no longer exhibits the characteristics. See 
40 CFR 261.4(d)(1).
    The other mechanism EPA uses to designate wastes as hazardous is 
``listing.'' The Agency has reviewed data on specific waste streams 
generated from a number of industrial processes and has determined that 
these wastes would pose hazards if mismanaged for one or more reasons, 
including the presence of significant levels of hazardous constituents 
listed in appendix VIII to 40 CFR part 261, the manifestation of one or 
more of the hazardous waste characteristics, or the potential to impose 
detrimental effects on the environment. (See generally 40 CFR 261.11). 
As discussed in detail in the preambles and in associated dockets 
accompanying the listings, EPA has generally determined that these 
wastes contain toxic constituents at concentrations which pose risks 
which are unacceptable for human or environmental exposure and that 
these constituents are mobile and persistent to the degree that they 
can reach environmental or human receptors.
    On May 19, 1980, as part of the final and interim final regulations 
implementing section 3001 of RCRA, EPA published two lists of hazardous 
wastes: One composed of wastes generated from non-specific sources 
(e.g., spent solvents) and one composed of wastes generated from 
specific sources (e.g., distillation bottoms from the production of 
benzyl chloride). The Agency also published two lists of discarded 
commercial chemical products, off-specification species, container 
residues, and spill residues thereof which are hazardous wastes under 
specific circumstances. These four lists have been amended several 
times, and are currently published in 40 CFR 261.31, 261.32, 261.33(e) 
and (f), respectively.

B. The Mixture and Derived-From Rules and the Contained-In Policy

1. Mixture and Derived-From Rules
a. Scope and Purpose of the Rules
    In 1980 EPA promulgated its first comprehensive regulatory program 
for the management of hazardous waste under RCRA. 45 FR 33066 (May 19, 
1980). As part of that rulemaking EPA promulgated several rules to 
identify hazardous wastes. Two of these rules clarify the scope of the 
hazardous waste listings. Under the mixture rule, a solid waste is a 
hazardous waste if it is mixed with one or more listed hazardous 
wastes. 40 CFR 261.3(a)(2)(iv). Under the derived-from rule a solid 
waste generated from the treatment, storage or disposal of a listed 
hazardous waste is also a hazardous waste. 40 CFR 261.3(c)(2)(i).
    EPA promulgated the mixture and derived-from rules to close 
potentially major loopholes in the subtitle C management system. 
Without a ``mixture'' rule, generators of hazardous wastes could 
potentially evade regulatory requirements by mixing listed hazardous 
wastes with other hazardous wastes or non-hazardous solid wastes to 
create a ``new'' waste that arguably no longer met the listing 
description, but continued to pose a serious hazard. Such a waste also 
might not exhibit any of the hazardous waste characteristics. 
Similarly, without a ``derived-from'' rule, hazardous waste generators 
and owners and operators of hazardous waste treatment, storage, and 
disposal facilities (TSDFs) could potentially evade regulation by 
minimally processing or managing a hazardous waste and claiming that 
resulting residue was no longer the listed waste, despite the continued 
hazards that could be posed by the residue even though it does not 
exhibit a characteristic. (See 57 FR 7628).
    It is for these reasons that the Agency continues to believe that 
the mixture and derived-from rules are extremely important in 
regulating hazardous wastes and reducing risk to human health and the 
environment. However, EPA acknowledges that the mixture and derived-
from rules apply regardless of the concentrations and mobilities of 
hazardous constituents in the waste. The purpose of this rulemaking is 
to reduce any overregulation of low-risk wastes captured by the mixture 
and derived-from rule.
b. Subsequent History
    Numerous industries that generate hazardous wastes challenged the 
1980 mixture and derived-from rules in Shell Oil v. EPA, 950 F. 2d 741 
(D.C. Cir. 1991). In December 1991 the D.C. circuit vacated the rules 
because they had been promulgated without adequate notice and 
opportunity to comment. The court, however, suggested that EPA might 
want to consider reinstating the rules pending full notice and comment 
in order to ensure continued protection of human health and the 
environment.
    In response to this decision, EPA promulgated an emergency rule 
reinstating the mixture and derived-from rules as interim final rules 
without providing notice and opportunity to comment. 57 FR 7628 (Mar.3, 
1992). EPA also promulgated a ``sunset provision'' which provided that 
the mixture and derived-from rules would remain in effect only until 
April 28, 1993. Shortly after, EPA published the proposal containing 
several options for revising the mixture and derived-from rules. See 57 
FR 21450 (May 20, 1992). This proposal also included options for 
exempting media contaminated with listed hazardous wastes that are 
regulated under the ``contained in'' policy.
    The May 1992 proposal and the time pressure created by the ``sunset 
provision'' generated significant controversy. In response, Congress 
included in EPA's 1992 appropriations bill several provisions 
addressing the mixture and derived-from rules. Pub. L. No. 102-389, 106 
Stat. 1571. First, Congress nullified the sunset provision by providing 
that EPA could not promulgate any revisions to the rules 

[[Page 66347]]
before October 1, 1993 and by providing that the reinstated regulations 
could not be ``terminated or withdrawn'' until revisions took effect. 
However, to ensure that EPA could not postpone the issue of revisions 
indefinitely, Congress also established a deadline of October 1, 1994 
for the promulgation of revisions to the mixture and derived-from 
rules. Congress made this deadline enforceable under RCRA's citizen 
suit provision.
    On October 30, 1992 EPA published two notices, one removing the 
sunset provision, and the other withdrawing the May 1992 proposal. See 
57 FR 49278, 49280. EPA had received many comments criticizing the May 
1992 proposal. The criticisms were due, in a large part, to the very 
short schedule imposed on the regulation development process itself. 
Commenters also feared that the proposal would result in a 
``patchwork'' of differing State programs because some states might not 
adopt the revisions. This fear was based on the belief that States 
would react in a negative manner to the proposal and refuse to 
incorporate it into their programs. Finally, many commenters also 
argued that the risk assessment used to support the proposed exemption 
levels failed to provide adequate protection of human health and the 
environment because it evaluated only the risks of human consumption of 
contaminated groundwater ignoring other pathways that could pose 
greater risks. Based on these concerns, and based on the Agency's 
desire to work through the individual elements of the proposal more 
carefully, the proposal was withdrawn.
    Meanwhile, a group of waste generating industries challenged the 
March 1992 action that reinstated the mixture and derived-from rules 
without change. Mobil Oil Corp. v. EPA, 35 F.3d 579 (D.C. Cir. 1994). 
EPA argued that the 1992 appropriations act made the challenge moot 
because it prevented both EPA and the courts from terminating or 
withdrawing the interim rules before EPA revised them, even if EPA 
failed to meet the statutory deadline for the revisions. In September, 
1994 the D.C. Circuit issued an opinion that dismissed the challenges 
as moot under the rationale that the Agency had offered.
    In early October 1994 several groups of waste generating and waste 
managing industries filed citizen suits to enforce the October 1 
deadline for revising the mixture and derived-from rules. The U.S. 
District Court for the District of Columbia Circuit entered a consent 
decree resolving the consolidated cases on May 3, 1993. Environmental 
Technology Council v. Browner, C.A. No. 94-2119 (TFH) (D.D.C. 1994) 
Under this decree the Administrator must sign a proposal to amend the 
mixture and derived-from rules by November 13, 1995 and a notice of 
final rulemaking by December 15, 1996. The decree also specifies that 
the deadlines in the 1992 appropriations act do not apply to any rule 
revising the separate regulations that establish jurisdiction over 
media contaminated with hazardous wastes.
c. Federal Advisory Committees Act (FACA) and Outreach
    After the withdrawal of the HWIR proposal, the Agency initiated a 
series of public meetings with invited representatives from industry, 
environmental groups, hazardous waste treaters, and States. These 
meetings focused on three major issues: --RCRA regulation of low hazard 
wastes with a particular interest in addressing issues raised regarding 
the mixture and derived-from rules; concerns that full RCRA 
requirements for contaminated media may unnecessarily impede clean-ups; 
and need to regulate additional high-risk wastes outside the scope of 
the current listings and characteristics.
    A strong and successful effort was made to encourage all the 
interested parties to participate in the public meetings. EPA forged a 
solid partnership with the States (both ASTSWMO and Environmental 
Commissioners under the National Governors Association) and the state 
representatives worked closely with EPA as co-regulators in our 
analyses of options.
    In July of 1993, EPA chartered this group as an advisory committee 
under the Federal Advisory Committee Act (Pub. L. 92-463)(58 FR 36200).
    The committee rather quickly formed two sub-committees to allow 
separate discussion of the low risk waste problem associated with the 
mixture and derived-from rules and the rules for managing contaminated 
media and other wastes during remediation.
    By September of 1994 the low risk waste group had made significant 
progress in identifying options for creating exemptions for low risk 
wastes. Despite significant investment of time and effort, however, the 
group was unable to reach consensus on many key issues.
    With the statutory deadline for revisions to the mixture and 
derived-from rules approaching, EPA requested that group to present a 
final report in late September of 1994. EPA and representatives from 
several state environmental agencies then took up the task of selecting 
options for creating an exit rule, crafting regulatory language, and 
developing necessary supporting materials. The FACA subcommittee's 
final report was taken into consideration during the development of 
today's proposal.
2. Contained-In Policy
    The Agency also has interpreted its regulatory definition of 
hazardous waste to extend to mixtures of hazardous wastes and 
environmental media (such as contaminated soil and groundwater).2 
See 40 CFR 261.3(c)(1) and (d)(2). Media that are contaminated with 
listed or characteristically hazardous waste must be managed as 
hazardous wastes until they no longer contain such wastes. To date, the 
Agency has not issued any general rules as to when, or at what levels, 
environmental media contaminated with hazardous wastes are no longer 
considered to ``contain'' those hazardous wastes. Media that contain 
hazardous wastes with constituent concentrations below the levels 
proposed today will be eligible for exemption under the procedures 
proposed today. In addition, in a separate rulemaking, the Agency plans 
to propose additional rules reducing regulation of contaminated media 
during remediation activities.

    \2\ EPA's ``contained in'' policy was upheld as a reasonable 
interpretation of 40 CFR 261.3(c)(1) and (d)(2) by the D.C. Circuit 
in Chemical Waste Management, Inc v. U.S. EPA, No. 869 F.2d 1526 
(D.C. Cir. 1989).
---------------------------------------------------------------------------

C. Overview of Expected Impacts of the Exit Rule
1. Listed Wastes
    The purpose of this rule is to exempt from hazardous waste 
regulation those solid wastes currently designated as hazardous waste 
even though they contain constituent concentrations at levels that pose 
very low risk to human health and the environment. While facilities 
generating such wastes can petition for delisting by rulemaking under 
the provisions of 40 CFR Sec. 260.20 and 260.22, EPA believes that the 
detailed waste-stream specific review required under delisting is not 
necessary for the low risk wastes that are identified by today's 
proposal. The alternative, generic exit rule proposed today will be 
faster and less resource-intensive for both the Agency and the 
regulated community. By providing an opportunity for a more self-
implementing exemption, the Agency intends to create incentives for 
effective and innovative waste minimization and waste treatment and to 
reduce unnecessary demand for Subtitle C disposal capacity, without 

[[Page 66348]]
compromising needed environmental protection.3

    \3\ As will be discussed further in this notice, the Agency 
believes that the delisting process will continue to be valuable for 
certain types of wastes which are not eligible for an exemption 
under this proposal. Thus the Agency is not proposing to eliminate 
or modify the delisting program as a result of this proposal.
---------------------------------------------------------------------------

    By proposing a risk-based ``floor'' to listed wastes, today's 
proposal should give a very strong incentive to generators of listed 
hazardous waste to apply pollution prevention to their processes to 
avoid Subtitle C control. This action should also give incentive for 
the development of innovative treatment technologies to render wastes 
less risky.
    Today's proposed rule specifies sampling and analysis requirements, 
public participation, reporting and record keeping requirements. Most 
of these provisions are alternatives to the safeguard of waste-specific 
review provided under the delisting program. The exit levels are risk-
based concentrations at which a human or wildlife species could be 
directly or indirectly exposed to the exempted waste, and would be 
unlikely to suffer adverse health effects. The exposure scenario used 
to develop these levels assume that the exempted waste will no longer 
be subject to Subtitle C control, but will be managed as a solid waste 
in one of a variety of non-hazardous waste management units regulated 
under Subtitle D.
2. Characteristic Wastes
    Listed hazardous wastes exempted under today's proposed rule which 
exhibit any of the characteristics will continue to be regulated as 
hazardous wastes until the characteristic is removed. In a number of 
cases, wastes were listed on the basis of containing both toxic 
hazardous constituents and exhibiting one or more of the hazardous 
waste characteristics that do not relate to chemical toxicity (e.g., 
ignitability, corrosivity, or reactivity). If such a waste still 
exhibits any characteristic after complying with the exemption criteria 
proposed in today's proposed rule, it must continue to be managed as a 
characteristically hazardous waste.

III. Scope of Revisions to the Mixture and Derived-From Rules

    The mixture and derived-from rules promulgated in 1980 and 
reinstated in 1992 require Subtitle C regulation of all mixtures of 
listed hazardous wastes and solid wastes and all residuals from 
treatment of hazardous wastes. The rules proposed today, however, allow 
rapid exemptions for mixtures and derived-from wastes that present no 
significant threats to human health and the environment. Those wastes 
that would remain subject to the mixture and derived-from rules 
typically will pose risks that warrant regulation under Subtitle C. To 
the extent that this is not true for a particular mixture or treatment 
residual, the delisting process remains available (at least at the 
state level) to exempt wastes with constituents at more site- and 
waste-specific levels. Consequently, EPA has tentatively determined 
that further revisions of the mixture and derived-from rules, with the 
exception of the one minor change to the derived-from rule discussed 
later in this section, are not warranted in this rulemaking. However, 
EPA requests comment on this conclusion.

A. Rationale for Retention of the Mixture and Derived-From Rules

    EPA continues to believe that it had ample statutory and regulatory 
authority to promulgate the original rules and that it also has ample 
authority to maintain the rules without further revisions. The mixture 
and derived-from rules, particularly with the revisions proposed today, 
ensure that hazardous wastes that are mixed with other wastes or 
treated in some fashion do not escape regulation so long as they are 
reasonably likely to continue to pose threats to human health and the 
environment. They thus retain jurisdiction over listed hazardous wastes 
and clarify that such wastes are not automatically eligible for exit 
when they are mixed or treated. Although RCRA sets out criteria for the 
identification of hazardous wastes to enter the subtitle C system, it 
is silent on the question of how to determine that a waste is eligible 
to exit the system. EPA's interpretation of the statute is thus 
entitled to deference so long as it is reasonable and consistent with 
RCRA's purposes.
    EPA believes that its decision to retain jurisdiction over major 
portions of the universe of waste mixtures and treatment residues is 
consistent with its authorities under sections 3002-3004 of RCRA to 
impose requirements on waste handlers until wastes have ``cease[d] to 
pose a hazard to the public''. Shell Oil Corp. v. EPA, 959 F.2d 741, 
754 (D.C. Cir. 1991). See also Chemical Manufacturers Assoc. v. EPA, 
919 F.2d 158, 162-65 (EPA may regulate the disposal of nonhazardous 
wastes in a hazardous waste impoundment under section 3004) and 
Chemical Waste Management, Inc. v. EPA, 976 F.2d 2, 8, 13-14 (D.C. Cir. 
1992) (EPA may require further treatment of wastes under section 3004 
even though they cease to exhibit a hazardous characteristic).
    The mixture and derived-from rules are also valid exercises of 
EPA's authority to list hazardous wastes under section 3001. That 
provision gives EPA broad authority to promulgate listing criteria. 
EPA's 1980 criteria authorize the listing of classes of hazardous 
wastes when it has reason to believe that wastes in the class are 
typically or frequently hazardous. See 40 CFR 261.11(b). Such class 
listings are permissible even if some members of the class do not 
actually pose hazards. Nothing in the section 1004(5) definition of 
hazardous waste, in section 3001, or in EPA's listing criteria require 
EPA to prove that every member of a class poses a hazard. In fact, many 
waste listings describe ``classes'' of hazardous wastes because they 
cover a range of materials that are not identical in composition. The 
mixture and derived-from rules thus are fully authorized as class 
``listings'' under section 3001.
    EPA has also made a reasonable factual determination that these 
classes of waste warrant regulation under sections 3002-3004 and 
section 3001. In 1980 EPA determined that the hazardous constituents 
contained in these wastes are not generally eliminated or rendered 
nontoxic simply because a waste is mixed with other wastes or managed 
in some fashion. In 1992, when EPA repromulgated the mixture and 
derived-from rules, it documented numerous instances of mixed and 
derived-from wastes that continued to pose hazards. See 57 FR 7629 
(March 3, 1992). Today, EPA is proposing that members of this class of 
wastes that pose low risks will be eligible for an expedited, self-
implementing exemption from Subtitle C regulation. Accordingly, EPA has 
an even better basis for believing that wastes which remain within the 
scope of the mixture and derived-from rules pose threats warranting 
regulation.
    Additionally, EPA continues to believe, as it did in 1980, that it 
would be virtually impossible to try to identify all possible waste 
mixtures and treated wastes and assess their hazards individually. 
EPA's rule reasonably retains jurisdiction over both broad classes and 
places the burden of proof on the regulated community to show that a 
particular waste has ceased to present a hazard. Today's self-
implementing exit proposal will reduce that burden significantly, 
ensuring that the mixture and derived-from rules represent a reasonable 
approach to regulating these classes of wastes.

[[Page 66349]]

B. Revision to Derived-from Rule for Wastes Listed Because They Exhibit 
the Characteristics of Ignitability, Corrosivity, or Reactivity

    In 1981 EPA responded to a number of comments on the scope of the 
original 1980 mixture rule by promulgating a number of exemptions for 
mixtures of solid wastes and listed hazardous wastes which, according 
to information submitted by commenters, posed no significant risk to 
human health and the environment. See 46 FR 56582 (Nov. 17, 1981). The 
1981 rule included an exemption for mixtures of solid wastes and 
hazardous wastes listed solely because they exhibited one or more of 
the hazardous waste characteristics, if the resultant mixtures no 
longer exhibited a characteristic. The exemption was based on a finding 
that such mixtures did not pose threats to human health and the 
environment warranting Subtitle C regulation. See 46 FR 56568 and the 
current text of the exemption at Sec. 261.3(a)(2)(iii). EPA notes that 
it has never promulgated any listings for wastes solely on the basis 
that they exhibit either the 1980 EP toxicity characteristic or the 
1990 toxicity characteristic; consequently, only mixtures containing 
wastes listed because they exhibit the characteristics of ignitability, 
corrosivity, or reactivity have been eligible to exit Subtitle C when 
they no longer exhibit the characteristic.
    The 1981 notice focused exclusively on issues concerning the 
mixture rule. Consequently, EPA did not propose any parallel exemption 
for such wastes for the separate derived-from rule (codified at 
Sec. 261.3(c)(2)(i)), even though the derived-from wastes would appear 
to present similarly low risks if they no longer exhibited a 
characteristic and were treated to meet LDR standards before land 
disposal. Recent inquiries from the public have highlighted the 
discrepancy in the scope of the mixture rule and the derived-from rule 
for wastes listed solely because they exhibit characteristics. EPA 
believes it has no reason to treat derivatives of wastes listed solely 
because they exhibit the characteristic of ignitability, corrosivity, 
or reactivity any differently from the way it treats mixtures of such 
wastes because both present similar low risks to human health and the 
environment.
    Consequently, EPA is today proposing a revision to the derived-from 
rule that will closely resemble the 1981 revision to the mixture rule. 
Since no listings to date have been based on the toxicity 
characteristic, EPA is proposing to limit the new revision to the 
derived-from rule to wastes listed because they exhibit only the 
characteristics of ignitability, corrosivity, or reactivity. EPA is 
also not proposing to exempt wastes that might in the future be listed 
only because of the toxicity characteristic because (as this rule 
proposal indicates) there can be risk concerns with the TC constituents 
below TC levels. EPA requests comment on this proposal to create a new 
exemption to the derived-from rule for this limited category of listed 
wastes.
    The proposed exemption will also remind the regulated community of 
the separate duty to comply with requirements imposed by the part 268 
regulations implementing the LDR program. In CWM v. EPA, 976 F.2d 2 
(D.C. Cir. 1992), the U.S Court of Appeals for the D.C. Circuit 
interpreted RCRA section 3004(m) as requiring treatment of de-
characterized hazardous wastes to meet LDR treatment standards even 
after the wastes cease exhibiting a characteristic. EPA believes that 
de-characterized derived-from residues from wastes listed because they 
exhibit characteristics also must meet LDR requirements, unless they 
are either delisted or are exempt at the point of generation pursuant 
to other provisions proposed in this rule (e.g., meeting HWIR levels at 
the point of generation).
    In 1992 EPA amended the 1981 exemption to mixture rule to provide a 
similar cross-reference and clarification for mixtures containing de-
characterized listed wastes. See 57 FR 37194, 37210-11 (Aug. 18, 1992). 
That 1992 clarification, however, only covers nonwastewater mixtures. 
As explained in that mixture rule preamble, EPA then regulated de-
characterized wastewaters much less stringently under the LDR program. 
Consequently, EPA did not believe it was necessary to remind the 
regulated community to comply with LDR requirements for wastewater 
mixtures.
    Later in 1992 the CWM v. EPA decision invalidated most of the 
distinctions between the LDR rules for wastewaters and nonwastewaters. 
EPA is now revising the LDR program to comply with that decision in the 
LDR Phase III and Phase IV rulemakings. To reflect the changes in LDR 
regulation of wastewaters, the derived-from rule exemption proposed 
today reminds the regulated community of the need to comply with part 
268 LDR requirements for all types of derived-from residues. EPA 
requests comment on this clarifying language. EPA also requests comment 
on whether it should revise the LDR clarification for the mixture rule 
as well.

IV. Development of Exit Levels and ``Minimize Threat'' Levels

A. Need for the Exit

    The primary purpose of this rule is to address listed hazardous 
wastes, mixtures of listed hazardous wastes and solid wastes, and 
residues derived-from managing listed hazardous waste that, under 
current rules, continue to be designated as ``hazardous waste'' 
although they are either generated with constituent concentrations that 
pose low risks or treated in a manner that reduces constituent 
concentrations to low levels of risk.
    EPA notes that there are currently exemptions, both codified and 
contained in policy directives, from the hazardous waste identification 
system, particularly the mixture and derived-from rules, for certain 
types of wastes or wastes with certain constituent concentrations. See 
e.g. 40 CFR 261.3(a)(2)(iv)(A) through (E) and policy memorandums such 
as the ``Skinner Memorandum'' dated August 23, 1995. EPA is not 
proposing to modify or replace any of these exemptions and policy 
statements.

B. Overview of the Exit

    For 191 of the 376 constituents of concern, EPA conducted a 
detailed human health risk analysis to develop risk-based levels for 
either the wastewater or nonwastewater form of a constituent (or both). 
To conduct this analysis, EPA identified five types of units actually 
and rather frequently used to manage nonhazardous wastes that covered 
the full range of environmental releases needing analysis. The May 1992 
proposal of exit levels for listed wastes, like many previous RCRA 
rules, assessed only risks from releases to groundwater. In response to 
complaints that such an assessment would not protect human health and 
the environment from other types of releases, EPA also assessed 
potential releases to air, surface water and soil in this proposal.
    For each category of releases, EPA evaluated both relatively simple 
pathways (such direct human ingestion of contaminated groundwater) and 
more complex pathways (such as the deposition of windblown waste 
particles on agricultural land, followed by crop uptake, consumption of 
the crop by cattle, and consumption of contaminated beef or milk by 
humans). EPA assessed approximately 8 to 27 release pathways depending 
on the type of waste management unit.
    Additionally, EPA screened the same group of 191 constituents to 
identify the highest priorities for assessment of 

[[Page 66350]]
ecological receptors. In addition, EPA considered for its assessment 
the toxicological effects of silver on ecological receptors. EPA 
conducted a specific assessment of ecological risks for 47 constituents 
using the same five units and the same pathways (modified to reflect 
ecological exposures) for each unit. This risk assessment is described 
in more detail in sections V.B. and C.
    Data limitations and resource constraints prevented EPA from 
conducting a risk analysis for the remaining constituents of concern. 
For each of these constituents, EPA extrapolated exit levels from 
levels derived-from the risk assessment for similar chemicals. EPA's 
extrapolation methodology is described in section IV.F.
    The current capabilities of analytical chemistry constrain EPA's 
ability to use some of concentrations as exit levels. For approximately 
one-fourth of the constituents, EPA found that available methods could 
not routinely measure the constituent at the modeled or extrapolated 
risk-based exit level.

C. Selection of Constituents of Concern

1. Development of the Master List
    EPA developed an initial ``Master List'' of 506 constituents to be 
evaluated for purposes of establishing exit criteria. This master list 
was developed by combining the constituents specifically listed in the 
following appendices of 40 CFR part 261: Appendix VII, Basis for 
Listing Hazardous Waste; Appendix VIII, Hazardous Constituents; and 
appendix IX of part 264, the Ground-Water Monitoring List. The master 
list includes the full list of constituents referenced in appendix VII, 
including the F039 constituents.
    Appendix VII to part 261, which was originally promulgated on May 
19, 1980 (45 FR 33084) sets out the chemical constituents found to pose 
threats to human health and the environment that served as the actual 
basis for each of EPA's original hazardous waste listings. Appendix 
VIII to Part 261, also promulgated in 1980, is a more general listing 
of chemicals found to pose potential threats to human health and the 
environment. (45 FR 33084). EPA considers wastes containing appendix 
VIII constituents to be candidates for listing determinations. EPA 
amends appendix VII from time to time as EPA identifies additional 
potentially toxic constituents.
    EPA later promulgated appendix IX to part 264 to identify those 
appendix VIII constituents which it could routinely expect owners and 
operators of permitted hazardous waste treatment, storage and disposal 
facilities to monitor in groundwater. EPA also included in this 
appendix 17 additional constituents found to pose significant risks 
that the Superfund program routinely monitored in groundwater. (52 FR 
25942, July 9, 1987).
    EPA established in these rulemakings that each of these 
constituents had significant potential to threaten human health, and, 
by implication, potential to threaten the environment. (Most of the 
data EPA utilized predicted toxic effects on humans.) EPA finds it 
reasonable to include each of these constituents on the list of 
chemicals of concern.
    Further, EPA believes that, with the exception of the six chemicals 
identified below, the three appendices identify the chemicals of 
current concern to EPA that are likely to be found in listed wastes.
    The Agency requests comment on whether the master list should also 
include six constituents that are not listed in any of the above 
sources. These six constituents, which are listed in Table 1, are found 
in six ``U'' listed wastes (commercial chemical products that become 
hazardous wastes when discarded). See 40 CFR 261.33(f). EPA originally 
listed these wastes because they routinely exhibited the characteristic 
of ignitability. Since the original listings, however, sufficient 
toxicity data have become available for these constituents. (The risk 
number for dimethylamine was recently withdrawn; however, EPA 
understands that it will shortly be replaced). Because of the toxicity 
data associated with these constituents, the Agency is taking comment 
on whether exit levels should be established for these six constituents 
in today's rulemaking. The Agency also requests comment on whether 
these six constituents should be added to Appendix VIII.

                            Table 1.--Constituents Not on Appendices VII, VIII, or IX                           
----------------------------------------------------------------------------------------------------------------
                                                                                              Nonwastewater     
                CAS #                              Constituent              Wastewater -------------------------
                                                                                           Totals       Leach   
----------------------------------------------------------------------------------------------------------------
 75-07-0.............................  Acetaldehyde (ethanal)............  ...........  ...........  ...........
 98-82-8.............................  Cumene............................          .67       18,000          2.5
124-40-3.............................  Dimethylamine.....................  ...........  ...........  ...........
110-00-9.............................  Furan.............................          .16         1300          .06
 79-10-7.............................  Acrylic acid......................        (\1\)        (\1\)        (\1\)
 98-01-1.............................  2-Furancarbox- aldehyde (furfural)        (\1\)        (\1\)        (\1\)
----------------------------------------------------------------------------------------------------------------
\1\ No exit levels because no EQC is available for this constituent. The criteria for exit would be to meet LDR 
  treatment standards in Sec.  268.                                                                             

    Full documentation concerning the selection of constituents of 
concern is available in the docket under The Background Document to 
Support Development of the Final Constituent List under the Waste Exit 
Rule.
2. Development of the Exit Constituent List
    The Agency narrowed the list of 506 constituents to consist of 376 
constituents that are included in the exemption list. 130 constituents 
were deleted from the master list. Criteria for constituent deletions 
from the master list include: Reactivity in air, analysis as a 
different constituent, reactivity in water, hydrolysis in soil or 
water, or is part of a chemical class with a specific constituent 
represented on the list. Because different methods and quantitation 
limits are necessary for solid and liquid matrices, two separate 
analyses were conducted. The Background Document to Support Development 
of the Final Constituent List under the Waste Exit Rule in the docket 
further justifies deletions of constituents from the master list and 
lists the deleted constituents.
    Molybdenum is not on the Appendices VII, VIII, or IX, which 
provided the scope of today's master list of constituents. In 
anticipation of the Petroleum listing, due to a Drinking Water Sewage 
Sludge regulatory level, and due to available toxicity information, the 
Agency has included molybdenum on the exemption list. Due to modeling 
time constraints, Molybdenum was not modeled for groundwater risk. The 
groundwater 

[[Page 66351]]
leach level was estimated by assuming a DAF of 10 and using the RfD. 
The Agency requests comment on whether molybdenum should be on the 
list.
    Two modeled constituents do not have estimated quantitation 
criteria (EQCs--see section IV.G.) and therefore do not have associated 
exit levels. These constituents are ethylene thiourea and phenyl 
mercuric acetate. The Agency requests comment on how to deal with these 
two constituents. The following table represents modeled results for 
these constituents for comment.

                                   Table 2.--Modeled Constituents Without EQCs                                  
----------------------------------------------------------------------------------------------------------------
                CASNUM                            Constituent            NWW totals     NWW leach     WW totals 
----------------------------------------------------------------------------------------------------------------
96-45-7...............................  Ethylene thiourea.............     0.51          0.00017         .00053 
62-38-4...............................  Phenyl mercuric acetate.......     0.0093        0.0045         0.012   
----------------------------------------------------------------------------------------------------------------

    EPA modeled chromium VI in the risk assessment. However, totals 
chromium appears on the exit tables based on the exit levels calculated 
from modeling chromium VI. This approach is consistent with the 
Toxicity Characteristic approach to chromium. The Agency asks for 
comment on this approach.
    The cyanide exit level was extrapolated. It is meant to be totals 
cyanide. The Agency requests comment on whether testing for totals 
cyanide is appropriate.
    The values in the exit tables for silver do not represent results 
of human toxicity data for silver, rather they represent ecological 
results from the risk assessment. The Agency has determined that the 
effect of silver on humans is not a human health problem, rather it is 
an aesthetic problem. The groundwater model did not model ecological 
exposure, therefore, there is no groundwater risk level for silver.
3. Constituents of Ecological Concern
    As explained above, EPA established in previous RCRA rulemakings 
that the constituents on the exit list (376) present significant 
threats to human health. Numerous comments submitted on EPA's May 1992 
proposal to establish exit levels urged EPA to conduct a more specific 
and detailed analysis of threats to non-human species. Consequently, in 
this rulemaking EPA determined the constituents it believed to also be 
reasonably likely to pose risks to ecological receptors.
    EPA has not set benchmarks for ecological impacts for a large 
number of constituents under any of its programs. Establishing such 
benchmarks for this proposal would be a resource-intensive and time-
consuming task. Accordingly, EPA narrowed the list of exit constituents 
for which ecological receptors would be evaluated. First, EPA decided 
to consider only the 191 constituents which it had already targeted for 
analysis to protect human health. Second, the Agency developed a 
methodology for screening the 191 constituents to identify those most 
likely to pose significant risks to ecological receptors.
    Based on an extensive review of available literature, EPA developed 
five criteria to indicate the potential for ecological risks:
    (1) Constituents that bioaccumulate (and possibly biomagnify) in 
the food chain that can present elevated exposures to certain 
predators;
    (2) Persistent constituents that are likely to increase long-term 
multi-generational exposures in wildlife;
    (3) Constituents that cause reproductive and developmental effects 
that can elicit adverse effects at sensitive life stages;
    (4) Constituents that may cause ecological effects that have no 
human analog (e.g., eggshell thinning); and
    (5) Constituents that may cause effects to ecological receptors 
continuously exposed.
    EPA also developed operational definitions for each criterion. The 
definitions were quantitative where possible. Further details can be 
found in appendix B of the Technical Support Document for the Risk 
Assessment for Human and Ecological Receptors.
    EPA decided to designate as constituents of ecological concern the 
47 constituents that exhibited at least two of the five criteria. The 
Agency believes these constituents present the highest priorities in 
terms of environmental risk. An additional 36 constituents exhibited 
only one criterion. EPA, however, chose not to designate them as 
constituents of concern because time and resource constraints would 
prevent the Agency from completing an analysis with these constituents. 
EPA, nevertheless, believes it has identified and analyzed sufficient 
constituents of concern to ensure that the exit levels proposed today 
provide for reasonable protection of the environment. Only 83 of 191 
screened constituents showed any significant potential to pose threats 
to the environment at levels protective of human health. Further, as 
discussed in more detail below, of the 47 constituents that EPA 
actually assessed for ecological impacts, only 6 wastewater 
constituents and 18 nonwastewater constituents required exit levels to 
protect environmental receptors lower than those necessary to protect 
human health under the baseline proposal. Consequently, EPA believes it 
is unlikely that all of the remaining constituents will present 
significant threats to ecological receptors at levels that would 
adequately protect human health.

D. Risk-Based Information

    The Agency's proposed option for establishing exit values is based 
on risk modeling to a hazard quotient of 1 and a 1 x 10-6 cancer 
risk. The Agency chose a hazard quotient of 1 as its toxicity benchmark 
value for non-carcinogens because evaluation of these compounds 
presumes there is a threshold exposure above which individuals would be 
at significant risk of suffering the adverse effects attributable to 
the compound. The HQ is the Agency's best attempt to estimate that 
level. Therefore, the Agency believes all exposures should remain below 
HQ 1. Some Agency programs rely on HQ values less than 1 in standard 
setting (the drinking water program uses an HQ of 0.20 to provide a 
safety factor which allows for exposure to the constituent from sources 
other than drinking water).
    The Agency chose a toxicity benchmark of 1  x  10-6 cancer 
risk for carcinogens for several reasons. A cancer risk level of 1  x  
10-5 risk was used as a clearly hazardous level in establishing 
the toxicity characteristic. Second, in the listings program, a 1  x  
10-4 cancer risk is used as the presumptive listing risk, and a 1 
x  10-6 as the presumptive no-list level. A cancer risk of 1  x  
10-5 represents a level of initial concern about risk. Therefore, 
in allowing listed hazardous waste to exit the requirements of Subtitle 
C, the Agency was targeting waste that is clearly not hazardous. Thus, 
the Agency believes the risk level should be at the 

[[Page 66352]]
low end of the risk range used to bring waste into the hazardous waste 
system.
    Similarly, the Agency sought to be protective of public health in 
developing its fate and exposure modeling. For the groundwater 
evaluation, the Agency used a DAF 10 (which represents an approximate 
90th percentile protection level) for infinite source type 
constituents. (Constituent-specific DAFs were developed using the same 
input assumptions, and different DAFs result from modeling of 
degradation or retardation factors in the environment). This is the 
generic DAF used in the delisting program for large volume wastes. 
Since this is a national program which will largely benefit the largest 
volume generators, the DAF 10 assumption is consistent with delisting 
practice. Also, the toxicity characteristic used a DAF of 100 
(representing an approximate 85th percentile protection level) for 
identifying clearly hazardous waste (for infinite source type 
constituents; regulation of hydrolysers was deferred). Again the policy 
goal of exits was to strive to be well below clearly hazardous levels. 
The Agency also modeled exposure at the nearest downgradient well. The 
TC rule restricted well placement to within the plume. Today's proposal 
attempts to balance the protectiveness level and well placement by 
requiring a more protective level than the TC rule, but is less 
restrictive in well location, e.g., wells outside of the plume, at 
significantly lower risk, are averaged in.
    For modeling of the non-groundwater pathways, the Agency used four 
high-end parameter values for which the modeling outcome is most 
sensitive as inputs to the analysis to be protective of public health 
and the environment. These include: Two high-end parameters in the 
waste management unit characterization and fate portions and two high-
end parameters in the exposure portions of the model. The remaining 
input parameters were evaluated at typical values or central tendency 
values. The Agency sought to be protective of a high percentile exposed 
population (at least 90th percentile).
1. Human Health Benchmarks
    For each constituent on the master list, the Agency evaluated the 
existing toxicity information to determine whether there were 
sufficient toxicity data to establish a benchmark. For those 
constituents with adequate data, the data were evaluated either by the 
Agency's CRAVE (Carcinogen Risk Assessment Verification Endeavor) 
Workgroup, Reference Dose/Reference Concentration (RfD/RfC) Workgroup, 
or the Office of Research and Development. This approach is consistent 
with the approach used in the Agency's other risk-based RCRA programs 
such as the Toxicity Characteristic, delisting petition evaluations, 
listings, as well as the CERCLA program. See Section 4, ``Benchmarks,'' 
of the Technical Support Document for the Hazardous Waste 
Identification Rule: Risk Assessment for Human and Ecological Receptors 
for more details.
a. Non-carcinogens
    The Agency proposes to use oral reference doses (RfDs) and 
inhalation reference concentrations (RfCs) as the basis for developing 
the exit criteria for non-carcinogenic constituents. An RfD or RfC is 
an estimate (with uncertainty spanning perhaps an order of magnitude) 
of a daily exposure to a constituent for the human population 
(including sensitive subgroups) that is likely to be without an 
appreciable risk of deleterious effects during a lifetime.
    The approach used to derive an RfD or RfC is to identify the 
highest test dose of a constituent associated with no effects or 
effects that are not considered adverse in an appropriate animal 
bioassay test. These experimental no-observed-adverse-effect-levels 
(NOAELs) or no-observed-effect-levels (NOELs) are considered to be an 
estimate of the animal population's physiological threshold for adverse 
effects. The RfD or RfC is derived by dividing the NOAEL or other 
toxicity benchmark by suitable uncertainty and modifying factors. In 
the event that an appropriate NOAEL or NOEL is not available, the 
lowest-observed-adverse-effect level (LOAEL) may be used with 
additional uncertainty factors.
    It is important to note that the contributions of the constituent 
from various sources in the environment (e.g., air, food, water) are 
not considered in the development of an RfD or RfC. Rather, the RfD or 
RfC reflects the estimated total permissible daily human exposure from 
all sources of exposure. RfDs and RfCs have been calculated for many, 
but not all, of the non-carcinogenic constituents for which the Agency 
is establishing exit criteria.
    The Agency prefers to use only RfDs and RfCs that have been 
evaluated and verified by the RfD/RfC Workgroup as the basis for 
setting regulatory levels. However, for some constituents, the Agency 
has not yet completed its verification process; thus, RfDs and RfCs 
under development are being used for purposes of this proposal for 
those constituents. If the final verified RfDs and RfCs differ from the 
RfDs and RfCs under development proposed in today's notice, the Agency 
will adopt the new (i.e., verified) values for the final rule after 
noticing the data in the Federal Register.
b. Carcinogens
    The Agency proposes to use the oral cancer slope factor and 
inhalation cancer unit risk as the basis for developing exit levels for 
carcinogenic constituents unless the non-carcinogenic effects occur at 
lower levels. EPA's CRAVE Workgroup and Office of Research and 
Development have estimated the carcinogenic slope factor (CSF) (i.e., 
the slope of the ``dose-response'' curve) and inhalation unit risks for 
humans exposed to low-dose levels of carcinogens in the environment. 
The slope factors indicate the upper-bound confidence limit estimate of 
excess cancer risk for individuals experiencing a given exposure over a 
70-year lifetime. In practice, a given dose multiplied by the slope 
factor gives an upper estimate of the lifetime risk to an individual of 
developing cancer. By specifying a level of lifetime risk (no matter 
how small), one can also estimate the corresponding dose using the 
slope factor.
    EPA proposes to quantify on a weight-of-evidence basis, as 
described below. EPA promulgated ``Guidelines for Carcinogen Risk 
Assessment'' on September 24, 1986 (51 FR 33992), which defined a 
scheme to characterize substances based on experimental data and the 
kinds of responses induced by a suspect carcinogen. These guidelines 
specify the following five classifications:

Group A--Human carcinogen (sufficient evidence from epidemiologic 
studies)
Group B--Probable human carcinogen
Group B1--Limited evidence of carcinogenicity in humans
Group B2--A combination of sufficient evidence in animals and 
inadequate or no evidence in humans
Group C--Possible human carcinogen (limited evidence of carcinogenicity 
in the absence of human data)
Group D--Not classifiable as to human carcinogenicity (inadequate human 
and animal evidence of carcinogenicity or no data available)
Group E--Evidence of non-carcinogenicity for humans (no evidence of 
carcinogenicity in at least two adequate animal tests in different 
species or in both adequate epidemiologic and animal studies).

    The weight-of-evidence basis was used to eliminate Group D and E 
constituents from further consideration as carcinogens. 

[[Page 66353]]

    Under each of the regulatory options presented in today's proposal, 
the Agency is using the same risk level for Groups A, B, and C 
carcinogens. This approach is consistent with the way carcinogens were 
treated in the 1990 Toxicity Characteristic rule, hazardous waste 
listing determinations, and the delisting program. The rationale for 
this approach is that while the classifications indicate the type 
(human or animal) and strength of the studies available which reflects 
upon the uncertainty about the carcinogenic potential, the severity of 
the effect, cancer, warrants equal treatment. It is important to note 
that a few Group C carcinogens do not have slope factors or unit risks. 
In these cases the Agency used the benchmark developed for the non-
cancer endpoint.
c. Consideration of MCLs
    The Agency is proposing two approaches for setting human health-
based levels for carcinogens and non-carcinogens in routes of exposure 
involving water ingestion. For the first approach, the Agency is 
proposing to use Maximum Contaminant Levels (MCLs) promulgated under 
the Safe Drinking Water Act (SDWA) of 1974, as amended in 1986, as the 
human health-based levels for the constituents for which they have been 
established. In general, MCLs for non-carcinogens are derived from the 
Reference Doses (RfDs), while MCLs for most carcinogens are set as 
close to zero as technically and economically feasible; this normally 
corresponds to risk levels that range from 10-4 to 10-6. 
(Note that, although the derivation of MCLs considers feasibility of 
treatment, analytic chemistry, and cost factors in addition to health 
effects, it also considers other routes of exposure. The Agency's 
policy has been to use MCLs, when available, in other similar 
concentration-based programs.) For those constituents which do not yet 
have MCLs, the Agency is proposing to use oral reference doses (RfDs) 
for non-carcinogens and oral slope factors for carcinogens as described 
above. However, if new MCLs are finalized under the SDWA prior to the 
promulgation of today's rule, the Agency proposes to substitute the new 
MCLs for the RfDs and slope factor-derived human health-based levels 
for water ingestion presented in today's notice.
    For the second approach, the Agency intends to propose to use only 
RfDs and slope factors in deriving human health-based levels for water 
ingestion. The Agency requests comment on these two approaches.
2. Ecological Benchmarks
    Ecological benchmarks were developed for a variety of ecological 
receptors based on the availability of data. Benchmarks were needed for 
mammals, birds, plants, soil fauna, fish, aquatic invertebrates, 
aquatic plants, and benthos (sediment-dwelling organisms). A much 
smaller number of constituents have been evaluated by the Agency for 
ecological effects than have been for human health effects, as 
discussed under V.A. In general, measurement endpoints were selected: 
(1) For consistency with the Agency's Framework for Ecological Risk 
Assessment (U.S. EPA 1992x), the Great Lakes Initiative, and other 
ecological efforts within the Agency, and (2) relevance to the 
ecological receptor. As discussed in ``Section D--Risk Assessment'' the 
ecological assessment focussed on inferring the sustainability of 
populations and communities within ecosystems. Therefore, benchmarks 
were derived from measurement endpoints (i.e., reproductive, 
developmental, growth, survival, and mortality) from which such 
inferences could be made. Reproductive studies (e.g., number of viable 
young per female) were preferred over other endpoints. For some 
constituents, acute or mortality studies were used, however, this 
occurred only for developing benchmarks for fish, aquatic 
invertebrates, and benthos where protocol exists (AWQC development) for 
using such data. The Agency seeks comment on the measurement endpoints 
selected for each ecological receptor.
    The toxicological benchmarks were established using the more 
conservative no effects level (or concentration) approach for 
ecological receptors as compared to a 20% effects level. The 20% 
effects level is the lowest level for ecological effects that can be 
detected in field population analyses (Suter et al., 1992). Although 
the 20% effects level may indeed be the lower limit that could be 
reliably confirmed in field studies, this level reflects our current 
analytical abilities and not necessarily the ecological significance of 
the effects level. The no effects approach was taken because the 
ecological analysis infers the sustainability of various populations 
under the assumption that if a sufficient number of populations within 
an ecosystem is protected, then the likelihood of adverse effects that 
are causally related to the chemical stressor will be reduced at the 
ecosystem level. The Agency was concerned that if an effects approach 
was taken, then the assumption underlying the ecological analysis would 
no longer be valid. The Agency seeks comment on the approach taken for 
setting toxicological benchmarks.
    Given the number and variety of ecological receptors included in 
the analysis (predatory birds to soil fauna) as well as the variety of 
effects and endpoints considered, the benchmark development process 
required an approach that was internally consistent and acknowledged, 
at least qualitatively, the uncertainty involved in estimating 
ecological benchmarks. The Agency, therefore, developed a benchmark 
classification scheme to incorporate both the relationship of the 
benchmark to the entire toxicity data set and the adequacy of the 
database used to derive the benchmark. Three classifications were 
established: Adequate, provisional, and interim. These classifications 
were developed on a receptor group-specific basis (i.e., fish and 
aquatic invertebrates, benthos, mammals, birds, soil fauna, and 
terrestrial plants) and represent a weight-of-evidence designation for 
the toxicological benchmark. In many respects, this classification 
scheme is similar in meaning to the human carcinogen weight-of-evidence 
groups and the difference between ``verified'' values on IRIS and 
``unverified'' values in HEAST. The classifications relate to the 
certainty assigned to a given ecological benchmark. The benchmarks were 
treated the same in the analysis regardless of classification. See 
Section 4 in the ``Technical Support Document for the Hazardous Waste 
Identification Rule: Risk Assessment for Human and Ecological 
Receptors'' for details on each classification and how they were used 
for each ecological receptor group. The Agency seeks comment on the 
classification developed for the analysis.
    Below is a discussion of how benchmarks were developed for each of 
the receptor groups. For a detailed discussion of each of their 
developments, see Section 4, ``Benchmarks,'' and Appendix B, 
``Toxicological Profiles for Ecological Receptors,'' of the ``Technical 
Support Document for the Hazardous Waste Identification Rule: Risk 
Assessment for Human and Ecological Receptors.'' The Agency seeks 
comment on the overall development of each of the ecological benchmarks 
generated for this proposed rule.
    For populations of birds and mammals, the overall approach used to 
establish toxicological benchmarks was similar to the methods used to 
establish RfDs for humans as described in IRIS. Each method uses a 
hierarchy for the selection of toxicity data (e.g., no effects 

[[Page 66354]]
levels are generally preferred to lowest effects levels) and 
extrapolates from a toxicity benchmark for the test species to a 
toxicity benchmark for the desired species. However, the procedures 
used to develop benchmarks (i.e., RfDs) for the protection for human 
health establish an acceptable daily dose for all individuals 
(including sensitive sub-populations) while the development of 
ecological benchmarks for this analysis establish a level that will 
sustain the reproductive fitness in a local population. Consequently, 
benchmarks for birds and mammals were established using three key 
guidelines. First, because the reproducing population was selected as 
the assessment endpoint, the benchmarks were d
FR Doc. 95-29458 Hazardous Waste Management System: Identification and Listing of Hazardous Waste: Hazardous Waste Identification Rule (HWIR)
eveloped from measures of 
reproductive success or, if unavailable, other effects that could 
conceivably impair the maintenance of the population.
    Second, the taxon of the test species was matched to the taxon of 
the wildlife species to the greatest extent possible. The evolutionary 
processes that result in obvious differences in taxa (e.g., morphology) 
also result in differences in the physiological processes that govern 
chemical response. Moreover, taxonomic similarities are generally 
associated with similarities in feeding habits, physiology, and 
chemical sensitivity at the family classification and, to a lesser 
extent, the order classification. For example, herbivores are generally 
more resistant to toxicants than predators because they are exposed to 
plant toxins, and the enzymatic system that detoxifies plant toxins 
also detoxifies pesticides and other organic chemicals.
    Third, a default safety factor of 10 was adopted only for 
extrapolating from an lowest-observed-effects level (LOEL) to a no-
effects level (NOEL). A ten-fold safety factor was not applied to sub-
chronic studies since reproductive and developmental toxicity studies 
are frequently short-term. Even among target organ toxicity studies, 
there are many instances where sub-chronic studies are actually more 
sensitive than chronic studies carried out on the same substance. Also, 
for mammals and birds, differences in interspecies uncertainty were 
indirectly addressed through the use of the species-scaling equation 
described in Section 4 of the ``Technical Support Document for the 
Hazardous Waste Identification Rule: Risk Assessment for Human and 
Ecological Receptors.'' The Agency requests comment on the use a safety 
factor of 10 when extrapolating from a LOEL to a NOEL. The Agency also 
requests comment on the use of a scaling approach to address 
interspecies uncertainty as described above. Furthermore, the Agency 
seeks comment on the inability of the Risk Assessment to evaluate the 
inhalation and dermal routes of exposure for birds and mammals.
    For the terrestrial plants, the approach used to establish 
toxicological benchmarks was adapted from the Effects Range Low (ER-L) 
approach developed by the National Oceanographic and Atmospheric 
Administration (NOAA). The NOAA ER-L approach estimates a percentile of 
the distribution of various toxic effects thresholds. The measurement 
endpoints were generally limited to growth and yield parameters because 
(1) they are the most common class of response reported in 
phytotoxicity studies and, therefore, will allow for benchmark 
calculations for a large number of constituents, and (2) they are 
ecologically significant responses both in terms of plant populations 
and, by extension, the ability of producers to support higher trophic 
levels. It should be noted that these benchmarks were limited to soil 
concentrations and do not explicitly consider the adverse impacts on 
plants from ambient contaminant concentrations in the air. Further 
details can be found in section 4.3.3 of the ``Technical Support 
Document for the Hazardous Waste Identification Rule: Risk Assessment 
for Human and Ecological Receptors.'' The Agency solicits comment on 
the overall approach taken to develop benchmarks for the terrestrial 
plant community.
    For the soil fauna, the toxicological benchmarks were established 
based on methods developed by the Dutch National Institute of Public 
Health and Environmental Protection (RIVM). The RIVM approach estimates 
a confidence interval containing the concentration at which the no 
observed effects concentration (NOEC) for p percent (95th percentile 
was selected) of the species within the community is not exceeded 50% 
of the time. A minimum data set was established in which key structural 
and functional components of the soil community (e.g., decomposer and 
grazing organisms) encompassing different sizes of organisms (i.e., 
microfauna, mesofauna, macrofauna) were represented. As with the 
Ambient Water Quality Criteria, measurement endpoints included 
reproductive effects as well as measures of growth, survival, 
mortality. The Agency requests comment on the use of the RIVM 
methodology, and protecting 95 percent of the community 50 percent of 
the time. The Agency also requests comment on its inability to fully 
quantify the effect of soil characteristics on toxicity of constituents 
to soil organisms.
    For populations of fish and aquatic invertebrates (represented by 
daphnids), a hierarchical approach was taken for use of data sources in 
deriving benchmarks. The first choice was final chronic values (FCVs) 
from the Sediment Quality Criteria effort by the EPA Office of Water, 
followed by values from the Great Lakes Initiative (GLI) effort, and 
finally, the Ambient Water Quality Criteria (AWQC). If these benchmarks 
were not available, then a benchmark was developed using AWQC 
procedures or, if data were inadequate, the GLI Tier II procedures for 
establishing chronic values (termed secondary chronic values--SCVs). 
The AWQC ranked third since many years have passed since their 
establishment and the SQC and GLI efforts re-evaluated the toxicity 
data sets of several of these. The Agency solicits comment on the 
hierarchical approach described above for deriving toxicity benchmarks.
    For aquatic plants, the approach used to establish toxicological 
benchmarks was adapted from the ER-L approach developed by NOAA. The 
NOAA ER-L approach estimates a percentile of the distribution of 
various toxic effects thresholds. However, due to the general lack of 
toxicity data, the default ER-L approach was used wherein the lowest 
LOEC for either vascular plants or algae was used. The Agency solicits 
comment on the overall approach taken to develop benchmarks for aquatic 
plants.
    For the sediment organisms, the approach used to establish 
toxicological benchmarks for non-ionic, hydrophobic organic chemicals 
was based on sediment quality criteria methods for non-ionic 
constituents. Two key assumptions form the basis for the proposed 
sediment quality criteria. First, benthic species, defined as either 
epibenthic or infaunal species, have a similar toxicological 
sensitivity as water column species. As a result, FCVs (or SCVs) 
developed for the fish and aquatic invertebrates can be used for the 
benthic community. Second, pore water and sediment carbon are assumed 
to be in equilibrium and the concentrations are related by a partition 
coefficient, Koc. This assumption, described as equilibrium 
partitioning (EqP), provides the rationale for the equality of water-
only and sediment-exposure-effects concentrations on a pore water 
basis: The sediment-pore water equilibrium system results in the same 
effects as a water-only exposure. The Agency requests comment on the 
use of this approach in support of today's proposal. In some cases, 
protecting these 

[[Page 66355]]
ecological receptors represents the critical pathway that limits the 
projected exit level for management of a waste stream outside of the 
Subtitle C hazardous waste program. These ecological receptors serve as 
the basis for the proposed exit levels for 18 constituents, including 6 
metals. To the extent that contaminants from these waste streams reach 
off site areas, the Agency based its proposal on modeling the 
ecological receptors on a neighboring land area of 500 acres or an 
adjacent stream (with a total length of 12 miles). This approach as 
currently modeled, may only serve as an indicator of a potential nearby 
threat to ecological receptors (e.g., the soil fauna and plant life), 
rather than serving as a measure or indicator of a broader threat to 
the environment. The Agency solicits comment on the appropriateness and 
relevance of these receptors as the basis for exit levels under the 
HWIR program.
3. Sources of Data
a. Human
    The two primary sources used to identify human health benchmarks 
were the Integrated Risk Information System (IRIS) and the Health 
Effects Assessment Summary Tables (HEAST). Both of these sources were 
developed and are maintained by the USEPA. For a few constituents, 
other Agency sources such as Carcinogen Assessment Group (CAG) 
profiles, Health Effect Assessments (HEAs), and Health Assessment 
Documents (HADs) were used to fill data gaps.
    IRIS is the Agency's official repository of Agency-wide consensus 
chronic human health risk information. IRIS evaluation are conducted by 
the Agency's Work Group review process that leads to internal Agency 
scientific consensus regarding risk assessment information on a 
chemical. This information is recorded on IRIS and is considered to be 
``Work Group Verified.''
    The HEAST is prepared by EPA's Office of Research and Development. 
They contain risk assessment information on chemicals that have 
undergone a more limited review and have the concurrence of individual 
Agency program offices; each is supported by an Agency reference. The 
information has not, however, had enough review to be recognized as 
Agency-wide consensus information.
b. Ecological
    A thorough literature review was conducted to identify 
toxicological data from laboratory and field studies for each of the 
constituents of ecological concern. The review included secondary 
sources such as the Synoptic Review Series published by the U.S. Fish 
and Wildlife Service, the Ambient Water Quality Criteria documents, and 
other Federal compendia of toxicity data (e.g. HEAs, the Derivation of 
Proposed Human Health and Wildlife Bioaccumulation Factors for the 
Great Lakes Initiative, Agency for Toxic Substances and Disease 
Registry documents, PHYTOTOX, GRIN, TERRETOX, and AQUIRE). Toxicity 
data on soil organisms were obtained for several constituents from van 
de Meent et al. (1990). In addition to AQUIRE, the other primary data 
source for toxicity data on aquatic plants were the Toxicological 
Benchmarks for Screening Potential Contaminants of Concern for Effects 
on Aquatic Biota:1994 Revision (Suter and Mabrey, 1994). On-line 
literature searches were conducted to identify primary sources of 
toxicity data on constituents lacking sufficient data in the secondary 
sources. Additional studies were identified in conventional literature 
reviews.

E. Risk Assessment

1. The Non-groundwater Risk Assessment
a. Introduction
    The risk assessment underlying today's proposed rule is based upon 
a comprehensive approach to evaluating the movement of many different 
waste constituents from their waste management units, through different 
routes of exposure or pathways, to the points where human and 
ecological receptors are potentially exposed to these constituents. 
This risk assessment is being used in today's proposed rule to 
determine which listed hazardous wastes can be defined as ``low-risk'' 
wastes, able to exit the Subtitle C system and be managed in non-
Subtitle C units. The previous approach taken in the May 20, 1992, 
proposed HWIR rule also addressed the risks associated with the 
management of wastes containing hazardous constituents with very 
diverse physical and chemical properties; however, only groundwater 
ingestion exposures from landfill units were evaluated. That approach 
led to a concern by the Agency, as well as commenters on the proposed 
rule, that leachate from landfills contaminating groundwater and 
subsequent consumption of the contaminated groundwater by humans may 
not be the only exposure pathway important to evaluate. Although the 
ingestion of contaminated groundwater pathway may be appropriate to 
propose exit levels for some wastes and constituents, it may be under-
protective for others, depending on the physical and chemical 
properties of each waste constituent. (For example, some constituents 
have a high potential to bioaccumulate or bioconcentrate in living 
organisms. Pathways in which these constituents come in contact with 
fish, grazing livestock, wildlife, or edible plants would be important 
to evaluate.) In addition, over the past 14 years of implementing the 
RCRA program, the Agency has learned more about potential routes of 
release to the environment from various management practices.
    Therefore, for today's proposal the Agency undertook an extensive 
risk assessment that examines numerous exposure pathways, rather than 
just the groundwater ingestion pathway. In selecting the exposure 
pathways, previous rulemakings were used as a guide, as well as other 
special studies by the Agency that implement analyses examining 
numerous pathways. (Tables A-1 and A-2 contain the human and ecological 
pathways, respectively, evaluated in the assessment, and are presented 
in appendix A to today's preamble.) With regard to waste management 
units considered in the assessment, it is important to note that 
because today's proposal establishes criteria for waste to exit the 
Subtitle C system, the assessment evaluated exposures associated with 
managing wastes in non-Subtitle C units. The human and ecological 
receptors considered in the assessment were selected to represent a 
range of behaviors, activities, dietary habits, and trophic levels that 
influence exposure levels.
    The risk assessment supporting this proposal is currently 
undergoing review by the Science Advisory Board and EPA's Office of 
Research and Development. As a result of these reviews, and of comments 
received during the public comment period, it is likely that EPA would 
make changes to the risk assessment or other parts of the rule. Topics 
on which the Agency has received informal comment include the use of 
ecological benchmarks for regulation and the overland transport of 
waste constituents. The Agency, to the extent consistent with the 
schedule negotiated in the consent decree for this rulemaking, would 
publish a supplemental notice proposing any significant changes before 
finalizing the rule.
b. How the Assessment is Structured
    The non-groundwater assessment acknowledges that not all human and 
ecological pathways arise from each 

[[Page 66356]]
source; for example, movement of particles from an active surface 
impoundment is not expected to occur. To account for this, the 
assessment matched the environmental transport pathways with both the 
releases from various types of waste management units and the various 
receptors for the nearly 200 constituents examined. All constituents 
were assessed in all pathways deemed plausible for a given waste 
management unit, if the data permitted. Tables A-3, A-4, and A-5 of 
appendix A show the pathways assessed for each waste management unit, 
human receptors assessed for each pathway, and ecological receptors 
assessed for each pathway, respectively. The assessment estimated the 
constituent-specific concentrations in a waste at the management unit 
that could be expected to result in an acceptable exposure for a human 
or ecological receptor (determined through using the toxicity 
benchmarks discussed in section V.B.), taking into account the various 
pathways by which the constituent may move through the environment from 
the waste management unit to the receptor.
    The waste management units considered in the assessment are not 
all-inclusive but were selected to reflect those that might be commonly 
associated with the management of exited hazardous wastes (from 
wastewaters to nonwastewaters) in non-Subtitle C waste management 
units. These units were identified as commonly used in the management 
of solid wastes in the 1988 Report to Congress entitled Solid Waste 
Disposal in the United States Report. The Agency believes that risks 
posed by other types of management of these exited wastes will be no 
greater than those from the units assessed.
    There is a high degree of variability in the physical and chemical 
properties of the approximately 200 constituents evaluated. An 
understanding of those properties and how they interact with the 
physical and chemical properties that control persistence and mobility 
in the environment is an essential element of the assessment. The 
management units could potentially be located in the range of 
environments that exist across the United States. These environments 
have differing characteristics (e.g., meteorological conditions, soil 
type) that are more conducive for the movement of certain constituents 
in certain pathways than others. For example, an environment with a 
high precipitation and high organic soil content may result in 
significant exposures to fishers by constituents that readily adsorb to 
soils (i.e., have a high log Kow) through erosion of contaminated 
soil and uptake in the food chain. For other pathways, however, an 
environment with these characteristics may result in relatively low 
exposures. The assessment was designed to determine what conditions 
would need to exist to cause higher exposures for each pathway rather 
than developing a scenario and determining all the types of exposures 
and receptors for that scenario. By determining the appropriate 
conditions for which higher exposures from a given pathway will occur, 
the Agency believes that environments where the conditions are not as 
likely for a constituent to move through a pathway are protected.
    The assessment was structured using a deterministic approach. A 
deterministic approach uses a single, point estimate of the value of 
each input or parameter and calculates a single result based on those 
point estimates. The assessment used the best data available to select 
typical (i.e., approximately 50th percentile) and high-end (i.e., 
approximately 90th percentile) values for each parameter or parameter 
group as discussed in Section E.2. below. Sometimes full distributions 
were available but, more commonly, ranges of values or point values 
were available with no description of distributions or variability. If 
there was not a sufficient distribution for the parameter, best 
professional judgement was used in determining typical and high-end 
values (which sometimes would be the maximum).
     The assessment is constructed as a set of calculations that begin 
with an acceptable exposure level for a constituent at a receptor, and 
back-calculates to a concentration in a waste in a management unit that 
corresponds to the acceptable exposure level. For the human receptors, 
the assessment was designed to determine constituent concentrations in 
waste for each waste management unit that would correspond to 
protecting receptors at the high-end of exposure (i.e., above the 90th 
percentile of each of the receptor populations and types of exposures 
being assessed). The Agency estimated waste concentrations 
corresponding to the high-end exposure by identifying four critical or 
sensitive parameters in the source/pathway/receptor equations and using 
high-end input values for those parameters and using central tendency 
values for the remaining parameters. The Agency also estimated central 
tendency (approximately the 50th percentile) and bounding estimates 
(worst-case) of constituent concentrations in waste for each of the 
receptor populations and types of exposures being assessed. For 
ecological receptors, the approximate percentile level of protection is 
difficult to discern. The Agency believes the ecological analysis is 
conservative with respect to the overall assessment endpoint (e.g., 
sustainability of the reproducing populations) because of the way the 
source, fate and transport parameters are set, the dietary habits 
assumed, and how the toxicity benchmarks are developed. However, the 
degree to which this conservativeness transfers to ecosystems is not 
known.
    The steps of the assessment which provide estimates of acceptable 
constituent-specific concentrations in waste include the following:
    Step 1--Specify acceptable risk levels for each constituent and 
each receptor. See Section V.B. in today's preamble for a discussion of 
how benchmarks are set for both human and ecological receptors.
    Step 2--Specify the exposure medium. Using the toxicity benchmarks 
as a starting point and the exposure equations, the assessment back-
calculates the concentration of contaminant in the medium (e.g., beef, 
milk, plant, air, water, soil) that corresponds to the ``acceptable'' 
exposure level. The exposure equations include a quantitative 
description of how a receptor comes into contact with the contaminant 
and how much the receptor takes in through specific mechanisms (e.g., 
ingestion, inhalation, dermal adsorption) over some specified period of 
time. Thus, for the subsistence farmer eating contaminated beef, the 
exposure specifies the amount of beef eaten on a daily basis, the 
period of time over which the contaminated beef is eaten, and 
descriptions for the individual such as body weight and lifetime. For 
this example, the concentration in the beef is what is back-calculated.
    Step 3--Calculate the point of release concentration from the 
exposure concentration. Based on the back-calculated concentration in 
the exposure medium (from Step 2), the concentration in the medium to 
which the contaminant is released to the environment (i.e., air, soil, 
groundwater) for each pathway/receptor was modeled. The end result of 
this calculation is a medium concentration at the point of release from 
the waste management unit.
    Step 4--Calculate the concentration in the waste that corresponds 
to the medium concentration at the point of release. This step depends 
on the characteristics (e.g., area, cover practices, waste consistency) 
of the waste management unit. 

[[Page 66357]]

    The output of the assessment is a range of constituent 
concentrations, reflecting the range of pathway-receptor combinations 
considered for each waste management unit. The lowest concentration 
(per constituent) of this range represents the highest exposure 
pathway-receptor combination for that waste management unit.
c. How Uncertainty is Addressed
    Any analysis of the magnitude used in this rule-making will have 
uncertainty associated with the outputs generated. The uncertainty can 
be associated with the models or equations used and the data relied on 
for the model parameters. In addition, policy assumptions, such as 
waste management units assessed and receptors assessed, may also affect 
the degree of representativeness of the assessment. In order to be 
consistent with Agency policy on the characterization of risk, 
stochastic and deterministic approaches were considered. A stochastic 
approach, such as Monte Carlo analysis, which produces a distribution 
of constituent concentrations, was initially considered due to the 
tremendous interest in, and use of, these techniques in risk 
assessment. However, after evaluation of the models and data available 
for use, the Agency decided to use a deterministic approach for the 
non-groundwater assessment.
    The Agency's deterministic approach used for this assessment, like 
most such approaches, uses point values in all calculations and 
produced point estimates of constituent concentrations for waste in 
each management unit-exposure pathway-receptor combination. However, in 
selecting and developing point values for parameters, EPA considered 
all available data. Wherever possible, the Agency developed both a 
central-tendency and high-end value for each parameter used in the 
assessment. This was not possible in all cases because some parameters 
were a property, such as density of water, and because some values were 
fixed by Agency-wide policy decisions. (For example, EPA used standard 
Agency-wide human toxicity benchmarks and body weights.) EPA then 
calculated constituent concentrations based on a mixture of central-
tendency and high-end values.
    EPA believes that the deterministic approach described above (based 
on identifying critical parameters and using higher-end values only for 
those parameters and central-tendency values for the other parameters) 
allowed it to derive constituent concentrations in waste for each waste 
management unit that are reasonably protective across a range of 
conditions and for a range of receptors. EPA also believes that this 
approach is consistent with EPA's risk assessment policy.
    EPA further believes that the approach chosen allows both the 
Agency and the public to determine more easily which parameters played 
the most critical roles in determining the constituent concentrations 
in waste for each waste management unit. This furthers general 
understanding of the assessment and helps commenters effectively target 
their resources for reviewing what EPA is proposing. It has also helped 
EPA target its own data collection and input selection efforts. It is 
often more difficult to identify critical parameters in a stochastic 
assessment because of the greater number of iterations and because 
results are reported as probability distributions. This is particularly 
true for an analysis with a large number of parameters such as the 
assessment used for this proposed rule.
    EPA notes that stochastic approaches are also consistent with 
Agency risk assessment policy. In fact, EPA applied a stochastic 
``Monte Carlo'' approach to the separate analysis of dilution and 
attenuation of groundwater performed for this proposal. That analysis, 
however, has been under development for many years and EPA is more 
familiar with the underlying data and the relationships between various 
parameters. In addition, the public has had a chance to comment on 
aspects of that analysis in previous rule-makings. EPA was more 
comfortable applying a stochastic analysis for the groundwater analysis 
than a stochastic approach to the non-groundwater analysis.
    EPA believes that it is not necessary to resolve all issues 
relating to the relative merits of the two approaches or to determine 
which approach would be ideal for each of the assessments described 
above. Rather, the debate should focus on whether the approaches chosen 
allowed EPA to reach reasonable regulatory decisions.
    The Agency solicits comment on the use of a deterministic approach 
as described above. Specifically, the Agency seeks comment on whether 
the approach proposed is a reasonable approach for setting protective 
levels across a set of types of management units and exposure pathways.
d. Linkage of the Non-groundwater Risk Assessment to the Groundwater 
Risk Assessment
    In the non-groundwater risk assessment, the pathways involving 
potentially contaminated groundwater (e.g., bathing) are back-
calculated from the receptor to the wellhead (i.e., the assessment 
provides constituent concentrations in the groundwater at the well). In 
order to determine the concentration of a constituent in leachate 
coming from a waste management unit that would result in the estimated 
constituent concentration at the water well, the Agency used a separate 
groundwater fate and transport risk analysis. That analysis is 
described in detail in Section D.8. elsewhere in today's proposal. The 
well concentrations estimated from the pathways involving bathing are 
used as input to the groundwater fate and transport modeling from which 
a leachate concentration is determined.
e. Risk Targets Used
    As previously discussed in Section V.B. of today's proposed rule, 
the Agency used existing toxicity benchmarks when available. However, 
many ecological benchmarks were developed for this rule-making, as 
discussed in Section V.B. of today's proposed rule. As described in 
that section, the Agency used a cancer risk target of 1  x 10-6, 
and a hazard quotient equal to 1 for non-carcinogens. For ecological 
benchmarks, a hazard quotient equal to 1 was used. The Agency solicits 
comment on the risk targets being used for today's proposed rule.
2. Detailed Overview of the Non-groundwater Risk Analysis
    The assessment can be broken down into six components: 
Constituents; toxicity benchmarks; receptors; exposure; fate and 
transport; and waste management units. Each of these components is 
discussed in turn below, except the constituents and toxicity 
benchmarks which were discussed earlier in section V.A and V.B. It is 
important to recognize that the assessment was not able to evaluate all 
constituents in all receptor-pathway-waste management unit combinations 
because of data gaps in either toxicity or chemical properties, or 
inadequate methodologies. Many of these gaps have been identified in 
different sections of the Technical Support Document for the Hazardous 
Waste Identification Rule: Risk Assessment for Human and Ecological 
Receptors'' (denoted ``Uncertainties and Issues of Concern''). The 
Agency requests additional data or other information that would assist 
in filling these gaps.
a. Waste Management Units
    The manner in which constituents are released to environmental 
media and the relative quantity released to each 

[[Page 66358]]
medium will affect the pathways of most concern for a particular 
constituent. The pathway presenting the highest risk to human or 
ecological receptors is not always easily determined because of the 
complex interactions of the waste management unit and its types of 
releases, the physical and chemical properties of the constituent, and 
the properties that control mobility and persistence in a particular 
environmental medium. For some constituents, the management practice 
will determine which exposure pathway is of most concern. For example, 
benzene tends to migrate to both air and groundwater. Upon examining 
the risks from exposure to these two media arising from releases from a 
quiescent surface impoundment, the groundwater ingestion pathway may 
pose the highest risks. But, when examining the risks from these two 
media for releases from an aerated tank, the air inhalation pathway may 
pose the higher risks. Further, the air inhalation risks may even be 
higher than groundwater ingestion risks from the quiescent surface 
impoundment.
    Therefore, and as stated earlier, the selection of non-Subtitle C 
waste management units examined in the assessment attempted to reflect 
both the influence of the type of unit on pathways and those that might 
be commonly associated with the management of exited hazardous wastes 
in non-Subtitle C waste management units. Again, the Agency believes 
that risks posed by other types of management of these exited wastes 
will be no greater than those from the units assessed. The management 
units examined include the following:
     Aerated treatment tanks. Relative to all other types of 
management, aerated tanks containing wastewaters can potentially have 
the most significant releases of volatile organics to air.
     Quiescent surface impoundments. This type of unit 
containing wastewaters also can potentially result in significant 
releases of volatile organic constituents to air. These units also have 
a potential to affect surface water bodies if the unit is not well 
maintained or constructed. The sludges generated, which may contain 
high concentrations of metals and hydrophobic constituents, may impact 
groundwater. (As discussed above, the groundwater fate and transport 
analysis was conducted in a separate analysis.)
     Land application. This type of unit, when used for non-
wastewaters can potentially have significant releases of certain 
constituents to nearby land and surface water bodies through erosion 
and runoff, particularly if run-on and run-off control measures are not 
practiced. In addition, significant releases of volatile organics 
constituents to air are possible. Further, after the unit is closed, 
significant on-site exposures to some persistent and relatively 
immobile constituents may occur as well as continued long-term releases 
to the nearby land and surface water bodies. The Agency believes such 
units will pose higher exposures relative to landfills in all pathways 
except those arising from groundwater. Therefore, the non-groundwater 
assessment did not examine landfills, but they were examined in the 
groundwater fate and transport analysis.
     Ash monofill. This type of unit used for ash disposal can 
potentially have significant releases of particulates to air which may 
be inhaled or may deposit on land and plants, and result in exposure 
through food and soil ingestion.
     Wastepiles. This type of unit used for nonwastewaters can 
have significant releases of particulates to air as well as significant 
releases of particulates through erosion and runoff.
    Each of the pathways that evaluates a receptor using contaminated 
groundwater other than as a source of drinking water (i.e., bathing) 
are back-calculated to a concentration in a drinking water well. The 
pathways are applicable to all of the waste management units modeled 
(except tanks). All of the waste management unit and chemical-specific 
portions of the groundwater fate and transport analysis and subsequent 
estimated leachate concentrations are contained in the Agency's 
separate groundwater fate and transport analysis (see Section E.3 
below).
    One exception to the above discussion of the types of waste 
management units evaluated involves the combustion of wastes. Although 
the Agency attempted to include this type of management in the 
assessment, it became clear that the emissions from combustion are not 
easily predicted from the waste inputs to the units. The combustion 
process both destroys and creates constituents. Although destruction of 
constituents can be predicted based on certain operating 
characteristics of combustion units, the creation of other 
constituents, referred to as products of incomplete combustion (PICs), 
is not easy to predict. It may be possible to make such predictions for 
a specific waste and a specific combustion unit; however, the extensive 
data (e.g., on the variety of combustion units, waste types, 
constituent combinations) needed for the assessment used in this 
rulemaking relating wastes with emissions are not available. Therefore, 
acceptable constituent levels in waste going to a combustion unit could 
not be established. However, the Agency is developing emission 
standards for various types of combustion units and those emission 
standards may be a more appropriate vehicle for addressing combustion.
    In addition, the assessment does not address accidental or 
catastrophic releases, such as transportation accidents or tank 
failures. The Agency determined that, although such releases are 
possible, they are of low probability and non-routine and, therefore, 
are not appropriate for developing exit criteria that apply to all 
wastes.
    The Agency has identified several specific areas giving rise to 
uncertainty in the characterization of the waste management units and 
for which the Agency seeks comment:
    (1) Use of Subtitle D Survey.
     The Agency relied upon data from a 1987 survey of Subtitle 
D facilities to characterize waste management units. That survey, used 
in the 1988 Report to Congress on Solid Waste Disposal in the United 
States, was designed primarily to collect estimates of the following 
parameters:
     Number of establishments that manage Subtitle D wastes on 
site;
     Number of establishments that manage Subtitle D wastes on 
site in land application units, wastepiles, surface impoundments, or 
landfills;
     Number of land application units, wastepiles, surface 
impoundments, or landfills used to manage Subtitle D wastes;
     Amount of Subtitle D wastes managed on site in land 
application units, wastepiles, surface impoundments, or landfills.
    In addition to these parameters, data were also collected for some 
other parameters, such as the area of the waste management units. 
Although the survey was not designed to collect accurate estimates for 
these other parameters, it is the most comprehensive date available to 
characterize these other parameters. One difficulty encountered in 
using these data is that the survey requested information on total area 
or waste quantity for all of each type of units at a facility. The 
total area or waste quantity was divided by the number of each type of 
unit at the facility (number of each unit being one of the primary 
parameters the survey was designed to estimate) to estimate average 
unit area. Further, it is not certain how well the on-site units (which 
are used routinely for wastes generated on-site) reflect the 
characteristics of off-site units. Uncertainty related to the 

[[Page 66359]]
representativeness of the data is important because exited wastes could 
be managed in units off-site as well as on-site. The Agency seeks 
comment on the use of the Subtitle D survey to characterize the waste 
management units.
    In evaluating the waste management unit components of the risk 
assessment, the Agency made certain assumptions when data were not 
available or were incomplete. A description of the waste management 
unit parameters for which there was little to no data is described 
below. The rationale behind these assumptions is presented (e.g., 
results of any sensitivity analyses, references to other work, etc.). 
The Agency requests comment on the specific issues raised for each 
management unit.
(2) Fate and Transport
    Fate processes, particularly biodegradation and hydrolysis, were 
accounted for only in the land application unit since that unit had 
wastes applied intermittently and that unit was being examined for on-
site risks after closure (assuming human occupation of the site begins 
10 years after closure occurs). Because waste is continuously applied 
to the other waste management units, biodegradation and hydrolysis were 
presumed to have minimal influence on the subsequent availability of 
constituents to the above ground pathways. The Agency requests comment 
on not considering biodegradation and hydrolysis in waste management 
units other than the land application unit. The Agency also requests 
comment on the appropriateness of the data and methods used to account 
for the fate and transport of constituents in waste management units, 
with particular emphasis on data and methods of determining 
biodegradation and hydrolysis of constituents in land application 
units.
(3) Ash Monofill
(i) Particle Size Distribution for Air Dispersion Modeling
    A size distribution of ash particles that become airborne from an 
ash monofill was not available. Therefore, a sensitivity analysis was 
performed to assess the importance of the particle size distribution in 
the calculation of air concentrations and deposition rates. Different 
distributions were modeled reflecting a variety of assumptions for 
particle size distributions between PM10 and PM30 classes. The greatest 
deviation among the modeled conditions in the estimated air 
concentration of PM10 was 12 percent; for the estimated deposition rate 
for PM30 the greatest deviation was 59 percent. Given the uncertainties 
and variabilities inherent in the assessment, these variations were 
considered minor, therefore, the Agency assumed an equal distribution 
of particle sizes between the two size classes used in the assessment.
(ii) Monofill Characterization
    Because limited data were available to characterize hazardous waste 
ash monofills, data from municipal waste ash monofills were used. 
However, because ash generation rates for municipal waste incinerators 
ere more than 100 times greater than ash generation rates for hazardous 
waste incinerators and reuse-as-fuel combustors resulting in 
significantly larger municipal monofills, EPA calculated an ash 
monofill volume for this analysis based on generation rates reported in 
the 1988 National Survey of Hazardous Waste Treatment, Storage, 
Disposal, and Recycling Facilities, assumed bulk density of the ash, 
and assumed lifetime of the monofill. The Agency is not certain that 
hazardous waste monofills should be sized in the same manner as 
municipal waste monofills. The Agency also assumed that each waste 
monofill would accept ash from only a single combustor. Accepting 
wastes from more than one combustor may underestimate monofill size.
(iii) Vehicle Traffic
    The estimates of number of ash trucks per day are dependent on the 
size of truck. Limited data were available on the sizes of trucks 
hauling ash. These data were used to characterize a range of truck 
sizes. The truck sizes may either under- or overestimate the size of 
trucks actually used at hazardous waste ash monofills depending on the 
representativeness of municipal waste ash truck sizes.
    No data were available on other vehicular traffic; therefore, these 
values were estimated, introducing additional uncertainty into the 
overall amount of traffic at the ash monofill.
(iv) Emission Equations for Ash Blown From Trucks and During Spreading 
and Compacting
    The emission equation used for ash blown from trucks was developed 
for windblown emissions from storage piles. This was adapted to trucks 
by using the truck speed to estimate frequency of wind greater than 5.4 
m/s. Because this equation was not derived for windblown emissions from 
moving trucks, the results of its application to such emissions are 
uncertain. It may over- or underestimate actual emissions of 
particulates blown from trucks.
    Similarly, the emission equation used for spreading and compacting 
was developed for agricultural tilling. Agricultural tilling was 
thought to approximate the process of spreading and compacting; 
however, the use of this equation may under- or overestimate emissions 
due to spreading and compacting.
(4) Land Application Unit
(i) Particle Size Distribution for Air Dispersion Modeling
    A size distribution of soil particles that become airborne was not 
available. The same assumption was made for soil particles as was done 
for ash particles when modelling the monofill (see above). As described 
above for ash particles, the Agency assumed an equal distribution of 
particle sizes between the two size classes.
(ii) Area of Land Application Unit Relative to Agricultural Field
    The assessment examined the impact of subsistence farming on the 
land application unit beginning 10 years after closure. Based on the 
distribution of sizes for land application units and agricultural 
fields, the Agency selected a combination of fields such that the 
central tendency land application unit (61,000 m2) is smaller in 
area than the central tendency agricultural field (2,000,000 m2). 
The significantly larger size of the agricultural field suggests that 
the model may inappropriately average the constituent concentration 
over the agricultural field. However, the Agency does not believe this 
to be a significant impact on the analysis because: (1) The area of the 
agricultural field is not an explicit input to the model; (2) the size 
of the land application unit is large enough to support a subsistence 
farmer; and (3) this pathway is driven by the assumptions for the high-
end analysis. The Agency requests comment on the relationship between 
the land application unit and the agricultural field.
(iii) Application Rate
    The waste application rate is an important parameter in determining 
the constituent's soil concentration after application. In practice, 
this rate is a function of the characteristics of the waste being 
applied, the characteristics of the receiving soil, the environmental 
conditions, and the purposes for which the waste is being applied. 
Information from the Subtitle D survey was used to calculate the rates, 
since those rates 

[[Page 66360]]
were not expressly requested in the survey. The rates were calculated 
from the area receiving the wastes and the waste quantity applied. This 
introduces uncertainty for it combines rates applicable to both 
treatment of wastes and rates for specific uses (e.g., farming, mine 
reclamation). To account for the potential of having application rates 
be much too high for the site they are being applied to, the data on 
receiving area and waste quantity applied were linked.
(iv) Waste Characteristics
    Limited data were available on the characteristics of wastes being 
land applied. As a result, soil values for most parameters (e.g., 
hydraulic conductivity, moisture retention index) were used to 
characterize nonwastewaters. It is not known to what extent these soil 
values differ from the waste properties.
(v) Depth of Contamination
    Depth of contamination affects the amount of constituent available 
for exposure. For the non-groundwater pathways, only constituents at 
the soil surface were assumed available for each exposure pathway. The 
Agency selected tilling depth as the depth of contamination available 
to the non-groundwater pathways as over time, the depth of the waste 
layer would increase and a portion of the mass of waste would move out 
of the zone available for the surface pathways. The model kept the 
depth of contaminated soil constant that was available for the surface 
pathways. The Agency recognizes that the use of the tilling depth may 
underestimate the depth of contamination in some cases and overestimate 
it in others. Thus, the Agency requests comment on the use of tilling 
depth as a surrogate for depth of contamination.
(vi) Partitioning
    Releases from the land application unit were partitioned among 
volatilization, evaporative losses, hydrolysis, erosion, runoff, and 
leaching. Periodic application of waste was factored into the 
partitioning model during the active life of the unit. Biodegradation 
was factored in during both the active life and closed period. The 
finite source Jury model was used to estimate volatilization emissions. 
The Jury model, which models the convection of constituents caused by 
the flux of water in soil, was used for evaporative losses. Runoff and 
leaching losses were calculated using the soil-water partition 
coefficient (Kd) to determine constituent concentration in the 
soil water and multiplying that by the land application unit area and 
runoff rate for run-off losses or recharge rate for leaching losses. 
(See Technical Support Document for the Hazardous Waste Identification 
Rule: Risk Assessment for Human and Ecological Receptors, Section 7, 
Land Application for full description.)
(5) Waste Pile
(i) Waste Pile Height
    No data were available on this parameter; therefore, the value is 
an estimate based on heights attainable by a front-end loader. This 
parameter is important in the air dispersion modeling, which is 
sensitive to the height of the pile. The Agency requests suggestions 
for alternatives to determining waste pile height and any data which 
would support those determinations.
(ii) Particle Size Distribution for Air Dispersion Modeling
    The same sensitivity analysis and assumptions discussed above for 
ash monofills were used for waste piles. Given that the air dispersion 
analysis is not very sensitive to particle size distribution, the 
simple assumption described above was believed to be an adequate 
approximation for the assessment.
(iii) Waste Characteristics
    Limited data were available on the characteristics of wastes in 
waste piles. As a result, soil values for most parameters (e.g., 
hydraulic conductivity, moisture retention index) were used to 
characterize the nonwastewaters disposed in piles. It is not known to 
what extent these soil values differ from the waste properties. The 
soil values, however, were not used for the ash waste pile. The ash 
disposed in the piles had the same properties as that disposed of in a 
monofill.
(iv) Vehicle Traffic
    The estimates of number of trucks per day are dependent on the size 
of truck and waste quantity. Limited data were available on truck 
sizes. These data were used to characterize a range of truck sizes. 
These truck sizes may either under- or overestimate the size of trucks 
actually used around waste piles.
(v) Emission Equation for Ash Blown from Trucks
    As described in the section above on ash monofills, the emission 
equation used for ash blown from trucks was developed for windblown 
emissions from waste piles. It may over- or underestimate actual 
emissions of particulates blown from trucks.
(6) Surface Impoundment
(i) Two-Phase Sludge Formation Model
    The two-phase sludge formation model simplifies the solids 
concentration gradient in a surface impoundment into two distinct and 
homogeneous layers, a liquid layer with the same average solids content 
as the inflow and a sediment or sludge layer with a much higher solids 
concentration.
(ii) Dilution of Waste During a Spill
    Overflows or breaches associated with surface impoundments are a 
waste release examined in the assessment. The algorithm used for spills 
does not account for dilution of the wastewater caused by excess run-
on. Such run-on is presumably relatively uncontaminated; thus the spill 
volume, consisting partly of contaminated wastewater from the 
impoundment and partly of uncontaminated run-on would have a lower 
concentration than the wastewater in the impoundment. By using the 
concentration in the impoundment, the mass of contaminant released to 
surface water is overestimated. This effect could be considerable for 
the central tendency impoundment, as the quantity of run-on is 
significant compared to the capacity of the central tendency 
impoundment. However, to determine the extent of such dilution, the 
degree to which such run-on becomes mixed with the wastewater would 
need to be estimated. No model has been found to assist in this 
estimation.
(7) Tank
(i) Unit characterization
    Limited data were available on Subtitle D tanks. The assessment 
used the profiles (specifies design and operating parameters) for 
uncovered aerated treatment tanks developed in the Hazardous Waste 
TSDF--Background Information for Proposed RCRA Air Emission Standards 
(TSDF--BID, U.S. EPA, 1991)
(ii) Volatilization
    The Agency used the well-mixed flow model. This model assumes that 
the contents of the system are well mixed and that the equilibrium 
concentration in the system is equal to the effluent concentration. The 
equilibrium concentration is the average concentration throughout the 
unit and the driving force for volatile emissions.
(8) Combustors
    For the reasons stated below, EPA did not modelled a combustion 
unit in the risk analysis for this regulation. EPA, 

[[Page 66361]]
however, asks for comments on that decision.
    In initial analyses (see Multipathway Analysis Background Document 
available through the docket), EPA modeled potential risks from several 
types of combustion units, using engineering judgment to make a best 
estimate for destruction and removal efficiencies for non-hazardous 
waste combustors. Early comments suggested that the assumptions might 
have overstated or understated the estimated risks by not reflecting 
actual practice in industrial boilers or other likely combustion 
facilities not regulated by Subtitle C. However, initial comparisons 
indicated that the combustion risk estimates back-calculated to the 
combustion unit were not often the most significant risk and, 
therefore, would not be the basis for the limiting exit criteria.
    EPA also recognized that there are many issues related to organics 
that are produced during the combustion process, but are not 
necessarily originally in the waste. The amount and type of these 
``products of incomplete combustion'' are generally believed to be 
dependent on a number of aspects of the design and operation of a 
facility, and not easily related to the composition of the wastes fed 
into the combustion unit. For purposes of this proposal, EPA decided 
that because of the high degree of uncertainty associated with 
developing waste concentrations from combustion units, it was not 
appropriate to use risks from combustion as a factor in deciding what 
wastes remain under the hazardous waste regulations. Rather, EPA 
believes there are more appropriate ways to regulate emissions from 
combustion units through various regulatory authorities, including 
regulation of a range of units under the Clean Air Act.
    EPA, however, asks comment on the appropriateness of this approach. 
In particular, there may be some constituents (e.g., certain metals 
that are difficult to capture in pollution control equipment) where a 
better correlation exists between waste input and potential risk from 
combustor emissions than for organics that are in the waste and also 
created as PICs during the combustion process.
b. Fate and Transport
(1) Pathways
    In selecting environmental fate and transport pathways to include 
in the assessment, EPA used as a guide previous rulemakings and other 
special studies by the Agency that examine numerous pathways. For 
example, the Agency has used similar risk assessment methodologies in 
several recent rules including: Wastes from Wood Surface Protection, 
Final Rule (59 FR 458, January 4, 1994); Standards for Use or Disposal 
of Sewage Sludge, Final Rule (58 FR 32, February 19, 1993); Corrective 
Action Management Units, Final Rule (58 FR 29, February 16, 1993); and 
rulemaking efforts on the Pulp and Paper Industry (56 FR 21802, May 10, 
1991 and 58 FR 66078, December 17, 1993).
    The sewage sludge and pulp and paper rulemakings in particular 
examined both human and ecological risk. Other rulemakings under 
development within the Office of Solid Waste also use non-groundwater 
risk assessment methodologies including various hazardous waste listing 
determinations and the dioxin emission rules for hazardous waste 
combustion units. Most of these assessments rely on several Agency 
guidance documents issued in recent years. In January 1990, the Agency 
issued an interim report, Methodology for Assessing Health Risks 
Associated with Indirect Exposure to Combustor Emissions (EPA/600/6-90/
003 and referred to as the Indirect Exposure Document). This document 
served as the basis for further development of non-groundwater pathway 
assessments by the Agency. In November 1993, the Agency issued an 
Addendum to the Indirect Exposure Document that updated and revised 
portions of the methodology presented in the Indirect Exposure 
document. In April 1994, OSW issued a draft implementation guidance 
entitled Implementation Guidance for Conducting Indirect Exposure 
Analysis at RCRA Combustion Units. In June 1994, the Agency released a 
review draft of Estimating Exposure to Dioxin-Like Compounds: Volumes 
I-III (EPA/600/6-88/005C), which presents an extensive and expanded 
version of the Agency's previous multiple pathway exposure assessments. 
Finally on November 16, 1994, the Agency issued Draft Soil Screening 
Guidance (59 FR 59225), which presents a multiple pathway assessment 
using air, groundwater, and soil pathways for soil screening levels at 
Superfund sites. The risk assessment presented relies on the 
methodologies presented in these Agency guidance documents to maintain 
consistency with previous Agency efforts.
    Based on these efforts by the Agency in conducting non-groundwater 
pathway assessments, comments by reviewers on previous draft versions 
of the risk assessment, and some screening analyses to identify 
pathways that are either very similar or unimportant compared to other 
pathways, the Agency selected the human and ecological exposure 
pathways presented in Table A-1 (human exposure pathways) of appendix A 
and Table A-2 (ecological exposure pathway) of appendix A. These 
exposure pathways are described in greater detail in the Technical 
Support Document for the Hazardous Waste Identification Rule: Risk 
Assessment for Human and Ecological Receptors.
    Tables A-1 and A-2 presents four columns: column 1 (exposure 
media), identifies the medium, such as air or soil, to which the 
receptor is exposed; column 2 (route of exposure), identifies the 
route, such as inhalation or ingestion, by which a receptor is exposed 
to the exposure medium; column 3 (type of fate and transport), 
classifies the pathway by the primary mode of fate and transport of the 
contaminant to the exposure medium, including direct air, air 
deposition, air diffusion, groundwater, overland, and soil; and column 
4 (exposure scenario), identifies the compartments in the pathway 
(e.g., source to air to humans), and describes the exposure scenario 
(e.g., inhalation of volatiles).
    The fate and transport pathways examined can be grouped into six 
types of initial release and movement away from a waste management 
unit, as follows:
     Direct air pathways--air emissions of volatiles and 
respirable (PM10) particulates;
     Air deposition pathways--air emissions of particulates 
that deposit on soil or plant surfaces;
     Air diffusion pathways--air emissions that, while in the 
vapor phase, diffuse directly into surface water or plants;
     Groundwater--groundwater releases (These are the pathways 
that link to the separate groundwater fate and transport analysis that 
then links to the waste management units.);
     Overland pathways--overland transport (i.e., surface 
runoff and soil erosion) to surface water or transport by soil erosion 
to off-site fields;
     Soil pathways--on-site soil exposures.
    There are three types of pathways not included in the analysis. 
Pathways involving the use of contaminated water (groundwater and 
surface water) for irrigation were removed due to modeling difficulties 
that could not be resolved, however early results indicated these are 
not the most significant pathways for any of the waste management 
units. Pathways involving the deposition of contaminated particles 
directly onto 

[[Page 66362]]
surface water bodies were not included because previous efforts by the 
Agency have shown these pathways not to be as significant when compared 
to particle deposition onto the watershed and subsequent erosion to the 
surface water body. Pathways involving wet deposition were not 
examined. An air model recently developed evaluates the impact of wet 
deposition and was not available to use at the time of this proposed 
rule. This new model also was addressing problems with the area 
component of earlier models. When the model is available, the Agency 
will determine whether its use will have an impact on the proposed exit 
criteria. If the Agency determines that there will be an impact, it 
will provide an opportunity for public comment on use of the updated 
model.
    As stated earlier, not all exposure pathways were evaluated for all 
waste management units. Constituents may be released from each waste 
management unit by a variety of mechanisms. Each release mechanism may 
be associated with certain exposure pathways. By examining the release 
mechanisms assumed for each waste management unit and identifying the 
exposure pathways associated with those release mechanisms, the 
appropriate pathways to be modeled for each waste management unit were 
identified. The exposure pathways modeled for each waste management 
unit are presented in Table A-5 of appendix A.
b. Equations
    Since the objective of the assessment was to generate acceptable 
levels in waste rather than determining risks posed by waste, the 
equations, which are designed to calculate risks, had to be turned 
around or run in reverse. The assessment began with a target risk (or 
acceptable risk to the receptor) that was used to back-calculate what 
constituent concentration in a waste would not exceed the target risk.
    Wherever appropriate, the equations used in the back-calculation 
were taken from Methodology for Assessing Health Risks Associated with 
Indirect Exposure to Combustor Emissions (U.S. EPA, 1990x; hereafter, 
the Indirect Exposure document, or IED) as modified by the November 10, 
1993, draft of Addendum: Methodology for Assessing Health Risks 
Associated with Indirect Exposure to Combustor Emissions, Working Group 
Recommendations (U.S. EPA, 1993x; hereafter, the Addendum). The 
Addendum is currently being revised based on comments from the Science 
Advisory Board and is being combined with the IED to generate a single 
methodology guidance document. Therefore, the equations may change 
after that revision is completed. If this occurs, the assessment used 
for this rule-making will be revised. If such a revision is needed and 
occurs, the Agency will provide an opportunity for public comment on 
those changes. For convenience, the methodology presented in the IED as 
modified by the Addendum will be referred to as the Indirect Exposure 
Methodology, or IEM.
    The equations presented in the IEM were modified to estimate the 
soil concentration for constituents eroding to an off-site field. The 
IEM did not address this pathway because it was developed for stack 
emissions from combustors rather than releases from land-based units. 
However, because soil erosion is a critical release pathway for this 
analysis, the Agency applied the Universal Soil Loss Equation (USLE) 
and other equations presented in the IEM to calculate soil erosion to 
the off-site field. However, the application of these equations 
resulted in concentrations greater at the receptor than in the waste 
management unit. This phenomenon, first noted in the Dioxin 
reassessment, occurred because the equations assumed that the amount of 
uncontaminated soil that was eroded into the field was negligible in 
comparison to the total mass of soil in the field. Therefore, the 
Agency modified these equations to reflect erosion of uncontaminated 
soil together with the constituents.
    Certain modifications to the equations used in the assessment were 
made for dioxin-like compounds to reflect the different behavior of 
these constituents in the environment. These modifications were based 
on Estimating Exposure to Dioxin-like Compounds, Volume III: Site-
Specific Assessment Procedures (U.S. EPA, 1994x), hereafter referred to 
as the Dioxin document. The Dioxin document defines dioxin-like 
compounds as ``* * * compounds with nonzero Toxicity Equivalency Factor 
(TEF) values as defined in the 1989 International scheme * * * [which] 
assigns nonzero values to all chlorinated dibenzodioxins (CDDs) and 
chlorinated dibenzofurans (CDFs) with chlorines substituted in the 
2,3,7,8 positions. Additionally, the analogous brominated compounds 
(BDDs and BDFs) and certain polychlorinated biphenyls (PCBs) have 
recently been identified as having dioxin-like toxicity * * * and thus 
are also included in the definition of dioxin-like compounds.''
    Although the modifications presented in the Dioxin document may be 
applicable to other highly lipophilic compounds, in keeping with this 
definition, the modifications for dioxin-like compounds were made only 
for 2,3,7,8-TCDDioxin Toxicity Equivalents (TEQs), and PCBs. Other 
dioxin congeners are addressed through the 2,3,7,8-TCDDioxin TEQ. The 
Agency solicits comment on not using these modifications for other 
highly lipophilic compounds.
(3) Specific Issues on Pathways and Equations
    Below are specific issues of the risk assessment related to the 
modeling of the fate and transport pathways on which the Agency is 
requesting comment on their use, improvements to them, or alternative 
ways to model them. A detailed discussion of these aspects is in 
Section 6, Fate and Transport Modeling, of the Technical Support 
Document for the Hazardous Waste Identification Rule: Risk Assessment 
for Human and Ecological Receptors. (Air emission and dispersion 
modeling is discussed in Section 7, Waste Management Units, in the 
technical support document. To be consistent, issues related to that 
modeling were presented earlier in this preamble in Section D.2.a.)
(i) Hydrolysis
    The Agency accounted for fate processes (e.g., biodegradation, 
hydrolysis) and transport processes (e.g., volatilization) for 
constituents throughout their movement from the point at which the 
constituent leaves the waste management unit until it reaches the 
location at which contact with the receptor occurs. During an initial 
screen, the Agency identified four constituents that were known to 
hydrolyze completely or rapidly. These constituents were not included 
in the detailed assessment and include: Benzotrichloride (98-07-7); 
maleic anhydride (108-31-6); phthalic anhydride (85-44-9); and 1,2-
diphenylhydrazine (122-66-7). In addition, 16 inorganic salts known to 
dissociate completely were also not assessed. These included: Calcium 
cyanide (592-01-8); copper cyanide (544-92-3); potassium cyanide (151-
50-8); potassium silver cyanide (506-61-6); silver cyanide (506-64-9); 
sodium cyanide (143-33-9); thallium (I) carbonate (6533-73-9); thallium 
(I) chloride (7791-12-0); thallium (I) nitrate (10102-45-1); thallium 
(I) sulfate (7446-18-6); zinc cyanide (557-21-1); zinc phosphide (1314-
84-7); cyanogen bromide (506-68-3); cyanogen chloride (506-77-4); 
hydrogen cyanide (74-90-8); and thallium acetate (563-68-8). The Agency 
solicits comment on not assessing these constituents. 

[[Page 66363]]

    Of the 192 constituents evaluated in the non-groundwater analysis, 
the Agency directly accounted for chemical hydrolysis for 18 
constituents. For the remaining constituents, hydrolysis was not 
considered for the following reasons: The constituent has no 
hydrolyzable chemical group; hydrolysis is not expected to be important 
or significant; the degradation half-life of the chemical, which 
includes hydrolysis, is greater than one year; or, there was no data 
available for the constituent.
    The extent to which fate and transport processes play a role in the 
removal of a constituent from a pathway, or its movement from one 
environmental compartment to another is determined by site-specific 
environmental conditions as well as chemical-specific parameters. To 
simplify the analysis, the Agency used fate and transport data based on 
one set of environmental conditions to represent all possible spatial 
and temporal environments encountered in any given exposure pathway. 
The Agency solicits comments on this simplification for modeling fate 
and transport processes throughout the exposure pathways considered in 
the MPA.
(ii) Other Fate and Transport Processes
    Fate and transport processes other than hydrolysis may be important 
in determining the concentration of a constituent reaching a receptor. 
The Agency's approach to incorporate consideration for these other 
processes involved the use of biodegradation and volatilization rates 
into the fate and transport pathways, when applicable. The Agency 
recognizes that the rate for many chemical-specific fate and transport 
processes (in particular, biodegradation) varies with characteristics 
of the environment (e.g., temperature, soil type). However, the Agency 
simplified the non-groundwater analysis by applying chemical-specific 
fate and transport rates generically across environmental settings 
found in the various exposure pathways. This simplification may 
overestimate the exit level in some instances and underestimate the 
exit level in other instances. The Agency solicits comments on this 
simplification for modeling fate and transport processes throughout the 
exposure pathways considered in the non-groundwater analysis.
(iii) Bioavailability
    With regard to the metals examined in the risk assessment, there is 
considerable uncertainty about their bioavailability that affects their 
fate, transport, and uptake in various media (e.g., plant tissue, 
animal tissue) and receptors. Speciation and associated solubility of 
metal species in wastes which contain metals are key factors that 
influence the bioavailability of metals. The Agency had no information 
on the speciation, solubility, or availability of the metals in the 
wastes in which they are disposed or how they may transform in the 
environment. The Agency assumed that the metals were in a soluble form, 
mobile, and available. In the absence of this information, the Agency 
assumed that metals are soluble, mobile, and bioavailable. The Agency 
seeks comment on this approach, and requests data on the speciation and 
solubility of metals in wastes, together with the conditions of the 
waste (e.g., pH) that could be disposed by the methods considered in 
this rulemaking and methodologies that account for the transformation 
of the metals through changing environmental conditions.
(iv) Meteorological Data
    The approach for setting central-tendency and high-end 
meteorological conditions in the risk assessment was to evaluate sets 
of meteorological data from a variety of locations, and then select 
locations that reflect central tendency or high-end conditions for a 
given exposure pathway.
    The Agency used the set of 29 meteorological stations identified 
during its efforts to develop soil screening levels for Superfund 
sites. These are considered representative of the United States. 
Central-tendency and high-end locations were then selected from these 
29 locations for the exposure pathways where meteorological conditions 
were required as input to the models; these were the air pathways and 
overland pathways. The meteorological data were evaluated as location 
sets as opposed to individual parameters. Once locations were selected, 
the annual average values for those locations were used.
    For air pathways, which required data on wind speed, wind 
direction, temperature, sunshine, cloud cover, and air mixing height, 
selection of meteorological data was waste management unit-specific and 
based on extensive sensitivity analysis. EPA considered only the effect 
of meteorological data on emissions and dispersion in selecting 
locations for air pathways. However, for consistency, once a pair of 
high-end and central tendency locations were selected for a pathway, 
any meteorological data used in that pathway were selected to 
correspond to the locations chosen, even in any overland transport 
component of the pathway.
    Overland pathways were driven by soil erosion, for which the 
critical meteorological input is the Universal Soil Loss Equation 
(USLE) rainfall factor (R). Therefore, to select central tendency and 
high-end locations for overland pathways, the 29 locations were ranked 
based on the rainfall factor, and the 50th and 90th percentile 
locations chosen for all overland pathways.
    See Section 6.8, Fate and Transport Inputs and Section 7.1.5. Air 
Modeling, of the Technical Support Document for the Hazardous waste 
Identification Rule: Risk Assessment for Human and Ecological Receptors 
for a detailed discussion of how meteorological data were selected and 
used. The Agency solicits comment on how meteorological data was 
selected and used in the risk assessment.
(v) Soil Data
    A variety of soil parameters were required for the modeling. These 
parameters are interdependent and vary with the type of soil (e.g., 
loam, clay). However, values for these parameters also vary within a 
soil type. Due to the interdependence of the parameter, the Agency 
chose to maintain them as a set and determine a central-tendency 
property set and a high-end property set.
    The Agency used loam type soils to characterize all soils simulated 
in the risk assessment because these types of soils are fairly 
prevalent in the United States. All soils are composed of varying 
percentages of sand, silt, and clay. Loam, by definition, is composed 
of equal proportions of sand, silt, and clay; therefore, it represents 
a combination of each of the physical properties of the individual soil 
textures. Central tendency and high-end values were selected from the 
range of values for loam soil so that each individual soil parameter 
required by the model is consistent with a loam soil. (Sec Section 6.8, 
Fate and Transport Inputs, in the Technical Support Document for the 
Hazardous Waste Identification Rule: Risk Assessment for Human and 
Ecological Receptors for more detail.) The Agency solicits comments its 
approach for characterizing soil in the assessment.
(vi) Soil Pathways
    The Agency seeks comment on the following issues related to the 
modeling of soil pathways:
     Use of the Universal Soil Loss Equation to predict soil 
erosion in a generic application - This is a widely-used model intended 
for site-specific 

[[Page 66364]]
applications where specific input data can be used for relatively small 
fields. Its use in a generic application, and for fairly large waste 
management units, may overestimate quantities of soil eroded.
     Handling of the Soil Loss Constant - This term is the sum 
of loss rates for leaching, erosion, runoff, biodegradation, 
hydrolysis, and volatilization. Possible uncertainties may arise 
because: the assessment assumes that these terms are first-order decay 
rates and therefore can be added together; loss processes are 
calculated independently, even though they may occur simultaneously.
     Use of the Soil Water Content Equation to predict soil 
water content in a generic application - The equation is from the 
Superfund Exposure Assessment Manual (U.S. EPA, 1988x), and was 
developed for site-specific applications.
     Area of garden and agricultural field - No data were 
available on the size of home gardens, gardens on subsistence farms, or 
yards of residential lots (for soil ingestion). Therefore, a single set 
of central tendency and high-end values was estimated for these, based 
on best professional judgment; this set is referred to as garden area, 
even though it might also apply to a yard. Because a larger area leads 
to greater dilution of deposited or eroded contaminant, a high-end 
garden would be one that was relatively small.
     Areas for agricultural fields were estimated from data in 
the 1992 Census of Agriculture (U.S. Department of Commerce, 1992). The 
Census gives average farm acreage by State for 48 States (the data are 
not yet complete for the two missing States). No percentile data were 
available. These data do not distinguish between commercial and 
subsistence farms.
     Mixing Depth--Mixing depth reflects the depth of soil to 
which deposited or eroded contaminant is mixed. It is important to 
distinguish between soil that is tilled for agricultural purposes and 
soil that is untilled in determining appropriate mixing depth values. A 
smaller mixing depth results in less dilution of a constituent, and 
therefore higher soil concentrations; therefore, a high-end mixing 
depth would be smaller than a central tendency mixing depth.
(vii) Surface Water Pathways
    Water column as well as benthic sediment concentrations were 
estimated. Water column concentr
FR Doc. 95-29458 Hazardous Waste Management System: Identification and Listing of Hazardous Waste: Hazardous Waste Identification Rule (HWIR)
ations include dissolved, sorbed to 
suspended sediments, and total (sorbed plus dissolved, or total 
contaminant divided by total water volume). Benthic sediment 
concentrations included: Dissolved in pore water, sorbed to benthic 
sediments, and total. The model accounts for three routes of 
constituent entry into the water-body were examined: Sorbed to soils 
eroding into the water-body; dissolved in runoff water; and diffusion 
of vapor phase contaminants into the water-body. Air deposition of 
constituents bound to particles into a water-body was not examined 
because earlier analysis demonstrated that its contribution would be 
negligible when compared to that of eroding particles. Volatilization 
of dissolved constituents and removal of constituents through burial in 
bed sediments were modeled as loss processes.
    Important assumptions made for the surface water modeling included: 
Water-body sufficiently large to support certain ecological receptors; 
sufficient fish to support a subsistence fisher; uniform mixing within 
the water-body (this tends to be more realistic for smaller water-
bodies as compared to large river systems); and equilibrium is 
established between constituents within the water column, bed 
sediments, and air.
    The Agency seeks comment on the following issues related to the 
modeling of surface water pathways:
     Water-body/Watershed Characterization--The water-body 
characterization parameters are another example of a set of parameters 
that are interdependent and therefore were used as a group. Watershed 
characterization relates to the water-body (in the case of the 
assessment, a stream) characterization. Streams are characterized 
(flow, water-body area, watershed area, depth, and various other 
parameters) by their ``order.'' A first-order stream has no tributary 
channels; a second-order stream forms when two first-order streams 
converge, and so on through stream order 10. The Agency used a stream 
order 4 as the high-end estimate because EPA believes this stream order 
would be among the smallest stream orders that would support sufficient 
fish or a subsistence fisher and the receptors assessed. A stream order 
5 was used as the central-tendency estimate based on the number of 
streams within each stream order. (See Section 6.8 in the Technical 
Support Document for the Hazardous Waste Identification Rule: Risk 
Assessment for Human and Ecological Receptors for more detail.)
     Total Suspended Solids--Total suspended solids (TSS) can 
range from 1 to 100 mg/L with a typical value being 10 mg/L for streams 
and rivers. This value is used as the central tendency value. No data 
on frequency of values in actual streams was available to estimate a 
90th percentile value. Since 80 mg/L is believed to be the maximum 
tolerable value for aquatic life; this value was used as the high-end 
value.
     Bed Sediment Concentration--The bed sediment concentration 
term is analogous to the bulk density for soil in that it describes the 
concentration of solids in terms of a mass per unit volume. A single 
value of 1 kg/L was used in the assessment given that this is 
considered a reasonable value in most situations and the range is quite 
narrow, 0.5 to 1.5 kg/L.
     Gas-Phase Transfer Coefficient--The gas-phase transfer 
coefficient is used to estimate volatile losses from the water-body. 
Volatile losses are calculated using a two-layer resistance model that 
incorporates a gas-phase transfer coefficient and a liquid-phase 
transfer coefficient. Both transfer coefficients are controlled by flow 
induced turbulence in flowing systems. The liquid-phase transfer 
coefficient is calculated based on chemical-specific properties. A 
single value of 36,500 m/yr. was used. There is some uncertainty 
related to setting this parameter to a single value that is not 
chemical specific. It is reasonable to assume that chemical properties 
affecting volatility would have some effect on this value, although it 
is not known how large such an effect would be.
     Fraction Organic Carbon in Bottom Sediment--The fraction 
organic carbon in bottom sediment is derived from the fraction organic 
carbon in watershed soils. For a fraction organic carbon of about 0.01 
in the watershed, the fraction organic carbon for bottom sediments is 
typically 0.03 to 0.05. The midpoint of this range, 0.04, divided by 
the fraction organic carbon of the watershed (0.01) derives a 
multiplier of 4 for calculating fraction organic carbon in bottom 
sediments from fraction organic carbon in watershed soils. The fraction 
organic carbon values used of 0.024 and 0.008 correspond to the central 
tendency and high-end values for soil fraction organic carbon of 0.006 
and 0.002, respectively. The fraction organic carbon in the bottom 
sediments was varied with the fraction organic carbon in soil.
(viii) Food-Chain Pathways
    The Agency seeks comment on the following issues related to the 
modeling of food-chain pathways: (Please note the fish uptake 
methodology is described below in Section D.2.c.2), Ecological 
Receptors and Exposure; the littoral methodology is used for humans): 

[[Page 66365]]

     Use of regression equations based on Kow to derive 
biotransfer factors for plants--The biotransfer factors are based upon 
empirical relationships with Kow defined by studies on relatively few 
chemicals.
     The lack of accounting for translocation of contaminants 
within plants--The plant uptake models do not account for translocation 
of contaminants (should such a translocation occur) from one part of a 
plant to another. The Agency is considering two models developed by 
Stephan Trapp, plantx and plantE, and solicits comment on their use.
     Use of regression equations based on Kow to derive 
biotransfer factors for beef and milk--The biotransfer factors for beef 
and milk are based upon empirical relationships with Kow defined by 
studies on relatively few chemicals.
c. Receptors
    Both human and ecological receptors are considered in the 
assessment. The human receptors evaluated were selected to represent a 
range of behaviors and activities that influence exposure levels. The 
Agency believes that these represent typical and more exposed types of 
behaviors and activities that might exist around waste management units 
or media contaminated by releases from waste management units. Each 
receptor was evaluated for individual exposure pathways (i.e., exposure 
to multiple pathways was not included). For ecological receptors, 
populations or communities were selected for the generic terrestrial 
and freshwater ecosystems based on behavior patterns such as dietary 
habits (plant-eater vs. meat-eater) as well as qualities such as 
significance and representativeness with respect to trophic structure 
in the ecosystem (bald eagle). The selection of ecological receptors 
was limited by the level of characterization available such as food 
intake and body weight. Again, the Agency believes that these represent 
the types of organisms that might exist around waste management units 
or media contaminated by releases from waste management units.
(1) Human Receptors and Exposure
    Human receptors assessed in the assessment included the following:
     Adult resident living in the vicinity of a management 
unit--This individual is representative of the general population in 
the United States and is evaluated independently through the following 
potential exposure pathways: Inhalation, ingestion of contaminated 
soil, ingestion of contaminated drinking water, dermal contact with 
contaminated soil, and dermal contact during bathing. In addition, the 
analysis evaluates exposures to an adult resident living on-site of a 
land application unit begining 10 years after closure of the unit.
     Child resident living in the vicinity of a management 
unit--Children are a special population considered in certain pathways 
because of their low body weight compared to high intake rates or 
surface area. A child is evaluated through the following potential 
exposure pathways: ingestion of contaminated soil, dermal contact with 
contaminated soil, and dermal contact during bathing.
     Home Gardener--This individual represents a sub-population 
that supplements their fruit and vegetable consumption with fruits and 
vegetables they grow on contaminated land.
     Subsistence Fisher--This individual represents a sub-
population that subsists on contaminated fish.
     General Fish Consumer--This individual represents a sub-
population that consumes contaminated fish and supplements their intake 
with other non-contaminated foods.
     Subsistence Farmer--This individual represents a sub-
population that grows or raises most of their own food on contaminated 
land. This individual is evaluated independently through the following 
exposure pathways: beef ingestion, milk ingestion, and fruit and 
vegetable ingestion.
     On-site Worker--This individual represents the working 
population that may be found at the waste management units. This 
individual is evaluated during the active phase of the unit for the 
following on-site exposures: Inhalation and dermal contact with 
contaminated soil.
    Each of the receptors has been matched with the most relevant 
exposure routes. Table A-3 in appendix A shows the pathways were 
modeled for each receptor.
    As previously discussed, the assessment begins with a target human 
toxicity benchmark and exposure assumptions tailored to each receptor, 
and back-calculates to constituent-specific concentrations in each 
media. In characterizing the exposure, two exposure parameters are set 
to high-end values and the rest of the exposure parameters are set to 
central tendency or default values. The two high-end exposure values 
were typically exposure duration and a parameter affecting intake of, 
or exposure to, a contaminant (e.g., fraction contaminated, consumption 
rate, inhalation rate).
    The exposure equations used for back-calculating media 
concentrations are based on standard risk equations used in most Agency 
risk assessments. For all inhalation and ingestion pathways, these 
equations were adapted from Risk Assessment Guidance for Superfund 
(RAGS): Volume I--Human Health Evaluation Manual (Part B, Development 
of Risk-based Preliminary Remediation Goals) (U.S. EPA, 1991x; 
hereafter, RAGS Part B) and subsequent modifications. For dermal 
pathways, which are not covered in RAGS Part B, the equations presented 
in Dermal Exposure Assessment: Principles and Applications, Interim 
Report (U.S. EPA 1992x; hereafter, the Dermal document) were used; this 
document reflects the current techniques for assessing dermal exposure. 
The Agency requests comment on the data sources and assumptions used in 
the human exposure portion of the risk assessment, described in detail 
in Section 5.0 of the Technical Support Document for the Hazardous 
Waste Identification Rule: Risk Assessment for Human and Ecological 
Receptors.
    The Agency seeks comment on the following types of human exposure 
that were not examined:
     Ingestion of contaminated water by humans while bathing or 
swimming--The ingestion rate of water while swimming or bathing is 30 
times smaller than the normal consumption rate of water used in the 
drinking water ingestion pathways; therefore, the drinking water 
ingestion pathways should be protective of the incidental water 
ingestion pathways.
     Inhalation of volatiles while bathing--No appropriate, 
chemical-specific equations could be found to address this pathway.
     Ingestion of airborne particulates--The ingestion rate of 
soil used in the soil ingestion pathways is many times larger than the 
ingestion rate from airborne particulates; therefore, the soil 
ingestion pathways should be protective of the ingestion of airborne 
particulates. Also, given the way the soil ingestion rates were 
empirically derived, ingestion of airborne particulates should, in 
effect, be accounted for in the estimated soil ingestion rates.
     Ingestion of contaminated soil by resident on active 
site--While the waste management units are active, it is assumed that 
access is limited to workers.
(2) Ecological Receptors and Exposure
    In addition to the human receptors, ecological receptors were 
evaluated in the assessment. Lacking an Agency precedent for the 
selection of ecological 

[[Page 66366]]
receptors for a generic analysis, a simple framework was developed for 
ecological receptor identification based on EPA's Framework for 
Ecological Risk Assessment (U.S. EPA, 1992x). During the problem 
formulation phase, a suite of ecological receptors was selected to 
include species that represent each of the trophic levels or feeding 
habits within an ecosystem. At best, one can only infer that an 
ecosystem is protected from chemical stressors. In addition, the 
toxicological data support the evaluation of individuals, populations, 
and occasionally communities, but are inadequate to address the 
complexities of an ecosystem in most cases. Thus, the approach taken in 
the assessment was to estimate protective levels for the populations 
and communities (inferred from the measurement endpoints used) found in 
generic ecosystems. The species included in the ecological assessment 
encompass a wide range of dietary preferences, sizes, and trophic 
levels.
    In selecting ecological receptors for the assessment, a number of 
ecosystem types (e.g., lakes, streams, estuaries, deserts, forests, 
grasslands) were considered because the waste could be disposed 
anywhere once it has exited the Subtitle C system. Two generic 
ecosystems were designed: A freshwater-based ecosystem and a 
terrestrial-based ecosystem. Specific details of these ecosystems are 
described in Section 3, Receptors, in the Technical Support Document 
for the Hazardous Waste Identification Rule: Risk Assessment of Human 
and Ecological Receptors. The Agency solicits comment on both the 
adequacy of the design of the ecosystems used in the assessment and the 
use of generic ecosystems to assess potential ecological hazards.
    Generally, ecological receptors were identified at different 
trophic levels as well as at different levels of biological 
organization and included species of relatively low ecological 
significance but high societal relevance (e.g., American kestrel). The 
final selection of receptors was based primarily on the availability of 
data with which to assess the risks to that receptor. As suggested in 
the Framework for Ecological Risk Assessment (1992x), the process of 
selecting appropriate assessment endpoints was iterative, including 
information from the other activities included in the assessment 
phase--the characterization of ecological effects. The ecological 
receptors included in the assessment were:
     Mammals--Mammals were evaluated for both generic 
ecosystems and include upper trophic level predators such as the mink 
or red fox, lower trophic level consumers such as the whitetail deer, 
and insectivores such as the meadow mole; species were selected to 
represent a variety of body sizes, habitats, and dietary habits for 
which data on body weight, food intake, etc., are available. Mammals 
may be exposed by eating contaminated prey items (e.g., fish, other 
vertebrates, insects) or plants, through incidental ingestion of 
contaminated soil while eating or preening, or through lactation or 
placental transfer.
     Birds--Birds were also evaluated for both generic 
ecosystems and include upper trophic level predators such as the red-
tailed hawk and lower trophic level consumers such as the American 
robin; species were selected to represent a variety of body sizes, 
habitats, and dietary preferences for which input parameters (e.g., 
body weight, diet, ingestion rates) are available. Birds are exposed 
through the ingestion of contaminated prey items (e.g., fish, worms), 
through incidental ingestion that occurs while eating or preening, or 
through maternal transfer to eggs.
     Terrestrial Plants--Vascular plants that might be common 
in a generic terrestrial ecosystem were evaluated. The species of 
plants used to represent plants within the terrestrial ecosystem were 
determined by the availability of data and included primarily forage 
grasses and food crops. Plants are exposed through soil-to-root uptake, 
deposition on the surface of leaves or bark, and during air-to-leaf 
transport of volatile or semi-volatile constituents.
     Soil Community--Representative species for the soil 
community were based on six metrics for measuring ecological function: 
(1) Location, (2) size, (3) abundance, (4) taxon richness, (5) trophic 
structure, and (6) energy metabolism. Organisms living in or on the 
soil are exposed through direct contact (e.g., insects), through the 
ingestion of contaminated soil (e.g., earthworms), and through the 
ingestion of other soil dwellers (e.g., centipedes). The Agency 
solicits comment on the representative species selected to comprise the 
soil community.
     Fish--Given the small percentage of freshwater species for 
which toxicological data are available, all species of freshwater fish 
were considered as potential receptors, regardless of size or dietary 
habits. Fish are subject to continuous exposure to contaminated water 
via gill exchange and may be exposed to bioaccumulative chemicals 
through the food chain.
     Aquatic Invertebrates (Daphnids)--Aquatic invertebrates 
are believed to be among the most sensitive aquatic species (Suter, 
1993x), daphnids were selected to represent free living aquatic 
invertebrates. Continuous exposure to contaminated water is considered 
the primary route of exposure.
     Aquatic Plants--Vascular aquatic plants and algae typical 
of aquatic ecosystems were evaluated. Aquatic plants are exposed during 
sediment-to-root uptake and through water-to-leaf transport.
     Benthic Community--Representative species include 
organisms that fall within any of the eight taxonomic genera used in 
the development of the Ambient Water Quality Criteria for the 
protection of aquatic life. Because these organisms spend most (if not 
all) of their lives in the sediment, they are exposed through direct 
contact and ingestion of contaminated sediments as well as through the 
ingestion of other sediment dwellers.
    Each of these receptors has been matched with the exposure pathways 
and waste management units likely to result in exposure. Table A-4 of 
appendix A shows which pathways were modeled for each receptor. The 
Agency solicits comment on the use of a single species to represent 
major trophic elements.
    The development of medium-specific concentrations for the 
protection of ecological receptors was based on ingestion of 
contaminated vegetation, water, soil, or prey or through continual 
contact with a contaminated medium (e.g., aquatic invertebrates with 
water or soil fauna with soil).
    Numerous studies have demonstrated the capacity of hydrophobic 
organic chemicals to bioaccumulate in the food chain that are orders of 
magnitude above the concentration in the contaminated medium (e.g., 
Oliver and Niimi, 1988x). However, it is important to recognize that 
food-chain pathways may be significant even for constituents that do 
not bioaccumulate appreciably. Dietary exposure to constituents that 
concentrate weakly in fish tissue (e.g., bioconcentration factor below 
10) may be more significant than exposure to contaminated drinking 
water simply because a particular animal may ingest relatively more 
fish than water.
    For constituents that bioaccumulate, particularly those that 
biomagnify, benchmarks should account for exposure through the 
ingestion of contaminated prey as well as contact with or ingestion of 
contaminated media. The majority of toxicological studies examined a 
single route of exposure and seldom considered the potential increase 
in exposure concentrations through successive 

[[Page 66367]]
trophic levels. As a result, toxicity benchmarks for bioaccumulative 
constituents cannot be used as acceptable medium exposure 
concentrations; exposure estimates must incorporate the bioaccumulation 
potential in the food chain. For nonbioaccumulating constituents, where 
toxicity benchmarks that are medium specific (i.e., concentration 
units--mg/kg or mg/L)) can be used as acceptable medium concentrations 
for ecological receptors (e.g., Ambient Water Quality Criteria).
    In the aquatic ecosystem, for bioaccumulative chemicals (log 
Kow>4), bioaccumulation factors (BAFs) were estimated using models 
developed by Thomann (1989x) for the limnetic (or pelagic) food chain 
and Thomann et al. (1992x) for the littoral food chain (i.e., sediment-
based). However, for constituents with log Kow above 6.5, only 
measured values were used. The Agency is considering using the Gobas 
model since it can be used for constituents with log Kow above 
6.5. Further, switching to the Gobas model would be consistent with the 
Great Lakes Initiative which recently switched to that model. The 
results produced by either the Thomann models or the Gobas model are 
very similar. The tissue concentration (TC) was estimated for prey 
based on the intake, body weight, and dietary preference (i.e., trophic 
level of fish consumed) of the representative predator species. 
Protective surface water concentration was calculated by dividing the 
tissue concentration (TC) by the bioaccumulation factor for the 
appropriate trophic level. For nonbioaccumulative chemicals, the 
protective surface water concentration for fish and aquatic organisms 
was the Final Chronic Value (FCV) or Secondary Chronic Value (SCV) as 
described in Section 4 of the Technical Support Document for the 
Hazardous Waste Identification Rule: Risk Assessment for Human and 
Ecological Receptors. For upper trophic level aquatic wildlife such as 
mink and osprey, protective surface water concentrations were 
calculated based on the consumption of contaminated fish and water. The 
benthic community was included in the littoral ecosystem. Protective 
sediment concentrations were estimated using the equilibrium 
partitioning (Eqp) methods developed by Di Toro et al. (1991x). As 
explained in Section 4 of the Technical Support Document for the 
Hazardous Waste Identification Rule: Risk Assessment for Human and 
Ecological Receptors, the sediment benchmark was calculated by 
multiplying the FCV (or SCV) by the octanol/carbon partition 
coefficient (Koc) and adjusting for the fraction organic carbon 
(foc) in the sediment. EPA requests comment on the selection of 
the bioaccumulation model, the potential switch to the Gobas model, 
BAFs used, dietary assumptions, and how tissue concentrations were 
calculated.
    For receptors in the generic terrestrial ecosystem, methods used 
represented a range of dietary habits across trophic levels for 
wildlife, including plants and organisms that live in the soil (i.e., 
soil fauna). (See the discussion on the development of soil and plant 
benchmarks elsewhere in today's rule.) For higher trophic level 
wildlife, dietary preferences, daily intake, and bioconcentration 
factors for prey items were identified or estimated to calculate 
protective soil concentrations. The key equation used to back-calculate 
soil concentrations as a function of dietary exposure (including soil 
ingestion), and the exposure inputs (e.g., body weights, daily intake) 
for ecological receptors are discussed in Section 5.3 of the Risk 
Assessment. The Agency requests comment on the equations and inputs 
used in the generic terrestrial ecosystem modeling.
    The following types of exposure were not assessed in the 
assessment:
     Inhalation by ecological receptors--No suitable 
methodology was available.
     Dermal contact with soil--No suitable methodology or 
sufficient toxicity data were available.
     Dermal contact with water--No suitable methodology or 
sufficient toxicity data were available.
3. Groundwater Fate and Transport Modeling
    In the risk analysis previously described in the section, the 
pathways involving groundwater are only modeled (back-calculated) to 
the wellhead, i.e., to the point of exposure at a water well. For 
groundwater modeling from the waste management unit (i.e., surface 
impoundment) to the water well, the Agency used a separate fate and 
transport analysis. This section describes the groundwater model and 
the modeling procedures for the various waste management scenarios for 
the groundwater path. The details of the model and the modeling 
procedures are presented in the background documents (USEPA, 1995 a-f).
    The Agency has developed specialized subsurface fate and transport 
modeling for four waste management options: (1) Landfills; (2) surface 
impoundments; (3) waste piles; and (4) land application units. All four 
waste management scenarios assume that the waste if exempted could be 
managed in the respective RCRA Subtitle D units. In deriving the 
exemption levels, the Agency needs to evaluate the fate and transport 
of constituents from the waste unit to the nearby drinking water wells. 
The potential migration of constituents from a waste unit to the 
leachate at the bottom of the waste unit can be simulated by the 
laboratory test, the Toxicity Leaching Procedure (TCLP), or the 
Synthetic Precipitation Leaching Procedure (SPLP), Method 1312. 
Although one procedure may be more applicable for some wastes than the 
other procedure, as described on page 21483 of the Federal Register 
Notice of May 20, 1992 (57 FR 21450), the Agency is soliciting comments 
on the applicability and use of one test over the other for this 
proposal.
    The fate and transport of constituents in leachate from the bottom 
of the waste unit through the unsaturated zone and to a drinking water 
well in the saturated zone is estimated using a fate and transport 
model. The Agency proposes to use EPACMTP (EPA's Composite Model for 
leachate migration with Transformation Products) for this purpose. The 
EPACMTP considers not only the subsurface fate and transport of 
chemical constituents, but also the formation and the fate and 
transport of transformation (daughter) products. The Agency also 
solicits comments on the technical correctness and applicability of the 
model and the data for this proposal.
    The Agency proposed the use of a subsurface fate and transport 
model (EPASMOD) on June 13,1986 (51 FR 21648) in the Toxicity 
Characteristic (TC) Rule. However, after receiving numerous comments, 
the Agency revised the model and the data used in the model (53 FR 
28692) and the enhanced model (EPACML) was used in the TC Final Rule 
(55 FR 11798). The EPACMTP replaces the EPACML for use in this 
proposal. The EPACMTP was recently published in a refereed journal 
(Kool, Sudicky and Saleem, Journal of Contaminant Hydrology 17(1994) 
69-90) and has been reviewed by the EPA's Science Advisory Board (SAB). 
The SAB commended the Agency for making for its significant 
improvements to the model. They also stated that it represents the 
state of the art for such analyses. However, they also recommended 
additional testing of the model.
    The modeling approach used for this proposed rulemaking includes 
three major categories of enhancements over the EPACML and the approach 
for the TC rule. The enhancements fall into the 

[[Page 66368]]
following categories: (1) Incorporation of additional fate and 
transport processes (e.g., degradation of chemical constituents); (2) 
Use of enhanced flow and transport solution algorithms and techniques 
(e.g., three-dimensional transport); and (3) Revision of the Monte 
Carlo methodology (e.g., site-based implementation of available input 
data). A discussion of the key enhancements which have been implemented 
in the EPACMTP is presented here and the details are provided in the 
background documents (USEPA, 1995a-g). The Agency is soliciting 
comments on the modeling enhancements and the modeling methodology as 
well as on the values derived for individual chemical constituents:
(1) Fate and Transport Processes
    Effects of groundwater mounding underneath waste unit.--The EPACML 
was limited to conditions of uniform groundwater flow. It could not 
handle accurately the conditions of significant groundwater mounding 
and non-uniform groundwater flow due to a high rate of infiltration 
from the waste units. These conditions increase the transverse 
horizontal as well as the vertical spreading of a contaminant plume. 
The EPACMTP accounts for these effects directly by simulating 
groundwater flow in the vertical as well as horizontal directions 
(USEPA, 1995 a).
    Transformation products.--The EPACMTP model has capability to 
simulate the formation and fate of multiple transformation products (up 
to seven) in the unsaturated as well as in the saturated zones. For 
constituents which have toxic transformation products, the EPACMTP can 
provide an assessment of the groundwater impact of the transformation 
products, along with that of the parent constituent. This methodology 
has been implemented for hydrolyzing organic constituents included in 
this proposal.
    Fate and transport of metals.--The EPACMTP can simulate fate and 
transport of metals, taking into account geochemical influences on the 
mobility of metals. The EPA's MINTEQA2 (USEPA, 1995 f) metals 
speciation model is used to generate effective sorption isotherms for 
individual metals, corresponding to a range of geochemical conditions. 
The transport modules in EPACMTP have been enhanced to incorporate the 
nonlinear MINTEQ sorption isotherms. This enhancement provides the 
model with capability to simulate, in the unsaturated and in the 
saturated zones, the impact of Ph, leachate organic matter, natural 
organic matter, iron hydroxide and the presence of other ions in the 
groundwater on the mobility of metals.
(2) Enhanced Solution Algorithms and Techniques
    Linkage between unsaturated zone and saturated zone modules.--The 
saturated zone module implemented in the EPACML was based on a Gaussian 
distribution of concentration of a chemical constituent in the 
saturated zone. The module also used an approximation to account for 
the initial mixing of the contaminant entering at the water table 
underneath the waste unit. The approximate nature of this mixing factor 
could sometimes lead to unrealistic values of contaminant concentration 
in the groundwater close to the waste unit, especially in cases of a 
high infiltration rate from the waste unit. The enhanced model 
incorporates a direct linkage between the unsaturated zone and 
saturated zone modules which overcomes these limitations of the EPACML.
    Numerical transport solution modules.--To enable a greater 
flexibility and range of conditions that can be modeled, the analytical 
saturated zone transport module has been replaced with a numerical 
module, based on the highly efficient state-of-the-art Laplace 
Transform Galerkin (LTG) technique. The enhanced module can simulate 
the anisotropic, non-uniform groundwater flow, and transient, finite 
source, conditions. The latter requires the model to calculate a 
maximum receptor well concentration over a finite time horizon, rather 
than just the steady state concentration which was calculated by the 
EPACML. The saturated zone modules have been implemented to provide 
either a fully three-dimensional solution, or a highly efficient quasi-
3D solution. The latter has been implemented for Monte Carlo 
applications and provides nearly the same accuracy as the fully three-
dimensional option, but is more computationally efficient. Both the 
unsaturated zone and the saturated zone transport modules can 
accommodate the formation and the transport of parent as well as of the 
transformation products.
    Solution for nonlinear metals transport.--A highly efficient semi-
analytical unsaturated zone transport module has been incorporated to 
handle the transport of metals in the unsaturated zone and can use 
MINTEQA2 derived linear or nonlinear sorption isotherms. Conventional 
numerical solution techniques are inadequate to handle extremely 
nonlinear isotherms. An enhanced method-of-characteristic based 
solution has been implemented which overcomes these problems and 
thereby enables the simulation of metals transport in the Monte Carlo 
framework. Non-linearity in the metals sorption isotherms is primarily 
of concern at higher concentration values; for low concentrations, the 
isotherms are linear or close to linear. Because of the attenuation in 
the unsaturated zone, and the subsequent dilution in the saturated 
zone, concentrations in the saturated zone are usually low enough so 
that properly linearized isotherms are used by the model in the 
saturated zone without significant errors.
    Elimination of biases in determination of receptor well location.--
The internal routines in the model which determine placement of the 
receptor well relative to the areal extent of the contaminant plume 
have been revised and enhanced to eliminate bias which was present in 
the implementation in the EPACML. The calculation of the areal extent 
of the plume has been revised to take into consideration the dimensions 
of the waste unit. The logic for placing a receptor well inside the 
plume limits has been improved to eliminate a bias towards larger waste 
unit areas and to ensure that the placement of the well inside these 
limits, for a given radial distance from the unit, is truly randomly 
uniform. However, for this proposal, the closest drinking water well is 
located anywhere on the downgradient side of the waste unit and the 
Agency is soliciting any comments on this procedure.
(3) Revisions of Monte Carlo methodology for nationwide assessment
    Data sources.--The data sources from which parameter distributions 
for nationwide Monte Carlo assessments are obtained have been 
evaluated, and where appropriate, have been revised to make use of the 
latest data available for modeling. Leachate rates for Subtitle D waste 
units have been revised using the latest version of the HELP model with 
the revised data inputs. Source specific input parameters (e.g., waste 
unit area and volume) have been developed for various different types 
of industrial waste units besides landfills. Input values for the 
groundwater related parameters have been revised to utilize information 
from a nationwide industry survey of actual contaminated sites.
    Finite-source methodology.--The original version of the model was 
implemented for Monte Carlo assessments assuming continuous source 
(infinite source) conditions only. This methodology did not take into 
account the finite volume and/or operational life of waste units. The 
EPACMTP model has been 

[[Page 66369]]
implemented for Monte Carlo assessments of either continuous source or 
finite source scenarios. In the latter scenario, predicted groundwater 
impact is not only based on the concentrations of contaminants in the 
leachate, but also on the amount of constituent in the waste unit and/
or the operational life of the unit. The Monte Carlo methodology was 
enhanced to allow determination of regulatory threshold levels for 
these two waste characteristics USEPA, 1995.
    Site-based regional analysis.--The Monte Carlo methodology has been 
fundamentally revised and enhanced to account for the interdependency 
among the various model input parameters based on regional 
distributions. The original methodology simply assumed that a waste 
site could be located anywhere in the US, and that the probability 
distributions of individual model parameters (e.g., infiltration rate, 
depth to groundwater, etc.) at any waste site were mutually independent 
and given by their nationwide frequency distributions. The model 
therefore only had limited capability to account for correlations and 
dependencies among the model parameters. To address this limitation, a 
site-based methodology has been implemented, based on the OSW's surveys 
of existing waste facilities in the US, and their geographical 
locations. The information of geographical location is used in this 
enhanced approach to select the other model parameters, such as 
infiltration rate and hydrogeological characteristics. A number of 
different sources were reviewed for the development of the site-based 
approach. Four of these sets were selected to derive the regional 
characteristics of the more important parameters for each sampled site: 
The OSW's survey of industrial waste management units (EPA, 1986); the 
infiltration and recharge analysis performed for U.S. climatic regions; 
the U.S. Geological Survey inventory of groundwater resources; and the 
API's (American Petroleum Institute) survey of hydrogeologic parameters 
for the different groundwater environments in the U.S.
(4) Implementation of EPACMTP
    The specific modeling options selected for the modeling analyses 
are summarized in Table 3 below. All modeling analyses were conducted 
in the finite source, Monte Carlo mode, for four industrial Subtitle D 
waste management scenarios. The groundwater fate and transport model 
was used to predict the maximum concentration at a receptor well placed 
down gradient from the waste unit. A 10,000 years time limit was 
imposed on the exposure time period, i.e., the calculated concentration 
is the highest exposure concentration occurring within 10,000 years 
following the initial release from the waste unit. The Monte Carlo fate 
and transport simulation provides a probability distribution of 
receptor well exposure concentrations as a function of waste and 
leachate concentrations. For this proposal, the groundwater modeling 
results were used to derive leachate concentration thresholds. For 
carcinogenic constituents, the exposure concentration calculated by the 
model corresponds to the maximum 30-year average receptor well 
concentration. For non-carcinogenic constituents, the peak receptor 
well concentration is used. The regulatory threshold leachate 
concentration limits were determined using a back-calculation 
procedure, to correspond to an approximate 90th percentile protection 
level. This means that the closest downgradient drinking-water wells at 
90% of the industrial Subtitle D waste management units would have 
water concentrations below the HBN/MCL. The wells further away at 90% 
of the sites would be protected at higher protection levels. The wells 
at the other 10% of the sites would be protected at lower protection 
levels.
    The Agency uses a 95th percentile protection level in the RCRA 
Delisting program and the 85th percentile for the toxicity 
characteristic program. These two programs have slightly different 
goals from the exemption proposed today. The recently developed 
Superfund soil-screening levels use a 90th percentile protection level 
to identify sites at which no additional investigation for possible 
remediation is required. The exit proposed today is similar to the 
soil-screening levels program. Today's proposed exit is intended to 
identify wastes no longer needing Subtitle C management. Finally, the 
90th percentile was chosen because it is nearly consistent with the 
protectiveness level in the other pathways of the multipath risk 
assessment performed for today's proposal as far as could be 
identified.
    Table 3 provides a summary of the methodology and/or data sources 
used to obtain values for the source-specific parameters, chemical-
specific parameters, unsaturated zone parameters, saturated zone 
parameters, and receptor well location parameters. Because the 
groundwater pathway analysis was performed in Monte Carlo mode, all 
parameters are in principle described by their probability 
distributions. Details on the actual distributions used are provided in 
the background documents (USEPA, 1995a-g). Probability distributions 
used for the unsaturated zone parameters, the saturated zone 
parameters, and receptor well location parameters were the same for all 
waste management scenarios and individual constituents that were 
analyzed for today's exit.
(5) Waste Management Scenarios
    The waste management unit represents the source term in the fate 
and transport model for the waste management scenarios evaluated for 
groundwater contamination. In the modeling framework, the source is 
defined in terms of four key parameters: (i) Waste unit area, (ii) 
Leachate flux (infiltration) rate, (iii) Leachate concentration, and 
(iv) Duration of leachate pulse. The first of these parameters, waste 
unit area, was determined from the nationwide OSW survey of industrial 
Subtitle D waste management facilities (USEPA, 1995 a-b). After 
screening out records with unreliable waste site area and/or volume, 
the OSW Industrial Subtitle D survey provides data on location, area 
and volume of 790 landfills, 1655 surface impoundments, 774 waste 
piles, and 311 land application sites nationwide. The weighted 
distributions of waste unit characteristics used as input to the model 
are based on the results of the survey.
    The leachate flux, or infiltration rate, and duration of the 
leachate pulse are determined from the design and operational 
characteristics of the waste management scenario being modeled. 
Consideration of a leachate pulse of finite duration is a fundamental 
aspect of the present analysis and distinguishes it from the continuous 
source (infinite source) assumption used for the 1990 Toxicity 
Characteristic (TC) Rule (55 FR 11798). It should be emphasized though 
that the results of the finite source analysis are not necessarily 
different from those of the continuous source analysis. If the source 
leaching duration is long enough to drive the maximum receptor well 
concentration to its steady state value, the finite source and 
continuous source analyses are in fact the same. In practice, the 
distinction between continuous source and finite source analysis is the 
most important for chemicals which are subjects to sorption, 
speciation, and/or degradation, including hydrolyzing organics and 
metals.
    The leachate concentration of specific constituents in the waste 
forms the basis for regulating the wastes. The leachate concentration 
is not specified a-priori, but rather it is back-calculated at the end 
of the Monte Carlo analysis to satisfy the regulatory criterion that 
the 

[[Page 66370]]
maximum groundwater exposure concentration should be at, or below, the 
constituent-specific health-based drinking water standard, in at least 
90 % of the cases.
    The following sections present background on the determination of 
the source parameters for each waste management scenario.
    Landfills.--The key characteristic of the landfill scenario is that 
the duration of the leachate pulse is independent of the operational 
life of the waste management unit, i.e., the period of time required to 
fill the landfill. The landfill is taken to be filled to capacity and 
covered when leaching begins. The time period during which the landfill 
is filled-up, usually on the order of 20 years, is considered to be 
small relative to the time required to leach all of the constituent 
mass out of the landfill. The model simulation results indicate that 
this assumption is not unreasonable; the model calculated leaching 
duration (see below) is typically on the order of several hundred 
years.
    The leachate flux, or infiltration rate, is determined using the 
HELP model. The net infiltration rate is calculated using a water 
balance approach, which considers precipitation, evapo-transpiration, 
and surface run-off. The HELP model was used to calculate landfill 
infiltration rates for a representative subtitle D landfill with 2-foot 
earthen cover, and no liner or leachate collection system, using 
climatic data from 97 climatic stations located throughout the US. 
These correspond to the reasonable worst case assumptions as explained 
in the Risk Assessment Background Document (USEPA, 1995b). The model 
calculates the daily water balance for the total period for which 
climatic data are available. For each waste site in the OSW survey, an 
infiltration rate was calculated using the data from the closest 
climate station (USEPA, 1995b).
    In the landfill scenario, the duration of the leaching period is 
not prescribed. Instead it is calculated as part of the Monte Carlo 
simulation from the total mass of constituent in the landfill, and the 
rate of leaching. This relationship is derived from a straight-forward 
mass balance principles. The methodology is documented in the 
Background Document for the Finite Source Procedure (USEPA, 1995-c); 
only the most salient aspects are presented here.
    The duration of the leachate pulse, Tp, is determined by the 
total mass of constituent that is initially present in the landfill, 
and the rate at which the constituent is removed by leaching:

Aw . d . Fh . Phw . CW=Aw . I . CL . 
TP
or
TP={d . Fh . Phw} over {I} CW over CL where
    Aw=Area of the waste unit (m\2\),
    d=Depth of waste unit (m),
    Fh=Fraction of waste unit volume occupied by this waste,
    Phw=Density of the waste (g/cm\3\),
    I=Leachate flux (Infiltration) rate (m/y),
    CW=Constituent waste concentration (mg/kg), and
    CL=Constituent leachate concentration (mg/L).

    The determination of Tp according to (2) tacitly assumes that 
the constituent does not degrade inside the waste unit, does not 
consider removal by mechanisms other than leaching (e.g., 
volatilization), and assumes that all of the constituent mass will 
eventually leach out. The formulation given above also assumes that the 
leachate concentration, CL, remains constant until all of the 
constituent mass has leached out. The methodology was adapted to handle 
a time-varying leachate concentration, e.g., a gradually diminishing 
leachate concentration to represent the depletion of the contaminant 
mass in the landfill over time. If it is assumed that the leaching of 
the constituent from the waste into the water phase is controlled by a 
linear equilibrium partitioning process, the reduction of the leachate 
concentration with time can be modeled as a first-order decay process 
(EPA, 1995c):

CL(t)=CL0e{-t}
where
    CL0=Initial leaching concentration (mg/L)
    =Apparent decay constant (y-1)
    t=Time (y)

The rate at which the leachate concentration is reduced is determined 
by the coefficient , which is given by:

={I} over [{d FhwPhw}{CW over CL0}]

Using (3), the leachate concentration will gradually and asymptotically 
be reduced to zero. The total amount of constituent that is released 
into the subsurface will be the same whether a constant leachate 
concentration of finite duration, or a gradually diminishing leachate 
concentration is assumed. In the latter case, the duration of the 
release period is longer, but the average leachate concentration lower, 
as compared to the former case.
    It can be seen from either (2) or (4) that the duration of the 
leachate pulse, or the rate of depletion, respectively, can be 
expressed as a function of the initial leachate concentration, CL. 
For the modeling analyses, equation (3) was used for organic 
constituents. The underlying assumption that the concentration is 
controlled by linear equilibrium partitioning is reasonable for organic 
constituents. For metals, the pulse release option (equation 2) with 
constant leaching concentration was used.
    The calculation of Tp (or ) requires a number of 
ancillary source and waste parameters. These are the depth of the waste 
unit (d), the fraction of the waste unit occupied by the waste 
(Fh), and the waste density (Phw). The waste unit depth is 
obtained directly from the OSW waste site survey. The survey provides 
data on both landfill areas and volumes, which allows the depth to be 
calculated for any landfill selected during the Monte Carlo simulation. 
The fraction of waste in the landfill is assigned a uniform 
distribution with lower and upper limits of 0.036 and 1.0, 
respectively, based on analysis of waste composition in Subtitle D 
landfills (EPA, 1995). The lower bound assures that the waste unit will 
always contains a minimum amount of the waste of concern. The waste 
density is assigned a value based on reported densities of hazardous 
waste, and varies between 0.7 and 2.1 g/cm\3\ (EPA, 1995c).
    Surface Impoundment.--The surface impoundment waste management 
scenario is that of a non-hazardous waste industrial impoundment. The 
area of the impoundment is obtained from the OSW Subtitle D Industrial 
Survey (USEPA 1995 b). No direct data is available on the rate of 
infiltration from surface impoundments. The rate of infiltration from 
the impoundment is calculated inside the EPACMTP fate and transport 
model. The rate of infiltration is calculated, using Darcy's Law, as a 
function of surface impoundment depth, and hydraulic conductivity and 
thickness of a low-permeability sediment layer at the base of the 
impoundment.
    Impoundment depth is obtained from the OSW survey, for each 
impoundment site in the survey, in the same way as the landfill depth 
is obtained (see above). The sediment layer at the base of the 
impoundment is taken to be 2 feet thick, and have an effective 
equivalent saturated conductivity of 10-7 cm/s . These values were 
selected in recognition of the fact that most non-hazardous waste 
surface impoundments do have some kind of liners in place (USEPA, 
1995b). During the Monte Carlo fate and transport simulation, the 
infiltration rate is calculated using the impoundment depth value for 
the specific unit selected for each Monte Carlo realization.
    The leachate concentration again is not determined a priori, but is 
determined after the analysis, based on 

[[Page 66371]]
the desired regulatory protection level (90th percentile). The surface 
impoundment is taken to have a 20-year operational life. After this 
period, the impoundment may be filled in, or simply abandoned. In the 
latter case, the waste in the impoundment will drain and/or evaporate 
relatively quickly. In the modeling analysis, the duration of the 
leaching period is therefore set equal to 20-years.
    Waste Pile.--The waste pile management scenario is conceptually 
similar to that of the landfill, but differs in a number of key 
aspects. In contrast to landfills which represent a long-term waste 
management scenario, waste piles represent a more temporary management 
scenario. During the operational life of the waste pile, it may be 
regarded as an uncovered landfill. Typically at the end of the active 
life of a waste pile, the waste material is either removed for land 
filling, or the waste pile is covered and left in place. If the waste 
is removed, there is no longer a source of potential contamination. If 
a waste pile is covered and left in place, it then becomes equivalent 
to a landfill, and consequently is to be regulated as a landfill. For 
the analyses, therefore, only the groundwater impacts associated with 
the period that the waste pile is active, are considered.
    Data on the waste pile area are obtained from the OSW Subtitle D 
survey. Infiltration rates for the waste pile are obtained by treating 
the waste pile as an uncovered landfill. HELP model derived landfill 
infiltration rates assuming a sandy loam soil cover were used to assign 
infiltration rates for waste piles. A sandy loam cover represents the 
most permeable cover considered for the landfill scenario, and most 
closely resembles a situation in which no cover is present. The 
methodology for assigning an infiltration rate to any specific waste 
pile in the OSW survey follows that used for landfills (see above).
    An active life of 20 years is assumed for the waste pile. This also 
determines the duration of the leaching period. As with the landfill 
and surface impoundment scenario, the leachate concentration is 
determined at the end of the analysis, to satisfy the regulatory 
protection level.
    Land Application Units.--Data on the location, area and waste 
application rates at industrial land application sites were obtained 
from the OSW survey of industrial Subtitle D sites. Location-specific 
infiltration rates were estimated for each land application site by 
applying the HELP model, using climatic data from the nearest climate 
station. Because wastes applied at land application sites typically 
have a high liquid content, this factor was accounted for in the water 
balance calculations. An annual waste application rate of six inches of 
waste, containing 85% water was assumed. This is typical of sludges 
which constitute a large fraction of waste at land application sites. 
Therefore, an additional 5.1 inches of water were added to the natural 
precipitation for the water balance evaluation at each land application 
site.
    The leaching duration for the land application unit was set to 40 
years, consistent with the release period modeled for the air pathway. 
No reliable data were available for the active life of land application 
units. Using a longer value than for surface impoundments and waste 
piles is warranted because part of the applied waste material may 
remain in the soil at the end of the active life of a land application 
unit, and may continue as a source of contaminant leaching.
(6) Determination of Regulatory Waste and Leachate Concentration Limits
    The objective of the Monte Carlo fate and transport analysis is the 
determination of regulatory limits for the concentration of individual 
toxic constituents in the leachate, CL. These limits are 
determined so as to satisfy the regulatory criterion that disposal of a 
waste in a subtitle D waste management unit should not lead to an 
exceedance of the health-based value or the drinking water standard, at 
a receptor well placed down gradient from the waste unit, in at least 
90% of the cases.
    The CL limits are specific to each waste management scenario, 
and are also constituent specific. CL limits are constituent 
specific because of their dependence on constituent specific health-
based standards, as well as on constituent specific fate and transport 
characteristics that affect the concentration received at the receptor 
well. The latter factors are discussed in the following section; this 
section discusses the determination of regulatory CL thresholds.
    Using Equation (2) or (3) and (4), the groundwater exposure 
concentration calculated by the fate and transport model can be 
expressed as a function CL. All other parameters used in the 
modeling analysis are obtained from prescribed probability 
distributions. Consequently, by comparing the predicted exposure 
concentration to the appropriate regulatory standard, e.g., health-
based value or a drinking-water standard, threshold levels of CL, 
can be calculated. Wastes for which the leachate concentration exceeds 
the CL threshold would not be exempted. Because the Monte Carlo 
analysis produces a probability distribution of exposure 
concentrations, the back-calculation of CL threshold levels can be 
performed for any desired level of protection.
     For those constituents that degrade (see next subsection) and 
produce toxic degradation products, the development of regulatory 
threshold values for CL considers not only the exposure 
concentration and toxicity of the parent constituent, but also the 
exposure concentration and toxicity of toxic transformation products. 
For instance, consider two waste constituents that have similar 
toxicity values, i.e., similar health-based levels, as well as similar 
fate and transport characteristics, so that they show comparable values 
for the model simulated receptor well exposure concentration. However, 
if one of the two chemicals produces toxic off-spring, but the other 
chemical does not, the chemical which has toxic daughter products will 
have more stringent limits for CL.
(7) Chemical--Specific Fate and Transport Processes
    The Monte Carlo fate and transport analysis considers chemical-
specific sorption and hydrolysis (degradation) characteristics. These 
characteristics directly affect the model-predicted groundwater 
exposure concentration. Chemicals which are subject to sorption and/or 
hydrolysis will exhibit lower exposure concentration as compared to 
non-sorbing, non-degrading chemicals. This translates into higher 
regulatory waste and concentration limits. Two broad groups of 
chemicals are considered under today's proposal. They are organic 
constituents and metals.
    Organic Constituents.--Organic constituents account for the largest 
group of chemicals addressed under today's proposal. The groundwater 
pathway analyses were performed for a total of 222 organic 
constituents. The fate and transport analysis accounts for sorption of 
organics onto soil and aquifer organic matter, as expressed by a 
chemical-specific organic-carbon partition coefficient (Koc), and 
degradation due to hydrolysis reactions, as expressed by chemical-
specific hydrolysis constants. Sorption is modeled as a reversible, 
linear equilibrium process. Degradation due to hydrolysis is modeled as 
a first-order kinetic process. The groundwater pathway analysis 
utilizes a comprehensive set of Koc values and hydrolysis rate 
constants compiled by the EPA-ORD (Environmental Fate 

[[Page 66372]]
Constants for Organic Chemicals Under Consideration for EPA's Hazardous 
Waste Identification Projects , EPA/600/R-93/132). Chemicals with 
identical Koc values and hydrolysis constants will exhibit the same 
fate and transport behavior, and given the same leachate concentration 
and leaching period, they will result in the same exposure 
concentration. Note, however, that they may still have different 
regulatory leachate concentration limits, if they have different 
health-based drinking water standards and/or produce toxic 
transformation products.
    For the groundwater pathway analysis, organic constituents with a 
hydrolysis half-life of 6,900 years or less (first-order degradation 
rate of 10-4 or greater) were classified as degraders, the 
remainder were classified as non-degraders. The EPACMTP can simulate 
the formation and subsequent fate and transport of transformation 
daughter products, enabling the groundwater exposure concentrations of 
any toxic transformation products to be determined and, therefore, 
included in the determination of leachate concentration thresholds.
    It has been established, by analyzing modeling results for 
different constituents with a range of sorption and degradation 
characteristics that, after normalizing the results against the 
chemical-specific HBN/MCL, the effect of sorption and degradation on 
the regulatory values can be expressed as a function of the Koc and 
hydrolysis rate coefficients, using a straight-forward scaling 
relationship. After these relationships have been established, it is 
not actually necessary to conduct the Monte Carlo fate and transport 
computer simulations for each individual constituent. Instead, for each 
waste management scenario of concern, a set of reference CL values 
are generated by running the Monte Carlo model for a selected range of 
values of Koc and hydrolysis rate coefficients using a normalized HBN/
MCL of 1 mg/L. Constituent-specific CLMIN values are then 
determined in two steps: First, the reference curves are scaled to the 
constituent specific Koc value, and (for degraders) hydrolysis rate 
coefficients. Secondly, an adjustment is made for the constituent-
specific value of the drinking water standard. The final values of 
CLMIN are obtained by multiplying the concentration limits 
based on the normalized drinking water standard, by the actual value of 
the drinking water standard of that particular constituent. For 
constituents with toxic transformation products, this procedure is 
repeated for the transformation products, to find the minimum values of 
CL (CLMIN) which ensure that the exposure concentrations 
of the parent constituent and any daughter products will not be 
exceeded. The benefit of this approach is that if additional 
constituents are to be regulated, or a different value of the drinking 
water standard HBN/MCL, the appropriate CLMIN can be 
determined with less effort, because it is not necessary to repeat the 
time-consuming complete Monte Carlo simulation.
    Metals.--Fate and transport of metals in the subsurface may be 
controlled by complex geochemical interactions. To account for these 
processes, the OSW has developed and implemented a modeling approach 
which utilizes the MINTEQA2 metals speciation model in conjunction with 
the EPACMTP subsurface fate and transport model. The MINTEQ model has 
been applied to generate effective sorption isotherms reflecting 
variations in four geochemical master variables affecting metals fate 
and transport. These factors are: Ph, leachate organic matter natural 
organic matter in the soil or aquifer, and ironhydroxide content. Each 
of these parameters has a range of values, reflecting their nationwide 
probability.

                                       Table 3.--EPACMTP Modeling Options                                       
----------------------------------------------------------------------------------------------------------------
                                                                                                                
----------------------------------------------------------------------------------------------------------------
Management Scenarios..........................................................  Industrial Subtitle D: (i)      
                                                                                 Landfill; (ii) Surface         
                                                                                 Impoundment; (iii) Waste Pile; 
                                                                                 and (iv) Land Application Unit.
Modeling Scenario.............................................................  Finite Source Monte Carlo.      
Regulatory Protection Level...................................................  90% (yields an approximate DAF  
                                                                                 of 10 for a continuous source  
                                                                                 landfill).                     
Source Parameters:                                                                                              
    Waste Unit Area...........................................................  Site based, form OSW Industrial 
                                                                                 Subtitle D Survey.             
    Waste Unit Volume.........................................................  Site based, from OSW Industrial 
                                                                                 Subtitle D Survey.             
    Infiltration Rate:                                                                                          
        Landfill..............................................................  Site-based, derived from water  
                                                                                 balance using HELP model.      
        Surface Impoundment...................................................  Site-based, derived from        
                                                                                 impoundment depth using Darcy's
                                                                                 law.                           
        Waste Pile............................................................  Site-based derived from water   
                                                                                 balance using HELP model.      
        Land Application Unit.................................................  Site-based, derived from water  
                                                                                 balance using HELP model.      
    Leaching Duration:                                                                                          
        Landfill..............................................................  Derived, continues until all    
                                                                                 constituent has leached out.   
        Surface Impoundment...................................................  20 years (operational life of   
                                                                                 waste unit).                   
        Waste Pile Land.......................................................  20 years (operational life of   
                                                                                 waste unit).                   
        Application Unit......................................................  40 years.                       
Chemical Specific Parameters:                                                                                   
    Decay Rate:                                                                                                 
        Organics..............................................................  Hydrolysis rates based on       
                                                                                 measurements or based on       
                                                                                 appropriate structure-activity 
                                                                                 relationships.                 
        Metals................................................................  No decay.                       
    Sorption:                                                                                                   
        Organics..............................................................  Koc estimated from Kow, which is
                                                                                 based on measurements or based 
                                                                                 on appropriate structure-      
                                                                                 activity relationships.        
        Metals................................................................  MINTEQ sorption isotherms (Pb,  
                                                                                 Hg, Ni, Cr (III), Ba, Cd).     
                                                                                pH dependent isotherms (As, Cr  
                                                                                 (VI), Se (VI), Th)             
Unsaturated Zone Parameters:                                                                                    
    Depth to groundwater......................................................  Site-based, from API/USGS       
                                                                                 hydrogeologic database.        
    Soil Hydraulic Parameters.................................................  National distribution for the   
                                                                                 main soil types.               
    Fraction Organic Carbon...................................................  National distribution for the   
                                                                                 main soil types.               
    Bulk Density..............................................................  National distribution for the   
                                                                                 main soil types.               
Saturated Zone Parameters:                                                                                      
    Recharge Rate.............................................................  Site-based, derived from        
                                                                                 precipitation/evaporation and  
                                                                                 soil type.                     

[[Page 66373]]
                                                                                                                
    Saturated Thickness.......................................................  Site-based, from API/USGS       
                                                                                 hydrogeologic database.        
    Hydraulic Conductivity....................................................  Site-based, from API/USGS       
                                                                                 hydrogeologic database.        
    Porosity..................................................................  Effective porosity derived from 
                                                                                 national distribution of       
                                                                                 aquifer particle diameter.     
    Bulk Density..............................................................  Derived from porosity.          
    Dispersivity..............................................................  Derived from a national         
                                                                                 distribution and is based on   
                                                                                 distance to the receptor well. 
    Groundwater Temperature...................................................  Site-based, from USGS regional  
                                                                                 temperature map.               
    Fraction Organic Carbon...................................................  National distribution, from EPA 
                                                                                 STORET database.               
    pH........................................................................  National distribution, from EPA 
                                                                                 STORET database.               
Receptor Well Location:                                                                                         
    Radial Distance...........................................................  Nationwide distribution based   
                                                                                 the survey.                    
    Angle Off-Center..........................................................  Uniform within  90  
                                                                                 deg. from plume centerline.    
    Depth of Intake Point.....................................................  (No restriction to be within    
                                                                                 plume) Uniform throughout      
                                                                                 saturated thickness of aquifer.
----------------------------------------------------------------------------------------------------------------

4. Other Risk Assessment Issues
a. Differences Between the Groundwater and Non-groundwater Analyses
    As mentioned previously, the Agency conducted separate analyses for 
the evaluation of risks from groundwater and non-groundwater pathways. 
The groundwater pathways relied on a full Monte Carlo analysis; whereas 
the non-groundwater pathway analyses were performed using high-end and 
central tendency parameters, consistent EPA's risk characterization 
guidance (EPA 1995).
    Although the approaches to the modeling differed, the Agency used 
the same data for parameter inputs (i.e., OSW's Industrial Subtitle D 
Survey, U.S. EPA 1986) to describe the waste management units common to 
both analyses (i.e, surface impoundments, waste piles, and land 
application units). However, even though the same data were used, some 
differences exist based on the different modeling approaches. These 
differences are discussed below.
(1) Infiltration
    For the groundwater pathway analysis, the Agency used the HELP 
model to calculate the net infiltration rate for landfills, land 
application units and waste piles, as a function of regional climatic 
conditions and waste unit design characteristics (see EPACMTP 
background Document). The analysis used the meteorological data from 93 
meteorological stations located throughout the United States to develop 
infiltration rate distributions using the HELP model.
    For the non-groundwater analysis, the Agency used rainfall to 
calculate the recharge rate. The rainfall was selected from 29 
meteorological stations distributed among 9 climate regions. However, 
the method for selecting the rainfall factor differed between the air 
release pathways and the overland release pathways.
     For the air release pathways, the Agency conducted a 
sensitivity analysis for each waste management unit type to rank the 29 
meteorological stations with respect to several air modeling outputs, 
including maximum air concentration of pollutants, average air 
concentrations over the agricultural field and water body, and average 
deposition over the agricultural field and water body. Based on these 
sensitivity analyses, the Agency selected a central tendency location 
and high-end location for the air pathway for each of the waste 
management units. Thus, locations with meteorologic data, including the 
rainfall factor, approaching the central tendency and high-end values 
were selected for each waste management unit.
     For the overland release pathways, the Agency ranked the 
rainfall factors from the 29 meteorological stations and selected the 
50th and 90th percentile based on the distribution of the 29 
meteorological stations.
(2) Density of Waste Applied to the Land Application Unit
    The approach used in the groundwater analysis assumed the bulk 
density of the applied waste to be 1 gram per cubic centimeter (g/cc) 
because the waste was assumed to be comprised predominantly of water. 
However, changes in the density of applied waste do not significantly 
affect the results of the groundwater modeling results.
    The approach used in the non-groundwater analysis assumed the bulk 
density of waste to be analogous to the density of sewage sludge (i.e., 
1
FR Doc. 95-29458 Hazardous Waste Management System: Identification and Listing of Hazardous Waste: Hazardous Waste Identification Rule (HWIR)
.4 g/cc). The waste in the LAU is a mixture of industrial waste and 
soil. The central tendency bulk density for soil (i.e., 1.5 g/cc) is 
similar to the bulk density assumed for industrial waste. Because the 
waste is incorporated into soil, the properties of the waste/soil 
mixture are needed. There is little variability in bulk density for the 
type of soil used in the analysis (i.e., loam), thus, the same value 
was used for central tendency and high-end estimates of the waste/soil 
mixture bulk density.
(3) Unsaturated Zone Characteristics
    The groundwater pathway analysis used the characteristics (e.g., 
percent organic matter, saturated hydraulic conductivity) of the entire 
unsaturated zone as input into the modeling analysis. The non-
groundwater pathway analysis used as input the characteristics of only 
the upper portions of the unsaturated zone because these 
characteristics were those significant for the surface exposure 
pathways.
(4) Hydrolysis Rates
    The hydrolysis rate for a chemical constituent is used in the Monte 
Carlo groundwater pathway analysis as a function of temperature and pH 
of the groundwater at the Monte Carlo realized site. The Agency used 
hydrolysis rates for constituents that have been measured through 
appropriate structure activity relationships. They have been reviewed 
by a panel of experts from the Agency's Office of Research and 
Development (USEPA, 1993). The non-groundwater pathway analysis used 
hydrolysis rates from the ``Handbook of Environmental Fate and Exposure 
Data for Organic Chemicals'' (Howard et. al, 1993).
b. Other Groundwater Pathway Analysis Issues
(1) Use of 1,000 Year Versus 10,000 Year Exposure Time Horizon
    The Agency's proposal is based on a 10,000 year time horizon for 
the groundwater pathway. This means that the determination of leachate 
concentration limits is based on the highest (30-year average) 
concentration that occurs within 10,000 years from the start of the 
release. Although this longer time horizon has been used in other 
programs (U.S. Nuclear Regulatory 

[[Page 66374]]
Commission and U.S. Department of Energy), the Agency is considering 
using 1,000 years as an alternative time horizon. The Agency requests 
comment on this issue which is described in more detail below.
    Using this shorter time horizon results in an increase of the 
leachate concentration limit for a number of constituents. The 
constituents affected are those which are strongly sorbed in the 
subsurface, and which therefore tend to migrate slowly. These 
constituents include organics with retardation factors (R) 
significantly greater than one. The organic carbon partition 
coefficient (koc) values for these constituents are about 3,500 g/
cm3 or greater, and certain metals such as lead and chromium(III). 
For organic constituents with koc values less than about 3,500 g/
cm3, the highest receptor well exposure concentration is generally 
reached in less than 1,000 years. Reducing the modeling time horizon 
from 10,000 to 1,000 years therefore does not affect the results of the 
pathway analysis for these constituents. The effect of using a 1,000 
year versus a 10,000 year time horizon is illustrated in Table 4. The 
constituent-specific differences are shown in Table B-1 of appendix B 
to the preamble. The table is based on a landfill waste management 
scenario, and all constituents are assumed to have identical toxicity 
values and not be subject to hydrolysis. For reference, the leachate 
concentration limit for constituents with koc=0 (no sorption, 
R=1), and a 10,000 year time horizon is equal to 1.0 mg/L. This table 
shows that the increase in leachate concentration limit for organic 
constituents is affected for a shorter modeling horizon (1,000 years) 
only when koc values (or R values) are very large. (About fifteen 
percent, out of a total of approximately 200, including eight metals, 
fall into this category.) The effect of hydrolysis rate is not 
considered in results shown in the table. While hydrolysis influences 
the magnitude of the exposure concentration at a receptor well, the 
time that it takes for a contaminant to reach the receptor well is 
independent from the chemical-specific hydrolysis rate. It is, however, 
strongly influenced by chemical-specific sorption characteristics, 
which for organics are expressed in terms of koc or R values.

 Table 4.--Effect of 1,000 Year Versus 10,000 Year Modeling Time Horizon
                     on Leachate Concentration Limit                    
------------------------------------------------------------------------
                                                      10,000     1,000  
                    koc (cm3/)                        years      years  
------------------------------------------------------------------------
0.0...............................................        1.0        1.0
3,384.............................................        1.0        1.0
(R=10)                                                                  
37,224............................................        1.0         60
(R=100)...........................................                      
------------------------------------------------------------------------

(2) Implementation of Parameter Bounds in Monte Carlo Procedure
    The Monte Carlo modeling procedure used in the groundwater pathway 
analysis uses data on waste site location from the EPA's Industrial 
Subtitle D Survey (USEPA, 1986). These data are combined with other 
data sets for climatic and hydrogeological parameters. Auxiliary 
parameters for which no direct data is available are calculated 
internally in the model. For instance, ground-water velocity is 
calculated from hydraulic conductivity, gradient and effective 
porosity, and the dispersivity is calculated from the receptor well 
distance (See EPACMTP Background Document and User's Manual). Each 
parameter furthermore can have specified upper and lower bounds to 
guard against the possibility that physically infeasible parameters 
and/or parameter combinations are not used. When the latter condition 
occurs, the particular Monte Carlo realization is rejected, and another 
realization is generated. The Agency is considering an alternative 
procedure in which only the offending parameter is regenerated, or, if 
necessary, set equal to its upper or lower bound to avoid selection of 
values beyond the minimum to the maximum values range. In first case, 
the frequency distribution of parameter values generated by the Monte 
Carlo module, may be different from its input distribution. The Agency 
has determined that the two alternative procedures have little impact 
on the overall modeling results in the case of landfills and land 
application units, but that the default procedure tends to favor the 
selection of sites with larger waste unit area in the case of waste 
piles and surface impoundments. Therefore it produces more conservative 
(lower) values for the final leachate concentration limits. The 
analysis results show that for the two alternative Monte Carlo 
procedures for surface impoundments, the default procedure results in a 
leachate concentration limit of 1.0 mg/L, the alternative procedure 
results in a concentration limit of about 31 mg/L for a chemical with 
R=1. The effect of changes in the hydrolysis rate or the R value on the 
resultant regulatory leachate concentration do not impact the results 
obtained by using the alternative Monte Carlo procedure described in 
this subsection. The Agency is also soliciting comments on the Monte 
Carlo parameter rejection procedure used for the results presented in 
this subsection.
(3) Hydraulic Conductivity of Surface Impoundment Bottom Layer
    The surface impoundment scenario modeled in the groundwater pathway 
analysis incorporates a 2 feet thick layer at the base of the 
impoundment. In the base case for this proposal, the layer is assigned 
a hydraulic conductivity of 10-7 cm/sec. The Agency recognizes that 
this value may or may not be appropriate value for bottom sediments as 
a nationwide typical for industrial Subtitle D surface impoundments. To 
evaluate the impact of varying this parameter, the Agency has compared 
modeling results obtained using a 10 times higher conductivity of 10-6 
cm/sec. A higher conductivity value corresponds to a greater leachate 
flux from the impoundment, and generally higher receptor well 
concentrations, which translates into a more conservative (lower) 
regulatory leachate concentration limit. The regulatory limit 
calculated for a conductivity value of 10-7 cm/sec is 1.0 mg/L, 
the corresponding value for a conductivity of 10-6 cm/sec would be 
0.35 mg/L. The effect of changes in hydraulic conductivity on the 
results is believed to be independent of the sorption or the hydrolysis 
characteristics of the chemical. The Agency is inviting comments on the 
appropriate value for the hydraulic conductivity of the bottom sediment 
layer for industrial D surface impoundments. In addition, the Agency 
requests the submission of hydraulic conductivity data for industrial 
Subtitle D surface impoundment bottom sludges.
(4) Waste Pile Infiltration Rates
    The Agency used the HELP model to calculate the net infiltration 
rate for landfills, land application units and waste piles, as a 
function of regional climatic conditions and waste unit design 
characteristics (see EPACMTP background Document). For waste piles, the 
Agency considered two alternatives. The procedure used in the base case 
considered a waste pile, for the purpose of estimating infiltration 
rates, to be similar to an uncovered landfill. The Monte Carlo modeling 
analysis therefore used landfill infiltration rates corresponding to 
the most permeable (sandy loam) of the three cover types 

[[Page 66375]]
used for landfill modeling. As an alternative, the Agency has used the 
HELP model to calculate infiltration rates for waste piles directly. In 
the initial evaluation, the runoff used in the water balance 
calculation was computed by the HELP model as a function of soil 
texture and vegetative cover (bare ground).The Agency has evaluated the 
impact of representative bare, but unevenly surfaced, waste piles on 
simulated runoff using the HELP model. A comparison of the impact of 
using this alternative procedure against the values used in this 
proposal for the base case, on the regulatory leachate concentration 
limit, was conducted. The comparison of regulatory leachate 
concentration limits is based on a non-degrading, non-sorbing 
constituent, which has a concentration limit of 1.0 mg/L in the 
proposal. Using the alternative procedure, the corresponding leachate 
concentration level changes to 0.77. The Agency is inviting comments on 
the two methods for the waste piles for the estimation of infiltration 
rates through them. If you have any data and other information to 
support your comment, send it along with your comments to the Docket.
(5) Land Application Unit Infiltration Rates
    In the calculation of infiltration rates for land application units 
for the base case in the proposal, it was assumed that land application 
units receive, on average, 1,295.4 m\3\ha (5.1 inches) of water 
annually through the application of the waste. This amount of water was 
included in the HELP model water balance calculation, resulting in an 
increased net infiltration as compared to ambient conditions. The waste 
application rate may or may not represent true field situations. As an 
alternative to the modeling procedure used for the base case of this 
proposal, the Agency evaluated the effect of using ambient recharge 
rates, i.e., the application of waste does not significantly alter the 
water balance, on the calculated leachate concentration limits. The 
comparison of this alternative with the procedure used for the base 
case shows that the regulatory leachate concentration limits for a non-
degrading, non-sorbing constituent in land application units changes to 
1.12 mg/L from 1.0 mg/L for the procedure used in the base case.
    (6) Aggregate Effects of Alternative Groundwater Modeling 
Procedures and Data
    The preceding sections have presented the effect of alternative 
modeling options and data sources that have been considered by the 
Agency. A consequence of the Monte Carlo exposure modeling approach is 
that the effects of changes in model parameters are not always linearly 
additive; rather the aggregate effect of changing multiple parameters 
or options may be to either magnify or reduce the effect of the 
individual changes. The Agency, therefore, has conducted modeling 
analyses of the aggregate effect of the alternatives discussed above 
for each of the four waste management scenarios. In addition to the 
alternatives presented in the preceding subsections, a modification was 
also made in the procedure for modeling waste sites for which the 
corresponding hydrogeological region was initially assigned as ``not 
classifiable''. Rather than ignoring the small fraction of sites 
involved, they were incorporated into the analysis by assigning them 
nationwide average values for the groundwater parameters. Table 5 
presents the aggregate effect of all changes for each of the four waste 
management scenarios modeled. The modeling results correspond to a non-
degrading, non-sorbing constituent. The leachate concentration limits 
are normalized with respect to a value of 1.0 mg/L for the landfill 
scenario, under the modeling procedure for the base case of this 
proposal. The results are presented for a 1,000 year time horizon; 
however for a non-sorbing constituent, these same results also hold for 
the 10,000 year time horizon.

     Table 5.--Aggregate Effect of Modeling Alternatives on Leachate    
  Concentration Limits for Non-Degrading, Non-Sorbing Constituents for  
                     Four Waste Management Scenarios                    
------------------------------------------------------------------------
                                                     HWIR    Alternative
            Waste management scenario              proposal    Options  
------------------------------------------------------------------------
Landfill........................................        1.0        0.71 
Surface Impoundment.............................       0.22        0.27 
Waste Pile......................................       0.29         484 
Land Application Unit...........................       0.08        0.22 
------------------------------------------------------------------------

    Table 5 shows that, except for landfills, the aggregate effect of 
the combined alternative options is a less conservative (higher) 
leachate concentration limit. For landfills, adoption of the 
alternative modeling options would have resulted in a 30 % less 
stringent regulatory leachate limit for the groundwater pathway for 
non-sorbing and non-degrading constituents. For surface impoundments, 
there is little overall impact because the opposing effects of 
increasing the impeding layer hydraulic conductivity, and the 
alternative Monte Carlo procedure for handling parameter bound 
exceedances, nearly cancel out. For waste piles on the other hand, the 
procedure used for the base case, results in a significantly more 
conservative leachate concentration limit as compared to the 
alternative modeling options. This is due to the handling of parameter 
exceedances in the Monte Carlo simulation. Because many waste piles 
have very small sizes (surface areas), the alternative Monte Carlo 
procedure has a large impact. For land application units, the 
procedures used in the proposal for the base case also result in a more 
conservative regulatory limit as compared to the alternative modeling 
options. The contributing factors are much the same as for waste piles, 
but the overall impact is much smaller, primarily because there are 
only few land application units with very small areas.

F. Additional Eco-Receptor Considerations

    EPA considered two different policy goals with respect to 
protection of terrestrial ecological receptors (i.e., soil fauna, 
birds, mammals, and plants). One goal protected terrestrial ecological 
receptors outside the boundaries of the waste management site, thus, 
the constituent had to travel off-site before exposures would be 
assessed. The alternative goal protected terrestrial ecological 
receptors on the closed land application site.
    The Agency chose to propose exit levels based on off-site impacts 
for several reasons. One reason is that there are many land use 
decisions that significantly affect terrestrial ecological receptors on 
the property of a party making those decisions (e.g., a decision to 
pave a portion of land as a parking lot). EPA does not generally 
regulate those sort of decisions. However, many impacts are judged 
through local zoning regulations. Congress has typically asked EPA or 
other Federal entities to regulate activities on a property when there 
are significant off-site impacts, such as a groundwater plume that 
migrates, an air release that moves beyond the property, a wetland 
(located on the property) that is a significant resource for migratory 
birds and has broader ecological significance, or an endangered species 
with social values beyond the impact on a specific landowners purview.
    EPA asks for comment, however, on the alternative of protecting 
terrestrial ecological receptors on-site. The rationale for this 
alternative approach would relate to protection from impacts on bird 
and mammal populations, and 

[[Page 66376]]
other ecological receptors, and to the regulation of certain 
constituents that could potentially result in environmental 
consequences that go significantly beyond the bounds of a current waste 
management unit.

G. Background Concentrations in Soils and Other Issues Relating to 
Results

    EPA has compared the exit levels for nonwastewaters to data on the 
variation in mean background concentrations found in soils. For some 
metals, the exit levels calculated based on risks at land application 
units are below 4 mean soil concentrations. One reason exit 
criteria may be below soil concentrations is that these metals 
bioaccumulate, causing greater exposure for higher trophic levels. 
Also, the acceptable levels for some of the metals that would be 
calculated for practices other than land application are significantly 
higher and not below mean soil concentrations.

    \4\ When compared with mean soil background levels provided by 
the USGS, the exit levels are not more that 1 order of magnitude 
more restrictive.
---------------------------------------------------------------------------

    If the final exit levels are below typical soil levels, EPA would 
consider promulgating levels based on concentrations that are either 
typical soil concentrations (national mean levels) or some percentile 
or portion of the naturally-occurring range such as the 10th 
percentile. If the effect of concern is an ecological impact, the 
rationale for using the 10th percentile (or similar figure if the data 
available does not allow that precision) would be that in 90 percent of 
locations, if the soil already contains those or greater levels, the 
ecological receptors existing in the area should already reflect the 
toxicity of the waste material; the rational for using the 10th 
percentile (or similar value) value is that human behavioral practices 
(e.g., treatment of groundwater prior to use) may already reflect 
protection from the potential toxicity of concern. EPA asks for comment 
on whether these are reasonable arguments.
    EPA is concerned, however, that there are also issues of the 
chemical and physical form in which compound or chemicals exist, in 
both natural conditions and in the waste and that a simple comparison 
of total concentrations in soils and in wastes might be misleading 
about potential ecological or human impacts. EPA requests comment on 
these issues. EPA's first preference will be to reexamine the risk 
modeling to identify any inappropriate assumptions or modeling issues 
that may explain the low proposed exit level, and to look more 
carefully at those constituents where this issue only arises from the 
modeling of risks from land application units, to identify potential 
contingent management solutions to this problem.
    Finally, EPA requests comment on whether these arguments could be 
extended to site-specific determinations where information on local 
background constituent concentrations and form in soil are available 
and have been reviewed by a State regulatory authority. EPA assumes 
that such an approach would only apply if the background concentrations 
were more than very localized and the concentrations were naturally-
occurring rather than due to past contamination. If a site-specific 
determination were adopted, two approaches are available that have been 
used in other contexts. One statistical technique for determining 
whether background data conform to a normal distribution assumption 
includes combining the Student-t difference of means test, presented in 
the Permit Guidance Manual on Unsaturated Zone Monitoring for Hazardous 
Waste Land Treatment Units, (EPA, 1986) with the normal tolerance 
interval approach found in Statistical Analysis of Ground Water at RCRA 
Facilities-Interim Final Guidance, (EPA, April 1989). The Student-t 
test compares averaged waste/media concentrations to background 
concentrations, and is used to determine if the waste/media as a whole 
is within a specified criteria. However, even if the waste/media passes 
the Student-t test, individual sample concentrations may still exceed 
the tolerance interval limit. The normal tolerance interval approach is 
used to compare sample concentrations to an upper tolerance value based 
on the background mean, standard deviation, and sample size.
    If such an approach is incorporated into the final rule, it would 
include criteria for defining and collecting adequate background 
samples. More specifically, the facility would be required to identify 
background locations, sample size, soil depth, etc. for at least four 
samples in a ``difference of means'' demonstration, and six to eight 
samples for a ``tolerance of means'' demonstration. The facility would 
also need to demonstrate the normalcy of the sample distribution. The 
Agency would require that this information be included as part of the 
facility's sampling and analysis plan and subject to review by the 
appropriate overseeing authority.
    A more simplified approach would be to establish exit levels at \1/
10\ of the naturally occurring background level. The rationale for 
using \1/10\ is that these levels would not appreciably contribute to 
the overall risk posed by elevated levels in the environmental media. 
EPA requests comment of this approach as well as the rationale.
    Alternatively, the rule could defer any background level 
demonstrations to an omnibus authority for the overseeing agency. Under 
this concept, a claimant could submit information on naturally 
occurring background level and a request for modified exit levels to 
the agency overseeing the exemption process, which would have 
discretion to grant modifications where they are clearly justified. 
Comment is requested on the need for this authority.
    The Agency solicits comments on other appropriate and generic ways 
(1) to identify background levels in soils, and (2) to incorporate the 
existing 40 CFR part 264, subpart F standards for establishing 
background levels for groundwater. Other suggestions that address the 
Agency's intent to promulgate a simplified exemption with little 
reliance on site-specific considerations but also allow for 
consideration of elevated background levels will be considered.
    EPA also observed that some of the exit levels for organic 
chemicals appear relatively high (see, for example, the level for 
xylene). EPA believes that these results occurred primarily because 
these chemicals either are toxic only at relatively high concentrations 
or undergo high dilution during transport. EPA, however, requests 
comment on whether these chemicals are frequently co-disposed and, if 
so, whether they might pose cumulative risks not assessed by the risk 
analysis. EPA is interested in information on issues such as whether a 
waste containing one or more of these constituents at concentrations 
near exit levels would be ignitable or threaten the integrity of 
control measures such as liners.

H. Constituents with Extrapolated Risk-based Levels

    EPA was unable to conduct the risk assessment for 187 of the 376 
constituents on the exit list. In most of these cases, EPA was unable 
to find acceptable human health benchmarks to serve as the starting 
place for the assessment. In a few cases, EPA could not find values for 
critical physical or chemical properties, such as log Kows. Based 
on its past experience, EPA believes it would need at least a year to 
develop a new human health benchmark value for any constituent. EPA has 
less experience with the type of research and peer review needed to 
develop values for physical and chemical properties, but it believes 
that this process also would be time-consuming. 

[[Page 66377]]

    Rather than not consider the 187 constituents for which EPA was 
unable to conduct the risk assessment as potential candidate 
constituents for exit criteria, EPA developed an approach for 
establishing exit criteria for these constituents. The Agency grouped 
the constituents on the exit list into classes, based on chemical 
structure. EPA selected the 50th percentile value from the range of 
modeled risk levels for each chemical class. This 50th percentile value 
serves as the extrapolated risk-based level for the un-modeled 
constituents in the corresponding chemical class. The constituents and 
their 50th percentile extrapolated risk-based levels are presented in a 
background document Background Document to Support the Methodology used 
in Extrapolating Exit Levels to Constituents with no Health-Based 
Benchmarks. EPA is proposing the 50th percentile level to avoid adding 
another conservative assumption to the derivation of exit levels for 
these constituents. EPA believes that the multipathway approach is 
already sufficiently conservative to protect human health and the 
environment even for these chemicals. EPA, however, requests comment on 
the alternative of using the 10th percentile or a different percentile 
from the modeled exit levels from each class. Such an approach would 
reduce the chances that the actual health benchmark for a particular 
level was lower than the extrapolated estimate. However, it would also 
increase the odds that the extrapolated level was higher than needed 
for many constituents. A complete list of extrapolated constituents and 
associated risk levels may be found in appendix C to today's preamble.
    EPA recognizes that this approach to generating exit levels is much 
less sophisticated and precise than the multipathway analysis. 
Nonetheless, EPA prefers it to any of the available alternatives. If 
EPA set no exit levels and made wastes containing any of these 
constituents ineligible for exit, a significant number of waste streams 
would probably be ineligible, even though they may pose no significant 
threat to human health and the environment. EPA's RIA data shows that 
some of these constituents, such as Cyanide and Anthracene, are fairly 
prevalent. Although other constituents, such as those found in the 
commercial chemical products on the P and U lists of hazardous wastes, 
are not very prevalent, they may be significant for generators that 
manage multiple waste streams in centralized wastewater treatment 
plants. In the absence of extrapolated exit criteria, a generator would 
lose its opportunity to claim an exit for an entire combined stream if 
any of these constituents is found in the waste stream. Furthermore, it 
would take a long time to complete the work necessary to conduct 
exposure pathway assessments for any significant number of these 187 
constituents.
    Alternatively, EPA could propose to allow wastes to exit without 
testing for constituents lacking modeled exit levels. EPA, however, 
finds this approach insufficiently protective, especially when it can 
at least approximate likely risk levels as described above.
    Finally, EPA considered the alternative of basing exit levels for 
these constituents on quantitation limits. As explained below, EPA is 
proposing to use EQCs as exit levels where they are higher than a 
constituent's multipathway or extrapolated exit level. (EPA is also 
proposing that wastes with such constituents meet the technology-based 
LDR standards for those constituents prior to exit.) EPA considered 
using this EQC and LDR approach for constituents lacking multipathway 
levels. Such an approach would actually produce more conservative exit 
levels, because EPA would not use extrapolated levels that are higher 
than EQCs. EQCs (and technology-based LDRs), however, are not based on 
risk. EPA prefers the extrapolated approach because it takes into 
account the toxicity and fate and transport of structurally similar 
chemicals. EPA believes it would be unreasonable to continue to 
regulate a chemical because chemistry can detect it, where the 
extrapolation described above suggests that the chemical poses no 
significant risks at the EQC level.
    EPA finds the option of basing exit levels on the extrapolation 
procedure described above to strike a reasonable balance between the 
goals of protecting human health and the environment and eliminating 
regulation of low-risk wastes. EPA, however, requests comment on all of 
the alternatives described in this section.

I. Analytical Considerations

    Some of the proposed exit levels established by the risk assessment 
and the extrapolation methodology are low. In some cases, existing 
analytical methods cannot routinely detect the constituents at those 
levels. EPA is proposing to cap these potential exit levels with 
reasonable analytical quantitation limits. The Agency is proposing 
quantitation limits that represent the lowest levels that can be 
reliably measured within acceptable limits of precision and accuracy 
during routine laboratory operating conditions using appropriate 
methods. These concentrations are referred to as ``exemption 
quantitation criteria,'' or EQCs. It is necessary to specify EQCs 
because a number of the constituents on the exemption list have either 
modeled or extrapolated risk-based levels that are not analytically 
achievable in all matrices. Appendix C to today's preamble lays out the 
comparison between the modeled or extrapolated risk level and the EQC 
for every constituent. Approximately one-quarter of the constituents 
have proposed modeled or extrapolated risk-based levels lower than EQC.
1. Development of Exemption Quantitation Criteria (EQC)
    To develop the EQCs proposed in today's notice, EPA compiled a 
master list of the quantitation limits published for the identified 
constituents in the Third Edition of Test Methods for Evaluating Solid 
Waste, (SW-846), including the first and second updates (both of which 
are widely distributed throughout the regulated community). The Agency 
believes that the resultant EQCs present achievable quantitation limits 
for the proposed exemption constituents in most matrices. The Agency 
requests comment on the proposed quantitation limits as well as any 
data supporting those comments.
    A regulatory action level (e.g., exit levels) must provide a clear 
distinction between those wastes subject to the regulation and those 
excluded. Action levels based on analytical determinations within a 
methods quantitative range can be used to determine regulatory status 
with a high degree of confidence. On the other hand, when an analyte is 
present at a concentration equal to the detection limit (DL) it will be 
detected only half the time. In other words there is a 50% risk of a 
false negative result when the analyte is present at the DL 
concentration. There is, however, a less than 1% risk of false positive 
results at this level. Therefore, regulations set at the detection 
limit would not identify non-compliance reliably.
    The Agency is in the process of re-evaluating EQCs for some 
constituents. Preliminary updated EQCs could not be incorporated into 
today's proposed rule, but have been included in the docket for 
comment.
2. EQCs and LDR Requirements as Exit Levels
    A comparison of the modeled or extrapolated risk-based levels with 
the EQCs reveals a number of cases where 

[[Page 66378]]
quantitative measurement of analyte concentration at the modeled or 
extrapolated risk-based level cannot be reliably achieved, using 
standardized analytical methods. In today's proposed rule, for wastes 
containing constituents with a modeled or extrapolated risk-based level 
lower than the EQC, exit criteria include meeting the EQC along with an 
additional requirement that the waste meet Land Disposal Restrictions 
(LDR) treatment standards from part 268, regardless of whether or not 
the waste is to be land disposed. The exit table for constituents with 
EQCs as exit levels is proposed appendix X of 40 CFR part 261, Table B.
a. EQCs as exit levels
    Only when the comparison between the modeled or extrapolated risk-
based level with that constituent's EQC level reveals that the 
constituent cannot be quantitated at the modeled or extrapolated risk-
based level, does the EQC become the exit level. For example, the 
modeled risk-based level for 2-nitropropane in wastewaters is 0.00019 
g/L. The EQC for 2-nitropropane in wastewaters is 0.0058 
g/L. 2-nitropropane is listed in appendix X, Table B, with an 
exemption level of 0.0058 g/L. In other words, the exemption 
level for 2-nitropropane has been met if the claimant demonstrates that 
the method used can achieve the EQC of 0.0058 g/L in the waste 
matrix, and the level detected by the method does not exceed 0.0058 
g/L.
    The Agency believes that, for those constituents that have a 
modeled or extrapolated risk-based level lower than the achievable 
quantitation limit, demonstration that the constituent is not present 
above the EQC is the most reasonable approach to setting a national 
exemption level. The Agency is proposing that quantitation limits cap 
the modeled or extrapolated risk-based levels because a reliable, 
consistent measure of the constituent below the quantitation limit is 
not achievable. By establishing EQCs as benchmarks (or maximum 
allowable quantitation limits), the Agency is ensuring that all 
exemption demonstrations will achieve acceptable analytical 
sensitivity, and that wastes with high levels of contamination that 
tend to confound analytical protocols are not exempted.
    The Agency requests comments on whether an exemption demonstration 
should be considered adequate if all proper method selection and QC 
procedures are followed and the constituents are not detected, even 
though the EQC level has not been analytically attained. This situation 
could arise even in relatively clean matrices if the constituents bind 
strongly to the matrix or if the constituents degrade rapidly during 
the analysis. However, the Agency would not want the exemption to be 
allowed if the EQC could not be achieved because of interference from 
other contaminants in the matrix, or if inappropriate methodology, 
i.e., sample preparation, cleanup (if necessary), or determinative, was 
used.
    EPA is not proposing that any exit level based on an EQC can serve 
as a ``minimize threat'' level capping current 40 CFR part 268 
treatment standards. Such levels are not sufficiently related to a 
constituent's risk.
b. LDR Requirements for Constituents With EQC Exit Levels
    EPA considered the option of setting exit levels for all 
constituents at their modeled or extrapolated levels, regardless of 
analytical considerations. EPA also considered the alternative of 
making wastes containing constituents with analytical limitations 
ineligible for exit. Both of these options, however, are likely to 
constrain significantly the number of waste streams eligible for exit. 
Approximately one-quarter of the constituents on the exit list have 
EQCs above risk-based or extrapolated levels. Some of these 
constituents, such as Beryllium and Arsenic, are fairly prevalent. For 
less prevalent constituents, EPA has the same concerns about limiting 
exit for wastes managed in centralized wastewater treatment systems 
that it described above in the section on extrapolated risk levels. 
Further, this approach would overregulate wastes where constituents 
were in fact below risk levels. EPA prefers options which would not 
prohibit all wastes with these constituents from exiting.
    The most promising alternative EPA found was setting exit levels 
for these constituents at EQC levels, and also requiring all wastes 
containing these constituents to comply with LDR treatment standards, 
even where such waste are not destined for land disposal. This 
alternative offers the possibility of additional risk reductions and, 
therefore, reduces the possibility that wastes posing significant 
threats will escape Subtitle C control.
    EPA is unable to characterize the amount of additional risk 
reduction for a number of reasons. First, as explained in more detail 
in the Minimize Threat section of the preamble, compliance with LDRs 
already will be required after exit before land disposal for all wastes 
(except those that are below exit levels at their point of generation). 
The LDR requirement for constituents with EQC exit levels may provide 
additional risk reduction, even for those constituents that are not 
managed in land disposal units. EPA currently does not know how 
frequently nonhazardous wastes are burned as fuel, incinerated, or 
otherwise managed outside of land disposal.
    Additionally, the Universal Treatment Standards (UTS) for 
nonwastewaters, were developed based on similar analytical chemistry 
considerations of detection limits. The majority of the UTS limits for 
nonwastewaters were based, however, on analysis of residuals from the 
treatment of what EPA determined to be the most difficult to treat 
wastes and, as a result, this often represented the most difficult to 
analyze treated matrix (i.e., higher detection limits than those 
represented by the EQCs). The majority of the UTS limits for 
wastewaters, on the other hand, were not developed based on limits of 
detection but rather they were based on analysis of treated effluents 
regulated under EPA's National Pollution Discharge Elimination System 
(NPDES).
    LDR requirements for all wastes subject to the UTS would be equal 
to or higher than the EQC exit levels themselves. However, for wastes 
subject to treatment standards based on application of specified 
treatment methods under Sec. 268.40, extending LDR requirements may 
provide additional risk reduction.
    EPA believes that the combined approach of requiring non-detection 
at EQC levels and compliance with LDR standards for all waste streams, 
regardless of whether or not the waste will be land disposal, offers a 
reasonable balance between the goals of reducing overregulation and 
ensuring that wastes with significant risks remain subject to Subtitle 
C. EPA, however, requests comment on all of the alternatives described 
above. EPA also requests comment on the option of basing exit levels 
for these constituents on EQCs alone and relying on continued, 
independent applicability of LDR requirements for wastes that exit and 
are destined for land disposal.
3. Exemption for Constituents Without EQCs
    There are several constituents covered in today's notice for which 
EQCs could not be developed. The universe of these constituents 
includes 78 constituents, most of which are not widely prevalent in 
wastes. Most are also found only in P and U listed wastes. These 
constituents are listed in table B to appendix X without associated 
exemption levels. The background document Background Document to 
Support the Development of Exemption 

[[Page 66379]]
Quantitation Criteria (EQCs) and Description of Analytical Methods 
under the Waste Exit Rule explains why EQCs could not be created.
    EPA is proposing that wastes containing these constituents (i.e., 
where an applicant has not documented that these constituents are not 
present--see section VIII.A.1.b.,) may remain eligible for an exemption 
under today's proposed rule by complying fully with LDR treatment 
standards applicable to the waste, as codified in 40 CFR part 268, 
regardless of whether the waste is to be land disposed. The Agency 
believes that any potential risks posed by these constituents are 
likely to be further reduced by applying LDR standards from part 268 to 
the waste, before the waste may be exempt, regardless of whether or not 
the waste is destined for land disposal. The Agency asks for comment on 
this approach.
    An alternative approach would be to allow wastes with these 
constituents to exit without additional LDR obligations, but relying on 
continued, independent applicability of LDR treatment requirements to 
wastes destined for land disposal only. Another approach would be to 
prohibit wastes containing these constituents from being eligible for 
exemption under today's proposed rule. An additional approach would be 
that these constituents could be deleted from the exit table. The 
Agency requests comment on each of these alternatives.
    EPA is not willing to propose to use LDR standards as exit levels 
for any other group of constituents. The technology-based LDR standards 
are not based on any risk assessment. A comparison of these standards 
with the multipathway risk levels that EPA produced shows that the LDR 
standards are sometimes more stringent and sometimes less stringent 
than risk-based levels. EPA believes that it is more prudent to base 
exit levels on risk assessment where possible because this better 
assures protection of human health and the environment. EPA views use 
of the LDR standards as the option of least preference, but necessary 
for exit for this group of constituents. EPA is willing to consider it 
only where there is no alternative to prohibiting a constituent from 
being eligible for exit.

V. Presentation of Exit Levels

    Today's proposed exemption criteria involves setting exemption 
levels for toxicants in listed waste, and in some cases requiring 
additional compliance with the requirements set forth at 40 CFR part 
268. To exit Subtitle C regulation as a listed hazardous waste, all the 
hazardous constituents listed in appendix X of part 261 would be 
required to be in concentrations less than or equal to the numeric exit 
levels and when specified, the waste would have to meet the applicable 
requirements at 40 CFR part 268. Appendix C to the preamble presents 
constituents, distinguishes between modeled and extrapolated 
constituents, and includes EQCs for each constituent.

A. Constituents With Modeled or Extrapolated Risk-Based Exit Levels

    The Table A of proposed appendix X to part 261 presents exit levels 
for constituents with modeled or extrapolated risk-based levels which 
can be reliably quantified. See section IV.H. for a description of how 
this was determined. Listed hazardous waste would be required to 
contain concentrations at or below the specified exit levels to be 
eligible to be exempted from Subtitle C requirements other than LDR. In 
some cases we are proposing to change the land disposal restriction 
requirements at 40 CFR part 268 as well. A totals analysis would be 
required for both wastewaters and nonwastewaters to show that the 
constituent does not exist in the wastestream at levels above the 
exemption level.
    For nonwastewaters, the Agency is also proposing that generators 
either use the TCLP test or a calculational screen to measure or 
calculate constituents' leachate from wastes. If the TCLP test shows 
leachate concentration in the waste is below the leach exit level, the 
waste would be considered to not pose a hazard to groundwater.
    The Agency has in the past experienced difficulty in using the TCLP 
test for some types of waste. The Agency solicits comment on how to 
consider oily wastes and other wastes that are difficult to filter in 
the TCLP test or whose impact on groundwater is believed to be 
underestimated by the TCLP (such as materials subject to non-aqueous 
phase transport). Comment on alternative tests for these wastes, as 
well as comment on how to define such wastes for regulatory purposes is 
sought. A more complete discussion of oily waste can be found in 
VIII.A.1.a.iv.
    Table A of appendix X of 40 CFR part 261 presents results of two 
alternatives for establishing the exit levels. These alternatives 
differ only in the benchmark used to calculate the modeled risk-based 
levels. For certain constituents there exists both a risk-based 
toxicity benchmark and a maximum concentration level (MCL) established 
under the Safe Drinking Water Act (SDWA). These numbers may differ 
because the MCLs are established using some non-risk considerations 
such as the cost of treatment and the availability of technology and 
consider exposure contributions from other sources for non-carcinogens. 
See section IV.D. of today's proposal for a complete discussion of 
toxicity benchmarks and MCLs.

B. Constituents With Quantitation-Based Exit Levels; Table B to 
Appendix X

    Table B of proposed appendix X to part 261 presents quantitation-
based exit levels for constituents with methods that cannot reliably 
quantify the modeled or extrapolated risk-based levels. All exit levels 
on Table B of appendix X to 40 CFR part 261 are based on EQCs. (See 
section IV.I.) Wastes containing any of these constituents must also 
comply with the applicable treatment standards set forth at 40 CFR part 
268, the Land Disposal Restrictions (LDR) in order to meet today's 
proposed exemption, regardless of whether or not the waste is to be 
land disposed.
    Some constituents on Table B of appendix X of 40 CFR part 261 do 
not have associated exit levels. Waste with these constituents may exit 
only after complying with the LDR treatment standards for the waste. 
(See section IV.I.2.b.)

C. How To Read the Exit Level Tables

    For a waste to be eligible to exit Subtitle C under the exit 
proposed in today's rulemaking, every constituent in the waste must be 
below its exit level. Proposed appendix X of 40 CFR part 261, Tables A 
and B are the exit constituents and the exit levels. The following is a 
description of how to read the tables.
     The constituent list is derived from constituents listed 
in appendix VII, Basis for Listing Hazardous Waste; Appendix VIII, 
Hazardous Constituents; and appendix IX of part 264, the Ground-Water 
Monitoring List. (See section IV.C.)
     Table A represents constituents and their risk exit 
values--where the risk values can be measured analytically. (See 
sections IV.E., and IV.I.)
     Table B represents constituents with quantitation limits 
(EQCs) as exit levels--where the constituent cannot be measured at the 
modeled or extrapolated risk value. An additional condition of exit, 
compliance with treatment standards in 40 CFR part 268, exists for any 
waste becoming exempt under today's rulemaking by using a constituent 
exit level on Table B. (See section IV.I.2.b.)
     There will be overlap for some constituents between Tables 
A & B. For 

[[Page 66380]]
example, the wastewater exit level for a constituent may be on Table A, 
whereas the nonwastewater exit level may be on Table B.
     Where an exit level does not exist on Table A or B for a 
particular constituent, the waste need not be tested for that 
constituent. For example, some constituents that are hydrolyzers have 
exit levels for nonwastewaters, but not for wastewaters. A complete 
discussion of deletions to the master constituent list can be found in 
section IV.C.
    The tables' columns:
     Columns 1 and 2 are the CAS numbers & constituent names.
     There are two proposed options for the development of 
today's proposed exit levels. Option 1 is the option whereby Maximum 
Contaminant Levels (MCLs) from the Drinking Water program are used as 
an acceptable toxicity exposure for human drinking water exposure and 
toxicity benchmarks are used for other exposures. Option 2 is the 
option whereby toxicity benchmarks are used as acceptable exposure 
levels for all exposures. A more complete discussion of these two 
options is found in section IV.D. of today's proposed rule. The effect 
of co-proposing these two options is that there are two independent 
sets of proposed exit levels.

--Columns 3, 4, and 5 represent the exit levels that were derived by 
using an MCL benchmark for drinking water ingestion & using toxicity 
benchmarks for all other routes of exposure.
--Columns 6, 7, and 8 represent the exit levels that were derived by 
using toxicity benchmarks for all routes of exposure.

     The definitions of wastewater and nonwastewater are 
discussed in VIII.A.1.a.ii.
     Columns 3 & 6 represent wastewater exit values. If a 
generator determines he/she has a wastewater, if each constituent in 
the waste meets these wastewater exit levels, it is eligible for 
exemption.

--Values in columns 3 & 6 were derived from the most limiting of non-
groundwater-ecological receptor, non-groundwater-human receptor, and 
groundwater pathway values from surface impoundments and tanks (the 
risk assessment's wastewater units).

     Columns (4 and 5) and (7 and 8) represent nonwastewater 
exit values. If a generator determines he/she has a non-wastewater, if 
each constituent in the waste meets both of these nonwastewater values, 
it is eligible for exemption. The totals level must be met by a totals 
analysis. The leach level must be met by a TCLP test or the 
calculational screen.

--Values in columns 4 & 7 were derived from the most limiting of the 
non-groundwater-ecological receptor and non-groundwater-human receptor 
pathway values from land application units, ash monofills, and waste 
piles (the risk assessment's nonwastewater units).
--Values in columns 5 & 8 were derived from the most limiting of the 
groundwater pathway values from land application units, landfills, and 
waste piles (the risk assessment's nonwastewater units).

VI. Minimize Threat Levels

A. Background

1. Summary of the Hazardous and Solid Waste Amendments of 1984
    The Hazardous and Solid Waste Amendments (HSWA), enacted on 
November 8, 1984, allow hazardous wastes to be land disposed of only if 
they satisfy either of two conditions: (1) They can either be treated 
or otherwise satisfy the requirements of section 3004(m), which 
requires EPA to set levels or methods of treatment, if any, which 
substantially diminish the toxicity of the water or substantially 
reduce the likelihood of migration of hazardous constituents from the 
water so that short term and long term threats to human health and the 
environment are minimized; or (2) they can be land disposed in units 
satisfying the so-called no migration standards in sections 3004(d)(1), 
(e)(1), and (g)(5). Land disposal includes any placement of hazardous 
waste in a landfill, surface impoundment, water pile, injection well, 
land treatment facility, salt dome formation, underground mine or cave. 
See RCRA section 3004(k).
    EPA was required to promulgate land disposal prohibitions and 
treatments standards by May 8, 1990 for all wastes that were either 
listed or identified hazardous at the time of the 1984 amendments, a 
task EPA completed within the statutory time frames. See RCRA section 
3004(d), (e), and (g). EPA is also required to promulgate prohibitions 
and treatment standards for wastes identified or listed after the date 
of the 1984 amendments within six months after the listing or 
identification takes effect. See RCRA section 3004(g)(4).
    The land disposal restrictions are effective on promulgation. See 
RCRA section 3004(h)(1). However, the Administrator may grant a 
national capacity variance from the effective date and establish a 
later effective date (not to exceed two years) based on the earliest 
date on which adequate alternative treatment, recovery, or disposal 
capacity that protects human health and the environment will be 
available. (RCRA section 3004(h)(2).) The Administrator may also grant 
a case-by-case extension of the effective date for up to one year, 
renewable once for up to one additional year when an applicant(s) 
successfully makes certain demonstrations. (RCRA section 3004(h)(3).) 
See 55 FR 22526 (June 1, 1990) for a more detailed discussion on 
national capacity variances and case-by-case extensions.
    As explained in the legislative history, the purpose of the land 
disposal restrictions is to reduce the risks associated with land 
disposal. Congress also intended the restrictions to reduce reliance on 
land disposal and promote waste minimization since land disposal was 
its least favored method of managing hazardous wastes.
2. EPA's Interpretation of Standard for Treatment Requirements
    The heart of the LDRs are the standards for treatment prior to land 
disposal, which must meet the statutory requirement to ``substantially 
diminish the toxicity of the water or substantially reduce the toxicity 
of the waste so that short term and long term threats to human health 
and the environment are minimized.'' RCRA Section 3004(m): EPA's 
interpretation of this ``minimize threat'' requirement has evolved 
through a long series of rulemakings.
    When EPA proposed its first set of LDR treatment standards it took 
the position that the most effective way to minimize threats was to 
base standards on the capabilities of generally available treatment 
technologies. (51 FR 16011 (January 14, 1986).) To avoid unnecessary 
treatment, however, EPA also proposed to ``cap'' the technology based 
standards with risk-based screening levels based on human health 
toxicity thresholds for individual hazardous constituents and modeling 
of the groundwater route for exposure. (51 FR 16011-13.)
    In the final rule EPA promulgated only the technology based 
standards. EPA explained that although it believed it had authority to 
promulgate risk-based standards, it was not promulgating the proposed 
risk-based caps because of extensive comments raising concerns about 
the scientific uncertainties of risk analysis. (52 FR 40578 (November 
7, 1986).) Industry challenged the final standards, claiming that they 
required treatment to concentrations below ``minimize threat'' levels. 
On review, the Court held that section 3004(m) authorized both 

[[Page 66381]]
technology based and risk-based standards, but remanded the rule to EPA 
for a fuller explanation of its decision to rely on technology-based 
standards alone. (Hazardous Waste Treatment Council v. EPA, 886 F. 2d 
355 (D.C. Circ. 1989). (``HWTC III'').) The court also held that EPA 
was not obligated to adopt either the RCRA characteristic test levels 
or the Safe Drinking Water Act Maximum Contaminant levels (MCLs) as 
``minimize threat'' levels because neither ``purports to establish a 
level at which safety is assured or `threats to human health and the 
environment are minimized'.'' (886 F. 2d at 363.)
    In its response to the remand, EPA stated that the best way to 
fulfill the requirements of section 3004(m) would be to ensure that no 
technology-based treatment standard required treatment of hazardous 
waste containing levels of hazardous constituents posing insignificant 
risks. (55 FR 6641 (Feb. 26, 1990).) EPA, however, explained that it 
was not yet able to promulgate such levels. EPA believed that it lacked 
a reliable predictive model for ground- water exposure, needed to 
assess exposure scenarios for air pathways, needed to consider impacts 
on ecological receptors, needed to develop additional analytic methods 
for hazardous constituents, and needed to develop an approach for 
constituents with threshold effect levels lower than detection limits. 
(Id. at 6642.)
    In the same notice, EPA noted that the ``minimize threat'' language 
of section 3004(m) could reasonably be interpreted to require more 
protection than the ``normal subtitle C command that standards be those 
necessary to protect human health and the environment.'' (Id. at 6641.) 
EPA found that the many portions of the 1984 amendments stressing the 
inherent uncertainties of land disposal buttressed this interpretation. 
See, e.g., RCRA sections 1002(b)(7), 3004(d)(1)(A), 3004(e)(i)(A), 
3004(g)(5). EPA also found support in the legislative history. For 
example, the Senate amendment containing the ``minimize threat'' 
standards replaced a committee bill that only would have required 
treatment to be ``protective of human health and the environment.'' See 
S. 757, section 3004(b)(7), printed at S. Pep. No. 284, 98th Cong., 2nd 
Session 86. Further, EPA noted that the ``no threat'' levels it had 
been using in site-specific and waste stream specific contexts, such as 
clean closures, delistings, and no-migration petitions, would not 
necessarily be appropriate for generally applicable standards required 
to minimize threats to health and the environment. (55 FR 6641, note 
1.)
    At the same time, EPA took the position that section 30004(m) does 
not require the elimination of every conceivable threat posed by land 
disposal of hazardous waste, citing a statement by Senator Chafee that 
``[i]t is not intended that every waste receive repetitive levels of 
treatment, nor must all inorganic constituents be reclaimed.'' 130 
Cong. Rec. S.9179 (daily ed., July 25, 1984). (55 FR 6641, note 1.) 
Clearly EPA did not interpret the minimize threat language to require 
the elimination of all threats.
    Today, the Agency is proposing to re-evaluate the basis for some of 
the existing performance standards established for listed wastes. Since 
EPA's response to the HWTC III remand in 1990, the state-of-the-art in 
making quantitative determinations of risk has advanced and available 
methods have improved significantly. In addition, the increased 
sensitivity of analytical methods has lowered achievable detection 
limits, better bioassays exist than in the past, and more extensive 
biological data is available for extrapolation. As a result, the 
universe of available health-based and ecological data has grown 
significantly, and the reliability of this information has improved. 
The Agency now believes that these data can be used to establish levels 
that minimize threats to human health and the environment.

B. Risk Assessment and Minimize Threat Levels

1. Rationale
a. Overview
    Today the Agency is proposing to establish risk-based LDR treatment 
requirements for some of the hazardous constituents for which exit 
levels are being proposed. These risk-based LDR requirements will 
minimize the short-term and long-term threats to human health and the 
environment posed by the hazardous waste constituents. The risk-based 
LDR levels (or ``minimize threat'' levels) would have the effect of 
capping, or limiting, treatment of those waste constituents where the 
current technology-based UTS standards require lower concentrations. 
EPA also hoped to propose most of these constituent-specific levels as 
``minimize threat'' levels under section 3004(m) of RCRA that would cap 
current technology-based treatment standards under at these levels the 
LDR program. However, EPA is proposing ``minimize threat'' levels only 
for those constituents that were evaluated under the multipathway risk 
analysis and are not capped by quantitation (EQC) limitations. EPA is 
proposing to promulgate such levels as replacements for the 
constituent-specific treatment levels in the LDR Universal Treatment 
Standards (UTS). (As explained in more detail in Section VI, EPA is not 
proposing to cap any LDR standards requiring the use of specified 
technologies.) As shown on Table 1, Sec. 268.60, EPA is proposing 
``minimize threat'' levels to cap UTS treatment requirements for either 
the wastewater or nonwastewater (or both) for approximately 70 
wastewater constituents and 90 nonwastewater constituents.
    EPA, however, is not proposing that any extrapolated levels serve 
as ``minimize threat'' levels for LDR purposes. EPA does not have as 
much confidence that this alternative methodology provides enough 
information on risks to human health and the environment to enable EPA 
to determine that risks have been minimized. Similarly, EPA is not 
proposing that any levels based on quantitation limits serve as 
``minimize threat'' levels. Such levels are not based on any analysis 
of risks to human health and the environment. In fact, as explained 
above, EPA is proposing to require compliance with technology-based LDR 
standards for all wastes which contain such constituents.
    If a claimant finds that all constituents in a waste are below exit 
levels at the waste's point of generation and if the claimant meets all 
of the requirements for filing an exit claim, EPA will not require 
compliance with the LDR treatment standards for the waste. EPA will 
take the position that such as waste never became subject to subtitle C 
regulations, so that LDR standards never applied to the waste. EPA is 
proposing to take this position for all exit levels, regardless of 
whether they were generated by the multipathway analysis, the 
extrapolation method, or EQC limitations. For further explanation, see 
section VI.D.
    EPA, however, is proposing that all listed wastes which as 
generated contain constituents exceeding exit levels must meet LDR 
requirements (current or as modified by this proposal), even if the 
waste subsequently becomes exempt from hazardous waste regulation under 
this rule. This requirement resembles EPA's current rules for ``de-
characterized'' wastes, which must meet LDR requirements even after 
they cease to exhibit the hazardous characteristic that made them 
subject to Subtitle C in the first place. 

[[Page 66382]]

b. ``Minimize Threat'' requirement of Section 3004(m)
    EPA continues to believe that the minimize threat language of 
section 3004(m) does not require the elimination of every conceivable 
threat posed by land disposal of a hazardous waste. The legislative 
history of LDR indicates that Congress did not intend to require wastes 
to undergo repetitive or ultimate levels of treatment. Rather, Congress 
wanted to require use of effective, but widely available treatment 
technologies. See 130 Cong. Rec. S 9178 (daily ed. July 25, 1984) 
(statement of Senator Chafee introducing the amendment that became 
section 3004(m).)). Requiring elimination of all conceivable threats 
would almost certainly require use of the most effective treatment 
methods available, and this appears to conflict with Congresses' 
treatment goals. Moreover, although the DC Circuit has cited the 
dictionary definition of ``minimize'' to uphold technology-based 
treatment standards below EPA standards such as MCLs and TC levels, EPA 
does not believe that the court meant that EPA literally must reduce 
threats to the maximum extent possible. (See Hazardous Waste Treatment 
Council III, 886 F.2d at 361; Chemical Waste Management II, 976 F 2d. 
at 14.) EPA notes that the court indicated that risk-based treatment 
standards would satisfy section 30004(m). Hazardous Waste Treatment 
Council III, 866 F.2d at 364-65. Further, in his concurring opinion, 
Judge Silberman stated that Congress would allow EPA to exercise 
reasonable amounts of discretion in determining the level of risk 
reduction needed to meet the minimize threat requirement. Id. at 372.
    The Agency believes that today's exit concentrations can serve as 
risk-based land disposal restriction levels for several reasons. First, 
the risk assessment, described in Section IV of today's proposal, 
significantly expands beyond the scope of past Agency risk assessment 
for wastes and waste constituents. Where adequate data are available, 
the analysis can evaluate the potential for waste constituent migration 
through almost all significant environmental fate and transport 
pathways leading to exposure for human and ecological receptors. As 
explained in more detail below, the Agency is also relying on 
reasonable conservative risk targets for both humans and ecological 
receptors in developing this risk assessment. The Agency believes that 
the proposed exit levels represent levels below which further treatment 
would not be needed to minimize threats to human health and the 
environment.
c. Scope of Risk Assessment
    The broad scope of the risk analysis is a critical factor in the 
Agency's conclusion that proposed exit levels minimize both short term 
and long-term threats to human health and the environment, for those 
constituents where data are relatively complete.
    The risk analysis evaluates all of the most common non-Subtitle C 
disposal options available to waste generators and treaters. These 
include disposal in landfills/monofills and by land farming, and 
management in surface impoundments, tanks and waste piles. The risk 
analysis assumes no minimum level of regulation of these facilities, 
and relies on available data to characterize them. As described in 
detail in Section IV and in the risk analysis report (EPA 1995), EPA 
modeled each disposal alternative using median values for most inputs, 
and high-end or conservative values for the two fate and transport and 
two exposure parameters for which the modeling outcome is most 
sensitive. The Agency believes that the modeling will also protect 
against exposures from similar disposal alternatives not specifically 
modeled.
    The risk analysis evaluates the movement of waste constituents from 
each of these disposal options through numerous environmental fate and 
transport pathways. These include pathways involving volatiles and 
respirable (PM10) particulates, particulate deposition on soil and 
plant surfaces, vapor phase diffusion into surface water and plants, 
and surface run-off and soil erosion. Many of these pathways can result 
in waste constituent movement through the food-chains. Therefore, human 
exposures resulting from these fate and transport pathways include 
inhalation, soil or groundwater ingestion, and dermal contact, as well 
as exposure through consumption of contaminated foods such as fish, 
beef or vegetables.
    EPA screened all multipathway constituents for potential to pose 
threats to ecological receptors. For 45 constituents, EPA 
quantitatively assessed likely risk to selected ecological receptors. 
Risks to both fresh water aquatic and terrestrial organisms were 
evaluated, representing different trophic levels and feeding habits of 
the ecosystem. Fish, daphnids, and benthic organisms, mammals, birds, 
plants, and soil organisms (nematodes, insects, etc.) were evaluated. 
The sustainability of the ecosystem and reproducing populations within 
the aquatic and terrestrial ecosystems was selected as an assessment 
endpoint, as described in Section IV of this Notice and in detail in 
Chapter 3 of the risk analysis support document (EPA 1995).
    In addition, as part of this overall risk assessment effort, the 
Agency has reviewed and reevaluated its modeling of waste and waste 
constituent movement through groundwater. As described in Section IV 
above, this responds to comments by interested parties on the original 
HWIR proposal, as well as incorporates additional data submitted to the 
Agency (API data base), and updated modeling of leaching from wastes 
(new HELP model; get Cite).
    In evaluating groundwater, the Agency examined both wells located 
on the landfill edge and closest wells anywhere down-gradient. Also, 
both finite source type and infinite-source type constituents (which 
behave as though there is an infinite supply of the constituent in the 
landfill, and will continue to leach forever) were evaluated. For 
finite source type constituents, the available constituent was not 
apportioned over the groundwater and other pathways, i.e., groundwater 
was modeled separately. Adsorption to soil and degradation of waste 
constituents (but not biodegradation) is modeled, and the toxicity of 
constituent daughter products (either more or less toxic than the 
parent compounds) is included. (There is a biodegradation module to the 
model; however, data to run that module for national conditions are not 
adequate at this time, although data were available for some sites. The 
Agency will continue to evaluate biodegradation data as they become 
available, and assess in the future whether national biodegradation 
estimates can be defensibly made). Leaching and groundwater migration 
from disposal in unregulated industrial landfills, surface 
impoundments, and waste piles have been modeled.
    In evaluating the results of this series of groundwater modeling 
exercises, the Agency selected the approximate 90th percentile from a 
distribution of wells closest to modelled sites. This means that there 
is about a 90% probability that the drinking water well closest to the 
landfill would be protected at the target concentration (MCL or HBN). 
All wells more distant would be protected to a greater extent.
    As described in section VI.E. above, the Agency then reviewed the 
risk assessment for groundwater and the pathways for each constituent, 
and selected as the exit level the concentration, back-calculated to 
the waste, from the most limiting (or highest risk) pathway. By using 
the most 

[[Page 66383]]
limiting pathway as the basis for the risk criterion, the Agency 
believes it has accounted for all significant risks resulting from 
disposal and management of the waste outside of Subtitle C.
    The agency believes it is also important to identify and discuss 
some of the limitations of the risk assessment, especially as they 
relate to determining whether short term and long-term threats to human 
health and the environment have been minimized.
    The analysis does not account for additivity of risk for exposure 
to multiple constituents. Evaluation of risk additivity can be a 
complex analysis when even a few constituents are included. In the case 
of multiple waste constituents, potentially occurring in one or more 
waste streams that might be considered for exit, the complexity of 
conducting and analysis of additivity of risk quickly becomes 
overwhelming. However, EPA believes it will often be the case that one 
constituent typically drives determinations of whether waste streams 
exit and additivity would often make little difference with respect to 
the calculated exit levels.
    Exposures to the same constituent from several pathways also are 
not added together, even though the risk analysis does apportion the 
available quantity of waste constituents over the different pathways 
evaluated. Again, EPA believes that often one result (in this case, one 
pathway) would contribute most of the risk and little would be gained 
from adding across pathways. EPA requests comment on this issue.
    Data also were not available for all human exposure routes for all 
constituents, although data for high-risk pathways were usually 
available. Nonetheless, the Agency believes the exit levels can be 
considered to represent levels that minimize threats to human health 
and the environment because of the comprehensive evaluation of possible 
exposure routes, consideration of both human and ecologic risk, 
selection of the most restrictive pathway overall, and the relatively 
conservative risk target, 10-6, used in setting the exit levels 
derived from cancer risk estimates.
    As mentioned above, EPA conducted a screening analysis to identify 
47 high priority constituents for ecological assessment. EPA did not 
model the ecological impacts for 36 additional constituents that 
displayed one characteristic indicating potential ecological impacts. 
EPA is proposing to set minimize threat levels for 19 of these 
constituents.
    EPA believes that it has adequately assured that the caps to BDAT 
treatment standards proposed today minimize threats to the environment. 
The specific ecological risk assessment conducted for 45 constituents 
(19 of which have minimize threat levels under this proposal) is the 
most extensive EPA has ever conducted under the RCRA program to date. 
EPA did not find threshold effects data for all seven groups of 
ecological receptors for any constituent evaluated for ecological 
risks. Rather, EPA typically had benchmarks for three to five groups. 
Nevertheless, its consideration of a broad range of species and use of 
reasonably conservative endpoints ensures that threats to ecological 
receptors are minimized.
    With regard to chemicals that did not undergo this detailed 
assessment, EPA has conducted an extensive review of risks to human 
health, including a thorough review of risks posed by indirect pathways 
and risks posed by constituents that bioaccumulate in plants and 
animals consumed by humans. (Bioaccumulation is a key concern for 
protection of many ecological species.) EPA believes that it is 
reasonable to assume that the exit levels identified by this analysis 
also minimize threats to ecological receptors unless it has some 
definite data indicating that additional protection is warranted. 
Reliance on these levels is particularly appropriate for those 
chemicals that did not display one of EPA's ecological screening 
characteristics. EPA finds it also appropriate for the 15 ``minimize 
threat'' chemicals which exhibited one ecological screening 
characteristic. EPA acknowledges that conducting a specific assessment 
of ecological risks for these 15 constituents would have provided 
additional assurance that threat to ecological receptors were 
minimized. EPA solicits comment on the option of declining to set 
minimize threat levels for these 15 constituents until it can complete 
an ecological assessment for them.
d. Risk Targets Minimize Threats
    The Agency believes that the risk targets used in the risk analysis 
to back calculate to waste concentrations minimize threats to human 
health and the environment. For cancer risks to human, a risk target of 
one in one million, over a lifetime is the risk target. For non-
carcinogens, a
FR Doc. 95-29458 Hazardous Waste Management System: Identification and Listing of Hazardous Waste: Hazardous Waste Identification Rule (HWIR)
 hazard quotient (HQ) based on a reference dose or other 
comparable value from the literature could not exceed one (hazard 
quotient (HQ)=1). Reference doses or comparable values are based on 
studies of toxicity and no-effect levels in test animals and 
extrapolated, using safety factors, to humans. For ecological 
receptors, population effects inferred from individual effects and 
effects on a substantial number of both aquatic and terrestrial species 
were evaluated.
    Other risk targets may be considered in establishing minimize 
threat levels. The Agency solicits comment on whether apportionment of 
the RfD ought to be used in establishing minimize threat levels (i.e., 
HQ<1). The Agency uses 20% of the Rfd in setting drinking water 
standards; a similar approach might be appropriate in establishing 
minimize threat levels and in establishing exit levels. EPA requests 
comment on this issue.
2. Public Policy Considerations
    Finally, the Agency believes that it represents good public policy 
to reduce or eliminate unneeded or duplicative regulatory requirements. 
In this case, the Agency believes that for the initial list of 
constituents listed in Table 1 of 40 CFR 268.60, treatment to the UTS/
LDR standard is no longer required beyond waste constituent 
concentrations where risks to human health and the environment are 
insignificant. Because there is no purpose in terms of protecting human 
health and the environment for retaining the more stringent LDR 
requirements, the Agency is proposing to revise them to the risk-based 
levels. This would reduce the overall number of different and distinct 
regulatory requirements on waste generators and treaters, would 
rationalize the RCRA regulations, and will provide significant 
pollution prevention opportunities and incentives. Waste generators 
would have only one target level to direct their pollution prevention 
effort toward. If generators met the LDR/exit levels, the waste would 
not be considered hazardous, and no additional treatment would be 
required before disposal in a subtitle D facility. Where waste 
continues to exceed one or more exit levels after LDR requirements are 
met, subtitle C disposal would be required.

C. Risk-based LDR Levels

1. List of Constituents and Minimize Threat Concentrations
    As was mentioned earlier in this section, only modeled 
constituents' risk-level results are eligible to serve as risk-based 
LDR levels meeting the statutory requirement of minimize threat. In 
addition, minimize threat levels are only proposed for those 
constituents where the risk level is higher (less stringent) than the 
associated 

[[Page 66384]]
technology-based treatment standard in Sec. 268.40 or the UTS level in 
Sec. 268.48.
    First, the Agency repeats that it is not proposing to set any 
alternative risk-based LDR standards expressed as specified 
technologies (rather than constituent concentrations.) Consequently, 
the option of complying with minimize threat levels in lieu of levels 
specified in part 268 will be available only for wastes with treatment 
standards expressed as constituent concentrations. This includes both 
wastes subject to waste-specific treatment requirements under the table 
to Sec. 268.40 and wastes subject to the Universal Treatment Standard 
levels in the table to Sec. 268.48
    The Agency proposes that for purposes of establishing nonwastewater 
and wastewater minimize threat values for wastes with BDAT treatment 
standards expressed as constituent concentrations, the levels proposed 
would utilize the LDR definitions of nonwastewater and wastewater from 
40 CFR 268.2(d) and (f). Therefore, any exit levels that are considered 
nonwastewater for purposes of exit will also be considered 
nonwastewater for purposes of minimize threat. Likewise, wastewater 
exit levels will be considered wastewater LDR levels. The Agency 
believes that consistent definitions of nonwastewater and wastewater is 
the only practical means to establish minimize threat levels. The 
Agency realizes, however, that the modeling and subsequent development 
of exit levels for today's proposed exit did not use the part 268 
definition of nonwastewater and wastewater. (A complete discussion of 
this may be found in section VIII.A.1.a.ii.) The effect of this would 
be that some wastes that would be defined as wastewaters under today's 
proposed exit scheme would be considered LDR non-wastewaters. The 
Agency requests comment on whether the definition in Part 268 should be 
adopted for purposes of establishing minimize threat levels.
    The Agency compared the exit levels to the current LDR treatment 
levels to determine whether a constituent's risk level should be 
proposed as a minimize threat level. For wastewater values, the LDR 
wastewater value was directly compared to the wastewater exit value. 
Where the UTS nonwastewater level is a total level, the comparison was 
made to the nonwastewater totals exit level. Where the LDR 
nonwastewater level is a leach level, the comparison was made to the 
nonwastewater leach exit level. However, for the reasons explained 
below, the nonwastewater minimize threat level would contain both a 
leach level and a totals level. For both wastewater and nonwastewater, 
where the most comparable exit level is higher (less stringent) than 
the current LDR level, the constituent's risk level is proposed as an 
optional minimize threat level. The Agency requests comment on this 
approach to determining which exit levels are higher than current LDR 
levels.
    The Agency is proposing that testing requirements when using 
minimize threat levels would be consistent with the current LDR testing 
requirements found in Sec. 268.7. The Agency proposes that if a 
claimant wishes to meet LDR requirements by complying with a minimize 
threat level, the claimant must meet the minimize threat levels with a 
totals analysis, and where specified, the waste must meet the leach 
level with a leachate analysis. The Agency believes that a totals 
analysis is preferable to a leach analysis for establishing minimize 
threat levels, as it more directly pertains to all pathways, not only 
the groundwater pathway.
    Today's proposed exit levels for nonwastewaters consist of two risk 
levels for each constituent. The totals (mg/kg) nonwastewater risk 
level is the result of the most limiting non-groundwater pathway. The 
leach (mg/L) nonwastewater risk level is the result of the most 
limiting groundwater pathway. The Agency believes it would be 
preferable to have one exit level, but the groundwater model results 
are a leach (mg/l), whereas the results from the multipathway analysis 
are a totals (mg/kg), and the science to extrapolate from a leach to 
totals is highly variable. Using only the leach or only the total risk 
level would reflect only a portion of the risks presented by the waste. 
A waste must meet both of these limits before it minimizes threats to 
human health and the environment. Consequently, EPA is proposing to 
include both levels in the minimize threat standards for 
nonwastewaters. The Agency proposes to allow generators to either use a 
calculational screen or perform the TCLP to make a determination that 
constituent concentrations do not exceed nonwastewater leach minimize 
threat levels. A full discussion and explanation of the calculational 
screen can be found in section VIII.A.1.a.iii. of today's proposal.
    Because extrapolating from a leach to a total varies with each 
constituent and is not easily measured, EPA has not directly compared 
both of the minimize threat levels with the LDR standard. The Agency 
requests data on specific constituents where the second, less easily-
compared nonwastewater minimize threat level may be harder to achieve 
than the current LDR standard. If such results occur, waste handlers 
will not be required to use the new minimize threat levels. The levels 
in the tables to Sec. 268.40 and Sec. 268.48 will continue to satisfy 
LDR requirements as they always have. The minimize threat levels will 
be located in Table 1 of Sec. 268.60, are optional, and are intended to 
be used to provide treatment relief. The Agency believes that minimize 
threat levels will only be used where they are less stringent than 
current LDR levels. The Agency requests comment on the proposed 
revisions to part 268 with respect to minimize threat levels.
    Table D-1 of appendix D to the preamble presents for comparison 
current LDR UTS standards and proposed minimize threat levels. The 
Agency is proposing that for the constituents listed below, the risk 
levels may substitute for current UTS treatment levels in 40 CFR 268.48 
or for treatment standards for these constituents in 40 CFR 268.40. A 
table of the proposed minimize threat levels can be found at proposed 
40 CFR 268.60 subpart F in the regulatory text following this preamble.
2. Constituents for Which Exit Levels Are Not Minimize Threat Levels
    As an alternative to the approach described in C.1 above, the 
Agency solicits comment on the background data underlying the risk 
evaluations for these constituents. The Agency believes, in general, 
that the constituents evaluated in the risk analysis have relatively 
complete assessments of risk. The Agency recognizes, however, that data 
quality and completeness can vary among constituents, even for those 
for which risk can be assessed. The Agency solicits comment on both 
general criteria for assessing completeness of data, and also specific 
constituents for which use as minimize threat levels to cap LDR 
requirements may be inappropriate.

D. Meeting LDR Requirements

1. Wastes Below Exit Levels as Generated
    EPA proposes that, if a generator samples a listed waste stream at 
its point of generation and analysis of the sample shows all 
constituents to be below exit levels, LDR requirements would not apply 
to the waste. EPA is proposing this result both for constituents with 
exit levels based on multipathway analysis (where, since exit levels 
can serve as LDR ``minimize threat'' levels that cap current treatment 
requirements, the LDR program will never require treatment to levels 
lower than exit levels) and constituents with 

[[Page 66385]]
exit levels based on extrapolation from the multipath analysis or 
quantitation levels (where, since EPA has not proposed to make exit 
levels into LDR minimize threat levels,the LDR programs may require 
treatment to levels lower than exit levels).
    To claim this relief generators would have to certify that they 
sampled their wastes at the point of generation. In the interim between 
sampling and receipt of analytical results, the generator would be 
required to manage the waste as hazardous. However, EPA would take the 
position that this brief period of Subtitle C regulation would not 
subject the waste to LDR requirements.
    EPA believes that position is consistent with its prior 
interpretations of LDR provisions and the D.C. Circuit's opinion in 
Chemical Waste Management II. At issue in that case was EPA's 
determination that LDR treatment standards apply to wastes that are 
characteristically hazardous at the point of generation but that 
subsequently cease to exhibit characteristics and become nonhazardous 
wastes. EPA took that position to ensure that characteristic wastes 
receive effective treatment. Without this requirement, for example, it 
would be possible to dilute characteristic wastes and evade LDR 
treatment requirements. The Court held that EPA must apply this 
interpretation consistently to characteristic wastes.
    It is not necessary, however, to follow this interpretation for 
wastes that are generated with all constituent concentrations below 
exit levels. EPA can reasonably distinguish between wastes that are 
below exit levels at the point of generation and wastes which achieved 
such levels at some subsequent time. Only wastes which exceed exit 
levels at the point of generation need continued LDR applicability to 
ensure that they reduce constituent concentration or constituent 
mobility by complying with LDR standards rather than using dilution or 
some other inferior form of treatment. A generator of wastes that meet 
exit levels as generated would not use waste treatment to evade LDR 
requirements. Rather, he or she might use waste minimization techniques 
to reduce concentration or mobility of constituents in the precursor to 
his waste.
    EPA notes that it is proposing to require listed wastes which 
exceed exit levels at the point of generation to meet LDR treatment 
requirements, even if the waste later meets exit levels. EPA believes 
that this requirement carries out the LDR requirements set out in the 
Third Third rule and the Chemical Waste decision.
    Finally, EPA notes that it would be possible to articulate 
alternative rationales for exempting from LDR requirements wastes which 
meet today's exit levels as generated. For exit levels based on 
extrapolations from the multipathway analysis, EPA could argue that 
extrapolated levels are LDR ``minimize threat'' levels. EPA, however, 
thinks protection of the environment is better served by refraining 
from such a step and requiring wastes which exceed such levels at the 
point of generation to meet current technology-based LDR standards. (As 
explained above, EPA is not entirely certain that these extrapolated 
levels actually minimize risks for all constituents.) For exit levels 
based on quantitation limits, imposing LDR requirements would not have 
any practical impact. LDR treatment standards are limited by the same 
quantitation limits proposed for this rule. Consequently, treatment 
standards for constituents limited by analytical capabilities are not 
lower than the exit levels.
2. Wastes Above Exit Levels as Generated
    Listed wastes that are above exit levels as generated would be 
required to be treated to the LDR standards in force at the time if 
they are placed on the land.

VII. Dilution

    The 1984 RCRA Amendments (HSWA) established a vigorous national 
policy for minimizing the generation of hazardous wastes. Section 1003 
of RCRA, as amended in 1984, established a national waste minimization 
policy stating that ``wherever feasible, the generation of hazardous 
waste is to be reduced or eliminated as expeditiously as possible''. 
The policy also cited the need to reduce the volume and toxicity of 
hazardous wastes which is nevertheless generated. Similarly, section 
3005(h) prescribed that effective September 1, 1985, all RCRA 
permittees who generate waste disposed of, treated, or stored on-site 
certify, on an annual basis, that the facility has waste minimization 
programs in place. In addition, section 3002(b) mandates that hazardous 
waste generators include a certification with their hazardous waste 
manifests that the generator has a waste minimization program in place 
and that the proposed method of off-site management minimizes threats 
to human health and the environment. In concert with these HSWA 
mandates, it is the Agency's policy to encourage source reduction 
(i.e., waste minimization) and waste treatment as preferable to 
disposal and dilution.
    EPA has recognized that successful implementation of the land 
disposal restrictions requires that, in general, dilution be prohibited 
as a partial or complete substitute for adequate treatment of 
restricted wastes. The legislative history indicates that such a 
prohibition ``is particularly important where regulations are based on 
concentrations of hazardous constituents'' (H.R. Rep. no. 198, Part I, 
98th Congress, 1st Session 38 (1983)).
    The Agency also opposes the dilution of hazardous wastes for 
several technical reasons. Most importantly, dilution is an 
environmentally inappropriate means to reduce toxicant concentrations 
because it does not reduce toxicant loadings to the environment. The 
same mass of toxicant is released to the environment when a diluted 
waste is disposed as would be if that same waste, prior to dilution, 
were to be disposed. While mass loading of the environment is itself a 
serious concern, the potential for environmental damage is magnified 
when toxicants (for example, pesticides and metals) bioaccumulate in 
the food chain. In addition, diluted wastes can create an unnecessary 
demand for scarce solid waste disposal capacity.
    For these reasons, dilution is generally prohibited as a means to 
achieve the exemption levels under today's proposal. Because today's 
rule proposes to amend the some of the current LDR levels by 
establishing minimize threat levels, allowing dilution as a means of 
achieving exemptions would be inconsistent with the ban on dilution 
included in the land disposal restrictions rule (40 CFR 268.3). In 
addition, dilution would be inconsistent with the Congressional purpose 
of encouraging waste minimization. Thus, today's proposed rule 
specifically prohibits dilution as a means of attaining the exemption 
levels except as provided under the LDR program under 40 CFR 268.3(b).

VIII. Implementation

    Today's proposed rulemaking would establish a generic set of 
constituent-specific exemption levels for listed hazardous wastes. 
Wastes with hazardous constituent concentrations below the generic 
exemption levels would be conditionally exempt from Subtitle C.5 
Today's proposed 

[[Page 66386]]
rulemaking would be self-implementing; that is, no prior governmental 
approval or review of documentation would be required before wastes are 
eligible to exit. Claimants of an exemption, however, would be required 
to meet certain prerequisites in addition to the generic constituent 
concentration levels before the wastes would be considered non-
hazardous. These testing and notification requirements are necessary to 
ensure that only those hazardous wastes which truly meet the exemption 
criteria exit the subtitle C system. In addition, certain testing and 
record-keeping conditions would be imposed to maintain the exemption to 
ensure that the waste continued to be eligible for the exemption. 
Failure to satisfy the conditions would void the exemption.

    \5\ Exempted wastes would continue to be solid wastes, and as 
such would require proper management under subtitle D and other 
applicable state laws.
---------------------------------------------------------------------------

A. Implementation Requirements

    To make an effective claim, persons would need to comply with the 
following requirements:

--The waste must be sampled and tested in accordance with a 
comprehensive sampling and analysis plan prepared prior to conducting 
sampling and analysis (EPA recommends, as guidance, using the basic 
elements of sampling and analysis plans described in Chapters One and 
Nine of SW-846);
--Representative samples collected in support of an exemption proposed 
in today's notice must consist of a sufficient number of samples to 
represent the spatial and temporal variability of the waste 
characteristics;
--The waste must be tested for all hazardous constituents except those 
that should not be present in the waste as defined by this rule, with 
documentation supporting determination not to test any constituent 
available on-site at the time of the notification;
--If the claimant must test for any hazardous constituents on table B 
of appendix X of 40 CFR part 261, the waste must also meet treatment 
standards for those constituents listed on UTS table of 40 CFR 268.48;
--A notification must be submitted to the Regional Administrator (or 
authorized State) (hereafter referred to as the implementation 
authority), along with
--A certification signed by the claimant's authorized representative 
attesting to the completeness and accuracy of the notification, and
--Verification that a notice of the exemption claim has been placed in 
a major local newspaper of general circulation.

    Any deficiencies in compliance with these requirements would 
prevent the exemption from being valid; that is, the waste would not 
exit the subtitle C system. Claimants would not be able to use their 
knowledge of the waste alone to make a determination. Furthermore, in 
order to defend a claim that a waste was exempt under today's proposed 
rule and thus exempt from hazardous waste regulation, claimants would 
bear the burden in an enforcement action of establishing that the waste 
in question met the exit levels and the other requirements for the 
exemption.
1. Testing Requirements
    In today's notice, the Agency is proposing concentration-based 
exemption criteria below which a listed hazardous waste would be 
conditionally exempt from subtitle C compliance. To best ensure 
accurate characterizations of constituent concentrations in these 
wastes, the Agency is also proposing sampling and analysis requirements 
for the exemption determination proposed today. Adherence to these 
requirements, however, does not ensure that the characterization is 
accurate and representative of a waste on a continual basis. It is the 
generator's responsibility to ensure that a waste always meets the 
exemption requirements proposed today for all appendix X of 40 CFR part 
261 constituents, regardless of which constituents the facility is 
required to test and how often testing is performed.
    To be eligible for an exemption, EPA is proposing that facilities 
must (1) demonstrate that each constituent of concern is not present 
above the specified exemption level in the waste, (2) demonstrate that 
the analysis could have detected the presence of the constituent at or 
below the specified exemption level, and, (3) where specified, comply 
with the LDR standards applicable to the waste. Today's proposed rule 
allows that any reliable analytical method may be used to demonstrate 
that no constituent of concern is present at concentrations above the 
exemption levels. It is the responsibility of the generator to ensure 
that the sampling and analysis is unbiased, precise, and representative 
of the waste.
    The Agency will consider that the exemption level was achieved in 
the waste matrix if an analysis in which the constituent is spiked at 
the exemption level indicates that the analyte is present at that level 
within analytical method performance limits (e.g., bias and precision). 
The Agency prefers this empirical demonstration of method performance 
through the successful analysis at the exemption level. The Agency 
requests comment on this and any other approaches to demonstrate method 
performance.
    In general, the Agency is proposing testing requirements that would 
consist of an initial test to characterize the waste as exempt, 
followed by subsequent testing to ensure ongoing compliance with 
constituents of concern. A generator of a listed waste on a one-time 
basis will only be required to comply with initial testing 
requirements. Wastes produced on an infrequent (batch) or continuous 
basis will have to comply with initial testing requirements and 
subsequent testing requirements as appropriate based on the volume of 
the waste. The Agency asks for comment on this general approach to 
testing requirements.
a. Data Evaluation
i. Compliance With the Exit Levels
    The Agency is requesting comment on three approaches of data 
evaluation.
    First, the Agency is proposing that, for exemptions under today's 
proposed rule, generators would be required to evaluate their waste 
based on the maximum detected concentrations of the exemption 
constituents. If any constituent concentration is greater than its 
specified exit level, then the waste would be ineligible for exemption 
under today's proposed rule. One advantage of this approach is that 
facilities can use process and waste knowledge to determine the 
appropriate number of representative samples without relying on a 
complex, potentially costly statistical approach to determine an 
appropriate number of samples. However, generators will need to be 
sufficiently knowledgeable about their waste and process to make an 
unbiased determination regarding the appropriate number of samples. 
Actual sample representativeness might be difficult to verify or 
otherwise assess (on a statistical basis). Finally, the level of 
uncertainty associated with the results cannot be defined. Because of 
this, under this approach, a single composite sample that validly 
exceeds the HWIR exit levels would indicate that the waste is hazardous 
and must be handled in Subtitle C.
    Second, the Agency requests comment on also allowing a second data 
evaluation method whereby the analytical results are evaluated in terms 
of an upper confidence limit around an average concentration. An 
example of one method for determining an upper confidence limit is 
presented in the statistical approach found in Chapter Nine of SW-846 
(Third Edition, as amended by Updates I, II, IIA, and IIB), 

[[Page 66387]]
where, for the purpose of evaluating solid wastes, the probability 
level (confidence interval) of 80 percent is used. Sample measurements 
for which the upper limit of the 80 percent confidence interval about 
the sample mean is below the regulatory level for the chemical 
contaminant are not considered to be present at levels of regulatory 
concern. One main advantage of this approach is that the number of 
samples is statistically determined and thus it eliminates any bias 
that might otherwise be introduced when using knowledge to determine 
the appropriate number of samples. In addition, the level of 
uncertainty associated with the results can be determined. However, the 
main disadvantage of this approach is that it could be more costly for 
some facilities than the proposed approach. For example, it might 
require multiple rounds of sampling to determine the mean and variance. 
Highly variable wastes may require the collection of many more 
additional samples than might otherwise be determined to be necessary 
using the first approach. However, this statistical approach allows 
occasional samples to be above exemption level, as long as the upper 
confidence limit of the data overall is below the exit level.
    The Agency also requests comment on a third data evaluation method 
that would allow facilities to use long-term average data to 
demonstrate compliance without consideration of the upper confidence 
limit. A rolling average of samples would be taken over the course of a 
year on a schedule determined by the initial sampling and analysis 
plan. As long as the average of the samples was below the HWIR exit 
level, the waste stream would be considered non-hazardous. This 
approach would have the advantage of being simpler than the second 
option, while allowing occasional exceedences of the exit levels by 
single samples, as long as the average concentration is below exit 
levels.
    EPA has modelled risk with the assumption that the constituents of 
concern are uniformly distributed within the waste at the exit 
concentrations. In discussion with the Hazardous Waste Identification 
Dialogue Group, some representatives noted that actual levels might 
need to average significantly below the exit levels if the exit 
criteria are to be consistently met. The second and third data 
evaluation methods discussed above help address this issue.
    However, EPA and the States have noted that the only practical 
approach for enforcement purposes is to independently collect samples 
for analysis (which may represent a composite of materials spatially or 
over a short time span) and to set up the regulation so that an 
exceedence by any single composite sample during an inspection could 
constitute a violation. It would then be the responsibility of the 
generator to refute this, using historic sampling data and possibly 
additional samples to show that the sample exceedence does not 
constitute an overall violation of the HWIR levels.
    EPA believes it is important to retain the practical approach 
whereby a single composite sample of a waste at some arbitrary point in 
time or space during a short visit is considered sufficient for 
enforcement purposes. However, because the exit numbers were modeled 
based on long-term average concentrations, the Agency requests comment 
on allowing occasional exceedences as long as the average concentration 
meets the exit level.
    In addition to the concern about enforceability, however, EPA has 
identified two additional concerns about using average concentration to 
determine compliance. First, not all waste streams would be disposed of 
in the same place. Thus the wastes may on average be in compliance when 
they are generated, but the wastes arriving at the disposal site 
(possibly from multiple sources) may not be, on average, below the exit 
levels. Second, EPA has not modeled the constituents for acute risk. 
While the average concentration of constituents may be below the exit 
levels, the occasional ``high'' concentration may be of concern due to 
acute health or ecological effects.
    One possible way to address some of these concerns is, in addition 
to requiring that the average meet the exit levels (as in the second 
and third data evaluation methods), EPA could require that all samples 
be below some ``peak'' concentration.
    Under this approach, if the average concentrations are below the 
exit levels, and all individual samples are below the higher peak 
level, then the generator would be in compliance and need take no 
further action to support the exemption. EPA or a State would then be 
able to confirm waste status without total reliance on the generator's 
data and without the expense of periodic sampling by EPA or the State. 
EPA requests comment on this issue, including any information on 
setting peak levels.
    For any of the three data evaluation approaches, representative 
samples must be collected in support of exemption under today's 
proposed rule, consisting of a sufficient number of samples to 
represent the spatial and temporal variability of the waste 
characteristics, regardless of how the sample number is determined.
    For the identification and handling of ``outliers'', the Agency is 
recommending that testing for outliers should be done if an observation 
seems particularly high or low compared to the rest of the data set. If 
an outlier is identified, the result should not be treated as such 
until a specific reason for the abnormal measurement can be determined 
(e.g. contaminated sampling equipment, laboratory contamination, data 
transcription error). If a specific reason is documented, the result 
should be excluded from further data evaluation. If a plausible reason 
cannot be found, the observations should be treated as a true, albeit 
extreme, value and not excluded from the data evaluation, as waste 
composition can vary. The Agency solicits comments on implementable 
techniques for the identification of analytical outliers.
    The results of the tests of all of the constituents on the 
exemption list would be required to show the constituent concentration 
to be at or below the exit level in order for the claimant to be 
eligible for an exemption. In the case where a constituent's exit level 
is based on the quantitation criteria (EQC, as described in section 
IV.E.), in addition to showing a non-detect at the exit level, the 
waste would be required to meet applicable requirements set forth at 40 
CFR part 268. Certain facilities may have difficulty quantifying a 
constituent at the exit level due to matrix interference effects, but 
the Agency expects exempted wastes to have relatively clean matrices 
such that exit levels should be able to be achieved. The Agency 
believes that the exit level must be met in order for a waste to exit 
Subtitle C; therefore, waste streams that cannot meet exit levels would 
not exit under today's rule. The Agency asks for comment on this 
approach.
ii. Wastewater and Nonwastewater Categories
    Throughout today's proposal and background documentation, all of 
the exit levels have been described as being applicable to two 
categories of wastes using the terms wastewater and non-wastewater 
6. EPA used these terms as an initial means of distinguishing two 
waste categories that are inherent to how the exit levels were 
developed, by taking into account how these wastes 

[[Page 66388]]
will be managed (i.e., stored, treated, and disposed), and also how the 
wastes would be expected to behave in the environment. In the 
development of the exit levels, several waste management units were 
evaluated in the underlying risk analysis. The units chosen for 
evaluation were those that are considered most likely to manage the 
types of wastes that would be expected to exit Subtitle C regulation 
under today's exemption. Although these units will likely receive to 
some degree both forms of waste, in general there are technical, 
physical, and sometimes legal constraints on what types of waste are 
managed in each. The Agency considered ash monofills, waste piles, and 
land application units as typically managing waste materials that can 
be considered ``solid'' or ``non-wastewater,'' while tanks and surface 
impoundments typically manage ``liquid'' or ``wastewater.'' Based on 
these assumptions, results from the analysis of risk from these 
specific waste management units were then used to generate the 
corresponding exit levels for non-wastewater and wastewater.

    \6\ The terms ``wastewater'' and ``non-wastewater'' are used 
generically in today's preamble and rule, and do not represent the 
land disposal restriction definitions in 40 CFR 268.2(d) and (f), 
although one option EPA is requesting comment on in this section is 
the use of those definitions.
---------------------------------------------------------------------------

    In considering how to develop final definitions and terms for these 
two waste categories, the Agency's goal is to establish definitions 
that are clear, concise, and easily distinguishable from other similar 
terms such that a generator can readily determine which set of exit 
levels to apply to the waste being evaluated for the exemption. EPA 
requests comment on three options for defining these two waste 
categories to determine which set of exit levels to apply to a listed 
waste eligible for today's proposed exemption. EPA emphasizes that 
these definitions will only apply in the context of today's exit rule.
    The Agency also requests comment on whether it is reasonable in all 
three options to allow a generator the alternative options of 
separating in the laboratory the solid (or nonwastewater) portion of 
the waste from the liquid (or wastewater) portion of the waste, 
analyzing the resultant portions, comparing the results to the 
corresponding exit levels, and treating the waste as exempt if all exit 
levels are met in both portions.
    Option 1: Using Percent Solids--EPA prefers the option of defining 
the two categories of exit levels as ``solid'' and ``liquid'' exit 
levels, where the distinction between solids and liquids is based upon 
the percent solids content of the waste, as determined using Section 
7.1 of the Toxicity Characteristic Leach Procedure (TCLP) in SW-846. 
Specifically, the option would define wastes containing 15 percent 
solids by weight or greater as solids,7, while wastes with less 
than 15 percent solids by weight be defined as liquids. EPA believes 
that the 15 percent cutoff is a reasonable distinction between the two 
categories of exit levels, for the following reasons. Because there are 
general prohibitions on liquids or wastes containing free liquids in 
non-hazardous waste landfills accepting municipal wastes, the Agency 
does not envision wastes containing less than 15 percent solids being 
managed in these units. Similarly, it is unlikely that waste containing 
less than 15 percent solids will be stored in waste piles due to 
obvious physical limitations. For land application units, EPA believes 
that 15 percent solids content by weight is a reasonable lower limit 
for the types of wastes typically managed in these units; indeed, this 
was the value used in the land application unit scenario in the 
groundwater modeling portion of the risk assessment underlying today's 
exit levels.

    \7\ EPA will avoid use of the term ``solid waste'' when 
describing the category of exit levels that are defined as solids 
under this option in today's proposal. This is to avoid confusion 
with the existing term ``solid waste'' in the RCRA program, which 
has specific statutory and regulatory definitions, which have no 
relationship to whether a waste is a physically a solid or a liquid.
---------------------------------------------------------------------------

    Because of these limitations, EPA believes that wastes containing 
less than 15 percent solids will more frequently be managed in the 
types of units associated with wastewater treatment, such as tanks and 
surface impoundments. In fact, EPA believes that many wastes falling 
into the liquid category under this definition, that can realistically 
exit under today's proposed exit rule, will likely be wastewaters that 
have undergone treatment and that contain much less than 15 percent 
solids. EPA presumes that in many cases the separation of water from 
solids will be occurring as part of routine wastewater treatment, and 
generators will be either be evaluating the solid residues (which would 
clearly meet our solid definition), or the treated water, much of which 
is currently discharged under the Clean Water Act and therefore likely 
has limits on the amount of solids present.
    EPA also requests comment on alternative ways of determining 
percent solids content, including generator knowledge of the waste or 
results of previous analyses. The Agency believes that in many cases, 
particularly for fairly dry or fairly wet wastes, the generator can 
immediately ascertain from a visual inspection that the percent solids 
content is well above or well below the 15 percent solids value.
    Option 2: Using LDR Definitions--EPA also requests comment on the 
use of the same terms and definitions currently used under the land 
disposal restrictions. Wastewater is defined as waste containing less 
than 1 percent total suspended solids (TSS) and less than 1 percent 
total organic carbon, or TOC (40 CFR 268.2(f)). Non-wastewater is 
defined as any waste that is not a wastewater (40 CFR 268.2(d)). The 
principle advantage of this approach is it allows the use of consistent 
definitions for wastewater and nonwastewater in both today's exit 
system for listed wastes, and the LDR program. The advantage of this 
consistency is particularly apparent for those cases where LDR 
treatment standards are conditions of exit under today's rule. One 
disadvantage of this approach is that it defines wastes containing 
greater than 1 percent TSS as non-wastewater, even though these wastes 
will likely be managed in wastewater treatment systems using tanks and 
surface impoundments, which is inconsistent with the way in which the 
results from the risk analysis were used in developing exit levels. The 
Agency requests comment on this approach as an alternative to Option 1.
    Option 3: Using the Paint Filter Liquids Test--The third option is 
to use the terms ``liquid'' and ``solid'' as in Option 1, but to use 
EPA Method 9095 from SW-846, the Paint Filter Liquids Test, to 
determine whether the waste being evaluated for exit is a liquid or a 
solid. Under this option, any waste determined to contain free liquids 
using Method 9095 would be considered a liquid, and the exit numbers 
currently in the wastewater category would apply to that waste. 
Conversely, a waste would be defined as a solid, and the nonwastewater 
exit levels would apply, if the waste does not contain free liquids 
using Method 9095. Under this option, EPA realizes that many wastes 
appearing like solid materials would actually be defined as liquids.
    Method 9095 is presently used in defining the term ``liquid waste'' 
in the solid waste disposal facility criteria, for determining 
compliance with the prohibition on disposing of bulk or containerized 
liquid in municipal solid waste landfills (see 40 CFR 258.28). Method 
9095 is also used in determining compliance with the prohibition on 
bulk or containerized liquids in hazardous waste landfills 
(264.314(c)).
iii. Totals and TCLP Analyses
    Today's rule proposes that the claimant would be required to test 
the waste for which today's exemption is 

[[Page 66389]]
being claimed to prove that constituent concentrations in the waste do 
not exceed the exit level(s) for each constituent that should be 
present in the waste.
    The claimant would determine which category of exit levels would 
apply (e.g., wastewater or nonwastewater) to his waste. In a previous 
section of today's rule, the Agency requests comment on several options 
to define these two categories. For a wastewater waste to be eligible 
for exit, every constituent in the waste must comply with the 
wastewater total constituent exit concentration. For a nonwastewater 
waste to be eligible for exit, every constituent in the waste must 
comply with the nonwastewater total constituent exit level as well as 
the nonwastewater leach exit level.
    A test for total concentration would be required for each 
constituent in the waste regardless of whether the waste is a 
wastewater or a nonwastewater to determine that the total constituent 
exit concentration has not been exceeded. For non-wastewaters, a 
claimant must also prove that the measurable leachate concentrations do 
not exceed the nonwastewater leach exit levels. The Agency proposes to 
allow claimants to either use a calculational screen or to use the 
Toxicity Characteristic Leaching Procedure (TCLP, Test Method 1311 in 
``Test Methods for Evaluating Solid Waste, Physical/Chemical Methods,'' 
EPA Publication SW-846) to make a determination that constituent 
concentrations do not exceed nonwastewater leach exit levels. 
Discussion concerning the methodology of a calculational screen is 
described below.
    Section 1.2 of the TCLP allows for a compositional (total) analysis 
in lieu of the TCLP when the constituent of concern is absent from the 
waste, or if present, is at such a low concentration that the 
appropriate regulatory level could not be exceeded.
    For wastes that are 100% solid as defined by the TCLP, the maximum 
theoretical leachate concentration can be calculated by dividing the 
total concentration of the constituent by 20. The dilution factor of 20 
reflects the liquid to solid ratio employed in the extraction 
procedure. This value then can be compared to the appropriate 
regulatory concentration. If this value is below the regulatory 
concentration, the TCLP need not be performed. If the value is above 
the regulatory concentration, the waste may then be subjected to the 
TCLP to determine its regulatory status.
    The same principal applies to wastes that are less than 100% solid. 
In this case, however, both the liquid and solid portion of the waste 
are analyzed for total constituency and the results are combined to 
determine the maximum leachable concentration of the waste. The 
following may be used to calculate the maximum theoretical 
concentration in the leachate.
[GRAPHIC][TIFF OMITTED]TP21DE95.000

where:

A = Concentration of the analyte in liquid portion of the sample (mg/L)
B = Volume of the liquid portion of the sample (L)
C = Concentration of the analyte in the solid portion of the sample 
(mg/kg)
D = Weight of the solid portion of the sample (kg)
E = Maximum theoretical concentration in leachate (mg/L)
If:

Eleach

Then: A TCLP need not be performed for this constituent because, even 
if 100% of the constituent leaches, the TCLP results would be less than 
the regulatory leach standard. This calculation is adequate proof that 
this waste is at or below its leach exit level.

    The above calculational screen may be used by a claimant in order 
not to perform the TCLP. The screen may be used to determine that a 
total analysis of the waste demonstrates that individual contaminants 
are at such low concentrations that the nonwastewater leach exit level 
could not possibly be exceeded, thus eliminating the need to run the 
TCLP.
    Example: To illustrate the calculational screen, the following 
example is provided: An analyst wishes to determine if a leach 
processing sludge could fail the nonwastewater leach exit level for 
lead. The sludge is reported to have a low concentration of lead, and 
the analyst decides to perform a compositional analysis (totals test). 
A representative sample of waste is subjected to a preliminary percent 
solids determination as described in the TCLP. The percent solids is 
found to be 90%. Thus, for each 100 grams of this waste filtered, 10 
grams of liquid and 90 grams of solid are obtained. It is assumed for 
the purpose of this calculation that the density of the filterable 
liquid is equal to one. The liquid and solid portion of the sample are 
then analyzed for total lead. The following data are generated:

Percent solids = 90%
Concentration of lead in the liquid phase = 0.023 mg/l
Volume of filtered liquid = 0.010 L
Concentration of lead in the solid phase = 85 mg/kg (wet weight)
Weight of the solid phase = 0.090 kg.
The calculated concentration is as follows:
[GRAPHIC][TIFF OMITTED]TP21DE95.001

    In this case, the maximum leachable concentration is below the 10 
mg/L regulatory concentration for lead, and the TCLP need not be 
performed.
iv. Oily Wastes
    In this proposed rulemaking, the Agency has modelled the transport 
of solutes in groundwater as well as movement along other environmental 
pathways. This groundwater modeling involves predicting rates of 
constituent leaching from wastes in land-based waste disposal units. In 
using this fate and transport modeling to develop regulatory exit 
levels, the Agency is proposing to rely on the use of leach tests to 
ensure that groundwater is not contaminated. Among the test methods 
that have been developed and employed to identify wastes which might 
pose an unacceptable hazard are: Methods 1310 (Extraction Procedure), 
1311 (Toxicity Characteristic Leaching Procedure, TCLP), 1320 (Multiple 
Extraction Procedure, MEP), and 1330 (Oily Waste Extraction Procedure, 
OWEP).
    However, these leach test procedures all have deficiencies in 
predicting the mobility of toxic chemicals from oily 

[[Page 66390]]
wastes. Method 1311 underestimates the mobility of constituents from 
many oily wastes due to filter clogging problems, can be imprecise for 
oily wastes, and has several operational problems. Conversely, Method 
1330 is believed to overestimate mobility of constituents from oily 
wastes since it emulates a worst case scenario by using solvents to 
extract contaminants from the oil. None of the available laboratory 
procedures is fully satisfactory. Rather, they bracket the range of 
possible leaching for oily wastes.
    In addition, EPA does not have a good definition for what 
constitutes an oily waste. EPA originally defined oily wastes as those 
materials that clogged the filter during Method 1311 (TCLP) extraction. 
EPA requests comment on how to better define what an oily waste is.
    EPA also requests comment on which of the two tests methods (1311 
or 1330) should be used and why should one test be chosen over the 
other for predicting the concentrations of contaminants in leachate 
from wastes being managed in landfills. EPA also requests comment on 
whether there are any alternative test methods or models that could be 
used for predicting the mobility of oily materials. Such procedures 
need to be both scientifically credible and environmentally protective. 
Methods need to identify material that might be released from the waste 
and enter the soil. Release is defined as movement of either the liquid 
phase of the waste or leached contaminants through the bottom of the 
waste unit to the subsurface soil immediately underlying the disposal 
point. Once contaminants pass this point their ultimate fate in terms 
of impact on down-gradient water supplies can be estimated by the 
ground-water fate and transport model (EPACMOW model).
    EPA also requests comment on any additional problems with oily 
waste leachability not covered here, and whether the volatilization or 
other attributes of constituents should be considered in the 
development of a test.
    Oily wastes also pose modeling challenges in groundwater because 
they do not disperse in the same pattern as aqueous liquids. This 
affects the movement of the constituents in the material. In the event 
of a release of waste at or near the soil surface, the waste will 
migrate downward until it reaches the water table. Light non-aqueous 
phase liquids (LNAPLs) will then tend to migrate laterally, forming a 
pancake on top of the water table. Dense non-aqueous phase liquids 
(DNAPLs) on the other hand will sink to the base of an aquifer and not 
show much lateral spreading until an impermeable layer is reached. EPA 
is requesting comment on what sort of wastes or what constituents 
exhibit these behaviors and how to define that set of wastes. 
Constituents that have been associated with DNAPLs include 
dichlorobenzenes, PCBs, napthalenes, chloroform, carbon tetrachloride 
pentachlorophenol, cresols, and several PAHs. However, trace amounts of 
these constituents are unlikely to pose a DNAPL problem. A DNAPL 
problem is likely to occur when there is sufficient concentration to 
flow as undissolved liquid that would then form the sort of complex 
reservoirs that subsequently slowly dissolve into groundwater. The 
Agency requests comment on concentrations of these or similar chemicals 
that are likely to pose DNAPL problems and whether the proposed exit 
levels in totals or, for nonwastewaters in leach levels, are sufficient 
to limit wastes exiting for which a DNAPL or LNAPL problem would need 
to be explicitly evaluated.
    The Agency is continuing to work on developing tests and models for 
determining the leaching potential of oily materials and may propose 
them in future rulemaking. In the meantime, EPA is today proposing to 
apply the levels as proposed in this rule to oily wastes, but seeks 
comment on whether instead there is a definable class of wastes for 
which these levels cannot reasonably be concluded to be protective.
b. Initial Test
    The Agency is proposing in today's rule that there would be an 
initial test before a facility would be eligible for an exemption. The 
initial test would be the primary tool to characterize the waste as 
exempt. Results from this initial test would be sent to the 
implementing agency. The public could request the implementing agency 
to make the results available.
    EPA is proposing to require initial testing of all of the 386 
constituents on appendix X of 40 CFR part 261 except those that the 
claimant determines should not be present in the waste. EPA would 
require the claimant to document the basis of each determination that a 
constituent should not be present. The claimant must submit the 
documentation to the implementing agency and retain a copy on site for 
three years. No claimant may determine that any of the following 
categories of constituents should not be present:

--Constituents set out in appendix VII to part 261 as the basis for 
listing the wastestream for which exemption is sought;
--Constituents listed in the table to 40 CFR 268.40 as regulated 
hazardous constituents for LDR treatment of the waste stream ;
--Constituents detected in any previous analysis of the same 
wastestream conducted by or on behalf of the claimant;
-- Constituents introduced into the process which generates the 
wastestream; and
--Constituents which the claimant knows or has reason to believe are 
byproducts or side reactions to the process that generates the 
wastestream.

The Agency requests comment on whether these are the appropriate 
criteria to be used to determine what should not be present in the 
waste. The Agency also requests comment on requiring claimants who are 
not waste generators to consult the generator prior to determining that 
a constituent is not introduced into the process or that a constituent 
is not a byproduct or side product of the process. EPA believes that it 
is unlikely that a non-generator claimant would have sufficient 
knowledge of the production process to make adequate determinations on 
these issues. EPA requests comment on the type of documentation that it 
should require. The generator could co-sign the document that sets out 
the reasons for determining that the claimant need not test for a 
constituent, or the generator could prepare a separate supporting 
document that would be attached to the document for submission to the 
implementing agency and retention in the claimant's files.
    The Agency is soliciting comment on whether the absence of 
constituents in the following documents could constitute sufficient 
justification for not analyzing all of the constituents listed in 40 
CFR part 261 appendix X.

--40 CFR part 261 appendix VII highlighted to show which constituents 
are listed for each waste code applicable to that waste;
--40 CFR 268.40 highlighted to show which constituents are regulated 
under the land disposal restrictions for each waste code applicable to 
that waste;
--EPCRA Toxic Release Inventory reports highlighted to show which 
constituents are reported as being ``used'' in the manufacturing 
process from which that waste is generated (based on the EPCRA 
definition of ``use'');
--NPDES discharge permits highlighted to show which constituents are 
required to be monitored in wastewaters with which that waste is 
commingled or will be commingled; 

[[Page 66391]]

--State or Local emissions monitoring permits or documents (e.g., stack 
emissions, fugitive emissions, groundwater monitoring, wastewater 
discharges, etc.,) highlighted to indicate which constituents are 
required to be monitored as potential emissions from units in which 
that waste is managed or will be managed;
--Responses to government and/or trade group data collection efforts 
(e.g., biennial reports, TSD surveys) that require submission of waste-
specific constituent information;
--Published literature (e.g., journals, presentations, chemical and 
engineering reference documents, health and safety handbooks, material 
safety data sheets, etc.,) highlighted to indicate constituents that 
are formed or potentially formed from side reactions, degradation, or 
reactivity of the products, reactants, or solvents used in the 
manufacturing process generating that waste;
--Plant-specific process flow diagrams or process descriptions 
highlighted to indicate constituents that are formed or potentially 
formed from side reactions, degradation, or reactivity of the products, 
reactants, or solvents used in the manufacturing process generating 
that waste;
--Product specifications or constituent-specific labeling requirements 
under federal regulations, state regulations, or non-governmental 
standards (i.e, per product-grade) that identify constituents that are 
expected to be present in the products from which the waste was 
generated, highlighted to indicate those constituents identified as 
part of these specifications or standards (excluding chemical additives 
or preservatives that are placed in the products subsequent to the 
generation of the waste for which exit is claimed);
--Waste profile data sheets, such as those submitted to commercial 
waste handlers, highlighted to show the constituents that were found or 
expected to be present in that waste; and/or
--A certified, third party engineering analysis of the process 
generating that waste that provides qualitative verification of the 
theories behind the anticipated absence of certain chemical classes or 
groups of Appendix X of 40 CFR 261 constituents such as pesticides, 
pharmaceutical, halogenated solvents, carbamate, organo-sulfur 
compounds, known gases, cyanides, etc.;
--Any other available quantitative or qualitative constituent 
information specific to that waste

    Relevant information includes not only those document sections that 
indicate which constituents are present, but also cover pages that 
indicate the source of the document segments and signature pages to 
verify authenticity of government-approved documents (where 
appropriate). For the verification purposes, page numbers should also 
be clearly identified for each document. EPA is also soliciting 
information on additional readily available documentation that could be 
added to this list that would not impose an unreasonable records burden 
on both the generator and enforcement officials (for example, the 
Agency believes that requiring highlighted copies of copious amounts of 
monitoring data would be redundant and would significantly impede 
enforcement review). EPA believes that requiring copies of only 
relevant portions of these documents, highlighted to indicate the 
chemicals present, should minimize the burden associated with this 
documentation requirement significantly.
    Regardless of which constituents a facility tests, the facility is 
responsible for ensuring that each constituent in the waste meets its 
applicable exit level.
    The Agency believes that the tailored initial test described above 
will ensure accurate waste characterizations of the waste streams while 
focusing testing requirements to those constituents that are of 
concern. A facility could determine whether a constituent would be 
present. A facility would not be authorized to determine that the 
constituents in the waste meet the exemption levels based on knowledge 
of the waste or material. This approach both reduces unnecessary 
testing costs and allows for more frequent monitoring of those 
constituents that are of concern.
    The Agency is soliciting comment on whether this proposed approach 
to an initial test is appropriate.
    The Agency asks for comment on taking the opposite approach: 
requiring each claimant to test only for those constituents that the 
claimant determines ``could be present'' for that waste. This would be 
a systematic way for facilities to focus the list of hazardous 
constituents to those that are mostly to be present in the waste. EPA 
requests comment on requiring at a minimum testing of the following 
categories of constituents:
--Constituents set out in appendix VII to part 261 as the basis for 
listing the wastestream for which exemption is sought;
--Constituents listed in the table to 40 CFR 268.40 as regulated 
hazardous constituents for LDR treatment of the waste stream ;
--Constituents detected in any previous analysis of the same 
wastestream conducted by or on behalf of the claimant;
--Constituents introduced into the process which generates the 
wastestream; and
--Constituents which the claimant knows or has reason to believe are 
byproducts or side reactions to the process that generates the 
wastestream.

    The Agency asks for comment on the completeness of the proposed 
mandatory testing criteria. In addition, the Agency requests comment on 
whether testing should be required for those constituents that do not 
meet any of the criteria of ``could be present.'' The Agency also 
requests comment on whether documentation should be required to 
demonstrate that those constituents that were not tested did not meet 
any of the ``could be present'' criteria.
    EPA requests comment on another approach to determining which 
constituents need to be analyzed by a claimant. The approach would be 
that the claimant needs to provide data on all additional constituents 
listed in appendix X of 40 CFR part 261 of today's rulemaking for which 
a method used by the generator to detect other constituents which the 
claimant is required to test can easily determine concentrations. Thus, 
for example, if a waste was listed for a constituent for which GC/MS is 
an appropriate method used by the claimant, the claimant would also be 
required to ask the laboratory to provide information on all other 
constituents listed in appendix X of 40 CFR part 261 of today's 
proposed rulemaking for which the GC/MS is also an appropriate method.
    EPA did not use this in its primary proposal because the Agency 
realized that implementation of this concept become more complex than 
it appears. For example, even when using GC/MS, there may be sample 
preparation techniques, dilutions, and similar issues that determine 
which constituents can be measured in the appropriate concentration 
ranges using the method.
    However, there is something intuitively reasonable and attractive 
in asking claimant to gather and provide information that is easily 
obtainable and would provide additional confidence and certainty. EPA 
solicits comments on this idea and ways to implement it.
    The Agency requests comment on whether there is some other way to 
focus the scope of testing requirements or if the only way to ensure 
accurate waste characterizations would be to require testing for all 
386 constituents.

[[Page 66392]]

    The FACA suggested EPA should define, for major waste streams, a 
set of constituents that it believes would fairly characterize those 
waste streams. The Agency believes such an approach may be desirable. 
However, the Agency notes that this could require it to expend 
significant resources. The Agency requests comments on the feasibility 
or need for this approach in the long term.
    EPA recognizes that some generators may wish to assert claims for 
protection of confidential business information (CBI) for some to the 
information that supports an exit claim. Material that is classified as 
CBI may be reviewed by EPA, but may not be released to the public. 
States may have similar provisions under state law. EPA requests 
comments on two options for addressing CBI information.
    First, EPA requests comment on the option of prohibiting any person 
from asserting a claim of exit under this rule if that person wishes to 
claim CBI protection for any data or information used to support the 
exit claim, including all information submitted to the implementing 
agency in the notification package and all information required to be 
maintained by the claimant on site and furnished to the agency on 
request. A generator who wished to rely on CBI data to support an 
exemption claim for a listed hazardous waste would need to file a 
delisting petition with EPA or a state authorized for delisting.
    EPA believes such an approach may be necessary because the exits 
proposed today are self-implementing. The public would not have the 
assurance of knowing that EPA or a state agency had reviewed the 
claimant's data and determined that it showed that the claimant's waste 
posed low risks to human health and the environment. Members of the 
public may not feel that they are adequately protected by the fact that 
EPA and authorized states could obtain the CBI data and use it (with 
appropriate precautions against disclosure) in an enforcement action if 
warranted. They may feel that the number of claims will strain agency 
inspection and enforcement resources, making it important for them to 
be able to bring their own citizen enforcement actions under section 
7002 of RCRA.
    At the same time EPA is sensitive to potentially legitimate 
business needs to protect information supporting an exit claim. Some 
firms may not wish to release detailed information about the chemical 
composition of their process waste streams. EPA also recognizes that 
the federal delisting process is considerably slower and imposes more 
procedural burdens than the self-implementing exit scheme. EPA requests 
comment on the alternative of creating a limited prior approval process 
for exit claims involving CBI claims. EPA anticipates that rulemaking 
would not be required. However, states that wish to obtain 
authorization for today's exit program might not be required to adopt 
this feature because they could argue that failure to provide a review 
process for CBI claims would not make their programs less stringent 
than the federal program.
    EPA also notes that CBI protection is not absolute. EPA has 
authority under RCRA to release CBI information to the public as 
necessary to support rulemaking proceedings. (In fact, EPA could try to 
support the first option above by arguing that it was exercising in 
this proceeding its authority to waive protection for all of the 
individual exit claims that ``implement'' the rule.) Also, a citizen 
that has sufficient evidence of a violation to file a complaint in 
court may be able to persuade the court to order a limited release of 
the data for use in the enforcement proceedings.
2. Notification Requirements
    The Agency is proposing that the required notification to the 
implementing authority would include the following information:

--The name, address, and RCRA ID number of the person claiming the 
exemption;
--The applicable EPA Hazardous Waste Codes;
--A brief description of the process that generated the waste;
--An estimate of the average and maximum monthly and annual quantities 
of each waste claimed to be exempt;
--Documentation for any claim that a constituent is not present;
--The results of all analyses and estimates of constituent 
concentrations and all quantitation limits achieved;
--Documentation that any constituents on Table B to appendix X of 40 
CFR part 261 have met the applicable treatment standards in 
Sec. 268.48, unless the claimant is claiming the exemption under 
Sec. 261.36(e);
--Evidence that the public notification requirements have been 
satisfied; and
--A certification signed by the person claiming the exemption or his 
authorized representative.

    The Agency is taking comment on whether the following additional 
information should also be sent to the implementing authority:

--The name and address of the laboratory which performed the analysis;
--A copy of the sampling and analysis plan used for making the 
exemption determination;
--A description of any chain-of-custody procedures;
--Whether the identity of the disposal facility should be included in 
the notification package;
--Dates of sampling and analysis; and
--A description of the (temporal and) spatial locations of the 
demonstration samples.

Also, the Agency is taking comment on whether, if the disposal facility 
is different than the claimant's facility, the claimant should also 
include as part of the notification package documentation that the 
claimant informed the disposal facility of the exempt status of the 
waste.
    A complete notification package would include all required 
information in the notification and all required certifications signed 
by the appropriate individual, as identified in the regulations. 
Failure to submit a notification package if the exemption is being 
claimed or submission of an incomplete notification package would be a 
violation of RCRA requirements and thus subject to penalties and 
injunctive relief under section 3008(a) of RCRA and possible criminal 
liability under section 3008(d) of RCRA. As a necessary prerequisite to 
claiming an exemption, the burden would be on the claimant to establish 
that a complete notification package was submitted to the implementing 
authority to assert in an enforcement action that the waste is exempt.
    It should be noted that, regardless of whether the sampling and 
analysis plan must be included with the notification to the 
implementing agency, a current sampling and analysis plan must be 
developed and used to establish the waste's eligibility for exemption, 
and must be available upon request to the implementing authority at the 
time the notification package is submitted and at least for three 
years. The sampling and analysis plan must demonstrate that the samples 
to be taken and analyzed will be representative of any spatial and 
temporal variations in the subject waste.
    Furthermore, it should be noted that submission of sampling and 
analysis plans with the notification to the implementing authority does 
not change the self-implementing nature of the exemption. Submission of 
such plans would not be for review or approval of exemption claims 
prior to the exemption becoming effective. The implementing agency 
would be under no obligation to undertake such review or approval prior 
to the exemption 

[[Page 66393]]
becoming effective, and failure to undertake such prior review would 
not preclude a subsequent enforcement action should the exemption claim 
later be determined to be inaccurate or otherwise invalid.
    As proposed, the certification required to accompany the 
notification must attest that the waste in question meets all relevant 
constituent concentration exit levels and that the information in the 
notification package is true, accurate, and complete. The Agency is 
taking comment on whether this certification is sufficient assurance 
that the claimant has made best efforts to accurately characterize the 
waste or if additional certification language or additional 
certifications (e.g., from an analytical laboratory) are necessary.
    The notification package would be required to be submitted by 
certified mail with return receipt requested, or other commercial 
carrier that provided written confirmation of delivery. No claim would 
be effective until the claimant received the return notification 
indicating that the package had been delivered.
    Submission of the notification package to the implementing 
authority, however, is not equivalent to approval or verification of 
the exemption claim. Submission of a notification package would not 
preclude or in any way limit the implementing authority's ability to 
take a subsequent enforcement action should it determine that the 
initial requirements of exemption were never met or that the conditions 
for maintaining the exemption are not satisfied.
    The Agency is taking comment on whether, instead of the exemption 
becoming effective upon confirmation of delivery of the notification 
package, there should be some brief waiting period prior to the 
exemption becoming effective.
    Such a period (e.g., 30 or 60 days) could be used by the 
implementing authority to review notification packages for completeness 
or for indicia of concerns that would lead to prioritized enforcement, 
although the exemption would still become automatic after the period 
regardless of whether any action was taken by the implementing 
authority. As an alternative, the period could be designed to provide 
the implementing authority an opportunity to determine that a claimant 
should not be able to avail itself of the exemption without some 
further review and to notify the claimant of its views.
    Under either approach, governmental review would be discretionary 
and the lack of such review would not be an indication of governmental 
approval of the exemption claim. To ensure that there would be no 
confusion on this point, the certification could include a statement of 
recognition that expiration of the delay period without comment by the 
overseeing agency is not the equivalent of agency approval that the 
claim is accurate. The Agency has not chosen to propose a delayed 
implementation approach because it believes a short time frame, 
particularly combined with an automatic effective date, would not 
provide an opportunity for thorough prior review and would, at best, 
provide only marginal benefits as a screening device for potentially 
problematic claims. The Agency, however, requests comment on whether 
such a delay would be beneficial to monitoring claims and if there are 
procedural or other concerns relating to such a delay.

B. Implementation Conditions

    After the exit claim has become effective, the claimant would have 
to continue to meet certain conditions to maintain the exemption. 
Failure to satisfy any of the conditions would void the exemption and 
subject the waste to applicable subtitle C requirements.
    Under this proposal, wastes must continue to meet the generic 
exemption levels established for exit to remain non-hazardous. Separate 
and distinct from any requirement or condition that might be 
established under this rulemaking, all generators--including claimants 
of today's proposed exemption--would have a continuing obligation to 
identify whether they are generating a hazardous waste and to notify 
the appropriate governmental official if they are generating a 
hazardous waste. Section 3010; 40 CFR 261.11. If wastes claimed as 
exempt under today's proposed rule test above exit levels at any time, 
that waste and subsequently generated waste would have to be managed as 
hazardous waste--including compliance with all notification 
requirements--until testing demonstrated that the waste was below exit 
levels.8

    \8\ Compliance with HWIR exemption levels will be measured from 
the last available test data or from the latest representative 
samples taken from the waste in question. Testing which shows 
constituent concentration levels above exemption levels will not 
affect wastes previously generated under a valid claim of exemption 
based upon representative samples. Similarly, testing, which shows 
that a waste which tested above exit levels once again tested below 
all relevant exit levels will exempt all waste generated on or after 
the date the samples were taken. Waste which exceeded the exit 
levels would not be able to requalify for the exemption.
---------------------------------------------------------------------------

1. Records Maintained on Site
    In addition to the information described in the Notification 
Section above, the Agency is also proposing that the following 
information concerning the initial testing and retesting be maintained 
in the files on site at the facility making the exemption claim for at 
least three years:

--All information required to be submitted to the implementing 
authority as part of the notification of the claim;
--The dates and times waste samples were obtained, and the dates the 
samples were analyzed;
--The names and qualifications of the person(s) who obtained the 
samples;
--A description of the (temporal and) spatial locations of the samples;
--The name and address of the laboratory facility at which analyses of 
the samples were performed;
--A description of the analytical methods used, including any clean-up 
and extraction methods;
--All quantitation limits achieved and all othe
FR Doc. 95-29458 Hazardous Waste Management System: Identification and Listing of Hazardous Waste: Hazardous Waste Identification Rule (HWIR)
r quality control 
results for the analyses (including method blanks, duplicate analyses, 
matrix spikes, etc.), laboratory quality assurance data, and a 
description of any deviations from published analytical methods or from 
the plan which occurred;
--All laboratory documentation that support the analytical results, 
unless a contract between the claimant and the laboratory provides for 
the documentation to be maintained by the laboratory for the period 
specified in Sec. 261.36(b)(2) and also provides for the availability 
of the documentation to the claimant upon request;
--If the generator claims a waste is exempt from part 268 requirements 
pursuant to Sec. 261.36(e), documentation to substantiate such a claim.

    The Agency requests comment on the proposed information maintenance 
requirements and comment on additional information that may be 
necessary.
    In addition, claimants will be required to retain certain 
information concerning retesting of wastes as described below and set 
out in the text of proposed 40 CFR 261.36(d)(6)(ii).
2. Testing Conditions
    Claimants would continue to periodically test their wastes as a 
condition of the exemption.9 Failure to test and maintain 
documentation of the 

[[Page 66394]]
testing in accordance with the requirements of proposed 40 CFR 
261.36(d) would void the exemption. The Agency believes that required 
subsequent testing is necessary to maintain accurate waste 
characterizations. Subsequent testing would be an ongoing exemption 
condition and would be the minimum testing required to maintain an 
exemption. A tailored constituent list setting out minimum requirements 
for testing purposes should not be confused with the facility's ongoing 
requirement to maintain constituent concentrations below exit levels 
for all constituents on appendix X of 40 CFR part 261. Results from 
subsequent testing would be required to be maintained on-site.

    \9\  Wastes generated on a one-time basis would not be subject 
to this requirement.
---------------------------------------------------------------------------

    The scope of subsequent testing would focus primarily on those 
constituents from appendix X of 40 CFR part 261 that are of concern 
based on the initial test. The list of constituents for which a 
claimant would be required to test would, at a minimum, include each 
constituent that was detected in the initial test within an order of 
magnitude below the exit level for that constituent, and any 
constituent listed in Table B of appendix X of 40 CFR part 261 that is 
also identified as a basis for listing the waste or appendix VII to 
part 261 or listed as a regulated hazardous constituent for the waste 
in the table to 40 CFR 268.40. The claimant would also be required to 
test for any other constituent which the claimant had reason to believe 
was newly present in the waste since the most recent previous test.
    The Agency proposes that the frequency with which a facility would 
be required to perform subsequent testing would be determined based on 
the volume of waste which the facility is declaring exempt. Those 
facilities with large-volume waste streams would perform subsequent 
testing more often than those facilities with low- or medium- volume 
waste streams. The claimant would be responsible for determining the 
volume of annual exempt waste. The Agency asks for ideas and comments 
on whether guidance should be made available for claimants on how to 
measure annual volumes. Justification of annual volumes would be sent 
to the Director in the notification package. The Agency believes that 
accurate waste characterizations are important for waste volumes of all 
sizes; however, inaccurately characterized large-volume wastes have 
greater potential to harm the environment than do smaller-volume 
wastes. In today's rule, the Agency is proposing the following 
requirements for the first three years of subsequent testing:

--Wastes generated at the time of exemption is initially claimed in 
volumes greater than 10,000 tons/year would be tested four times a year 
for the first three years of the exemption.
--Wastes generated at the time of exemption is initially claimed in 
volumes greater than 1000 tons/year but less than 10,000 tons/year 
would be tested twice a year for the first three years of the 
exemption.
--Wastes generated at the time of exemption is initially claimed in 
volumes less than 1000 tons/year would be tested once a year for the 
first three years of the exemption.

    EPA requests comment on whether it should allow the Agency proposes 
that if a waste maintains exempt status for three years, the frequency 
of subsequent testing would then be reduced to once a year, regardless 
of the volume produced. The Agency believes that three years of 
subsequent testing should provide a facility with adequate data to 
assess the potential for variability in the waste. The Agency requests 
comment on the frequency of subsequent testing.
    The Agency requests comment on an approach that the FACA suggested. 
The approach consisted of a comprehensive test, similar to an initial 
test, that is required every 3 or 5 years of an exemption because of 
the strong reliance on the initial test's results in determining the 
scope of subsequent testing.
    The Agency also requests comment on whether follow-up testing 
should be eliminated entirely after the first three year period. In 
addition, the Agency asks if a certification of compliance with all 
relevant exit levels could suffice in lieu of testing at the end of 
three years.
3. Testing Frequency and Process Change
    Under today's proposal, the claimant has a continuing obligation to 
verify that the waste continues to meet the exemption criteria, 
including meeting the exemption constituent concentration levels. 
Process changes that may either increase the number of hazardous 
constituents in the exempted waste or increase the concentration of 
hazardous constituents already present, should put a claimant on notice 
that there may be changes in the waste that may affect its continued 
eligibility for exemption. The Agency, however, is not proposing to 
require new sampling and analysis whenever there is a process change 
that may affect the exempt status of the waste.
    The Agency is taking comment on whether it is necessary to require 
as a condition of maintaining the exemption that wastes be re-tested 
after a process change and, if so, what the scope of such re-testing 
should be. The Agency would like to know if the testing frequency 
proposed or more frequent testing would provide a clearer indicator of 
waste changes of concern than triggering re-testing through a narrative 
description of a process change. Another alternative is to require the 
claimant to notify the implementing authority that a process change has 
occurred and to certify that the exemption criteria continue to be met 
if the claimant determines that the waste still maintains its exempt 
status. The Agency is taking comment on how process change should be 
defined in the event one of the alternatives is chosen. It should be 
noted that if waste for which an exemption has been claimed at any time 
tests above exemption levels, that waste and all subsequently generated 
waste is hazardous. The claimant could not assert a new exit claim 
until a new batch of waste tests below the exit levels. The exemption 
proposed today would not relieve generators of their responsibility 
under Sec. 262.11, nor would any test data previously obtained prevent 
a claimant from failing to satisfy the exemption criteria should an 
inspector conduct waste sampling that establishes hazardous 
constituents at concentrations above exit levels.

C. Public Participation

    As a self-implementing exemption effective upon receipt of the 
notification by the implementing authority, there is no decision prior 
to exit being made by the implementing authority regarding the waste. 
The opportunity for public participation in an exemption claim is the 
opportunity that exists at all times for the public to bring to the 
implementing authority's attention any circumstance that might aid that 
authority in its monitoring and enforcement efforts. The public, 
furthermore, would have the ability to bring a citizen suit for a 
claimant's failure to comply with any requirement of the exemption.
    The Agency is proposing to require that the public be notified by 
the claimant that an exemption claim is being asserted. This 
notification would be accomplished by publication of a notice in a 
major newspaper, local to the claimant and of general circulation, that 
contains the information required by the regulations. Evidence that the 
notice has been submitted for publication must be part of the 
notification package submitted to the implementing facility. 

[[Page 66395]]

    The Agency is requesting comment on whether such a notice should be 
placed in a newspaper local to the claimant's facility or to the 
disposal facility or both, should those facilities be located in 
different areas not served by the same newspaper.
    Requiring notification of facilities receiving exiting wastes has 
also been raised to the Agency in discussions. The Agency solicits 
public comment on the need for and possible approaches to requiring 
that waste generators that are exiting their listed waste, notify 
receiving facilities that wastes are HWIR exited wastes. Additional 
discussion of this issue appears in the docket under ``Receiving 
Facility Notification Process.''
    As discussed above, the Agency is also taking comment on whether 
providing a ``delay'' in the effective date when the exemption attaches 
(e.g., 30 or 60 days) would provide a significant and meaningful 
opportunity for public comment prior to the waste having exited the 
subtitle C system. Possible benefits of a waiting period before 
effectiveness of the exit could include greater opportunity for State 
review or citizen comment before waste is actually disposed outside of 
Subtitle C. Under such an approach, the waiting period would begin with 
receipt by the State of a complete certification package, and would run 
for the designated time (30 or 60 calendar days).
    The Agency is taking comment on whether access to claim 
documentation through the appropriate implementing agency will be 
sufficient to provide public access to documentation. One alternative 
would be to require the claimant to provide access to the information. 
If that option is selected, the Agency requests comment on how, and for 
how long, the claimant should be required to provide access to the 
documentation, and on what kind of protection for CBI would be 
appropriate.

IX. Request for Comment on Options for Conditional Exemptions

    The Agency has at different times considered contingent management 
approaches to disposal of hazardous wastes. Under such approaches, 
wastes that would be considered hazardous if managed in an uncontrolled 
manner, could be considered non-hazardous if managed in a sufficiently 
controlled manner. The following section discusses and requests public 
comment on several approaches to setting higher exit levels tied to 
meeting certain management requirements. These approaches would allow 
wastes with higher concentrations of hazardous constituents to be 
managed safely outside of Subtitle C.
    Many Subtitle C requirements were written generically to address 
all hazardous wastes and, consequently, provide protection for those 
wastes that pose the greatest risks. Others are either explicitly or 
implicitly technology-based rather than risk-based. Some of these 
requirements are statutory and cannot easily be adjusted to take risk 
into account. Nevertheless, EPA generally believes that it would be 
desirable to tailor waste management requirements to more closely 
coincide with risks. The exit levels proposed today take an initial 
significant step in this process by allowing very low-risk hazardous 
wastes to be exempt from Subtitle C requirements, leaving them subject 
only to less prescriptive federal and state controls for nonhazardous 
wastes. They also take an initial step towards setting different exit 
levels for different situations by recognizing that wastewater and non-
wastewaters are typically handled in different ways and pose different 
risks, hence today's notice proposes different exit levels for 
wastewaters and non-wastewaters.
    Within the time constraints imposed by the court-ordered deadline 
for this proposal, EPA has begun exploring whether it would be possible 
to create additional exemptions to allow more flexible management of 
additional wastes now classified as hazardous without compromising 
protection of human health and the environment. These options are 
premised on the theory that a waste's risk is due not only to its 
chemical composition, but also the manner in which it is managed, which 
can greatly affect the amount of chemical constituents that ultimately 
reach a human or environmental receptor. The multipathway analysis 
prepared to support the exit levels shows that the concentration at 
which a hazardous constituent threatens human health or the environment 
varies significantly with the type of management that a waste 
receives--some forms of management appear to present greater risks than 
others. The following discussion presents the legal framework for 
management-based exemptions, and outlines in some detail the options 
which EPA finds to be most promising for rapid promulgation.

A. Legal Basis for Conditional Exemptions

    EPA originally interpreted RCRA's definition of hazardous waste to 
focus on the inherent chemical composition of the waste and to assume 
that mismanagement would occur so that people or organisms would come 
into contact with the waste's constituents. See 45 FR 33113 (May 19, 
1980). However, EPA even in the past tried to consider ``reasonable'' 
mismanagement scenarios, scenarios that where reasonably likely or 
plausible even if not proven to necessarily have occurred or be typical 
for a specific waste. However, after more than a decade of experience 
with waste management, EPA believes that it may no longer be accurate 
or necessary to assume that worst-case mismanagement will occur. In 
recent hazardous waste listing decisions, for example, EPA has 
identified some likely ``mismanagement'' scenarios that are reasonable 
for almost all wastewaters or non-wastewaters, and looked hard at 
available data to then determine if any of these are for some reason 
very unlikely for the specific wastes being considered, or if other 
scenarios are likely given available information about current waste 
management practices. As a further extension of that logic, EPA now 
believes it may be appropriate to find that, where mismanagement is not 
likely or has been adequately addressed by other programs, EPA need not 
classify a waste as hazardous and that there may be ways to recognize 
situations where the limitations on likely ``mismanagement'' are 
specific to a State, a type of waste, or a facility-specific condition 
on how a waste is managed.
    EPA believes that it can interpret the definition of ``hazardous 
waste'' in RCRA section 1004(5) to authorize this approach to 
classifying wastes as hazardous. Section 1004(5)(B) defines as 
``hazardous'' any waste which may present a substantial present or 
potential hazard ``when mismanaged''. EPA reads this provision to allow 
it to determine the circumstances under which a waste may present a 
hazard and to regulate the waste only when those conditions occur. 
Support for this reading can be found by contrasting section 1004(5)(B) 
with section 1004(5)(A), which defines certain inherently dangerous 
wastes as ``hazardous'' no matter how they are managed. The legislative 
history of Subtitle C of RCRA also appears to support this 
interpretation, stating that ``the basic thrust of this hazardous waste 
title is to identify what wastes are hazardous in what quantities, 
qualities and concentrations, and the methods of disposal which may 
make such wastes hazardous.'' H.Rep. No. 94-1491, 94th Cong., 2d Sess.6 
(1976), reprinted in A Legislative History of the Solid Waste Disposal 
Act, as Amended, Congressional Research Service, Vol.1, 567 (1991) 
(emphasis added).
    EPA also believes that section 3001 provides it with flexibility to 
consider 

[[Page 66396]]
the need to regulate wastes as hazardous. Section 3001 requires that 
EPA, in determining whether to list or otherwise identify a waste as 
hazardous waste, decide whether a waste ``should'' be subject to the 
requirements of Subtitle C. Hence, section 3001 authorizes EPA to 
determine that Subtitle C regulation is not appropriate where a waste 
is not likely to be managed in such a way that it will threaten human 
health or the environment. Moreover, regulation of such waste under 
Subtitle C would not appear ``necessary to protect human health or the 
environment'' under RCRA sections 3002(a), 3003(a) and 3004(a). As 
noted elsewhere in this proposal, EPA interprets these provisions to 
give it broad flexibility in fashioning criteria to allow hazardous 
wastes to exit the Subtitle C regulatory system. EPA's existing 
regulatory standards for listing hazardous wastes also allow 
consideration of a waste's potential for mismanagement. See 
Sec. 261.11(a)(3) (incorporating the language of RCRA section 
1004(5)(B)) and Sec. 261.11(c)(3)(vii) (requiring EPA to consider 
plausible types of mismanagement). Where mismanagement of a waste is 
implausible, the listing regulations do not require EPA to classify a 
waste as hazardous.
    Two decisions by the U.S. Court of Appeals for the District of 
Columbia Circuit provide potential support for this approach to 
defining hazardous waste. In Edison Electric Institute v. EPA, 2 F.3d 
438, (D.C. Cir. 1993) the Court remanded EPA's RCRA Toxicity 
Characteristic (``TC'') as applied to certain mineral processing wastes 
because the TC was based on modeling of disposal in a municipal solid 
waste landfill, yet EPA provided no evidence that such wastes were ever 
placed in municipal landfills or similar units. This suggests that the 
Court might approve a decision to exempt a waste from Subtitle C 
regulation if EPA were to find that mismanagement was unlikely to 
occur. In the same decision the Court upheld a temporary exemption from 
Subtitle C for petroleum-contaminated media because such materials are 
also subject to Underground Storage Tanks regulations under RCRA 
Subtitle I. The court considered the fact that the Subtitle I standards 
could prevent threats to human health and the environment to be an 
important factor supporting the exemption. Id. at 466. In NRDC v. EPA, 
25 F.3d 1063 (D.C. Cir. 1994) the Court upheld EPA's finding that 
alternative management standards for used oil promulgated under section 
3014 of RCRA reduced the risks of mismanagement and eliminated the need 
to list used oil destined for recycling. (The Court, however, did not 
consider arguments that taking management standards into account 
violated the statute because petitioners failed to raise that issue 
during the comment period.)

B. Improvements in Management of Non-Hazardous Waste and in Risk 
Assessment Methodology

    EPA's early regulations defining hazardous waste reached broadly to 
ensure that wastes presenting hazards were quickly brought into the 
system. When EPA promulgated its first listings and characteristic 
rules in 1980, its knowledge of toxic constituents, constituent 
transport pathways, and waste management options was more limited than 
it is today.
    In addition, significant changes and improvements in waste 
management have occurred since the early 1980's. Many states have 
established or strengthened industrial nonhazardous waste programs 
since that time. For example, currently 26 states require liners and 28 
states require ground-water monitoring for at least some surface 
impoundments. Up to 45 states require ground-water monitoring and 38 
states require liners for at least some landfills. It is important to 
recognize however, that within a state, applicable requirements may 
vary according to a number of factors, including unit type, waste 
source, and location. See ``State Requirements for Industrial Non-
Hazardous Waste Management Facilities'' EPA 1994. At the same time, 
industries have gained experience in managing wastes and many have 
improved waste management practices under incentives such as public 
access pursuant to the Emergency Preparedness and Community Right to 
Know Act, and avoiding liabilities under Superfund, RCRA corrective 
action and state cleanup programs.
    EPA's ability to predict the risks that a waste may pose has also 
improved significantly. EPA has collected much more data on a variety 
of waste management units and other factors that impact the ability of 
waste constituents to reach a receptor. Models such as the EPACMTP and 
the models used in the multipathway analysis provide more sophisticated 
means of assessing the risks of a range of waste management options. As 
a result of all these changes, EPA is now in a position to begin to 
implement a more carefully tailored risk-based approach to regulating 
hazardous wastes.

C. Overview of Options for Conditional Exemptions

    The Agency has identified several different approaches to providing 
conditional exemptions that would allow more wastes to exit the 
Subtitle C system. These options fall into two broad categories: (1) 
Establishing national conditional exemptions based on unit type either 
with or without assuming additional management controls; and (2) 
granting conditional exemptions to qualified state programs that ensure 
additional management controls.
1. National Approach: EPA Would Establish National Exit Levels for 
Contingently Managed Waste
    The contingent management program could be adopted by any state 
that wants to implement it, without consideration of state programs for 
non-hazardous waste. The contingent exit levels would differ according 
to the degree of management/disposal restrictions imposed as a 
condition of exit. The possible options would include progressively 
more restrictive requirements, and allow progressively higher exit 
levels as disposal options are further restricted. The options under 
this approach are:
a. Distinguish Between Disposal in Land Application Units and Other 
Units
    The multipathway risk assessment methodology used for this 
rulemaking takes into account management scenarios (such as land 
treatment of a waste), or exposure pathways (such as wind transport 
from an uncovered pile or volatilization from an open tank), resulting 
in calculated exit levels based on the riskiest scenario. In some cases 
this exit level may be significantly lower than the next most risky 
exposure pathway. The riskiest exposure pathway may not be applicable 
to some management situations. On review of the risk analysis results, 
the Agency determined that disposal in a land application unit is 
frequently the highest risk disposal option in both the multipath and 
groundwater modeling.
    As described in detail in Section X. below, the Agency has 
developed for proposal an approach to contingent management relying on 
the multipathway exposure analysis, risk level of 10-6 and HQ of 1, and 
using the base case uncontrolled management scenarios, but with land 
application units removed from the analysis. Exit concentrations would 
still be protective across a wide variety of conditions nationally, for 
all non-land application unit disposal. The Agency is proposing 

[[Page 66397]]
one national exit level for each constituent based on the next riskiest 
pathway, on condition that wastes are not disposed in land application 
units.
     This option was considered by the Agency to be the simplest 
approach to contingent management. It would be somewhat easier to 
enforce than other options described below, since there would still be 
only one conditional exit level for each constituent. Implementation 
mechanisms to assure that the wastes go only to allowable unit types 
are described below.
b. Unit-Specific Exit Levels for Each Disposal
    Another approach to contingent management considered by the Agency 
would be to establish a set of exit levels for each waste management 
unit evaluated based on risks at unregulated units of that type. Units 
that would be evaluated, at HQ 1 and 1 E-6 risk, would be land 
application units, waste piles, landfills, surface impoundments and 
tanks. Base case assumptions would be used to describe the units. The 
Agency has not included specific exit levels for this approach here, 
but solicits comment on its potential benefits, and potentially greater 
complexity of implementation and compliance assurance.
    Under option 2 the Agency would set separate exit levels for each 
type of waste management unit. Generators would be allowed to choose 
the type of non-subtitle C waste management unit in which to manage 
their waste, and would be required to meet the unit-specific exit 
levels for all constituents in order to manage the waste in that unit. 
Testing and implementation would be similar to the requirements for 
exit based on the most limiting pathway. However, the Agency believes 
this option would increase the complexity of tracking wastes that met 
the varying concentration exit levels tied to specific allowable units.
    The Agency believes allowing use of exit levels tailored to waste 
management can be a practical and appropriate way to allow greater 
volumes of waste to exit Subtitle C without increasing risks to above 
the toxicity benchmarks described in Section IV.D, providing that 
characteristics of various waste unit types can be clearly defined 
(such as the difference between surface impoundments, tanks, and 
perhaps covered tanks for the management of wastewaters), and providing 
the Agency can design a viable implementation scheme that does not rely 
primarily on statements of proposed future disposal. Tracking and 
monitoring of actual waste management could be one way to assure 
disposal in the appropriate facilities. Limiting disposal to on-site 
facilities could also better assure proper disposal, although this 
would limit the usefulness of contingent management approaches. The 
Agency requests comment on additional implementation requirements that 
might be needed to assure the waste is managed in the designated unit 
type only.
    EPA has not developed this as a general approach in this rulemaking 
because the risk modelling that was done, while more multifaceted and 
comprehensive than many past analyses, was not designed for this 
purpose. For efficiency in modelling, EPA did not always model each 
pathway for each specific unit. EPA sometimes only modelled an exposure 
pathway of concern (such as air emissions) from certain types of units 
that EPA thought might be the limiting scenario, and risk from organic 
constituents in a landfill were not modeled. Therefore the modelling 
work to date may not identify the most limiting pathway if each unit is 
judged individually. To fully develop exit levels for a full range of 
unit types, EPA believes it would have to do supplemental risk analysis 
to fill in the gaps in modeling for each of the waste management units, 
or at least evaluate whether the risk analysis done to date is 
sufficiently representative. Tables 21-39 in the November 1995 
Supplement to the multipath analysis present the modeled risk values 
for each constituent disposed in each of the five options modeled, and 
for each pathway. These tables can aid commenters in understanding what 
a unit-specific exit value for any particular constituent could be.
c. Consideration of Additional Management Unit Design or Management 
Practices
    A third option is that EPA would use a somewhat modified 
multipathway exposure model to evaluate whether adding additional 
specific design or operating controls for particular unit types, would 
allow less conservative exit levels. These conditional exit 
concentrations would be promulgated on a unit-type specific basis, and 
could be used only by units employing the specified additional controls 
that would reduce the risk level to 10-6. Such an approach could be 
self-implementing for a facility owner/operator, and would not 
necessarily be tied into a permitting authority.
    While such an approach could take into account the effects of a 
combination of added controls on each unit type (such as size of the 
unit, ground-water monitoring, liners, caps, etc.) the Agency believes 
that there are a number of significant implications associated with 
this approach. It could be interpreted by industries and states as an 
indirect way to define a broader set of management standards for 
industrial non-hazardous waste management units. Also, if the approach 
were self-implementing, it could be extremely difficult to ascertain 
that a particular unit meets a complex set of controls and therefore to 
assure compliance with the conditional exit levels. The more complex a 
judgement required to determine compliance with the conditions (such as 
whether a liner that is hard to inspect during operation is properly 
installed and protected from tears), the more appropriate it is likely 
to be that such determinations be made in the context of a permitting 
authority or prior approval rather than as a condition on a self-
implementing exemption.
    As a variation on this approach, The Agency could take into account 
certain regional, local, or site-specific factors in establishing exit 
levels. These could include the effect of local rainfall, regional 
hydrogeology, or size of facility on exit values. These issues are 
described in greater detail in section 3 below.
    Because of the complexity of implementation, the Agency would 
attempt to define very limited additional control(s) to limit exposures 
and reduce risks to 10-6 level. EPA particularly asks for comments on 
unit design attributes that are easily ascertainable in a spot 
inspection versus those that require more detailed engineering review, 
or review or monitoring of operations. For this option, as with options 
one and two, the Agency would have to conduct additional risk modelling 
work to adequately evaluate additional parameters on a unit specific 
basis.
    One issue common to all of the options discussed above is the legal 
status of wastes subject to such conditioned exemptions when there is a 
violation of the conditions. The Agency requests comments on how to 
make them enforceable in a practical way that is fair to those 
involved. If the waste concentration/unit requirements are conditions 
of an exemption, any violation of a condition means that the waste 
generator, or other individual managing the waste, has violated the 
full range of RCRA requirements and has been illegally managing a 
``hazardous waste'' as a ``nonhazardous'' waste. Because the 
conditional requirements are not clearly tied to other non-hazardous 
waste authorities, 

[[Page 66398]]
there would not be a remedy for the violations outside of the hazardous 
waste program. An alternative approach is discussed in the following 
options allowing conditional exit levels in states with qualified 
industrial non-hazardous waste programs. As long as the state has clear 
enforcement authority under its non-hazardous waste management program, 
these conditions could be crafted so that a violation of the condition 
was not illegal disposal of hazardous waste involving multiple RCRA 
counts. Rather it would be enforced as a violation of the relevant 
State authorities. The Agency requests comment on the advantages and 
disadvantages of these approaches, as well as whether there might be 
other approaches to ensure adequate legal remedies for violations of 
the conditional exit requirements, when the contingencies are not based 
on qualified state industrial non-hazardous waste programs.
2. State Program Approach
    As noted earlier in this section, many state industrial non-
hazardous waste programs have improved significantly since the early 
days of Subtitle C. State programs may offer the advantages both of 
requiring management controls which ensure protection of human health 
and the environment and ongoing oversight on a facility specific basis 
through permitting, inspection and enforcement activities. While every 
state program may not be operating at the same level, the Agency 
believes that a number of state programs may offer reasonable, 
protective systems to serve as the basis for less stringent exit 
levels. Qualified state programs would be allowed to manage listed 
waste in their non-hazardous waste management program under certain 
conditions. These qualified state programs would ensure that risks were 
reduced to protect human health and the environment.
    There are three key factors the Agency believes would need to be 
considered in establishing state-based contingent management programs. 
These are (1) establishing a risk-based cap on waste constituent 
concentrations that can be managed contingently; (2) the type of 
program review of a state program that EPA would perform to identify 
qualified state programs, and (3) the breadth of state program 
controls.
    For the risk cap, the Agency has considered using either a 1 E-4 
cancer risk and HQ 1, or 1 E-3 cancer risk and HQ 10 as options. The 
caps would be modeled based on management in unregulated disposal 
facilities, as in the base-case exit level modeling.
    Regarding program review, the Agency would either conduct a 
qualitative review of the State program, examining it to ensure it 
addresses key considerations, or would require states to conduct 
quantitative risk assessment of planned management practices to 
demonstrate their safety down to 1 E-6 cancer risk and HQ 1 or an 
alternative risk target.
    For the qualitative review, EPA would specify environmental and 
administrative performance goals and the state would have to submit a 
narrative description demonstrating how the particular combination of 
technical standards and administrative requirements in their program 
protects human health and the environment and meets those performance 
goals, for example:
     Ground-water protection: A state program must address 
adequately contamination of groundwater from a facility.
     Surface water protection: A state program must address 
adequately prevention of contamination of surface water which may occur 
through the run-off of pollutants from the disposal facility to surface 
waters.
     Address other environmental and performance goals such as 
controlling air exposures, siting, ensuring long-term integrity of the 
site, etc.
     Permitting and enforcement authorities and public 
participation: A state program has appropriate authorities and a system 
for prior approval of waste management facilities, and public 
participation either on a site-specific basis or for input to 
development of class permits.
     Adequate resources: A state program has adequate resources 
for administration of the program including permitting, inspections and 
enforcement.
    Under a quantitative risk review approach, a state would have to 
document their permitting and enforcement authorities and public 
participation requirements, as well as the adequacy of their program 
resources. The state would also have to demonstrate to EPA how the 
particular combination of technical management controls or design 
standards in its industrial non-hazardous waste program would ensure 
meeting 10-6 risk levels. In order to do this, EPA would have to refine 
or expand the multipathway exposure model. EPA would then either make 
its multipath model available to states or work with them to 
demonstrate that unit-specific state program controls would meet the 
10-6 risk level for a particular class of facilities receiving 
conditionally exited wastes. The Agency solicits public comment on 
whether states can propose alternative risk targets for use in state 
contingent management programs.
    Regarding program breadth, the Agency believes either broad, state-
wide programs, or more narrowly focused contingent management programs 
could be developed. Under a broad-based state program approach, the 
Agency would approve as qualified only those state subtitle D programs 
that adequately regulate all state non-hazardous waste management and 
wastes. Under this approach, states with programs deficient in certain 
aspects would be required to upgrade before participating in the 
contingent management program. However, the Agency recognizes that 
state subtitle D programs vary widely in the particular units and waste 
types that are covered, among other factors. Therefore, as an 
alternative approach, EPA might determine that a program qualifies for 
conditional exit only for particular units (i.e. for landfills only, or 
for landfills and surface impoundments, etc.). In other cases, a state 
program might focus narrowly on developing appropriate contingent 
management for particular waste streams generated by key industries in 
the state.
    In considering how to use these key factors in developing 
contingent management regulations, the Agency identified three options 
in addition to the three options described above under the national 
programs. These will be identified in this discussion as options four, 
five and six.
    Under option four, the Agency would use the 1 E-4 and HQ 1 risk cap 
on waste and would conduct a qualitative review of the state program 
using the criteria described above. This could be done either on a 
narrow program basis, or based on a program that qualifies broadly.
    Under option five, the Agency would also use the 1 E-4 and HQ 1 
risk cap for waste being contingently managed, but would require that 
states conduct risk modeling of proposed disposal to demonstrate that 
risks from the waste as disposed would be not greater than the 1E-6 and 
HQ1 risk targets of the base case. This approach could be taken either 
with the entire state program, or only certain waste management 
practices. In particular, site-specific factors, as described below, 
could be considered under this approach. These could include facility 
size, local rainfall, or local hydrogeology, among others. Location of 
the nearest drinking water well might also be considered by the state 
in evaluating risks, if allowed under state regulations and regulatory 
policies. In this case, the state would be 

[[Page 66399]]
required to demonstrate to EPA, using the multipathway analysis or 
another risk assessment model, how they would ensure on a site-specific 
basis that facilities disposing of conditionally exited wastes meet a 
10-6 risk level. Development of this approach might also require quite 
different risk models, since the multipathway model as it currently 
exists incorporates a number of simplifying assumptions to capture a 
broad range of possible conditions. The Agency would have to ensure 
that a model used for this analysis can incorporate complex site-
specific variables, or develop a set of simplified models that could be 
applied by states. However, this approach would provide maximum 
flexibility to states and generators to tailor exit levels to 
particular waste and site characteristics.
    Under option six, the Agency would allow wastes posing up to 1 E-3 
cancer risk and HQ 10 (in an unregulated management setting), and allow 
either a qualitative or quantitative review of the state program, but 
allow participation only by state programs that are broadly qualified, 
i.e., that are qualified in all aspects of the program, for currently 
managed industrial non-hazardous waste. The Agency would be more 
comfortable with this approach because it would be more assured of safe 
management of the waste regardless of where in the state it is 
disposed.
    The Agency also solicits public comment on whether more than one of 
the options discussed above should be developed at the same time. For 
example, the Agency might establish both the option 1 proposal 
described below, and establish a state-based contingent management 
program based on any of options four, five or six. By doing so, the 
Agency would establish option 1 as a minimum national standard, but 
this approach would allow that states to go further they choose to do 
so.
3. Establish Exit Levels That Consider Regional or Site-Specific 
Factors That Might Affect Constituent Fate and Transport'
    In addition to facility design factors, there are other location-
specific factors that may substantially affect the risks and the 
appropriate exit levels for waste management units. Examples of such 
factors include: Rainfall and hydrogeology at the site and the distance 
to off-site receptors. The average amount of precipitation falling on 
these waste management units may affect both the amount of leachate to 
groundwater and soil run off to off-site receptors. Thus, the Agency 
could determine geographic regions based upon climatic zones, could 
require precipitation data from the most appropriate certified rain 
gauge, or could require site specific precipitation information. 
However, in order to do this the Agency would need to verify that the 
other model inputs are appropriate for each of the regions or else 
develop new region-specific inputs. Therefore, the Agency solicits data 
and comment on technically appropriate ways to establish exit levels 
based on rainfall levels.
    Other site-specific factors that may significantly affect the 
groundwater pathway are the hydraulic conductivity of the soil 
surrounding the waste management unit and the distance to the nearest 
drinking water wells. If the hydraulic conductivity of surrounding soil 
is relatively low--such as in soils dominated by clays--then the flow 
of any potentially contaminated leachate to ground water could be 
effectively retarded for long periods of time (though flow to surface 
waters or other pathways might change, perhaps increasing). Landfills 
located in soils with low hydraulic conductivities (for example, 10-6 
cm/sec or lower) could provide an extra level of environmental 
protectiveness for ground water that could be considered in developing 
this approach. For example, the Agency might address this effect by 
developing exit levels corresponding to different classes of hydraulic 
conductivity. Alternatively, differences in hydraulic conductivity 
could be considered through a site-specific process. This approach 
would not be relying on engineered controls, but on natural attributes 
of the location. EPA solicits comments on whether such attributes can 
be readily determined or in what circumstances they can be readily 
determined and relied upon.
    The Agency did some limited sensitivity analysis with respect to 
ground water risk modelling to look at the concept of developing 
different exit levels depending on broad hydrogeological regions. The 
results of that analysis are in the docket. The Agency requests comment 
as to the value of investing in this approach and practical 
considerations the Agency should weigh in deciding whether to pursue 
this approach.
    Finally, where the nearest drinking water wells are at an unusually 
great distance from the waste management unit, corresponding exit level 
concentrations associated with groundwater exposures that took that 
distance into account could be significantly lower if the Agency's goal 
were solely the prevention of current exposure to groundwater 
contamination. However, many states have policies to not degrade 
groundwater and EPA believes it is quite difficult to predict future 
needs for uncontaminated groundwater. EPA believes that the groundwater 
modelling done for this rule reflects a balanced view by using the 
distribution of nearest wells. However, EPA expects it will receive 
comments suggesting that it should consider allowing facilities with no 
moderately nearby drinking water wells to take that into account. The 
Agency seeks comment on the implementation issues associated with 
taking these factors into account and the related policy judgement as 
to whether the goal of more site-specific assessment should be 
prevention of risk based on current ground water use, reasonably 
foreseeable use, or based on distances that would be more protective of 
the potential future use of ground water.
    The Agency also seeks comment on other location-specific factors or 
combinations of factors that may be particularly important in 
mitigating the risks associated with waste disposal. The Agency also 
requests comment on alternative approaches for taking these location-
specific factors into consideration in developing exit levels for waste 
management. One option for doing so would be to develop additional 
tables of exit levels (in addition to Option 2) for waste management 
units that reflect the effect of some of the most important location-
specific factors (e.g., exit levels for areas with low annual rainfall, 
or indexed to landfill size). As an alternative option, the Agency 
could develop ``reduced form'' equations that specifically relate the 
exit level concentration to critical location-specific factors (such as 
annual rainfall). The Agency requests comment on the merits of these 
approaches and on alternative options that might be used to better 
accommodate the effect of location-specific factors on exit levels.

D. Land Disposal Restrictions for Contingent Management Options

    Any conditional exemption would offer much more significant relief 
if it eliminated or reduced the need to comply with more stringent LDR 
treatment requirements. As explained above in Section VI of today's 
proposed rulemaking, however, under Chemical Manufacturers Association 
v. EPA (the ``Third Third'' decision) LDR treatment standards generally 
continue to apply even if a waste ceases to be classified as a 
hazardous waste. If an LDR treatment standard were lower (more 
stringent) than a contingent management exit level, the waste would 
still need to meet the LDR standard.

[[Page 66400]]

    EPA has proposed two approaches to integrating HWIR exit levels and 
LDR treatment requirements for the base option. First, EPA is proposing 
that LDR treatment requirements will never apply to wastes that meet 
all applicable exit levels at the point of generation. Second, for 
wastes which meet exit levels subsequent to the point of generation 
and, consequently, remain subject to the LDR regime, EPA is proposing 
to allow some exit levels to serve as alternative risk-based treatment 
standards meeting the ``minimize threat'' standard under RCRA section 
3004(m). EPA expects these proposals to reduce the burden of complying 
with LDR requirements.
    As explained more fully in the detailed presentation of option 1 
below, EPA is proposing both of these approaches for contingent 
management option 1 (relaxed exit values for wastes that are not placed 
in land application units). EPA's rationales are set out in that 
discussion.
    EPA anticipates that it might also be willing to propose to use 
exit levels developed under option 2 (separate exit levels for each 
major type of waste management unit) to serve as risk-based ``minimize 
threat'' standards. If EPA filled the gaps in its current multipathway 
risk assessment, it would feel fairly confident that the multipathway 
analysis plus the groundwater analysis identified constituent 
concentrations that minimize threats to human health and the 
environment for each class of waste management units. The modeling for 
both analyses would assume each type of unit was located in a 
``reasonable worst case'' physical setting and was subject to minimal 
management controls. EPA, however, would expect some members of the 
public to argue that unit-specific exit levels should not be considered 
``minimize threat'' levels because risks to human health and the 
environment would not be minimized if exempted waste ended up in the 
wrong type of management unit. EPA might try to address such concerns 
by imposing conditions such as tracking or reporting systems on persons 
claiming the exemptions.
    EPA would expect similar objections to the option of allowing 
wastes that meet option 2 levels to exit if their constituent 
concentrations met unit-specific exit levels at the point of 
generation. Members of the public might again be concerned about the 
possibility that wastes could be placed in a unit type requiring lower 
(more restrictive) exit levels. As suggested above, however, EPA could 
impose conditions to help ensure that exempted waste goes only to a 
unit where the exit levels in fact minimize threats.
    Providing LDR relief for the remaining options for conditional 
exemptions would raise additional legal and practical issues. All of 
the remaining national and state-based options rely on design or 
operating controls (such as liners) to help prevent dangerous 
concentrations of hazardous constituents from reaching human or 
environmental receptors. EPA, for example, would be reluctant to take 
into account control measures that would be difficult for inspectors to 
verify during site visits.
    It might be somewhat easier to take into account factors--such as 
annual rainfall, depth to groundwater, and subsurface soil and rock 
formations--that relate to a unit's physical setting. EPA has already 
proposed to interpret section 3004(m) to allow consideration of a 
unit's physical setting in making site-specific minimize threat 
findings. See the proposed LDR standards for contaminated soil, 58 Fed. 
Reg. 48123 and 48155 (Sept. 14, 1993). EPA requests comments on all of 
these issues related to the integration of conditional exemption 
options to the LDR standards.

E. Contingent Management of Mixed Waste

    The Department of Energy (DOE) has also expressed interest in EPA's 
contingent management approaches to managing waste that is mixed 
radiologic and RCRA hazardous waste (``mixed waste''). Mixed waste may 
be managed by DOE-regulated facilities or commercial facilities 
regulated by the Nuclear Regulatory Commission (NRC). EPA expects that 
the general approach in today's proposed regulation would be applicable 
to mixed wastes as well as listed-only hazardous wastes. DOE has 
suggested that because mixed wastes subject to RCRA are also subject to 
AEA disposal requirements which control releases of and exposure to 
radioactive hazards, these AEA requirements may address releases of 
chemically hazardous constituents as well, and it would be reasonable 
to allow more mixed wastes to exit Subtitle C because of the AEA 
requirements. DOE believes these AEA requirements would also provide 
adequate protection of human health and the environment from 
chemically-hazardous constituents. DOE has submitted several studies to 
EPA in support of their views, and the Agency has placed those 
documents in the public docket for review. The Agency will also 
undertake a review of these data to better understand the additional 
increment of protection provided by AEA low-level waste site 
performance standards. With that review ongoing, the Agency is 
proposing, and requesting public comment on, adaption of option four 
above to DOE's special circumstances. The Agency requests comment on 
allowing mixed waste meeting conditional exit levels for chemical 
toxicity estimated at 10-4 cancer risk and HQ 1 (modeled at an 
uncontrolled site), to exit Subtitle C if managed in AEA disposal 
facilities.
    DOE has also urged the Agency to consider establishing a 
categorical exclusion from RCRA requirements for mixed waste debris 
that is immobilized. One of several macro- or microencapsulation 
methods could be used to immobilize the debris, including use of 
portland or other cement products, or various polymer products. Under 
such an exclusion, all immobilized mixed debris could be managed 
outside of Subtitle C, but would still be required to be disposed in 
AEA disposal facilities. No testing of the debris would be required to 
identify toxic constituents or the levels at which they might be 
present. DOE has conducted a study of leaching rates for certain toxic 
constituents from stabilized debris and submitted it to the Agency for 
review in support of DOE's conclusion that immobilized debris can be 
managed safely outside of subtitle C if disposed in an AEA facility. 
Because the Agency has only recently received this study, it has been 
unable to adequately review and evaluate the data presented. The Agency 
solicits public comment on this approach, the DOE study, and solicits 
any other available data that are relevant to this topic.
    Finally, DOE has developed data on vitrified waste, and requested 
that the Agency consider the environmental protection conferred by this 
treatment process. Again, the Agency has not had adequate time to 
review and evaluate the DOE data, but has placed it in the public 
docket and solicits public comment on the data and DOE's preferred 
approach to mixed waste management.
    In soliciting comment on these exit procedures for mixed waste, the 
Agency recognizes that a number of states hosting DOE facilities have 
expressed concern over the proposal's effect on their states ability to 
adequately regulate mixed waste under states and federal law as 
intended by RCRA and the Federal Facilities Compliance Act. These 
states also believe that significant details of the DOE proposal are 
lacking and additional analysis would need to occur before the 
procedures can receive adequate comment. Therefore, the Agency intends, 
to the extent consistent 

[[Page 66401]]
with the schedule negotiated in the consent decree for this rulemaking, 
to publish a supplemental proposal on HWIR mixed waste exit criteria 
after initial comments have been received. The supplemental proposal 
would further describe the regulatory options being considered and will 
solicit additional comment on more specific options.

X. Implementation of Conditional Exemption Option 1

A. Introduction

    Using the concept of contingent management, EPA is proposing to 
create a second, alternative set of exit levels for nonwastewaters that 
are managed in landfills or monofills, but not land treatment units. 
Persons wishing to utilize this alternative exit scheme would not only 
have to meet the recalculated concentration limits for all constituents 
in their wastes, but also comply with conditions prohibiting land 
treatment. Compliance with notification and tracking requirements 
described in more detail below will also be necessary. The exit levels 
for this alternative are set out in appendix XI of 40 CFR part 261; the 
requirements and conditions are set out in proposed Sec. 261.37. 
Nonwastewaters that do not meet the exit levels in appendix X to 40 CFR 
part 261 will be eligible for exit only if they meet the more relaxed 
levels in appendix XI of 40 CFR part 261 and comply with all relevant 
conditions.
    EPA derived the levels for this alternative by deleting all of the 
modeling results for the land treatment scenario from its risk 
assessment data base, and selecting the lowest remaining exit value 
from the remaining modeling results for other types of waste management 
units. The same approach used to establish exit levels presented in 
Section V. of today's proposed rulemaking was used to establish exit 
levels under this option. That is, where complete risk data was not 
available, surrogates were used to extrapolated exit levels (see 
Section IV.H) and where analytical limitations existed, EQCs were used 
as exit levels (see Section IV.I). As a practical matter, this approach 
affects only the exit levels for nonwastewaters. As explained above in 
section IV, EPA created the original exit levels for nonwastewaters by 
grouping the modeling results for the unit types typically used to 
manage solid materials (ash monofills, piles, and land treatment units) 
and selecting the lowest value from all pathways modeled for these 
scenarios. EPA created the separate wastewater exit levels by grouping 
the results from units typically used to manage liquid wastes (tanks 
and surface impoundments). Consequently, the wastewater exit levels are 
not based on the modeling of land treatment units, and these levels are 
not affected by the decision to exclude results from the land treatment 
scenario.
    The Agency is proposing that the contingent management exemption be 
self-implementing. Therefore, the claimant would have the burden of 
demonstrating that all of the provisions for the contingent management 
exemption described herein have been met. In an enforcement action, a 
waste for which a contingent management exemption is claimed would be 
considered a Subtitle C hazardous waste unless the claimant was able to 
produce evidence that all of the conditions of the exemption have been 
met.

B. When Contingent Management Exemptions Become Effective

    The Agency is proposing two options for the point at which the 
contingent management exemption would become effective.
1. Option 1A--Placement of the Waste in a Qualifying Unit
    Under the first option, the conditional exemption for ``contingent 
management'' nonwastewaters would not become effective until the waste 
had been placed in a qualifying unit. Prior to actual disposal, the 
nonwastewater would be managed as a hazardous waste according to all 
applicable RCRA provisions, including 40 CFR parts 262 (for generators) 
and 263 (for transporters) and part 268 (regarding treatment prior to 
land disposal). These requirements include compliance with the waste 
manifest provisions of 40 CFR part 262, subpart B, and the pre-
transport provisions of 40 CFR part 262, subpart C, which contains, 
among other provisions, the provisions governing hazardous waste 
accumulation. Treatment and storage prior to disposal would remain 
subject to parts 264, 265, and 270.
    The Agency believes this approach makes it easier to ensure 
consistent implementation and safe management of the waste. It also 
decreases the potential implementation concerns that may arise if some 
states adopt this rule as part of their authorized programs and others 
do not. For example, this approach would reconcile transportation 
concerns that could arise if waste, conditionally-exempt in one state, 
were transported through a state that had not adopted the contingent 
management exemption as part of its authorized program.
    Under this option, the Agency is considering and requesting comment 
on the applicability of amending 40 CFR 264.1 and 265.1 to allow off-
site disposal facilities to store candidate contingent management 
exempt wastes for up to 10 days without becoming a subtitle C 
treatment, storage, and disposal facility, prior to ultimate disposal 
in a monofill or landfill. The Agency requests comment on whether 10 
days is a sufficient or appropriate length of time, and if not, what 
time period may be appropriate.
    Under the above approach, contingent management exempt 
nonwastewaters being disposed of on-site also would not become exempt 
until placed in a disposal unit meeting the requirements established 
under this rule. However, since the current waste accumulation 
provisions of 40 CFR 262.34, allow a generator to store hazardous waste 
on-site in tanks, containers or containment buildings for 90 days 
without becoming a Subtitle C storage facility, EPA believes that this 
approach should not place undue burdens on a generator. EPA requests 
comment on whether Sec. 262.34 will in fact enable generators of exempt 
nonwastewaters to store wastes on-site in unpermitted units for a 
reasonable period of time prior to land disposal. EPA acknowledges that 
nonwastewaters are typically not stored in tanks.
2. Option 1B--Effective Upon Meeting the Exit Levels
    The second option that EPA is considering would allow a 
nonwastewater to become exempt from all hazardous waste requirements 
except part 268 as soon as it meets appendix XI of 40 CFR part 261 exit 
levels and the claimant has met all the requirements and conditions of 
the exemption, including certifying that the waste will be managed in a 
monofill or land disposal unit. The goal of this approach is to ensure 
nonwastewaters will not be managed in a land treatment unit, which was 
found to pose the greatest risk for many routes of exposure. Under this 
approach, storage, treatment and transportation of the nonwastewater 
could take place outside of Subtitle C control upon meeting the 
requirements and conditions for the exemption. If EPA were to adopt 
such an approach, it would impose conditions to ensure that the 
exempted nonwastewater reached the types of units for which the 
exemption was designed. Various options are suggested below in Section 
D.1.
    Finally, EPA notes that the proposed approaches have different 
implications for LDR relief. These differences, which 

[[Page 66402]]
principally concern the availability of LDR relief for nonwastewaters 
which meet the appendix XI of 40 CFR part 261 exit levels at their 
point of generation, are discussed in more detail in section H. below.

C. Requirements for Obtaining an Exemption

    The following requirements would be applicable to both of the 
approaches discussed above. Requirements for meeting the contingent 
management exemption would include the sampling and testing 
requirements of Sec. 261.37 (b)(1), the public notice requirements of 
Sec. 261.37 (b)(3) and the notification to the implementing Agency 
requirements of Sec. 261.37 (b)(4), similar to those respective 
requirements for the base exemption in Secs. 261.36 (b) (1), (3) and 
(4). The Agency notes that these provisions would be directly 
enforceable Subtitle C requirements imposed prior to obtaining an 
exemption rather than conditions for maintaining the exemption.
1. Sampling and Testing Requirements for Contingent Management 
Exemptions
    The Agency is proposing that the sampling and testing requirements 
for the contingent management exemption be the same as those proposed 
for the base exemption in Section 261.36 (b)(1). The Agency requests 
comment on whether the sampling and testing requirements for the base 
exemption would be appropriate for the contingent management exemption.
2. Requirements for Public Participation in Contingent Management 
Exemptions
    To provide the public with access to information, the Agency is 
proposing to require compliance with the public notice requirements in 
proposed Sec. 261.37(b)(3), similar to those in Sec. 261.36(b)(3). The 
first time a claimant provides the Agency with notification of an 
exemption claim for contingent management wastes, he will be required 
to publish a notice of the claim in a major local newspaper general 
circulation. The notice must include the name and address of the 
facility, the description of the waste (as contained in the 
notification), a brief general description of the process producing the 
waste, an estimate of the quantities of waste claimed to be exempt, and 
information about the Agency where the claimant has sent the 
notification and supporting information. In addition, the public notice 
must include that the waste meets the contingent management exemption 
levels in appendix XI of 40 CFR part 261 and that the waste will be 
disposed of in a monofill or land disposal unit.
3. Notification Requirements for Contingent Management Exemptions
    To qualify for a contingent management exemption, a claimant would 
need to submit to the authorized State Agency Director a formal 
notification of its claim that waste meets the contingent management 
exemption levels in Appendix XI of 40 CFR part 261 and will be managed 
in accordance with the management conditions. In addition to the 
requirements under Sec. 261.36 (b)(4), the contingent management 
exemption notification to the implementing Agency must include an 
accompanying certification that the waste meets the contingent 
management exemption levels in appendix XI of 40 CFR part 261 and that 
the waste will be disposed of in a monofill or land disposal unit.
    The Agency requests comment on whether these requirements, similar 
to Sec. 261.36 (b)(1),(3) and (4), will provide adequate information to 
the implementing agency and the public on what exemption levels, i.e., 
appendix X to 40 CFR part 261 or appendix XI of 40 CFR part 261, are 
being claimed and on how the waste is being managed. These provisions 
would be requirements rather than conditions.

D. Implementation Conditions

    As set out in Sec. 261.37 (d) and explained in the base exemption 
implementation preamble (section VIII. B., Implementation Conditions) 
certain conditions have to be met to maintain the exemption after the 
claim has become effective. Under both option 1A and 1B, the following 
conditions would have to be met to maintain the contingent management 
option: Submitting changes in notification information to the Director 
within 10 days of the change, following the schedule for retesting, 
preparing and complying with a sampling and analysis plan for every 
retest, maintaining constituent concentrations in the nonwastewater at 
or below the exemption levels in appendix XI, meeting applicable 
treatment levels under Sec. 268.40, and maintaining records on-site for 
three years. These conditions are very similar to those proposed for 
the base exit in Section VIII of today's proposed rulemaking. In 
addition to those conditions established for the base exemption, the 
claimant would also have to ensure that the waste was managed in a 
qualifying unit.
    Claimants, under both options, always have the obligation to 
identify whether they are generating a hazardous waste and to notify 
the appropriate government official if they are generating a hazardous 
waste. (Section 3010; 40 CFR 261.11.) If any nonwastewater claimed as 
exempt under the contingent management proposal tested above the exit 
levels in appendix XI to 40 CFR part 261 at any time, that waste and 
any mixture or derived-from forms of that waste would have to be 
managed as hazardous waste, including compliance with all notification 
requirements, until testing demonstrated that the waste was below the 
exit levels.
1. Tracking Conditions
    EPA is proposing to modify the manifest regulations to reflect the 
fact that wastes exiting under this exemption need not be disposed of 
in treatment, storage or disposal facilities that are subject to the 
requirements of Sec. 264.71-264.72 or Section 265.71-264.72 requiring 
the facility that receives the waste to sign and return the manifest. 
EPA is not proposing to require the owners and operators of 
nonhazardous waste facilities that accept wastes exempted under this 
option to comply with these duties. As EPA concluded when it decided 
not to extend recordkeeping duties related to the LDR program to 
nonhazardous waste facilities accepting de-characterized hazardous 
wastes, it would probably be difficult to provide reasonable notice to 
all the members of this diverse universe, which has little or no other 
contact with the hazardous waste management regime, of these Subtitle C 
responsibilities.
    EPA is proposing instead that the claimant of the exemption be 
responsible for ensuring that the manifest is returned and that it--or 
some other document--provides information showing that the facility 
designated on the manifest did in fact receive the waste and did place 
it in a landfill or monofill (and not a land treatment unit). Billing 
documents may already supply some of the needed information. Where they 
do not, EPA believes that claimants should generally be able to 
contract with the receiving facilities to obtain the necessary 
information. In some states, nonhazardous waste rules may also require 
disposers to furnish generators with some of the necessary information. 
EPA proposes to revise the manifest document as necessary to ensure 
that nonhazardous waste facilities can be designated as receiving 
facilities for listed wastes meeting all of the other requirements for 
obtaining an exemption under this option.

[[Page 66403]]

    The alternative to this approach would be to require owners and 
operators of nonhazardous waste facilities to sign and return manifests 
as a condition of the exemption. Failure to satisfy this condition 
would void the exemption and return the waste to the hazardous waste 
management regime, even if it were in fact safely placed in an 
appropriate waste management unit. EPA requests comment on this 
alternative.
    Under option 1A, where all Subtitle C regulations apply until 
placement of the nonwastewater in a monofill or landfill, EPA is 
proposing conditions that make the claimant responsible for obtaining a 
copy of the manifest to ensure the waste has reached its destination. 
The claimant would also have the burden of acquiring evidence from the 
receiving facility that the waste was placed in either a monofill or 
land disposal unit.
    Under Option 1B, where the exemption becomes effective upon the 
waste meeting the appendix XI of 40 CFR part 261 exit levels, any 
tracking system established would be a condition that the claimant 
would have to meet to maintain the contingent management exemption. To 
ensure that listed wastes exempted under this option actually go to a 
landfill or monofill, EPA is proposing to require exemption claimants 
to comply with the requirements of part 262 (with the modification 
discussed above) relating to the uniform hazardous waste manifest.
    Since this option allows wastes to go to facilities that are not 
subject to the duty to return the manifest under Sec. 264.71-264.72 or 
Sec. 265.71-264.72, EPA is proposing to require the claimant to ensure 
that the manifest is returned and that it--or some other document--
provides information showing that the facility designated on the 
manifest did in fact receive the waste and did place it in a landfill 
or monofill (and not a land treatment unit). The duties would be 
identical to those proposed above for claimants under the first option. 
The rationale for imposing the duties on the claimant--and not the 
receiving facility--is also the same.
    An alternative which EPA requests comment on is the concept of 
imposing conditions that require a uniform, national tracking document 
similar to the current uniform manifest to accompany the waste until it 
reaches its final destination. This document could inform transporters 
and other waste handlers that the waste is an exempt hazardous waste 
that must be managed in a monofill or land disposal facility and loses 
its exemption if it is managed in a land treatment unit. EPA could 
further require that the disposal facility certify that the 
nonwastewater was disposed in a monofill or land disposal unit and 
return the tracking document and certification to the original 
exemption claimant. EPA could also ensure that the implementing agency 
(EPA or an authorized state) received notice of any problems in waste 
disposal by imposing requirements similar to the current Sec. 262.42 
exception reporting provisions.
    Another alternative would be to require, in lieu of a tracking 
document, a contractual agreement between the exemption claimant and 
the receiving facility specifying the type of waste the receiving 
facility will accept, the type of units it will use, and information on 
the volume and frequency of deliveries. EPA could require either the 
claimant or the receiving facility (or both) to maintain a copy of the 
agreement on-site and make it available to state or EPA inspectors. EPA 
also could require exemption claimants and transporters to create and 
keep similar contracts. EPA, however, requests comment on whether 
transporters would require claimants to provide information on the 
exempted waste's origin and the regulatory limits on its disposal 
options even without federal regulation.
    EPA requests comment on whether any of these alternatives can 
adequately ensure that mismanagement will not occur so that these 
wastes managed under this option 1B approach would not need to be 
classified as hazardous.
2. Qualifying Unit
    A ``qualifying unit'' for today's contingent management proposal is 
a landfill or monofill. For purposes of today's proposal, a landfill is 
defined in Sec. 260.10 as being ``a disposal facility or part of a 
facility where hazardous waste is placed in or on land and which is not 
a pile, a land treatment facility, a surface impoundment, an 
underground injection well, a salt dome formation, a salt bed 
formation, an underground mine, a cave or a corrective action 
management unit.'' The Agency is proposing a definition for monofill in 
Sec. 260.10 as a landfill where waste of only one kind or type is 
placed in or on land and which is not a pile, a land treatment 
facility, a surface impoundment, an underground injection well, a salt 
dome formation, a salt bed formation, an underground mine, a cave, or a 
corrective action management unit. Also, for today's proposal, a land 
treatment facility is defined in Sec. 260.10 as being ``a facility or 
part of a facility at which hazardous waste is applied onto or 
incorporated into the soil surface; such facilities are disposal 
facilities if the waste will remain after closure.'' The Agency 
requests comment on whether other units could be considered 
``qualifying units'' for contingent management exempt waste and whether 
additional modeling is needed to assess risks from management of 
nonwastewaters from other units.
    The Agency modeled risks from waste piles in both its multipathway 
and groundwater analyses. It modeled only groundwater risks form 
landfills. As explained elsewhere in this preamble, EPA believes that 
the nongroundwater risks posed by piles generally are higher than the 
nongroundwater risks posed by landfills. EPA, however, is not proposing 
to allow wastes placed in piles to be exempt under the exit levels for 
contingent management option 1. Piles, as defined in Part 260, are 
temporary units. To ensure that exempted wastes removed form piles went 
only to landfills or monofills, EPA would have to impose additional 
tracking conditions. These could be difficult to craft and enforce 
effectively. EPA currently thinks that excluding piles from eligibility 
will provide much better assurance that exempted wastes will n
FR Doc. 95-29458 Hazardous Waste Management System: Identification and Listing of Hazardous Waste: Hazardous Waste Identification Rule (HWIR)
ot be 
mismanaged.
    EPA acknowledges that the exit levels for this option, which are 
based in many cases on the evaluation of waste piles, may, for some 
pathways, be more restrictive than levels for landfills. If EPA later 
completes a multipathway analysis of landfill units, it will be able to 
use the levels from that modeling in lieu of the modeling from piles to 
derive exit levels for this option.
    The Agency requests comment on the proposal to exclude wastes 
placed in piles from being eligible for exemption under this option. 
The Agency also requests comment on the alternatives of allowing wastes 
to be exempt either permanently or temporarily (e.g., for one year) 
after they are placed in piles.
3. Claimant's Duty To Ensure Compliance With All Requirements and 
Conditions
    Today's proposal requires that, in order to claim a contingent 
management exemption, the person submitting the claim must manage the 
waste for which the exemption is claimed in accordance with the 
requirements and conditions established by this rule. To satisfy this 
rule, the claimant must ensure that the waste is actually disposed of 
in a qualifying unit. The burden of satisfying all conditions for the 
exemption falls on the claimant as the person in the best position to 
determine eligibility of a waste for an exemption and to ensure 
informed waste management decisions. The claimant may enter into 
contractual 

[[Page 66404]]
arrangements with receiving facilities to allocate responsibility for 
satisfaction of the conditions among themselves although such 
arrangements will not relieve the claimant of liability if the 
receiving facility manages the waste improperly. It should be noted, 
however, that facilities receiving contingent management exemption 
wastes could also become liable for violations of permitting, Subtitle 
C treatment, storage and disposal standards should they dispose of the 
nonwastewaters that do not qualify.
    Under today's proposal, Sec. 261.37(g), the burden of proof to 
establish conformance with the exemption criteria is on the claimant in 
the event of an enforcement action. One alternative for simplifying the 
claimant's burden of proving compliance with all conditions would be to 
set out in the rule certain documentation that, while not necessarily 
required of the claimant, presumptively would be sufficient evidence of 
satisfaction of the management condition. Of course, EPA could rebut 
this presumption regarding actual disposal through evidence that the 
claimant's documentation is deficient or inaccurate. For example, 
claimants might be able to develop rebuttable evidence of proper off-
site disposal by keeping correspondence with the receiving facility, 
indicating that the waste went to a landfill or monofill, and by 
keeping a returned manifest which indicates that the waste reached that 
facility. The Agency is taking comment on whether establishing certain 
evidentiary standards would provide useful guidance to claimants on how 
to satisfy the management condition and provide helpful incentive for 
claimants to maintain proper documentation of their exemption claims.
    Comment is also requested on whether any additional conditions or 
requirements, substantive or procedural, should be imposed on claimants 
to ensure that the contingent management exemption waste is actually 
managed in a qualifying unit.

E. Retesting and Recordkeeping Conditions for Contingent Management 
Exemptions

    Claimants continuing to generate or otherwise manage waste for 
which they continue to claim a contingent management exemption would be 
required, under Sec. 261.37(d)(2), to retest the waste with the same 
frequency and under the same conditions as is being proposed for the 
base exemptions, Sec. 261.36(d)(2). If a claimant finds that the 
exempted waste no longer meets the constituent concentration levels on 
Appendix XI of 40 CFR part 261 for the contingent management exemption, 
or that the waste has not been placed in a landfill or monofill, the 
claimant must comply with all applicable requirements for generators of 
listed wastes (including disposal of waste at a Subtitle C facility) 
and the disposal facility would have to comply with all of the 
requirements for owner/operators of treatment, storage, and disposal 
facilities under 40 CFR parts 262-270. The generator and disposal 
facility's obligations would also include renotifying the Agency of 
hazardous waste management activity using EPA form 8700-12.
    Under Sec. 261.37(d)(6), claimants also would be required to 
maintain on-site, for at least three years after Agency receipt of the 
notification and certification, all documentation required under this 
rule including, but not limited to, the sampling and analysis plan and 
test data and the accompanying notification and certification. These 
requirements are similar to those proposed for the ``base'' exemption 
in Sec. 261.36.
    The Agency requests comment on alternative record retention periods 
for claimants such as 5 years, which corresponds to the applicable 
statute of limitations period at 28 U.S.C. 2462. An extended record 
retention period may assist claimants in substantiating their 
conformance with the contingent management exemption criteria. The 
documentation must be available for review by the Agency or an 
authorized State at the time of site inspection. The three-year 
claimant record retention period will be automatically extended during 
the course of any unresolved enforcement action regarding the regulated 
activity.

F. Compliance Monitoring and Enforcement for Contingent Management 
Exemptions

    Since contingent management exemptions are self-implementing, the 
Agency needs to rely on its enforcement authorities to ensure that the 
exemptions are being applied in an appropriate manner and that only 
those wastes that are truly nonhazardous are relieved from Subtitle C 
disposal requirements. Compliance monitoring and enforcement of the 
contingent management program would be carried out under existing 
authorities and conditions with which the regulated community should 
already be familiar.
    Claimants must comply with all of the previously described 
conditions of the exemptions to qualify for the exemptions. All persons 
who manage waste for which an exemption has been claimed must manage 
the waste as required under Subtitle C during periods when any of those 
conditions are not met. Claimants that fail to comply with the 
applicable conditions of the contingent management exemption risk 
enforcement action for violations of Subtitle C requirements, including 
administrative, civil and criminal penalties.
1. Compliance Monitoring
    The Agency is proposing that compliance monitoring of the 
contingent management exemption occur through EPA and State oversight, 
primarily through review of notifications and inspections.
    The Agency has the authority, under section 3007 of RCRA, to 
require submission of information and to conduct inspections of 
facilities which EPA has reason to believe may be generating or 
managing a hazardous waste. EPA and States may do confirmatory sampling 
and analysis to determine whether a waste meets the exemption levels. 
Under this authority, the Agency would be able to inspect a non-
Subtitle C facility receiving contingent management exemption waste.
    Inspections of off-site laboratories may also be performed.
2. Enforcement
    The contingent management exemption criteria proposed today would 
create an exit from the Subtitle C system only so long as the 
requirements and conditions established for the exemption are met. 
Failure to comply with any of the conditions for the exemption would 
mean that the wastes would not be exempt from Subtitle C, and the 
claimant could be subject to immediate enforcement action for violation 
of Subtitle C requirements.
    The Agency has the authority under this regulation and RCRA Section 
3007 to require submission of information on the management of exempted 
wastes in a situation where the Agency suspects the claimant has not 
satisfactorily determined whether a waste meets the appropriate 
exemption levels. Alternatively, the Agency may require improved 
analysis using an administrative or civil action under section 3013. 
Failure to manage the contingent management exemption waste in 
accordance with the conditions would void the exemption and the 
conditionally exempt waste would be subject to full Subtitle C 
regulation. The receiving facility, therefore, would become a Subtitle 
C treatment, storage, and/or disposal facility requiring a permit. 

[[Page 66405]]

    In an enforcement action, compliance with the terms and conditions 
of the exemption may be raised as an affirmative defense, but the 
burden will be on the defendant to establish eligibility for the 
exemption and compliance with the conditions necessary to maintain the 
exemption. See 50 FR 642 (Jan. 4, 1985) for a discussion of EPA's 
authority to place such burdens on defendants.
    Claimants may not use the contingent management exemption as a 
means of avoiding enforcement actions. For example, a generator who is 
the subject of an Agency enforcement action cannot claim that the waste 
in question is exempted from Subtitle C under the contingent management 
exemption unless a valid exemption notification for that waste has been 
previously submitted to the Agency and the required documentation to 
support the claim exists at the facility and satisfies the requirements 
of the regulations. The contingent management exemption cannot be used 
in a retroactive fashion to avoid enforcement actions. Similarly, these 
exemptions cannot be used as a legal defense prior to the effective 
date of promulgation of this rule.

G. Exports of Wastes Eligible for Contingent Management Exemptions

    Under option 1A of today's proposal, contingent management 
exemption wastes would remain hazardous until actually disposed of in a 
qualifying unit. The waste would thus remain subject to all applicable 
requirements of 40 CFR parts 262 and 263, including export 
requirements.
     Under option 1B where the waste becomes exempt upon meeting the 
contingent management exit levels, comment is requested on whether 
these exempt wastes should still remain subject to the export 
requirements of 40 CFR part 262. Comment is requested on whether these 
export requirements are necessary to ensure that the contingent 
management exemption waste will be properly managed in the receiving 
country.

H. Land Disposal Restrictions

    As discussed above in section VI, EPA is proposing two approaches 
to integrating LDR requirements with the exit levels for the base 
option. First, EPA is proposing that LDR treatment requirements will 
never apply to wastes that meet exit levels for the base option at the 
point of generation. Second, for wastes which remain subject to LDR 
requirements, EPA is proposing to allow exit levels based solely on the 
combined multipathway and groundwater analyses to serve as alternative 
risk-based LDR standards meeting the ``minimize threat'' standard in 
section 3004(m) of RCRA. EPA believes that both approaches are 
appropriate for contingent management option 1.
    To eliminate the duty to comply with the LDR rules for wastes that 
meet the base option exit level at the point of generation, EPA is 
taking the position that such wastes are defined as hazardous waste 
pursuant to their listing descriptions for such a brief period of time 
that they effectively never become subject to Subtitle C requirements, 
and LDR requirements never apply. It is relatively easy to apply this 
theory to option 1B presented above in section B.2. that allows 
nonwastewaters to exit as soon as they have met the appropriate 
concentration limits and to remain exempt so long as they are managed 
in landfills or monofills. Such wastes need only meet the exit levels 
to obtain their exemption. If they meet them at the point of 
generation, they would appear just as entitled to LDR relief as wastes 
meeting the exit levels for the base option.
    Under option 1A, however, nonwastewaters will not exit until they 
both meet the exit levels and are placed in a landfill or monofill. 
Such wastes would not be eligible for exit at the point of generation 
even if their constituent concentrations were low enough. Rather, they 
would be subject to Subtitle C regulation for a significant portion of 
their ``cradle-to-grave'' management cycle. It would be difficult to 
argue that these wastes had never really been regulated as hazardous 
wastes, and that LDR treatment requirements did not apply. 
Consequently, EPA is not proposing to allow nonwastewaters to become 
exempt from LDR requirements at the point of generation under this sub-
option. EPA requests comment on alternative legal theories that would 
provide a better basis for arguing that nonwastewaters subject to this 
sub-option could be exempt for the LDR rules if they meet exit levels 
at the point of generation.
    Both options 1A and 1B have identical exit levels based on removing 
the predictions for land treatment units and using the next-highest 
concentration as the exit level. EPA is proposing to allow the exit 
levels that are based solely on the multipathway/groundwater risk 
analyses to serve as minimize threat levels for both options 1A and 1B. 
These levels represent concentrations posing minimal low threats for 
nonwastewater placed in landfills, monofills and waste piles. They are 
based on the same risk assessment used for the assessment for the base 
option. They make the same ``reasonable worst case'' assumptions about 
the units' physical setting and the same minimal assumptions about 
control measures. Hence, EPA believes that these exit levels 
sufficiently reduce threats to human health and the environment to meet 
section 3004(m)'s ``minimize threat'' standard.
    EPA acknowledges that option 1B, allowing wastes to exit Subtitle C 
before they are placed in the right kind of land disposal unit, 
presents an additional type of risk. Under option 1B, it may be more 
difficult for EPA to ensure that exited wastes will not be placed in 
land treatment units. (Under the alternative option, option 1A, 
Subtitle C manifest and tracking requirements would apply.) As 
explained above in section B., however, EPA will create conditions for 
option 1B to help ensure that exempted wastes are not disposed of in 
land treatment units. EPA believes that these conditions will 
sufficiently reduce the risk of inappropriate disposal that the exit 
levels will continue to minimize threats. EPA requests comment on this 
aspect of the proposal.

XI. Relationship to Other RCRA Regulatory Programs

    Today's rule proposes specific conditions and exit criteria that 
would exempt listed hazardous wastes, including waste mixtures and 
derived-from wastes, from Subtitle C regulation. Below is a discussion 
of how this proposed rule would affect other relevant RCRA regulatory 
programs.

A. Hazardous Waste Determination

    Under current RCRA regulations, any person who generates a solid 
waste must determine if that waste is a hazardous waste in accordance 
with the procedures outlined in 40 CFR 262.11. According to 262.11, 
generators must first determine if their waste is excluded from 
regulation under 40 CFR 261.4. Generators must then determine if the 
waste is listed in subpart D of part 261. If the waste was not listed, 
or for purposes of compliance with 40 CFR part 268, generators must 
then determine if the waste exhibits a characteristic defined in 
subpart C of part 261.
    Today's proposed rule is an exemption for listed wastes meeting the 
exit criteria, and does not change the general requirements for 
generators making hazardous waste determinations under Sec. 262.11 (see 
discussion of characteristic waste below).

B. Characteristic Hazardous Waste

    Today's proposed rule establishes exemption criteria for hazardous 

[[Page 66406]]
    constituents in eligible listed wastes, waste mixtures, or derived-from 
wastes. If the waste satisfies the exemption criteria proposed today, 
the waste would not be considered listed hazardous waste. However, the 
generator must still determine whether the waste exhibits any 
characteristics of a hazardous waste as specified in 40 CFR 261.21 
through 261.24 and continue to meet hazardous waste requirements if the 
waste does exhibit a characteristic.

C. Toxicity Characteristic Level for Lead

    Toxicity characteristic constituents are among those evaluated for 
exit values in this proposal. In developing the risk assessment for all 
constituents, including the TC constituents, the Agency examined risks 
via groundwater and other pathways to humans, and also environmental 
receptors. In evaluating risks resulting from the groundwater pathway, 
the Agency used its newly developed CMTP model, and the MINTEQ metals 
speciation component. The CMTP model estimates groundwater transport 
using finite source assumptions, and accounting for hydrolysis and 
adsorption of chemicals to soils. The MINTEQ component estimates 
dissolution and speciation of metals in groundwater. Using these 
models, the Agency has developed and is proposing estimates of 
transport through groundwater specific to each constituent. These 
estimates are analogous to constituent-specific dilution and 
attenuation factors (DAFs). These constituent-specific DAFs were 
contemplated for several constituents proposed for regulation in the TC 
rulemaking, but not finalized, because the modeling work was not 
complete. TC levels were set using generic DAFs of 100.
    In developing the constituent-specific DAFs, the Agency estimated 
that lead moves through groundwater much more slowly than predicted by 
the generic DAF of 100. While the modeling analyses supporting the TC 
rule and today's proposed rule are somewhat different from one another, 
the constituent-specific DAF for lead leaching from a landfill was 
estimated as 5000 rather than the 100 used in the TC rule. Higher 
leaching rates (giving lower DAF values) were estimated for some other 
disposal options evaluated in the updated modeling, such as land 
application and management in surface impoundments. This analysis 
raised the question of how the TC and today's proposed rules would 
relate to one another, and whether these results warranted 
consideration of a change to the TC level of 5 mg/l for lead (updated 
groundwater modeling of other TC constituents did not show the large 
disparity between the TC and exit level proposed in today's notice for 
lead).
    In considering these issues, the Agency reviewed several factors. 
First, the human health risk evaluation for lead has changed since the 
TC rule was promulgated, resulting in the MCL (on which the TC is 
based) for lead being reduced from 50 ppb to 15 ppb. Using the new DAF 
from the landfill scenario plus the new drinking water standard could 
raise the TC level to 75 mg/l from the current 5 mg/l. However, when 
lead movement from a land treatment scenario was modeled, a DAF of 
approximately 770 resulted, and a TC level based on this and the new 
drinking water standard could be approximately 10 mg/l. Another 
relevant reference point for lead in the environment includes the 
current OSWER soil direct ingestion level for lead of 400 ppm (as a 
total concentration, not leachate).
    The Agency considered several approaches to potentially proposing 
revisions to the TC level, including basing a new TC level on 
groundwater modeling only, basing it on the soil ingestion estimate, or 
basing it on the driving pathway value and exit level, which considers 
adverse ecologic effects.
    After carefully considering the issue, the Agency concluded that 
the issue of lead toxicity and movement through the environment is very 
complex and changes to existing rules could have significant impacts on 
management of lead-bearing waste and public health. The agency believes 
regulation of lead-bearing wastes warrants careful consideration and 
full evaluation of and review of the policy issues associated with 
considering all potential exposure pathways and risk to human health 
and the environment. Questions include whether the TC level would be a 
leachate or totals value, and whether it would be based on groundwater 
only or other exposure routes and whether it would be human health 
based or based on ecological risk considerations. Such a comprehensive 
evaluation is not feasible in the context of the rulemaking proposed 
today, and so the agency has determined to defer any action on the lead 
TC level. The Agency recognizes that this is an issue of considerable 
interest to the public, and will consider review of management of lead-
bearing waste at the soonest practical time. In the interim, the lead 
TC regulation and the exemption regulation proposed today (when 
finalized) would co-exist as independent regulations.
    As described in Section IV.E.3, the Agency has developed 
groundwater modeling based on both 10,000 year and 1000 year time 
frames. Today's proposal is based on the 10,000 year modeling time 
horizon, and the Agency is soliciting public comment on the alternative 
of using 1000 years. One aspect of the 1000 year modeling results is 
that the groundwater-based exit levels for more constituents would be 
above current TC levels for those constituents. These constituents 
include, in addition to lead, chromium, cadmium, selenium, and mercury. 
The Agency seeks public comment on this aspect of using the 1000 year 
time horizon modeling for risk assessment in the HWIR rule.

D. Hazardous Waste Listings

    The Agency evaluated the likelihood that untreated hazardous wastes 
would be able to meet the exemption criteria in an ``pure'' state 
(e.g., untreated and unmixed) and determined that it is unlikely that 
the constituent concentrations in many untreated hazardous wastes would 
be below today's proposed exemption levels or the applicable BDAT 
standards, particularly for nonwastewaters. Specifically, the Agency's 
hazardous waste characterization data indicate that the concentrations 
of toxicants of concern in untreated listed wastes are typically 
present at levels many times higher than health-based levels or BDAT 
values. Therefore, it is unlikely that the Agency's current criteria 
for listing wastes as hazardous will change as a result of the 
introduction of today's exit criteria into the RCRA regulations. 
However, EPA has been utilizing a more comprehensive risk analysis in 
the listing program, looking at multiple pathways for the movement of 
constituents through the environment, similar to the approach taken in 
today's proposal. Today's proposed approach may also provide the Agency 
with a means of assessing whether or not future listings might 
inadvertently bring into the RCRA system the types of low-concentration 
wastestreams that would subsequently be eligible for exit under today's 
proposal.

E. Delisting

    The evaluation criteria used for delisting may vary from today's 
exemption criteria for various reasons. First, delisting is an 
interactive process that considerable oversight by EPA or authorized 
State agencies. In delisting, the overseeing agency evaluates the 
processes generating a specific wastestream in order to determine the 
constituents likely to be present, as well as the potential variability 
in the waste. 

[[Page 66407]]
EPA (or the State) closely reviews sampling procedures, analytical test 
results, and the accompanying QA/QC data. This oversight increases the 
confidence in the quality and representativeness of the waste analysis.
    Second, delisting is specific to one wastestream, which decreases 
uncertainties that arise in the more generic approach proposed today. 
For example, a delisting petition will typically provide the annual 
generation volume of the waste. Using a specific waste volume as an 
input to various models has allowed EPA to calculate exit levels that 
may be somewhat higher than the levels proposed in today's rule. EPA 
believes that it is reasonable to use higher exit levels for the 
smaller waste volumes in delisting petitions (see 56 FR 32993 (Reynolds 
Metals) for further description of volume impact).
    The delisting process also allows more certainty in the plausible 
management scenarios that are modeled to generate exit levels. For 
example, the characteristics of the waste may dictate the likely 
disposal method (e.g., disposal in a landfill of de-watered process 
sludge). In some cases, special management standards may also be a 
factor (e.g., radioactive wastes are regulated under the Atomic Energy 
Act, therefore if such a hazardous waste were delisted, disposal 
options would be severely limited (see 60 FR 6054 (Hanford delisting)).
    EPA also considers the applicability of available groundwater 
monitoring data from land-based waste management units that have 
received the petitioned waste. Such data are typically required under 
permitting regulations for hazardous waste facilities (see 40 CFR parts 
264 and 265). If any contamination of groundwater appears to be due to 
constituents from the petitioned waste, EPA will consider this as a 
basis to deny the petition. The more generic waste identification rule 
proposed today does not incorporate this additional evaluation 
criterion.
    EPA may also require special testing regimes to ensure waste 
consistently meets delisting criteria (e.g., see (cite Reynolds Metals, 
CSI, Hanford)). Because the overseeing agency reviews the petition in 
some detail, the testing frequency may be closely tied to the potential 
variability of the waste. A facility that accepts and treats waste from 
diverse sources would typically have frequent testing requirements (see 
40 CFR part 261 appendix IX (Envirite)). In other cases, the testing 
requirements for some initial period will be extensive, but the 
subsequent testing may be reduced.
    Delisting petitions for wastes that contain toxic constituents 
which exceed the exemption levels proposed today will continue to be 
accepted and reviewed by the Agency after promulgation of today's rule. 
With the exception of a potentially reduced petition review burden, the 
Agency does not anticipate any changes in the current review of 
delisting petitions as a result of the implementation of today's 
proposed exemption. EPA does request comment on which risk models 
should be used to evaluate future delisting petitions.

F. Requirements for Treatment, Storage, and Disposal Facilities and 
Interim Status Facilities

    In order to implement the changes proposed today, owners or 
operators of RCRA permitted or interim status facilities may have to 
amend their waste analysis plans if required under 40 CFR 264.13 and 
265.13. Such changes will most likely include the addition of the 
appropriate analysis methods and changes that may be required in the 
frequency of testing.
    Permitted facilities, in unauthorized States, who elect to employ 
the exemption procedures and who subsequently prepare changes to their 
waste analysis plans should, following promulgation of this rule, 
submit a Class I permit modification to EPA. (EPA is aware that 
although most States have either become authorized for, or have 
adopted, the 3-class permit modification regulations, some states may 
still be operating under the older ``major/minor'' permit modification 
procedures. Under those procedures, changes to the waste analysis plan 
would be considered a major modification).

G. Closure

    Under today's proposed rule, a hazardous waste management unit that 
receives wastes that are exempt under today's exit criteria would 
continue to be a regulated Subtitle C unit subject to the requirements 
of 40 CFR parts 264 or 265, including closure requirements, until the 
owner/operator completed clean closure of the unit or unless all of the 
waste in the unit were delisted. A unit receiving only waste that is 
exempt under today's proposal would no longer be receiving hazardous 
waste upon the effective date of the exemption; such a unit would 
normally become subject to Subtitle C closure requirements, which are 
triggered by the final receipt of hazardous waste by the unit. The 
facility owner or operator is required to complete closure activities 
within 180 days after receiving the final volume of hazardous waste. 40 
CFR 264.113(b) and 265.113(b). However, RCRA closure requirements do 
allow certain waste management units to delay closure, while continuing 
to receive non-hazardous waste (such as waste exempt under today's 
proposed rule), provided certain conditions are met.
    The RCRA delay-of-closure regulations, promulgated on August 14, 
1989 (54 FR 33376), allow owners or operators to delay the closure of 
landfills, land treatment units, and surface impoundments in cases 
where the unit stops receiving hazardous waste but the owner or 
operator wishes to continue using the unit to manage only non-hazardous 
waste. These requirements are outlined in 40 CFR 264.113(d) and (e) and 
265.113(d) and (e). Owners or operators wishing to delay closure must 
request a permit modification at least 120 days prior to final receipt 
of hazardous wastes, or, if the facility is in interim status, submit 
an amended part B application at least 180 days prior to the final 
receipt of hazardous wastes. The request for a permit modification or 
the amended part B application must include demonstrations that the 
unit has the existing design capacity to manage non-hazardous wastes, 
and that the non-hazardous wastes are not incompatible with any wastes 
in the unit. In addition, certain facility information including the 
waste analysis plan, groundwater monitoring plans, closure and post-
closure plans, cost estimates, and financial assurance demonstrations 
must be updated as necessary to account for receipt of only non-
hazardous waste. Sections 264.113(d) and 265.113(d). In addition, 
surface impoundments that do not meet the minimum technological 
requirements (MTRs) for liners and leachate collection of RCRA 3004(o) 
must comply with additional requirements in order to delay closure, 
including the removal of hazardous wastes to the extent practicable 
from the unit. Sections 264.113(e) and 265.113(e).
    The delay of closure regulations apply only to landfills, land 
treatment units, and surface impoundments. In the case of other RCRA 
units such as tanks and waste piles, the Agency did not feel that the 
delay-of-closure regulations were necessary for these types of units in 
order to receive only non-hazardous wastes (54 FR 33383). The closure 
requirements in subpart G for these units include removal or 
decontamination of waste residues, containers, liners, bases and 
contaminated soils, equipment, and other containment system components; 
these closure requirements are not incompatible with the reuse of these 

[[Page 66408]]
units for receipt of only non-hazardous waste. Once the unit has been 
emptied of all hazardous wastes and decontaminated, it could receive 
non-hazardous waste. However, the Agency also recognizes that some 
flexibility may be warranted in converting the use of a unit such as a 
tank from hazardous to non-hazardous waste management. EPA solicits 
comment on whether an owner or operator might demonstrate removal of 
hazardous waste residues from the tank by demonstrating that all waste 
in the tank is below exemption levels, without removing the waste from 
the tank. In cases where the owner or operator could not demonstrate 
that all wastes in the tank were below exemption levels, he or she 
would have to remove the hazardous waste in order to achieve closure of 
the unit. In some cases, the facility owner or operator may be able to 
demonstrate that a tank no longer managed hazardous waste (because the 
waste met today's proposed exemption criteria), but did not achieve 
clean closure because of soil and perhaps groundwater contamination. In 
this case, EPA solicits comment on whether the facility owner or 
operator should be required to remove the contamination to clean 
closure levels, or close the area as a landfill while using the tank to 
manage nonhazardous wastes, as long as this activity did not interfere 
with cleanup activities or control of the contaminated areas.
    The Agency also believes that the availability of a delay-of-
closure option provides much of the flexibility needed to allow for the 
uninterrupted management of exempt waste, while providing assurance 
that the protections afforded by the closure regulations for Subtitle C 
units (e.g., evaluation of soil and groundwater at closure) are not 
lost. This approach makes sense in light of the fact that today's 
proposed exemption is self-implementing, which the Agency feels is 
appropriate for waste identification purposes, but not necessarily so 
for determining whether a Subtitle C unit may become a Subtitle D unit 
without first undergoing closure.

H. HWIR-Media Rule/Subtitle C Corrective Action

    The Agency is currently planning on proposing a rule (``HWIR 
Media'') addressing waste management issues relating to environmental 
media (e.g., soil, groundwater, and sediments). The goal of this rule 
is to allow more effective cleanups at contaminated sites. As currently 
drafted, the media proposal will supplement the regulatory system under 
RCRA for the management of RCRA hazardous contaminated media, 
applicable to sites that are undergoing cleanup overseen by EPA or 
authorized States. Such sites include cleanups at RCRA corrective 
action sites, State cleanups, and Superfund remedial actions. The media 
rule will propose a ``bright-line'' distinction between hazardous 
contaminated media (i.e., media containing hazardous waste that is 
therefore regulated as hazardous) subject to modified Subtitle C 
standards, and less contaminated media subject to more site-specific, 
flexible standards implemented by State agencies. This new system will 
supplement the current approach(es) to identifying RCRA applicability 
to the management of contaminated media. The rule will also propose 
streamlined permit requirements for cleanups. It will not specify 
cleanup standards.
    Today's proposal applies to listed hazardous wastes (e.g. process 
wastes, sludges, discarded commercial chemical products, etc.), 
including mixtures of one or more listed wastes with other solid 
wastes, and residues derived from the treatment, storage, or disposal 
of one or more listed hazardous wastes. Media that contain listed 
hazardous wastes, mixtures, or derived-from wastes with constituent 
concentrations below today's proposed exemption levels will be eligible 
for exemption under the procedures proposed today. EPA or an authorized 
State may continue to assess contaminated media with concentrations 
higher or lower than the exit levels proposed today on a case-by-case 
basis by making site-specific determinations as to whether a media 
``contains'' a RCRA hazardous waste.

I. Land Disposal Restriction Program

    Today's rule contains several important areas of overlap with the 
RCRA Land Disposal Restrictions (LDR) program that are discussed 
elsewhere in today's rule. First, as described in more detail elsewhere 
in this notice, EPA is proposing that exit levels produced under the 
multipathway analysis for constituents with adequate analytical methods 
should ``cap'' existing technology-based LDR standards, where the exit 
levels are less stringent than the current LDR values. If a waste 
contains only constituent with ``capped'' LDR values, it should be able 
to satisfy LDR requirements and exit Subtitle C for all other purposes 
as soon as the waste achieved those levels.
    Under today's proposal the uncapped LDR requirements for listed 
hazardous wastes continue to apply to a waste even after the waste 
becomes exempt from Subtitle C under the exemption criteria. 
Furthermore, for listed wastes containing certain constituents with 
analytical problems, compliance with the LDRs (either numerical levels, 
specified treatment, or both) is part of the criteria for exempting 
that waste under today's proposal. Specifically, for constituents where 
there are no adequate analytical methods for determining whether or not 
the exit levels have been met, a combination of meeting applicable LDR 
standards and a showing of non-detect estimated quantitation 
concentration is required to satisfy the exit criteria for these 
constituents. This is explained in more detail in Section IV.I of 
today's rule.
    If, however, a listed waste is below the exit concentrations 
proposed today at the point where the waste is ``first'' generated, 
that is, the point where the waste first meets the listing description 
and is potentially subject to Subtitle C, then a hazardous waste is 
never really ``generated'' and the LDR requirements do not attach to 
the waste. The EPA does not expect many listed wastes to be at or below 
the exit criteria at the point of first generation, where waste 
characterization data indicate that this is where wastes contain higher 
concentrations of hazardous constituents. Nonetheless, where a 
particular process generates a waste that is perhaps inappropriately 
captured by a listing, or where pollution prevention efforts by the 
generator result in a waste of lower constituent concentrations, if the 
waste meets the exemption criteria at the moment it is first generated, 
the LDR requirements would not apply. In contrast, once a listed waste 
is generated and managed the LDR requirements attach, and remain even 
after the waste exits Subtitle C under today's exemption (unless, as 
stated, where the exit levels are considered equivalent to a minimize 
threat standard). This issue is discussed in more detail in Section VI 
in today's proposal.
    It should be noted that the Agency is currently reviewing the 
definition of ``point-of-generation'' with respect to the application 
of the LDRs. Since November 1986 (51 FR 40620), EPA has required LDR 
determinations to be made at the point which hazardous wastes are 
generated. In the Phase III LDR rule (March 2, 1995, 60 FR 11702), EPA 
solicited comment on the issue of where the point of generation should 
be defined. EPA presented three options to narrowly redefine the point 
at which the land disposal prohibitions attach: (1) Similar 
wastestreams generated by similar processes, (2) wastestreams from a 
single process, and (3) ``battery limits.'' With Option 1 the point of 
generation would be defined at the point after which like wastestreams 
are generated from like processes and combined as a matter of routine 

[[Page 66409]]
practice. Option 2 would consider the point of generation to occur when 
wastestreams from a single process are combined (e.g., residual 
wastestreams collected in a common unit such as a sump). In many cases, 
these wastestreams are similar in composition because they all come 
from a common unit process. The Option 3 ``battery limits,'' is similar 
to Option 2; however instead of limiting aggregation to that normally 
occurring within a single unit process, the facility would view an 
entire battery of processes (associated with making a single product or 
related group of products) as a single manufacturing step. In the Phase 
III LDR proposal, EPA identified listed hazardous wastes as situations 
where existing point of generation determinations may remain 
appropriate. This is because EPA has carefully reviewed the various 
waste streams and has defined the point of generation as part of the 
listing description. Therefore, it may be inappropriate to modify that 
description with a more generic ``point of prohibition'' rule. This is 
important because today's rule applies only to listed hazardous wastes.
    Lastly, under today's proposal, mixtures containing listed 
hazardous waste and residues from the treatment, storage, or disposal 
of listed hazardous waste that contain some constituents with 
concentrations below exit levels and some constituents with 
concentrations above exit levels would continue to be managed as listed 
hazardous wastes. Today's notice does not allow for partial exemptions, 
because the Agency does not believe that a self-implemented exemption 
process is well suited to partial exemptions. It is not always clear 
what the origin of a hazardous constituent is, particularly for 
constituents that are formed as by-products of treatment or waste 
interactions. Further, the proposed exemption criteria are not waste-
specific, and thus are not suited to waste-specific or partial 
exemptions. Thus, the determination that a waste that carries two 
listing numbers should no longer bear one of the listing numbers is not 
always a straight-forward decision. The Agency has designed the 
exemption process proposed today to remove as much subjective decision 
making from the process as possible.
    However, while the Agency is not today proposing an alternative 
that would allow these wastes to use only the hazardous waste codes for 
those listed wastes that are the origin of the constituents above the 
exit levels, the Agency believes that there could be merit in the 
concept for a future proposed rulemaking should the implementation 
concerns stated above be overcome. Therefore, the Agency requests 
information on actual cases with waste characterization data where a 
waste bears more than one waste code which results in conflicting 
treatment standards under the land disposal restrictions rules. If the 
Agency finds that there is a serious compliance issue for multiple 
listing wastes, the Agency may reconsider this decision, as well as 
other potential solutions to any documented problems.

J. RCRA Air Emission Standards

    Today's proposed rule, when promulgated, may have an impact on the 
effectiveness of two other RCRA rules developed by the Agency under 
HSWA authority. Section 3004(n) of HSWA directed the Agency to 
promulgate regulations controlling air emissions from hazardous waste 
TSDFs ``as necessary to protect human health and the environment.'' 
Subsequent Agency analysis demonstrated that air emissions from TSDFs 
do pose substantial risk in the absence of controls, and that controls 
were therefore required under the HSWA mandate. The Agency is 
fulfilling this mandate in phases; EPA completed the first phase when 
it promulgated RCRA air standards that control organic emissions vented 
from certain hazardous waste treatment processes, as well as from leaks 
in certain ancillary equipment used for hazardous waste management 
processes (55 FR 25454, June 21, 1990; 40 CFR part 264/265, subparts AA 
and BB). More recently, EPA completed the second phase when it 
promulgated RCRA air standards for tanks, surface impoundments, 
containers, and miscellaneous units operated at TSDFs (59 FR 62896, 
December 6, 1994; 40 CFR part 264/265, subpart CC). Together, these 
rules would reduce the risk from air emissions from the vast majority 
of these facilities to well within the risk range of other RCRA 
standards. After more thorough analysis, the Agency may issue a third 
phase of these regulations to address any residual risk. The emission 
reductions achieved by these rules would also significantly reduce the 
formation of ozone, which has adverse effects on human health and the 
environment.
    Hazardous waste that satisfies the exemption criteria proposed 
today (including any constituent-specific exit concentrations for 
volatile organic chemicals, or VOCs), would be exempt from Subtitle C 
regulations, including regulations promulgated to date under RCRA 
3004(n). In other words, once a waste is no longer regulated as 
hazardous, any unit in which the waste is managed (assuming no other 
hazardous wastes are being/have been managed in the unit) is not 
subject to Subtitle C regulations, including 40 CFR parts 264 and 265, 
subparts AA, BB, and CC. However, the Agency believes that it is 
important to ensure that the risks associated with air emissions both 
from hazardous wastes, and from wastes that would be eligible for exit 
under today's proposal, are adequately addressed. In the final rule 
establishing air emission controls for tanks, surface impoundments, 
containers, and miscellaneous units (the ``Subpart CC'' rule), the 
Agency established a threshold level of 100 ppmw (parts per million by 
weight) for total volatile organics in a waste, a concentration which 
if equaled or exceeded that would trigger the emission control 
requirements for these units. Because there are examples of exit levels 
proposed today for specific volatile organic constituents that exceed 
this 100 ppmw threshold, the Agency considered whether today's exit 
levels adequately addressed the air emission concerns of 3004(n) in 
allowing waste to exit Subtitle C. There are important differences in 
the underlying risk modeling between the two rules. However, the Agency 
believes that the constituent-specific risk evaluation done for this 
rulemaking results in proposed exit levels that for VOCs will not be 
less protective than the standards established to date under RCRA 
3004(n). Despite these differences, the Agency requests comment on 
whether or not a total VOC concentration of 100 ppmw (parts per million 
weight), which is the concentration that triggers air emission controls 
under the Subpart CC rule, would be appropriate for use in the exit 
rule proposed today, and if so, how this level would be used.

K. Hazardous Debris

    Hazardous debris that contains one or more listed hazardous wastes 
is eligible for exiting Subtitle C under today's proposed rule. The EPA 
notes, however, that certain exemptions already exist relating to 
hazardous debris. On August 18, 1992, the EPA published a final rule on 
the Land Disposal Restrictions for Newly Listed Wastes and Hazardous 
Debris (57 FR 37194). In that rule, EPA required that hazardous debris 
be treated prior to land disposal, using specified treatment 
technologies from the treatment categories of extraction, destruction, 
or immobilization. (See 40 CFR 268.45, Table 1.) EPA also added a 
conditional exemption at Sec. 261.3(f) for non-characteristic hazardous 
debris (i.e., 

[[Page 66410]]
debris that is hazardous solely because it contains one or more listed 
hazardous wastes). Section 261.3(f)(1) exempts debris from Subtitle C 
regulation provided that the debris is treated using one of the 
extraction or destruction technologies specified in Table 1 of 
Sec. 268.45. Alternatively, non-characteristic hazardous debris can be 
exempt under Sec. 261.3(f)(2) if it is determined to be no longer 
hazardous by the Regional Administrator, after considering the extent 
of contamination of the debris, i.e., after a ``contained-in'' 
determination is made. However, non-characteristic hazardous debris 
contaminated with a listed waste, that is treated by a specified 
immobilization technology is not eligible for the conditional exemption 
in Sec. 261.3(f)(1), and therefore remains subject to Subtitle C 
regulation after treatment.
    In today's rule, EPA is not proposing to change the current 
exemption under Sec. 261.3(f); therefore, non-characteristic hazardous 
debris that requires LDR treatment by extraction or destruction 
technologies will be exempt from Subtitle C regulation, once treated. 
As was explained more thoroughly in the final rule for hazardous 
debris, the Agency gave careful consideration to many factors before 
exempting certain treated debris, including whether each debris/
contaminant type would be effectively treated by each BDAT technology 
to levels that would no longer pose a hazard to human health or the 
environment (57 FR 37240). However, hazardous debris that contains 
listed waste, and for which immobilization is the specified LDR 
treatment, may exit using today's proposed exit criteria. See also the 
discussion of a contingent management option above for a description of 
an alternative for encapsulated debris contaminated by radioactive 
``mixed'' hazardous wastes. Finally, EPA is not proposing to change the 
contained-in exemption under Sec. 261.3(f)(2) for hazardous debris; 
that is, the Regional Administrator may continue to determine on a 
case-by-case basis that hazardous debris no longer contains listed 
hazardous waste, and should therefore be exempt from RCRA Subtitle C.

L. Hazardous Wastes Used in a Manner Constituting Disposal

    Section 266.20 (b) of the regulations states that hazardous wastes 
and hazardous waste-derived products that are legitimately recycled by 
being applied to or placed on the land are largely exempt from subtitle 
C regulation provided they satisfy three conditions: the recyclable 
materials must have undergone a chemical reaction so as not to be 
separable by physical means, the product must be produced for the 
general public's use, and land disposal restriction treatment standards 
for every hazardous waste in the hazardous waste-derived product must 
be satisfied. (The shorthand for this type of recycling is ``use in a 
manner constituting disposal''. See Sec. 261.2(c)(1).) EPA developed 
Sec. 266.20(b) largely as a stop-gap to provide some modicum of safety 
while EPA studied further whether various disposal-like uses of 
hazardous waste-derived products in fact were safe or warranted 
control. 50 FR 614, 628-29, 647 (Jan,. 4, 1985). Since then, the Agency 
has studied particular use constituting disposal practices and 
determined, or proposed, that such uses either be prohibited or allowed 
based on more individualized determinations of risk. See 53 FR 31138, 
31164 (August 17, 1988) (allowing use of fertilizers derived from waste 
K 061 because of similarity to other zinc-containing fertilizers); 59 
FR 43496, 43500 (August 24, 1994) (prohibiting anti-skid uses of K 061-
derived sags); 59 FR 67256 (Dec. 29, 1994) (proposing to allow certain 
uses of K 061 if risk-based criteria are satisfied); 60 FR 11702, 11732 
(March 2, 1995) (proposing to prohibit hazardous waste use as fill 
material).
    EPA solicits comment today on the relationship of today's proposed 
exit levels and the general use constituting disposal provisions in 
Sec. 266.20(b) stating that such uses can occur if land disposal 
restriction treatment standards are satisfied. These land disposal 
restriction standards are not fully protective in all cases: the 
standards are technology-based rather than risk-based, and, for metal 
hazardous constituents, only control leachable amounts of the metal. 
Yet in many situations, total metal levels, rather than leachable 
levels, will be the critical factor because of the possibilities of 
direct contact through inhalation of abraded or wind-dispersed 
contaminants, or surface runoff. These exposure pathways are critical 
for uses constituting disposal because the hazardous waste are not 
placed in a confined unit. 60 FR at 11733, 59 FR at 43499.
    The exit levels proposed today, on the other hand, are risk-based 
(although some are capped by quantitation limits), are expressed as 
both total and leachable concentrations, and consider exposure pathways 
in some cases similar to those relevant in analyzing uses constituting 
disposal. The Agency solicits comment as to the appropriateness of 
applying these levels to hazardous wastes used in a manner constituting 
disposal (or at least to those uses where the hazardous waste-derived 
products are not comparable to non-hazardous waste based products that 
would be used in their place). One approach would be to replace the 
requirement to meet LDR treatment standards with a requirement to meet 
the exit levels proposed today. This approach should assure that exit 
levels for unconfined hazardous wastes (i.e. hazardous wastes used in a 
manner constituting disposal) are never less stringent than exit levels 
for hazardous wastes placed in confined units. EPA believes that the 
risk assessment it conducted for the exit levels considered scenarios 
sufficiently similar to use constituting disposal scenarios to ensure 
that the exit levels would be reasonably protective for uses (and more 
protective than LDR levels, in many cases, because of the analysis of 
impacts from total concentrations of constituents). EPA, however, 
requests comment on the reasonableness of this approach.
    Another option would be to require persons wishing to use hazardous 
wastes in a manner constituting disposal to meet the lower of the LDR 
treatment standards and the exit levels. Because EPA is today proposing 
setting exit levels for both total and leachable concentrations, and 
because LDR standards are expressed as either total or leachable 
levels, however, EPA is not certain how to meaningfully compare 
relative stringency.
    With respect to the current requirement in Sec. 266.20(b) that 
persons wishing to use waste in a manner constituting disposal meet the 
treatment standards from the LDR program, EPA notes that compliance 
with LDR tracking and recordkeeping rules is not required. EPA proposes 
today to require compliance only with the exit levels where they 
substitute for LDR treatment levels, although it requests comment on 
the option of requiring persons using wastes in this manner also to 
file the exit notification package proposed today. EPA does not intend 
that such persons be required to comply with conditions that continue 
to apply after exit, such as periodic retesting.
    Finally, EPA proposes to eliminate the requirement that wastes to 
be used in a manner constituting disposal undergo a chemical reaction 
so as to be inseparable by physical means. EPA does not believe it is 
necessary to retain this requirement since wastes will be evaluated for 
total constituent concentrations. (EPA, however, will retain this 
requirement for wastes with treatment standards expressed as a 
specified technology, rather than concentration levels.) 

[[Page 66411]]

    Were EPA to proceed on this course, the Agency would adjust the 
timing of any regulatory action so that it does not supersede the 
separate rulemaking the Agency is now conducting on certain uses of 
residues derived from K 061 recovery facilities. 59 FR 67256. Thus, the 
Agency does not intend to take final action affecting these uses until 
the analysis begun in that rulemaking is completed on the schedule 
established in that rulemaking.
    With respect to the other pending proposal, involving a prohibition 
on placement of hazardous waste as fill material, the Agency requests 
comment on whether it should substitute permission to use waste that 
has met the proposed exit levels for the proposed prohibition. The risk 
assessment underlying today's proposal addressed the major pathways 
that would arise from use as fill, but may not have used input values 
that fully reflect the fill scenario for some important parameters. For 
example, unit depths may be greater for fill sites than for land 
application units. At the same time, use of hazardous waste as fill is 
a proven cause of human health and environmental harm, contributing 
significantly to a number of Superfund sites. See Docket F-95-PH3P-
FFFFF (record for the pending proposal). In light of this, the Agency 
questions whether to substitute today's proposed exit approach for the 
proposed prohibition.

XII. CERCLA Impacts

    All listed hazardous wastes are listed as hazardous substances 
under section 101(14)(C) of the Comprehensive Environmental Response, 
Compensation, and Liability Act (CERCLA) of 1980, as amended. Under 
section 103(a) of CERCLA, notification must be made to the Federal 
government of a release of any CERCLA hazardous substance in an amount 
equal to or greater than the reportable quantity (RQ) assigned to that 
substance within a 24 hour period. (See 40 CFR part 302 for a list of 
CERCLA hazardous substances and their Rqs.) If a specific waste from a 
particular facility meets the exemption criterion in this rule, the 
waste is not a listed hazardous waste and therefore not a hazardous 
substance by virtue of its hazardous waste listing. Thus, notification 
under CERCLA of a release of the exempted waste may not be necessary. 
In this situation, CERCLA notification of releases of the waste would 
only be required if the waste or any of the constituents of the waste 
are CERCLA hazardous substances by virtue of Section 101(14) (A), (B), 
(D), (E), or (F) of CERCLA or 40 CFR 302.4(b), and are released in 
amounts greater than or equal to their Rqs. The Agency requests comment 
on this approach.
    Exit levels also may be applicable to the CERCLA program where it 
has been documented that RCRA listed hazardous waste has been disposed 
of at the site. Section 121(d) of CERCLA, as amended by the Superfund 
Amendments and Reauthorization Act (SARA) of 1986, requires that CERCLA 
actions comply with, or justify a waiver of, applicable or relevant and 
appropriate requirements (ARARs) under federal and state environmental 
laws. The options proposed in this rule would determine the legal 
applicability of federal RCRA managements requirements to remediation 
wastes generated at Superfund sites. They may also be considered in 
determining whether RCRA is relevant and appropriate in cases where it 
is not applicable.
    At sites undergoing CERCLA remedial activities where no listed 
hazardous wastes have been identified, the Agency will generally use a 
site-specific risk assessment for all chemicals for which there are no 
ARARs. In some cases, these health-based cleanup levels will be higher 
than the exemption levels, based on a reasonably conservative exposure 
scenario which does not include leachate ingestion. In other cases, the 
CERCLA health-based clean-up levels will be lower than exemption levels 
when additive effects are considered or when specialized analytical 
techniques are required in order to lower quantitation limits. The 
CERCLA health-based clean-up levels may also be different than 
exemption levels based on the consideration of site-specific factors.

XIII. State Authority

A. Applicability of Rules in Authorized States

    Under section 3006 of RCRA, EPA may authorize qualified States to 
administer and enforce the RCRA program within the State. (See 40 CFR 
part 271 for the standards and requirements for authorization.) 
Following authorization, EPA retains enforcement authority under 
sections 3008, 7003, and 3013 of RCRA, although authorized States have 
primary enforcement responsibility.
    Prior to the Hazardous and Solid Waste Amendments (HSWA) of 1984, a 
State with final authorization administered its hazardous waste program 
entirely in lieu of EPA administering the Federal program in that 
State. The Federal requirements no longer applied in the authorized 
State and EPA could not issue permits for any facility in the State 
that the State was authorized to permit. When new, more stringent 
Federal requirements were promulgated or enacted, the State was obliged 
to enact equivalent authority within specified time frames. New Federal 
requirements did not take effect in an authorized State until the State 
adopted the requirements as State law.
    In contrast, under section 3006(g) of RCRA, 42 U.S.C. 6926(g), new 
requirements and prohibitions imposed by the HSWA take effect in 
authorized States at the same time that they take effect in non-
authorized States. EPA is directed to implement HSWA requirements and 
prohibitions in an authorized State, including the issuance of permits, 
until the State is granted authorization to do so. While States must 
still adopt HSWA-related provisions as State law to retain final 
authorization, HSWA applies in authorized States in the interim.

B. Effect of State Authorizations

    Today's proposal, if finalized, will promulgate regulations that 
are not effective under HSWA in authorized States. Thus, the exemption 
will be applicable only in those States that do not have final 
authorization.
    Authorized States are only required to modify their programs when 
EPA promulgates Federal regulations that are more stringent or broader 
in scope than the authorized State regulations. For those changes that 
are less stringent or reduce the scope of the Federal program, States 
are not required to modify their programs. This is a result of section 
3009 of RCRA, which allows States to impose more stringent regulations 
than the Federal program. Today's proposal for exit levels is 
considered to be less stringent than, or a reduction in the scope of, 
the existing Federal regulations because it would exempt certain wastes 
now subject to RCRA Subtitle C. Therefore, authorized States are not 
required to modify their programs to adopt regulations consistent with 
and equivalent to today's proposal.
    Even though States are not required to adopt most options in 
today's proposal, EPA strongly encourages States to do so as quickly as 
possible. As already explained in this preamble, today's proposal will 
reduce over-regulation of dilute wastes and will provide an alternative 
to delisting. States are therefore urged to consider the adoption of 
today's proposal (when promulgated); EPA will expedite review of 
authorized State program revision applications.

C. Streamlining Issues

    EPA is considering a new approach to state authorization for rules 
revising the 

[[Page 66412]]
RCRA program. Under this new approach EPA would vary the requirements 
for state submissions and for EPA's review to reflect differences in 
the scope and complexity of various program revisions. This 
differential approach to authorization also would recognize the fact 
that many states now have more than a decade of experience in 
implementing large portions of the RCRA program and commensurate 
experience in obtaining authorization for program revisions. EPA 
believes that adjusting authorization requirements will strike an 
appropriate balance between recognizing state experience and ensuring 
environmental protection.
    EPA recently proposed a greatly streamlined set of procedures for 
the least complex changes to the LDR program in the ``LDR Phase IV'' 
rulemaking. EPA, however, proposed to retain the current authorization 
process for other portions of the rule that presented more complex and 
novel regulations.
    EPA is also developing a different approach to streamlining 
authorization for the ``HWIR media'' proposal scheduled for publication 
later in 1995. Although EPA expects some aspects of these state 
authorization procedures to be unique to the HWIR- media rulemaking, 
EPA will determine whether some of the concepts can be used to craft 
streamlined procedures for additional RCRA rules.
    EPA was not able to develop a streamlined authorization process for 
this rule in time to include it in this proposal. EPA, however, intends 
to describe such a process in more detail in the preamble to the 
proposed HWIR-media rule. EPA anticipates that most elements of the 
basic waste exit scheme proposed in today's notice would be eligible 
for a greatly streamlined approach to authorization. For example, the 
new LDR standards based on ``minimize threat'' findings would be good 
candidates for streamlined authorization because states that are 
already authorized for significant portions of the LDR program are 
familiar with the type of rule changes needed, have adopted all or most 
of the underlying LDR program, and have experience in implementing and 
enforcing the rules. The exit levels, along with the self-implementing 
approach to exit determinations, are also likely to be eligible for a 
greatly streamlined approach. The scheme is very similar to the 
existing program for determining whether a waste exhibits any of the 
hazardous waste characteristics, particularly the 1980 EP Toxicity 
Characteristic and the expanded 1990 Toxicity Characteristic. Under 
both the characteristic rules and today's proposal, generators are 
responsible for determining whether or not a waste meets a numerical 
definition of ``hazard''. States must then enforce by reviewing records 
of determinations and/or conducting their own analysis of wastes 
determined not to be hazardous. Consequently, States which have been 
authorized for the base program already have experience in adopting and 
enforcing rules which resemble the exit scheme proposed today. EPA, 
however, notes that adopting the exit scheme proposed in today's notice 
will place additional demands on state inspection and enforcement 
resources. EPA will give careful consideration to balancing the need to 
ensure that a state has sufficient resources to implement an exit 
program with the goal of streamlining the authorization process.
    Today's scheme does differ from the original characteristics and 
the 1990 Toxicity Characteristic by including some requirements which 
must be enforced as conditions of exit. These requirements, however, 
are requirements for testing, notification and recordkeeping that are 
relatively easy to meet and relatively easy to detect if violated. 
Accordingly, EPA does not at this time anticipate that these conditions 
would require it to retain the current authorization process.
    EPA currently finds it unlikely that it will propose a greatly 
streamlined authorization process for any of the contingent management 
options presented for discussion in today's proposal. These options 
will raise novel legal, implementation and enforcement issues. A more 
conventional approach to the review of state authorities and 
capabilities may be warranted. If EPA proposes any of these options in 
the future, it will consider the possibility of adapting the approach 
to authorization that it is currently developing for the HWIR-media 
proposal.

XIV. Regulatory Requirements

A. Analytical Requirements

1. Executive Order 12866
    Under Executive Order 12866, (58 FR 51735 (October 4, 1993)) the 
Agency must determine whether this regulatory action is 
``significant.'' A determination of significance will subject this 
action to full OMB review and compliance under Executive Order 12866 
requirements. The order defines ``significant regulatory action'' as 
one that is likely to result in a rule that may:
    (a) Have an annual effect on the economy of $100 million or more, 
adversely affect in a material way the economy, a sector of the 
economy, productivity, competition, jobs, the environment, public 
health or safety, or state, local, or tribal governments or 
communities;
    (b) Create a serious inconsistency or otherwise interfere with an 
action taken or planned by another agency;
    (c) Materially alter the budgetary impact of entitlement, grants, 
user fees, or loan programs, or the rights and obligations of 
recipients thereof; or
    (d) Raise novel legal or policy issues arising out of legal 
mandates, the President's priorities, or the principles set forth in 
the terms of the Executive Order.
    The proposed rule is expected to have an annual effect on the 
economy greater than $100 million. Furthermore, although voluntary, the 
adoption of this action may burden state or tribal governments with 
increased regulatory review requirements. Today's action may also raise 
novel legal or policy issues as they relate to the President's 
priorities for environmental protection within a regulatory system 
facing resource limitations. The Agency, therefore, has determined that 
today's proposed rule is a ``significant regulatory action.'' As a 
result, this rulemaking action, and supporting analyses, are subject to 
full OMB review under the requirements of the Executive Order. The 
Agency has prepared an Assessment of The Potential Costs and Benefits 
of The Hazardous Waste Identification Rule for Industrial Process 
Wastes, as Proposed, in support of today's action. A summary of this 
Assessment and findings is presented in section D below.
2. Regulatory Flexibility Analysis
    Pursuant to the Regulatory Flexibility Act of 1980, 5 U.S.C. 601 et 
seq., when an agency publishes a notice of rulemaking, for a rule that 
will have a significant effect on a substantial number of small 
entities, the agency must prepare and make available for public comment 
a regulatory flexibility analysis. This analysis shall consider the 
effect of the rule on small entities (i.e.: Small business, small 
organizations, and small governmental jurisdictions).
    Under the Agency's revised Guidelines for Implementing the 
Regulatory Flexibility Act, dated May 4, 1992, the Agency committed to 
considering regulatory alternatives in rulemakings when there were any 
economic impacts estimated on any small entities. Previous guidance 
required alternatives to be examined only when significant economic 
effects were estimated for a substantial number of small entities. The 
Agency has 

[[Page 66413]]
prepared a Regulatory Flexibility Analysis in support of today's 
action. A summary of this analysis and findings is presented in section 
E below.
3. Environmental Justice
    Executive Order 12898, ``Federal Actions to Address Environmental 
Justice in Minority Populations and Low-Income Populations,'' directs 
each Federal Agency to ``make achieving environmental justice part of 
its mission by identifying and addressing, as appropriate, 
disproportionately high and adverse human health and environmental 
effects of its programs, policies, and activities on minority 
populations and low-income populations * * *''
    The Executive Order requires that where environmental justice 
concerns or the potential for concerns are identified, appropriate 
analysis of the issue(s) be evaluated. To the extent practicable, the 
ecological, human health (taking into account subsistence patterns and 
sensitive populations) and socio-economic impacts of the proposed 
decision-document in minority and low-income communities should also be 
evaluated.
    The Agency has examined Environmental Justice concerns relevant to 
today's action. A summary of this analysis and findings is presented in 
section F below.
4. Paperwork Reduction Act
    The information collection requirements in this proposed rule have 
been submitted for approval to the Office of Management and Budget 
(OMB) under the Paperwork Reduction Act, 44 U.S.C. 3501 et seq. An 
Information Collection Request (ICR) document has been prepared by EPA 
(ICR No. 1766.01) and a copy may be obtained from Sandy Farmer, OPPE 
Regulatory Information Division; U.S. Environmental Protection Agency 
(2137); 401 M St., SW.; Washington, DC 20460 or by calling (202) 260-
2740.
    This information collection is required to provide documentation of 
solid waste exemptions from Subtitle C requirements, and will allow for 
certification and verification as the program evolves. Exemptions under 
today's action require no formal preapproval. As such, information 
collection, maintenance and reporting issues are especially important 
due to the self-implementing nature of this action. Successful 
implementation of today's proposal will depend upon the documentation, 
certification, and verification provided by the information collection.
    The general authority for this proposal is sections 2002(a), 3001, 
3002, 3004, and 3006 of the Solid Waste Disposal Act of 1970, as 
amended by the Resource Conservation and Recovery Act of 1976 (RCRA), 
as amended by the Hazardous and Solid Waste Amendments of 1984 (HSWA), 
42 U.S.C. 6912(a), 6921, 6922, 6924, and 6926. The specific authority 
for the collection of information is 40 CFR 261.36, Exemption for 
Listed Hazardous Wastes Containing Low Concentrations of Hazardous 
Constituents.
    The Agency has prepared a full Information Collection request (ICR) 
in support of today's action. A summary of the methodology and findings 
from this document is presented in section G below.

B. Background

    In 1976, Congress passed the Resource Conservation and Recovery Act 
(RCRA) to address problems associated with annual nationwide generation 
of large quantities of municipal and industrial solid waste. This Act 
was significantly amended in 1984 by the Hazardous and Solid Waste 
Amendments (HSWA). Under RCRA, the Agency regulates non-hazardous solid 
waste through the Subtitle D program, and hazardous solid waste under 
the Subtitle C program. Subtitle C regulations differ from Subtitle D 
in two important areas. First, Subtitle C regulations are developed and 
promulgated by EPA, while Subtitle D requirements have been largely 
delegated to the states. Second, non-hazardous wastes regulated under 
Subtitle D are generally subject to standards that are considerably 
less stringent and less costly than those under Subtitle C. All wastes 
addressed under this action are currently managed under Subtitle C 
regulations.
    RCRA is divided into four programs: Underground storage, medical 
waste, nonhazardous solid waste, and hazardous solid waste. Under RCRA 
3001(a), Congress has required EPA to identify those wastes that should 
be classified as hazardous. In accordance with this provision, the 
Agency has designated wastes as hazardous in two ways: 
``characteristic,'' or ``listed.'' Hazardous waste is considered 
characteristic if it has any of the properties or characteristics that 
would present a potential hazard if managed improperly. The Agency has 
identified four characteristics which, if exhibited, lead to hazardous 
classification. These are: Ignitability, corrosivity, reactivity, and 
toxicity. Under the toxicity characteristic, specific health-based 
concentration standards have been developed for approximately forty 
(40) constituents. Wastes exhibiting any of these characteristics are 
subject to Subtitle C regulation. Hazardous wastes are identified as 
listed based on an extensive listing procedure. This procedure may 
identify a waste as hazardous under three broad categories: if it 
exhibits one of the characteristics identified above but has not been 
classified as characteristically hazardous, if it is determined to be 
acutely toxic or hazardous, or if the waste meets the statutory 
definition of a hazardous waste.
    The Agency, however, was concerned that generators and managers of 
hazardous waste might avoid regulatory requirements in two major ways: 
(1) By mixing listed hazardous waste with non-hazardous solid waste, 
and, (2) by minimal processing and treatment of hazardous waste. These 
activities could result in a waste or residual material that was no 
longer legally defined as haza
FR Doc. 95-29458 Hazardous Waste Management System: Identification and Listing of Hazardous Waste: Hazardous Waste Identification Rule (HWIR)
rdous under Subtitle C. In many cases, 
the Agency believed these materials could continue to pose unacceptable 
hazards to human health and the environment. The Agency promulgated 
mixture and derived-from rules in May of 1980, in response to these 
potential loopholes.

C. Need for Regulation

    The mixture and derived-from rules created what was perceived as 
being federal over-regulation, where listed hazardous waste continued 
to remain under Subtitle C jurisdiction regardless of constituent 
concentration or presence in the waste, either before or after 
treatment. This problem was exacerbated with the passage of HSWA in 
1984. HSWA set Land Disposal Restrictions (LDR) requiring best 
demonstrated available technology (BDAT) treatment for all listed 
hazardous wastes prior to disposal. In cases where a specific listed 
wastestream contained relatively innocuous constituents, or very low 
concentrations, BDAT treatment requirements were felt to be overly 
protective, and unnecessarily expensive.
    By requiring Subtitle C management for some low risk wastes, the 
current RCRA regulatory system may inhibit the efficient allocation of 
limited societal resources. From a social perspective, too many 
resources devoted to managing low risk wastes may reduce resource 
availability for managing higher risk wastes. Resource availability for 
general productivity investments and innovative technologies are also 
reduced. The Agency's delisting program has not provided an efficient 
solution to this problem. The delisting process has proven to be overly 
time 

[[Page 66414]]
and resource intensive for both industry and EPA.
    The Agency believes that a simpler exemption process is necessary 
to reduce the over-regulation of low risk hazardous waste while, at the 
same time, reducing the time and resource burden on industry and 
government. This revised exemption process would also reduce the burden 
on the delisting program which will continue under current regulations. 
To meet these goals, the Agency is proposing the current action that 
would establish a single set of exit levels for constituents found in 
listed hazardous waste. This action would cover wastes as-generated, 
derived-from wastes, including BDAT treatment residuals, mixtures with 
solid wastes, and environmental media that contain hazardous wastes.

D. Assessment of Potential Costs and Benefits

1. Introduction and Summary
    The U.S. Environmental Protection Agency (EPA) has prepared an 
Assessment of The Potential Costs and Benefits (Assessment) to 
accompany today's proposed rulemaking action. This action will 
establish concentration-based exemption criteria for certain hazardous 
wastes, creating a mechanism to exclude from Subtitle C regulation 
those listed industrial process wastes that the Agency believes are 
clearly not of Federal regulatory concern. Today's proposed rule 
addresses low hazard wastes, mixtures, treatment residuals, and media 
that contain hazardous wastes.
    The Agency anticipates that the proposed rule will provide cost 
savings to selected generators and managers of low hazard wastes. Under 
the preferred option, annual nationwide treatment and disposal cost 
savings for exempted wastes may be as high as $75 million. Annual cost 
savings for a single facility may be as high as $5.03 million. 
Potential cost reductions beyond treatment and disposal savings may be 
associated with waste minimization incentives, avoided treatment costs 
for wastes remaining within Subtitle C, and administrative cost 
savings.
    Exemption of eligible wastes from Subtitle C management 
requirements is projected to have negligible effects on human health 
and the environment. The proposed exemption levels are based on 
detailed analysis of numerous possible routes of exposure. These 
exemption levels are designed to be protective of both human health and 
ecological systems when exempted wastes are managed under Subtitle D, 
including state regulated waste disposal systems.
    The Agency has also evaluated other impacts of the proposed rule. 
These include: Environmental justice, unfunded mandates, regulatory 
takings, and waste minimization incentives. Environmental justice 
concerns associated with today's proposed action may be in the form of 
economic benefits and/or human health effects. Today's proposal 
implements no enforceable requirements on states. Federal unfunded 
mandates, therefore, are not relevant to today's proposed rulemaking. 
Regulatory takings under today's proposed rulemaking will not approach 
land or productive value impacts discussed in past House and Senate 
Bills presented on this issue. This rulemaking provides opportunities 
for generators to implement waste minimization procedures to gain 
additional savings.
    The complete document, Assessment of The Potential Costs and 
Benefits of The Hazardous Waste Identification Rule for Industrial 
Process Wastes, as Proposed (Assessment), is available in the docket 
established for this proposed rule. This document details the data, 
methodology, findings, regulatory issues, and analytical limitations 
associated this Assessment. The rapid evolution of this action resulted 
in continuous technical modifications throughout the development of 
this proposal. An Addendum to the Assessment document that details 
final quantity and cost savings estimates is included in the docket 
materials. Findings presented in this preamble present final estimates.
    A summary of the Assessment methodology and findings is presented 
below. The analysis conducted for this Notice of Proposed Rulemaking is 
to be considered preliminary. The Agency welcomes review and comment of 
this document and urges the submission of data in support of any 
comment or response.
2. Regulatory Options
    The Agency's Assessment, conducted in support of today's action, 
addresses the costs, benefits, and other potential impacts of the 
preferred option. The Assessment also examines various other regulatory 
options based on exit levels that are both more and less stringent. 
Findings presented in this preamble discuss the preferred option and 
one primary alternative. A full discussion of findings associated with 
various alternative regulatory options is presented in the Assessment 
and Addendum.
a. Preferred (Proposed) Option
    Under the preferred option, exit criteria are established for 
approximately 400 constituents, allowing hazardous wastes (including 
waste mixed with or derived-from listed wastes) to exit Subtitle C if 
the concentration of all constituents is less than or equal to the 
exemption criteria. The exit levels apply to all listed wastes, 
regardless of origin.
    Exit levels for most constituents are based on risks posed to human 
health and the environment. The Agency's goal is to ensure, through 
Federal or State management requirements, that humans are not exposed 
to carcinogens in concentrations that will increase the statistical 
risk of cancer by more that one-in-one-million (1 x 10-6). For 
non-carcinogens, the Agency's goal is to ensure that humans are not 
exposed to concentrations where the hazard quotient exceeds one (1). 
The Agency feels that, above this level, selected populations may 
experience carcinogenic effects at a 10-6 risk level and non-
carcinogenic effects at a hazard quotient greater than one (1).
    To determine the concentrations at which exempt wastes would not 
pose human health risks in excess of these target levels, EPA conducted 
a ``Multipathway'' Analysis that included ecological exposure pathways. 
In addition, EPA considered the effects of direct exposure to 
contaminants in groundwater. The analyses consider several types of 
waste management units. For non-wastewaters these unit types include 
landfills, land application units, waste piles, and ash monofills. For 
wastewaters management units included tanks and surface impoundments.
    The concentrations from all other pathways were compared to the 
groundwater concentrations in determining the exit level. The more 
stringent of the multipathway or groundwater numbers was chosen as the 
exit level. Exit levels for some constituents are based on surrogates, 
or Exemption Quantitation Criteria (EQCs). MCLs were not used in the 
development of exit levels analyzed for this option. The Agency 
believes that levels established under this process will ensure 
protection of human health and the environment. These exit levels are 
presented in the regulatory language for this proposed rulemaking.
b. Other Options
    In developing the preferred option, the Agency compared the 
proposed rule to several alternative regulatory options. These are 
discussed in the full 

[[Page 66415]]
document, Assessment of The Potential Costs and Benefits of The 
Hazardous Waste Identification Rule for Industrial Process Wastes, as 
Proposed. Additional options are discussed in the supporting Addendum 
to the Assessment document. These options consider alternative waste 
management requirements, target risk levels, dilution and attenuation 
factors (DAFs), and exposure pathways. This Preamble discusses one 
primary alternative to the preferred option. This alternative is the 
same as the preferred option but drops land application units from 
consideration as a management source. Exempt nonwastewater wastestreams 
could not be land applied. There would be no change for wastewaters.
3. Implementation Requirements
    Implementation requirements include the steps that generators (or 
waste managers) must take to achieve exemption of their wastes, 
regardless of the exit levels selected. These requirements include 
waste sampling and analysis, and related recordkeeping and reporting. 
Under the proposed rule, the facility must first perform a 
comprehensive analysis of the waste, testing for all constituents 
identified in appendix X to 40 CFR part 261. Reduced initial testing 
may be possible only if a facility is able to document that such 
constituents are not present in the waste. The generator must then 
prepare a notification/certification package and submit it to the EPA 
Regional Administrator or authorized state agency. The generator must 
repeat a comprehensive analysis periodically according to the schedule 
established in the proposed rule, along with more frequent tailored 
scans that focus on the constituents of concern. Related documentation 
must be maintained on-site and be available for review.
    The Agency has estimated annual sampling, analysis, recordkeeping, 
and reporting costs (collectively referred to as ``implementation 
costs'') that may be required under this rule. These estimates range 
from approximately $21,000 for a less complex, solvent wastestream with 
testing every 12 months, to $169,000 for a complex high quantity F039 
wastestream with testing every three months.
4. Analysis and Findings
    Under the proposed rule, listed wastes from industrial processes 
may be eligible for exemption from Subtitle C hazardous waste 
requirements if they contain low concentrations of contaminants. This 
exemption may allow generators and waste managers to avoid some or all 
costs associated with Subtitle C requirements. The most significant 
cost savings relate to waste treatment and disposal; this rule will 
allow generators to avoid the costs of treatment required for 
compliance with the Land Disposal Restrictions as well as the costs of 
disposing wastes in highly protective Subtitle C facilities.
    In addition to assessing these cost savings, the Assessment 
addresses a number of other potential effects of the regulations. It 
analyzes the relative effects of the regulatory options on human health 
and the environment and considers issues related to ensuring 
environmental justice, eliminating federal mandates, encouraging waste 
minimization, and providing flexibility for small businesses.
a. Eligible Waste
    The universe of annual listed waste generation, both wastewaters 
and nonwastewaters, potentially affected by today's proposed rulemaking 
is estimated to total 303.6 million tons. The universe of potentially 
affected wastes includes approximately 25,300 wastestreams from 10,700 
facilities. Wastewaters account for the vast majority of total waste 
quantity (99 percent).
    To determine whether these wastes are likely to be eligible for 
exemption, EPA developed the Process Waste Model. This model uses data 
on the characteristics of individual listed waste-streams first 
collected in 1986 for EPA's National Survey of Hazardous Waste 
Generators, which has since been updated, refined, and in some cases, 
corrected. The model first compares the reported concentrations of 
constituents in each wastestream to the proposed rule exit levels to 
determine whether the waste is likely to be eligible for exemption 
without further treatment. If the waste is not eligible as-reported, 
the model then considers whether it may be eligible after treatment. In 
this comparison, the concentration standards established under EPA's 
Land Disposal Restrictions (which are based on the use of the best 
demonstrated and available technology) are used as a proxy for the 
lowest concentrations achievable by treatment. If the waste is not 
eligible for exemption as-reported or after treatment, EPA assesses 
whether waste minimization or pollution prevention methods could be 
used to cost-effectively achieve the exit levels. This model does not 
address contaminated media.
    The analysis indicates that:
     Under the preferred option, total nonwastewater quantity 
exempted, including BDAT treatment residuals and sludge from 
wastewater, is estimated at 0.40 million tons. Total wastewater 
(liquid) quantity exempted is approximately 64 million tons.
     Under the primary alternative option (no land 
application), approximately 65 million tons of wastewaters, and 0.60 
million tons of nonwastewaters, including BDAT treatment residuals and 
sludge from wastewaters, may be eligible for exemption.
b. Cost Savings
    The proposed rule will allow waste generators and managers to avoid 
costs associated with Subtitle C requirements. Specifically, this 
exemption will allow them to avoid treatment costs and/or costs of 
disposing wastes in Subtitle C facilities. Wastes which meet exit 
levels at the point of generation may accrue treatment cost savings 
because the wastes will not require any treatment that would have been 
needed to comply with the Subtitle C Land Disposal Restrictions prior 
to disposal. All exempt wastes are likely to accrue disposal cost 
savings because the costs of disposing wastes in non-Subtitle C 
facilities are generally lower than the cost of more protective 
Subtitle C facilities.
    The analysis indicates that:
     Under the preferred option, the high-end estimate of 
annual treatment and disposal cost savings is approximately $75 
million.

--A large portion of these savings are attributable to avoided 
treatment costs.

     Under the primary alternative, the high-end estimate of 
cost savings is $99 million.
    The above estimates for quantities exempted and cost savings assume 
zero implementation costs. The incorporation of implementation costs 
into the analytical model will have a significant impact on facilities 
and wastestreams affected, while having only a marginal impact on total 
quantities exempted.
c. Affected Wastestreams and Facilities
    Under the preferred option (unconditional exemption), as high as 41 
percent (10,300) of the potentially affected wastestreams may be 
eligible for exemption. These eligible wastestreams are generated by 56 
percent (6000) of the facilities producing listed waste. Total 
wastestreams and facilities potentially eligible for exemption under 
the primary alternative option (no land application) are estimated at 
12,200 (48 percent), and 7,000 (65 percent), respectively. 

[[Page 66416]]

    The majority of the wastestreams eligible for exemption under the 
preferred option are very small in quantity. The median annual 
generation size of an eligible wastewater wastestream is 20 tons. The 
median for eligible nonwastewaters is 2.0 tons. For small wastestreams, 
the costs accrued due to the exemption are likely to be counterbalanced 
by the costs associated with gaining the exemption.
    While a relatively large number of wastestreams and facilities meet 
the eligibility criteria for exemption, many may not gain exemption 
because the costs of exemption may outweigh the estimated cost savings 
from exemption. For example, if implementation costs average $35,000 
annually per wastestream, the estimate of facilities generating an 
exempted wastestream may be overstated by as much as 90 percent. 
However, small generators may choose to aggregate their wastes to avoid 
this problem.
d. Relative Impacts on Human Health and the Environment
    Today's proposed rule will allow low concentration hazardous wastes 
to exit RCRA Subtitle C regulation and be disposed of in Subtitle D 
nonhazardous waste units. The Agency believes that today's proposed 
rule will have little effect on human health for the following reasons:
     The acceptable daily exposure levels used to set the exit 
levels are based on maximum risk levels for carcinogens of 10-6 
and on acceptable daily doses for non-carcinogens at which no adverse 
effects are likely to occur.
     The waste management units modeled in the Multipathway 
Analysis provide high potential release rates for the various groups of 
constituents being considered in the analysis based on their physical 
and chemical properties.
     The pathways included in the Multipathway Analysis are 
generally considered to be the most critical.
     The Multipathway Analysis includes populations that are 
likely to be exposed more than the average adult due to proximity to a 
contaminant source, behavior patterns, activities, and body size.
     High-end values were used for selected parameters in the 
Multipathway Analysis to calculate acceptable waste concentrations.
     Exit levels represent acceptable constituent concentration 
levels for Subtitle D waste management based on all of the potential 
combinations of management units, and receptors in the Multipathway 
Analysis.
     Exit levels for several constituents are below the 
acceptable waste concentrations for human health due to the inclusion 
of ecological receptors.
    Ecological risks were also evaluated for selected key constituents. 
The inclusion of such risk in solid waste regulation at a national 
level is an important step, and is preferable to establishing exit 
criteria based only on human health risks.
5. Other Regulatory Issues
a. Environmental Justice
    Economic benefits may occur to selected communities as affected 
local facilities reinvest cost savings derived from reduced treatment 
and/or disposal costs. Human health effects are expected to be 
negligible due to the stringency of the exit levels. Included in these 
exit levels are pathways of particular concern for selected low income 
populations such as subsistence fishing and farming.
b. Other Issues
    Today's proposal is expected to have no impact in the area of 
Unfunded Federal Mandates or Regulatory Takings. Waste minimization 
procedures are likely to be stimulated under this proposal.
6. Implications and Conclusions
    The analysis indicates that approximately 11 percent of the 
quantity of all nonwastewaters containing listed codes, and 21 percent 
of all such wastewaters may be eligible for exemption under the 
proposed rule. This exempt quantity is dominated by a small number of 
very large wastestreams, and includes a large number of very small 
wastestreams. For some small wastestreams, exemption may not be cost 
effective unless generators aggregate their wastes or otherwise work 
cooperatively to minimize the costs of gaining the exemptions.
    Today's proposal could also provide incentives for industry to 
implement process changes and increased recycling in an effort to gain 
additional savings. Preliminary estimates indicate that savings from 
these activities, when combined with treatment and disposal savings 
from the preferred option, are likely to result in total annual cost 
savings greater than $100 million. However, limitations of our analysis 
suggest that the cost savings estimates from such activities are highly 
uncertain. Additional savings related to administrative requirements 
and reduced treatment for hazardous wastes may also accrue. These 
potential additional cost savings are discussed in greater detail in 
the Assessment document.
    The Agency believes that today's proposal will result in a net 
benefit to society. Wastes gaining exemption under the preferred option 
will not pose unacceptable incremental risks to human health and the 
environment because the exit levels are based on extensive analysis of 
possible human and ecological risks associated with exempt wastes.
    EPA's analysis of the impact of today's proposal on industry groups 
indicates that a limited number of industries are likely to benefit 
from exemption. Under the preferred option (unconditional exemption), 
three industries account for 51 percent of eligible nonwastewater and 
wastewater sludge quantity and 53 percent of total treatment and 
disposal cost savings. These industries are: Chemicals and allied 
products (SIC 28); fabricated metals (SIC 34); and primary metals (SIC 
33).
    The Agency also compared benefits gained from exemption to key 
industry data such as national pollution abatement expenditures and 
considered facility level impacts of the proposal. To evaluate the 
relative magnitude of cost savings that would accrue under the proposed 
rule, EPA compared cost savings estimates to total pollution abatement 
expenditures and the total value of industry shipments. Total treatment 
and disposal cost savings under the preferred option account for 
approximately 3.5 percent of annual operating costs for hazardous waste 
pollution abatement activities, and less than 0.002 percent of the 
total value of industry shipments. The facility-level impacts of the 
proposal vary greatly.

E. Regulatory Flexibility Analysis.

    The Regulatory Flexibility Act requires analysis of the impact of 
regulations on small entities. Because today's proposal is 
deregulatory, it is not expected to have adverse impacts on small 
businesses. In general, generators of large quantity wastestreams 
posing low hazards will benefit substantially from the regulations. The 
impacts on small quantity generators is less certain and depends on the 
degree to which they aggregate their wastes and work cooperatively to 
cost-effectively gain exemption.

F. Environmental Justice

    It is the Agency's policy that environmental justice be considered 
as an integral part in the development of all policies, guidance and 
regulations. Further, Executive Order 12898, ``Federal Actions to 
Address 

[[Page 66417]]
Environmental Justice in Minority Populations and Low-Income 
Populations'', directs each Federal Agency to ``make achieving 
environmental justice part of its mission by identifying and 
addressing, as appropriate, disproportionately high and adverse human 
health and environmental effects of its programs, policies, and 
activities on minority populations and low-income populations * * * ''
    The Executive Order requires that where environmental justice 
concerns or the potential for concerns are identified, appropriate 
analysis of the issue(s) be evaluated. To the extent practicable, the 
ecological, human health (taking into account subsistence patterns and 
sensitive populations) and socio-economic impacts of the proposed 
decision-document in minority and low-income communities should also be 
evaluated. Examples include how a policy on future land use would 
impact minority or low-income communities versus non-minority, affluent 
communities, or how subsistence farming or fishing patterns relate to 
risk-assessment policies.
    For the purposes of today's proposed rulemaking, the Agency has 
taken an approach for proposal consistent with Executive Order 12898. 
As currently drafted, the multipathway analysis which was used to 
develop the exit levels takes into account subsistence farmers and 
subsistence fishers; however, subsistence fishers were evaluated using 
a recreational fisher database (one does not exist for subsistence 
fishers). Sensitive populations are accounted for in the RfDs, RfCs, 
and slope factors and ecological receptors were also evaluated.

G. Paperwork Reduction Act

    As stated earlier, the level of implementation costs (i.e. 
sampling, analysis, recordkeeping, and reporting) will have a 
significant impact on the number of wastestreams and facilities 
affected by this proposal. Assuming annual implementation costs of 
$35,000 per wastestream, as many as 269 facilities, generating up to 
285 different wastestreams may seek exemptions, and therefore be 
affected by the recordkeeping and reporting requirements. The actual 
number of facilities and wastestreams affected will depend upon the 
level of implementation costs. The higher the implementation cost to 
the facility, the fewer the number of facilities expected to 
participate in the HWIR program.
    The estimated hour burden ranges from 382 hours to 573 hours per 
wastestream in the first year, and from 31 hours to 146 hours per 
wastestream in years two and three. The variation in burden estimates 
results from different assumptions in (1) the complexity of the waste 
(and therefore of the test methods required), and (2) the frequency of 
reporting. The estimated total hour burden over the first three years 
ranges from 206,900 to 293,465 hours, averaging 68,967 to 97,821 hours 
per year.
    The estimated total start-up cost of recordkeeping and reporting in 
the first year ranges from $55,000 to $235,000 per wastestream. The 
annual cost in the second and third years is estimated to be $9,000 to 
$209,000 per wastestream (of which $8,000 to $203,000 is the cost of 
shipping samples to a laboratory and paying to have them tested). In 
years four and five the high-end cost drops to $53,000. The estimated 
annual recordkeeping and reporting cost per wastestream, annualized at 
seven percent over five years, is $21,000 to $170,000. The total 
recordkeeping and reporting cost burden over the first three years is 
$28,000,000 to $32,000,000.
    Burden means the total time, effort, or financial resources 
expended by persons to generate, maintain, retain, or disclose or 
provide information to or for a Federal agency. This includes the time 
needed to review instructions; develop, acquire, install, and utilize 
technology and systems for the purposes of collecting, validating, and 
verifying information, processing and maintaining information, and 
disclosing and providing information; adjust the existing ways to 
comply with any previously applicable instructions and requirements; 
train personnel to be able to respond to a collection of information; 
search data sources; complete and review the collection of information; 
and transmit or otherwise disclose the information.
    An Agency may not conduct or sponsor, and a person is not required 
to respond to a collection of information unless it displays a 
currently valid OMB control number. The OMB control numbers for EPA's 
regulations are listed in 40 CFR part 9 and 48 CFR chapter 15.
    Comments are requested on the Agency's need for this information, 
the accuracy of the provided burden estimates, and any suggested 
methods for minimizing respondent burden, including through the use of 
automated collection techniques. Send comments on the ICR to the 
Director, OPPE Regulatory Information Division; U.S. Environmental 
Protection Agency (2137); 401 M St., SW.; Washington, DC 20460; and to 
the Office of Information and Regulatory Affairs, Office of Management 
and Budget, 725 17th St., NW., Washington, DC 20503, marked 
``Attention: Desk Officer for EPA.'' Include the ICR number in any 
correspondence. Since OMB is required to make a decision concerning the 
ICR between 30 and 60 days after December 21, 1995, a comment to OMB is 
best assured of having its full effect if OMB receives it by January 
22, 1996. The final rule will respond to any OMB or public comments on 
the information collection requirements contained in this proposal.

List of Subjects in 40 CFR 261 and 268

    Identification and listing of hazardous waste. Land disposal 
restrictions.

    Dated: November 13, 1995.
Carol Browner,
Administrator.

XV. References

U.S. Environmental Protection Agency, Environmental Monitoring 
Systems Laboratory; ``Performance Testing of Method 1312--QA Support 
for RCRA Testing.'' EPA/600/4-89/022, June 1989.
Research Triangle Institute; ``Interlaboratory Comparison of Methods 
1310, 1311, and 1312 for Lead in Soil''. U.S. EPA Contract 68-01-
7075, November 1988.
U.S. Environmental Protection Agency, Office of Solid Waste and 
Emergency Response; OSWER Directive No. 9285.7; ``Human Health 
Evaluation Manual, Part B: Development of Risk-based Preliminary 
Remediation Goals;'' from Henry Longest II, Director, Office of 
Emergency and Remedial Response; and Bruce Diamond, Director, Office 
of Waste Programs Enforcement; to Regional Waste Management Division 
Directors; December 13, 1991.
U.S. Environmental Protection Agency, Office of Solid Waste and 
Emergency Response; OSWER Directive No. 9850.4; ``Interim Final 
Guidance for Soil Ingestion Rates;'' from J. Winston Porter, OSWER 
Assistant Administrator; to Regional Administrators (I-X); January 
27, 1989.
U.S. Environmental Protection Agency, Office of Research and 
Development, Office of Health and Environmental Assessment; 
``Exposure Factors Handbook;'' EPA/600/8-89/043, March 1990.
U.S. Environmental Protection Agency, Office of Solid Waste: EPA's 
Composite Model for Leachate Migration with Transformation Products 
(EPACMTP), Background Document, 1995a.
U.S. Environmental Protection Agency, Office of Solid Waste: EPA's 
Composite Model for Leachate Migration with Transformation Products 
(EPACMTP), User's Guide, 1995b.
U.S. Environmental Protection Agency, Office of Solid Waste: Finite 
Source Methodology for Non-Degrading and Degrading Chemicals with 
Transformation Products, 1995c.
U.S. Environmental Protection Agency, Office of Solid Waste: 
Background 

[[Page 66418]]
Document for EPACMTP: Fate and Transport Modeling of Metals, 1995d.
U.S. Environmental Protection Agency, Office of Research 
Development. Finite Source Methodology for Wastes Containing Metals, 
1992.
U.S. Environmental Protection Agency, Office of Research Development 
MINTEQA2/PRODEFA2, A Geochemical Assessment Model for Environmental 
Systems: Version 3.0 User's Manual. EPA/600/3-91/021, March 1991.
U.S. Environmental Protection Agency, Office of Research 
Development. Environmental Fate Constants for Chemicals Under 
Consideration for EPA's Hazardous Waste Identification Projects, 
compiled by Heinz Kollig, 1993.

Appendix A

                                       Table A-1.--Human Exposure Pathways                                      
----------------------------------------------------------------------------------------------------------------
       Exposure medium              Route of exposure        Type of fate and transport         Pathway a       
----------------------------------------------------------------------------------------------------------------
Groundwater.................  Ingestion...................  Groundwater................  1                      
                                                                                         WMU           
                                                                                          groundwater  
                                                                                          humans                
                                                                                         Ingestion of           
                                                                                          contaminated          
                                                                                          groundwater as a      
                                                                                          drinking water source.
Air.........................  Inhalation..................  Direct air.................  2a (on site or off     
                                                                                          site)                 
                                                                                         WMU  air  humans         
                                                                                         Inhalation of volatiles
Air.........................  Inhalation..................  Direct air.................  2b (on site or off     
                                                                                          site)                 
                                                                                         WMU  air  humans         
                                                                                         Inhalation of suspended
                                                                                          particulates          
Soil........................  Ingestion...................  Direct soil................  3 (on site)            
                                                                                         WMU  humans   
                                                                                         Ingestion of           
                                                                                          contaminated soil     
Soil........................  Ingestion...................  Overland...................  3 (off site)           
                                                                                         WMU  overland 
                                                                                           humans      
                                                                                         Ingestion of           
                                                                                          contaminated soil     
Soil........................  Ingestion...................  Air deposition.............  4                      
                                                                                         WMU  air  deposition to  
                                                                                          soil  humans 
                                                                                         Ingestion of           
                                                                                          contaminated soil     
Soil........................  Dermal......................  Direct soil................  5 (on site)            
                                                                                         WMU  humans   
                                                                                         Dermal contact with    
                                                                                          contaminated soil     
Soil........................  Dermal......................  Overland...................  5 (off site)           
                                                                                         WMU  overland 
                                                                                           humans      
                                                                                         Dermal contact with    
                                                                                          contaminated soil     
Soil........................  Dermal......................  Air deposition.............  6                      
                                                                                         WMU  air  deposition to  
                                                                                          surface soil 
                                                                                          humans                
                                                                                         Dermal contact with    
                                                                                          contaminated soil     
Plant (veg/root)............  Ingestion...................  Air deposition.............  8                      
                                                                                         WMU  air  deposition to  
                                                                                          soil/gard crops  garen crops  humans         
                                                                                         Consumption of         
                                                                                          contaminated crops    
                                                                                          grown in home gardens 
Plant (veg).................  Ingestion...................  Air diffusion..............  8a                     
                                                                                         WMU  air  garden crops  humans         
                                                                                         Consumption of         
                                                                                          contaminated crops    
                                                                                          grown in home gardens 
Plant (veg/root)............  Ingestion...................  Direct soil................  9 (on site)            
                                                                                         WMU  garden   
                                                                                          crops  humans
                                                                                         Consumption of         
                                                                                          contaminated crops    
                                                                                          grown in home gardens 
Plant (veg/root)............  Ingestion...................  Overland...................  9 (off site)           
                                                                                         WMU  overland 
                                                                                           garden crops
                                                                                           humans      
                                                                                         Consumption of         
                                                                                          contaminated crops    
                                                                                          grown in home gardens 
Animal (beef/milk)..........  Ingestion...................  Air deposition.............  10                     
                                                                                         WMU  air  deposition to  
                                                                                          soil/feed crops  cattle  humans         
                                                                                         Consumption of animal  
                                                                                          products with elevated
                                                                                          levels of toxicant    
                                                                                          caused by eating      
                                                                                          contaminated feed     
                                                                                          crops and soil        
Animal (beef/milk)..........  Ingestion...................  Air diffusion..............  10a                    
                                                                                         WMU  air  feed crops  cattle  humans         
                                                                                         Consumption of animal  
                                                                                          products with elevated
                                                                                          levels of toxicant    
                                                                                          caused by eating      
                                                                                          contaminated feed     
                                                                                          crops                 
Animal (beef/milk)..........  Ingestion...................  Direct soil................  11 (on site)           
                                                                                         WMU  feed     
                                                                                          crops  cattle
                                                                                           humans      
                                                                                         Consumption of animal  
                                                                                          products with elevated
                                                                                          levels of toxicant    
                                                                                          caused by eating      
                                                                                          contaminated feed     
                                                                                          crops and soil        
Animal (bedf/milk)..........  Ingestion...................  Overland...................  11 (off site)          
                                                                                         WMU  overland 
                                                                                           feed crops/ 
                                                                                          soil  cattle 
                                                                                           humans      
                                                                                         Consumption of animal  
                                                                                          products with elevated
                                                                                          levels of toxicant    
                                                                                          caused by eating      
                                                                                          contaminated feed     
                                                                                          crops and soil        
Groundwater.................  Dermal (bathing)............  Groundwater................  14                     
                                                                                         WMU           
                                                                                          groundwater  
                                                                                          humans                
                                                                                         Ingestion of           
                                                                                          contaminated surface  
                                                                                          water as a drinking   
                                                                                          water source          
Surface water...............  Ingestion...................  Air diffusion..............  17                     
                                                                                         WMU           
                                                                                          groundwater  
                                                                                          humans                
                                                                                         Dermal bathing contact 
                                                                                          with contaminated     
                                                                                          groundwater           

[[Page 66419]]
                                                                                                                
Surface water...............  Ingestion...................  Overland...................  19                     
                                                                                         WMU  overland 
                                                                                          flow  surface
                                                                                          water  humans
                                                                                         Ingestion of           
                                                                                          contaminated surface  
                                                                                          water as a drinking   
                                                                                          water source          
Surface water...............  Ingestion...................  Air deposition.............  20                     
                                                                                         WMU  air  deposition to  
                                                                                          soil         
                                                                                          overland flow  surface water  
                                                                                           humans      
                                                                                         Ingestion of           
                                                                                          contaminated surface  
                                                                                          water as a drinking   
                                                                                          water source          
Fish........................  Ingestion...................  Air diffusion..............  21                     
                                                                                         WMU  air  surface water  
                                                                                           fish  humans         
                                                                                         Consumption f fish     
                                                                                          contaminated by       
                                                                                          toxicants in surface  
                                                                                          water                 
Fish........................  Ingestion...................  Overland...................  23                     
                                                                                         WMU  overland 
                                                                                           surface     
                                                                                          water  fish  
                                                                                           humans      
                                                                                         Consumption f fish     
                                                                                          contaminated by       
                                                                                          toxicants in surface  
                                                                                          water                 
Fish........................  Ingestion...................  Air deposition.............  24                     
                                                                                         WMU  air  deposition to  
                                                                                          surface soil 
                                                                                          overland flow  surface water  
                                                                                           fish  humans         
                                                                                         Consumption f fish     
                                                                                          contaminated by       
                                                                                          toxicants in surface  
                                                                                          water                 
Animal (beef/milk)..........  Ingestion...................  Air diffusion..............  33                     
                                                                                         WMU  air  suface water  cattle  humans         
                                                                                         Consumption of animal  
                                                                                          products with elevated
                                                                                          levels of toxicant    
                                                                                          caused by drinking    
                                                                                          contaminated surface  
                                                                                          water                 
Animal (beef/milk)..........  Ingestion...................  Overland...................  35                     
                                                                                         WMU  overland 
                                                                                          flwo  surface
                                                                                          water  cattle
                                                                                           humans      
                                                                                         Consumption of animal  
                                                                                          products with elevated
                                                                                          levels of toxicant    
                                                                                          caused by drinking    
                                                                                          contaminated surface  
                                                                                          water                 
Animal (beef/milk)..........  Ingestion...................  Air deposition.............  36                     
                                                                                         WMU  air  deposition to  
                                                                                          soil         
                                                                                          overland flow  surface water  
                                                                                           cattle  humans         
                                                                                         Consumption of animal  
                                                                                          products with elevated
                                                                                          levels of toxicant    
                                                                                          caused by drinking    
                                                                                          contaminated surface  
                                                                                          water                 
Surface water...............  Dermal (bathing)............  Air diffusion..............  37                     
                                                                                         WMU  air  surface water  
                                                                                           humans      
                                                                                         Dermal bathing contact 
                                                                                          with contaminated     
                                                                                          surface water         
Surface water...............  Dermal (bathing)............  Air deposition.............  38                     
                                                                                         WMU  air      
                                                                                          deposition to soil  overland flow  
                                                                                           surface     
                                                                                          water  humans
                                                                                         Dermal bathing contact 
                                                                                          with contaminated     
                                                                                          surface water         
Surface water...............  Dermal (bathing)............  Overland...................  42                     
                                                                                         WMU  overland 
                                                                                          flow  surface
                                                                                          water  humans
                                                                                         Dermal bathing contact 
                                                                                          with contaminated     
                                                                                          surface water         
----------------------------------------------------------------------------------------------------------------
Overland = Soil erosion; Overland flow = Both runoff and sold erosion; or, for surface impoundments, a spill    
  directly to surface water. Veg = Aboveground fruits and vegetables. Root = Belowground (or root) vegetables.  
                                                                                                                
a Some pathway numbers are missing, reflecting pathways that have been eliminated from the analysis or combined 
  with other pathways.                                                                                          

                                                        Table A-2.--Ecological Exposure Pathways                                                        
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                  Exposure medium                 Route of exposure            Type of fate and transport             Pathways a        
--------------------------------------------------------------------------------------------------------------------------------------------------------
Terr I..................  Soil...........................  Ingestion......................  Direct soil....................  3 (on site)                
                                                                                                                             WMU  mammals,     
                                                                                                                              birds, soil fauna         
                                                                                                                             Ingestion of contaminated  
                                                                                                                              soil                      
                          Soil...........................  Direct contact.................  Direct soil....................  5 (on site)                
                                                                                                                             WMU  plants, soil 
                                                                                                                              fauna                     
                                                                                                                             Direct contact with        
                                                                                                                              contaminated soil         
                          Plant..........................  Ingestion......................  Direct soil....................  9 (on site)                
                                                                                                                             WMU  vegetation  mammals, birds     
                                                                                                                             Consumption of contaminated
                                                                                                                              vegetation (e.g., forage  
                                                                                                                              grasses)                  
                          Soil fauna.....................  Ingestion......................  Direct soil....................  11a (on site)              
                                                                                                                             WMU  soil fauna  mammals, birds     
                                                                                                                             Consumption of soil fauna  
                                                                                                                              (e.g., earthworms,        
                                                                                                                              insects) with elevated    
                                                                                                                              levels of toxicant        
                          Animals........................  Ingestion......................  Direct soil....................  11b (on site)              
                                                                                                                             WMU  soil fauna/  
                                                                                                                              vegetation       
                                                                                                                              animals          
                                                                                                                              predatory mammals, birds  
                                                                                                                             Consumption of animals with
                                                                                                                              elevated levels of        
                                                                                                                              toxicant                  
Terr II.................  Soil...........................  Ingestion......................  Overland.......................  3 (off site)               
                                                                                                                             WMU  overland  mammals, birds,    
                                                                                                                              soil fauna                
                                                                                                                             Ingestion of contaminated  
                                                                                                                              soil                      

[[Page 66420]]
                                                                                                                                                        
                          Soil...........................  Direct contact.................  Overland.......................  5 (off site)               
                                                                                                                             WMU  overland  plants, soil fauna 
                                                                                                                             Direct contact with        
                                                                                                                              contaminated soil         
                          Plant..........................  Ingestion......................  Overland.......................  9 (off site)               
                                                                                                                             WMU  overland  vegetation  mammals, birds     
                                                                                                                             Consumption of contaminated
                                                                                                                              vegetation (e.g., forage  
                                                                                                                              grasses)                  
                          Soil fauna.....................  Ingestion......................  Overland.......................  11c (off site)             
                                                                                                                             WMU  overland  soil fauna  mammals, birds     
                                                                                                                             Consumption of soil fauna  
                                                                                                                              (e.g., earthworms,        
                                                                                                                              insects) with elevated    
                                                                                                                              levels of toxicant        
                          Animals........................  Ingestion......................  Overland.......................  11d (off site)             
                                                                                                                             WMU  soil fauna/  
                                                                                                                              vegetation       
                                                                                                                              animals          
                                                                                                                              predatory mammals, birds  
                                                                                                                             Consumption of animals with
                                                                                                                              elevated levels of        
                                                                                                                              toxicant                  
Terr III................  Soil...........................  Ingestion......................  Air deposition.................  4                          
                                                                                                                             WMU  air 
                                                                                                                              deposition to soil  mammals, birds,    
                                                                                                                              soil fauna                
                                                                                                                             Ingestion of contaminated  
                                                                                                                              soil                      
                          Soil...........................  Direct contact.................  Air deposition.................  6                          
                                                                                                                             WMU  air 
                                                                                                                              deposition to surface soil
                                                                                                                               plants, soil    
                                                                                                                              fauna                     
                                                                                                                             Direct contact with        
                                                                                                                              contaminated soil         
Terr IV.................  Plant..........................  Ingestion......................  Air deposition.................  8                          
                                                                                                                             WMU  air 
                                                                                                                              deposition to soil  vegetation  mammals, birds     
                                                                                                                             Consumption of contaminated
                                                                                                                              vegetation (e.g., forage  
                                                                                                                              grasses)                  
Terr V..................  Plant..........................  Ingestion......................  Air diffusion..................  8                          
                                                                                                                             WMU  air 
                                                                                                                              vegetation       
                                                                                                                              mammals, birds            
                                                                                                                             Consumption of contaminated
                                                                                                                              vegetation (e.g., forage  
                                                                                                                              grasses)                  
Aq I....................  Surface water..................  Ingestion......................  Air diffusion..................  17                         
                                                                                                                             WMU  air 
                                                                                                                              surface water    
                                                                                                                              mammals, birds            
                                                                                                                             Ingestion of contaminated  
                                                                                                                              surface water as a        
                                                                                                                              drinking water source     
                          Fish...........................  Ingestion......................  Air diffusion..................  21                         
                                                                                                                             WMU  air 
                                                                                                                              surface water    
                                                                                                                              fish  mammals,   
                                                                                                                              birds, fish               
                                                                                                                             Consumption of fish        
                                                                                                                              contaminated by toxicants 
                                                                                                                              in surface water          
                          Surface water..................  Direct contact.................  Air diffusion..................  37                         
                                                                                                                             WMU  air 
                                                                                                                              surface water    
                                                                                                                              fish, daphnids, benthos   
                                                                                                                             Direct contact with        
                                                                                                                              contaminated surface      
                                                                                                                              water, sediments          
Aq II...................  Surface water..................  Ingestion......................  Air deposition.................  37                         
                                                                                                                             WMU  air 
                                                                                                                              deposition to soil  overland flow  surface water  mammals, birds     
                                                                                                                             Ingestion of contaminated  
                                                                                                                              surface water as a        
                                                                                                                              drinking water source     
                          Fish...........................  Ingestion......................  Air deposition.................  24                         
                                                                                                                             WMU  air 
                                                                                                                              deposition to surface soil
                                                                                                                               overland flow  surface water  fish      
                                                                               
FR Doc. 95-29458 Hazardous Waste Management System: Identification and Listing of Hazardous Waste: Hazardous Waste Identification Rule (HWIR)
                                               mammals, birds, fish      
                                                                                                                             Consumption of fish        
                                                                                                                              contaminated by toxicants 
                                                                                                                              in surface water          
                          Surface water..................  Direct contact.................  Air deposition.................  38                         
                                                                                                                             WMU  air 
                                                                                                                              deposition to soil  overland flow  surface water  fish, daphnids,    
                                                                                                                              benthos                   
                                                                                                                             Direct contact with        
                                                                                                                              contaminated surface      
                                                                                                                              water, sediments          
Aq III..................  Surface water..................  Ingestion......................  Overland.......................  19                         
                                                                                                                             WMU  overland flow
                                                                                                                               surface water  mammals, birds     
                                                                                                                             Ingestion of contaminated  
                                                                                                                              surface water as a        
                                                                                                                              drinking water source     
                          Fish...........................  Ingestion......................  Overland.......................  23                         
                                                                                                                             WMU  overland flow
                                                                                                                               surface water  fish      
                                                                                                                              mammals, birds, fish      
                                                                                                                             Consumption of fish        
                                                                                                                              contaminated by toxicants 
                                                                                                                              in surface water          
                          Surface water..................  Direct contact.................  Overland.......................  42                         
                                                                                                                             WMU  overland flow
                                                                                                                               surface water  fish, daphnids,    
                                                                                                                              benthos                   
                                                                                                                             Direct contact with        
                                                                                                                              contaminated surface      
                                                                                                                              water, sediments          
--------------------------------------------------------------------------------------------------------------------------------------------------------
Overland=Soil erosion. Overland flow=Both runoff and soil erosion; or, for surface impoundments, a spill directly to surface water.                     

[[Page 66421]]
                                                                                                                                                        
a Some pathway numbers are missing, reflecting pathways that have been eliminated from the analysis.                                                    

                          Table A-3.--Summary of Human Receptors for Exposures Pathways                         
----------------------------------------------------------------------------------------------------------------
                                                                   Receptor                                     
                             -----------------------------------------------------------------------------------
           Pathway                                       Subs.       Home        Subs.       Fish               
                                 Adult       Child      farmer     gardener     fisher     consumer     Worker  
----------------------------------------------------------------------------------------------------------------
1: Groundwater-ingestion....                                                                           
                                      a   ..........  ..........  ..........  ..........  ..........  ..........
2a: Direct air-inhalation of                                                                                    
 violates (on site).........                                                                           
                                      a   ..........  ..........  ..........  ..........  ..........   
2a: Direct air-inhalation of                                                                                    
 volatiles (off site).......     ..........  ..........  ..........  ..........  ..........  ..........
2b: Direct air-inhalation of                                                                                    
 particles (on site)........                                                                           
                                      a   ..........  ..........  ..........  ..........  ..........   
2b: Direct air-inhalation of                                                                                    
 particles (off site).......     ..........  ..........  ..........  ..........  ..........  ..........
3: Direct soil-soil                                                                                             
 ingestion (on site)........                                                                           
                                      a                                                                
                                                  a   ..........  ..........  ..........  ..........  ..........
3: Overland-soil ingestion                                                                                      
 (off site).................        ..........  ..........  ..........  ..........  ..........
4: Air deposition-soil                                                                                          
 ingestion..................        ..........  ..........  ..........  ..........  ..........
5: Direct soil-dermal (soil)                                                                                    
 (on site)..................                                                                           
                                      a                                                                
                                                  a   ..........  ..........  ..........  ..........   
5: Direct Soil-dermal (off                                                                                      
 site)......................        ..........  ..........  ..........  ..........  ..........
6: Air deposition-dermal                                                                                        
 (soil).....................        ..........  ..........  ..........  ..........  ..........
8: Air deposition-veg/root                                                                                      
 ingestion..................  ..........  ..........           ..........  ..........
8a: Air diffusion-veg/root                                                                                      
 ingestion..................  ..........  ..........        ..........  ..........  ..........
9: Direct soil-veg/root                                                                                         
 ingestion (on site)........  ..........  ..........                                                   
                                                              a                                        
                                                                          a   ..........  ..........  ..........
9: Overland-veg/root                                                                                            
 ingestion (on site)........  ..........  ..........        ..........  ..........  ..........
10: Air deposition-beef/milk                                                                                    
 ingestion..................  ..........  ..........     ..........  ..........  ..........  ..........
10a: Air diffusion-beef/milk                                                                                    
 ingestion..................  ..........  ..........     ..........  ..........  ..........  ..........
11: Direct soil-bee/milk                                                                                        
 ingestion (on site)........  ..........  ..........                                                   
                                                              a   ..........  ..........  ..........  ..........
11: Overland-beef/milk                                                                                          
 ingestion (off site).......  ..........  ..........     ..........  ..........  ..........  ..........
14: Groundwater-dermal                                                                                          
 (bathing)..................        ..........  ..........  ..........  ..........  ..........
17: Air diffusion-drinking                                                                                      
 water ingestion............     ..........  ..........  ..........  ..........  ..........  ..........
19: Overland-drinking water                                                                                     
 ingestion..................     ..........  ..........  ..........  ..........  ..........  ..........
20: Air deposition-drinking                                                                                     
 water ingestion............     ..........  ..........  ..........  ..........  ..........  ..........
21: Air diffusion-fish                                                                                          
 ingestion..................     ..........  ..........  ..........        ..........
23: Overland-fish ingestion.     ..........  ..........  ..........        ..........
24: Air deposition-fish                                                                                         
 ingestion..................     ..........  ..........  ..........        ..........
33: Air diffusion (SW)-beef/                                                                                    
 milk ingestion.............  ..........  ..........     ..........  ..........  ..........  ..........
35: Overland (SW)-beef/milk                                                                                     
 ingestion..................  ..........  ..........     ..........  ..........  ..........  ..........
36: Air deposition (OF/SW)-                                                                                     
 beef/milk ingestion........  ..........  ..........     ..........  ..........  ..........  ..........
37: Air diffusion (SW)-                                                                                         
 dermal (bathing)...........        ..........  ..........  ..........  ..........  ..........
38: Air deposition (OF/SW)-                                                                                     
 dermal (bathing............        ..........  ..........  ..........  ..........  ..........
42: Overland (SW)-dermal                                                                                        
 (bathing)..................        ..........  ..........  ..........  ..........  ..........
----------------------------------------------------------------------------------------------------------------
a On-site pathways for receptors other than workers are modeled only for the land application unit after        
  closure.                                                                                                      

                        Table A-4.--Summary of Ecological Receptors by Exposure Pathways                        
----------------------------------------------------------------------------------------------------------------
                                                                   Receptor                                     
           Pathway           -----------------------------------------------------------------------------------
                                Mammals      Birds      Plants    Soil fauna     Fish      Daphnids     Benthos 
----------------------------------------------------------------------------------------------------------------
3: Direct soil-soil                                                                                             
 ingestion (on site)........                                                                           
                                      a                                                                
                                                  a   ..........     ..........  ..........  ..........
3: Direct soil-soil                                                                                             
 ingestion (off site).......        ..........     ..........  ..........  ..........
4: Air deposition-soil                                                                                          
 ingestion..................        ..........     ..........  ..........  ..........
5: Direct soil-dermal soil                                                                                      
 (on site)..................  ..........  ..........        ..........  ..........  ..........
5: Direct soil-dermal soil                                                                                      
 (off site).................  ..........  ..........        ..........  ..........  ..........
6: Air deposition-dermal                                                                                        
 soil.......................  ..........  ..........        ..........  ..........  ..........
8: Air deposition-veg/root                                                                                      
 ingestion..................        ..........  ..........  ..........  ..........  ..........
8a: Air diffusion-veg                                                                                           
 ingestion..................        ..........  ..........  ..........  ..........  ..........
9: Direct soil-veg/root                                                                                         
 ingestion (on site)........        ..........  ..........  ..........  ..........  ..........
9: Overland-veg/root                                                                                            
 ingestion (off site).......        ..........  ..........  ..........  ..........  ..........
11a: Direct soil-soil fauna                                                                                     
 ingestion (on site)........        ..........  ..........  ..........  ..........  ..........
11b: Direct soil-animals                                                                                        
 ingestion (on site)........        ..........  ..........  ..........  ..........  ..........
11c: Overland-soil fauna                                                                                        
 ingestion (off site).......        ..........  ..........  ..........  ..........  ..........
11d: Overland-animals                                                                                           
 ingestion (off site).......        ..........  ..........  ..........  ..........  ..........
17: Air diffusion-drinking                                                                                      
 water ingestion............        ..........  ..........  ..........  ..........  ..........
18: Groundwater (SW)-                                                                                           
 drinking water ingestion...        ..........  ..........  ..........  ..........  ..........
19: Overland-drinking water                                                                                     
 ingestion..................        ..........  ..........  ..........  ..........  ..........
20: Air deposition-drinking                                                                                     
 water ingestion............        ..........  ..........  ..........  ..........  ..........
21: Air diffusion-fish                                                                                          
 ingestion..................        ..........  ..........     ..........  ..........
22: Groundwater (SW)-fish                                                                                       
 ingestion..................        ..........  ..........     ..........  ..........
23: Overland-fish ingestion.        ..........  ..........     ..........  ..........
24: Air deposition-fish                                                                                         
 ingestion..................        ..........  ..........     ..........  ..........
37: Air diffusion (SW)-                                                                                         
 direct contact.............  ..........  ..........  ..........  ..........         
38: Air deposition (OF/SW)-                                                                                     
 direct contact.............  ..........  ..........  ..........  ..........         
40: Groundwater (SW)-direct                                                                                     
 contact....................  ..........  ..........  ..........  ..........         

[[Page 66422]]
                                                                                                                
42: Overland (SW)-direct                                                                                        
 contact....................  ..........  ..........  ..........  ..........         
----------------------------------------------------------------------------------------------------------------
a On-site pathways are modeled only for the land application unit after closure.                                

                           Table A-5.--Pathways Modeled for Each Waste Management Unit                          
----------------------------------------------------------------------------------------------------------------
                                                                   Waste management unit                        
                                         -----------------------------------------------------------------------
                 Pathway                      Ash     Land appl.                Surface                         
                                           monofill      unit      Wastepile   impound.      Tank      Water use
----------------------------------------------------------------------------------------------------------------
1: Groundwater-ingestion................  ..........           ..........  ..........
2a: Direct air-inhalation volatiles.....  ..........              ..........
2b: Direct air-inhalation particles.....           ..........  ..........  ..........
3: Direct soil-soil ingestion...........  ..........        ..........  ..........  ..........
4: Air deposition-soil ingestion........           ..........  ..........  ..........
5: Direct soil-dermal (soil)............  ..........        ..........  ..........  ..........
6: Air deposition-dermal (soil).........           ..........  ..........  ..........
8: Air deposition-veg/root ingestion....           ..........  ..........  ..........
8a: Air diffusion-veg/root ingestion....  ..........              ..........
9: Direct soil or overland-veg/root                                                                             
 ingestion..............................  ..........        ..........  ..........  ..........
10: Air deposition-beef/milk ingestion..           ..........  ..........  ..........
10a: Air diffusion-beef/milk ingestion..  ..........              ..........
11: Direct soil or overland-beef/milk                                                                           
 ingestion..............................  ..........        ..........  ..........  ..........
14: Groundwater-dermal (bathing)........  ..........  ..........  ..........  ..........  ..........   
17: Air diffusion-drinking water                                                                                
 ingestion..............................  ..........              ..........
19: Overland-drinking water ingestion...  ..........           ..........  ..........
20: Air deposition-drinking water                                                                               
 ingestion..............................           ..........  ..........  ..........
21: Air diffusion-fish ingestion........  ..........              ..........
23: Overland-fish ingestion.............  ..........           ..........  ..........
24: Air deposition-fish ingestion.......           ..........  ..........  ..........
33: Air diffusion (SW)-beef/milk                                                                                
 ingestion..............................  ..........              ..........
35: Overland (SW)-beef/milk ingestion...  ..........           ..........  ..........
36: Air deposition (OF/SW)-beef/milk                                                                            
 ingestion..............................           ..........  ..........  ..........
37: Air diffusion (SW)-dermal (bathing).  ..........              ..........
38: Air deposition (OF/SW)-dermal                                                                               
 (bathing)..............................           ..........  ..........  ..........
42: Overland (SW)-dermal (bathing)......  ..........           ..........  ..........
----------------------------------------------------------------------------------------------------------------
OF=Overland flow.    SW=Surface water.                                                                          

Appendix B

                                                                                                                

[[Page 66423]]
                   Table B-1.--Comparison of Groundwater Modeling Results for 1000 vs. 10,000 Years Time Horizon (HQ=1 and Risk=10-6)                   
                                   [Threshold Chemical Concentrations for 1000 and 10,000 years Groundwater Modeling]                                   
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                  1000 yrs time horizon        10,000 yrs time horizon  
                                                                                             -----------------------------------------------------------
   No.      CAS No.                              Name of Chemical                             Nonwastewater*  Wastewater**  Nonwastewater*  Wastewater**
                                                                                                leach mg/l     leach mg/l     leach mg/l     leach mg/l 
--------------------------------------------------------------------------------------------------------------------------------------------------------
1........      83329  Acenaphthene..........................................................       6.30E+00       3.60E+02       4.90E+00       3.10E+01
2........      67641  Acetone (2-propanone).................................................       6.00E+00       1.56E+01       6.00E+00       1.56E+01
3........      75058  Acetonitrile (methyl cyanide).........................................       3.00E-01       7.80E-01       3.00E-01       7.80E-01
4........      98862  Acetophenone..........................................................       6.40E+00       1.68E+01       6.40E+00       1.68E+01
5........     107028  Acrolein..............................................................       1.00E+06       1.00E+06       1.00E+06       1.00E+06
6........      79061  Acrylamide #..........................................................       3.80E-05       2.80E-04       3.80E-05       2.60E-04
7........     107131  Acrylonitrile #.......................................................       3.40E-04       1.10E-03       3.40E-04       1.10E-03
8........     309002  Aldrin #..............................................................       6.70E-04       6.50E-02       3.70E-06       4.70E-03
9........     107051  Allyl Chloride........................................................  ..............  ............  ..............  ............
10.......      62533  Aniline #.............................................................       1.70E-02       5.30E-02       1.70E-02       5.30E-02
176......    7440360  Antimony..............................................................       4.57E+01       1.18E+02       5.30E-02       1.36E-01
177......    7440382  Arsenic #.............................................................       3.08E-02       7.92E-02       1.48E-04       3.84E-04
178......    7440393  Barium................................................................       1.67E+01       4.29E+01       1.55E+01       3.32E+01
12.......      71432  Benzene #.............................................................       5.40E-03       1.80E-02       5.40E-03       1.77E-02
13.......      92875  Benzidine #...........................................................       6.80E-07       2.24E-06       6.80E-07       2.24E-06
14.......      50328  Benzo[a]pyrene #......................................................       5.50E-04       5.50E-02       7.00E-06       3.60E-03
15.......     205992  Benzo[b]fluoranthene #................................................       1.10E-02       4.90E-01       6.60E-05       1.60E-02
16.......     100516  Benzyl alcohol........................................................       1.50E+01       4.00E+01       1.50E+01       3.90E+01
17.......     100447  Benzyl chloride #.....................................................       1.00E+06       1.00E+06       1.00E+06       1.00E+06
11.......      56553  Benz[a]anthracene #...................................................       1.10E-04       1.10E-02       4.30E-06       7.20E-04
179......    7440417  Beryllium #...........................................................       1.06E-03       2.72E-03       3.20E-04       8.27E-04
18.......     111444  Bis(2-chloroethyl)ether #.............................................       3.68E-04       1.92E-02       3.60E-04       6.48E-04
19.......      4E+07  Bis(2-chloroisopropyl)ether #.........................................       1.90E-03       7.90E-03       1.90E-03       7.00E-03
20.......     117817  Bis(2-ethylhexyl)phthalate #..........................................       1.80E+00       1.80E+02       1.10E-03       1.20E+01
21.......      75274  Bromodichloromethane #................................................       2.52E-03       1.05E-02       2.52E-03       8.54E-03
22.......      74839  Bromomethane..........................................................       2.87E+03       5.63E+04       2.87E+03       4.13E+04
23.......      71363  Butanol...............................................................       6.00E+00       1.56E+01       6.00E+00       1.56E+01
24.......      85687  Butyl benzyl phthalate................................................       1.10E+02       1.10E+04       6.40E+01       4.40E+02
25.......      88857  Butyl-4,6-dinitrophenol,2-sec-........................................       6.40E-02       1.92E-01       6.40E-02       1.92E-01
180......    7440439  Cadmium...............................................................       1.18E+01       3.05E+01       1.10E-01       2.40E-01
26.......      75150  Carbon disulfide......................................................       6.40E+00       2.08E+01       6.40E+00       1.84E+01
27.......      56235  Carbon tetrachloride #................................................       1.61E-03       1.40E-02       1.61E-03       1.40E-02
28.......      57749  Chlordane #...........................................................       1.50E-02       1.50E+00       1.60E-04       1.00E-01
29.......     126998  Chloro-1,3-butadiene 2-(Chloroprene)..................................  ..............  ............  ..............  ............
30.......     106478  Chloroaniline p-......................................................       1.60E-01       4.20E-01       1.60E-01       4.20E-01
31.......     108907  Chlorobenzene.........................................................       1.33E+00       4.83E+00       1.33E+00       4.76E+00
32.......     510156  Chlorobenzilate #.....................................................       7.50E-03       1.02E+00       5.70E-03       5.40E-02
33.......     124481  Chlorodibromomethane #................................................       1.80E-03       6.90E-03       1.80E-03       6.60E-03
34.......      67663  Chloroform #..........................................................       1.70E-02       5.80E-02       1.70E-02       5.70E-02
35.......      74873  Chloromethane.........................................................  ..............  ............  ..............  ............
36.......      95578  Chlorophenol 2-.......................................................       3.20E-01       9.00E-01       3.20E-01       9.00E-01
181......   16065381  Chromium (+3).........................................................       1.32E+05       3.40E+05       2.37E+04       6.12E+04
182......    7440473  Chromium (+6).........................................................       1.88E+01       4.85E+01       4.76E-01       1.24E+00
37.......     218019  Chrysene..............................................................       2.70E-02       2.90E+00       1.20E-03       1.00E-01
183......    7440508  Copper................................................................       1.32E+05       3.40E+05       1.08E+03       2.79E+03
38.......     108394  Cresol m-.............................................................       3.20E+00       8.80E+00       3.20E+00       8.40E+00
39.......      95487  Cresol o-.............................................................       3.20E+00       8.80E+00       3.20E+00       8.40E+00
40.......     106445  Cresol p-.............................................................       3.20E-01       8.80E-01       3.20E-01       8.40E-01
41.......      98828  Cumene................................................................       2.50E+00       1.50E+01       2.50E+00       1.50E+01
42.......      72548  DDD #.................................................................       2.80E+03       1.00E+06       2.80E+03      9.10E+05 

[[Page 66424]]
                                                                                                                                                        
43.......      72559  DDE #.................................................................       3.30E-02       3.30E+00       1.70E-04       2.30E-01
44.......      50293  DDT, p,p'- #..........................................................       8.40E+03       1.00E+06       5.40E-03       2.04E+01
47.......    2303164  Diallate #............................................................       4.60E-01       2.80E+03       4.60E-01       9.00E+01
48.......      53703  Dibenz[a,h]- anthracene #.............................................       2.50E-04       2.50E-02       6.30E-07       1.80E-03
49.......      96128  Dibromo-3-chloropropane1,2- #.........................................       1.14E-04       7.20E-04       1.14E-04       6.60E-04
50.......      95501  Dichlorobenzene1,2-...................................................       6.10E+00       3.00E+01       6.10E+00       3.00E+01
51.......     106467  Dichlorobenzene1,4- #.................................................       1.16E-02       6.80E-02       1.08E-02       5.60E-02
52.......      91941  Dichloro- benzidine3,3 #..............................................       7.80E-04       5.40E-03       7.20E-04       4.20E-03
53.......      75718  Dichlorodifluoromethane...............................................       1.19E+01       3.57E+01       1.19E+01       3.57E+01
54.......      75343  Dichloroethane 1,1- #.................................................       1.71E-03       9.90E-03       6.00E-05       1.60E-04
55.......     107062  Dichloroethane1,2- #..................................................       1.62E-03       9.00E-03       6.00E-05       1.60E-04
56.......     166592  Dichloroethylene cis-1,2..............................................       6.40E-01       1.72E+00       6.40E-01       1.68E+00
57.......     156605  Dichloroethylene trans-1,2............................................       1.12E+00       2.94E+00       1.12E+00       2.94E+00
58.......      75354  Dichloroethylene1,1-(Vinylidene chloride:) #..........................       1.80E-04       5.90E-04       1.80E-04       5.90E-04
59.......     120832  Dichlorophenol 2,4-...................................................       1.80E-01       6.30E-01       1.80E-01       6.20E-01
60.......      94757  Dichlorophenoxyacetic acid, 2,4-......................................       6.00E-01       1.56E+00       6.00E-01       1.56E+00
61.......      78875  Dichloropropane 1,2- #................................................       2.30E-03       2.60E-02       2.30E-03       2.30E-02
62.......      1E+07  Dichloropropene trans-1,3- #..........................................       1.15E+03       9.00E+04       1.15E+03       9.00E+04
63.......     542756  Dichloropropene 1,3-(mixture of isomers) #............................       8.50E-04       2.80E-03       8.50E-04       2.80E-03
64.......      1E+07  Dichloropropene cis-1,3- #............................................       1.15E+03       9.00E+04       1.15E+03       9.00E+04
65.......      60571  Dieldrin #............................................................       5.40E-01       2.90E+04       5.40E-01       6.80E+02
66.......      84662  Diethyl phthalate.....................................................       6.00E+01       4.50E+02       5.40E+01       1.86E+02
67.......      56531  Diethylstilbestrol #..................................................       1.20E-07       9.20E-06       6.50E-08       4.30E-07
68.......      60515  Dimethoate............................................................       7.70E-01       2.94E+01       7.70E-01       2.94E+01
69.......     119904  Dimethoxybenzidine 3,3'- #............................................       1.20E-02       3.36E-02       1.02E-02       3.36E-02
70.......     131113  Dimethyl phthalate....................................................       1.04E+03     1.1.12E+04       3.00E+01       7.80E+01
72.......     119937  Dimethylbenzidine 3,3'- #.............................................       1.89E-05       8.10E-05       1.80E-05       7.02E-05
71.......      57976  Dimethylbenz[a]anthracene 7,12-.......................................       1.20E-03       1.40E-01       2.80E-06       1.30E-02
73.......     105679  Dimethylphenol 2,4-...................................................       1.19E+00       3.78E+00       1.19E+00       3.78E+00
45.......      84742  Di-n-butyl phthalate..................................................       5.70E+01       6.30E+03       2.50E+01       2.30E+02
74.......      99650  Dinitrobenzene 1,3-...................................................       6.40E-03       1.68E-02       6.40E-03      1.68E--02
75.......      51285  Dinitrophenol 2,4-....................................................       1.05E-01       2.73E-01       1.05E-01       2.73E-01
76.......     121142  Dinitrotoluene 2,4-...................................................       1.12E-01       3.01E-01       1.12E-01       2.94E-01
77.......     606202  Dinitrotoluene 2,6-...................................................       6.40E-02       1.68E-01       6.40E-02       1.68E-01
46.......     117840  Di-n-octyl phthalate..................................................       3.10E+02       5.20E+04       1.00E-01       1.30E+03
78.......     123911  Dioxane 1,4- #........................................................       1.36E-02       4.24E-02       1.36E-02       4.24E-02
79.......     122394  Diphenylamine.........................................................       2.60E+00       1.50E+01       2.60E+00       1.50E+01
80.......     298044  Disulfoton............................................................       1.30E+01       5.80E+02       1.30E+01       4.60E+02
81.......     115297  Endosulfan(Endosulfan I and II, mixture)..............................       1.00E+00       1.26E+01       9.40E-01       6.00E+00
82.......      72208  Endrin................................................................       3.20E+01       2.70E+05       3.20E+00       6.60E+03
83.......     106898  Epichlorohydrin #.....................................................       5.40E+03       4.14E+05       5.40E+03       4.14E+05
84.......     110805  Ethoxyethanol 2-......................................................       1.50E+01       3.90E+01       1.50E+01       3.90E+01
85.......     141786  Ethyl acetate.........................................................       1.14E+02       6.00E+02       1.14E+02       3.90E+02
86.......      60297  Ethyl ether...........................................................       1.05E+01       2.73E+01       1.05E+01       2.73E+01
87.......      97632  Ethyl methacrylate....................................................       6.60E+00       6.90E+01       6.60E+00       2.40E+01
88.......      62500  Ethyl methanesulfonate #..............................................       1.17E+04       9.30E+05       1.17E+04       9.30E+05
89.......     100414  Ethylbenzene..........................................................       8.10E+00       3.90E+01       8.10E+00       3.90E+01
90.......     106934  Ethylene dibromide (1,2-Dibromoethane) #..............................       1.50E-05       4.20E-04       1.50E-05       3.60E-04
91.......      96457  Ethylene thiourea #...................................................       1.70E-04       5.30E-04       1.70E-04       5.30E-04
92.......     206440  Fluoranthene..........................................................       7.50E+00       7.80E+02       1.70E+00      2.70E+01 

[[Page 66425]]
                                                                                                                                                        
93.......      86737  Fluorene..............................................................       5.00E+00       3.90E+02       3.40E+00       2.20E+01
94.......      50000  Formaldehyde..........................................................       1.05E+01       2.73E+01       1.05E+01       2.73E+01
95.......      61486  Formic acid...........................................................       1.05E+02       2.73E+02       1.05E+02       2.73E+02
96.......     110009  Furan.................................................................       6.00E-02       1.60E-01       6.00E-02       1.56E-01
97.......     319857  HCH beta- #...........................................................       2.10E-04       1.30E-03       2.10E-04       1.30E-03
99.......     319846  HCH alpha- #..........................................................       1.10E-01       2.10E+01       1.10E-01       2.10E+01
98.......      58899  HCH (Lindane) gamma- #................................................       6.93E+01       1.19E+02       6.93E-01       1.19E+02
100......      76448  Heptachlor #..........................................................       1.00E+06       1.00E+06       1.00E-06       1.00E+06
101......    1024573  Heptachlor epoxide #..................................................       4.50E+01       3.15E+04       4.50E-01       7.83E+02
102......      87683  Hexachloro-1,3-butadene #.............................................       2.30E+02       2.10E+00       6.90E-03       8.10E+02
103......     118741  Hexachlorobenzene #...................................................       3.50E+03       3.50E+01       1.10E-04       2.23E+02
104......      77474  Hexachlorocyclopentadiene.............................................       1.00E+06       1.00E+06       1.00E-06       1.00E+06
105......      67721  Hexachloroethane #....................................................       4.02E-02        110E+00       3.30E-02       2.16E-01
106......      70304  Hexachlorophene.......................................................       1.40E-02       1.50E+00       1.40E-03       5.20E-01
107......     193395  Indeno[1,2,3-cd]pyrene................................................       4.60E-03       5.00E-01       2.40E-05       1.70E-02
108......      78831  Isobutyl alcohol......................................................       1.50E+01       3.90E+01       1.50E+01       3.90E+01
109......      78591  Isophorone #..........................................................       1.62E-01       5.49E-01       1.62E-01       5.31E-01
110......     143500  Kepone #..............................................................       5.80E-05       4.80E-03       3.20E-05       2.20E-04
184......    7439921  Lead..................................................................       1.32E+05       3.40E+05       1.16E+01       3.00E+01
185......    7439976  Mercury...............................................................       1.81E+01       4.67E+01       1.38E-01       2.96E-01
111......     126987  Methacrylonitrile.....................................................       6.00E-03       1.64E-02       6.00E-03       1.56E-02
112......      67561  Methanol..............................................................       3.00E+01       7.80E+01       3.00E+01       7.80E+01
113......      72435  Methoxychlor..........................................................       1.00E+06       1.00E+06       1.00E+06       1.00E+06
114......      78933  Methyl ethyl ketone...................................................       3.00E+01       7.80E+01       3.00E+01       7.80E+01
115......     108101  Methyl isobutyl ketone................................................       3.00E+00       8.00E+00       3.00E+00       7.80E+00
116......      80626  Methyl methacrylate...................................................       8.10E+00       8.40E+01       8.10E+00       2.82E+01
117......     298000  Methyl parathion......................................................       2.34E+01       9.90E+02       2.34E+01       7.80E+01
118......      56495  Methylcholanthrene 3- #...............................................       1.70E-03       1.70E-01       1.40E-06       1.20E-02
119......      74953  Methylene bromide.....................................................       6.80E-01       2.32E+00       1.90E-01       2.32E+00
120......      75092  Methylene Chloride #..................................................       6.80E-01       2.36E+00       1.50E-02       3.90E-02
186......    7439987  Molybdenum............................................................  ..............  ............  ..............  ............
129......      91203  Naphthalene...........................................................       2.70E+00       1.40E+01       2.70E+00       1.40E+01
187......    7440020  Nickel................................................................       9.95E+00       2.56E+01       4.89E+00       1.05E+01
130......      98953  Nitrobenzene..........................................................       3.20E-02       8.40E-02       3.20E-02       8.40E-02
131......      79469  Nitropropane 2-.......................................................  ..............  ............  ..............  ............
123......      55185  N-Nitrosodiethylamine #...............................................       1.02E-06       3.18E-06       1.02E-06       3.18E-06
124......      62759  N-Nitrosodimethylamine #..............................................       3.40E-06       1.06E-05       3.40E-06       1.06E-05
121......     924163  N-Nitroso-di-n-butylamine #...........................................       3.60E-05       1.32E-04       3.60E-05       1.22E-04
122......     621647  N-Nitroso-di-n-propylamine #..........................................       1.70E-05       5.40E-05       1.70E-05       5.30E-05
125......      86306  N-Nitrosodiphenylamine #..............................................       4.80E-02       2.60E-01       4.60E-02       2.00E-01
126......      1E+07  N-Nitrosomethylethylamine #...........................................       6.80E-06       2.16E-05       6.80E-06       2.12E-05
127......     100754  N-Nitrosopiperidine #.................................................       3.40E-06       1.06E-05       3.40E-06       1.06E-05
128......     930552  N-Nitrosopyrrolidine #................................................       6.80E-05       2.12E-04       6.80E-05       2.12E-04
132......     152169  Octamethyl pyrophosphoramide..........................................       1.05E-01       2.80E-01       1.05E-01       2.73E-01
133......      56382  Parathion (ethyl).....................................................       1.16E+04       5.60E+05       1.16E+04       4.40E+05
134......     608935  Pentachlorobenzene....................................................       1.44E+01       1.56E+03       5.70E-01       5.10E+00
135......      82688  Pentachloronitrobenzene (PCNB) #......................................       2.37E-02       2.19E+00       5.40E-03       8.10E-02
136......      87865  Pentachlorophenol #...................................................       4.20E-04       2.50E-03       4.10E-04       2.00E-03
137......     108952  Phenol................................................................       3.20E+01       8.40E+01       3.20E+01       8.40E-01
138......      62384  Phenyl mercuric acetate...............................................       4.50E-03       1.17E-02       4.50E-03       1.17E-02
139......     108452  Phenylenediamine, 1,3-................................................       3.00E-01       7.80E-01       3.00E-01       7.80E-01
140......     298022  Phorate...............................................................       1.00E+06       1.00E+06       1.00E+06       1.00E+06
141......    1336363  Polychlorinated biphenyls (Aroclors) #................................       9.10E-04       8.80E-02       4.80E-06       6.10E-03
142......      2E+07  Pronamide.............................................................       5.70E+00       2.19E+01       5.70E+00       2.13E+01
143......     129000  Pyrene................................................................       1.40E+01       1.50E+03       1.70E+00       5.40E+01
144......     110861  Pyridine..............................................................       6.00E-02       1.56E-01       6.00E-02       1.56E-01
145......      94597  Safrole #.............................................................       9.50E-04       3.80E-03       9.50E-04       3.50E-03
188......    7782492  Selenium..............................................................       1.38E+00       3.57E+00       3.57E-01       9.27E-01
189......    7440224  Silver................................................................       1.32E+00       3.40E+00       8.90E-02       1.91E-01

[[Page 66426]]
                                                                                                                                                        
146......      57249  Strychnine and salts..................................................       1.60E-02       4.50E-02       1.60E-02       4.50E-02
147......     100425  Styrene...............................................................       1.54E+01       6.51E+01       1.54E+01       6.37E+01
148......    1746016  TCDDioxin 2,3,7,8, #..................................................       2.70E-08       2.70E-06       1.80E-10       1.90E-07
149......      95943  Tetrachlorobenzene 1,2,4,5- #.........................................       6.00E-02       5.70E+00       3.20E-02    2.30E-01150
              630206  Tetrachloroethane 1,1,1,2- #..........................................       7.80E-03       7.50E-02       7.80E-03       7.50E-02
151......      79345  Tetrachloroethane 1,1,2,2- #..........................................       9.60E-03       2.92E-01       8.00E-03       2.40E-02
152......     127184  Tetrachloroethylene...................................................       6.80E-01       2.08E+00       6.80E-01       2.04E+00
153......      58902  Tetrachlorophenol 2,3,4,6-............................................       5.80E-01       1.90E+00       5.80E-01       1.90E+00
154......    3689245  Tetraethyl dithiopyrophosphate........................................       1.00E+06       1.00E+06       1.00E+06        1.00+06
190......    7440280  Thallium..............................................................       3.96E+02       1.02E+03       1.92E-02       5.00E-02
155......     108883  Toluene...............................................................       1.26E+01       4.20E+01       1.26E+01       4.13E+01
156......      95807  Toluenediamine 2,4- #.................................................       5.10E-05       1.59E-04       5.10E-05       1.59E-04
158......      95534  Toluidine o- #........................................................       6.80E-04       2.24E-03       6.80E-04       2.24E-03
157......     106490  Toluidine p- #........................................................       6.80E-04       2.24E-03       2.24E-03       2.24E-03
159......    8001352  Toxaphene (chlorinated camphenes) #...................................       1.10E-01       6.70E+02       1.10E-01       2.20E+01
160......      75252  Tribromomethane #.....................................................       1.80E-02       6.80E-02       1.80E-02       6.40E-02
161......      76131  Trichloro-1,2,2-trifluoro- ethane 1,1,2-..............................       2.40E+03        1.40E04       2.40E+03       1.10E+04
162......     120821  Trichlorobenzene 1,2,4-...............................................       2.10E+00       1.70E+02       1.30E+00       9.30E+00
163......      71556  Trichloroethane 1,1,1-................................................       5.00E+00       1.20E+02       4.60E+00       1.20E+02
164......      79005  Trichloroethane 1,1,2- #..............................................       1.80E-03       7.40E-03       1.80E-03       7.00E-03
165......      79016  Trichloroethylene (1,1,2-Trichloroethylene) #.........................       1.44E-02       5.28E-02       1.28E-02       3.84E-02
166......      75694  Trichlorofluoromethane................................................       1.60E+01        4.90+01       1.60E+01       4.80E+01
168......      95954  Trichlorophenol 2,4,5-................................................       4.20E+00       2.00E+01       4.20E+00       4.40E+01
167......      88062  Trichlorophenol 2,4,6- #..............................................       1.52E-02       5.76E-02       1.52E-02       5.36E-02
170......      93765  Trichlorophenoxyacetic acid 2,4,5-....................................       6.40E-01       1.68E+00       6.40E-01       1.68E+00
169......      93721  Trichlorophenoxypropionic acid........................................       4.80E-00       1.32E+00       4.80E-01       1.26E+00
171......      96184  Trichloropropane 1,2,3-...............................................       3.40E-01       2.20E+00       3.40E-01       1.10E+00
172......      99354  Trinitrobenzene (1,3,5-Trinitrobenzene) sym-..........................       3.00E-03       8.00E-03       3.00E-03       7.80E-03
173......     126727  Tris (2,3-dibromoprophyl) phosphate B19 #.............................       9.90E-05       2.52E-03       9.90E-05       2.52E-03
191......    7440622  Vanadium..............................................................       8.82E+00       2.27E+01       3.71E+00       9.58E+00
174......      75014  Vinyl chloride #......................................................       6.80E-05       2.16E-04       6.00E-05       1.56E-04
175......    1330297  Xylenes (total).......................................................       1.47E+02       9.10E+02       1.47E+02       8.60E+02
192......    7440666  Zinc..................................................................       1.08E+02       2.79E+02       3.84E+01       9.90E+01
--------------------------------------------------------------------------------------------------------------------------------------------------------
For Trichloroethane 1,1,1 the MCL, 0.20 mg/L was used in conic. calculation.                                                                            
                                                                                                                                                        
*Represents the lowest results from either landfills, waste piles, or land application units waste management scenarios.                                
**Represents results from surface impoundments.                                                                                                         
# Carcinogen.                                                                                                                                           

[[Page 66427]]

Appendix C

                                                  Table C-1.--Summary of Constituent-Specific Exit Level Development Using Toxicity Benchmarks                                                  
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                   WW totals (mg/l)                           NWW totals (mg/kg)                      NWW leach (mg/l)          
                                                                 -------------------------------------------------------------------------------------------------------------------------------
                                                                                                                      Multipath                                                                 
            CAS No.                            Name                Multipath  Groundwater  Extrapolated                modeled   Extrapolated              Groundwater  Extrapolated            
                                                                    modeled     modeled     exit level     WW EQC       leach     leach level    NWW EQC     modeled     each level     WW EQC  
                                                                  exit level   exit level                               level                               each level                          
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
83-32-9........................  Acenaphthene...................        49.5         31.2  ............      0.0018        9480  ............      0.0742          4.9  ............      0.0018
208-96-8.......................  Acenaphthylene.................  ..........  ...........      0.00285         0.02  ..........          3.9          0.7  ...........    0.0000661         0.02
67-64-1........................  Acetone........................      232000         15.6  ............         0.2       17400  ............       0.027            6  ............         0.2
75-05-8........................  Acetonitrile...................        6.58         0.78  ............       0.015         923  ............       0.014          0.3  ............       0.015
98-86-2........................  Acetophenone...................        5960         16.8  ............     0.00158        1210  ............        0.03          6.4  ............     0.00158
75-36-5........................  Acetyl chloride................  ..........  ...........        0.023   ..........  ..........        30.85   ..........  ...........        0.015   ..........
591-08-2.......................  Acetyl-2-thiourea,1-...........  ..........  ...........      0.11775            1  ..........         1.66           70  ...........          6.4            1
53-96-3........................  Acetylaminofluorene, 2-........  ..........  ...........      0.02762         0.02  ..........         3.28            1  ...........      0.00884         0.02
107-02-8.......................  Acrolein.......................     0.00248  ...........  ............       0.013        2.63  ............       0.075  ...........  ............       0.013
79-06-1........................  Acrylamide.....................        3.67      0.00026  ............        0.01     0.00436  ............         0.1     0.000038  ............        0.01
107-13-1.......................  Acrylonitrile..................     0.00428       0.0011  ............       0.008       0.961  ............         0.7      0.00034  ............       0.008
1402-68-2......................  Aflatoxins.....................  ..........  ...........         14.7   ..........  ..........         6900   ..........  ...........         10.5   ..........
116-06-3.......................  Aldicarb.......................  ..........  ...........    0.0069415         0.05  ..........        0.194            1  ...........         0.48         0.05
309-00-2.......................  Aldrin.........................   5.640E-07      0.00469  ............    0.000034    0.000444  ............      0.0006    3.670E-06  ............    0.000034
107-18-6.......................  Allyl alcohol..................  ..........  ...........           39   ..........  ..........        36700   ..........  ...........           15   ..........
107-05-1.......................  Allyl chloride.................      0.0742  ...........  ............       0.002         258  ............       0.002  ...........  ............       0.002
92-67-1........................  Aminobiphenyl, 4-..............  ..........  ...........      0.02762         0.02  ..........         3.28            1  ...........      0.00884         0.02
2763-96-4......................  Aminomethyl-3-isoxazolol, 5-...  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
504-24-5.......................  Aminopyridine, 4-..............  ..........  ...........      0.02762   ..........  ..........         3.28   ..........  ...........      0.00884   ..........
61-82-5........................  Amitrole.......................  ..........  ...........    0.0069415   ..........  ..........        0.194   ..........  ...........         0.48   ..........
62-53-3........................  Aniline........................       0.444        0.053  ............     0.00023        4.21  ............      0.0132        0.017  ............     0.00023
120-12-7.......................  Anthracene.....................  ..........  ...........      0.00285        0.007  ..........          3.9          0.5  ...........    0.0000661        0.007
7440-36-0......................  Antimony.......................        8210        0.136  ............      0.0008        8.72  ............           2        0.053  ............      0.0008
140-57-8.......................  Aramite........................  ..........  ...........         14.7         0.02  ..........         6900            1  ...........         10.5         0.02
7440-38-2......................  Arsenic........................        40.5     0.000384  ............      0.0005        0.17  ............      0.3031     0.000148  ............      0.0005
2465-27-2......................  Auramine.......................  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
115-02-6.......................  Azaserine......................  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
7440-39-3......................  Barium.........................  ..........         33.2  ............       0.001        2080  ............         0.2         15.5  ............       0.001
71-43-2........................  Benzene........................      0.0209       0.0177  ............     0.00004         109  ............      0.0001       0.0054  ............     0.00004
92-87-5........................  Benzidine......................     0.00015    2.240E-06  ............      0.0025   0.0000298  ............       0.042    6.800E-07  ............      0.0025
106-51-4.......................  Benzoquinone, p-...............  ..........  ...........         14.7         0.01  ..........         6900          0.7  ...........         10.5         0.01
98-07-7........................  Benzotrichloride...............  ..........  ...........        0.081   ..........  ..........          142        0.004  ...........       0.0317   ..........
50-32-8........................  Benzo(a)pyrene.................     0.00231      0.00364  ............    0.000023       0.227  ............      0.0621    7.040E-06  ............    0.000023
205-99-2.......................  Benzo(b)fluoranthene...........    0.000805       0.0164  ............    0.000018         3.7  ............      0.0699    0.0000661  ............    0.000018
205-82-3.......................  Benzo(j)fluoranthene...........  ..........  ...........      0.00285       0.0002  ..........          3.9         0.01  ...........    0.0000661       0.0002
207-08-9.......................  Benzo(k)fluoranthene...........  ..........  ...........      0.00285       0.0002  ..........          3.9          0.7  ...........    0.0000661       0.0002
191-24-2.......................  Benzo[g,h,i,]perylene..........  ..........  ...........      0.00285       0.0008  ..........          3.9          0.7  ...........    0.0000661       0.0008
100-51-6.......................  Benzyl alcohol.................       22500           39  ............     0.00074        2740  ............       0.034           15  ............     0.00074
100-44-7.......................  Benzyl chloride................        1.13          3.9  ............   5.000E-06        37.5  ............     0.00276           15  ............   5.000E-06
56-55-3........................  Benz(a)anthracene..............      0.0138     0.000717  ............    0.000013         0.1  ............      0.0826    4.300E-06  ............    0.000013
225-51-4.......................  Benz[c]acridine................  ..........  ...........      0.00285       0.0005  ..........          3.9         0.03  ...........    0.0000661       0.0005
7440-41-7......................  Beryllium......................        10.1     0.000827  ............     0.00003      0.0591  ............         0.1      0.00032  ............      0.0003
39638-32-9.....................  Bis (2-chloroisopropyl) ether..       0.569        0.007  ............     0.00145       0.944  ............      0.0586       0.0019  ............     0.00145
111-44-4.......................  Bis(2-chlorethyl)ether.........     0.00141     0.000648  ............      0.0003       0.115  ............      0.0651      0.00036  ............      0.0003
117-81-7.......................  Bis(2-ethylhexyl)phthalate.....     0.00044         12.4  ............     0.00027         225  ............       0.143      0.00112  ............     0.00027
542-88-1.......................  Bis(chloromethyl)either........  ..........  ...........        0.023   ..........  ..........        30.85   ..........  ...........        0.015   ..........
598-31-2.......................  Bromoacetone...................  ..........  ...........        0.023        0.005  ..........        30.85         0.03  ...........        0.015        0.005
75-27-4........................  Bromodichloromethane...........        33.3      0.00854  ............     0.00008          19  ............      0.0012      0.00252  ............     0.00008
75-25-2........................  Bromoform (Tribromomethane)....       0.178        0.064  ............      0.0002         173  ............        0.02        0.018  ............      0.0002
101-55-3.......................  Bromophenyl phenyl ether, 4-...  ..........  ...........        0.023         0.01  ..........        30.85          0.7  ...........        0.015         0.01
357-57-3.......................  Brucine........................  ..........  ...........        0.159           20  ..........       19.955   ..........  ...........        0.105           20
71-36-3........................  Butanol........................       38600         15.6  ............       0.014       18200  ............        0.23            6  ............       0.014
88-85-7........................  Butyl-4,6-dinitrophenol, 2-sec-        15.4        0.192  ............     0.00029         772  ............       0.042        0.064  ............     0.00029
                                  (Dinoseb).                                                                                                                                                    
85-68-7........................  Butylbenzylphthalate...........         235          437  ............    0.000042          87  ............       0.049           64  ............    0.000042
7440-43-9......................  Cadmium........................        1600         0.24  ............     0.00005        14.1  ............         0.2         0.11  ............     0.00005
86-74-8........................  Carbazole......................  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
75-15-0........................  Carbon disulfide...............       0.738         18.4  ............     0.00121         330  ............      0.0002          6.4  ............     0.00121
353-50-4.......................  Carbon oxyfluoride.............  ..........  ...........        0.023   ..........  ..........        30.85   ..........  ...........        0.015   ..........
56-23-5........................  Carbon tetrachloride...........      0.0115        0.014  ............     0.00021        8.54  ............        0.02      0.00161  ............     0.00021
75-87-6........................  Chloral........................  ..........  ...........        0.081   ..........  ..........          142   ..........  ...........       0.0317   ..........
305-03-3.......................  Chlorambucil...................  ..........  ...........        0.081   ..........  ..........          142   ..........  ...........       0.0317   ..........
57-74-9........................  Chlordane......................    0.000014       0.0998  ............     0.00004     0.00976  ............      0.0015     0.000163  ............     0.00004
494-03-1.......................  Chlomaphazin...................  ..........  ...........        0.081   ..........  ..........          142   ..........  ...........       0.0317   ..........
126-99-8.......................  Chloro-1, 3-butadiene, 2-             0.515  ...........  ............       0.002         288  ............     0.00099  ...........  ............       0.002
                                  (Chloroprene).                                                                                                                                                
107-20-0.......................  Chloroacetaldehyde.............  ..........  ...........        0.023   ..........  ..........        30.85   ..........  ...........        0.015   ..........
106-47-8.......................  Chloroaniline, p-..............         517         0.42  ............     0.00066         142  ............      0.0592         0.16  ............     0.00066
108-90-7.......................  Chlorobenzene..................         1.5         4.76  ............     0.00004        2470  ............      0.0002         1.33  ............     0.00004
510-15-6.......................  Chlorobenzilate................      0.0731        0.054  ............     0.00504        6.82  ............       0.069       0.0057  ............     0.00504
124-48-1.......................  Chlorodibromomethane...........        16.3       0.0066  ............     0.00007        27.5  ............     0.00085       0.0018  ............     0.00007
75-00-3........................  Chloroethane (ethyl chloride)..  ..........  ...........        0.023        0.005  ..........        30.85        0.005  ...........        0.015        0.005
110-75-8.......................  Chloroethyl vinyl ether, 2-....  ..........  ...........        0.081   ..........  ..........          142        0.005  ...........       0.0317   ..........
67-66-3........................  Chloroform.....................     0.00759        0.057  ............     0.00003        6.74  ............       0.002        0.017  ............     0.00003

[[Page 66428]]
                                                                                                                                                                                                
59-50-7........................  Chloro-m-cresol, p-............  ..........  ...........        0.081         0.02  ..........          142            1  ...........       0.0317         0.02
107-30-2.......................  Chloromethyl methyl ether......  ..........  ...........        0.023   ..........  ..........        30.85        0.005  ...........        0.015   ..........
91-58-7........................  Chloronaphthalene, 2-..........  ..........  ...........        0.081         0.01  ..........          142          0.7  ...........       0.0317         0.01
95-57-8........................  Chlorophenol, 2-...............         134          0.9  ............     0.00058         104  ............      0.0758         0.32  ............     0.00058
7005-72-3......................  Clorophenyl phenyl ether, 4-...  ..........  ...........        0.023         0.01  ..........        30.85          0.7  ...........        0.015         0.01
5344-82-1......................  Chlorophenyl thiourea, 1-o-....  ..........  ...........        0.023   ..........  ..........        30.85   ..........  ...........        0.015   ..........
542-76-7.......................  Chloropropionitrile, 3-........  ..........  ...........        0.081          0.1  ..........          142          0.5  ...........       0.0317          0.1
7440-47-3......................  Chromium.......................        1300         1.24  ............       0.002        9.76  ............       0.003        0.476  ............       0.002
218-01-9.......................  Chrysene.......................        1.32          0.1  ............     0.00015        34.6  ............       0.084      0.00119  ............     0.00015
6358-53-8......................  Citrus red No. 2...............  ..........  ...........         14.7   ..........  ..........         6900   ..........  ...........         10.5   ..........
7440-48-4......................  Cobalt.........................  .........
FR Doc. 95-29458 Hazardous Waste Management System: Identification and Listing of Hazardous Waste: Hazardous Waste Identification Rule (HWIR)
.  ...........         1.24          0.5  ..........         8.72            5  ...........       0.4165          0.5
7440-50-8......................  Copper.........................         674         2790  ............      0.0007        5.91  ............         0.5         1080  ............      0.0007
108-39-4.......................  Cresol, m-.....................         615          8.4  ............     0.00046       21500  ............       0.035          3.2  ............     0.00046
95-48-7........................  Cresol, o-.....................         656          8.4  ............     0.00055       27400  ............       0.027          3.2  ............     0.00055
106-44-5.......................  Cresol, p-.....................        63.5         0.84  ............     0.00046        2550  ............       0.035         0.32  ............     0.00046
4170-30-3......................  Crotonaldehyde.................  ..........  ...........          7.8         0.06  ..........         1210            4  ...........          6.2         0.06
57-12-5........................  Cyanide........................  ..........  ...........        0.159          0.2  ..........       19.955          0.2  ...........        0.105          0.2
14901-08-7.....................  Cycasin........................  ..........  ...........         14.7   ..........  ..........         6900   ..........  ...........         10.5   ..........
108-94-1.......................  Cyclohexanone..................  ..........  ...........          7.8           10  ..........         1210           10  ...........          6.2           10
131-89-5.......................  Cyclohexyl-4,6-dinitrophenol, 2- ..........  ...........       0.0252          0.1  ..........        2.991            7  ...........       0.0083          0.1
                                  .                                                                                                                                                             
50-18-0........................  Cyclophosphamide...............  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
20830-81-3.....................  Daunomycin.....................  ..........  ...........         14.7   ..........  ..........         6900   ..........  ...........         10.5   ..........
72-54-8........................  DDD............................    0.000126       913000  ............     0.00005     0.00648  ............      0.0012         2800  ............     0.00005
53-19-0........................  DDD (o,p\1\)...................  ..........  ...........    0.0069415   ..........  ..........        0.194   ..........  ...........         0.48   ..........
72-55-9........................  DDE............................   9.110E-06        0.228  ............    0.000058    0.000936  ............      0.0006    0.0000623  ............    0.000058
3424-82-6......................  DDE (o,p\1\)...................  ..........  ...........    0.0069415   ..........  ..........        0.194   ..........  ...........         0.48   ..........
50-29-3........................  DDT............................   0.0000181         20.4  ............    0.000081     0.00315  ............      0.0006       0.0054  ............    0.000081
789-02-6.......................  DDT (o.p\1\)...................  ..........  ...........    0.0069415   ..........  ..........        0.194   ..........  ...........         0.48   ..........
2303-16-4......................  Diallate.......................        0.26         90.1  ............     0.00063        1.26  ............       0.023         0.46  ............     0.00063
132-64-9.......................  Dibenzofuran...................  ..........  ...........          8.4         0.01  ..........        27400          0.7  ...........          3.2         0.01
192-65-4.......................  Dibenzo[a,e]pyrene.............  ..........  ...........      0.00285       0.0002  ..........          3.9         0.01  ...........    0.0000661        0.001
189-64-0.......................  Dibenzo[a,h]pyrene.............  ..........  ...........      0.00285       0.0002  ..........          3.9         0.01  ...........    0.0000661       0.0002
189-55-9.......................  Dibenzo[a,i]pyrene.............  ..........  ...........      0.00285       0.0002  ..........          3.9         0.01  ...........    0.0000661       0.0002
194-59-2.......................  Dibenzo[c,g]carbazole, 7H-.....  ..........  ...........      0.00285         0.01  ..........          3.9          0.7  ...........    0.0000661         0.01
226-36-8.......................  Dibenz(a,h)acridine............  ..........  ...........      0.00285       0.0002  ..........          3.9         0.01  ...........    0.0000661       0.0002
53-70-3........................  Dibenz(a,h)anthracene..........   8.440E-06      0.00176  ............     0.00003    0.000155  ............       0.084    6.340E-07  ............     0.00003
224-42-0.......................  Dibenz[a,j]acridine............  ..........  ...........      0.00285        0.001  ..........          3.9          0.7  ...........    0.0000661        0.001
96-12-8........................  Dibromo-3-chloropropane, 1,2-..      0.0723      0.00066  ............     0.00026       0.663  ............      0.0003     0.000114  ............     0.00026
764-41-0.......................  Dichloro-2-butene, 1,4-........  ..........  ...........        0.023        0.005  ..........        30.85        0.005  ...........        0.015        0.005
110-57-6.......................  Dichloro-2-butene, trans-1,4-..  ..........  ...........        0.023        0.005  ..........        30.85        0.005  ...........        0.015        0.005
96-23-1........................  Dichloro-2-propanol, 1,3-......  ..........  ...........        0.081         0.01  ..........          142         0.05  ...........       0.0317         0.01
95-50-1........................  Dichlorobenzene, 1,2-..........        15.4         29.5  ............     0.00003       50000  ............      0.0002          6.1  ............     0.00003
541-73-1.......................  Dichlorobenzene, 1,3-..........  ..........  ...........        0.023        0.005  ..........        30.85          0.7  ...........        0.015        0.005
106-46-7.......................  Dichlorobenzene, 1,4-..........        3.01        0.056  ............     0.00004        63.9  ............      0.0001       0.0108  ............     0.00004
91-94-1........................  Dichlorobenzidine, 3,3 \1\-....      0.0037       0.0042  ............      0.0024      0.0524  ............       0.116      0.00072  ............      0.0024
75-71-8........................  Dichlorodifluoromethane........        14.7         35.7  ............      0.0001        8070  ............      0.0052         11.9  ............      0.0001
75-34-3........................  Dichloroethane, 1,1-...........        37.4      0.00016  ............     0.00004        24.2  ............      0.0002      0.00006  ............     0.00004
107-06-2.......................  Dichloroethane, 1,2-...........     0.00698      0.00016  ............     0.00006         6.1  ............      0.0001      0.00006  ............     0.00006
75-35-4........................  Dichloroethylene, 1,1-.........     0.00345      0.00059  ............     0.00012        2.55  ............      0.0014      0.00018  ............     0.00012
156-59-2.......................  Dichloroethylene, cis-1,2-.....       30000         1.68  ............     0.00012        5400  ............        0.02         0.64  ............     0.00012
156-60-5.......................  Dichloroethylene, trans-1,2-...       44200         2.94  ............     0.00006       13800  ............      0.0006         1.12  ............     0.00006
111-91-1.......................  Dichloromethoxy ethane.........  ..........  ...........        0.023         0.01  ..........        30.85          0.7  ...........        0.015         0.01
98-87-3........................  Dichloromethylbenzene (benzal    ..........  ...........        0.023        0.005  ..........        30.85          0.3  ...........        0.015        0.005
                                  chloride).                                                                                                                                                    
120-83-2.......................  Dichlorophenol, 2,4-...........        6.94         0.62  ............     0.00041         769  ............      0.0788         0.18  ............     0.00041
87-65-0........................  Dichlorophenol, 2,6-...........  ..........  ...........        0.023         0.01  ..........        30.85          0.7  ...........        0.015         0.01
94-75-7........................  Dichlorophenoxyacetic acid, 2,4-       58.5         1.56  ............     0.00029        3140  ............     0.00011          0.6  ............     0.00029
                                   (2,4-D).                                                                                                                                                     
78-87-5........................  Dichloropropane, 1,2-..........       0.303        0.023  ............     0.00004        16.9  ............      0.0001       0.0023  ............     0.00004
542-75-6.......................  Dichloropropene, 1,3-..........     0.00476       0.0028  ............      0.0009        32.4  ............      0.0003      0.00085  ............      0.0009
10061-01-5.....................  Dichloropropene, cis-1,3-......     0.00485        90000  ............     0.00069        2.64  ............      0.0003         1150  ............     0.00069
10061-02-6.....................  Dichloropropene, trans-1,3-....      0.0049        90000  ............     0.00094        2.67  ............      0.0003         1150  ............     0.00094
60-57-1........................  Dieldrin.......................    0.000059          682  ............    0.000044     0.00176  ............      0.0006         0.54  ............    0.000044
1464-53-5......................  Diepoxybutane, 1,2,3,4- (2,2\1\- ..........  ...........         14.7        0.005  ..........         6900        0.005  ...........         10.5        0.005
                                  bioxirane).                                                                                                                                                   
84-66-2........................  Diethyl phthalate..............        3560          186  ............     0.00025        4490  ............       0.022           54  ............     0.00025
311-45-5.......................  Diethyl-p-nitrophenyl phosphate  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
56-53-1........................  Diethylstibestrol..............   7.720E-07    4.290E-07  ............      0.0078   2.470E-11  ............           1    6.500E-08  ............      0.0078
94-58-6........................  Dihydrosafrole.................  ..........  ...........         14.7         0.05  ..........         6900            3  ...........         10.5         0.05
60-51-5........................  Dimethoate.....................        38.1         29.4  ............     0.00029         1.6  ............      0.0691         0.77  ............     0.00029
131-11-3.......................  Dimethyl phthalate.............      200000           78  ............     0.00064           3  ............       0.013           30  ............     0.00064
77-78-1........................  Dimethyl sulfate...............  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........

[[Page 66429]]
                                                                                                                                                                                                
60-11-7........................  Dimethylaminoazobenzene, p-....  ..........  ...........      0.02762         0.01  ..........         3.28          0.7  ...........      0.00884         0.01
119-93-7.......................  Dimethylbenzidine, 3,3\1\-.....    0.000625    0.0000702  ............      0.0033     0.00062  ............         0.7     0.000018  ............      0.0033
57-97-6........................  Dimethylbenz(a)anthracene, 7,12-  3.820E-06      0.00464  ............     0.00037     0.00263  ............       0.039    2.760E-06  ............     0.00037
                                  .                                                                                                                                                             
79-44-7........................  Dimethylcarbamoyl chloride.....  ..........  ...........        0.081   ..........  ..........          142   ..........  ...........       0.0317   ..........
122-09-8.......................  Dimethylphenethylamine, alpha,   ..........  ...........        0.159         0.05  ..........       19.955            3  ...........        0.105         0.05
                                  alpha-.                                                                                                                                                       
105-67-9.......................  Dimethylphenol, 2,4-...........         151         3.78  ............     0.00047       11300  ............       0.052         1.19  ............     0.00047
119-90-4.......................  Dimethyoxybenzidine, 3,3\1\-...        1.78       0.0336  ............      0.0077       0.236  ............           7       0.0102  ............      0.0077
84-74-2........................  Di-n-butyl phthalate...........         883          227  ............     0.00033       90000  ............       0.249         25.2  ............     0.00033
99-65-0........................  Dinitrobenzene, l,3-...........        1.28       0.0168  ............     0.00011        5.54  ............        0.25       0.0064  ............     0.00011
100-25-4.......................  Dinitrobenzene, l,4-...........  ..........  ...........       0.0252         0.04  ..........        2.991            3  ...........       0.0083         0.04
534-52-1.......................  Dinitro-o-cresol, 4,6-.........  ..........  ...........       0.0252         0.05  ..........        2.991            3  ...........       0.0083         0.05
51-28-5........................  Dinitrophenol, 2,4-............        50.2        0.273  ............     0.00042        56.1  ............        0.03        0.105  ............     0.00042
121-14-2.......................  Dinitrotoluene, 2,4-...........        10.7        0.294  ............     0.00002         213  ............        0.26        0.112  ............     0.00002
606-20-2.......................  Dinitrotoluene, 2,6-...........        12.9        0.168  ............     0.00031        86.3  ............        0.25        0.064  ............     0.00031
117-84-0.......................  Di-n-octyl phthalate...........       0.002         1260  ............    0.000042        4480  ............       0.139          0.1  ............    0.000042
123-91-1.......................  Dioxane, 1,4-..................         558       0.0424  ............       0.012        13.2  ............      0.0005       0.0136  ............       0.012
122-39-4.......................  Diphenylamine..................          29         14.7  ............     0.00151       11800  ............       0.041          2.6  ............     0.00151
122-66-7.......................  Diphenylhydrazine, 1,2-........  ..........  ...........        0.159         0.01  ..........       19.955          0.7  ...........        0.105         0.01
298-04-4.......................  Disulfoton.....................      0.0131          458  ............     0.00007        42.6  ............      0.0035           13  ............     0.00007
541-53-7.......................  Dithiobiuret...................  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
115-29-7.......................  Endosulfan.....................        6.62            6  ............     0.00004        73.1  ............      0.0005         0.94  ............     0.00004
959-98-8.......................  Endosulfan I...................  ..........  ...........    0.0069415       0.0003  ..........        0.194        0.009  ...........         0.48       0.0003
332-13-65-9....................  Endosulfan II..................  ..........  ...........    0.0069415       0.0004  ..........        0.194        0.003  ...........         0.48       0.0004
1031-07-8......................  Endosulfan sulfate.............  ..........  ...........    0.0069415       0.0004  ..........        0.194         0.04  ...........         0.48       0.0004
145-73-3.......................  Endothall......................  ..........  ...........    0.0069415          0.1  ..........        0.194   ..........  ...........         0.48          0.1
72-20-8........................  Endrin.........................      0.0729         6550  ............     0.00039         026  ............      0.0036           32  ............     0.00039
7421-93-4......................  Endrin aldehyde................  ..........  ...........    0.0069415       0.0005  ..........        0.194         0.02  ...........         0.48       0.0005
53494-70-5.....................  Endrin ketone..................  ..........  ...........    0.0069415       0.0005  ..........        0.194         0.03  ...........         0.48       0.0005
106-89-8.......................  Epichlorohydrin................       0.335       414000  ............     0.06519          44  ............      0.0714         5400  ............     0.06519
51-43-4........................  Epinephrine....................  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
110-80-5.......................  Ethoxyethanol, 2-..............        14.7           39  ............        1.16        6900  ............        2.03           15  ............        1.16
141-78-6.......................  Ethyl acetate..................  ..........          390  ............       0.009      272000  ............        0.18          114  ............      0.0009
51-79-6........................  Ethyl carbamate................  ..........  ...........         14.7         0.05  ..........         6900            3  ...........         10.5         0.05
107-12-0.......................  Ethyl cyanide (propionitrile)..  ..........  ...........        0.159          0.1  ..........       19.955          0.1  ...........        0.105          0.1
60-29-7........................  Ethyl ether....................  ..........         27.3  ............     0.00153       41200  ............     0.00319         10.5  ............     0.00153
97-63-2........................  Ethyl methacrylate.............       25500           24  ............     0.00345        3420  ............      0.0011          6.6  ............     0.00345
62-50-0........................  Ethyl methanesulfonate.........      0.0055       930000  ............     0.00106       00133  ............       0.018        11700  ............     0.00106
100-41-4.......................  Ethylbenzene...................        74.5           39  ............     0.00006      550000  ............      0.0002          8.1  ............     0.00006
106-93-4.......................  Ethylene Dibromide.............    0.000928      0.00036  ............     0.00006     0.00745  ............      0.0001     0.000015  ............     0.00006
75-21-8........................  Ethylene oxide.................  ..........  ...........         14.7        0.001  ..........         6900         0.07  ...........         10.5        0.001
96-45-7........................  Ethylene thiourea..............        17.7      0.00053  ............  ..........        0.51  ............  ..........      0.00017  ............  ..........
151-56-4.......................  Ethyleneimine (aziridine)......  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
52-56-4........................  Famphur........................  ..........  ...........    0.0069415         0.02  ..........        0.194            1  ...........         0.48         0.02
640-19-7.......................  Fluoracetamide, 2-.............  ..........  ...........        0.023   ..........  ..........        30.85   ..........  ...........        0.015   ..........
62-74-8........................  Flouracetic acid, sodium salt..  ..........  ...........    0.0069415   ..........  ..........        0.194   ..........  ...........         0.48   ..........
206-44-0.......................  Fluoranthene...................        1580         27.5  ............     0.00021        5970  ............       0.084         1.74  ............     0.00021
86-73-7........................  Fluorene.......................        1310         22.4  ............     0.00021       89800  ............        0.08          3.4  ............     0.00021
16984-48-8.....................  Fluoride.......................  ..........  ...........            0         0.05  ..........            0   ..........  ...........            0         0.05
50-00-0........................  Formaldehyde...................      0.0158         27.3  ............      0.0232        48.8  ............           4         10.5  ............      0.0232
64-18-6........................  Formic Acid....................  ..........          273  ............         0.2      301000  ............          10          105  ............         0.2
765-34-4.......................  Glycidylaldehyde...............  ..........          7.8  ............  ..........        1210  ............  ..........          6.2  ............            
319-86-8.......................  HCH, delta-....................  ..........  ...........    0.0069415       0.0002  ..........        0.194       0.0006  ...........         0.48       0.0002
76-44-8........................  Heptachlor.....................   0.0000237  ...........  ............     0.00004        7.79  ............      0.0008  ...........  ............     0.00004
1024-57-3......................  Heptachlor epoxide.............    0.000528          783  ............    0.000032      0.0264  ............      0.0006         0.45  ............    0.000032
87-68-3........................  Hexachloro-1,3-butadiene.......     0.00788       0.0806  ............      0.0001        36.4  ............       0.046      0.00691  ............      0.0001
118-74-1.......................  Hexachlorobenzene..............    0.000424       0.0226  ............     0.00161      0.0116  ............      0.0723     0.000113  ............     0.00161
319-84-6.......................  Hexachlorocyclohexane, alpha-      0.000142           21  ............    0.000035      0.0333  ............      0.0008         0.11  ............    0.000035
                                  (alpha-BHC).                                                                                                                                                  
319-85-7.......................  Hexachlorocyclohexane, beta-       0.000445       0.0013  ............    0.000023        0.12  ............      0.0006      0.00021  ............    0.000023
                                  (beta-BHC).                                                                                                                                                   
58-89-9........................  Hexachlorocyclohexane, gamma-      0.000783          119  ............    0.000025       0.102  ............       0.002        0.693  ............    0.000025
                                  (Lindane).                                                                                                                                                    
77-47-4........................  Hexachlorocyclopentadiene......     0.00521  ...........  ............     0.00018        1450  ............       0.092  ...........  ............     0.00018
67-72-1........................  Hexachloroethane...............       0.049        0.212  ............   1.600E-06        80.6  ............      0.0206        0.033  ............   1.600E-06
70-30-4........................  Hexachlorophene................   5.150E-06       0.0521  ............       0.207   0.0000241  ............        1.87      0.00136  ............       0.207
1888-71-7......................  Hexachloropropene..............  ..........  ...........        0.081         0.01  ..........          142          0.7  ...........       0.0317         0.01
757-58-4.......................  Hexaethyl tetraphosphate.......  ..........  ...........         14.7   ..........  ..........         6900   ..........  ...........         10.5   ..........
591-78-6.......................  Hexanone, 2-...................  ..........  ...........          7.8        0.005  ..........         1210        0.005  ...........          6.2        0.005
302-01-2.......................  Hydrazine......................  ..........  ...........        0.159   ..........  ..........       19.955          0.3  ...........        0.105   ..........
193-39-5.......................  Indeno (1,2,3-cd) pyrene.......     0.00285       0.0165  ............    0.000043         3.9  ............      0.0748    0.0000241  ............    0.000043
                                                                                                                                                                                                

[[Page 66430]]
                                                                                                                                                                                                
74-88-4........................  Iodomethane....................  ..........  ...........        0.023        0.005  ..........        30.85        0.005  ...........        0.015        0.005
78-83-1........................  Isobutyl alcohol...............      180000           39  ............       0.011       55200  ............      0.0035           15  ............       0.011
465-73-6.......................  Isodrin........................  ..........  ...........    0.0069415         0.02  ..........        0.194            1  ...........         0.48         0.02
78-59-1........................  Isophorone.....................        78.6        0.531  ............        0.01         743  ............      0.0719        0.162  ............        0.01
120-58-1.......................  Isosafrole.....................  ..........  ...........         14.7         0.01  ..........         6900          0.7  ...........         10.5         0.01
143-50-0.......................  Kepone.........................   0.0000264      0.00022  ............       0.016    0.000277  ............       0.097     0.000032  ............       0.016
303-43-4.......................  Lasiocarpine...................  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
7439-92-1......................  Lead...........................      907000           30  ............        0.01         568  ............           2         11.6  ............        0.01
108-31-6.......................  Maleic anhydride...............  ..........  ...........         14.7   ..........  ..........         6900         0.07  ...........         10.5   ..........
123-33-1.......................  Maleic hydrazide...............  ..........  ...........        0.159         0.05  ..........       19.955            3  ...........        0.105         0.05
109-77-3.......................  Malononitrile..................  ..........  ...........        0.159          0.1  ..........       19.955          0.5  ...........        0.105          0.1
148-82-3.......................  Melphalan......................  ..........  ...........         14.7   ..........  ..........         6900   ..........  ...........         10.5   ..........
7439-97-6......................  Mercury........................         125        0.296  ............     0.00009       0.598  ............         0.1        0.138  ............     0.00009
126-98-7.......................  Methacrylonitrile..............      0.0708       0.0156  ............       0.009        8.91  ............      0.0005        0.006  ............       0.009
74-93-1........................  Methanethiol...................  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
67-56-1........................  Methanol.......................  ..........           78  ............       0.021      138000  ............        0.46           30  ............       0.021
91-80-5........................  Methapyrilene..................  ..........  ...........        0.159          0.1  ..........       19.955            7  ...........        0.105          0.1
16752-77-5.....................  Methomyl.......................  ..........  ...........    0.0069415         0.05  ..........        0.194            3  ...........         0.48         0.05
72-43-5........................  Methoxychlor...................        6.73  ...........  ............    0.000086        19.4  ............      0.0057  ...........  ............    0.000086
74-83-9........................  Methyl bromide (Bromomethane)..        0.37         3.12  ............     0.00011         504  ............        0.02         0.92  ............     0.00011
74-87-3........................  Methyl chloride (Chloromethane)      0.0959  ...........  ............     0.00013        90.8  ............        0.02  ...........  ............     0.00013
78-93-3........................  Methyl ethyle ketone...........         141           78  ............        0.01      112000  ............     0.00834           30  ............        0.01
1338-23-4......................  Mehtyl ethyl ketone peroxide...  ..........  ...........          7.8   ..........  ..........         1210   ..........  ...........          6.2   ..........
60-34-4........................  Mehty hydrazine................  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
108-10-1.......................  Methyl isobutyl ketone.........        10.3          7.8  ............     0.00083       17000  ............     0.00315            3  ............     0.00083
80-62-6........................  Methyl methacrylate............       69900         28.2  ............       0.005       39500  ............      0.0027          8.1  ............       0.005
66-27-3........................  Methyl methanesulfonate........  ..........  ...........      0.11775         0.01  ..........         1.66          0.7  ...........          6.4         0.01
91-57-6........................  Methyl naphthalene, 2-.........  ..........  ...........      0.00285         0.01  ..........          3.9          0.7  ...........    0.0000661         0.01
298-00-0.......................  Methyl paratyhion..............       0.662           78  ............        0.01        1.43  ............      0.0691         23.4  ............        0.01
75-55-8........................  Methylaziridine, 2-............  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
56-49-5........................  Methylcholanthrene, 3-.........   9.880E-06       0.0117  ............        0.01    0.000128  ............       0.046    1.410E-06  ............        0.01
74-95-3........................  Methylene bromide..............       11700         2.32  ............     0.00024        8400  ............      0.0001         0.19  ............     0.00024
75-09-2........................  Methylene chloride.............       0.376        0.039  ............     0.00026         306  ............        0.02        0.015  ............     0.00026
101-14-4.......................  Methylenebis, 4,4'-(2-           ..........  ...........      0.02762   ..........  ..........         3.28   ..........  ...........      0.00884   ..........
                                  chloroaniline).                                                                                                                                               
70-25-7........................  Methyl-nitro-nitrosoguanidine    ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
                                  (MNNG).                                                                                                                                                       
56-04-2........................  Methylthiouracil...............  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
50-07-7........................  Mitomycin C....................  ..........  ...........         14.7   ..........  ..........         6900   ..........  ...........         10.5   ..........
7439-98-7......................  Molybdenum.....................      121000         1.83  ............       0.001         114  ............         0.3         1.83  ............       0.001
91-20-3........................  Naphthalene....................         385           14  ............      0.0018      120000  ............      0.0665          2.7  ............      0.0018
130-15-4.......................  Naphthoquinone, 1,4-...........  ..........  ...........         14.7         0.01  ..........         6900          0.7  ...........         10.5         0.01
86-88-4........................  Naphthyl-2-thiourea, 1-........  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
134-32-7.......................  Naphthylamine, 1-..............  ..........  ...........        0.159         0.01  ..........       19.955          0.7  ...........        0.105         0.01
91-59-8........................  Naphthylamine, 2-..............  ..........  ...........        0.159         0.01  ..........       19.955          0.7  ...........        0.105         0.01
7440-02-0......................  Nickel.........................        5040         10.5  ............       0.005         106  ............           1         4.89  ............       0.005
54-11-5........................  Nicotine and salts.............  ..........  ...........        0.159         0.02  ..........       19.955            1  ...........        0.105         0.02
88-74-4........................  Nitroaniline, 2-...............  ..........  ...........      0.02762         0.05  ..........         3.28            3  ...........      0.00884         0.05
99-09-2........................  Nitroaniline, 3-...............  ..........  ...........      0.02762         0.05  ..........         3.28            3  ...........      0.00884         0.05
100-01-6.......................  Nitroaniline, 4-...............  ..........  ...........      0.02762         0.02  ..........         3.28            1  ...........      0.00884         0.02
99-95-3........................  Nitrobenzene...................       0.345        0.084  ............      0.0064        44.8  ............      0.0544        0.032  ............      0.0064
55-86-7........................  Nitrogen mustard...............  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
51-75-2........................  Nitrogen mustard hydrochloride   ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
                                  salt.                                                                                                                                                         
126-85-2.......................  Nitrogen mustard N-Oxide.......  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
302-70-5.......................  Nitrogen mustard N-Oxide, HCI    ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
                                  salt.                                                                                                                                                         
55-63-0........................  Nitroglycerine.................  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
99-55-8........................  Nitro-o-toluidine, 5-..........  ..........  ...........      0.02762         0.01  ..........         3.28          0.7  ...........      0.00884         0.01
88-75-5........................  Nitrophenol, 2-................  ..........  ...........       0.0252         0.01  ..........        2.991          0.7  ...........       0.0083         0.01
100-02-7.......................  Nitrophenol, 4-................  ..........  ...........       0.0252         0.05  ..........        2.991            3  ...........       0.0083         0.05
79-46-9........................  Nitropropane, 2-...............     0.00019  ...........  ............     0.00577       0.128  ............      0.0022  ...........  ............     0.00577
56-57-5........................  Nitroquinoline-1-oxide, 4-.....  ..........  ...........        0.159         0.04  ..........       19.955            3  ...........        0.105         0.04
55-18-5........................  Nitrosodiethylamine............   0.0000406    3.180E-06  ............       0.002     0.00064  ............           1    1.020E-06  ............       0.002
62-75-9........................  Nitrosodimethylamine...........    0.000268    0.0000106  ............      0.0006     0.00245  ............       0.074    3.400E-06  ............      0.0006
924-16-3.......................  Nitrosodi-n-butylamine.........    0.000279     0.000122  ............        0.06       0.094  ............        0.03     0.000036  ............        0.06
10595-95-6.....................  Nitrosomethylethylamine........       0.129    0.0000212  ............       0.028     0.00244  ............       0.016    6.800E-06  ............       0.028
1116-54-7......................  M-Nitrosodiethanolamine........  ..........  ...........    0.0000371         0.01  ..........     0.012875          0.7  ...........    0.0000119         0.01
621-64-7.......................  N-Nitrosodi-n-propylamine......      0.0644     0.000053  ............       0.026      0.0233  ............      0.0144     0.000017  ............       0.026
86-30-6........................  N-Nitrosodiphenylamine.........        7.54          0.2  ............        0.05        1270  ............      0.0846        0.046  ............        0.05
4549-40-0......................  N-Nitrosomethyl vinyl amine....  ..........  ...........    0.0000371   ..........  ..........     0.012875   ..........  ...........    0.0000119   ..........
59-89-2........................  N-Nitrosomorpholine............  ..........  ...........        0.159         0.05  ..........       19.955            3  ...........        0.105         0.05
759-73-9.......................  N-Nitroso-N-ethylurea..........  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
684-93-5.......................  N-Nitroso-N-methylurea.........  ..........  ...........        0.159         0.01  ..........       19.955          0.7  ...........        0.105        0.01 

[[Page 66431]]
                                                                                                                                                                                                
615-53-2.......................  N-Nitroso-N-methylurethane.....  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
16543-55-8.....................  N-Nitrosonomicotine............  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
100-75-4.......................  N-Nitrosopiperidine............      0.0106    0.0000106  ............     0.00135     0.00247  ............       0.033    3.400E-06  ............     0.00135
930-55-2.......................  N-Nitrosopyrrolidine...........       0.101     0.000212  ............      0.0047      0.0534  ............       0.042     0.000068  ............      0.0047
13256-22-9.....................  N-Nitrososarcosine.............  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
103-85-5.......................  N-Phenylthiourea...............  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
1615-80-1......................  N,N-Diethylihydrazine..........  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
152-16-9.......................  Octamethyl- pyro- phosphoramide        7310        0.273  ............      0.0053          31  ............       0.146        0.105  ............      0.0053
20816-12-0.....................  Osmium tetroxide...............  ..........  ...........         1.24            3  ..........         8.72          200  ...........       0.4165            3
297-97-2.......................  O,O-Diethyl O-pyrazinyl          ..........  ...........      0.11775         0.02  ..........         1.66            1  ...........          6.4         0.02
                                  phosphorothioate.                                                                                                                                             
126-68-1.......................  O,O,O-Triethyl phosphorothioate  ..........  ...........      0.11775         0.05  ..........         1.66            3  ...........          6.4         0.05
123-63-7.......................  Paraldehyde....................  ..........  ...........          7.8            1  ..........         1210           70  ...........          6.2            1
56-38-2........................  Parathion......................        2.63       440000  ............      0.0005       0.128  ............       0.025        11600  ............      0.0005
608-93-5.......................  Pentachlorobenzene.............        7.86         5.15  ............    0.000038         205  ............        0.02       0.0543  ............    0.000038
76-01-7........................  Pentachloroethane..............  ..........  ...........        0.023        0.005  ..........        30.85         0.01  ...........        0.015        0.005
82-68-8........................  Pentachloronitrobenzene (PCNB).        13.9        0.081  ............        0.02        11.4  ............       0.052       0.0054  ............        0.02
87-86-5........................  Pentachlorophenol..............       0.301      0.00204  ............     0.00008        2.92  ............      0.1222      0.00041  ............     0.00008
62-44-2........................  Phenacetin.....................  ..........  ...........         14.7         0.02  ..........         6900            1  ...........         10.5         0.02
85-01-8........................  Phenanthrene...................  ..........  ...........      0.00285        0.006  ..........          3.9          0.7  ...........    0.0000661        0.006
108-95-2.......................  Phenol.........................       19300           84  ............     0.00028      163000  ............      0.2185           32  ............     0.00028
62-38-4........................  Phenyl mercuric acetate........       0.506       0.0117  ............  ..........     0.00932  ............  ..........       0.0045  ............  ..........
25265-76-3.....................  Phenylenediamines (N.O.S.).....  ..........  ...........        0.159         0.01  ..........       19.955          0.7  ...........        0.105         0.01
108-45-2.......................  Phenylenediamine, m-...........        5440         0.78  ............      0.0174         784  ............         0.7          0.3  ............      0.0174
106-50-3.......................  Phenylenediamine, p-...........  ..........  ...........        0.159         0.01  ..........       19.955          0.7  ...........        0.105         0.01
298-02-2.......................  Phorate........................       0.106  ...........  ............     0.00004         157  ............       0.002  ...........  ............     0.00004
298-06-6.......................  Phosphorodithioic acid, o-o-     ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
                                  diethyl ester.                                                                                                                                                
3288-58-2......................  Phosphorodithioic acid, o-o-     ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
                                  diethyl-s-methyl.                                                                                                                                             
2953-29-9......................  Phosphorodithioic acid,          ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
                                  trimethyl ester.                                                                                                                                              
85-44-9........................  Phthalic anhydride.............  ..........  ...........          132   ..........  ..........       2352.5            7  ...........         27.6   ..........
109-06-8.......................  Picoline, 2-...................  ..........  ...........        0.159        0.001  ..........       19.955         0.07  ...........        0.105        0.001
1336-36-3......................  Polychlorinated biphenyls......    0.000286      0.00614  ............      0.0005     0.00596  ............        0.04    4.810E-06  ............      0.0005
23950-58-5.....................  Pronamide......................        80.3         21.3  ............     0.00145         438  ............       0.097          5.7  ............     0.00145
1120-71-4......................  Propane sultone, 1,3-..........  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
107-10-8.......................  Propylamine, n-................  ..........  ...........        0.159        0.005  ..........       19.955        0.005  ...........        0.105        0.005
51-52-5........................  Propylthiouracil...............  ..........  ...........      0.11775          0.1  ..........         1.66            7  ...........          6.4          0.1
107-19-7.......................  Propyn-1-ol, 2-................  ..........  ...........           39         0.01  ..........        36700         0.05  ...........           15         0.01
129-00-0.......................  Pyrene.........................        3040         54.1  ............     0.00027       15800  ............      0.0726         1.69  ............     0.00027
110-86-1.......................  Pyridine.......................       0.522        0.156  ............       0.011         814  ............         0.2         0.06  ............       0.011
50-55-5........................  Reserpine......................  ..........  ...........        0.159         0.05  ..........       19.955            3  ...........        0.105         0.05
108-46-3.......................  Resorcinol.....................  ..........  ...........    0.0069415          0.1  ..........        0.194            7  ...........         0.48          0.1
81-07-2........................  Saccharin and salts............  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
94-59-7........................  Safrole........................      0.0829       0.0035  ............      0.0021        10.5  ............       0.015      0.00095  ............      0.0021
7782-49-2......................  Selenium.......................         822        0.927  ............      0.0006        1.94  ............           5        0.357  ............      0.0006
7440-22-4......................  Silver.........................         199  ...........  ............      0.0005       0.134  ............         0.3  ...........  ............      0.0005
18883-66-4.....................  Streptozotocin.................  ..........  ...........         14.7   ..........  ..........         6900   ..........  ...........         10.5   ..........
57-24-9........................  Strychnine.....................        3.34        0.045  ............      0.0084      0.0041  ............           3        0.016  ............      0.0084
100-42-5.......................  Styrene........................        75.7         63.7  ............     0.00004      629000  ............       0.004         15.4  ............     0.00004
18496-25-8.....................  Sulfide........................  ..........  ...........            0            2  ..........            0            2  ...........            0            2
1746-01-6......................  TCDD, 2,3,7,8-.................   1.050E-09    1.880E-07  ............   1.000E-08   7.980E-06  ............   1.000E-06    1.780E-10  ............   1.000E-08
95-94-3........................  Tetrachlorobenzene, 1,2,4,5-...        14.8        0.234  ............     0.00141         168  ............       0.034       0.0317  ............     0.00141
630-20-6.......................  Tetrachloroethane, 1,1,1,2-....      0.0241        0.075  ............     0.00005         133  ............      0.0001       0.0078  ............     0.00005
79-34-5........................  Tetrachloroethane, 1,1,2,2-....      0.0037        0.024  ............      0.0002        29.3  ............      0.0002       0.0077  ............      0.0002
127-18-4.......................  Tetrachloroethylene............       15600         2.04  ............     0.00014       13300  ............      0.0007         0.68  ............     0.00014
58-90-2........................  Tetrachlorophenol, 2,3,4,6-....        2720         1.89  ............     0.00062        6150  ............        0.04         0.58  ............     0.00062
107-49-3.......................  Tetraethyl pyrophosphate.......  ..........  ...........         14.7   ..........  ..........         6900            3  ...........         10.5   ..........
3689-24-5......................  Tetraethyldithiopyrophosphate..        0.23  ...........  ............    0.000058        2.81  ............      0.0039  ...........  ............    0.000058
7440-28-0......................  Thallium (I)...................         646         0.05  ............      0.0007        5.12  ............           3       0.0192  ............      0.0007
62-55-5........................  Thioacetamide..................  ..........  ...........        0.159            1  ..........       19.955   ..........  ...........        0.105            1
39196-18-4.....................  Thiofanox......................  ..........  ...........      0.11775         0.05  ..........         1.66            3  ...........          6.4         0.05
108-98-5.......................  Thiophenol.....................  ..........  ...........      0.11775         0.02  ..........         1.66            1  ...........          6.4         0.02
79-19-6........................  Thiosemicarbazide..............  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
62-56-6........................  Thiourea.......................  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
137-26-8.......................  Thiram.........................  ..........  ...........    0.0069415         0.05  ..........        0.194            3  ...........         0.48         0.05
7440-31-5......................  Tin............................  ..........  ...........         1.24            8  ..........         8.72          500  ...........       0.4165            8
108-88-3.......................  Toluene........................        29.8         41.3  ............     0.00011      176000  ............      0.0002         12.6  ............     0.00011
584-84-9.......................  Toluene diisocyanate...........  ..........  ...........        0.159   ..........  ..........       19,955            7  ...........        0.105   ..........
95-80-7........................  Toluenediamine, 2,4-...........       0.211     0.000159  ............      0.0134      0.0101  ............           1     0.000051  ............      0.0134
823-40-5.......................  Toluenediamine, 2,6-...........  ..........  ...........        0.159         0.02  ..........       19.955            1  ...........        0.105         0.02

[[Page 66432]]
                                                                                                                                                                                                
496-72-0.......................  Toluenediamine, 3,4-...........  ..........  ...........        0.159         0.02  ..........       19.955            1  ...........        0.105         0.02
636-21-5.......................  Toluidine hydrochloride, o-....  ..........  ...........        0.159         0.01  ..........       19.955          0.7  ...........        0.105         0.01
95-53-4........................  Toluidine, o-..................       0.441      0.00224  ............      0.0121        2.35  ............       0.029      0.00068  ............      0.0121
106-49-0.......................  Toluidine, p-..................       0.703      0.00224  ............      0.0168       0.128  ............       0.043      0.00068  ............      0.0168
8001-35-2......................  Toxaphene......................    0.000364         21.5  ............     0.00127    0.000176  ............      0.0295         0.11  ............     0.00127
76-13-1........................  Trichloro-1,2,2-                       2210        11000  ............     0.00108  ..........  ............     0.00114         2400  ............     0.00108
                                  trifluoroethane, 1,1,2-.                                                                                                                                      
120-82-1.......................  Trichlorobenzene, 1,2,4-.......       0.685         9.31  ............      0.0002        3450  ............       0.574          1.3  ............      0.0002
71-55-6........................  Trichloroethane, 1,1,1-........        73.9          120  ............     0.00008       48200  ............      0.0002       0.0539  ............     0.00008
79-00-5........................  Trichloroethane, 1,1,2-........      0.0117        0.007  ............      0.0001        11.3  ............       0.004       0.0018  ............      0.0001
79-01-6........................  Trichloroethylene..............         138       0.0384  ............     0.00019         567  ............      0.0001       0.0128  ............     0.00019
75-69-4........................  Trichlorofluoromethane.........        51.4           48  ............     0.00008       25800  ............       0.001           16  ............     0.00008
75-70-7........................  Trichloromethanethiol..........  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
95-95-4........................  Trichlorophenol, 2,4,5-........        38.8         18.1  ............     0.00049       11500  ............      0.0672          4.2  ............     0.00049
88-06-2........................  Trichlorophenol, 2,4,6-........         0.1       0.0536  ............      0.0004         124  ............      0.0785       0.0152  ............      0.0004
93-76-5........................  Trichlorophenoxyacetic acid,           15.5         1.68  ............     0.00008        63.2  ............      0.0063         0.64  ............     0.00008
                                  2,4,5- (245-T).                                                                                                                                               
93-72-1........................  Trichlorophenoxypropionic acid,        9.72         1.26  ............     0.00008        6.36  ............     0.00028         0.48  ............     0.00008
                                  2,4,5- (Silvex).                                                                                                                                              
96-18-4........................  Trichloropropane, 1,2,3-.......         707          1.1  ............     0.00032         872  ............      0.0009         0.34  ............     0.00032
99-35-4........................  Trinitrobenzene, sym-..........           3       0.0078  ............     0.00026       0.442  ............        0.25        0.003  ............     0.00026
126-72-7.......................  Tris (2,3-dibromopropyl)           0.000237      0.00252  ............      0.0245       0.357  ............       0.061     0.000099  ............      0.0245
                                  phosphate.                                                                                                                                                    
52-24-4........................  Tris (1-azridinyl) phosphine     ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
                                  sulfide.                                                                                                                                                      
72-57-1........................  Trypan blue....................  ..........  ...........         14.7   ..........  ..........         6900   ..........  ...........         10.5   ..........
66-75-1........................  Uracil mustard.................  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
7440-62-2......................  Vanadium.......................       15800         9.58  ............       0.003         250  ............           1         3.71  ............       0.003
108-05-4.......................  Vinyl acetate..................  ..........  ...........         14.7        0.005  ..........         6900        0.005  ...........         10.5        0.005
75-01-4........................  Vinyl chloride.................     0.00199     0.000156  ............     0.00017        1.23  ............      0.0017      0.00006  ............     0.00017
81-81-2........................  Warfarin.......................  ..........  ...........    0.0069415         0.05  ..........        0.194            3  ...........         0.48         0.05
1330-20-7......................  Xylenes (total)................        22.4          859  ............       0.002      172000  ............      0.0002          147  ............       0.002
7440-66-6......................  Zinc...........................       23200           99  ............       0.002         316  ............         0.3         38.4  ............       0.002
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

                                                   Table C-2.--Summary of Constituent-Specific Exit Level Development Using MCL-Based Numbers                                                   
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                   WW totals (mg/l)                           NWW totals (mg/kg)                      NWW leach (mg/l)          
                                                                 -------------------------------------------------------------------------------------------------------------------------------
            CAS No.                            Name                Multipath  Groundwater                             Multipath                            Groundwater                          
                                                                    modeled     modeled    Extrapolated    WW EQC      modeled   Extrapolated    NWW EQC     modeled    Extrapolated    WW EQC  
                                                                  exit level   exit level   exit level               exit level   exit level               Leach level   Leach level            
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
83-32-9........................  Acenaphthene...................        49.5         31.2  ............      0.0018        9480  ............      0.0742          4.9  ............      0.0018
208-96-8.......................  Acenaphthylene.................  ..........  ...........      0.00285         0.02  ..........          3.9          0.7  ...........      0.00119         0.02
67-64-1........................  Acetone........................      232000         15.6  ............         0.2       17400  ............       0.027            6  ............         0.2
75-05-8........................  Acetonitrile...................        6.58         0.78  ............       0.015         923  ............       0.014          0.3  ............       0.015
98-86-2........................  Acetophenone...................        5960         16.8  ............     0.00158        1210  ............        0.03          6.4  ............     0.00158
75-36-5........................  Acetyl chloride................  ..........  ...........       0.0241   ..........  ..........        30.85   ..........  ...........       0.0115   ..........
591-08-2.......................  Acetyl-2-thiourea, 1-..........  ..........  ...........      0.11775            1  ..........         1.66           70  ...........          6.4            1
53-96-3........................  Acetylaminofluorene, 2-........  ..........  ...........      0.02762         0.02  ..........         3.28            1  ...........      0.00884         0.02
107-02-8.......................  Acrolein.......................     0.00248  ...........  ............       0.013        2.63  ............       0.075  ...........  ............       0.013
79-06-1........................  Acrylamide.....................        3.67      0.00026  ............        0.01     0.00436  ............         0.1     0.000038  ............        0.01
107-13-1.......................  Acrylonitrile..................     0.00428       0.0011  ............       0.008       0.961  ............         0.7      0.00034  ............       0.008
1402-68-2......................  Aflatoxins.....................  ..........  ...........         14.7   ..........  ..........         6900   ..........  ...........         10.5   ..........
116-06-3.......................  Aldicarb.......................  ..........  ...........    0.0069415         0.05  ..........        0.194            1  ...........         0.54         0.05
309-00-2.......................  Aldrin.........................   5.640E-07      0.00469  ............    0.000034    0.000444  ............      0.0006    3.670E-06  ............    0.000034
107-18-6.......................  Allyl alcohol..................  ..........  ...........           39   ..........  ..........        36700   ..........  ...........           15   ..........
107-05-1.......................  Allyl chloride.................      0.0742  ...........  ............       0.002         258  ............       0.002  ...........  ............       0.002
92-67-1........................  Aminobiphenyl, 4-..............  ..........  ...........      0.02762         0.02  ..........         3.28            1  ...........      0.00884         0.02
2763-96-4......................  Aminomethyl-3-isoxazolol, 5-...  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
504-24-5.......................  Aminopyridine, 4-..............  ..........  ...........      0.02762   ..........  ..........         3.28   ..........  ...........      0.00884   ..........
61-82-5........................  Amitrole.......................  ..........  ...........    0.0069415   ..........  ..........        0.194   ..........  ...........         0.54   ..........
62-53-3........................  Aniline........................       0.444        0.053  ............     0.00023        4.21  ............      0.0132        0.017  ............     0.00023
120-12-7.......................  Anthracene.....................  ..........  ...........      0.00285        0.007  ..........          3.9          0.5  ...........      0.00119        0.007
7440-36-0......................  Antimony.......................        8210        0.136  ............      0.0008        8.72  ............           2        0.053  ............      0.0008
140-57-8.......................  Aramite........................  ..........  ...........         14.7         0.02  ..........         6900            1  ...........         10.5         0.02
7440-38-2......................  Arsenic........................        40.5        0.384  ............      0.0005        0.17  ............      0.3031         0.15  ............      0.0005
2465-27-2......................  Auramine.......................  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
115-02-6.......................  Azaserine......................  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
7440-39-3......................  Barium.........................  ..........           28  ............       0.001        2080  ............         0.2         10.8  ............       0.001
71-43-2........................  Benzene........................      0.0209       0.0295  ............     0.00004        .109  ............      0.0001        0.009  ............     0.00004
92-87-5........................  Benzidine......................     0.00015   2.2400E-06  ............      0.0025   0.0000298  ............       0.042    6.800E-07  ............      0.0025

[[Page 66433]]
                                                                                                                                                                                                
106-51-4.......................  Benzoquinone, p-...............  ..........  ...........         14.7         0.01  ..........         6900          0.7  ...........         10.5         0.01
98-07-7........................  Benzotrichloride...............  ..........  ...........         0.27   ..........  ..........          142        0.004  ...........        0.033   ..........
50-32-8........................  Benzo(a)pyrene.................     0.00231         1.88  ............    0.000023       0.227  ............      0.0621       0.0036  ............    0.000023
205-99-2.......................  Benzo(b)fluoranthene...........    0.000805       0.0164  ............    0.000018         3.7  ............      0.0699    0.0000661  ............    0.000018
205-82-3.......................  Benzo(j)fluoranthene...........  ..........  ...........      0.00285       0.0002  ..........          3.9         0.01  ...........      0.00119       0.0002
207-08-9.......................  Benzo(k)fluoranthene...........  ..........  ...........      0.00285       0.0002  ..........          3.9          0.7  ...........      0.00119       0.0002
191-24-2.......................  Benzo[g,h,i]perylene...........  ..........  ...........      0.00285       0.0008  ..........          3.9          0.7  ...........      0.00119       0.0008
100-51-6.......................  Benzyl alochol.................       22500           39  ............     0.00074        2740  ............       0.034           15  ............     0.00074
100-44-7.......................  Benzyl chloride................        1.13          3.9  ............   5.000E-06        37.5  ............     0.00276           15  ............   5.000E-06
56-55-3........................  Benz(a)anthracene..............      0.0138     0.000717  ............    0.000013         0.1  ............      0.0826    4.300E-06  ............    0.000013
225-51-4.......................  Benz(c)acridine................  ..........  ...........      0.00285       0.0005  ..........          3.9         0.03  ...........      0.00119       0.0005
7440-41-7......................  Beryllium......................        10.1     0.000827  ............      0.0003      0.0591  ............         0.1      0.00032  ............      0.0003
39638-32-9.....................  Bis (2-chloroisoproply) ether..       0.569        0.007  ............     0.00145       0.944  ............      0.0586       0.0019  ............     0.00145
111-44-4.......................  Bis(2-chlorethyl)ether.........     0.00141     0.000648  ............      0.0003       0.115  ............      0.0651      0.00036  ............      0.0003
117-81-7.......................  Bis(2-ethylhexyl)phthalate.....     0.00044         1260  ............     0.00027         225  ............       0.143        0.108  ............     0.00027
542-88-1.......................  Bis(chloromethyl) ether........  ..........  ...........       0.0241   ..........  ..........        30.85   ..........  ...........       0.0115   ..........
598-31-2.......................  Bromoacetone...................  ..........  ...........       0.0241        0.005  ..........        30.85         0.03  ...........       0.0115        0.005
75-27-4........................  Bromodichloromethane...........        33.3      0.00854  ............     0.00008          19  ............      0.0012      0.00252  ............     0.00008
75-25-2........................  Bromoform (Tribromomethane)....       0.178        0.064  ............      0.0002         173  ............        0.02        0.018  ............      0.0002
101-55-3.......................  Bromopheynl phenyl ether, 4-...  ..........  ...........       0.0241         0.01  ..........        30.85          0.7  ...........       0.0115         0.01
357-57-3.......................  Brucine........................  ..........  ...........        0.159           20  ..........       19.955   ..........  ...........        0.105           20
71-36-3........................  Butanol........................       38600         15.6  ............       0.014       18200  ............        0.23            6  ............       0.014
88-85-7........................  Butyl-4,6-dinitrophenol, 2-sec-        15.4       0.0336  ............     0.00029         772  ............       0.042       0.0112  ............     0.00029
                                  (Dinoseb).                                                                                                                                                    
85-68-7........................  Butylbenzylphthalate...........         235          437  ............    0.000042          87  ............       0.049           64  ............    0.000042
7440-43-9......................  Cadmium........................        1600        0.038  ............     0.00005        14.1  ............         0.2        0.015  ............     0.00005
86-74-8........................  Carbazole......................  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
75-15-0........................  Carbon disulfide...............       0.738         18.4  ............     0.00121         330  ............      0.0002          6.4  ............     0.00121
353-50-4.......................  Carbon oxyfluoride.............  ..........  ...........       0.0241   ..........  ..........        30.85   ..........  ...........       0.0115   ..........
56-23-5........................  Carbon tetrachloride...........      0.0115          0.1  ............     
FR Doc. 95-29458 Hazardous Waste Management System: Identification and Listing of Hazardous Waste: Hazardous Waste Identification Rule (HWIR)
0.00021        8.54  ............        0.02       0.0115  ............     0.00021
75-87-6........................  Chloral........................  ..........  ...........         0.27   ..........  ..........          142   ..........  ...........        0.033   ..........
305-03-3.......................  Chlorambucil...................  ..........  ...........         0.27   ..........  ..........          142   ..........  ...........        0.033   ..........
57-74-9........................  Chlordane......................    0.000014           24  ............     0.00004     0.00976  ............      0.0015        0.036  ............     0.00004
494-03-1.......................  Chlomaphazin...................  ..........  ...........         0.27   ..........  ..........          142   ..........  ...........        0.033   ..........
126-99-8.......................  Chloro-1,3-butadiene, 2-              0.515  ...........  ............       0.002         288  ............     0.00099  ...........  ............       0.002
                                  (Chloroprene).                                                                                                                                                
107-20-0.......................  Chloroacetaldehyde.............  ..........  ...........       0.0241   ..........  ..........        30.85   ..........  ...........       0.0115   ..........
106-47-8.......................  Chloroaniline, p-..............         517         0.42  ............     0.00066         142  ............      0.0592         0.16  ............     0.00066
108-90-7.......................  Chlorobenzene..................         1.5         0.68  ............     0.00004        2470  ............      0.0002         0.19  ............     0.00004
510-15-6.......................  Chlorobenzilate................      0.0731        0.054  ............     0.00504        6.82  ............       0.069       0.0057  ............     0.00504
124-48-1.......................  Chlorodibromomethane...........        16.3       0.0066  ............     0.00007        27.5  ............     0.00085       0.0018  ............     0.00007
75-00-3........................  Chloroethane (ethyl chloride)..  ..........  ...........       0.0241        0.005  ..........        30.85        0.005  ...........       0.0115        0.005
110-75-8.......................  Chloroethyl vinyl ether, 2-....  ..........  ...........         0.27   ..........  ..........          142        0.005  ...........        0.033   ..........
67-66-3........................  Chloroform.....................     0.00759        0.057  ............     0.00003        6.74  ............       0.002        0.017  ............     0.00003
59-50-7........................  Chloro-m-cresol, p-............  ..........  ...........         0.27         0.02  ..........          142            1  ...........        0.033         0.02
107-30-2.......................  Chloromethyl methyl ether......  ..........  ...........       0.0241   ..........  ..........        30.85        0.005  ...........       0.0115   ..........
91-58-7........................  Chloronaphthalene, 2-..........  ..........  ...........         0.27         0.01  ..........          142          0.7  ...........        0.033         0.01
95-57-8........................  Chlorophenol, 2-...............         134          0.9  ............     0.00058         104  ............      0.0758         0.32  ............     0.00058
7005-72-3......................  Chlorophenyl phenyl ether, 4-..  ..........  ...........       0.0241         0.01  ..........        30.85          0.7  ...........       0.0115         0.01
5344-82-1......................  Chlorophenyl thiourea, 1-o-....  ..........  ...........       0.0241   ..........  ..........        30.85   ..........  ...........       0.0115   ..........
542-76-7.......................  Chloropropionitrile, 3-........  ..........  ...........         0.27          0.1  ..........          142          0.5  ...........        0.033          0.1
7440-47-3......................  Chromium.......................        1300        0.618  ............       0.002        9.76  ............       0.003        0.238  ............       0.002
218-01-9.......................  Chrysene.......................        1.32          0.1  ............     0.00015        34.6  ............       0.084      0.00119  ............     0.00015
6358-53-8......................  Citrus red No. 2...............  ..........  ...........         14.7   ..........  ..........         6900   ..........  ...........         10.5   ..........
7440-48-4......................  Cobalt.........................  ..........  ...........        0.618          0.5  ..........         8.72            5  ...........        0.194          0.5
7440-50-8......................  Copper.........................         674         2790  ............      0.0007        5.91  ............         0.5         1080  ............      0.0007
108-39-4.......................  Cresol, m-.....................         615          8.4  ............     0.00046       21500  ............       0.035          3.2  ............     0.00046
95-48-7........................  Cresol, o-.....................         656          8.4  ............     0.00055       27400  ............       0.027          3.2  ............     0.00055
106-44-5.......................  Cresol, p-.....................        63.5         0.84  ............     0.00046        2550  ............       0.035         0.32  ............     0.00046
4170-30-3......................  Crotonaldehyde.................  ..........  ...........          7.8         0.06  ..........         1210            4  ...........          6.2         0.06
57-12-5........................  Cyanide........................  ..........  ...........        0.159          0.2  ..........       19.955          0.2  ...........        0.105          0.2
14901-08-7.....................  Cycasin........................  ..........  ...........         14.7   ..........  ..........         6900   ..........  ...........         10.5   ..........
108-94-1.......................  Cyclohexanone..................  ..........  ...........          7.8           10  ..........         1210           10  ...........          6.2           10
131-89-5.......................  Cyclohexyl-4,6-dinitrophenol, 2- ..........  ...........       0.0252          0.1  ..........        2.991            7  ...........       0.0083          0.1
                                  .                                                                                                                                                             
50-18-0........................  Cyclophosphamide...............  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
20830-81-3.....................  Daunomycin.....................  ..........  ...........         14.7   ..........  ..........         6900   ..........  ...........         10.5   ..........
72-54-8........................  DDD............................    0.000126       913000  ............     0.00005     0.00648  ............      0.0012         2800  ............     0.00005
53-19-0........................  DDD (o,p').....................  ..........  ...........    0.0069415   ..........  ..........        0.194   ..........  ...........         0.54   ..........
72-55-9........................  DDE............................   9.110E-06        0.228  ............    0.000058    0.000936  ............      0.0006    0.0000623  ............    0.000058
3424-82-6......................  DDE (o,p').....................  ..........  ...........    0.0069415   ..........  ..........        0.194   ..........  ...........         0.54   ..........

[[Page 66434]]
                                                                                                                                                                                                
50-29-3........................  DDT............................   0.0000181         20.4  ............    0.000081     0.00315  ............      0.0006       0.0054  ............    0.000081
789-02-6.......................  DDT (o,p').....................  ..........  ...........    0.0069415   ..........  ..........        0.194   ..........  ...........         0.54   ..........
2303-16-4......................  Diallate.......................        0.26         90.1  ............     0.00063        1.26  ............       0.023         0.46  ............     0.00063
132-64-9.......................  Dibenzofuran...................  ..........  ...........          8.4         0.01  ..........        27400          0.7  ...........          1.8         0.01
192-65-4.......................  Dibenzo[a,e]pyrene.............  ..........  ...........      0.00285        0.001  ..........          3.9          0.7  ...........      0.00119        0.001
189-64-0.......................  Dibenzo[a,h]pyrene.............  ..........  ...........      0.00285       0.0002  ..........          3.9         0.01  ...........      0.00119       0.0002
189-55-9.......................  Dibenzo[a,i]pyrene.............  ..........  ...........      0.00285       0.0002  ..........          3.9         0.01  ...........      0.00119       0.0002
194-59-2.......................  Dibenzo[c,g]carbazole, 7H-.....  ..........  ...........      0.00285         0.01  ..........          3.9          0.7  ...........      0.00119         0.01
226-36-8.......................  Dibenz(a,h)acridine............  ..........  ...........      0.00285       0.0002  ..........          3.9         0.01  ...........      0.00119       0.0002
53-70-3........................  Dibenz(a,h)anthracene..........   8.440E-06      0.00176  ............     0.00003    0.000155  ............       0.084    6.340E-07  ............     0.00003
                  224-42-0.....  Dibenz[a,j]acridine............  ..........  ...........      0.00285        0.001  ..........          3.9          0.7  ...........      0.00119        0.001
                  96-12-8......  Dibromo-3-chloropropane, 1,2-..      0.0723       0.0022  ............     0.00026       0.663  ............      0.0003      0.00038  ............     0.00026
                  864-41-0.....  Dichloro-2-butene, 1,4-........  ..........  ...........       0.0241        0.005  ..........        30.85        0.005  ...........       0.0115        0.005
                  110-57-6.....  Dichloro-2-butene, trans-1,4-..  ..........  ...........       0.0241        0.005  ..........        30.85        0.005  ...........       0.0115        0.005
                  96-23-1......  Dichloro-2-propanol, 1,3-......  ..........  ...........         0.27         0.01  ..........          142         0.05  ...........        0.033         0.01
                  95-50-1......  Dichlorobenzene, 1,2-..........        15.4          7.8  ............     0.00003       50000  ............      0.0002         1.62  ............     0.00003
                  541-73-1.....  Dichlorobenzene, 1,3-..........  ..........  ...........       0.0241        0.005  ..........        30.85          0.7  ...........       0.0115        0.005
                  106-46-7.....  Dichlorobenzene, 1,4-..........        3.01         1.12  ............     0.00004        63.9  ............      0.0001        0.216  ............     0.00004
                  91-94-1......  Dichlorobenzidine, 3,3'-.......      0.0037       0.0042  ............      0.0024      0.0524  ............       0.116      0.00072  ............      0.0024
                  75-71-8......  Dichlorodiflouromethane........        14.7         35.7  ............      0.0001        8070  ............      0.0052         11.9  ............      0.0001
                  75-34-3......  Dichloroethane, 1,1-...........        37.4      0.00016  ............     0.00004        24.2  ............      0.0002      0.00006  ............     0.00004
                  107-06-2.....  Dichloroethane, 1,2-...........     0.00698       0.0475  ............     0.00006         6.1  ............      0.0001        0.009  ............     0.00006
                  75-35-4......  Dichloroethylene, 1,1-.........     0.00345       0.0413  ............     0.00012        2.55  ............      0.0014       0.0216  ............     0.00012
                  156-59-2.....  Dichloroethylene, cis-1,2-.....       30000        0.294  ............      000012        5400  ............        0.02        0.112  ............     0.00012
                  156-60-5.....  Dichloroethylene, trans-1,2-...       44200         0.42  ............     0.00006       13800  ............      0.0006         0.16  ............     0.00006
                  111-91-1.....  Dichloromethoxyethane..........  ..........  ...........       0.0241         0.01  ..........        30.85          0.7  ...........       0.0115         0.01
                  98-87-3......  Dichloromethylbenezene (benzal   ..........  ...........       0.0241        0.005  ..........        30.85          0.3  ...........       0.0115        0.005
                                  chloride).                                                                                                                                                    
                  120-83-2.....  Dichlorophenol, 2,4-...........        6.94         0.62  ............     0.00041         769  ............      0.0788         0.18  ............     0.00041
                  87-65-0......  Dichlorophenol, 2,6-...........  ..........  ...........       0.0241         0.01  ..........        30.85          0.7  ...........       0.0115         0.01
                  94-75-7......  Dichlorophenoxyacetic acid, 2,4-       58.5        0.273  ............     0.00029        3140  ............     0.00011        0.105  ............     0.00029
                                   (2,4-D).                                                                                                                                                     
                  78-87-5......  Dichloropropane, 1,2-..........       0.303        0.115  ............     0.00004        16.9  ............      0.0001       0.0115  ............     0.00004
                  542-75-6.....  Dichloropropene, 1,3-..........     0.00476       0.0028  ............      0.0009        32.4  ............      0.0003      0.00085  ............      0.0009
                  10061-91-5...  Dichloropropene, cis-1,3-......     0.00485        90000  ............     0.00069        2.64  ............      0.0003         1150  ............     0.00069
                  10061-02-6...  Dichloropropene, trans-1,3-....      0.0049        90000  ............     0.00094        2.67  ............      0.0003         1150  ............     0.00094
                  60-57-1......  Dieldrin.......................    0.000059          682  ............    0.000044     0.00176  ............      0.0006         0.54  ............    0.000044
                  1464-53-5....  Diepoxybutane, 1,2,3,4- (2,2'-   ..........  ...........         14.7        0.005  ..........         6900        0.005  ...........         10.5        0.005
                                  bioxirane.                                                                                                                                                    
                  84-66-2......  Diethl phthalate...............        3560          186  ............     0.00025        4490  ............       0.022           54  ............     0.00025
                  311-45-5.....  Diethyl-p-nitrophenyl phosphate  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
                  56-53-1......  Diethylstillbestrol............   7.710E-07   4.2900E-07  ............      0.0078   2.470E-11  ............           1    6.500E-08  ............      0.0078
                  94-58-6......  Dihydrosafrole.................  ..........  ...........         14.7         0.05  ..........         6900            3  ...........         10.5         0.05
                  60-51-5......  Dimethoate.....................        38.1         29.4  ............     0.00029         1.6  ............      0.0691         0.77  ............     0.00029
                  131-11-3.....  Dimethyl phthalate.............      200000           78  ............     0.00064           3  ............       0.013           30  ............     0.00064
                  77-78-1......  Dimethyl sulfate...............  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4           60
                  60-11-7......  Dimethylaminoazobenzene, p-....  ..........  ...........      0.02762         0.01  ..........         3.28          0.7  ...........      0.00884         0.01
                  119-93-7.....  Dimethylbenzidine, 3,3'-.......    0.000625    0.0000702  ............      0.0033     0.00062  ............         0.7     0.000018  ............      0.0033
                  57-97-6......  Dimethylbenz(a)anthracene, 7,12-  3.820E-06      0.00464  ............     0.00037     0.00263  ............       0.039    2.760E-06  ............     0.00037
                                  .                                                                                                                                                             
79-44-7........................  Dimethylcarbamoyl chloride.....  ..........  ...........         0.27   ..........  ..........          142   ..........  ...........        0.033   ..........
122-09-8.......................  Dimethylphenethylamine, alpha,   ..........  ...........        0.159         0.05  ..........       19.955            3  ...........        0.105         0.05
                                  alpha-.                                                                                                                                                       
105-67-9.......................  Dimethylphenol,2,4-............         151         3.78  ............     0.00047       11300  ............       0.052         1.19  ............     0.00047
119-90-4.......................  Dimethyloxybenzidine,3,3'-.....        1.78       0.0336  ............      0.0077       0.236  ............           7       0.0102  ............      0.0077
84-74-2........................  Di-n-butyl phthalate...........         883          900  ............     0.00033       90000  ............       0.249          100  ............     0.00033
99-65-0........................  Dinitrobenzene,1,3-............        1.28       0.0168  ............     0.00011        5.54  ............        0.25       0.0064  ............     0.00011
100-25-4.......................  Dinitrobenzene,1,4-............  ..........  ...........       0.0252         0.04  ..........        2.991            3  ...........       0.0083         0.04
534-52-1.......................  Dinitro-o-cresol,4,6-..........  ..........  ...........       0.0252         0.05  ..........        2.991            3  ...........       0.0083         0.05
51-28-5........................  Dinitrophenol,2,4-.............        50.2        0.273  ............     0.00042        56.1  ............        0.03        0.105  ............     0.00042
121-14-2.......................  Dinitrotoluene,2,4-............        10.7        0.294  ............     0.00002         213  ............        0.26        0.112  ............     0.00002
606-20-2.......................  Dinitrotoluene,2,6-............        12.9        0.168  ............     0.00031        86.3  ............        0.25        0.064  ............     0.00031
117-84-0.......................  Di-n-octyl phthalate...........       0.002         1260  ............    0.000042        4480  ............       0.139          0.1  ............    0.000042
123-91-1.......................  Dioxane,1,4-...................         558       0.0424  ............       0.012        13.2  ............      0.0005       0.0136  ............       0.012
122-39-4.......................  Diphenylamine..................          29         14.7  ............     0.00151       11800  ............       0.041          2.6  ............     0.00151
122-66-7.......................  Diphenylhydrazine,1,2-.........  ..........  ...........        0.159         0.01  ..........       19.955          0.7  ...........        0.105         0.01
298-04-4.......................  Disulfoton.....................      0.0131          458  ............     0.00007        42.6  ............      0.0035           13  ............     0.00007
541-53-7.......................  Dithiobiuret...................  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
115-29-7.......................  Endosulfan.....................        6.62            6  ............     0.00004        73.1  ............      0.0005         0.94  ............     0.00004
959-98-8.......................  Endosulfan I...................  ..........  ...........    0.0069415       0.0003  ..........        0.194        0.009  ...........         0.54       0.0003
33213-65-9.....................  Endosulfan II..................  ..........  ...........    0.0069415       0.0004  ..........        0.194        0.003  ...........         0.54      0.0004 

[[Page 66435]]
                                                                                                                                                                                                
1031-07-8......................  Endosulfan sulfate.............  ..........  ...........    0.0069415       0.0004  ..........        0.194         0.04  ...........         0.54       0.0004
145-73-3.......................  Endothall......................  ..........  ...........    0.0069415          0.1  ..........        0.194   ..........  ...........         0.54          0.1
72-20-8........................  Endrin.........................      0.0729         4800  ............     0.00039        0.26  ............      0.0036           24  ............     0.00039
7421-93-4......................  Endrin aldehyde................  ..........  ...........    0.0069415       0.0005  ..........        0.194         0.02  ...........         0.54       0.0005
53494-70-5.....................  Endrin ketone..................  ..........  ...........    0.0069415       0.0005  ..........        0.194         0.03  ...........         0.54       0.0005
106-89-8.......................  Epichlorohydrin................       0.335       414000  ............     0.06519          44  ............      0.0714         5400  ............     0.06519
51-43-4........................  Epinephrine....................  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
110-80-5.......................  Ethoxyethanol,2-...............        14.7           39  ............        1.16        6900  ............        2.03           15  ............        1.16
141-78-6.......................  Ethyl acetate..................  ..........          390  ............       0.009      272000  ............        0.18          114  ............       0.009
51-79-6........................  Ethyl carbamate................  ..........          390         14.7         0.05  ..........         6900            3  ...........         10.5         0.05
107-12-0.......................  Ethyl cyanide (propionitrile)..  ..........  ...........        0.159          0.1  ..........       19.955          0.1  ...........        0.105          0.1
60-29-7........................  Ethyl ether....................  ..........         27.3  ............     0.00153       41200  ............     0.00319         10.5  ............     0.00153
97-63-2........................  Ethyl methacrylate.............       25500           24  ............     0.00345        3420  ............      0.0011          6.6  ............     0.00345
62-50-0........................  Ethyl methanesulfonate.........      0.0055       930000  ............     0.00106     0.00133  ............       0.018        11700  ............     0.00106
100-41-4.......................  Ethylbenzene...................        74.5          8.4  ............     0.00006      550000  ............      0.0002         1.75  ............     0.00006
106-93-4.......................  Ethylene Dibromide.............    0.000928        0.018  ............     0.00006     0.00745  ............      0.0001      0.00075  ............     0.00006
75-21-8........................  Ethylene oxide.................  ..........  ...........         14.7        0.001  ..........         6900         0.07  ...........         10.5        0.001
96-45-7........................  Ethylene thiourea..............        17.7      0.00053  ............  ..........        0.51  ............  ..........      0.00017  ............  ..........
151-56-4.......................  Ethyleneimine (azirindine).....  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
52-85-7........................  Famphur........................  ..........  ...........    0.0069415         0.02  ..........        0.194            1  ...........         0.54         0.02
640-19-7.......................  Fluoracetamide, 2-.............  ..........  ...........       0.0241   ..........  ..........        30.85   ..........  ...........       0.0115   ..........
62-74-8........................  Fluoracetic acid, sodium salt..  ..........  ...........    0.0069415   ..........  ..........        0.194   ..........  ...........         0.54   ..........
206-44-0.......................  Fluoranthene...................        1580         27.5  ............     0.00021        5970  ............       0.084         1.74  ............     0.00021
86-73-7........................  Fluorene.......................        1310         22.4  ............     0.00021       89800  ............        0.08          3.4  ............     0.00021
16984-48-8.....................  Fluoride.......................  ..........  ...........            0         0.05  ..........            0   ..........  ...........            0         0.05
50-00-0........................  Formaldehyde...................      0.0158         27.3  ............      0.0232        48.8  ............           4         10.5  ............      0.0232
64-18-6........................  Formic Acid....................  ..........          273  ............         0.2      301000  ............          10          105  ............         0.2
765-34-4.......................  Glycidylaldehyde...............  ..........  ...........          7.8   ..........  ..........         1210   ..........  ...........          6.2   ..........
319-86-8.......................  HCH, delta-....................  ..........  ...........    0.0069415       0.0002  ..........        0.194       0.0006  ...........         0.54       0.0002
76-44-8........................  Heptachlor.....................   0.0000237  ...........  ............     0.00004        7.79  ............      0.0008  ...........  ............     0.00004
1024-57-3......................  Heptachlor epoxide.............    0.000528        17400  ............    0.000032      0.0264  ............      0.0006           66  ............    0.000032
87-68-3........................  Hexachloro-1,3-butadiene.......     0.00788       0.0806  ............      0.0001        36.4  ............       0.046      0.00691  ............      0.0001
118-74-1.......................  Hexachlorobenzene..............    0.000424          3.6  ............     0.00161      0.0116  ............      0.0723        0.018  ............     0.00161
319-84-6.......................  Hexachlorocyclohexane, alpha-      0.000142           21  ............    0.000035      0.0333  ............      0.0008         0.11  ............    0.000035
                                  (alpha-BHC).                                                                                                                                                  
319-85-7.......................  Hexachlorocyclohexane, beta-       0.000445       0.0013  ............    0.000023        0.12  ............      0.0006      0.00021  ............    0.000023
                                  (beta-BHC).                                                                                                                                                   
58-89-9........................  Hexachlorocyclohexane, gamma-      0.000783          340  ............    0.000025       0.102  ............       0.002         1.98  ............    0.000025
                                  (Lindane).                                                                                                                                                    
77-47-4........................  Hexachlorocyclopentadiene......     0.00521  ...........  ............     0.00018        1450  ............       0.092  ...........  ............     0.00018
67-72-1........................  Hexachloroethane...............       0.049        0.212  ............   1.600E-06        80.6  ............      0.0206        0.033  ............   1.600E-06
70-30-4........................  Hexachlorophene................   5.150E-06       0.0521  ............       0.207   0.0000241  ............        1.87      0.00136  ............       0.207
1888-71-7......................  Hexachloropropene..............  ..........  ...........         0.27         0.01  ..........          142          0.7  ...........        0.033         0.01
757-58-4.......................  Hexaethyl tetraphosphate.......  ..........  ...........         14.7   ..........  ..........         6900   ..........  ...........         10.5   ..........
591-78-6.......................  Hexanone, 2-...................  ..........  ...........          7.8        0.005  ..........         1210        0.005  ...........          6.2        0.005
302-01-2.......................  Hydrazine......................  ..........  ...........        0.159   ..........  ..........       19.955          0.3  ...........        0.105   ..........
193-39-5.......................  Indeno(1,2,3-cd) pyrene........     0.00285       0.0165  ............    0.000043         3.9  ............      0.0748    0.0000241  ............    0.000043
74-88-4........................  Iodomethane....................  ..........  ...........       0.0241        0.005  ..........        30.85        0.005  ...........       0.0115        0.005
78-83-1........................  Isobutyl alcohol...............      180000           39  ............       0.011       55200  ............      0.0035           15  ............       0.011
465-73-6.......................  Isodrin........................  ..........  ...........    0.0069415         0.02  ..........        0.194            1  ...........         0.54         0.02
78-59-1........................  Isophorone.....................        78.6        0.531  ............        0.01         743  ............      0.0719        0.162  ............        0.01
120-58-1.......................  Isosafrole.....................  ..........  ...........         14.7         0.01  ..........         6900          0.7  ...........         10.5         0.01
143-50-0.......................  Kepone.........................   0.0000264      0.00022  ............       0.016    0.000277  ............       0.097     0.000032  ............       0.016
303-43-4.......................  Lasiocarpine...................  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
7439-92-1......................  Lead...........................      907000           30  ............        0.01         568  ............           2           12  ............        0.01
108-31-6.......................  Maleic anhydride...............  ..........  ...........         14.7   ..........  ..........         6900         0.07  ...........         10.5   ..........
123-33-1.......................  Maleic hydrazide...............  ..........  ...........        0.159         0.05  ..........       19.955            3  ...........        0.105         0.05
109-77-3.......................  Malononitrile..................  ..........  ...........        0.159          0.1  ..........       19.955          0.5  ...........        0.105          0.1
148-82-3.......................  Melphalan......................  ..........  ...........         14.7   ..........  ..........         6900   ..........  ...........         10.5   ..........
7439-97-6......................  Mercury........................         125       0.0596  ............     0.00009       0.598  ............         0.1        0.023  ............     0.00009
126-98-7.......................  Methacrylonitrile..............      0.0708       0.1056  ............       0.009        8.91  ............      0.0005        0.006  ............       0.009
74-93-1........................  Methanethiol...................  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
67-56-1........................  Methanol.......................  ..........           78  ............       0.021      138000  ............        0.46           30  ............       0.021
91-80-5........................  Methapyrilene..................  ..........  ...........        0.159          0.1  ..........       19.955            7  ...........        0.105          0.1
16752-77-5.....................  Methomyl.......................  ..........  ...........    0.0069415         0.05  ..........        0.194            3  ...........         0.54         0.05
72-43-5........................  Methoxychlor...................        6.73  ...........  ............    0.000086        19.4  ............      0.0057  ...........  ............    0.000086
74-83-9........................  Methyl bromide (Bromomethane)..        0.37         3.12  ............     0.00011         504  ............        0.02         0.92  ............     0.00011
74-87-3........................  Methyl chloride (Chloromethane)      0.0959  ...........  ............     0.00013        90.8  ............        0.02  ...........  ............     0.00013
78-93-3........................  Methyl ethyl ketone............         141           78  ............        0.01      112000  ............     0.00834           30  ............        0.01
1338-23-4......................  Methyl ethyl ketone peroxide...  ..........  ...........          7.8   ..........  ..........         1210   ..........  ...........          6.2   ..........
60-34-4........................  Methyl hydrazine...............  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........

[[Page 66436]]
                                                                                                                                                                                                
108-10-1.......................  Methyl isobutyl ketone.........        10.3          7.8  ............     0.00083       17000  ............     0.00315            3  ............     0.00083
80-62-6........................  Methyl methacrylate............       69900         28.2  ............       0.005       39500  ............      0.0027          8.1  ............       0.005
66-27-3........................  Methyl methanesulfonate........  ..........  ...........      0.11775         0.01  ..........         1.66          0.7  ...........          6.4         0.01
91-57-6........................  Methyl naphthalene, 2-.........  ..........  ...........      0.00285         0.01  ..........          3.9          0.7  ...........      0.00119         0.01
298-00-0.......................  Methyl parathion...............       0.662           78  ............        0.01        1.43  ............       0.691         23.4  ............        0.01
75-55-8........................  Methylazinidine, 2-............  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
56-49-5........................  Methylcholanthrene, 3-.........   9.880E-06       0.0117  ............        0.01    0.000128  ............       0.046    1.410E-06  ............        0.01
74-95-3........................  Methylene bromide..............       11700        0.029  ............     0.00024        8400  ............      0.0001       0.0085  ............     0.00024
75-09-2........................  Methylene chloride.............       0.376        0.039  ............     0.00026         306  ............        0.02         0.09  ............     0.00026
101-14-4.......................  Methylenegbis, 4,4'-(2-          ..........  ...........      0.02762   ..........  ..........         3.28   ..........  ...........      0.00884   ..........
                                  chloraoniline).                                                                                                                                               
70-25-7........................  Methyl-nitro-nitrosoguanidine    ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
                                  (MNNG).                                                                                                                                                       
56-04-2........................  Methylthiouracil...............  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
50-07-7........................  Mitomycin C....................  ..........  ...........         14.7   ..........  ..........         6900   ..........  ...........         10.5   ..........
7439-98-7......................  Molybdenum.....................      121000         1.83  ............       0.001         114  ............         0.3         1.83  ............       0.001
91-20-3........................  Naphthalene....................         385           14  ............      0.0018      120000  ............      0.0665          2.7  ............      0.0018
130-15-4.......................  Naphthoquinone, 1,4-...........  ..........  ...........         14.7         0.01  ..........         6900          0.7  ...........         10.5         0.01
86-88-4........................  Naphthyl-2-thiourea, 1-........  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
134-32-7.......................  Naphthylamine, 1-..............  ..........  ...........        0.159         0.01  ..........       19.995          0.7  ...........        0.105         0.01
91-59-8........................  Naphthylamine, 2-..............  ..........  ...........        0.159         0.01  ..........       19.955          0.7  ...........        0.105         0.01
7440-02-0......................  Nickel.........................        5040         4.38  ............       0.005         106  ............           1         2.04  ............       0.005
54-11-5........................  Nicotine and salts.............  ..........  ...........        0.159         0.02  ..........       19.955            1  ...........        0.105         0.02
88-74-4........................  Nitroaniline, 2-...............  ..........  ...........      0.02762         0.05  ..........         3.28            3  ...........      0.00884         0.05
99-09-2........................  Nitroaniline, 3-...............  ..........  ...........      0.02762         0.05  ..........         3.28            3  ...........      0.00884         0.05
100-01-6.......................  Nitroaniline, 4-...............  ..........  ...........      0.02762         0.02  ..........         3.28            1  ...........      0.00884         0.02
98-95-3........................  Nitrobenzene...................       0.345        0.084  ............      0.0064        44.8  ............      0.0544        0.032  ............      0.0064
55-86-7........................  Nitrogen mustard...............  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
51-75-2........................  Nitrogen mustard hydrochloride   ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
                                  salt.                                                                                                                                                         
126-85-2.......................  Nitrogen mustard N-Oxide.......  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
302-70-5.......................  Nitrogen mustard N-Oxide, HCI    ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
                                  salt.                                                                                                                                                         
55-63-0........................  Nitroglycerine.................  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
99-55-8........................  Nitro-o-toluidine, 5-..........  ..........  ...........      0.02762         0.01  ..........         3.28          0.7  ...........      0.00884         0.01
88-75-5........................  Nitrophenol, 2-................  ..........  ...........       0.0252         0.01  ..........        2.991          0.7  ...........       0.0083         0.01
100-02-7.......................  Nitrophenol, 4-................  ..........  ...........       0.0252         0.05  ..........        2.991            3  ...........       0.0083         0.05
79-46-9........................  Nitropropane, 2-...............     0.00019  ...........  ............     0.00577       0.128  ............      0.0022  ...........  ............     0.00577
56-57-5........................  Nitroquinoline-1-oxide, 4-.....  ..........  ...........        0.159         0.04  ..........       19.955            3  ...........        0.105         0.04
55-18-5........................  Nitrosodiethylamine............   0.0000406   3,1800E-06  ............       0.002     0.00064  ............           1    1.020E-06  ............     0.00262
62-75-9........................  Nitrosodimethylamine...........    0.000268    0.0000106  ............      0.0006     0.00245  ............       0.074    3.400E-06  ............      0.0006
924-16-3.......................  Nitrosodi-n-butylamine.........    0.000279     0.000122  ............        0.06       0.094  ............        0.03     0.000036  ............        0.06
10595-95-6.....................  Nitrosomethylethylamine........       0.129     0.000212  ............       0.028     0.00244  ............       0.016    6.800E-06  ............       0.028
1116-54-7......................  N-Nirtrosodiethanolamine.......  ..........  ...........    0.0000371         0.01  ..........     0.012875          0.7  ...........    0.0000119         0.01
621-64-7.......................  N-Nitrosodi-n-propylamine......      0.0644     0.000053  ............       0.026      0.0233  ............      0.0144     0.000017  ............       0.026
86-30-6........................  N-Nitrosodiphenylamine.........        7.54          0.2  ............        0.05        1270  ............      0.0846        0.046  ............        0.05
4549-40-0......................  N-Nitrosomethyl vinyl amine....  ..........  ...........    0.0000371   ..........  ..........     0.012875   ..........  ...........    0.0000119   ..........
59-89-2........................  N-Nitrosomorpholine............  ..........  ...........        0.159         0.05  ..........       19.955            3  ...........        0.105         0.05
759-73-9.......................  N-Nitroso-N-ethylurea..........  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
684-93-5.......................  N-Nitroso-N-methylurea.........  ..........  ...........        0.159         0.01  ..........       19.955          0.7  ...........        0.105         0.01
615-53-2.......................  N-Nitroso-N-methylurethane.....  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
16543-55-8.....................  N-Nitrosonornicotine...........  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
100-75-4.......................  N-Nitrosopiperidine............      0.0106    0.0000106  ............     0.00135     0.00247  ............       0.033    3.400E-06  ............     0.00135
930-55-2.......................  N-Nitrosopyrrolidine...........       0.101     0.000212  ............      0.0047      0.0534  ............       0.042     0.000068  ............      0.0047
13256-22-9.....................  N-Nitrososarcosine.............  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
103-85-5.......................  N-Phenylthiourea...............  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
1615-80-1......................  N,N-Diethylhydrazine...........  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
152-16-9.......................  Octamethylpyrophosphoramide....        7310        0.273  ............      0.0053          31  ............       0.146        0.105  ............      0.0053
20816-12-0.....................  Osmium tetroxide...............  ..........  ...........        0.618            3  ..........         8.72          200  ...........        0.194            3
297-97-2.......................  O,O-Diethyl O-pyrazinyl          ..........  ...........       0.1175         0.02  ..........         1.66            1  ...........           64          002
                                  phosphorothioate.                                                                                                                                             
126-68-1.......................  O,O,O-Triethyl phosphorothioate  ..........  ...........      0.11775         0.05  ..........         1.66            3  ...........          6.4         0.05
123-63-7.......................  Paraldehyde....................  ..........  ...........          7.8            1  ..........         1210           70  ...........          6.2            1
56-38-2........................  Parathion......................        2.63       440000  ............      0.0005       0.128  ............       0.025        11600  ............      0.0005
608-93-5.......................  Pentachlorobenzene.............        7.86         5.15  ............    0.000038         205  ............        0.02       0.0543  ............    0.000038
76-01-7........................  Pentachloroethane..............  ..........  ...........       0.0241        0.005  ..........        30.85         0.01  ...........       0.0115        0.005
82-68-8........................  Pentachloronitrobenzene (PCNB).        13.9         0.27  ............        0.02        11.4  ............       0.052        0.018  ............        0.02
87-86-5........................  Pentachlorophenol..............       0.301      0.00204  ............     0.00008        2.92  ............      0.1222      0.00041  ............     0.00008
62-44-2........................  Phenacetin.....................  ..........  ...........         14.7         0.02  ..........         6900            1  ...........         10.5         0.02
85-01-8........................  Phenanthrene...................  ..........  ...........      0.00285        0.006  ..........          3.9          0.7  ...........      0.00119        0.006
108-95-2.......................  Phenol.........................       19300           84  ............     0.00028      163000  ............      0.2185           32  ............     0.00028
62-38-4........................  Phenyl mercuric acetate........       0.506       0.0117  ............  ..........     0.00932  ............  ..........       0.0045  ............  ..........

[[Page 66437]]
                                                                                                                                                                                                
25265-76-3.....................  Phenylenediamines (N.O.S.).....  ..........  ...........        0.159         0.01  ..........       19.955          0.7  ...........        0.105         0.01
108-45-2.......................  Phenylenediamine, m-...........        5440         0.78  ............      0.0174         784  ............         0.7          0.3  ............      0.0174
106-50-3.......................  Phenylenediamine, p-...........  ..........  ...........        0.159         0.01  ..........       19.955          0.7  ...........        0.105         0.01
298-02-2.......................  Phorate........................       0.106  ...........  ............     0.00004         157  ............       0.002  ...........  ............     0.00004
298-06-6.......................  Phosphorodithioic acid, o-o-     ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
                                  diethyl ester.                                                                                                                                                
3288-58-2......................  Phosphorodithioic acid, o-o-     ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
                                  diethyl-s-methyl.                                                                                                                                             
2953-29-9......................  Phosphorodithioic acid,          ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
                                  trimethyl ester.                                                                                                                                              
85-44-9........................  Phthalic anhydride.............  ..........  ...........          132   ..........  ..........       2352.5            7  ...........           42   ..........
109-06-8.......................  Picoline, 2-...................  ..........  ...........        0.159        0.001  ..........       19.955         0.07  ...........        0.105        0.001
1336-36-3......................  Polychlorinated biphenyls......    0.000286         11.5  ............      0.0005     0.00596  ............        0.04        0.009  ............      0.0005
23950-58-5.....................  Pronamide......................        80.3         21.3  ............     0.00145         438  ............       0.097          5.7  ............     0.00145
1120-71-4......................  Propane sultone, 1,3-..........  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
107-10-8.......................  Propylamine, n-................  ..........  ...........        0.159        0.005  ..........       19.955        0.005  ...........        0.105        0.005
51-52-5........................  Propylthiouracil...............  ..........  ...........      0.11775          0.1  ..........         1.66            7  ...........          6.4          0.1
107-19-7.......................  Propyn-1-ol, 2-................  ..........  ...........           39         0.01  ..........        36700         0.05  ...........           15         0.01
129-00-0.......................  Pyrene.........................        3040         54.1  ............     0.00027       15800  ............      0.0726         1.69  ............     0.00027
110-86-1.......................  Pyridine.......................       0.522        0.156  ............       0.011         814  ............         0.2         0.06  ............       0.011
50-55-5........................  Reserpine......................  ..........  ...........        0.159         0.05  ..........       19.955            3  ...........        0.105         0.05
108-46-3.......................  Resorcinol.....................  ..........  ...........    0.0069415          0.1  ..........        0.194            7  ...........         0.54          0.1
81-07-2........................  Saccharin and salts............  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
94-59-7........................  Safrole........................      0.0829       0.0035  ............      0.0021        10.5  ............       0.015      0.00095  ............      0.0021
7782-49-2......................  Selenium.......................         822        0.232  ............      0.0006        1.94  ............           5       0.0892  ............      0.0006
7440-22-4......................  Silver.........................         199  ...........  ............      0.0005       1.134  ............         0.3  ...........  ............      0.0005
18883-66-4.....................  Streptozotocin.................  ..........  ...........         14.7   ..........  ..........         6900   ..........  ...........         10.5   ..........
57-24-9........................  Strychnine.....................        3.34        0.045  ............      0.0084      0.0041  ............           3        0.016  ............      0.0084
100-42-5.......................  Stryene........................        75.7         0.91  ............     0.00004      629000  ............       0.004         0.22  ............     0.00004
18496-25-8.....................  Sulfide........................  ..........  ...........            0            2  ..........            0            2  ...........            0            2
1746-01-6......................  TCDD, 2,3,7,8-.................   1.050E-09      0.00057  ............   1.000E-08    7.80E-06  ............   1.000E-06    5.400E-07  ............   1.000E-08
95-94-3........................  Tetrachlorobenzene, 1,2,4,5-...        14.8        0.234  ............     0.00141         168  ............       0.034       0.0317  ............     0.00141
630-20-6.......................  Tetrachloroethane, 1,1,1,2-....      0.0241        0.075  ............     0.00005         133  ............      0.0001       0.0078  ............     0.00005
79-34-5........................  Tetrachloroethane, 1,1,2,2-....      0.0037        0.024  ............      0.0002        29.3  ............      0.0002       0.0077  ............      0.0002
127-18-4.......................  Tetrachloroethylene............       15600       0.0255  ............     0.00014       13300  ............      0.0007       0.0085  ............     0.00014
58-90-2........................  Tetrachlorophenol, 2,3,4,6-....        2720         1.89  ............     0.00062        6150  ............        0.04         0.58  ............     0.00062
107-49-3.......................  Tetraethyl pyrophosphate.......  ..........  ...........         14.7   ..........  ..........         6900            3  ...........         10.5   ..........
3689-24-5......................  Tetraethyldithiopyrophosphate..        0.23  ...........  ............    0.000058        2.81  ............      0.0039  ...........  ............    0.000058
7440-28-0......................  Thallium (l)...................         646       0.0353  ............      0.0007        5.12  ............           3        0.014  ............      0.0007
62-55-5........................  Thioacetamide..................  ..........  ...........        0.159            1  ..........       19.955   ..........  ...........        0.105            1
39196-18-4.....................  Thiofanox......................  ..........  ...........      0.11775         0.05  ..........         1.66            3  ...........          6.4         0.05
108-98-5.......................  Thiophenol.....................  ..........  ...........      0.11775         0.02  ..........         1.66            1  ...........          6.4         0.02
79-19-6........................  Thiosemicarbazide..............  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
62-56-6........................  Thiourea.......................  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
137-26-8.......................  Thiram.........................  ..........  ...........    0.0069415         0.05  ..........        0.194            3  ...........         0.54         0.05
7440-31-5......................  Tin............................  ..........  ...........        0.618            8  ..........         8.72          500  ...........        0.194            8
108-88-3.......................  Toluene........................        29.8          5.9  ............     0.00011      176000  ............      0.0002          1.8  ............     0.00011
584-84-9.......................  Toluene diisocyanate...........  ..........  ...........        0.159   ..........  ..........       19.955            7  ...........        0.105   ..........
95-80-7........................  Toluenediamine, 2,4-...........       0.211     0.000159  ............      0.0134      0.0101  ............           1     0.000051  ............      0.0134
823-40-5.......................  Toluenediamine, 2,6-...........  ..........  ...........        0.159         0.02  ..........       19.955            1  ...........        0.105         0.02
496-72-0.......................  Toluenediamine, 3,4-...........  ..........  ...........        0.159         0.02  ..........       19.955            1  ...........        0.105         0.02
636-21-5.......................  Toluidine hydrochloride, o-....  ..........  ...........        0.159         0.01  ..........       19.955          0.7  ...........        0.105         0.01
95-53-4........................  Toluidine, o-..................       0.441      0.00224  ............      0.0121        2.35  ............       0.029      0.00068  ............      0.0121
106-49-0.......................  Toluidine, p-..................       0.703      0.00224  ............      0.0168       0.128  ............       0.043      0.00068  ............      0.0168
8001-35-2......................  Toxaphene......................    0.000364         1170  ............     0.00127    0.000176  ............      0.0295          6.3  ............     0.00127
76-13-1........................  Trichloro-1,2,2-                       2210         0.77  ............     0.00108  ..........  ............     0.00114        0.168  ............     0.00108
                                  trifluoroethane, 1,1,2-.                                                                                                                                      
120-82-1.......................  Trichlorobenzene, 1,2,4-.......       0.685         9.31  ............      0.0002        3450  ............      0.0574          1.3  ............      0.0002
71-55-6........................  Trichloroethane, 1,1,1-........        73.9          120  ............     0.00008       48200  ............      0.0002       0.0539  ............     0.00008
79-00-5........................  Trichloroethane, 1,1,2-........      0.0117        0.035  ............      0.0001        11.3  ............       0.004        0.009  ............      0.0001
79-01-6........................  Trichloroethylene..............         138        0.024  ............     0.00019         567  ............      0.0001        0.008  ............     0.00019
75-69-4........................  Trichlorofluoromethane.........        51.4           48  ............     0.00008       25800  ............       0.001           16  ............     0.00008
75-70-7........................  Trichloromethanethiol..........  ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
95-95-4........................  Trichlorophenol, 2,4,5-........        38.8         18.1  ............     0.00049       11500  ............      0.0672          4.2  ............     0.00049
88-06-2........................  Trichlorophenol, 2,4,6-........         0.1       0.0536  ............      0.0004         124  ............      0.0785       0.0152  ............      0.0004
93-76-5........................  Trichlorophenoxyacetic acid,           15.5         1.68  ............     0.00008        63.2  ............      0.0063         0.64  ............     0.00008
                                  2,4,5- (245-T).                                                                                                                                               
93-72-1........................  Trichlorophenoxypropionic acid,        9.72         0.21  ............     0.00008        6.36  ............     0.00028         0.08  ............     0.00008
                                  2,4,5- (Silvex).                                                                                                                                              
96-18-4........................  Trichloropropane, 1,2,3-.......         707          1.1  ............     0.00032         872  ............      0.0009         0.34  ............     0.00032
99-35-4........................  Trinitrobenzene, sym-..........           3       0.0078  ............     0.00026       0.442  ............        0.25        0.003  ............     0.00026
126-72-7.......................  Tris (2,3-dibromopropyl)           0.000237      0.00252  ............      0.0245       0.357  ............       0.061     0.000099  ............      0.0245
                                  phosphate.                                                                                                                                                    

[[Page 66438]]
                                                                                                                                                                                                
52-24-4........................  Tris(1-azridinyl) phosphine      ..........  ...........      0.11775   ..........  ..........         1.66   ..........  ...........          6.4   ..........
                                  sulfide.                                                                                                                                                      
72-57-1........................  Trypan blue....................  ..........  ...........         14.7   ..........  ..........         6900   ..........  ...........         10.5   ..........
66-75-1........................  Uracil mustard.................  ..........  ...........        0.159   ..........  ..........       19.955   ..........  ...........        0.105   ..........
7440-62-2......................  Vanadium.......................       15800         9.58  ............       0.003         250  ............           1         3.71  ............       0.003
108-05-4.......................  Vinyl acetate..................  ..........  ...........         14.7        0.005  ..........         6900        0.005  ...........         10.5        0.005
75-01-4........................  Vinyl chloride.................     0.00199       0.0078  ............     0.00017        1.23  ............      0.0017        0.003  ............     0.00017
81-81-2........................  Warfarin.......................  ..........  ...........    0.0069415         0.05  ..........        0.194            3  ...........         0.54         0.05
1330-20-7......................  Xylenes (total)................        22.4           88  ............       0.002      172000  ............      0.0002           21  ............       0.002
7440-66-6......................  Zinc...........................       23200           99  ............       0.002         316  ............         0.3         38.4  ............       0.002
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Appendix D

                                  Table D-1.--Comparison Between Modeled Exit Levels and Universal Treatment Standards                                  
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                   Wastewater                            Nonwastewater                  
                                                                           -----------------------------------------------------------------------------
                  CAS                                  Name                  Exit level                Exit level   UTS  (mg/    Exit level             
                                                                               (mg/l)    UTS  (mg/l)    (mg/kg)        kg)         (mg/l)    UTS  (mg/l)
--------------------------------------------------------------------------------------------------------------------------------------------------------
83-32-9...............................  Acenaphthene......................           31        0.059         9500          3.4            5  ...........
67-64-1...............................  Acetone...........................           16         0.28        17000          160            6  ...........
75-05-8...............................  Acetonitrile......................         0.78          5.6          920         *1.8          0.3  ...........
98-86-2...............................  Acetophenone......................           17         0.01         1200          9.7            6  ...........
107-02-8..............................  Acrolein..........................    eqc               0.29  ...........  ...........  ...........  ...........
107-13-1..............................  Acrylonitrile.....................    eqc               0.24         0.96           84    eqc        ...........
107-05-1..............................  Allyl chloride....................        0.074         0.36          260           30  ...........  ...........
62-53-3...............................  Aniline...........................        0.053         0.81            4           14        0.017  ...........
7440-36-0.............................  Antimony..........................         0.14          1.9            9  ...........        0.053          2.1
7440-38-2.............................  Arsenic...........................    eqc                1.4    eqc        ...........    eqc                  5
7440-39-3.............................  Barium............................           33          1.2         2100  ...........           16          7.6
56-55-3...............................  Benz(a)anthracene.................      0.00072        0.059          0.1          3.4    eqc        ...........
71-43-2...............................  Benzene...........................        0.018         0.14          110           10       0.0054  ...........
50-32-8...............................  Benzo(a)pyrene....................       0.0023        0.061         0.23          3.4    eqc        ...........
205-99-2..............................  Benzo(b)fluoranthene..............      0.00081         0.11            4          6.8     0.000066  ...........
7440-41-7.............................  Beryllium.........................      0.00083         0.82    eqc        ...........      0.00032        0.014
39638-32-9............................  Bis (2-chloroisopropyl) ether.....        0.007        0.055         0.94          7.2       0.0019  ...........
111-44-4..............................  Bis(2-chlorethyl)ether............      0.00065        0.033         0.12            6      0.00036  ...........
117-81-7..............................  Bis(2-ethylhexyl)phthalate........      0.00044         0.28          230           28       0.0011  ...........
75-27-4...............................  Bromodichloromethane..............       0.0085         0.35           19           15       0.0025  ...........
75-25-2...............................  Bromoform (Tribromomethane).......        0.064         0.63          170           15        0.018  ...........
71-36-3...............................  Butanol...........................           16          5.6        18000          2.6            6  ...........
88-85-7...............................  Butyl-4,6-dinitrophenol, 2-sec-            0.19        0.066          770          2.5        0.064  ...........
                                         (Dinoseb).                                                                                                     
85-68-7...............................  Butylbenzylphthalate..............          240        0.017           87           28           64  ...........
7440-43-9.............................  Cadmium...........................         0.24         0.69           14  ...........         0.11         0.19
75-15-0...............................  Carbon disulfide..................         0.74          3.8          330  ...........            6          4.8
56-23-5...............................  Carbon tetrachloride..............        0.012        0.057            9            6       0.0016  ...........
57-74-9...............................  Chlordane.........................    eqc             0.0033       0.0098         0.26      0.00016  ...........
126-99-8..............................  Chloro-1,3-butadiene, 2-                   0.52        0.057          290         0.28  ...........  ...........
                                         (Chloroprene).                                                                                                 
106-47-8..............................  Chloroaniline, p-.................         0.42         0.46          140           16         0.16  ...........
108-90-7..............................  Chlorobenzene.....................            2        0.057         2500            6            1  ...........
510-15-6..............................  Chlorobenzilate...................        0.054          0.1  ...........  ...........  ...........  ...........
124-48-1..............................  Chlorodibromomethane..............       0.0066        0.057           28           15       0.0018  ...........
67-66-3...............................  Chloroform........................       0.0076        0.046            7            6        0.017  ...........
95-57-8...............................  Chlorophenol, 2-..................          0.9        0.044          100          5.7         0.32  ...........
7440-47-3.............................  Chromium..........................            1         2.77           10  ...........         0.48         0.86
218-01-9..............................  Chrysene..........................          0.1        0.059           35          3.4       0.0012  ...........
108-39-4..............................  Cresol, m-........................            8         0.77        22000          5.6            3  ...........
95-48-7...............................  Cresol, o-........................            8         0.11        27000          5.6            3  ...........
106-44-5..............................  Cresol, p-........................         0.84         0.77         2600          5.6         0.32  ...........
72-54-8...............................  DDD...............................      0.00013        0.023       0.0065        0.087         2800  ...........
72-55-9...............................  DDE...............................    eqc              0.031      0.00094        0.087     0.000062  ...........
50-29-3...............................  DDT...............................    eqc             0.0039       0.0032        0.087       0.0054  ...........
84-74-2...............................  Di-n-butyl phthalate..............          230        0.057        90000           28           25  ...........
117-84-0..............................  Di-n-octyl phthalate..............        0.002        0.017         4500           28          0.1  ...........
96-12-8...............................  Dibromo-3-choloropropane, 1,2-....      0.00066         0.11         0.66           15    eqc        ...........
95-50-1......
FR Doc. 95-29458 Hazardous Waste Management System: Identification and Listing of Hazardous Waste: Hazardous Waste Identification Rule (HWIR)
.........................  Dichlorobenzene, 1,2-.............           15        0.088        50000            6            6  ...........
106-46-7..............................  Dichlorobenzene, 1,4-.............        0.056         0.09           64            6        0.011  ...........
75-71-8...............................  Dichlorodifluoromethane...........           15         0.23         8100          7.2           12  ...........
75-34-3...............................  Dichloroethane, 1,1-..............      0.00016        0.059           24            6      0.00006  ...........
107-06-2..............................  Dichloroethane, 1,2-..............      0.00016         0.21            6            6      0.00006  ...........
75-35-4...............................  Dichloroethylene, 1,1-............      0.00059        0.025            3            6      0.00018  ...........
156-60-5..............................  Dichloroethylene, trans-1,2-......            3        0.054        14000           30            1  ...........
120-83-2..............................  Dichlorophenol, 2,4-..............         0.62        0.044          770           14         0.18  ...........

[[Page 66439]]
                                                                                                                                                        
94-75-7...............................  Dichlorophenoxyacetic acid, 2,4-              2         0.72         3100           10          0.6  ...........
                                         (2,4-D).                                                                                                       
78-87-5...............................  Dichloropropane, 1,2-.............        0.023         0.85           17           18       0.0023  ...........
10061-01-5............................  Dichloropropene, cis-1,3-.........       0.0049        0.036            3           18         1200  ...........
10061-02-6............................  Dichloropropene, trans-1,3-.......       0.0049        0.036            3           18         1200  ...........
60-57-1...............................  Dieldrin..........................     0.000059        0.017       0.0018         0.13         0.54  ...........
84-66-2...............................  Diethyl phthalate.................          190          0.2         4500           28           54  ...........
131-11-3..............................  Dimethyl phthalate................           78        0.047            3           28           30  ...........
105-67-9..............................  Dimethylphenol,2,4-...............            4        0.036        11000           14            1  ...........
51-28-5...............................  Dinitrophenol,2,4-................         0.27         0.12           56          160         0.11  ...........
121-14-2..............................  Dinitrotoluene,2,4-...............         0.29         0.32          210          140         0.11  ...........
606-20-2..............................  Dinitrotoluene,2,6-...............         0.17         0.55           86           28        0.064  ...........
123-91-1..............................  Dioxane,1,4-......................        0.042          *NA           13          170        0.014  ...........
122-39-4..............................  Diphenylamine.....................           15         0.92        12000           13            3  ...........
298-04-4..............................  Disulfoton........................        0.013        0.017           43          6.2           13  ...........
72-20-8...............................  Enndrin...........................        0.073       0.0028         0.26         0.13           32  ...........
141-78-6..............................  Ethyl acetate.....................          390         0.34       270000           33          110  ...........
60-29-7...............................  Ethyl ether.......................           27         0.12        41000          160           11  ...........
97-63-2...............................  Ethyl methacrylate................           24         0.14         3400          160            7  ...........
100-41-4..............................  Ethylbenzene......................           39        0.057       550000           10            8  ...........
206-44-0..............................  Flouranthene......................           28        0.068         6000          3.4            2  ...........
86-73-7...............................  Flourene..........................           22        0.059        90000          3.4            3  ...........
76-44-8-..............................  Heptachlor........................    eqc             0.0012            8        0.066  ...........  ...........
1024-57-3.............................  Heptachlor epoxide................      0.00053        0.016        0.026        0.066         0.45  ...........
87-68-3...............................  Hexachloro-1,3-butadiene..........       0.0079        0.055           36          5.6       0.0069  ...........
118-74-1..............................  Hexachlorobenzene.................    eqc              0.055    eqc                 10    eqc        ...........
319-84-6..............................  Hexachlorocyclohexane, alpha-           0.00014      0.00014        0.033        0.066         0.11  ...........
                                         (alpha-BHC).                                                                                                   
319-85-7..............................  Hexachlorocyclohexane, beta-(beta-      0.00044      0.00014         0.12        0.066      0.00021  ...........
                                         BHC).                                                                                                          
58-89-9...............................  Hexachlorocyclohexane, gamma-           0.00078       0.0017          0.1        0.066         0.69  ...........
                                         (Lindane).                                                                                                     
77-47-4...............................  Hexachlorocyclopentadiene.........       0.0052        0.057         1500          2.4  ...........  ...........
67-72-1...............................  Hexachloroethane..................        0.049        0.055           81           30        0.033  ...........
193-39-5..............................  Indeno(1,2,3-cd) pyrene...........       0.0029       0.0055            4          3.4    eqc        ...........
78-83-1...............................  Isobutyl alcohol..................           39          5.6        55000          170           15  ...........
7439-92-1.............................  Lead..............................           30         0.69          570  ...........           12         0.37
7439-97-6.............................  Mercury...........................          0.3         0.15          0.6  ...........         0.14        0.025
126-98-7..............................  Methacrylonitrile.................        0.016         0.24  ...........  ...........  ...........  ...........
67-56-1...............................  Methanol..........................           78          5.6       140000  ...........           30         0.75
72-43-5...............................  Methoxychlor......................            7         0.25           19         0.18  ...........  ...........
74-83-9...............................  Methyl bromide (Bromomethane).....         0.37         0.11          500           15         0.92  ...........
74-87-3...............................  Methyl chloride (Chloromethane)...        0.096         0.19           91           30  ...........  ...........
78-93-3...............................  Methyl ethyl ketone...............           78         0.28       110000           36           30  ...........
108-10-1..............................  Methyl isobutyl ketone............            8         0.14        17000           33            3  ...........
80-62-6...............................  Methyl methacrylate...............           28         0.14        40000          160            8  ...........
298-00-0..............................  Methyl parathion..................         0.66        0.014            1          4.6           23  ...........
74-95-3...............................  Methylene bromide.................            2         0.11         8400           15         0.19  ...........
75-09-2...............................  Methylene chloride................        0.039        0.089          310           30        0.015  ...........
86-30-6...............................  N-Nitrosodiphenylamine............          0.2         0.92         1300           13    eqc        ...........
930-55-2..............................  N-Nitrosopyrrolidine..............    eqc              0.013        0.053           35    eqc        ...........
91-20-3...............................  Naphthalene.......................           14        0.059       120000          5.6            3  ...........
7440-02-0.............................  Nickel............................           11         3.98          110  ...........            5            5
98-95-3...............................  Nitrobenzene......................        0.084        0.068           45           14        0.032  ...........
924-16-3..............................  Nitrosodi-n-butylamine............  ...........  ...........        0.094           17    eqc        ...........
56-38-2...............................  Parathion.........................            3        0.014         0.13          4.6        12000  ...........
608-93-5..............................  Pentachlorobenzene................            5        0.055          210           10    eqc        ...........
82-68-8...............................  Pentachloronitrobenzene (PCNB)....        0.081        0.055           11          4.8    eqc        ...........
87-86-5...............................  Pentachlorophenol.................        0.002        0.089            3          7.4      0.00041  ...........
108-95-2..............................  Phenol............................           84        0.039       160000          6.2           32  ...........
298-02-2..............................  Phorate...........................         0.11        0.021          160          4.6  ...........  ...........
1336-36-3.............................  Polychlorinated biphenyls.........    eqc                0.1    eqc                 10    eqc        ...........
23950-58-5............................  Pronamide.........................           21        0.093          440          1.5            6  ...........
129-00-0..............................  Pyrene............................           54        0.067        16000          8.2            2  ...........
110-86-1..............................  Pyridine..........................         0.16        0.014          810           16         0.06  ...........
94-59-7...............................  Safrole...........................       0.0035        0.081           11         0.16    eqc        ...........
7782-49-2.............................  Selenium..........................         0.93         0.82    eqc        ...........         0.36         0.16
7440-22-4.............................  Silver............................          200         0.43    eqc        ...........  ...........          0.3
1746-01-6.............................  TCDD,2,3,7,8......................    eqc           0.000063    8.000E-06        0.001    eqc        ...........
95-94-3...............................  Tetrachlorobenzene, 1,2,4,5-......         0.23        0.055          170           14        0.032  ...........
630-20-6..............................  Tetrachloroethane, 1,1,1,2-.......        0.024        0.057          130            6       0.0078  ...........
79-34-5...............................  Tetrachloroethane, 1,1,2,2-.......       0.0037        0.057           29            6       0.0077  ...........
127-18-4..............................  Tetrachloroethylene...............            2        0.056        13000            6         0.68  ...........
58-90-2...............................  Tetrachlorophenol, 2,3,4,6-.......            2         0.03         6200          7.4         0.58  ...........
7440-28-0.............................  Thallium (l)......................         0.05          1.4            5        0.078        0.019  ...........
108-88-3..............................  Toluene...........................           30         0.08       180000           10           13  ...........
8001-35-2.............................  Toxaphene.........................    eqc             0.0095    eqc                2.6         0.11  ...........
76-13-1...............................  Trichloro-1,2,2-trifluoroethane,           2200        0.057  ...........           30         2400  ...........
                                         1,1,2-.                                                                                                        
120-82-1..............................  Trichlorobenzene, 1,2,4-..........         0.69        0.055         3500           19            1  ...........
71-55-6...............................  Trichloroethane, 1,1,1-...........           74        0.054        48000            6        0.054  ...........
79-00-5...............................  Trichloroethane, 1,1,2-...........        0.007        0.054           11            6       0.0018  ...........
79-01-6...............................  Trichloroethylene.................        0.038        0.054          570            6        0.013  ...........
75-69-4...............................  Trichlorofluoromethane............           48         0.02        26000           30           16  ...........

[[Page 66440]]
                                                                                                                                                        
95-95-4...............................  Trichlorophenol, 2,4,5-...........           18         0.18        12000          7.4            4  ...........
88-06-2...............................  Trichlorophenol, 2,4,6-...........        0.054        0.035          120          7.4        0.015  ...........
93-76-5...............................  Trichlorophenoxyacetic acid, 2,4,5-           2         0.72           63          7.9         0.64  ...........
                                          (245-T).                                                                                                      
93-72-1...............................  Trichlorophenoxypropionic acid,               1         0.72            6          7.9         0.48  ...........
                                         2,4,5- (Silvex).                                                                                               
96-18-4...............................  Trichloropropane, 1,2,3-..........            1         0.85          870           30         0.34  ...........
126-72-7..............................  Tris (2,3-dibromopropyl) phosphate    eqc               0.11         0.36          0.1    eqc        ...........
7440-62-2.............................  Vanadium..........................           10          4.3          250  ...........            4         0.23
75-01-4...............................  Vinyl chloride....................    eqc               0.27            1            6    eqc        ...........
1330-20-7.............................  Xylenes (total....................           22         0.32       170000           30          150  ...........
7440-66-6.............................  Zinc..............................           99         2.61          320  ...........           38          5.3
--------------------------------------------------------------------------------------------------------------------------------------------------------

    For the reasons set out in the preamble, Chapter I of Title 40 of 
the Code of Federal Regulations is amended as follows:

PART 260--HAZARDOUS WASTE MANAGEMENT SYSTEM: GENERAL

    1. The authority citation for part 260 continues to read as 
follows:

    Authority: 42 U.S.C. 6905, 6912(a), 6921-6927, 6930, 6934, 6935, 
6937, 6938, 6939, and 6974.

    2. In Sec. 260.10, add the following definitions in alphabetical 
order:
* * * * *
    Director means the Regional Administrator or the State Director, as 
the context requires, or an authorized representative. When there is no 
approved State program, and there is an EPA administered program, 
Director means the Regional Administrator. When there is an approved 
State program, Director normally means the State Director. In some 
circumstances, however, EPA retains the authority to take certain 
actions even when there is an approved State program. In such cases, 
the term Director means the Regional Administrator and not the State 
Director.
* * * * *
    Monofill means a landfill where waste of only one kind or type is 
placed in or on land and which is not a pile, a land treatment 
facility, a surface impoundment, an underground injection well, a salt 
dome formation, a salt bed formation, an underground mine, a cave, or a 
corrective action management unit.

PART 261--IDENTIFICATION AND LISTING OF HAZARDOUS WASTE

    3. The authority citation for part 261 continues to read as 
follows:

    Authority: 42 U.S.C. 6905, 6912(a), 6921, and 6922.

    4. Section 261.3 is amended by revising the first sentence of 
paragraph (a)(2)(iv) and the first sentence of paragraph (c)(2)(i) to 
read as follows:

Sec. 261.3  Definition of hazardous waste.

* * * * *
    (a) * * *
    (2) * * *
    (iv) It is a mixture of solid waste and one or more hazardous 
wastes listed in subpart D of this part and has not been excluded from 
paragraph (a)(2) of this section under either Secs. 260.20 and 260.22, 
Sec. 261.36, or Sec. 261.37 of this chapter; however, the following 
mixtures of solid wastes and hazardous wastes listed in subpart D of 
this part are not hazardous wastes (except by application of paragraph 
(a)(2) (i) or (ii) of this section) if the generator can demonstrate 
that the mixture consists of wastewater the discharge of which is 
subject to regulation under either section 402 or section 307(b) of the 
clean water act (including wastewater at facilities which have 
eliminated the discharge of wastewater) and:
* * * * *
    (c) * * *
    (2) * * *
    (i) Except as otherwise provided in paragraph (c)(2)(ii) of this 
section, Sec. 261.36, or Sec. 261.37 of this chapter, any solid waste 
generated from the treatment, storage, or disposal of a hazardous 
waste, including any sludge, spill residue, ash, emission control dust, 
or leachate (but not including precipitation run-off) is a hazardous 
waste. * * *
* * * * *
    5. A new Sec. 261.36 is added to subpart D to read as follows:

Sec. 261.36  Exemption for listed hazardous wastes containing low 
concentrations of hazardous constituents.

    (a) Any hazardous waste listed under this subpart, any mixture of 
such a listed waste with a solid waste, or any waste derived from the 
treatment, storage, or disposal of a listed hazardous waste that does 
not exhibit any of the characteristics of hazardous waste in subpart C 
of this part 261 and that meets all of the requirements in 
Sec. 261.36(b)-(d) is exempt from all requirements of parts 262-266 and 
part 270 of this chapter. Any such waste which also meets the 
requirements of Sec. 261.36(e) is also exempt from the requirements of 
part 268 of this chapter.
    (b) Requirements for qualifying for an exemption.--(1) Testing. (i) 
For each waste for which an exemption is claimed, the claimant must 
test for all of the constituents on appendix X to this part 261 except 
those that the claimant determines should not be present in the waste. 
The claimant is required to document the basis of each determination 
that a constituent should not be present. No claimant may determine 
that any of the following categories of constituents should not be 
present:
    (A) Constituents identified in appendix VII to this part 261 as the 
basis for listing the waste for which exemption is sought;
    (B) Constituents listed in the table to Sec.  268.40 of this 
chapter as regulated hazardous constituents for LDR treatment of the 
waste;
    (C) Constituents detected in any previous analysis of the same 
waste conducted by or on behalf of the claimant;
    (D) Constituents introduced into the process which generates the 
waste; and
    (E) Constituents which the claimant knows or has reason to believe 
are byproducts or side reactions to the process that generates the 
waste.

    Note: Any claim under this section must be valid and accurate 
for all hazardous constituents; a determination not to test for a 
hazardous constituent will not shield a claimant from liability 
should that constituent later be found in the waste.

    (ii) The claimant must develop a sampling and analysis plan for 
each waste for which an exemption is sought. The plan must identify:
    (A) Sampling procedures and locations sufficient to characterize 
the entire waste for which the exemption is 

[[Page 66441]]
claimed. Grab sampling is acceptable for this purpose.
    (B) Analytical methods that the claimant will use to determine, for 
wastewaters and nonwastewaters, the total concentration of each 
constituent on appendix X to this part except for those constituents 
which the claimant has determined should not be present under 
Sec. 261.36(b)(1)(i).
    (iii) The claimant must conduct sampling and analysis in accordance 
with the plan.
    (iv) The results of the sampling and analysis must show, for both 
wastewaters and nonwastewaters, that all total constituent 
concentrations in the waste are at or below the exemption levels in 
appendix X to this part 261 and, for nonwastewaters, that all leachable 
constituent concentrations are either:
    (A) At or below exemption levels in Appendix X to this part 261, as 
determined by testing an extract using test method 1311 (the Toxicity 
Characteristic Leaching Procedure, set out in ``Test Methods for 
Evaluating Solid Waste, Physical/Chemical Methods'' (SW-846)), or
    (B) Estimated to be at or below exemption levels using the equation 
{[(A x B)+(C x D)]/[B+(20 x D)]} leach exit level, where 
A=concentration of the analyte in the liquid portion of the sample; 
B=Volume of the liquid portion of the sample; C=Concentration of the 
analyte in the solid portion of the sample; D=Weight of the solid 
portion of the sample.
    (2) Treatment requirements.  Any waste that exits using an exit 
level on Table B to appendix X to this part 261 must meet the treatment 
standard for such a constituent under Sec. 268.40 of this chapter, 
regardless of whether or not the waste is intended for land disposal, 
unless the claimant meets the exemption requirements in Sec. 261.36(e).
    (3) Public Notice. The claimant must submit for publication in a 
major newspaper of general circulation, local to the claimant, a notice 
entitled ``Notification of Exemption Claim for Listed Hazardous Wastes 
Containing Low Concentrations of Hazardous Constituents Under the 
Resource Conservation and Recovery Act'' containing the following 
information:
    (i) The name, address, and RCRA ID number of the claimant's 
facility;
    (ii) The applicable EPA Hazardous Waste Code of the waste for which 
the exemption is claimed and the narrative description associated with 
the listing from this part 261 subpart D;
    (iii) A brief, general description of the manufacturing, treatment, 
or other process or operation producing the waste;
    (iv) An estimate of the average and maximum monthly and annual 
quantities of the waste claimed to be exempt;
    (v) The name and mailing address of the agency to which the 
claimant is submitting the notification required under 
Sec. 261.36(b)(4).
    (4) Notification to implementing agency. Prior to managing any 
waste as exempt under this section, the claimant must send to the 
Director via certified mail or other mail service that provides written 
confirmation of delivery a notification of the exemption claim meeting 
the following requirements:
    (i) The name, address, and RCRA ID number of the person claiming 
the exemption;
    (ii) The applicable EPA Hazardous Waste Codes;
    (iii) A brief description of the process that generated the waste;
    (iv) An estimate of the average and maximum monthly and annual 
quantities of each waste claimed to be exempt;
    (v) Documentation for any claim that a constituent is not present 
as described under Sec. 261.36 (b)(1)(i);
    (vi) The results of all analyses and estimates of constituent 
concentrations required under Sec. 261.36(b)(1)(iv) and all 
quantitation limits achieved;
    (vii) Documentation that any waste that exits using a constituent 
exit level from Table B to Appendix X to this part has met the 
applicable treatment standards in Sec. 268.40 of this chapter, unless 
the claimant is also claiming the exemption under Sec. 261.36(e);
    (viii) Evidence that the public notification requirements of 
Sec. 261.36(b)(3) have been satisfied; and
    (ix) The following statement signed by the person claiming the 
exemption or his authorized representative:

    ``Under penalty of criminal and civil prosecution for making or 
submitting false statements, representations, or omissions, I 
certify that the requirements of 40 CFR 261.36(b) have been met for 
all waste identified in this notification. Copies of the records and 
information required at 40 CFR 261.36(d)(7) are available at the 
claimant's facility. Based upon my inquiry of the individuals 
immediately responsible for obtaining the information, the 
information is, to the best of my knowledge and belief, true, 
accurate, and complete. I am aware that there are significant 
penalties for submitting false information, including the 
possibility of fine and imprisonment for knowing violations.''

    (c) Effectiveness of exemption. No claim shall take effect until 
the claimant receives confirmation of delivery for the notification 
required under Sec. 261.36 (b)(4).
    (d) Conditions for maintaining the exemption. To maintain any 
exemption claimed pursuant to this section, the claimant must satisfy 
the following conditions:
    (1) Changes in information. The claimant must submit to the 
Director any change in any information submitted under 
Sec. 261.36(b)(4) within ten business days of the claimant's first 
knowledge of the change.
    (2) Schedule for retesting. The claimant must retest the waste for 
which the exemption was claimed on the following schedule:
    (i) For the first three years of the exemption, the claimant must:
    (A) Test wastes generated at the time the exemption is claimed in 
volumes greater than 10,000 tons/year on a quarterly basis;
    (B) Test wastes generated at the time the exemption is claimed in 
volumes greater than 1000 tons/year but less than 10,000 tons/year must 
on a semi-annual basis;
    (C) Test wastes generated at the time the volume is claimed in 
volumes less than 1000 tons/year on an annual basis.
    (ii) After the first three years of an exemption, the claimant must 
retest the waste for which the exemption was claimed on an annual 
basis.
    (3) For every retest the claimant must prepare and comply with a 
sampling and analysis plan meeting the requirements of 
Sec. 261.36(b)(1)(ii) and determine the concentration of:
    (i) Each constituent from Table A to appendix X to this part that 
was detected in the initial test within an order of magnitude below 
either its total or leachable exemption level and each constituent from 
Table B to appendix X of this part that is identified as a basis for 
listing the waste on appendix VII to this part or is listed as a 
regulated hazardous constituent for the waste in the table of 
``Treatment Standards for Hazardous Wastes'' in Sec. 268.40 of this 
chapter; and
    (ii) Any other constituent that the claimant has reason to believe 
may be newly present in the waste since the most recent test.
    (4) Exemption levels. The concentrations of all constituents tested 
must meet the criteria set out in Sec. 261.36(b)(1)(iv).
    (5) Treatment requirements. Any waste exiting by using an exit 
level for a hazardous constituent from Table B to appendix X to this 
part must meet the treatment requirements for such a constituent under 
Sec. 268.40 of this chapter prior to exit regardless of whether or not 
the waste is intended for land disposal, unless the claimant meets 

[[Page 66442]]
the exemption requirements in Sec. 261.36(e).
    (6) Records. The claimant must maintain records of the following 
information in files on-site for three years after the date of the 
relevant test:
    (i) For initial testing, all information submitted under 
Sec. 261.36(b)(4), all revisions to such material submitted under 
Sec. 261.36(d)(1) and all information required to be maintained under 
Sec. 261.36(d)(6)(iii);
    (ii) For retests:
    (A) All volume determinations made for the purpose of determining 
testing frequency under Sec. 261.36(d)(2);
    (B) All sampling and analysis plans required under 
Sec. 261.36(d)(3);
    (C) All analytical results and estimates of leachable 
concentrations (if any) for constituents required to be assessed under 
Sec. 261.35(d)(3);
    (D) Documentation showing that a waste exiting using any 
constituent exit level from Table B to appendix X to this part and is 
required to be reassessed under Sec. 261.36(d)(3) has met applicable 
treatment standards under Sec. 268.40 of this chapter, unless the 
claimant also claims the exemption under Sec. 261.36(e); and
    (iii) For both initial tests and retests, the claimant must also 
retain records of:
    (A) The dates and times waste samples were obtained, and, for total 
concentrations and leachable concentrations that were analyzed, the 
dates of the analyses;
    (B) The names and qualifications of the person(s) who obtained the 
samples;
    (C) A description of the temporal and spatial locations of the 
samples;
    (D) The name and address of the laboratory facility at which 
analyses of the samples were performed;
    (E) A description of the analytical methods used, including any 
clean-up and extraction methods;
    (F) All quantitation limits achieved and all other quality control 
results (including any method blanks, duplicate analyses, and matrix 
spikes), laboratory quality assurance data, and a description of any 
deviations from published analytical methods or from the plan which 
occurred; and
    (G) All laboratory documentation that supports the analytical 
results, unless a contract between the claimant and the laboratory 
provides for the documentation to be maintained by the laboratory for 
the period specified in Sec. 261.36 (b)(2) and also provides for the 
availability of the documentation to the claimant upon request.

    Note: Failure to satisfy any of these conditions voids the 
exemption and requires management of the waste for which the 
exemption has been claimed as hazardous waste. Submission of 
notification to the Director that all waste conditions have been 
satisfied re-establishes the exemption for all waste generated after 
that date.

    (e) Exemption from part 268 requirements.--If all hazardous 
constituent levels in a waste qualifying for exemption are at or below 
the appendix X to this part concentration levels at the waste's point 
of generation, prior to any mixing with other solid or hazardous wastes 
and prior to any treatment, the waste is exempt from all requirements 
of part 268 of this chapter. The claimant also must meet the following 
documentation requirements:
    (1) For initial tests, in place of the certification required at 
Sec. 261.36 (b)(4)(ix), the claimant must submit the following 
statement signed by the person claiming the exemption or his authorized 
representative and, if the claimant is not the generator of the waste, 
also signed by the generator or his authorized representative:

    Under penalty of criminal and civil prosecution for making or 
submitting false statements, representations, or omissions, I 
certify that, for the waste identified in this notification, the 
concentration of all constituents assessed as required under 
Sec. 261.36 (b)(1)(iv) met the applicable levels in appendix X to 
this part 261 at the point of generation and that all other 
requirements of 40 CFR Sec. 261.36 (b) have been met. Copies of the 
records and information required at 40 CFR Sec. 261.36 (d)(4) are 
available at the claimant's facility. Based upon my inquiry of the 
individuals immediately responsible for obtaining the information, 
the information is, to the best of my knowledge and belief, true, 
accurate, and complete. I am aware that there are significant 
penalties for submitting false information, including the 
possibility of fine and imprisonment for knowing violations.''; or

    (2) For every retest required under Sec. 261.36(d)(2), the claimant 
must document that the concentrations of all constituents retested as 
required under Sec. 261.36(d)(3) met the applicable levels in appendix 
X to this part 261 at the waste's point of generation, must include 
information supporting this claim from the waste's generator if the 
generator is not the person asserting the claim, and must retain such 
documentation in files on-site for three years after the date of the 
relevant test.
    (f) Nothing in this paragraph preempts, overrides, or otherwise 
negates the provision in Sec. 262.11 of this chapter, which requires 
any person who generates a solid waste to determine if that waste is a 
hazardous waste.
    (g) In an enforcement action, the burden of proof to establish 
conformance with the exemption criteria shall be on the claimant.
    6. A new Sec. 261.37 is added to read as follows:

Sec. 261.37  Exemption for listed hazardous wastes containing low 
concentrations of hazardous constituents and managed in landfills and 
monofills.

    (a) Any hazardous waste listed under this subpart, any mixture of 
such a listed waste with a solid waste, or any waste derived from the 
treatment, storage or disposal of such a listed waste is exempt from 
regulation as a hazardous waste under parts 262-266 and 270 of this 
chapter if it meets the requirements in Sec. 261.37(b) and (d) 
(including the requirement that all hazardous constituents present in 
the waste be at or below the levels listed in appendix XI to this part 
and that the waste be disposed in a landfill or monofill, but not a 
land application unit). To maintain the exemption, the waste must 
satisfy the conditions in Sec. 261.37(e). Any such waste which also 
meets the requirements of 261.37(f) is also exempt from the 
requirements of part 268 of this chapter.
    (b) Requirements for qualifying for an exemption--(1) Testing. (i) 
For each waste for which an exemption is claimed, the claimant must 
test for all of the constituents on appendix XI to this part 261 except 
those that the claimant determines should not be present in the waste. 
The claimant is required to document the basis of each determination 
that a constituent should not be present. No claimant may determine 
that any of the following categories of constituents should not be 
present:
    (A) Constituents identified in appendix VII to this part 261 as the 
basis for listing the waste for which exemption is sought;
    (B) Constituents listed in the table to Sec. 268.40 as regulated 
hazardous constituents for LDR treatment of the waste;
    (C) Constituents detected in any previous analysis of the same 
waste conducted by or on behalf of the claimant;
    (D) Constituents introduced into the process which generates the 
waste; and
    (E) Constituents which the claimant knows or has reason to believe 
are byproducts or side reactions to the process that generates the 
waste.

    Note: Any claim under this section must be valid and accurate 
for all hazardous constituents; a determination not to test for a 
hazardous constituent will not shield a claimant from liability 
should that constituent later be found in the waste.

    (ii) The claimant must develop a sampling and analysis plan for 
each 

[[Page 66443]]
waste for which an exemption is sought. The plan must identify:
    (A) Sampling procedures and locations sufficient to characterize 
the entire waste for which the exemption is claimed. Grab sampling is 
acceptable for this purpose.
    (B) Analytical methods that the claimant will use to determine, for 
wastewaters and nonwastewaters, the total concentration of each 
constituent on appendix XI to this part except for those constituents 
which the claimant has determined should not be present under 
Sec. 261.37(b)(1)(i).
    (iii) The claimant must conduct sampling and analysis in accordance 
with the plan.
    (iv) The results of the sampling and analysis must show, for both 
wastewaters and nonwastewaters, that all total constituent 
concentrations in the waste are at or below the exemption levels in 
appendix XI to this part 261 and, for nonwastewaters, that all 
leachable constituent concentrations are either:
    (A) At or below exemption levels in appendix XI to this Part 261, 
as determined by testing an extract using test method 1311 (the 
Toxicity Characteristic Leaching Procedure, set out in ``Test Methods 
for Evaluating Solid Waste, Physical/Chemical Methods'' (SW-846)), or
    (B) Estimated to be at or below exemption levels using the equation 
{(AxB)+(CxD)}/{B+(20xD)} < leach exit level, where A=concentration of 
the analyte in the liquid portion of the sample; B = Volume of the 
liquid portion of the sample; C=Concentration of the analyte in the 
solid portion of the sample; D = Weight of the solid portion of the 
sample.
    (2) Treatment requirements. Any waste that exits using an exit 
level on Table B to appendix XI to this Part 261 must meet the 
treatment standard for such a constituent under Sec. 268.40 of this 
chapter, regardless of whether or not the waste is intended for land 
disposal, unless the claimant meets the exemption requirements in 
Sec. 261.37(f).
    (3) Public Notice. The claimant must submit for publication in a 
major newspaper of general circulation, local to the claimant, a notice 
entitled ``Notification of Exemption Claim for Listed Hazardous Wastes 
Containing Low Concentrations of Hazardous Constituents and Managed in 
Landfills and Monofills Under the Resource Conservation and Recovery 
Act'' containing the following information:
    (i) The name, address, and RCRA ID number of the claimant's 
facility;
    (ii) The applicable EPA Hazardous Waste Code of the waste for which 
the exemption is claimed and the narrative description associated with 
the listing from this part 261 subpart D;
    (iii) A brief, general description of the manufacturing, treatment, 
or other process or operation producing the waste;
    (iv) An estimate of the average and maximum monthly and annual 
quantities of the waste claimed to be exempt;
    (v) The name and mailing address of the agency to which the 
claimant is submitting the notification required under 
Sec. 261.37(b)(4);
    (vi) The following statement:

    The exemption for this waste from the hazardous waste regulatory 
scheme is conditioned disposing of the waste in a landfill or 
monofill (and not a land application unit.)

    (4) Notification to implementing agency. Prior to managing any 
waste as exempt under this section, the claimant must send to the 
Director via certified mail or other mail service that provides written 
confirmation of delivery a notification of the exemption claim meeting 
the following requirements:
    (i) The name, address, and RCRA ID number of the person claiming 
the exemption;
    (ii) The applicable EPA Hazardous Waste Codes;
    (iii) A brief description of the process that generated the waste;
    (iv) An estimate of the average and maximum monthly and annual 
quantities of each waste claimed to be exempt;
    (v) Documentation for any claim that a constituent is not present 
as described under Sec. 261.37(b)(1)(i);
    (vi) The results of all analyses and estimates of constituent 
concentrations required under Sec. 261.37(b)(1)(iv) and all 
quantitation limits achieved;
    (vii) Documentation that any waste that exits using a constituent 
exit level from Table B to appendix XI to this part have met the 
applicable treatment standards in Sec. 268.40, of this chapter, unless 
the claimant is also claiming the exemption under Sec. 261.37(f);
    (viii) Evidence that the public notification requirements of 
Sec. 261.37(b)(3) have been satisfied; and
    (ix) The following statement signed by the person claiming the 
exemption or his authorized representative:

    Under penalty of criminal and civil prosecution for making or 
submitting false statements, representations, or omissions, I 
certify that the requirements of Sec. 261.37(b) have been met, 
including the requirement that all hazardous constituents present in 
the waste are at or below the levels listed on appendix XI to this 
part, for all listed wastes identified in this notification. I also 
certify that arrangements have been made to dispose of the waste in 
a landfill or monofill (and not a land application unit). Copies of 
the records and information required at Sec. 261.37 (e)(7) are 
available) at the claimant's facility. Based upon my inquiry of the 
individuals immediately responsible for obtaining the information, 
the information is, to the best of my knowledge and belief, true, 
accurate, and complete. I am aware that there are significant 
penalties for submitting false information, including the 
possibility of fine and imprisonment for knowing violations.

    (5) The claimant must receive confirmation of delivery for the 
notification required under Sec. 261.37 (b)(4).
    (c) Tracking, storage, treatment and other management prior to 
disposal. Until a listed hazardous waste meeting the requirements of 
Sec. 261.37(b) is placed in a landfill or monofill, it remains subject 
to all requirements of parts 262-266 and 270 of this chapter. The waste 
is also subject to the requirements of part 268 of this chapter unless 
it qualifies for an exemption under Sec. 261.37(f).
    (d) Disposal in a landfill or monofill. The claimant must ensure 
that any listed waste meeting the requirements of Sec. 261.37(b) for 
which an exemption is sought is disposed of in either a landfill or 
monofill (and not a land application unit). The landfill or monofill 
need not be subject to regulation as a hazardous waste management unit. 
The waste becomes exempt as soon as it is placed in a landfill or 
monofill unit.
    (e) Conditions for maintaining the exemption. To maintain any 
exemption claimed pursuant to this section, the claimant must satisfy 
the following conditions:
    (1) Compliance with modified hazardous waste manifest system. If 
the landfill or monofill in which the waste is disposed is not a 
hazardous waste disposal unit subject to part Sec. 264.71-264.72 or 
Sec. 265.71-265.72 of this chapter, the claimant must:
    (i) Ensure that the manifest form is returned from the disposal 
facility, and
    (ii) Obtain information showing that the disposal facility 
designated on the manifest received the waste for which the exemption 
is sought and placed it in either a landfill or monofill (and not a 
land treatment unit).
    (2) Changes in information. The claimant must submit to the 
Director any change in any information submitted under 
Sec. 261.37(b)(4) within ten business days of the claimant's first 
knowledge of the change.
    (3) Schedule for retesting. The claimant must retest the waste for 
which the exemption was claimed on the following schedule: 

[[Page 66444]]

    (i) For the first three years of the exemption, the claimant must:
    (A) Test wastes generated at the time the exemption is claimed in 
volumes greater than 10,000 tons/year on a quarterly basis;
    (B) Test wastes generated at the time the exemption is claimed in 
volumes greater than 1000 tons/year but less than 10,000 tons/year must 
on a semi-annual basis;
    (C) Test wastes generated at the time the volume is claimed in 
volumes less than 1000 tons/year on an annual basis.
    (ii) After the first three years of an exemption, the claimant must 
retest the waste for which the exemption was claimed on an annual 
basis.
    (4) For every retest the claimant must prepare and comply with a 
sampling and analysis plan meeting the requirements of 
Sec. 261.37(b)(1)(ii) and determine the concentration of:
    (i) Each constituent from Table A to appendix XI to this part that 
was detected in the initial test within an order of magnitude below 
either its total or leachable exemption level and each constituent from 
Table B to appendix XI to this part that is identified as a basis for 
listing the waste on appendix VII to this part or is listed as a 
regulated hazardous constituent for the waste in the table of 
``Treatment Standards for Hazardous Wastes'' in Sec. 268.40 of this 
chapter; and
    (ii) Any other constituent that the claimant has reason to believe 
may be newly present in the waste since the most recent test.
    (5) Exemption levels.--The concentrations of all constituents 
tested must meet the criteria set out in Sec. 261.37(b)(1)(iv).
    (6) Treatment requirements.--Any waste exiting by using an exit 
level for a hazardous constituent from Table B to Appendix XI to this 
part must meet the treatment requirements for such a constituent under 
Sec. 268.40 of this chapter prior to exit regardless of whether or not 
the waste is intended for land disposal, unless the claimant meets the 
exemption requirements in Sec. 261.37(f).
    (7) Records.--The claimant must maintain records of the following 
information in files on-site for three years after the date of the 
relevant test:
    (i) For initial testing, all information submitted under 
Sec. 261.37(b)(4) and all revisions to such material submitted under 
Sec. 261.37(e)(2), all information obtained under Sec. 261.37(e)(1), 
and all information required to be maintained under 
Sec. 261.37(e)(7)(iii);
    (ii) For retests:
    (A) All volume determinations made for the purpose of determining 
testing frequency under Sec. 261.37(e)(3);
    (B) All sampling and analysis plans required under 
Sec. 261.37(e)(4);
    (C) All analytical results and estimates of leachable 
concentrations (if any) for constituents required to be assessed under 
Sec. 261.37 (e)(5);
    (D) Documentation showing that a waste exiting using any 
constituent exit level from Table B to Appendix XI to this part has met 
applicable treatment standards under Sec. 268.40 of this chapter, 
unless the claimant also claims the exemption under Sec. 261.37(f); and
    (iii) For both initial tests and retests, the claimant must also 
retain records of:
    (A) The dates and times waste samples were obtained, and, for total 
concentrations and leachable concentrations that were analyzed, the 
dates of the analyses;
    (B) The names and qualifications of the person(s) who obtained the 
samples;
    (C) A description of the temporal and spatial locations of the 
samples;
    (D) The name and address of the laboratory facility at which 
analyses of the samples were performed;
    (E) A description of the analytical methods used, including any 
clean-up and extraction methods;
    (F) All quantitation limits achieved and all other quality control 
results (including any method blanks, duplicate analyses, and matrix 
spikes), laboratory quality assurance data, and a description of any 
deviations from published analytical methods or from the plan which 
occurred; and
    (G) All laboratory documentation that supports the analytical 
results, unless a contract between the claimant and the laboratory 
provides for the documentation to be maintained by the laboratory for 
the period specified in Sec. 261.37 (b)(2) and also provides for the 
availability of the documentation to the claimant upon request. Failure 
to satisfy any of these conditions voids the exemption and requires 
management of the waste for which the exemption has been claimed as 
hazardous waste. Submission of notification to the Director that all 
waste conditions have been satisfied re-establishes the exemption for 
all waste generated after that date.
    (f) Exemption from part 268 requirements.--If all hazardous 
constituent levels in a waste qualifying for exemption are at or below 
the appendix XI to this part concentration levels at the waste's point 
of generation, prior to any mixing with other solid or hazardous wastes 
and prior to any treatment, the waste is exempt from all requirements 
of part 268 of this chapter. The claimant also must meet the following 
documentation requirements:

    (1) For initial tests, in place of the certification required at 
Sec. 261.37 (b)(4)(ix), the claimant must submit the following 
statement signed by the person claiming the exemption or his authorized 
representative and, if the claimant is not the generator of the waste, 
also signed by the generator or his authorized representative:

    Under penalty of criminal and civil prosecution for making or 
submitting false statements, representations, or omissions, I 
certify that, for the waste identified in this notification, the 
concentration of all constituents assessed as required under 
Sec. 261.37 (b)(1)(iv) met the applicable levels in appendix XI to 
this part 261 at the point of generation and that all other 
requirements of 40 CFR 261.37 (b) have been met. I also certify that 
arrangements have been made to dispose of the waste in a landfill or 
monofill (and not a land application unit). Copies of the records 
and information required at 40 CFR 261.37 (e)(7) are available at 
the claimant's facility. Based upon my inquiry of the individuals 
immediately responsible for obtaining the information, the 
information is, to the best of my knowledge and belief, true, 
accurate, and complete. I am aware that there are significant 
penalties for submitting false information, including the 
possibility of fine and imprisonment for knowing violations.''; and

    (2) For every retest required under Sec. 261.37(e)(3), the claimant 
must document that the concentrations of all constituents retested as 
required under Sec. 261.37(e)(4) met the applicable levels in appendix 
XI to this part 261 at the waste's point of generation, must include 
information supporting this claim from the waste's generator if the 
generator is not the person asserting the claim, and must retain such 
documentation in files on-site for three years after the date of the 
relevant test.

    (g) Nothing in this paragraph preempts, overrides, or otherwise 
negates the provision in Sec. 262.11 of this chapter, which requires 
any person who generates a solid waste to determine if that waste is a 
hazardous waste.

    (h) In an enforcement action, the burden of proof to establish 
conformance with the exemption criteria shall be on the claimant.

    7. Appendix X is added to read as follows:

                                                                                                                                                        

[[Page 66445]]
                                                                       Appendix X                                                                       
                                                Table A.--Modeled or Extrapolated Risk-Based Exit Levels                                                
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                             MCL benchmark option                                 Toxicity benchmark option             
                                           -------------------------------------------------------------------------------------------------------------
        CAS No.                 Name            Wastewater                 Nonwastewater               Wastewater                Nonwastewater          
                                           -------------------------------------------------------------------------------------------------------------
                                               Totals (mg/l)     Totals (mg/kg)     Leach (mg/l)      Totals (mg/l)    Totals (mg/kg)     Leach (mg/l)  
--------------------------------------------------------------------------------------------------------------------------------------------------------
83-32-9................  Acenaphthene.....          31              9500                 5                31              9500                 5        
208-96-8...............  Acenaphthylene...       (\1\)                 4             (\1\)             (\1\)                 4             (\1\)        
67-64-1................  Acetone..........          16             17000                 6                16             17000                 6        
75-05-8................  Acetonitrile.....           0.78            920                 0.3               0.78            920                 0.3      
98-86-2................  Acetophenone.....          17              1200                 6                17              1200                 6        
75-36-5................  Acetyl chloride..       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
591-08-2...............  Acetyl-2-               (\1\)             (\1\)                 6             (\1\)             (\1\)                 6        
                          thiourea, 1-.                                                                                                                 
53-96-3................  Acetylaminofluore           0.028             3             (\1\)                 0.028             3             (\1\)        
                          ne, 2-.                                                                                                                       
107-02-8...............  Acrolein.........       (\1\)                 3          ................     (\1\)                 3          ................
79-06-1................  Acrylamide.......       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
107-13-1...............  Acrylonitrile....       (\1\)                 0.96          (\1\)             (\1\)                 0.96          (\1\)        
1402-68-2..............  Aflatoxins.......       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
116-06-3...............  Aldicarb.........       (\1\)             (\1\)                 0.54          (\1\)             (\1\)                 0.48     
309-00-2...............  Aldrin...........       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
107-18-6...............  Allyl Alcohol....       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
107-05-1...............  Allyl chloride...           0.074           260          ................         0.074           260          ................
92-67-1................  Aminobiphenyl, 4-           0.028             3             (\1\)                 0.028             3             (\1\)        
2763-96-4..............  Aminomethyl-3-          (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          isoxazolol, 5-.                                                                                                               
504-24-5...............  Aminophyridine, 4-      (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          .                                                                                                                             
61-82-5................  Amitrole.........       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
62-53-3................  Aniline..........           0.053             4                 0.017             0.053             4                 0.017    
120-12-7...............  Anthracene.......       (\1\)                 4             (\1\)             (\1\)                 4             (\1\)        
7440-36-0..............  Antimony.........           0.14              9                 0.053             0.14              9                 0.053    
140-57-8...............  Aramite..........          15              6900                11                15              6900                11        
7440-38-2..............  Arsenic..........           0.38          (\1\)                 0.15          (\1\)             (\1\)             (\1\)        
2465-27-2..............  Auramine.........       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
115-02-6...............  Azaserine........       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
7440-39-3..............  Barium...........          28              2100                11                33              2100                16        
71-43-2................  Benzene..........           0.021           110                 0.009             0.018           110                 0.0054   
92-87-5................  Benzidine........       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
106-51-4...............  Benzoquinone, p-.          15              6900                11                15              6900                11        
98-07-7................  Benzotrichloride.       (\1\)               140             (\1\)             (\1\)               140             (\1\)        
50-32-8................  Benzo(a)pyrene...           0.0023            0.23              0.0036            0.0023            0.23          (\1\)        
205-99-2...............  Benzo(b)-                   0.00081           4                 0.000066          0.00081           4                 0.000066 
                          fluoranthene.                                                                                                                 
205-82-3...............  Benzo(j)-                   0.0029            4                 0.0012            0.0029            4             (\1\)        
                          fluoranthene.                                                                                                                 
207-08-9...............  Benzo(k)-                   0.0029            4                 0.0012            0.0029            4             (\1\)        
                          fluoranthene.                                                                                                                 
191-24-2...............  Benzo[g,h,i]-               0.0029            4                 0.0012            0.0029            4             (\1\)        
                          perylene.                                                                                                                     
100-51-6...............  Benzyl alcohol...          39              2700                15                39              2700                15        
100-44-7...............  Benzyl chloride..           1                38                15                 1                38                15        
56-55-3................  Benz(a)                     0.00072           0.1           (\1\)                 0.00072           0.1           (\1\)        
                          anthracene.                                                                                                                   
225-51-4...............  Benz[c]acridine..           0.0029            4                 0.0012            0.0029            4             (\1\)        
7440-41-7..............  Beryllim.........           0.00083       (\1\)                 o.00032           0.00083       (\1\)                 0.00032  
39638-32-9.............  Bis (2-                     0.007             0.94              0.0019            0.007             0.94              0.0019   
                          chloroisopropyl)                                                                                                              
                          ether.                                                                                                                        
111-44-4...............  Bis(2-                      0.00065           0.12              0.00036           0.00065           0.12              0.00036  
                          chlorethyl)ether.                                                                                                             
117-81-7...............  Bis(2-                      0.00044         230                 0.11              0.00044         230                 0.0011   
                          ethylhexyl)phtha                                                                                                              
                          late.                                                                                                                         
542-88-1...............  Bis(chloromethyl)       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          ether.                                                                                                                        
598-31-2...............  Bromoacetone.....           0.024            31                 0.012             0.023            31                 0.015    
75-27-4................  Bromodichlorometh           0.0085           19                 0.0025            0.0085           19                 0.0025   
                          ane.                                                                                                                          
75-25-2................  Bromoform                   0.064           170                 0.018             0.064           170                 0.018    
                          (Tribromomethane                                                                                                              
                          ).                                                                                                                            
101-55-3...............  Bromophyenyl                0.024            31                 0.012             0.023            31                 0.015    
                          ether, 4-.                                                                                                                    
357-57-3...............  Brucine..........       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
71-36-3................  Butanol..........          16              1800                 6                16             18000                 6        
88-85-7................  Butyl-4,6-                  0.034           770                 0.011             0.19            770                 0.064    
                          dinitrophenol, 2-                                                                                                             
                          sec- (Dinoseb).                                                                                                               
85-68-7................  Butylbenzylphthal         240                87                64               240                87                64        
                          ate.                                                                                                                          
7440-43-9..............  Cadmium..........           0.038            14                 0.015             0.24             14                 0.11     
86-74-8................  Carbazole........       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        

[[Page 66446]]
                                                                                                                                                        
75-15-0................  Carbon disulfide.           0.74            330                 6                 0.74            330                 6        
353-50-4...............  Carbon                  (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          oxyfluoride.                                                                                                                  
56-23-5................  Carbon                      0.012             9                 0.012             0.012             9                 0.0016   
                          tetrachloride.                                                                                                                
75-87-6................  Chloral..........       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
305-03-3...............  Chlorambucil.....       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
57-74-9................  Chlordane........       (\1\)                 0.0098            0.036         (\1\)                 0.0098            0.00016  
494-03-1...............  Chlornaphazin....       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
126-99-8...............  Chloro-1,3-                 0.52            290          ................         0.52            290          ................
                          butadiene, 2-                                                                                                                 
                          (Chloroprene).                                                                                                                
107-20-0...............  Chloroacetaldehyd       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          e.                                                                                                                            
106-47-8...............  Chloroaniline, p-           0.42            140                 0.16              0.42            140                 0.16     
108-90-7...............  Chlorobenzene....           0.68           2500                 0.19              2              2500                 1        
510-15-6...............  Chlorobenzilate..           0.054             7                 0.0057            0.054             7                 0.0057   
124-48-1...............  Chlorodibromometh           0.0066           28                 0.0018            0.0066           28                 0.0018   
                          ane.                                                                                                                          
75-00-3................  Chloroethane                0.024            31                 0.012             0.023            31                 0.015    
                          (ethyl chloride).                                                                                                             
110-75-8...............  Chloroethyl vinyl       (\1\)               140             (\1\)             (\1\)               140             (\1\)        
                          ether, 2-.                                                                                                                    
67-66-3................  Chloroform.......           0.0076            7                 0.017             0.0076            7                 0.017    
59-50-7................  Chloro-m-cresol,            0.27            140                 0.033             0.081           140                 0.032    
                          p-.                                                                                                                           
107-30-2...............  Chloromethyl            (\1\)                31             (\1\)             (\1\)                31             (\1\)        
                          methyl ether.                                                                                                                 
91-58-7................  Chloronaphthalene           0.27            140                 0.033             0.081           140                 0.032    
                          , 2-.                                                                                                                         
95-57-9................  Chlorophenol, 2-.           0.9             100                 0.32              0.9             100                 0.32     
7005-72-3..............  Chlorophenyl                0.024            31                 0.012             0.023            31                 0.015    
                          phenyl ether, 4-.                                                                                                             
5344-82-1..............  Chlorophenyl            (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          thiourea, 1-0-.                                                                                                               
542-76-7...............  Chloropropionitri           0.27            140             (\1\)             (\1\)               140             (\1\)        
                          le, 3-.                                                                                                                       
7440-47-3..............  Chromium.........           0.62             10                 0.24              1                10                 0.48     
218-01-9...............  Chrysene.........           0.1              35                 0.0012            0.1              35                 0.0012   
6358-53-8..............  Citrus red No. 2.       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
7440-48-4..............  Cobalt...........           0.62              9             (\1\)                 1                 9             (\1\)        
7440-50-8..............  Copper...........         670                 6              1100               670                 6              1100        
108-39-4...............  Cresol, m-.......           8             22000                 3                 8             22000                 3        
95-48-7................  Cresol, o-.......           8             27000                 3                 8             27000                 3        
106-44-5...............  Cresol, p-.......           0.84           2600                 0.32              0.84           2600                 0.32     
4170-30-3..............  Crotonaldehyde...           8              1200                 6                 8              1200                 6        
57-12-5................  Cyanide..........       (\1\)                20             (\1\)             (\1\)                20             (\1\)        
14901-08-7.............  Cycasin..........       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
108-94-1...............  Cyclohexanone....       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
131-89-5...............  Cyclohexyl-4,6-         (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          dinitrophenol, 2-                                                                                                             
                          .                                                                                                                             
50-18-0................  Cyclophosphamide.       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
20830-81-3.............  Daunomycin.......       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
72-54-8................  DDD..............           0.00013           0.0065         2800                 0.00013           0.0065         2800        
53-19-0................  DDD (o,p').......       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
72-55-9................  DDE..............       (\1\)                 0.00094           0.000062      (\1\)                 0.00094           0.00062  
3424-82-6..............  DDE (o,p').......       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
50-29-3................  DDT..............       (\1\)                 0.0032            0.0054        (\1\)                 0.0032            0.0054   
789-02-6...............  DDT (o,p').......       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
2303-16-4..............  Diallate.........           0.26              1                 0.46              0.26              1                 0.46     
132-64-9...............  Dibenzofuran.....           8             27000                
FR Doc. 95-29458 Hazardous Waste Management System: Identification and Listing of Hazardous Waste: Hazardous Waste Identification Rule (HWIR)
 2                 8             27000                 3        
192-64-9...............  Dibenzo[a,e]pyren           0.0029            4                 0.0012            0.0029            4             (\1\)        
                          e.                                                                                                                            
189-64-0...............  Dibenzo[a,h]pyren           0.0029            4                 0.0012            0.0029            4             (\1\)        
                          e.                                                                                                                            
189-55-9...............  Dibenzo[a,i]pyren           0.0029            4                 0.0012            0.0029            4             (\1\)        
                          e.                                                                                                                            
194-59-2...............  Dibenzo[c,g]carba       (\1\)                 4             (\1\)             (\1\)                 4             (\1\)        
                          zole, 7H-.                                                                                                                    
226-36-8...............  Dibenz(a,h)acridi           0.0029            4                 0.0012            0.0029            4             (\1\)        
                          ne.                                                                                                                           
53-70-3................  Dibenz(a,h)anthra       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          cene.                                                                                                                         
224-42-0...............  Dibenz[a,j]acridi           0.0029            4                 0.0012            0.0029            4             (\1\)        
                          ne.                                                                                                                           
96-12-8................  Dibromo-3-                  0.0022            0.66              0.00038           0.00066           0.66          (\1\)        
                          chloropropane,                                                                                                                
                          1,2-.                                                                                                                         
764-41-0...............  Dichloro-2-                 0.024            31                 0.012             0.023            31                 0.016    
                          butene, 1,4-.                                                                                                                 
110-57-6...............  Dichloro-2-                 0.024            31                 0.012             0.023            31                 0.015    
                          butene, trans-                                                                                                                
                          1,4-.                                                                                                                         

[[Page 66447]]
                                                                                                                                                        
96-23-1................  Dichloro-2-                 0.27            140                 0.033             0.081           140                 0.032    
                          propanol, 1,3-.                                                                                                               
95-50-1................  Dichlorobenzene,            8             50000                 2                15             50000                 6        
                          1,2-.                                                                                                                         
541-73-1...............  Dichlorobenzene,            0.024            31                 0.012             0.023            31                 0.015    
                          1,3-.                                                                                                                         
106-46-7...............  Dichlorobenzene,            1                64                 0.22              0.056            64                 0.011    
                          1,4-.                                                                                                                         
91-94-1................  Dichlorobenzidine           0.0037        (\1\)             (\1\)                 0.0037        (\1\)             (\1\)        
                          , 3,3').                                                                                                                      
75-71-8................  Dichlorodifluorom          15              8100                12                15              8100                12        
                          ethane.                                                                                                                       
75-34-3................  Dichloroethane,             0.00016          24                 0.0006            0.00016          24                 0.00006  
                          1,1-.                                                                                                                         
107-06-2...............  Dichloroethane,             0.007             6                 0.009             0.00016           6                 0.00006  
                          1,2-.                                                                                                                         
75-35-4................  Dichloroethylene,           0.0035            3                 0.013             0.00059           3                 0.00018  
                          1,1-.                                                                                                                         
156-59-2...............  Dichloroethylene,           0.29           5400                 0.11              2              5400                 0.64     
                          cis-1,2-.                                                                                                                     
156-60-5...............  Dichloroethylene,           0.42          14000                 0.16              3             14000                 1        
                          trans-1,2-.                                                                                                                   
111-91-1...............  Dichloromethoxy             0.024            31                 0.012             0.023            31                 0.015    
                          ethane.                                                                                                                       
98-87-3................  Dichloromethylben           0.024            31                 0.012             0.023            31                 0.015    
                          zene (benzal                                                                                                                  
                          chloride).                                                                                                                    
120-83-2...............  Dichlorophenol,             0.62            770                 0.18              0.62            770                 0.18     
                          2,4-.                                                                                                                         
87-65-0................  Dichlorophenol,             0.024            31                 0.012             0.023            31                 0.015    
                          2,6-.                                                                                                                         
94-75-7................  Dichlorophenoxyac           0.27           3100                 0.11              2              3100                 0.6      
                          etic acid, 2,4-                                                                                                               
                          (2,4-D).                                                                                                                      
78-87-5................  Dichloropropane,            0.12             17                 0.012             0.023            17                 0.0023   
                          1,2-.                                                                                                                         
542-75-6...............  Dichloropropene,            0.0028           32             (\1\)                 0.0028           32             (\1\)        
                          1,3-.                                                                                                                         
10061-01-5.............  Dichloropropene,            0.0049            3              1200                 0.0049            3              1200        
                          cis-1,3-.                                                                                                                     
10061-02-6.............  Dichloropropene,            0.0049            3              1200                 0.0049            3              1200        
                          trans-1,3-.                                                                                                                   
60-57-1................  Dieldrin.........           0.000059          0.0018            0.54              0.000059          0.0018            0.54     
1464-53-5..............  Diepoxybutane,             15              6900                11                15              6900                11        
                          1,2,3,4- (2,2'-                                                                                                               
                          bioxirane).                                                                                                                   
84-66-2................  Diethyl phthalate         190              4500                54               190              4500                54        
311-45-5...............  Diethyl-p-              (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          nitrophenyl                                                                                                                   
                          phosphate.                                                                                                                    
56-53-1................  Diethylstilbestro       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          l.                                                                                                                            
94-58-6................  Dihydrosafrole...          15              6900                11                15              6900                11        
60-51-5................  Dimethoate.......          29                 2                 0.77             29                 2                 0.77     
131-11-3...............  Dimethyl                   78                 3                30                78                 3                30        
                          phthalate.                                                                                                                    
77-78-1................  Dimethyl sulfate.       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
60-11-7................  Dimethylaminoazob           0.028             3             (\1\)                 0.028             3             (\1\)        
                          enzene, p-.                                                                                                                   
119-93-7...............  Dimethylbenzidine       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          , 3,3'.                                                                                                                       
57-97-6................  Dimethylbenz(a)an       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          thracene, 7,12.                                                                                                               
79-44-7................  Dimethylcarbamoyl       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          chloride.                                                                                                                     
122-09-8...............  Dimethylphenethyl           0.16             20                 0.11              0.16             20                 0.11     
                          amine, alpha,                                                                                                                 
                          alpha-.                                                                                                                       
105-67-9...............  Dimethylphenol,             4             11000                 1                 4             11000                 1        
                          2,4-.                                                                                                                         
119-90-4...............  Dimethyoxybenzidi           0.034         (\1\)                 0.01              0.034         (\1\)                 0.01     
                          ne, 3,3-.                                                                                                                     
84-74-2................  Di-n-butyl                880             90000               100               230             90000                25        
                          phthalate.                                                                                                                    
99-65-0................  Dinitrobenzene,             0.017             6                 0.0064            0.017             6                 0.0064   
                          1,3-.                                                                                                                         
100-25-4...............  Dinitrobenzene,         (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          1,4-.                                                                                                                         
534-52-1...............  Dinitro-o-cresol,       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          4,6-.                                                                                                                         
51-28-5................  Dinitrophenol,              0.27             56                 0.11              0.27             56                 0.11     
                          2,4-.                                                                                                                         
121-14-2...............  Dinitrotoluene,             0.29            210                 0.11              0.29            210                 0.11     
                          2,4-.                                                                                                                         
606-20-2...............  Dinitrotoluene,             0.17             86                 0.064             0.17             86                 0.064    
                          2,6-.                                                                                                                         
117-84-0...............  Di-n-octyl                  0.002          4500                 0.1               0.002          4500                 0.1      
                          phthalate.                                                                                                                    
123-91-1...............  Dioxane, 1,4-....           0.042            13                 0.014             0.042            13                 0.014    
122-39-4...............  Diphenylamine....          15              1200                 3                15             12000                 3        
122-66-7...............  Diphenylhydrazine           0.16             20                 0.11              0.16             20                 0.11     
                          , 1,2-.                                                                                                                       
298-04-4...............  Disulfoton.......           0.013            43                13                 0.013            43                13        
541-53-7...............  Dithiobiuret.....       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         D, salts, esters,           0.0069        (\1\)                 0.54              0.0069        (\1\)                 0.48     
                          2,4-.                                                                                                                         
115-29-7...............  Endosulfan.......           6                73                 0.94              6                73                 0.94     
959-98-8...............  Endosulfan I.....           0.0069            0.19              0.54              0.0069            0.19              0.48     
33213-65-9.............  Endosulfan II....           0.0069            0.19              0.54              0.0069            0.19              0.48     
1031-07-8..............  Endosulfan                  0.0069            0.19              0.54              0.0069            0.19              0.48     
                          sulfate.                                                                                                                      
145-73-3...............  Endothall........       (\1\)             (\1\)                 0.54          (\1\)             (\1\)                 0.48     
72-20-8................  Endrin...........           0.073             0.26             24                 0.073             0.26             32        
7421-93-4..............  Endrin aldehyde..           0.0069            0.19              0.54              0.0069            0.19              0.48     
53494-70-5.............  Endrin ketone....           0.0069            0.19              0.54              0.0069            0.19              0.48     
106-89-8...............  Epichlorohydrin..           0.34             44              5400                 0.34             44              5400        
51-43-4................  Epinephrine......       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
110-80-5...............  Ethoxyethanol, 2-          15              6900                15                15              6900                15        
141-78-6...............  Ethyl acetate....         390            270000               110               390            270000               110        
51-79-6................  Ethyl carbamate..          15              6900                11                15              6900                11        
107-12-0...............  Ethyl cyanide               0.16             20                 0.11              0.16             20                 0.11     
                          (propionitrile).                                                                                                              
60-29-7................  Ethyl ether......          27             41000                11                27             41000                11        
97-63-2................  Ethl methacrylate          24              3400                 7                24              3400                7         

[[Page 66448]]
                                                                                                                                                        
62-50-0................  Ethyl                       0.0055        (\1\)             12000                 0.0055        (\1\)             12000        
                          methanesulfonate.                                                                                                             
100-41-4...............  Ethylbenzene.....           8            550000                 2                39            550000                 8        
 106-93-4..............  Ethylene                    0.00093           0.0075            0.00075           0.00036           0.0075        (\1\)        
                          Dibromide.                                                                                                                    
 75-21-8...............  Ethylene oxide...          15              6900                11                15              6900                11        
 96-45-7...............  Ethylene thiourea       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
 151-56-4..............  Ethyleneimine           (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          (aziridine).                                                                                                                  
 52-85-7...............  Famphur..........       (\1\)             (\1\)                 0.54 B        (\1\)             (\1\)                 0.48     
 640-19-7..............  Fluoracetamide, 2-      (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          .                                                                                                                             
 62-74-8...............  Fluoracetic acid,       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          sodium salt.                                                                                                                  
 206-44-0..............  Fluoranthene.....          28              6000                 2                28              6000                 2        
 86-73-7...............  Fluorene.........          22             90000                 3                22             90000                 3        
 16984-48-8............  Fluoride.........  ..................  ................  ................  ................  ................  ................
 50-00-0...............  Formaldehyde.....       (\1\)                49                11             (\1\)                49                11        
 64-18-6...............  Formia Acid......         270            300000               110               270            300000               110        
 765-34-4..............  Glycidylaldehyde.       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
 319-86-8..............  HCH, delta-......           0.0069            0.19              0.54              0.0069            0.19              0.48     
 76-44-8...............  Heptachlor.......       (\1\)                 8          ................     (\1\)                 8          ................
 1024-57-3.............  Heptachlor                  0.00053           0.026            66                 0.00053           0.026             0.45     
                          epoxide.                                                                                                                      
 87-68-3...............  Hexachloro-1,3-             0.0079           36                 0.0069            0.0079           36                 0.0069   
                          butadiene.                                                                                                                    
 118-74-1..............  Hexachlorobenzene       (\1\)             (\1\)                 0.018         (\1\)             (\1\)             (\1\)        
 319-84-6..............  Hexachloro-                 0.00014           0.0033            0.11              0.00014           0.033             0.11     
                          cyclohexane,                                                                                                                  
                          alpha- (alpha-                                                                                                                
                          BHC).                                                                                                                         
 319-85-7..............  Hexach- lorocyclo-          0.00044           0.12              0.00021           0.00044           0.12              0.00021  
                           hexane, beta-                                                                                                                
                          (beta-BHC).                                                                                                                   
 58-89-9...............  Hexach- lorocyc-            0.00078           0.1               2                 0.00078           0.1               0.69     
                          lohexane, gamma-                                                                                                              
                          (Lindane).                                                                                                                    
 77-47-4...............  Hexach- lorocyc-            0.0052         1500          ................         0.0052         1500          ................
                          lopentadiene.                                                                                                                 
 67-72-1...............  Hexachloroethane.           0.049            81                 0.033             0.049            81                 0.033    
 70-30-4...............  Hexachlorophene..       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
 1888-71-7.............  Hexachloropropene           0.27            140                 0.033             0.081           140                 0.032    
 757-58-4..............  Hexae- thylte-          (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          traphosphate.                                                                                                                 
 591-75-6..............  Hexanone, 2-.....           8              1200                 6                 8              1200                 6        
 302-01-2..............  Hydrazine........       (\1\)                20             (\1\)             (\1\)                20             (\1\)        
 193-39-5..............  Indeno(1,2,3-cd)            0.0029            4             (\1\)                 0.0029            4             (\1\)        
                          pyrene.                                                                                                                       
 74-88-4...............  Iodomethane......           0.024            31                 0.012             0.023            31                 0.015    
 78-83-1...............  Isobutyl alcohol.          39             55000                15                39             55000                15        
 465-73-6..............  Isodrin..........       (\1\)             (\1\)                 0.54          (\1\)             (\1\)                 0.48     
 78-59-1...............  Isophorone.......           0.53            740                 0.16              0.53            740                 0.16     
 120-58-1..............  Isosafrole.......          15              6900                11                15              6900                11        
 143-50-0..............  Kepone...........       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
 303-43-4..............  Lasiocarpine.....       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
 7439-92-1.............  Lead.............          30               570                12                30               570                12        
 108-31-6..............  Maleic anhydride.       (\1\)              6900             (\1\)             (\1\)              6900             (\1\)        
 123-33-1..............  Maleic hydrazide.           0.16             20                 0.11              0.16             20                 0.11     
 109-77-3..............  Malononitrile....           0.16             20                 0.11              0.16             20                 0.11     
 148-82-3..............  Melphalan........       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
 7439-97-6.............  Mercury..........           0.06              0.6               0.023             0.3               0.6               0.14     
 126-98-7..............  Methacrylonitrile           0.016             9             (\1\)                 0.016             9             (\1\)        
 74-93-1...............  Methanethiol.....       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
 67-56-1...............  Methanol.........          78            140000                30                78            140000                30        
 91-80-5...............  Methapyrilene....           0.16             20                 0.11              0.16             20                 0.11     
 16752-77-5............  Methomyl.........       (\1\)             (\1\)                 0.54          (\1\)             (\1\)                 0.48     
 72-43-5...............  Methoxychlor.....           7                19          ................         7                19          ................
 74-83-9...............  Methyl bromide              0.37            500                 0.92              0.37            500                 0.92     
                          (Bromomethane).                                                                                                               
 74-87-3...............  Methyl chloride             0.096            91          ................         0.096            91          ................
                          (Chloromethane).                                                                                                              
 78-93-3...............  Methyl ethyl               78            110000                30                78            110000                30        
                          ketone.                                                                                                                       
 1338-23-4.............  Methyl ethyl            (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          ketone peroxide.                                                                                                              
 60-34-4...............  Methyl hydrazine.       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
 108-10-1..............  Methyl isobutyl             8             17000                 3                 8             17000                 3        
                          ketone.                                                                                                                       

[[Page 66449]]
                                                                                                                                                        
 80-62-6...............  Methyl                     28             40000                 8                28             40000                 8        
                          methacrylate.                                                                                                                 
 66-27-3...............  Methyl                      0.12              2                 6                 0.12              2                 6        
                          methanesulfonate.                                                                                                             
 91-57-6...............  Methyl                  (\1\)                 4             (\1\)             (\1\)                 4             (\1\)        
                          naphthalene, 2-.                                                                                                              
 298-00-0..............  Methyl parathion.           0.66              1                23                 0.66              1                23        
 75-55-8...............  Methylaziridine,        (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          2-.                                                                                                                           
 56-49-5...............  Methylcholanthren       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          e, 3-.                                                                                                                        
74-95-3................  Methylene bromide           0.029          8400                 0.0085            2              8400                 0.19     
75-09-2................  Methylene                   0.039           310                 0.09              0.039           310                 0.015    
                          chloride.                                                                                                                     
101-14-4...............  Methylenebis,           (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          4,4'-(2-                                                                                                                      
                          chloroaniline).                                                                                                               
70-25-7................  Methyl-nitro-           (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          nitrosoguanidine                                                                                                              
                          (MNNG).                                                                                                                       
56-04-2................  Methylthiouracil.       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
50-07-7................  Mitomycin C......       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
7439-98-7..............  Molybdenum.......           2               110                 2                 2               110                 2        
91-20-3................  Naphthalene......          14            120000                 3                14            120000                 3        
130-15-4...............  Naphthoquinone,            15              6900                11                15              6900                11        
                          1,4-.                                                                                                                         
86-88-4................  Naphthyl-2-             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          thiourea, 1-.                                                                                                                 
134-32-7...............  Naphthylamine, 1-           0.16             20                 0.11              0.16             20                 0.11     
91-59-8................  Naphthylamine, 2-           0.16             20                 0.11              0.16             20                 0.11     
7440-02-0..............  Nickel...........           4               110                 2                11               110                 5        
54-11-5................  Nicotine and                0.16             20                 0.11              0.16             20                 0.11     
                          salts.                                                                                                                        
88-74-4................  Nitroaniline, 2-.       (\1\)                 3             (\1\)             (\1\)                 3             (\1\)        
99-09-2................  Nitroaniline, 3-.       (\1\)                 3             (\1\)             (\1\)                 3             (\1\)        
100-01-6...............  Nitroaniline, 4-.           0.028             3             (\1\)                 0.028             3             (\1\)        
98-95-3-...............  Nitrobenzene.....           0.084            45                 0.032             0.084            45                 0.032    
55-86-7................  Nitrogen mustard.       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
51-75-2................  Nitrogen mustard        (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          Hydrochloride                                                                                                                 
                          salt.                                                                                                                         
126-85-2...............  Nitrogen mustard        (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          N-Oxide.                                                                                                                      
302-70-5...............  Nitrogen mustard        (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          N-Oxide, HCI                                                                                                                  
                          salt.                                                                                                                         
55-63-0................  Nitroglycerine...       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
99-55-8................  Nitro-o-                    0.028             3             (\1\)                 0.028             3             (\1\)        
                          toluidine, 5-.                                                                                                                
88-75-5................  Nitrophenol, 2-..           0.025             3             (\1\)                 0.0.25            3             (\1\)        
100-02-7...............  Nitrophenol, 4-..       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
79-46-9................  Nitropropane, 2-.       (\1\)                 0.13       ................     (\1\)                 0.13       ................
56-57-5................  Nitroquinoline-1-           0.16             20                 0.11              0.16             20                 0.11     
                          oxide, 4-.                                                                                                                    
55-18-5................  Nitrosodiethylami       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          ne.                                                                                                                           
62-75-9................  Nitrosodimethylam       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          ine.                                                                                                                          
924-16-3...............  Nitrosodi-n-            (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          butylamine.                                                                                                                   
10595-95-6.............  Nitro- somethyle        (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          thylamine.                                                                                                                    
1116-54-7..............  N-Nitro- sodietha-      (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           nolamine.                                                                                                                    
621-64-7...............  N-Nitrosodi-n-          (\1\)                 0.023         (\1\)             (\1\)                 0.023         (\1\)        
                          propylamine.                                                                                                                  
86-30-6................  N-Nitro- sodiphe-           0.2            1300             (\1\)                 0.2            1300             (\1\)        
                          nylamine.                                                                                                                     
4549-40-0..............  N-Nitrosomethyl         (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          vinyl amine.                                                                                                                  
59-89-2................  N-                          0.16             20                 0.11              0.16             20                 0.11     
                          Nitrosomorpholin                                                                                                              
                          e.                                                                                                                            
759-73-9...............  N-Nitroso-N-            (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          ethylurea.                                                                                                                    
684-93-5...............  N-Nitroso-N-                0.16             20                 0.11              0.16             20                 0.11     
                          methylurea.                                                                                                                   
615-53-2...............  N-Nitroso-N-            (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          methylurethane.                                                                                                               
16543-55-8.............  N-                      (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          Nitrosonornicoti                                                                                                              
                          ne.                                                                                                                           
100-75-4...............  N-                      (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          Nitrosopiperidin                                                                                                              
                          e.                                                                                                                            
930-55-2...............  N-                      (\1\)                 0.053         (\1\)             (\1\)                 0.053         (\1\)        
                          Nitroopyrrolidin                                                                                                              
                          e.                                                                                                                            
13256-22-9.............  N-                      (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          Nitrososarcosine.                                                                                                             
103-85-5...............  N-Phenylthiourea.       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
1615-80-1..............  N,N-                    (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          Diethylhydrazine.                                                                                                             
152-16-9...............  Octame- thylpyro-           0.27             31                 0.11              0.27             31                 0.11     
                          phospho- ramide.                                                                                                              
20816-12-0.............  Osmium Tetroxice.       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
297-97-2...............  O,O-Diethyl O-              0.12              2                 6                 0.12              2                 6        
                          pyrazinyl                                                                                                                     
                          phosphorothioate.                                                                                                             
126-68-1...............  O,O,O-Triethyl              0.12          (\1\)                 6                 0.12          (\1\)                 6        
                          phosphorothioate.                                                                                                             
123-63-7...............  Paraldehyde......           8              1200                 6                 8              1200                 6        
56-38-2................  Parathion........           3                 0.13          12000                 3                 0.13          12000        
608-93-5...............  Pentachlorobenzen           5               210                 0.054             5               210                 0.054    
                          e.                                                                                                                            
76-01-7................  Pentachloroethane           0.024            31                 0.012             0.023            31                 0.015    
82-68-8................  Penta- chloro-              0.27             11             (\1\)                 0.081            11             (\1\)        
                          nitro-benzene                                                                                                                 
                          (PCNB).                                                                                                                       
87-86-5................  Pentachlorophenol           0.002             3                 0.00041           0.002             3                 0.00041  
62-44-2................  Phenacetin.......          15              6900                11                15              6900                11        
85-01-8................  Phenanthrene.....       (\1\)                 4             (\1\)             (\1\)                 4             (\1\)        
108-95-2...............  Phenol...........          84            160000                32                84            160000                32        
62-38-4................  Phenyl mercuric         (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          acetate.                                                                                                                      

[[Page 66450]]
                                                                                                                                                        
25265-76-3.............  Phenylenediamines           0.16             20                 0.11              0.16             20                 0.11     
                          (N.O.S.).                                                                                                                     
108-45-2...............  Phenylenediamine,           0.78            780                 0.3               0.78            780                 0.3      
                          m-.                                                                                                                           
106-50-3...............  Phenylenediamine,           0.16             20                 0.11              0.16             20                 0.11     
                          p-.                                                                                                                           
298-02-2...............  Phorate..........           0.11            160          ................         0.11            160          ................
                         Phosphorodithioic       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          acid,                                                                                                                         
                          dimethylethylest                                                                                                              
                          er.                                                                                                                           
298-06-6...............  Phosphorodithioic       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          acid, o-o-                                                                                                                    
                          diethyl ester.                                                                                                                
3288-58-2..............  Phosphorodithioic       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          acid, o-o-                                                                                                                    
                          diethyl-s-methyl.                                                                                                             
2953-29-9..............  Phosphorodithioic       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          acid, trimethyl                                                                                                               
                          ester.                                                                                                                        
85-44-9................  Phthalic                (\1\)              2400             (\1\)             (\1\)              2400             (\1\)        
                          anhydride.                                                                                                                    
109-06-8...............  Picoline, 2-.....           0.16             20                 0.11              0.16             20                 0.11     
1336-36-3..............  Polychlorinated         (\1\)             (\1\)                 0.009         (\1\)             (\1\)             (\1\)        
                          biphenyls.                                                                                                                    
23950-58-5.............  Pronamide........          21               440                 6                21               440                 6        
1120-71-4..............  Propane sultone,        (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          1,3-.                                                                                                                         
107-10-8...............  Propylamine, n-..           0.16             20                 0.11              0.16             20                 0.11     
51-52-5................  Propylthiouracil.           0.12          (\1\)                 6                 0.12          (\1\)                 6        
107-19-7...............  Propyn-1-ol,2-...          39             37000                15                39             37000                15        
129-00-0...............  Pyrene...........          54             16000                 2                54             16000                 2        
110-86-1...............  Pyridine.........           0.16            810                 0.06              0.16            810                 0.06     
50-55-5................  Reserpine........           0.16             20                 0.11              0.16             20                 0.11     
108-46-3...............  Resorcinol.......       (\1\)             (\1\)                 0.54          (\1\)             (\1\)                 0.48     
81-07-2................  Saccharin and           (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          salts.                                                                                                                        
94-59-7................  Safrole..........           0.0035           11             (\1\)                 0.0035           11             (\1\)        
7782-49-2..............  Selenium.........           0.23          (\1\)                 0.089             0.93          (\1\)                 0.36     
7440-22-4..............  Silver...........         200             (\1\)          ................       200             (\1\)          ................
18883-66-4.............  Streptozotocin...       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
57-24-9................  Strychnine.......           0.045         (\1\)                 0.016             0.045         (\1\)                 0.016    
100-42-5...............  Stryene..........           0.91         630000                 0.22             64            630000                15        
18496-25-8.............  Sulfide..........  ..................  ................  ................  ................  ................  ................
1746-01-6..............  TCDD,2,3,7,8-....       (\1\)                 8.000E-06         5.400E-07     (\1\)                 8.000E-06     (\1\)        
95-94-3................  Tetrachlorobenzen           0.23            170                 0.032             0.23            170                 0.032    
                          e, 1,2,4,5-.                                                                                                                  
630-20-6...............  Tetrachloroethane           0.024           130                 0.0078            0.024           130                 0.0078   
                          , 1,1,1,2-.                                                                                                                   
79-34-5................  Tetrachloroethane           0.0037           29                 0.0077            0.0037           29                 0.0077   
                          , 1,1,2,2-.                                                                                                                   
127-18-4...............  Tetrachloroethyle           0.026         13000                 0.0085            2             13000                 0.68     
                          ne.                                                                                                                           
58-90-2................  Tetrachlorophenol           2              6200                 0.58              2              6200                 0.58     
                          , 2,3,4,6-.                                                                                                                   
107-49-3...............  Tetraethylpyropho       (\1\)              6900             (\1\)             (\1\)              6900           ( \1\ )        
                          sphate.                                                                                                                       
3689-24-5..............  Tetraethyldithiop           0.23              3          ................         0.23              3          ................
                          yrophosphate.                                                                                                                 
7440-28-0..............  Thallium (l).....           0.035             5                 0.014             0.05              5                 0.019    
62-55-5................  Thioacetamide....       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)           ( \1\ )        
39196-18-4.............  Thiofanox........           0.12          (\1\)                 6                 0.12          (\1\)                 6        
108-98-5...............  Thiophenol.......           0.12              2                 6                 0.12              2                 6        
79-19-6................  Thiosemicarbazide       (\1\)             (\1\)          (\1\)(\1\)           (\1\)             (\1\)             (\1\)        
62-56-6................  Thiourea.........       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
137-26-8...............  Thiram...........       (\1\)             (\1\)                 0.54          (\1\)             (\1\)                 0.48     
7440-31-5..............  Tin..............       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
108-88-3...............  Toluene..........           6            180000                 2                30            180000                13        
584-84-9...............  Toluene                 (\1\)                20             (\1\)             (\1\)                20             (\1\)        
                          diisocyanate.                                                                                                                 
95-80-7................  Toluenediamine,2,       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          4-.                                                                                                                           
823-40-5...............  Toluenediamine,2,           0.16             20                 0.11              0.16             20                 0.11     
                          6-.                                                                                                                           
496-72-0...............  Toluenediamine,3,           0.16             20                 0.11              0.16             20                 0.11     
                          4-.                                                                                                                           
636-21-5...............  Toluidine                   0.16             20                 0.11              0.16             20                 0.11     
                          hydrochloride, o-                                                                                                             
                          .                                                                                                                             
95-53-4................  Toluidine, o-....       (\1\)                 2             (\1\)             (\1\)                 2             (\1\)        
106-49-0...............  Toluidine, p-....       (\1\)                 0.13          (\1\)             (\1\)                 0.13          (\1\)        
8001-35-2..............  Toxaphene........       (\1\)             (\1\)                 6             (\1\)             (\1\)                 0.11     
76-13-1................  Trichloro-1,2,2-            0.77       ................         0.17           2200          ................      2400        
                          trifluoroethane,                                                                                                              
                          1,1,2-.                                                                                                                       
                                                                                                                                                        

[[Page 66451]]
                                                                                                                                                        
120-82-1...............  Trichlorobenzene,           0.69           3500                 1                 0.69           3500                 1        
                          1,2,4-.                                                                                                                       
72-55-6................  Trichloroethane,           74             48000                 0.054            74             48000                 0.054    
                          1,1,1-.                                                                                                                       
79-00-5................  Trichloroethane,            0.012            11                 0.009             0.007            11                 0.0018   
                          1,1,2-.                                                                                                                       
79-01-6................  Trichloroethylene           0.024           570                 0.008             0.038           570                 0.013    
75-69-4................  Trichlorofluorome          48             26000                16                48             26000                16        
                          thane.                                                                                                                        
75-70-7................  Trichloromethanet       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          hiol.                                                                                                                         
95-95-4................  Trichlorophenol,           18             12000                 4                18             12000                 4        
                          2,4,5-.                                                                                                                       
88-06-2................  Trichlorophenol,            0.054           120                 0.015             0.054           120                 0.015    
                          2,4,6-.                                                                                                                       
93-76-5................  Trichlorophenoxya           2                63                 0.64              2                63                 0.64     
                          cetic acid,                                                                                                                   
                          2,4,5- (245-T).                                                                                                               
93-72-1................  Trichlorophenoxyp           0.21              6                 0.08              1                 6                 0.48     
                          ropionic acid,                                                                                                                
                          2,4,5-(Silvex).                                                                                                               
96-18-4................  Trichloropropane,           1               870                 0.34              1               870                 0.34     
                          1,2,3-.                                                                                                                       
99-35-4................  Trinitrobenzene,            0.0078            0.44              0.003             0.0078            0.44              0.003    
                          sym-.                                                                                                                         
126-72-7...............  Tris (2,3-              (\1\)                 0.36          (\1\)             (\1\)                 0.36          (\1\)        
                          dibromopropyl)                                                                                                                
                          phosphate.                                                                                                                    
52-24-4................  Tris(1-                 (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          azridinyl)phosph                                                                                                              
                          ine sulfide.                                                                                                                  
72-57-1................  Trypan blue......       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
66-75-1................  Uracil mustard...       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
7440-62-2..............  Vanadium.........          10               250                 4                10               250                 4        
108-05-4...............  Vinyl acetate....          15              6900                11                15              6900                11        
75-01-4................  Vinyl chloride...           0.002             1                 0.003         (\1\)                 1             (\1\)        
81-81-2................  Warfarin.........       (\1\)             (\1\)                 0.54          (\1\)             (\1\)                 0.48     
1330-20-7..............  Xylenes (total)..          22            170000                21                22            170000               150        
7440-66-6..............  Zinc.............          99               320                38                99               320                38        
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ See Table B.                                                                                                                                        

                                                        Table B.--Quantitation-Based Exit Levels                                                        
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                              MCL benchmark option                                Toxicity benchmark option             
                                             -----------------------------------------------------------------------------------------------------------
         CAS No.                 Name            Wastewater                Nonwastewater               Wastewater                Nonwastewater          
                                             -----------------------------------------------------------------------------------------------------------
                                                Totals (mg/l)    Totals (mg/kg)     Leach (mg/l)      Totals (mg/l)    Totals (mg/kg)     Leach (mg/l)  
--------------------------------------------------------------------------------------------------------------------------------------------------------
208-96-8................  Acenaphthylene....         0.02       ................         0.02              0.02       ................         0.02     
75-36-5.................  Acetyl chloride...     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
591-08-2................  Acetyl-2-thiourea,         1                70          ................         1                70          ................
                           1-.                                                                                                                          
53-96-3.................  Acetylaminofluoren  ................  ................         0.02       ................  ................         0.02     
                           e, 2-.                                                                                                                       
107-02-8................  Acrolein..........         0.013      ................  ................         0.013      ................  ................
79-06-1.................  Acrylamide........         0.01              0.1               0.01              0.01              0.1               0.01     
107-13-1................  Acrylonitrile.....         0.008      ................         0.008             0.008      ................         0.008    
1402-68-2...............  Aflatoxins........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
116-06-3................  Aldicarb..........         0.05              1          ................         0.05              1          ................
309-00-2................  Aldrin............         0.000034          0.0006            0.000034          0.000034          0.0006            0.000034 
107-18-6................  Allyl alcohol.....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
92-67-1.................  Aminobiphenyl, 4-.  ................  ................         0.02       ................  ................         0.02     
2763-96-4...............  Aminomethyl-3-         (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           isoxazolol, 5-.                                                                                                              
504-24-5................  Aminopyridine, 4-.     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
61-82-5.................  Amitrole..........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
120-12-7................  Anthracene........         0.007      ................         0.007             0.007      ................         0.007    
7440-38-2...............  Arsenic...........  ................         0.3        ................         0.0005            0.3               0.0005   
2465-27-2...............  Auramine.
FR Doc. 95-29458 Hazardous Waste Management System: Identification and Listing of Hazardous Waste: Hazardous Waste Identification Rule (HWIR)
.........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
115-02-6................  Azaserine.........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
92-87-5.................  Benzidine.........         0.0025            0.042             0.0025            0.0025            0.042             0.0025   
98-07-7.................  Benzotrichloride..     (\1\)          ................     (\1\)             (\1\)          ................     (\1\)        
50-32-8.................  Benzo(a)pyrene....  ................  ................  ................  ................  ................         0.000023 
205-82-3................  Benzo(j)fluor-      ................  ................  ................  ................  ................         0.0002   
                           anthene.                                                                                                                     
207-08-9................  Benzo(k)-           ................  ................  ................  ................  ................         0.0002   
                           fluoranthene.                                                                                                                
191-24-2................  Benzo[g,h,i]-       ................  ................  ................  ................  ................         0.0008   
                           perylene.                                                                                                                    
56-55-3.................  Benz(a)anth-        ................  ................         0.000013   ................  ................         0.000013 
                           racene.                                                                                                                      
225-51-4................  Benz[c]acri- dine.  ................  ................  ................  ................  ................         0.0005   
7440-41-7...............  Beryllium.........  ................         0.1        ................  ................         0.1        ................
542-88-1................  Bis(chloro-            (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           methyl) ether.                                                                                                               
357-57-3................  Brucine...........        20             (\1\)                20                20             (\1\)                20        
86-74-8.................  Carbazole.........      (\1\             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
353-50-4................  Carbon oxyfluoride     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        

[[Page 66452]]
                                                                                                                                                        
75-87-6.................  Chloral...........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
305-03-3................  Chlorambucil......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
57-74-9.................  Chlordane.........         0.00004    ................  ................         0.00004    ................  ................
494-03-1................  Chlornaphazin.....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
107-20-0................  Chloroacetaldehyde      (\1\             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
110-75-8................  Chloroethyl vinyl      (\1\)          ................     (\1\)             (\1\)          ................     (\1\)        
                           ether, 2-.                                                                                                                   
107-30-2................  Chloromethyl           (\1\)          ................     (\1\)             (\1\)          ................     (\1\)        
                           methyl ether.                                                                                                                
5344-82-1...............  Chlorophenyl           (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           thiourea, 1-o-.                                                                                                              
542-76-7................  Chloropropionitril  ................  ................         0.1               0.1        ................         0.1      
                           e, 3-.                                                                                                                       
6358-53-8...............  Citrus red No. 2..     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
7440-48-4...............  Cobalt............  ................  ................         0.5        ................  ................         0.5      
57-12-5.................  Cyanide...........         0.2        ................         0.2               0.2        ................         0.2      
14901-08-7..............  Cycasin...........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
108-94-1................  Cyclohexanone.....        10          ................        10                10          ................        10        
131-89-5................  Cyclohexyl-4,6-            0.1               7                 0.1               0.1               7                 0.1      
                           dinitrophenol, 2-.                                                                                                           
50-18-0.................  Cyclophosphamide..     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
20830-81-3..............  Daunomycin........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
53-19-0.................  DDD (o,p\1\)......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
72-55-9.................  DDE...............         0.000058   ................  ................         0.000058   ................  ................
3424-82-6...............  DDE (o,p\1\)......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
50-29-3.................  DDT...............         0.000081   ................  ................         0.000081   ................  ................
789-02-6................  DDT (o,p\1\)......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
192-65-4................  Dibenzo[a,e]-       ................  ................  ................  ................  ................         0.001    
                           pyrene.                                                                                                                      
189-64-0................  Dibenzo[a,h]-       ................  ................  ................  ................  ................         0.0002   
                           pyrene.                                                                                                                      
189-55-9................  Dibenzo(a,i)pyrene  ................  ................  ................  ................  ................         0.0002   
194-59-2................  Dibenzo(c,g)car-           0.01       ................         0.01              0.01       ................         0.01     
                           bazole, 7H-.                                                                                                                 
226-36-8................  Dibenz(a,h)acri-    ................  ................  ................  ................  ................         0.0002   
                           dine.                                                                                                                        
53-70-3.................  Dibenz(a,h)ant-            0.00003           0.084             0.00003           0.00003           0.084             0.00003  
                           hracene.                                                                                                                     
224-42-0................  Dibenz(a,j)acridin  ................  ................  ................  ................  ................         0.001    
                           e.                                                                                                                           
96-12-8.................  Dibromo-3-          ................  ................  ................  ................  ................         0.00026  
                           chloropropane,                                                                                                               
                           1,2-.                                                                                                                        
91-94-1.................  Dichlorobenzidine,  ................         0.12              0.0024     ................         0.012             0.0024   
                           3,3\1\-.                                                                                                                     
542-75-6................  Dichloropropene,    ................  ................         0.0009     ................  ................         0.0009   
                           1,3-.                                                                                                                        
311-45-5................  Diethyl-p-             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           nitrophenyl                                                                                                                  
                           phosphate.                                                                                                                   
56-53-1.................  Diethylstilbestrol         0.0078            1                 0.0078            0.0078            1                 0.0078   
77-78-1.................  Dimethyl sulfate..     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
60-11-7.................  Dimethylaminoazobe  ................  ................         0.01       ................  ................         0.01     
                           nzene, p-.                                                                                                                   
119-93-7................  Dimethylbenzidine,         0.0033            0.7               0.0033            0.0033            0.7               0.0033   
                           3,3\1\-.                                                                                                                     
57-97-6.................  Dimethylbenz-              0.00037           0.039             0.00037           0.00037           0.039             0.00037  
                           (a)anthracene,                                                                                                               
                           7,12-.                                                                                                                       
79-44-7.................  Dimethylcarbamoyl      (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           chloride.                                                                                                                    
119-90-4................  Dimethyoxybenzidin  ................         7          ................  ................         7          ................
                           e, 3,3\1\-.                                                                                                                  
100-25-4................  Dinitrobenzene,            0.04              3                 0.04              0.04              3                 0.4      
                           1,4-.                                                                                                                        
534-52-1................  Dinitro-o-cresol,          0.05              3                 0.05              0.05              3                 0.05     
                           4,6-.                                                                                                                        
541-53-7................  Dithiobiuret......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                          D, salts, esters,   ................         0.2        ................  ................         0.2        ................
                           2,4-.                                                                                                                        
145-73-3................  Endothall.........         0.1           (\1\)          ................         0.1           (\1\)          ................
51-43-4.................  Epinephrine.......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
62-50-0.................  Ethyl               ................         0.018      ................  ................         0.018      ................
                           methanesulfonate.                                                                                                            
106-93-4................  Ethylene Dibromide  ................  ................  ................  ................  ................         0.00006  
96-45-7.................  Ethylene thiourea.     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
151-56-4................  Ethyleneimine          (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           (aziridine).                                                                                                                 
52-85-7.................  Famphur...........         0.02              1          ................         0.02              1          ................
640-19-7................  Fluoracetamide, 2-     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
62-74-8.................  Fluoracetic acid,      (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           sodium salt.                                                                                                                 
16984-48-8..............  Fluoride..........  ................  ................  ................  ................  ................  ................
50-00-0.................  Formaldehyde......         0.023      ................  ................         0.023      ................  ................
765-34-4................  Glycidylaldehyde..     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
76-44-8.................  Heptachlor........         0.00004    ................  ................         0.00004    ................  ................

[[Page 66453]]
                                                                                                                                                        
118-74-1................  Hexachlorobenzene.         0.0016            0.072      ................         0.0016            0.072             0.0016   
70-30-4.................  Hexachlorophene...         0.21              2                 0.21              0.21              2                 0.21     
757-58-4................  Hexaethyl              (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           tetraphosphate.                                                                                                              
302-01-2................  Hydrazine.........     (\1\)          ................     (\1\)             (\1\)          ................     (\1\)        
193-39-5................  Indeno(1,2,3-cd)    ................  ................         0.000043   ................  ................         0.000043 
                           pyrene.                                                                                                                      
465-73-6................  Isodrin...........         0.02              1          ................         0.02              1          ................
143-50-0................  Kepone............         0.016             0.097             0.016             0.016             0.097             0.016    
303-43-4................  Lasiocarpine......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
108-31-6................  Maleic anhydride..     (\1\)          ................     (\1\)             (\1\)          ................     (\1\)        
148-82-3................  Melphalan.........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
126-98-7................  Methacrylonitrile.  ................  ................         0.009      ................  ................         0.009    
74-93-1.................  Methanethiol......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
16752-77-5..............  Methomyl..........         0.05              3          ................         0.05              3          ................
1338-23-4...............  Methyl ethyl           (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           ketone peroxide.                                                                                                             
60-34-4.................  Methyl hydrazine..     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
91-57-6.................  Methyl                     0.01       ................         0.01              0.01       ................         0.01     
                           naphthalene, 2-.                                                                                                             
75-55-8.................  Methylaziridine, 2-    (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           .                                                                                                                            
56-49-5.................  Methylcholanthrene         0.01              0.046             0.01              0.01              0.046             0.01     
                           , 3-.                                                                                                                        
101-14-4................  Methylenebis,          (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           4,4\1\-(2-                                                                                                                   
                           chloroaniline).                                                                                                              
70-25-7.................  Methyl-nitro-          (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           nitrosoguanidine                                                                                                             
                           (MNNG).                                                                                                                      
56-04-2.................  Methylthiouracil..     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
50-07-7.................  Mitomycin C.......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
86-88-4.................  Naphthyl-2-            (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           thiourea, 1-.                                                                                                                
88-74-4.................  Nitroaniline, 2-..         0.05       ................         0.05              0.05       ................         0.05     
99-09-2.................  Nitroaniline, 3-..         0.05       ................         0.05              0.05       ................         0.05     
100-01-6................  Nitroaniline, 4-..  ................  ................         0.02       ................  ................         0.02     
55-86-7.................  Nitrogen mustard..     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
51-75-2.................  Nitrogen mustard       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           hydrochloride                                                                                                                
                           salt.                                                                                                                        
126-85-2................  Nitrogen mustard N-    (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           Oxide.                                                                                                                       
302-70-5................  Nitrogen mustard N-    (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           Oxide, HCI salt.                                                                                                             
55-63-0.................  Nitroglycerine....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
99-55-8.................  Nitro-o-toluidine,  ................  ................         0.01       ................  ................         0.01     
                           5-.                                                                                                                          
88-75-5.................  Nitrophenol, 2-...  ................  ................         0.01       ................  ................         0.01     
100-02-7................  Nitrophenol, 4-...         0.05              3                 0.05              0.05              3                 0.05     
79-46-9.................  Nitropropane, 2-..         0.0058     ................  ................         0.0058     ................  ................
55-18-5.................  Nitrosodiethylamin         0.002             1                 0.002             0.002             1                 0.002    
                           e.                                                                                                                           
62-75-9.................  Nitrosodimethylami         0.0006            0.074             0.0006            0.0006            0.074             0.0006   
                           ne.                                                                                                                          
924-16-3................  Nitrosodi-n-               0.06       ................         0.06              0.06       ................         0.06     
                           butylamine.                                                                                                                  
10595-95-6..............  Nitrosomethylethyl         0.028             0.016             0.028             0.028             0.016             0.028    
                           amine.                                                                                                                       
1116-54-7...............  N-                         0.01              0.7               0.01              0.01              0.7               0.01     
                           Nitrosodiethanola                                                                                                            
                           mine.                                                                                                                        
621-64-7................  N-Nitrosodi-n-             0.026      ................         0.026             0.026      ................         0.026    
                           propylamine.                                                                                                                 
86-30-6.................  N-                  ................  ................         0.05       ................  ................         0.05     
                           Nitrosodiphenylam                                                                                                            
                           ine.                                                                                                                         
4549-40-0...............  N-Nitrosomethyl        (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           vinyl amine.                                                                                                                 
759-73-9................  N-Nitroso-N-           (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           ethylurea.                                                                                                                   
615-53-2................  N-Nitroso-N-           (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           methylurethane.                                                                                                              
16543-55-8..............  N-                     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           Nitrosonornicotin                                                                                                            
                           e.                                                                                                                           
100-75-4................  N-                         0.0014            0.033             0.0014            0.0014            0.033             0.0014   
                           Nitrosopiperidine.                                                                                                           
930-55-2................  N-                         0.0047     ................         0.0047            0.0047     ................         0.0047   
                           Nitrosopyrrolidin                                                                                                            
                           e.                                                                                                                           
13256-22-9..............  N-Nitrososarcosine     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
103-85-5................  N-Phenylthiourea..     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
1615-80-1...............  N,N-                   (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           Diethylhydrazine.                                                                                                            
20816-12-0..............  Osmium tetroxide..         3               200                 3                 3               200                 3        
126-68-1................  O,O,O-Triethyl      ................         3          ................  ................         3          ................
                           phosphorothioate.                                                                                                            
82-68-8.................  Pentachloronitrobe  ................  ................         0.02       ................  ................         0.02     
                           nzene (PCNB).                                                                                                                
85-01-8.................  Phenanthrene......         0.006      ................         0.006             0.006      ................         0.006    
62-38-4.................  Phenyl mercuric        (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           acetate.                                                                                                                     
                          Phosphorodithiolic     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           acid,                                                                                                                        
                           dimethylethyleste                                                                                                            
                           r.                                                                                                                           
298-06-6................  Phosphorodithioic      (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           acid, o-o-diethyl                                                                                                            
                           ester.                                                                                                                       
3288-58-2...............  Phosphorodithioic      (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           acid, o-o-diethyl-                                                                                                           
                           s-methyl.                                                                                                                    
2953-29-9...............  Phosphorodithioic      (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           acid, trimethyl                                                                                                              
                           ester.                                                                                                                       
85-44-9.................  Phthalic anhydride     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
1336-36-3...............  Polychlorinated            0.0005            0.04       ................         0.0005            0.04              0.0005   
                           biphenyls.                                                                                                                   
1120-71-4...............  Propane sultone,       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           1,3-.                                                                                                                        
51-52-5.................  Propylthiouracil..  ................         7          ................         7          ................                  
108-46-3................  Resorcinol........         0.1               7          ................         0.1               7          ................
81-07-2.................  Saccharin and          (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           salts.                                                                                                                       

[[Page 66454]]
                                                                                                                                                        
94-59-7.................  Safrole...........  ................  ................         0.0021     ................  ................         0.0021   
94-59-7.................  Safrole...........  ................  ................         0.0021     ................  ................         0.0021   
7782-49-2...............  Selenium..........  ................         5          ................  ................         5          ................
7440-22-4...............  Silver............  ................         0.3        ................  ................         0.3        ................
18883-66-4..............  Streptozotocin....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
57-24-9.................  Strychnine........  ................         3          ................  ................         3          ................
1746-01-6...............  TCDD, 2,3,7,8-....         1.000E-08  ................  ................         1.000E-08  ................         1.000E-08
107-49-3................  Tetraethyl             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           pyrophosphate.                                                                                                               
62-55-5.................  Thioacetamide.....         1             (\1\)                 1                 1             (\1\)                 1        
39196-18-4..............  Thiofanox.........  ................         3          ................  ................         3          ................
79-19-6.................  Thiosemicarbazide.     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
62-56-6.................  Thiourea..........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
137-26-8................  Thiram............         0.05              3          ................         0.05              3          ................
7440-31-5...............  Tin...............         8               500                 8                 8               500                 8        
584-84-9................  Toluene                (\1\)          ................     (\1\)             (\1\)          ................  ................
                           diisocyanate.                                                                                                                
95-80-7.................  Toluenediamine,            0.013             1                 0.013             0.013             1                 0.013    
                           2,4-.                                                                                                                        
95-53-4.................  Toluidine, o-.....         0.012      ................         0.012             0.012      ................         0.012    
106-49-0................  Toluidine, p-.....         0.017      ................         0.017             0.017      ................         0.017    
8001-35-2...............  Toxaphene.........         0.0013            0.03       ................         0.0013            0.03       ................
75-70-7.................  Trichloromethaneth     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           iol.                                                                                                                         
126-72-7................  Tris (2,3-                 0.025      ................         0.025             0.025      ................         0.025    
                           dibromopropyl)                                                                                                               
                           phosphate.                                                                                                                   
52-24-4.................  Tris(1-azridinyl)      (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                           phosphine sulfide.                                                                                                           
72-57-1.................  Trypan blue.......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
66-75-1.................  Uracil mustard....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
75-01-4.................  Vinyl chloride....  ................  ................  ................         0.00017    ................         0.00017  
81-81-2.................  Warfarin..........         0.05              3          ................         0.05              3          ................
--------------------------------------------------------------------------------------------------------------------------------------------------------

                                                                                                                                                        

[[Page 66455]]
    8. Appendix XI is added to read as follows:                                                                                                         
Appendix XI                                                                                                                                             
                                                                                                                                                        

                                          Table A.--Modeled or Extrapolated Risk-Based Conditional Exit Levels                                          
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                              MCL benchmark option                                Toxicity benchmark option             
                                             -----------------------------------------------------------------------------------------------------------
       CAS No.                  Name             Wastewater                Nonwastewater               Wastewater                Nonwastewater          
                                             -----------------------------------------------------------------------------------------------------------
                                                Totals (mg/l)    Totals (mg/kg)     Leach (mg/l)      Totals (mg/l)    Totals (mg/kg)     Leach (mg/l)  
--------------------------------------------------------------------------------------------------------------------------------------------------------
83-32-9..............  Acenaphthene.........        31             63000                13                31             63000                13        
208-96-8.............  Acenaphthylene.......     (\1\)                 4             (\1\)             (\1\)                 4             (\1\)        
67-64-1..............  Acetone..............        16             39000                21                16             39000                21        
75-05-8..............  Acetonitrile.........         0.78           2200                 1                 0.78           2200                 1        
98-86-2..............  Acetophenone.........        17             75000                22                17             75000                22        
75-36-5..............  Acetyl chloride......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
591-08-2.............  Acetyl-2-thiourea, 1-     (\1\)               590                24             (\1\)               590                24        
53-96-3..............  Acetylaminofluorne, 2-        0.028            88                 0.038             0.028            88                 0.038    
                        .                                                                                                                               
107-02-8.............  Acrolein.............     (\1\)                11          ................     (\1\)                11          ................
79-06-1..............  Acrylamide...........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
107-13-1.............  Acrylonitrile........     (\1\)                 2             (\1\)             (\1\)                 2             (\1\)        
1402-68-2............  Aflatoxins...........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
116-06-3.............  Aldicarb.............     (\1\)                 6                 4             (\1\)                 6                 3        
309-00-2.............  Aldrin...............     (\1\)                 0.0045        (\1\)             (\1\)                 0.0045        (\1\)        
107-18-6.............  Allyl alcohol........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
107-05-1.............  Allyl chloride.......         0.074           260          ................         0.074           260          ................
92-67-1..............  Aminobiphenyl, 4-....         0.028            88                 0.038             0.028            88                 0.038    
2763-96-4............  Aminomethyl-3-            (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        isoxazolol, 5-.                                                                                                                 
504-24-5.............  Aminopyridine, 4-....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
61-82-5..............  Amitrole.............     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
62-53-3..............  Aniline..............         0.053           170                 0.072             0.053           170                 0.072    
120-12-7.............  Anthracene...........     (\1\)                 4             (\1\)             (\1\)                 4             (\1\)        
7440-36-0............  Antimony.............         0.14             85                 0.18              0.14             85                 0.18     
140-57-8.............  Aramite..............        15              6900                37                15              6900                37        
7440-38-2............  Arsenic..............         0.38              0.53              0.52          (\1\)                 0.53              0.00052  
2465-27-2............  Auramine.............     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
115-02-6.............  Azaserine............     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
7440-39-3............  Barium...............        28             34000                38                33             34000                45        
71-43-2..............  Benzene..............         0.021           250                 0.039             0.018           250                 0.023    
92-87-5..............  Benzidine............     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
106-51-4.............  Benzoquinone, p-.....        15              6900                37                15              6900                37        
98-07-7..............  Benzotrichloride.....     (\1\)              1200             (\1\)             (\1\)              1200             (\1\)        
50-32-8..............  Benzo(a)pyrene.......         0.0023            0.23              0.0036            0.0023            0.23          (\1\)        
205-99-2.............  Benzo(b) fluoranthene         0.00081           4                 0.000066          0.00081           4                 0.000066 
205-82-3.............  Benzo(j) fluoranthene         0.0029            4                 0.0012            0.0029            4             (\1\)        
207-08-9.............  Benzo(k) fluoranthene         0.0029            4                 0.0012            0.0029            4             (\1\)        
191-24-2.............  Benzo[g, h,                   0.0029            4                 0.0012            0.0029            4             (\1\)        
                        i]perylene.                                                                                                                     
100-51-6.............  Benzyl alcohol.......        39            130000                53                39            130000                53        
100-44-7.............  Benzyl chloride......         1                81                50                 1                81                50        
56-55-3..............  Benz(a) anthracene...         0.00072           0.1           (\1\)                 0.00072           0.1           (\1\)        
225-51-4.............  Benz[c] acridine.....         0.0029            4                 0.0012            0.0029            4             (\1\)        
7440-41-7............  Beryllium............         0.00083           0.22              0.0011            0.00083           0.22              0.0011   
39638-32-9...........  Bis (2-                       0.007            97                 0.0088            0.007            97                 0.0088   
                        chloroisopropyl)                                                                                                                
                        ether.                                                                                                                          
111-44-4.............  Bis(2-chlore-                 0.00065           1                 0.002             0.00065           1                 0.002    
                        thyl)ether.                                                                                                                     
117-81-7.............  Bis(2-ethy-                   0.00044         740                 0.11              0.00044         740                 0.0011   
                        lexyl)phthalate.                                                                                                                
542-88-1.............  Bis(chlor-                (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        omethyl)ether.                                                                                                                  
598-31-2.............  Bromoacetone.........         0.024           140                 0.054             0.023           140                 0.053    
75-27-4..............  Bromodich-                    0.0085          240                 0.011             0.0085          240                 0.011    
                        loromethane.                                                                                                                    
75-25-2..............  Bromoform                     0.064          1600                 0.081             0.064          1600                 0.081    
                        (Tribromomethane).                                                                                                              
101-55-3.............  Bromophenyl phenyl            0.024           140                 0.054             0.023           140                 0.053    
                        ether, 4-.                                                                                                                      
357-57-3.............  Brucine..............     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
71-36-3..............  Butanol..............        16             41000                21                16             41000                21        
88-85-7..............  Butyl-4,6-                    0.034          6000                 0.043             0.19           6000                 0.24     
                        dinitrophenol, 2-sec-                                                                                                           
                         (Dinoseb).                                                                                                                     
85-68-7..............  Butylbenzyl-                240                87                67               240                87               67         
                        phthalate.                                                                                                                      

[[Page 66456]]
                                                                                                                                                        
7440-43-9............  Cadmium..............         0.038           110                 0.051             0.24            110                 0.32     
86-74-8..............  Carbazole............     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
75-15-0..............  Carbon disulfide.....         0.74           3800                24                 0.74           3800                24        
353-50-4.............  Carbon oxyfluoride...     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
56-23-5..............  Carbon tetrachloride.         0.012           130                 0.055             0.012           130                 0.0077   
75-87-6..............  Chloral..............     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
305-03-3.............  Chlorambucil.........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
57-74-9..............  Chlordane............     (\1\)                 0.19              0.036         (\1\)                 0.19              0.00016  
494-03-1.............  Chlornaphazin........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
126-99-8.............  Chloro-1,3-butabiene,         0.52           1700          ................         0.52           1700          ................
                        2-(Chloroprene).                                                                                                                
107-20-0.............  Chloroacetaldehyde...     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
106-47-8.............  Chlororoaniline, p-..         0.42           5800                 0.56              0.42           5800                 0.56     
108-90-7.............  Chlorobenzene........         0.68          41000                 0.81              2             41000                 6        
510-15-6.............  Chlorobenzilate......         0.054            14                 0.029             0.054            14                 0.029    
124-48-1.............  Chlorodibromomethane.         0.0066          200                 0.0079            0.0066          200                 0.0079   
75-00-3..............  Chloroethane (ethyl           0.024           140                 0.054             0.023           140                 0.053    
                        chloride).                                                                                                                      
110-75-8.............  Chloroethyl vinyl         (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        ether, 2-.                                                                                                                      
67-66-3..............  Chloroform...........         0.0076           76                 0.075             0.0076           76                 0.075    
59-50-7..............  Chloro-m-cresol, p-..         0.27           1200                 0.068             0.081          1200                 0.06     
107-30-2.............  Chloromethyl methyl       (\1\)               140             (\1\)             (\1\)               140             (\1\)        
                        ether.                                                                                                                          
91-58-7..............  Chloronaphthalene, 2-         0.27           1200                 0.068             0.081          1200                 0.06     
95-57-8..............  Chlorophenol, 2-.....         0.9            8500                 1                 0.9            8500                 1        
7005-72-3............  Chlorophenyl phenyl           0.024           140                 0.054             0.023           140                 0.053    
                        ether, 4-.                                                                                                                      
5344-82-1............  Chlorophenyl              (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        thiourea, 1-o-.                                                                                                                 
542-76-7.............  Chloropropionitrile,          0.27           1200             (\1\)             (\1\)              1200             (\1\)        
                        3-.                                                                                                                             
7440-47-3............  Chromium.............         0.62             16                 0.31              1                16                 2        
218-01-9.............  Chrysene.............         0.1              35                 0.0012            0.1              35                 0.0012   
6358-53-8............  Citrus red No. 2.....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
7440-48-4............  Cobalt...............         0.62            110             (\1\)                 1               110                 1        
7440-50-8............  Copper...............       670               950              3800               670               950              3800        
108-39-4.............  Cresol, m-...........         8             30000                11                 8             30000                11        
95-48-7..............  Cresol, o-...........         8             46000                11                 8             46000                11        
106-44-5.............  Cresol, p-...........         0.84           2900                 1                 0.84           2900                 1        
4170-30-3............  Crotonaldehyde.......         8             38000                22                 8             38000                22        
57-12-5..............  Cyanide..............     (\1\)                51                 0.37          (\1\)                51                 0.37     
14901-08-7...........  Cycasin..............     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
108-94-1.............  Cyclohexanone........     (\1\)             38000                22             (\1\)             38000                22        
131-89-5.............  Cyclohexyl-4,6-           (\1\)                42             (\1\)             (\1\)                42             (\1\)        
                        dinitrophenol, 2-.                                                                                                              
50-18-0..............  Cyclophosphamide.....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
20830-81-3...........  Daunomycin...........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
72-54-8..............  DDD..................         0.00013           0.26           6800                 0.00013           0.26           6800        
53-19-0..............  DDD (o,p')...........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
72-55-9..............  DDE..................     (\1\)                 0.033             0.000062      (\1\)                 0.033             0.000062 
3424-82-6............  DDE (o,p')...........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
50-29-3..............  DDT..................     (\1\)                 0.11              0.0054        (\1\)                 0.11              0.0054   
789-02-6.............  DDT (o,p')...........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
2303-16-4............  Diallate.............         0.26              7                11                 0.26              7                11        
132-64-9.............  Dibenzofuran.........         8             38000                 9                 8             38000                11        
192-65-4.............  Dibenzo- [a,e]pyrene.         0.0029            4                 0.0012            0.0029            4             (\1\)        
189-64-0.............  Dibenzo- [a,h]pyrene.         0.0029            4                 0.0012            0.0029            4             (\1\)        
189-55-9.............  Dibenzo- [a,i]pyrene.         0.0029            4                 0.0012            0.0029            4             (\1\)        
194-59-2.............  Dibenzo-                  (\1\)                 4             (\1\)             (\1\)                 4             (\1\)        
                        [c,g]carbazole, 7H-.                                                                                                            
226-36-8.............  Dibenz- (a,h)acridine         0.0029            4                 0.0012            0.0029            4             (\1\)        
53-70-3..............  Dibenz- (a,h)anth-        (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        racene.                                                                                                                         
244-42-0.............  Dibenz- [a,j]acridine         0.0029            4                 0.0012            0.0029            4             (\1\)        
96-12-8..............  Dibromo-3-chloropro-          0.0022            7                 0.0017            0.00066           7                 0.00052  
                        pane, 1,2-.                                                                                                                     
764-41-0.............  Dichloro-2-butene,            0.024           140                 0.054             0.023           140                 0.053    
                        1,4-.                                                                                                                           

[[Page 66457]]
                                                                                                                                                        
110-57-6.............  Dichloro-2-butene,            0.024           140                 0.054             0.023           140                 0.053    
                        trans-1,4-.                                                                                                                     
96-23-1..............  Dichloro-2-propanol,          0.27           1200                 0.068             0.081          1200                 0.06     
                        1,3-.                                                                                                                           
95-50-1..............  Dichlorobenzene, 1,2-         8            530000                 8                15            530000                32        
541-73-1.............  Dichlorobenzene, 1,3-         0.024           140                 0.054             0.023           140                 0.053    
106-46-7.............  Dichlorobenzene, 1,4-         1               650                 1                 0.056           650                 0.06     
91-94-1..............  Dichlorobenzidine,            0.0037            1                 0.0036            0.0037            1                 0.0036   
                        3,3'-.                                                                                                                          
75-71-8..............  Dichloro-                    15              8400                45                15              8400                45        
                        difluoromethane.                                                                                                                
75-34-3..............  Dichloroethane, 1,1-.         0.00016         110                 0.00021           0.00016         110                 0.00021  
107-06-2.............  Dichloroethane, 1,2-.         0.007            59                 0.011             0.00016          59                 0.00021  
75-35-4..............  Dichloroethy lene,            0.0035           20                 0.054             0.00059          20                 0.00077  
                        1,1-.                                                                                                                           
156-59-2.............  Dichlorethylene, cis-         0.29          46000                 0.39              2             46000                 2        
                        1,2-.                                                                                                                           
150-60-5.............  Dichlorethylene,              0.42         130000                 0.56              3            130000                 4        
                        trans-1,2-.                                                                                                                     
111-91-1.............  Dichloromethoxy               0.024           140                 0.054             0.023           140                 0.053    
                        ethane.                                                                                                                         
98-87-3..............  Dichloromethylbenzene         0.024           140                 0.054             0.023           140                 0.053    
                        (benzal chloride).                                                                                                              
120-83-2.............  Dichlorophenol, 2,4-.         0.62            770                 0.76              0.62            770                 0.76     
87-65-0..............  Dichlorophenol, 2,6-.         0.024           140                 0.054             0.023           140                 0.053    
94-75-7..............  Dichlorophenoxyacetic         0.27          12000                 0.37              2             12000                 2        
                        acid, 2,4- (2,4-D).                                                                                                             
78-87-5..............  Dichloropropane, 1,2-         0.12            180                 0.055             0.023           180                 0.011    
542-75-6.............  Dichloropropene, 1,3-         0.0028           68                 0.0038            0.0028           68                 0.0038   
10061-01-5...........  Dichloropropene, cis-         0.0049           65             10000                 0.0049           65             10000        
                        1,3-.                                                                                                                           
10061-02-6...........  Dichloropropene,              0.0049           62             10000                 0.0049           62             10000        
                        trans-1,3-.                                                                                                                     
60-57-1..............  Dieldrin.............         0.000059          0.048            36                 0.000059          0.048            36        
1464-53-5............  Diepoxybutane,               15              6900                37                15              6900                37        
                        1,2,3,4- (2,2'-                                                                                                                 
                        bioxirane).                                                                                                                     
84-66-2..............  Diethyl phthalate....       190             19000               220               190             19000               220        
311-45-5.............  Diethyl-p-nitrophenyl     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        phosphate.                                                                                                                      
56-53-1..............  Diethylstilbestrol...     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
94-58-6..............  Dihydrosafrole.......        15              6900                37                15              6900                37        
60-51-5..............  Dimethoate...........        29                 7                 4                29                 7                 4        
131-11-3.............  Dimethyl phthalate...        78                 3               110                78                 3               110        
77-78-1..............  Dimethyl sulfate.....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
60-11-7..............  Dimethyl- aminoazo-           0.028            88                 0.038             0.028            88                 0.038    
                        benzene, p-.                                                                                                                    
119-93-7.............  Dimethylbenzidine,        (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        3,3'-.                                                                                                                          
57-97-6..............  Dimethyl- benz(a)-        (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        anthracene, 7,12-.                                                                                                              
79-44-7..............  Dimethylcarbamoyl         (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        chloride.                                                                                                                       
122-09-8.............  Dimethyl- phenethyl-          0.16             51                 0.37              0.16             51                 0.37     
                        amine, alpha, alpha-.                                                                                                           
105-67-9.............  Dimethylphenol, 2,4-.         4             24000                 5                 4             24000                 5        
119-90-4.............  Dimethyoxy-                   0.034         (\1\)                 0.045             0.034         (\1\)                 0.045    
                        benzidine, 3,3'-.                                                                                                               
84-74-2..............  Di-n-butyl phthalate.       880             90000               100               230             90000                25        
99-65-0..............  Dinitrobenzene, 1,3-.         0.017            60                 0.022             0.017            60                 0.022    
100-25-4.............  Dinitrobenzene, 1,4-.     (\1\)                42             (\1\)             (\1\)                42             (\1\)        
534-52-1.............  Dinitro-o-cresol, 4,6-    (\1\)                42             (\1\)             (\1\)                42             (\1\)        
                        .                                                                                                                               
51-28-5..............  Dinitrophenol, 2,4-..         0.27            450                 0.37              0.27            450                 0.37     
121-14-2.............  Dinitrotoluene, 2,4-.         0.29           1400                 0.39              0.29           1400                 0.39     
606-20-2.............  Dinitrotoluene, 2,6-.         0.17            420                 0.22              0.17            420                 0.22     
117-84-0.............  Di-n-octyl phthalate.         0.002         21000                 0.1               0.002         21000                 0.1      
123-91-1.............  Dioxane, 1,4-........         0.042            71                 0.058             0.042            71                 0.058    
122-39-4.............  Diphenylamine........        15             12000                15                15             12000                15        
122-66-7.............  Diphenylhydrazine,            0.16             51                 0.37              0.16             51                 0.37     
                        1,2-.                                                                                                                           
298-04-4.............  Disulfoton...........         0.013            58               120                 0.013            58               120        
541-53-7.............  Dithiobiuret.........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                       D, salts, esters, 2,4-        0.0069            6                 4                 0.0069            6                 3        
                        .                                                                                                                               
115-29-7.............  Endosulfan...........         6               150                 4                 6               150                 4        
959-98-8.............  Endosulfan I.........         0.0069            6                 4                 0.0069            6                 3        
33213-65-9...........  Endosulfan II........         0.0069            6                 4                 0.0069            6                 3        
1031-07-8............  Endosulfan sulfate...         0.0069            6                 4                 0.0069            6                 3        
145-73-3.............  Endothall............     (\1\)             (\1\)                 4             (\1\)             (\1\)                 3        
72-20-8..............  Endrin...............         0.073            27               880                 0.073    
FR Doc. 95-29458 Hazardous Waste Management System: Identification and Listing of Hazardous Waste: Hazardous Waste Identification Rule (HWIR)
        27               770        
7421-93-4............  Endrin Aldehyde......         0.0069            6                 4                 0.0069            6                 3        
53494-70-5...........  Endrin ketone........         0.0069            6                 4                 0.0069            6                 3        
106-89-8.............  Epichlorohydrin......         0.34             96             47000                 0.34             96             47000        
51-43-4..............  Epinephrine..........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
110-80-5.............  Ethoxyethanol, 2-....        15              6900                53                15              6900                53        
141-78-6.............  Ethyl acetate........       390            600000               510               390            600000               510        
51-79-6..............  Ethyl carbamate......        15              6900                37                15              6900                37        
107-12-0.............  Ethyl cyanide                 0.16             51                 0.37              0.16             51                 0.37     
                        (propionitrile).                                                                                                                
60-29-7..............  Ethyl ether..........        27            260000                37                27            260000                37        

[[Page 66458]]
                                                                                                                                                        
97-63-2..............  Ethyl methacrylate...        24            100000                27                24            100000                27        
62-50-0..............  Ethyl                         0.0055        (\1\)             99000                 0.0055        (\1\)             99000        
                        methanesulfonate.                                                                                                               
100-41-4.............  Ethylbenzene.........         8          ................         9                39          ................        42        
106-93-4.............  Ethylene Dibromide...         0.00093           0.06              0.0049            0.00036           0.06              0.000098 
75-21-8..............  Ethylene oxide.......        15              6900                37                15              6900                37        
96-45-7..............  Ethylene thiourea....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
151-56-4.............  Ethyleneimine             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        (aziridine).                                                                                                                    
52-85-7..............  Famphur..............     (\1\)                 6                 4             (\1\)                 6                 3        
640-19-7.............  Fluoracetamide, 2-...     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
62-74-8..............  Fluoracetic acid,         (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        sodium salt.                                                                                                                    
206-44-0.............  Fluoranthene.........        28             21000                 2                28             21000                 2        
86-73-7..............  Fluorene.............        22             90000                 7                22             90000                 7        
16984-48-8...........  Fluoride.............  ................  ................  ................  ................  ................                  
50-00-0..............  Formaldehyde.........     (\1\)                54                37             (\1\)                54                37        
64-18-6..............  Formic Acid..........       270            680000               370               270            680000               370        
765-34-4.............  Glycidylaldehyde.....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
319-86-8.............  HCH, delta-..........         0.0069            6                 4                 0.0069            6                 3        
76-44-8..............  Heptachlor...........     (\1\)                 8          ................     (\1\)                 8          ................
1024-57-3............  Heptachlor epoxide...         0.00053           0.56           1900                 0.00053           0.56             10        
87-68-3..............  Hexachloro-1,3-               0.0079          290                 0.0069            0.0079          290                 0.0069   
                        butadiene.                                                                                                                      
118-74-1.............  Hexachlorobenzene....     (\1\)                 0.27              0.018         (\1\)                 0.27          (\1\)        
319-84-6.............  Hexachlorocyclohexane         0.00014           0.18              2                 0.00014           0.18              2        
                        , alpha- (alpha-BHC).                                                                                                           
319-85-7.............  Hexachlorocyclohexane         0.00044           0.64              0.0009            0.00044           0.64              0.0009   
                        , beta- (beta-BHC).                                                                                                             
58-89-9..............  Hexachlorocyclohexane         0.00078           0.75             26                 0.00078           0.75              9        
                        , gamma- (Lindane).                                                                                                             
77-47-4..............  Hexachlorocyclopentad         0.0052         1500          ................         0.0052         1500          ................
                        iene.                                                                                                                           
67-72-1..............  Hexachloroethane.....         0.049           890                 0.11              0.049           890                 0.11     
70-30-4..............  Hexachlorophene......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
1888-71-7............  Hexachloropropene....         0.27           1200                 0.068             0.081          1200                 0.06     
757-58-4.............  Hexaethyl                 (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        tetraphosphate.                                                                                                                 
591-78-6.............  Hexanone, 2-.........         8             38000                22                 8             38000                22        
302-01-2.............  Hydrazine............     (\1\)                51             (\1\)             (\1\)                51             (\1\)        
193-39-5.............  Indeno(1,2,3-cd)              0.0029            4             (\1\)                 0.0029            4             (\1\)        
                        pyrene.                                                                                                                         
74-88-4..............  Iodomethane..........         0.024           140                 0.054             0.023           140                 0.053    
78-83-1..............  Isobutyl alcohol.....        39            120000                53                39            120000                53        
465-73-6.............  Isodrin..............     (\1\)                 6                 4             (\1\)                 6                 3        
78-59-1..............  Isophorone...........         0.53           2000                 0.69              0.53           2000                 0.69     
120-58-1.............  Isosafrole...........        15              6900                37                15              6900                37        
143-50-0.............  Kepone...............     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
303-43-4.............  Lasiocarpine.........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
7439-92-1............  Lead.................        30              1600                41                30              1600                41        
108-31-6.............  Maleic anhydride.....     (\1\)              6900             (\1\)             (\1\)              6900             (\1\)        
123-33-1.............  Maleic hydrazide.....         0.16             51                 0.37              0.16             51                 0.37     
109-77-3.............  Malononitrile........         0.16             51                 0.37              0.16             51                 0.37     
148-82-3.............  Melphalan............     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
7439-97-6............  Mercury..............         0.06             39                 0.081             0.3              39                 0.4      
126-98-7.............  Methacrylonitrile....         0.016            72                 0.021             0.016            72                 0.021    
74-93-1..............  Methanethiol.........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
67-561...............  Methanol.............        78            310000               110                78            310000               110        
91-80-5..............  Methapyrilene........         0.16             51                 0.37              0.16             51                 0.37     
16752-77-5...........  Methomyl.............     (\1\)                 6                 4             (\1\)                 6                 3        
72-43-5..............  Methoxychlor.........         7               280          ................         7               280          ................
74-83-9..............  Methy bromide                 0.37            850                 4                 0.37            850                 4        
                        (Bromomethane).                                                                                                                 
74-87-3..............  Methyl chloride               0.096            91          ................         0.096            91          ................
                        (Chloromethane).                                                                                                                
78-93-3..............  Methyl ethyl ketone..        78            250000               110                78            250000               110        
1338-23-4............  Methyl ethyl ketone       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        peroxide.                                                                                                                       
60-34-4..............  Methyl hydrazine.....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
108-10-1.............  Methyl isobutyl               8             38000                11                 8             38000                11        
                        ketone.                                                                                                                         

[[Page 66459]]
                                                                                                                                                        
80-62-6..............  Methyl methacrylate..        28            100000                33                28            100000                33        
66-27-3..............  Methyl                        0.12            590                24                 0.12            590                24        
                        methanesulfonate.                                                                                                               
91-57-6..............  Methyl naphthalene, 2-    (\1\)                 4             (\1\)             (\1\)                 4             (\1\)        
                        .                                                                                                                               
298-00-0.............  Methyl parathion.....         0.66              6               110                 0.66              6               110        
75-55-8..............  Methylaziridine, 2-..     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
56-49-5..............  Methylcholanthrene, 3-    (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        .                                                                                                                               
74-95-3..............  Methylene bromide....         0.029         21000                 0.037             2             21000                 0.19     
75-09-2..............  Methylene chloride...         0.039           720                 0.09              0.039           720                 0.053    
101-14-4.............  Methylenebis, 4,4'-       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        (2-chloroaniline).                                                                                                              
70-25-7..............  Methyl-nitro-             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        nitrosoguanidine                                                                                                                
                        (MNNG).                                                                                                                         
56-04-2..............  Methylthiouracil.....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
50-07-7..............  Mitomycin C..........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
7439-98-7............  Molybdenum...........         2              1200                 2                 2              1200                 2        
91-20-3..............  Naphthalene..........        14            430000                15                14            430000                15        
130-15-4.............  Naphthoquinone, 1,4-.        15              6900                37                15              6900                37        
86-88-4..............  Naphthyl-2-thiourea,      (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        1-.                                                                                                                             
134-32-7.............  Naphthylamine, 1-....         0.16             51                 0.37              0.16             51                 0.37     
91-59-8..............  Naphthylamine, 2-....         0.16             51                 0.37              0.16             51                 0.37     
7440-02-0............  Nickel...............         4              8600                 6                11              8600                14        
54-11-5..............  Nicotine and salts...         0.16             51                 0.37              0.16             51                 0.37     
88-74-4..............  Nitroaniline, 2-.....     (\1\)                88             (\1\)             (\1\)                88             (\1\)        
99-09-2..............  Nitroaniline, 3-.....     (\1\)                88             (\1\)             (\1\)                88             (\1\)        
100-01-6.............  Nitroaniline, 4-.....         0.028            88                 0.038             0.028            88                 0.038    
98-95-3..............  Nitrobenzene.........         0.084           520                 0.11              0.084           520                 0.11     
55-86-7..............  Nitrogen mustard.....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
51-75-2..............  Nitrogen mustard          (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        hydrochloride salt.                                                                                                             
126-85-2.............  Nitrogen mustard N-       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        Oxide.                                                                                                                          
302-70-5.............  Nitrogen mustard N-       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        Oxide, HCI salt.                                                                                                                
55-63-0..............  Nitroglycerine.......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
99-55-8..............  Nitro-o-toluidine, 5-         0.028            88                 0.038             0.028            88                 0.038    
88-75-5..............  Nitrophenol, 2-......         0.025            42                 0.034             0.025            42                 0.034    
100-02-7.............  Nitrophenol, 4-......     (\1\)                42             (\1\)             (\1\)                42             (\1\)        
79-46-9..............  Nitropropane, 2-.....     (\1\)                 3          ................     (\1\)                 3          ................
56-57-5..............  Nitroquinoline-1-             0.16             51                 0.37              0.16             51                 0.37     
                        oxide, 4-.                                                                                                                      
55-18-5..............  Nitrosodiethylamine..     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
62-75-9..............  Nitrosodimethylamine.     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
924-16-3.............  Nitrosodi-n-              (\1\)                 1             (\1\)             (\1\)                 1             (\1\)        
                        butylamine.                                                                                                                     
10595-95-6...........  Nitrosomethylethylami     (\1\)                 0.035         (\1\)             (\1\)                 0.035         (\1\)        
                        ne.                                                                                                                             
1116-54-7............  N-                        (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        Nitrosodiethanolamin                                                                                                            
                        e.                                                                                                                              
621-64-7.............  N-Nitrosodi-n-            (\1\)                 0.22          (\1\)             (\1\)                 0.22          (\1\)        
                        propylamine.                                                                                                                    
86-30-6..............  N-                            0.2            3600                 0.24              0.2            3600                 0.24     
                        Nitrosodiphenylamine.                                                                                                           
45490-40-0...........  N-Nitrosomethyl vinyl     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        amine.                                                                                                                          
59-89-2..............  N-Nitrosomorpholine..         0.16             51                 0.37              0.16             51                 0.37     
759-73-9.............  N-Nitroso-N-ethylurea     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
684-93-5.............  N-Nitroso-N-                  0.16             51                 0.37              0.16             51                 0.37     
                        methylurea.                                                                                                                     
100-75-4.............  N-Nitrosopiperidine..     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
930-55-2.............  N-Nitrosopyrrolidine.     (\1\)                 0.36          (\1\)             (\1\)                 0.36          (\1\)        
13256-22-9...........  N-Nitrososarcosine...     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
103-85-5.............  N-Phenylthiourea.....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
1615-80-1............  N,N-Diethylhydrazine.     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
152-16-9.............  Octamethylpyrophospho         0.27             31                 0.37              0.27             31                 0.37     
                        ramide.                                                                                                                         
20816-12-0...........  Osmium tetroxide.....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
297-97-2.............  O,O-Diethyl O-                0.12            590                24                 0.12            590                24        
                        pyrazinyl                                                                                                                       
                        phosphorothioate.                                                                                                               
126-68-1.............  O,O,O-Triethyl                0.12            590                24                 0.12            590                24        
                        phosphorothioate.                                                                                                               
123-63-7.............  Paraldehyde..........         8             38000                22                 8             38000                22        
56-38-2..............  Parathion............         3                19            160000                 3                19            160000        
608-93-5.............  Pentachlorobenzene...         5              2300                 0.054             5              2300                 0.054    
76-01-7..............  Pentachloroethane....         0.024           140                 0.054             0.023           140                 0.053    
82-68-8..............  Pentachloro-                  0.27            140             (\1\)                 0.081           140             (\1\)        
                        nitrobenzene (PCNB).                                                                                                            
87-86-5..............  Pentachlorophenol....         0.002            22                 0.0022            0.002            22                 0.0022   
62-44-2..............  Phenacetin...........        15              6900                37                15              6900                37        
85-01-8..............  Phenanthrene.........     (\1\)                 4             (\1\)             (\1\)                 4             (\1\)        
108-95-2.............  Phenol...............        84            390000               110                84            390000               110        
62-38-4..............  Phenyl mercuric           (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        acetate.                                                                                                                        
25265-76-3...........  Phenylenediamines             0.16             51                 0.37              0.16             51                 0.37     
                        (N.O.S.).                                                                                                                       
108-45-2.............  Phenylenediamine, m-.         0.78           1700                 1                 0.78           1700                 1        

[[Page 66460]]
                                                                                                                                                        
106-50-3.............  Phenylenediamine, p-.         0.16             51                 0.37              0.16             51                 0.37     
298-06-2.............  Phorate..............         0.11            510          ................         0.11            510          ................
                       Phosphorodithioic         (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        acid,                                                                                                                           
                        dimethylethylester.                                                                                                             
298-06-6.............  Phosphorodithioic         (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        acid, o-o-diethyl                                                                                                               
                        ester.                                                                                                                          
3288-58-2............  Phosphorodithioic         (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        acid, o-o-diethyl-s-                                                                                                            
                        methyl.                                                                                                                         
2953-29-9............  Phosphorodithioic         (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        acid, trimethyl                                                                                                                 
                        ester.                                                                                                                          
85-44-9..............  Phthalic anhydride...     (\1\)              9600             (\1\)             (\1\)              9600             (\1\)        
109-06-8.............  Picoline, 2-.........         0.16             51                 0.37              0.16             51                 0.37     
1336-36-3............  Polychlorinated        See Table B              0.25              0.009      See Table B              0.25          (\1\)        
                        biphenyls.                                                                                                                      
12305-58-5...........  Pronamide............        21            230000                25                21            230000                25        
1120-71-4............  Propane sultone, 1,3-     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
107-10-8.............  Propylamine, n-......         0.16             51                 0.37              0.16             51                 0.37     
51-52-5..............  Propylthiouracil.....         0.12            590                24                 0.12            590                24        
107-19-7.............  Propyn-1ol, 2-.......        39            130000                53                39            130000                53        
129-00-0.............  Pyrene...............        54             16000                 2                54             16000                 2        
110-86-1.............  Pyridine.............         0.16            930                 0.21              0.16            930                 0.21     
50-55-5..............  Reserpine............         0.16             51                 0.37              0.16             51                 0.37     
108-46-3.............  Resorcinol...........     (\1\)             (\1\)                 4             (\1\)             (\1\)             (\1\)        
81-07-2..............  Saccharin and salts..     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)                          
94-59-7..............  Safrole..............         0.0035           28                 0.0044            0.0035           28                 0.0044   
7782-49-2............  Selenium.............         0.23            280                 0.12              0.93            280                 1        
7440-22-4............  Silver...............       200                 9          ................       200                 9          ................
18883-66-4...........  Streptozotocin.......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
57-24-9..............  Strychnine...........         0.045         (\1\)                 0.059             0.045         (\1\)                 0.059    
10-42-5..............  Stryene..............         0.91       ................         1                64          ................        70        
18496-25-8...........  Sulfide..............  ................  ................  ................  ................  ................  ................
1746-01-6............  TCDD, 2,3,7,8-.......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
95-94-3..............  Tetrachlorobenzene,           0.23           1600                 0.032             0.23           1600                 0.032    
                        1,2,4,5-.                                                                                                                       
630-20-6.............  Tetrachloroethane             0.024           370                 0.042             0.024           370                 0.042    
                        1,1,1,2-.                                                                                                                       
79-34-5..............  Tetrachloroethane,            0.0037           70                 0.0077            0.0037           70                 0.0077   
                        1,1,2,2-.                                                                                                                       
127-18-4.............  Tetrachloroethylene..         0.026        100000                 0.032             2            100000                 3        
58-90-2..............  Tetrachlorophenol,            2             35000                 2                 2             35000                 2        
                        2,3,4,6-.                                                                                                                       
107-49-3.............  Tetraethyl                (\1\)              6900             (\1\)             (\1\)              6900             (\1\)        
                        pyrophosphate.                                                                                                                  
107-49-3.............  Tetraethyl                (\1\)              6900             (\1\)             (\1\)              6900             (\1\)        
                        pyrophosphate.                                                                                                                  
3689-24-5............  Tetraethyldithiopyrop         0.23           1200          ................         0.23           1200          ................
                        hosphate.                                                                                                                       
7440-28-0............  Thallium (I).........         0.035            33                 0.048             0.05             33                 0.071    
62-55-5..............  Thioacetamide........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
39196-18-4...........  Thiofanox............         0.12            590                24                 0.12            590                24        
108-98-5.............  Thiophenol...........         0.12            590                24                 0.12            590                24        
79-19-6..............  Thiosemicarbazide....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
62-566...............  Thiourea.............     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
137-26-8.............  Thiram...............     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
7440-31-5............  Tin..................     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
108-88-3.............  Toluene..............         6            560000                 7                30            560000                51        
584-84-9.............  Toluene diisocyanate.     (\1\)             (\1\)             (\1\)          ................  ................                  
95-80-7..............  Toluenediamine, 2,4--     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
823-40-5.............  Toluenediamine, 2,6-.         0.16             51                 0.37              0.16             51                 0.37     
496-72-0.............  Toluenediamine, 3,4-.         0.16             51                 0.37              0.16             51                 0.37     
636-21-5.............  Toulidene,3,4-.......         0.16             51                 0.37              0.16             51                 0.37     
95-53-4..............  Toluidine, o-........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
106-49-0.............  Toluidine, p-........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
8001-35-2............  Toxaphene............     (\1\)             (\1\)               160             (\1\)             (\1\)                 3        
76-13-1..............  Trichloro-1,2,2-              0.77       ................         0.84           2200          ................     12000        
                        trifuoroethane,                                                                                                                 
                        1,1,2.                                                                                                                          
120-82-1.............  Trichlorobenzene,             0.69          62000                 3                 0.69          62000                 3        
                        1,2,4-.                                                                                                                         
71-55-6..............  Trichloroethane,             74            630000                 0.054            74            630000                 0.054    
                        1,1,1-.                                                                                                                         
79-00-5..............  Trichloroethane,              0.012           190                 0.039             0.007           190                 0.0077   
                        1,1,2-.                                                                                                                         

[[Page 66461]]
                                                                                                                                                        
79-01-6..............  Trichloroethylene....         0.024          3200                 0.031             0.038          3200                 0.049    
79-69-4..............  Trichlorofluoromethan        48            170000                61                48            170000                61        
                        e.                                                                                                                              
75-70-7..............  Trichloromethanethiol     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)                22        
95-95-4..............  Trichlorophenol,             18             55000                22                18             55000                22        
                        2,4,5-.                                                                                                                         
88-06-2..............  Trichlorophenol,              0.054           160                 0.068             0.054           160                 0.068    
                        2,4,6-.                                                                                                                         
93-76-5..............  Trichlorophenoxyaceti         2               150                 2                 2               150                 2        
                        c acid, 2,4,5- (245-                                                                                                            
                        T).                                                                                                                             
93-72-1..............  Trichlorophenoxypropi         0.21            520                 0.28              1               520                 2        
                        onic acid, 2,4,5-                                                                                                               
                        (Silvex).                                                                                                                       
96-18-4..............  Trichloropropane,             1             14000                 1                 1             14000                 1        
                        1,2,3-.                                                                                                                         
99-35-4..............  Trintrobenzene, sym-.         0.0078           23                 0.011             0.0078           23                 0.011    
126-72-7.............  Tris (2,3-                (\1\)                 0.76          (\1\)             (\1\)                 0.76          (\1\)        
                        dibromopropyl)                                                                                                                  
                        phosphate.                                                                                                                      
52-24-4..............  Tris (1-azridinyl)        (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                        phosphine sulfide.                                                                                                              
72-57-1..............  Trypan blue..........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
66-75-1..............  Uracil mustard.......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
7440-62-2............  Vanadium.............        10              2700                13                10              2700                13        
108-05-4.............  Vinyl acetate........        15              6900                37                15              6900                37        
75-01-4..............  Vinyl chloride.......         0.002             3                 0.011         (\1\)                 3                 0.00021  
81-81-2..............  Warfarin.............     (\1\)                 6                 4             (\1\)                 6                 3        
1330-20-7............  Xylenes (total)......        22            710000               100                22            710000               700        
7440-66-6............  Zinc.................        99             51000               130                99             51000               130        
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ See table B.                                                                                                                                        

                                                                                                                                                        

[[Page 66462]]
                                                  Table B.--Quantitation-Based Conditional Exit Levels                                                  
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                              MCL benchmark option                                Toxicity benchmark option             
                                             -----------------------------------------------------------------------------------------------------------
        CAS No.                 Name             Wastewater                Nonwastewater               Wastewater                Nonwastewater          
                                             -----------------------------------------------------------------------------------------------------------
                                               Totals  (mg/l)    Totals  (mg/kg)    Leach  (mg/l)    Totals  (mg/l)    Totals  (mg/kg)    Leach  (mg/l) 
--------------------------------------------------------------------------------------------------------------------------------------------------------
208-96-8..............  Acenaphthylene......         0.02       ................         0.02              0.02       ................  ................
75-36-5...............  Acetyl chloride.....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
591-08-2..............  Acetyl-2-thiourea,..         1          ................  ................         1          ................  ................
107-02-8..............  Acrolein............         0.013      ................  ................         0.013      ................  ................
79-06-1...............  Acrylamide..........         0.01              0.1               0.01              0.01              0.1               0.01     
107-13-1..............  Acrylonitrile.......         0.008      ................         0.008      ................         0.008                      
1402-68-2.............  Aflatoxins..........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
116-06-3..............  Aldicarb............         0.05       ................  ................         0.05       ................  ................
309-00-2..............  Aldrin..............         0.000034   ................         0.000034          0.000034   ................         0.000034 
107-18-6..............  Allyl alcohol.......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
2763-96-4.............  Aminomethyl-3-           (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         isoxazolol, 5-.                                                                                                                
504-24-5..............  Aminopyridine, 4-...     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
61-82-5...............  Amitrole............     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
120-12-7..............  Anthracene..........         0.007      ................         0.007             0.007      ................         0.007    
7440-38-2.............  Arsenic.............  ................  ................  ................         0.0005     ................  ................
2465-27-2.............  Auramine............     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
115-02-6..............  Azaserine...........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
92-87-5...............  Benzidine...........         0.0025            0.042             0.0025            0.0025            0.042             0.0025   
98-07-7...............  Benzotrichloride....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
50-32-8...............  Benzo(a)pyrene......  ................  ................  ................  ................  ................         0.000023 
205-82-3..............  Benzo(j)fluoranthene  ................  ................  ................  ................  ................         0.0002   
207-08-9..............  Benzo(k)fluoranthene  ................  ................  ................  ................  ................         0.0002   
191-24-2..............  Benzo[g,h,i]perylene  ................  ................  ................  ................  ................         0.0008   
56-55-3...............  Benz(a)anthracene...  ................  ................         0.000013   ................  ................         0.000013 
225-51-4..............  Benz[c]acridine.....  ................  ................  ................  ................  ................         0.0005   
542-88-1..............  Bis(chloromethyl)        (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         ether.                                                                                                                         
357-57-3..............  Brucine.............        20             (\1\)                20                20             (\1\)                20        
86-74-8...............  Carbazole...........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
353-50-4..............  Carbon oxyfluoride..     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
75-87-6...............  Chloral.............     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
305-03-3..............  Chlorambucil........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
57-74-9...............  Chlordane...........         0.00004    ................  ................         0.00004    ................  ................
494-03-1..............  Chlornaphazin.......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
107-20-0..............  Chloroacetaldehyde..     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
110-75-8..............  Chloroethyl vinyle       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         ether, 2-.                                                                                                                     
107-30-2..............  Chloromethyl methyl      (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         ether.                                                                                                                         
5344-82-1.............  Chlorophenyl             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         thiourea, 1-o-.                                                                                                                
542-76-7..............  Chloropropionitrile,  ................  ................         0.1               0.1        ................         0.1      
                         3-.                                                                                                                            
6358-53-8.............  Citrus red No. 2....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
7440-48-4.............  Cobalt..............  ................  ................         0.5        ................  ................  ................
57-12-5...............  Cyanida.............         0.2        ................  ................         0.2        ................  ................
14901-08-7............  Cycasin.............     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
108-94-1..............  Cyclohexanone.......        10          ................  ................        10             (\1\)             (\1\)        
131-89-5..............  Cyclohexyl-4,6-              0.1           (\1\)                 0.1               0.1           (\1\)                 0.1      
                         dinitrophenol, 2-.                                                                                                             
50-18-0...............  Cyclophosphamide....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
20830-81-3............  Daunomycin..........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
53-19-0...............  DDD (o,p')..........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
72-55-9...............  DDE.................         0.000058   ................  ................         0.000058   ................  ................
3424-82-6.............  DDE (o,p')..........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
50-29-3...............  DDT.................         0.000081   ................  ................         0.000081   ................  ................
789-02-6..............  DDT (o,p')..........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
192-65-4..............  Dibenzo-              ................  ................  ................  ................  ................         0.001    
                         [a,e]ypyrene.                                                                                                                  
189-64-0..............  Dibenzo- [a,h]pyrene  ................  ................  ................  ................  ................         0.0002   
189-64-9..............  Dibenzo- [a,i]pyrene  ................  ................  ................  ................  ................         0.0002   
194-59-2..............  Dibenzo-                    (0.01       ................         0.01              0.01       ................         0.01     
                         [c,g]carbazole, 7H-.                                                                                                           
226-36-8..............  Dibenz-               ................  ................  ................  ................  ................         0.0002   
                         (a,h)acridine.                                                                                                                 
53-70-3...............  Dibenz- (a,h)ant-            0.00003           0.084             0.00003           0.00003           0.084             0.00003  
                         hracene.                                                                                                                       
224-42-0..............  Dibenz[a,j] acridine  ................  ................  ................  ................  ................         0.001    
311-45-5..............  Diethyl-p-               (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         nitrophenyl                                                                                                                    
                         phosphate.                                                                                                                     
56-53-1...............  Diethylstibestrol...         0.0078            1                 0.0078            0.0078            1                 0.0078   
77-78-1...............  Dimethyl sulfate....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
119-93-7..............  Dimethybenzidine,            0.0033            0.7               0.0033            0.0033            0.7               0.0033   
                         3,3'-.                                                                                                                         
57-97-6...............  Dimethyl- benz(a)-           0.00037           0.039             0.00037           0.00037           0.039             0.00037  
                         anthracene, 7,12-.                                                                                                             

[[Page 66463]]
                                                                                                                                                        
79-44-7...............  Dimethylcarbamoyl        (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         chloride.                                                                                                                      
119-90-4..............  Dimethy- oxyben-      ................         7          ................  ................         7          ................
                         zidine, 3,3'-.                                                                                                                 
100-25-4..............  Dinitrobenzene, 1,4-         0.04       ................         0.04              0.04       ................         0.04     
534-52-1..............  Dinitro-o-cresol,            0.05       ................         0.05              0.05       ................         0.05     
                         4,6-.                                                                                                                          
541-53-7..............  Dithiobiuret........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
145-73-3..............  Endothall...........         0.1           (\1\)          ................         0.1           (\1\)          ................
51-43-4...............  Epinephrine.........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
62-50-0...............  Ethyl                 ................         0.018      ................  ................         0.018      ................
                         methanesulfonate.                                                                                                              
96-45-7...............  Ethylene thiourea...     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
151-56-4..............  Ethyleneimine            (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         (aziridine).                                                                                                                   
52-85-7...............  Famphur.............         0.02       ................  ................         0.02       ................  ................
640-19-7..............  Fluoracetamide, 2-..     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
62-74-8...............  Fluoracetic acid,        (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         sodium salt.                                                                                                                   
16984-48-8............  Fluoride............  ................  ................  ................  ................  ................  ................
50-00-0...............  Formaldehyde........         0.023      ................  ................         0.023      ................  ................
765-34-4..............  Glycidylaldehyde....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
76-44-8...............  Heptachlor..........         0.00004    ................  ................         0.00004    ................  ................
118-74-1..............  Hexachlorobenzene...         0.0016     ................  ................         0.0016     ................         0.0016   
70-30-4...............  Hexachlorophene.....         0.21              2                 0.21              0.21              2                 0.21     
757-58-4..............  Hexaethyl                (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         tetraphosphate.                                                                                                                
302-01-2..............  Hydrazine...........     (\1\)          ................     (\1\)             (\1\)          ................     (\1\)        
193-39-5..............  indeno(1,2,3-         ................  ................         0.000043   ................  ................         0.000043 
                         cde)pyrene.                                                                                                                    
465-73-6..............  Isodrin.............         0.02       ................  ................         0.02       ................  ................
143-50-0..............  Kepone..............         0.016             0.097             0.016             0.016             0.097             0.016    
303-43-4..............  Lasiocarpine........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
108-31-6..............  Maleic anhydride....     (\1\)          ................     (\1\)             (\1\)          ................     (\1\)        
148-82-3..............  Melphalan...........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
74-93-1...............  Methanethiol........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
16752-77-5............  Methomyl............         0.05       ................  ................         0.05       ................  ................
1338-23-4.............  Methyl ethyl ketone      (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         peroxide.                                                                                                                      
60-34-4...............  Methyl hydrazine....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
91-57-6...............  Methyl naphthalene,          0.01       ................         0.01              0.01       ................         0.01     
                         2-.                                                                                                                            
75-55-8...............  Methylaziridine, 2-.     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
56-49-5...............  Methylcholanthrene,          0.01              0.046             0.01              0.01              0.046             0.01     
                         3-.                                                                                                                            
101-14-4..............  Methylenebis, 4,4'-      (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         (2-chloroaniline).                                                                                                             
70-25-7...............  Methyl-nitro-            (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         nitrosoguanidine                                                                                                               
                         (MNNG).                                                                                                                        
56-04-2...............  Methylthiouracil....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
50-07-7...............  Mitomycin C.........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
86-88-4...............  Naphthyl-2-thiourea,     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         1-.                                                                                                                            
88-74-4...............  Nitroaniline, 2-....         0.05       ................         0.05              0.05       ................         0.05     
99-09-2...............  Nitroaniline, 3-....         0.05       ................         0.05              0.05       ................         0.05     
55-86-7...............  Nitrogen mustard....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
51-75-2...............  Nitrogen mustard         (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         hydrochloride salt.                                                                                                            
126-85-2..............  Nitrogen mustard N-      (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         Oxide.                                                                                                                         
302-70-5..............  Nitrogen mustard N-      (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         Oxide, HCI salt.                                                                                                               
55-63-0...............  Nitroglycerine......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
110-02-7..............  Nitrophenol, 4-.....         0.05       ................         0.05              0.05       ................         0.05     
79-46-9...............  Nitropropane, 2-....         0.0058     ................  ................         0.0058     ................  ................
55-18-5...............  Nitrosodiethylamine.         0.002         (\1\)                 0.002             0.002             1                 0.002    
62-75-9...............  Nitrosodimethylamine         0.0006            0.074             0.0006            0.0006            0.074             0.0006   
924-16-3..............  Nitrosodi-n-                 0.06       ................         0.06              0.06       ................         0.06     
                         butylamine.                                                                                                                    
10595-95-6............  Nitrosomethylethylam         0.028      ................         0.028             0.028      ................         0.028    
                         ine.                                                                                                                           
1116-54-7.............  N-                           0.01              0.7               0.01              0.01              0.7               0.01     
                         Nitrosodiethanolami                                                                                                            
                         ne.                                                                                                                            
621-64-7..............  N-Nitrosodi-n-               0.026      ................         0.026             0.026      ................         0.026    
                         propyamine.                                                                                                                    

[[Page 66464]]
                                                                                                                                                        
4549-40-0.............  N-Nitrosomethy vinyl     (\1\)             (\1\)             (\1\)             (\1\)          (\1\) D(\1\)                      
                         amine.                                                                                                                         
759-73-9..............  N-Nitroso-N-             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         ethylurea.                                                                                                                     
615-53-2..............  N-Nitroso-N-             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         methylurethane.                                                                                                                
16543-55-8............  N-Nitrosonornicotine     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
100-75-4..............  N-Nitrosopiperidine.         0.0014            0.033             0.0014            0.0014            0.033             0.0014   
930-55-2..............  N-Nitrosopyrrolidine         0.0047     ................         0.0047            0.0047     ................         0.0047   
13256-22-9............  N-Nitrososarcosine..     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
103-85-5..............  N-Phenylthiourea....     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
1615-80-1.............  N,N-Diethylhydrazine     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
20816-12-0............  Osmium tetroxide....         3               200                 3                 3               200                 3        
82-68-8...............  Pentachloronitrobenz  ................  ................         0.02       ................  ................         0.02     
                         ene (PCNB).                                                                                                                    
85-01-8...............  Phenanthrene........         0.006      ................         0.006             0. 006     ................         0.006    
62-38-4...............  Phenyl mercuric          (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         acetate.                                                                                                                       
                        Phosphorodithioic        (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         acid,                                                                                                                          
                         dimethylethylester.                                                                                                            
298-06-6..............  Phosphorodithioic        (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         acid, o-o-diethyl                                                                                                              
                         ester.                                                                                                                         
3288-58-2.............  Phosphorodithioic        (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         acid, o-o-diethyl-s-                                                                                                           
                         methlyl.                                                                                                                       
2953-29-9.............  Pyhosphorodithioic       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         acid, trimethyl                                                                                                                
                         ester.                                                                                                                         
85-44-9...............  Phthalic anhydride..     (\1\)          ................     (\1\)             (\1\)          ................     (\1\)        
1336-36-3.............  Polychlorinated              0.0005     ................  ................         0.0005     ................         0.0005   
                         biphenyls.                                                                                                                     
1120-71-4.............  Propane sultone, 1,3-    (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         .                                                                                                                              
108-46-3..............  Resorcinol..........         0.1               7          ................         0.1               7          ................
81-07-2...............  Saccharin and salts.     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
18883-66-4............  Strepto
FR Doc. 95-29458 Hazardous Waste Management System: Identification and Listing of Hazardous Waste: Hazardous Waste Identification Rule (HWIR)
zotocin......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
57-24-9...............  Strychnine..........  ................         3          ................  ................         3          ................
1746-01-6.............  TCDD, 2, 3, 7.8-....         1.000E-08  ................  ................         1.000E-08  ................         1.000E-08
107-49-3..............  Tetraethyl               (\1\)          ................     (\1\)             (\1\)          ................     (\1\)        
                         pyrophosphate.                                                                                                                 
62-55-5...............  Thioacetamide.......         1             (\1\)                 1                 1             (\1\)                 1        
79-19-6...............  Thiosemicarbazide...     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
62-56-6...............  Thiourea............     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
137-26-8..............  Thiram..............         0.05       ................  ................         0.05       ................  ................
7440-31-5.............  Tin.................         8               500                 8                 8               500                 8        
584-84-9..............  Toluene diisocyanate     (\1\)          ................     (\1\)             (\1\)          ................     (\1\)        
95-80-7...............  Toluenediamine, 2,4-         0.013             1                 0.013             0.013             1                 0.013    
95-53-4...............  Toluidine, 0-.......         0.012      ................         0.012             0.012      ................         0.012    
106-49-0..............  Toluidine, p-.......         0.017      ................         0.017             0.017      ................         0.017    
8001-35-2.............  Toxaphene...........         0.0013            0.03       ................         0.0013            0.03       ................
75-70-7...............  Trichloromethanethio     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         l.                                                                                                                             
126-72-7..............  Tris (2, 3-                  0.025      ................         0.025             0.025      ................         0.025    
                         dibromopropyl)                                                                                                                 
                         phosphate.                                                                                                                     
52-24-4...............  Tris (1-azridinyl)       (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
                         phosphine sulfide.                                                                                                             
72-57-1...............  Trypan blue.........     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
66-75-1...............  Uracil mustard......     (\1\)             (\1\)             (\1\)             (\1\)             (\1\)             (\1\)        
75-01-4...............  Vinyl chloride......  ................  ................  ................         0.00017    ................  ................
81-81-2...............  Warfarin............         0.05       ................  ................         0.05       ................  ................
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ No testing required; additional LDR requirements apply.                                                                                             

PART 266--STANDARDS FOR THE MANAGEMENT OF SPECIFIC HAZARDOUS WASTES 
AND SPECIFIC TYPES OF HAZARDOUS WASTE FACILITIES

    9. The authority citation for part 266 continues to read as 
follows:
    Authority: 42 U.S.C. 6905, 6912(a), 6924, and 6934.

    10. Section 266.20 is amended by revising the first sentence of 
paragraph (b) to read as follows:

* * * * *

    (b) Products produced for the general public's use that are used in 
a manner that constitutes disposal and that contain recyclable 
materials are not presently subject to regulation if, for each 
hazardous constituent in each recyclable material (i.e., hazardous 
waste) that they contain, they meet the 

[[Page 66465]]
applicable exit levels in appendix X to Part 261 of this chapter. * * *

PART 268--LAND DISPOSAL RESTRICTIONS

    11. The authority citation for part 268 continues to read as 
follows:

    Authority: 42 U.S.C. 6905, 6912(a) 6921, and 6924.
    12. Section 268.2 is amended by adding paragraph (j) to read as 
follows:
* * * * *
    (j) Land treatment means waste is applied onto or incorporated into 
the soil surface.
    13. Section 268.40 is amended by revising the first sentence of 
paragraph (a), revising paragraph (e), and adding paragraph (g) to read 
as follows:

Sec. 268.41  Applicability of treatment standards

    (a) Except as provided in paragraph (g) of this section, a waste 
identified in the table ``Treatment Standards for Hazardous Wastes'' 
may be land disposed only if it meets the requirements found in the 
table. * * *
* * * * *
    (e) Except as provided in paragraph (g) of this section, for all 
characteristic wastes (D001, D002, and D012-D043) that are subject to 
treatment standards in the following table ``Treatment Standards for 
Hazardous Wastes,'' all underlying constituents (as defined in 
Sec. 268.20(i)) must meet Universal Treatment Standards, found in 
Sec. 268.48, Table UTS, prior to land disposal.
* * * * *
    (g) Wastes subject to either the treatment standards described in 
paragraph (a)(1) or (a)(2) of this section or the Universal Treatment 
Standards described in paragraph (e) of this section may be land 
disposed if they meet either of the alternative, risk-based standards 
found in subpart F and G of this part and representing levels at which 
threats to human health or the environment are minimized.
    14. Part 268 is amended by adding Subpart F consisting of 
Sec. 268.60 to read as follows:

Subpart F--Minimize Threat Levels Without Management Requirements

Sec. 268.60  Minimize threat levels.

    (a) Table ``Minimize Threat Levels'' identifies risk-based 
standards representing levels at which threats to human health and the 
environment are minimized. These levels may be used as alternatives to 
waste-specific treatment standards in the table to Sec. 268.40 and to 
the Universal Treatment Standards in the table to Sec. 268.48. 
Nonwastewaters must meet both the total and waste extract levels 
contained in the table of ``Minimize Threat Levels''.
    (b) Wastes identified in the Table to Sec. 268.40 may be land 
disposed if they meet either the requirements in that Table or the 
standards in the Minimize Threat Table for all constituents. 
Characteristic wastes that are subject to the requirement for meeting 
Universal Treatment Standards under Sec. 268.40(e) must also meet the 
requirements of Table UTS or the Minimize Threat Table for all 
underlying hazardous constituents as defined in Sec. 268.2(i).
    (c) Wastes containing either regulated hazardous constituents under 
the Table to Sec. 268.40 or UTS constituents which do not have 
treatment standards listed in the Minimize Threat Table must continue 
to comply with treatment standards for these constituents in the tables 
to Sec. 268.40 or Sec. 268.48 prior to land disposal.

                                    268.60  Table 1.--Minimize Threat Levels                                    
----------------------------------------------------------------------------------------------------------------
                                                            WW standard  (mg/   NWW standard      NWW standard  
             CAS                     Constituent name              l)              (mg/kg)           (mg/l)     
----------------------------------------------------------------------------------------------------------------
83-32-9......................  Acenaphthene...............        31              9500                 5        
67-64-1......................  Acetone....................        16             17000                 6        
75-05-8......................  Acetonitrile...............  ................       920                 0.3      
98-86-2......................  Acetophenone...............        17              1200                 6        
107-05-1.....................  Allyl chloride.............  ................       260          ................
7440-39-3....................  Barium.....................        33              2100                16        
71-43-2......................  Benzene....................  ................       110                 0.0054   
117-81-7.....................  Bis(2-ethylhexyl)phthalate.  ................       230                 0.0011   
75-27-4......................  Bromodichloromethane.......  ................        19                 0.0025   
75-25-2......................  Bromoform (Tribromomethane)  ................       170                 0.018    
71-36-3......................  Butanol....................        16             18000                 6        
88-85-7......................  Butyl-4,6-dinitrophenol, 2-         0.19            770                 0.064    
                                sec- (Dinoseb).                                                                 
85-68-7......................  Butylbenzylphthalate.......       240                87                64        
75-15-0......................  Carbon disulfide...........  ................       330                 6        
56-23-5......................  Carbon tetrachloride.......  ................         9                 0.0016   
126-99-8.....................  Chloro-1,3-butadiene, 2-            0.52            290          ................
                                (Chloroprene).                                                                  
106-47-8.....................  Chloroaniline, p-..........  ................       140                 0.16     
108-90-7.....................  Chlorobenzene..............         2              2500                 1        
124-48-1.....................  Chlorodibromomethane.......  ................        28                 0.0018   
67-66-3......................  Chloroform.................  ................         7                 0.017    
95-57-8......................  Chlorophenol, 2-...........         0.9             100                 0.32     
218-01-9.....................  Chrysene...................         0.1              35                 0.0012   
108-39-4.....................  Cresol, m-.................         8             22000                 3        
95-48-7......................  Cresol, o-.................         8             27000                 3        
106-44-5.....................  Cresol, p-.................         0.84           2600                 0.32     
84-74-2......................  Di-n-butyl phthalate.......       230             90000                25        
117-84-0.....................  Di-n-octyl phthalate.......  ................      4500                 0.1      
95-50-1......................  Dichlorobenzene, 1,2-......        15             50000                 6        
106-46-7.....................  Dichlorobenzene, 1,4-......  ................        64                 0.011    
75-71-8......................  Dichlorodifluoromethane....        15              8100                12        
75-34-3......................  Dichloroethane, 1,1-.......  ................        24                 0.00006  
156-60-5.....................  Dichloroethylene, trans-1,2-        3             14000                 1        
                                .                                                                               
120-83-2.....................  Dichlorophenol, 2,4-.......         0.62            770                 0.18     
94-75-7......................  Dichlorophenoxyacetic acid,         2              3100                 0.6      
                                2,4- (2,4-D).                                                                   
84-66-2......................  Diethyl phthalate..........       190              4500                54        
131-11-3.....................  Dimethyl phthalate.........        78          ................  ................

[[Page 66466]]
                                                                                                                
105-67-9.....................  Dimethylphenol, 2,4-.......         4             11000                 1        
51-28-5......................  Dinitrophenol, 2,4-........         0.27       ................  ................
121-14-2.....................  Dinitrotoluene, 2,4-.......  ................       210                 0.11     
606-20-2.....................  Dinitrotoluene, 2,6-.......  ................        86                 0.064    
122-39-4.....................  Diphenylamine..............        15             12000                 3        
298-04-4.....................  Disulfoton.................  ................        43                13        
72-20-8......................  Endrin.....................         0.073             0.26             32        
141-78-6.....................  Ethyl acetate..............       390            270000               110        
60-29-7......................  Ethyl ether................        27             41000                11        
97-63-2......................  Ethyl methacrylate.........        24              3400                 7        
100-41-4.....................  Ethylbenzene...............        39            550000                 8        
206-44-0.....................  Fluoranthene...............        28              6000                 2        
86-73-7......................  Fluorene...................        22             90000                 3        
76-44-8......................  Heptachlor.................  ................         8          ................
87-68-3......................  Hexachloro-1,3-butadiene...  ................        36                 0.0069   
319-85-7.....................  Hexachlorocyclohexane, beta-        0.00044           0.12              0.00021  
                                 (beta-BHC).                                                                    
58-89-9......................  Hexachlorocyclohexane,       ................         0.1               0.69     
                                gamma- (Lindane).                                                               
77-47-4......................  Hexachlorocyclopentadiene..  ................      1500          ................
67-72-1......................  Hexachloroethane...........  ................        81                 0.033    
78-83-1......................  Isobutyl alcohol...........        39             55000                15        
7439-92-1....................  Lead.......................        30               570                12        
7439-97-6....................  Mercury....................         0.3               0.6               0.14     
67-56-1......................  Methanol...................        78            140000                30        
72-43-5......................  Methoxychlor...............         7                19          ................
74-83-9......................  Methyl bromide                      0.37            500                 0.92     
                                (Bromomethane).                                                                 
74-87-3......................  Methyl chloride              ................        91          ................
                                (Chloromethane).                                                                
78-93-3......................  Methyl ethyl ketone........        78            110000                30        
108-10-1.....................  Methyl isobutyl ketone.....         8             17000                 3        
80-62-6......................  Methyl methacrylate........        28             40000                 8        
298-00-0.....................  Methyl parathion...........         0.66       ................  ................
74-95-3......................  Methylene bromide..........         2              8400                 0.19     
75-09-2......................  Methylene chloride.........  ................       310                 0.015    
91-20-3......................  Naphthalene................        14            120000                 3        
7440-02-0....................  Nickel.....................        11               110                 5        
98-95-3......................  Nitrobenzene...............         0.084            45                 0.032    
56-38-2......................  Parathion..................         3          ................  ................
608-93-5.....................  Pentachlorobenzene.........         5          ................  ................
82-68-8......................  Pentachloronitrobenzene             0.081      ................  ................
                                (PCNB).                                                                         
108-95-2.....................  Phenol.....................        84            160000                32        
298-02-2.....................  Phorate....................         0.11            160          ................
23950-58-5...................  Pronamide..................        21               440                 6        
129-00-0.....................  Pyrene.....................        54             16000                 2        
110-86-1.....................  Pyridine...................         0.16            810                 0.06     
7782-49-2....................  Selenium...................         0.93       ................  ................
7440-22-4....................  Silver.....................       200          ................  ................
95-94-3......................  Tetrachlorobenzene, 1,2,4,5-     0;23               170                 0.032    
                                .                                                                               
630-20-6.....................  Tetrachloroethane, 1,1,1,2-  ................       130                 0.0078   
79-34-5......................  Tetrachloroethane, 1,1,2,2-  ................        29                 0.0077   
127-18-4.....................  Tetrachloroethylene........         2             13000                 0.68     
58-90-2......................  Tetrachlorophenol, 2,3,4,6-         2              6200                 0.58     
7440-28-0....................  Thallium (l)...............  ................         5                 0.019    
108-88-3.....................  Toluene....................        30            180000                13        
76-13-1......................  Trichloro-1,2,2,-                2200          ................  ................
                                trifluoroethane, 1,1,2-.                                                        
120-82-1.....................  Trichlorobenzene, 1,2,4-...         0.69           3500                 1        
71-55-6......................  Trichloroethane, 1,1,1-....        74             48000                 0.054    
79-00-5......................  Trichloroethane, 1,1,2-....  ................        11                 0.0018   
79-01-6......................  Trichloroethylene..........  ................       570                 0.013    
75-69-4......................  Trichlorofluoromethane.....        48             26000                16        
95-95-4......................  Trichlorophenol, 2,4,5-....        18             12000                 4        
88-06-2......................  Trichlorophenol, 2,4,6-....         0.054           120                 0.015    
93-76-5......................  Trichlorophenoxyacetic              2                63                 0.64     
                                acid, 2,4,5- (245-T).                                                           
93-72-1......................  Trichlorophenoxypropionic           1          ................  ................
                                acid, 2,4,5- (Silvex).                                                          
96-18-4......................  Trichloropropane, 1,2,3-...         1               870                 0.34     
7440-62-2....................  Vanadium...................        10               250                 4        
1330-20-7....................  Xylenes (total)............        22            170000               150        
7440-66-6....................  Zinc.......................        99               320                38        
----------------------------------------------------------------------------------------------------------------

                                                                                                
[[Page 66467]]

    15. Part 268 is amended by adding subpart G consisting of 
Secs. 268.70 and 268.71 to read as follows:

Subpart G--Conditioned Minimize Threat Levels with Management 
Requirements

Sec. 268.70  Conditioned Minimize Threat Levels.

    (a) Table ``Conditioned Minimize Threat Levels'' identifies risk-
based standards representing levels at which threats to human health 
and the environment are minimized for wastes which are placed in 
landfills or monofills (but not land application units). These levels 
may be used as alternatives to waste-specific treatment standards in 
the table to Sec. 268.40 and to the Universal Treatment Standards in 
the table to Sec. 268.48 for wastes which comply with the requirements 
of Sec. 268.71. Nonwastewaters must meet both the total and waste 
extract levels contained in the table of ``Minimize Threat Levels''.
    (b) Wastes identified in the Table to Sec. 268.40 may be land 
disposed if they meet, for all hazardous constituents identified in the 
table to Sec. 268.40, either the requirements in that table, the 
standards in the Minimize Threat Table in subpart F, or, if they meet 
the requirements in Sec. 268.71, the standards in the Conditioned 
Minimize Threat Table. Characteristic wastes that are subject to the 
requirement for meeting Universal Treatment Standards under 
Sec. 268.40(e) must also meet the requirements of Table UTS, the 
Minimize Threat Table, or, if they meet the requirements of 
Sec. 268.71, the Conditioned Minimize Threat Table, for all underlying 
hazardous constituents as defined in Sec. 268.2(i).
    (c) Wastes containing either regulated hazardous constituents under 
the Table to Sec. 268.40 or UTS constituents which do not have 
treatment standards listed in the Minimize Threat Table must continue 
to comply with treatment standards for these constituents in the tables 
to Sec. 268.40, Sec. 268.48, or the Minimize Threat Table to Subpart F 
prior to land disposal.

                              268.70  Table 1.--Conditional Minimize Threat Levels                              
----------------------------------------------------------------------------------------------------------------
                                                            WW standard  (mg/   NWW standard      NWW standard  
             CAS                     Constituent name              l)              (mg/kg)           (mg/l)     
----------------------------------------------------------------------------------------------------------------
83-32-9......................  Acenaphthene...............        31             63000                13        
67-64-1......................  Acetone....................        16             39000                21        
75-05-8......................  Acetonitrile...............  ................      2200                 1        
98-86-2......................  Acetophenone...............        17             75000                22        
107-05-1.....................  Allyl chloride.............  ................       260          ................
62-53-3......................  Aniline....................  ................       170                 0.072    
7440-39-3....................  Barium.....................        33             34000                45        
71-43-2......................  Benzene....................  ................       250                 0.023    
39638-32-9...................  Bis (2-chloroisopropyl)      ................        97                 0.0088   
                                ether.                                                                          
117-81-7.....................  Bis(2-ethylhexyl)phthalate.  ................       740                 0.0011   
75-27-4......................  Bromodichloromethane.......  ................       240                 0.011    
75-25-2......................  Bromoform (Tribromomethane)  ................      1600                 0.081    
71-36-3......................  Butanol....................        16             41000                21        
88-85-7......................  Buthl-4,6-dinitrophenol, 2-         0.19           6000                 0.24     
                                sec- (Dinoseb).                                                                 
85-68-7......................  Butylbenzylphthalate.......       240                87                67        
7440-43-9....................  Cadmium....................  ................       110                 0.32     
75-15-0......................  Carbon disulfide...........  ................      3800                24        
56-23-5......................  Carbon tetrachloride.......  ................       130                 0.0077   
126-99-8.....................  Chloro-1,3-butadiene, 2-            0.52           1700          ................
                                (Chloroprene).                                                                  
106-47-8.....................  Chloroaniline, p-..........  ................      5800                 0.56     
108-90-7.....................  Chlorobenzene..............         2             41000                 6        
124-48-1.....................  Chlorodi- bromo- methane...  ................       200                 0.0079   
67-66-3......................  Chloroform.................  ................        76                 0.075    
95-57-8......................  Chlorophenol, 2-...........         0.9            8500                 1        
7440-47-3....................  Chromium...................  ................        16                 2        
218-01-9.....................  Chrysene...................         0.1              35                 0.0012   
108-39-4.....................  Cresol, m-.................         8             30000                11        
95-48-7......................  Cresol, o-.................         8             46000                11        
106-44-5.....................  Cresol, p-.................         0.84           2900                 1        
72-54-8......................  DDD........................  ................         0.26           6800        
50-29-3......................  DDT........................  ................         0.11              0.0054   
84-74-2......................  Di-n-butyl phthalate.......       230             90000                25        
117-84-0.....................  Di-n-octyl phthalate.......  ................     21000                 0.1      
95-50-1......................  Dichlorobenzene, 1,2-......        15            530000                32        
106-46-7.....................  Dichlorobenzene, 1,4-......  ................       650                 0.06     
75-71-8......................  Dichloro- difluoro- methane        15              8400                45        
75-34-3......................  Dichloroethane, 1,1-.......  ................       110                 0.00021  
107-06-2.....................  Dichloroethane, 1,2-.......  ................        59                 0.00021  
156-60-5.....................  Dichloro- ethylene, trans-          3            130000                 4        
                                1,2-.                                                                           
120-83-2.....................  Dichlorophenol, 2,4-.......         0.62            770                 0.76     
94-75-7......................  Dichlorophen- oxyacetic             2             12000                 2        
                                acid, 2,4- (2,4-D).                                                             
78-87-5......................  Dichloropropane, 1,2-......  ................       180                 0.011    
10061-01-5...................  Dichloropropene, cis-1,3-..  ................        65             10000        
10061-02-6...................  Dichloropro- pene, trans-    ................        62             10000        
                                1,3-.                                                                           
84-66-2......................  Diethyl phthalate..........       190             19000               220        
131-11-3.....................  Dimethyl phthalate.........        78          ................  ................
105-67-9.....................  Dimethylphenol, 2,4-.......         4             24000                 5        
51-28-5......................  Dinitrophenol, 2,4-........         0.27            450                 0.37     
121-14-2.....................  Dinitrotoluene, 2,4-.......  ................      1400                 0.39     

[[Page 66468]]
                                                                                                                
606-20-2.....................  Dinitrotoluene, 2,6-.......  ................       420                 0.22     
122-39-4.....................  Diphenyla- mine............        15             12000                15        
298-04-4.....................  Disulfoton.................  ................        58               120        
72-20-8......................  Endrin.....................         0.073            27               770        
141-78-6.....................  Ethyl acetate..............       390            600000               510        
60-29-7......................  Ethyl ether................        27            260000                37        
97-63-2......................  Ethyl methacrylate.........        24            100000                27        
100-41-4.....................  Ethylbenzene...............        39          ................        42        
206-44-0.....................  Fluoranthene...............        28             21000                 2        
86-73-7......................  Fluorene...................        22             90000                 7        
76-44-8......................  Heptachlor.................  ................         8          ................
1024-57-3....................  Heptachlor epoxide.........  ................         0.56             10        
87-68-3......................  Hexachloro-1,3-butadiene...  ................       290                 0.0069   
319-84-6.....................  Hexachloro- cyclohex- ane,   ................         0.18              2        
                                alpha- (alpha-BHC).                                                             
319-85-7.....................  Hexachloro- cyclohex- ane,          0.00044           0.64              0.0009   
                                beta- (beta-BHC).                                                               
58-89-9......................  Hexachloro- cyclohex- ane,   ................         0.75              9        
                                gamma- (Lindane).                                                               
77-47-4......................  Hexachloro- cyclopent-       ................      1500          ................
                                adiene.                                                                         
67-72-1......................  Hexachloroethane...........  ................       890                 0.11     
78-83-1......................  Isobutyl alcohol...........        39            120000                53        
7439-92-1....................  Lead.......................        30              1600                41        
7439-97-6....................  Mercury....................         0.3              39                 0.4      
67-56-1......................  Methanol...................        78            310000               110        
72-43-5......................  Methoxychlor...............         7               280          ................
74-83-9......................  Methyl bromide (Bromo-              0.37            850                 4        
                                methane).                                                                       
74-87-3......................  Methyl chloride (Chloro-     ................        91          ................
                                methane).                                                                       
78-93-3......................  Methyl ethyl ketone........        78            250000               110        
108-10-1.....................  Methyl isobutyl ketone.....         8             38000                11        
80-62-6......................  Methyl methacrylate........        28            100000                33        
298-00-0.....................  Methyl parathion...........         0.66              6               110        
74-95-3......................  Methylene bromide..........         2             21000                 0.19     
75-09-2......................  Methylene chloride.........  ................       720                 0.053    
86-30-6......................  N-Nitrosodi- phenylamine...  ................      3600                 0.24     
91-20-3......................  Naphthalene................        14            430000                15        
7440-02-0....................  Nickel.....................        11              8600                14        
98-95-3......................  Nitrobenzene...............         0.084           520                 0.11     
152-16-9.....................  Octamethyl- pyrophos-        ................        31                 0.37     
                                phoramide.                                                                      
56-38-2......................  Parathion..................         3                19            160000        
608-93-5.....................  Pentachlorobenzene.........         5          ................  ................
82-68-8......................  Pentachloro- nitrobenzene           0.081      ................  ................
                                (PCNB).                                                                         
87-86-5......................  Pentachlorophenol..........  ................        22                 0.0022   
108-95-2.....................  Phenol.....................        84            390000               110        
298-02-2.....................  Phorate....................         0.11            510          ................
23959-58-5...................  Pronamide..................        21            230000                25        
129-00-0.....................  Pyrene.....................        54             16000                 2        
110-86-1.....................  Pyridine...................         0.16            930                 0.21     
94-59-7......................  Safrole....................  ................        28                 0.0044   
7782-49-2....................  Selenium...................         0.93       ................  ................
7440-22-4....................  Silver.....................       200          ................  ................
95-94-3......................  Tetrachloro- benzene,               0.23           1600                 0.032    
                                1,2,4,5-.                                                                       
630.20-6.....................  Tetrachloro- ethane,         ................       370                 0.042    
                                1,1,1,2-.                                                                       
79-34-5......................  Tetrachloro- ethane,         ................        70                 0.0077   
                                1,1,2,2,-.                                                                      
127-18-4.....................  Tetrachloro- ethylene......         2            100000                 3        
53-90-2......................  Tetrachloro- phenol,                2             35000                 2        
                                2,3,4,6-.                                                                       
7440-28-0....................  Thallium (l)...............  ................        33                 0.071    
108-88-3.....................  Toluene....................        30            560000                51        
76-13-1......................  Trichloro-1,2,2,-                2200          ................     12000        
                                trifluoroethane, 1,1,2-.                                                        
120-82-1.....................  Trichlorobenzene, 1,2,4-...         0.69          62000                 3        
71-55-6......................  Trichloroeth- ane, 1,1,1-..  ................       190                 0.0077   
79-01-6......................  Trichloroeth- ylene........  ................      3200                 0.049    
75-69-4......................  Trichlorofluo- romethane...        48            170000                61        
95-95-4......................  Trichlorophenol, 2,4,5-....        18             55000                22        
88-06-2......................  Trichlorophenol, 2,4,6-....         0.054           160                 0.068    
93-76-5......................  Trichlorophenoxyacetic              2               150                 2        
                                acid, 2,4,5-(245-T).                                                            
93-72-1......................  Triclorophen- oxypropionic          1               520                 2        
                                acid, 2,4,5- (Silvex).                                                          
96-18-4......................  Trichloropro- pane, 1,2,3-.         1             14000                 1        
7440-62-2....................  Vanadium...................        10              2700                13        
1330-20-7....................  Xylenes (total)............        22            710000               700        
7440-66-6....................  Zinc.......................        99             51000               130        
----------------------------------------------------------------------------------------------------------------

                                                                                                
[[Page 66469]]

Sec. 268.71  Associated Management Requirements.

    Waste may meet the standards set out in the Conditional Minimize 
Threat Table as an alternative to the treatment standards in the tables 
to Subpart D of this part or the Minimize Threat Table to subpart F of 
this part only if they are placed in a landfill or a monofill as 
defined in 40 CFR 260.10. Waste that is placed in land application 
units must comply with the minimize threat levels set forth in subpart 
F of this part or the treatment standards set forth in subpart D of 
this part.

[FR Doc. 95-29458 Filed 12-20-95; 8:45 am]
BILLING CODE 6560-50-P

Complete official Federal Register PDF

Continue your research in ChatGPT or Claude

Connect Omnilex to search the legal corpus from your AI assistant.